Citrus Sinensis ID: 005471
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 695 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZT07 | 833 | G-type lectin S-receptor- | yes | no | 0.951 | 0.793 | 0.534 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.964 | 0.792 | 0.536 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.939 | 0.768 | 0.465 | 1e-168 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.884 | 0.785 | 0.447 | 1e-159 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.935 | 0.771 | 0.448 | 1e-155 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.952 | 0.772 | 0.429 | 1e-155 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.916 | 0.756 | 0.443 | 1e-155 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.925 | 0.784 | 0.440 | 1e-154 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.925 | 0.759 | 0.442 | 1e-153 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.926 | 0.785 | 0.435 | 1e-149 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 745 bits (1923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/676 (53%), Positives = 481/676 (71%), Gaps = 15/676 (2%)
Query: 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNP 81
S+DTI Q ++DG+VI+S+ K +A GFFS G+S RYVGIWY QISQ T++WVANR++P
Sbjct: 18 SVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHP 77
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNT-VAQLLDTGNLVLVRNDTG 140
INDTSG++ + +GNL ++ + T +W N+S++ T VA L D GNLVL TG
Sbjct: 78 INDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTG 137
Query: 141 ETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLL 200
+ W+SFDHPTDT LP MR G+ ++ GL+R +T+WKS DPGSG+ ++ GFPQ +L
Sbjct: 138 RSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLIL 197
Query: 201 YKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNE 260
YK WR G WTG R+SG PEM +IFN ++++N+DEV G+ D S I R ++NE
Sbjct: 198 YKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNE 257
Query: 261 TGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKYP 320
TG + RFTW RD+RW +W+ P E+CD Y HCGPN C+ + FECTCLPGFEPK+P
Sbjct: 258 TGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFP 317
Query: 321 KEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSN 380
+ WFLRD SGGC +K+ S C + +GF+KL+RMK+PDTS A+VDMN+ LK C+++CL N
Sbjct: 318 RHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTS-DASVDMNITLKECKQRCLKN 376
Query: 381 CSCVAYASASAETNRG-IGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSN 439
CSCVAYASA E+ RG IGCL +HG + D R Y N+GQD ++R + ELA +++
Sbjct: 377 CSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARW----NRNG 432
Query: 440 RARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSERE 499
+ KRR+ LI+++++ V+LL + F + R ER++ R N + + +
Sbjct: 433 LSGKRRVLLILISLIAAVMLLTVILFCVVR-------ERRKSNRHRSSSANFAPVPFDFD 485
Query: 500 ASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR 559
S + +K R ++ F+L+T++AAT+NFS+ NKLG GGFGPVYKG L N EIAVKR
Sbjct: 486 ESFRFEQDKA-RNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKR 544
Query: 560 LSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES 619
LS SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E ML+YE++PNKSLDYFIF E
Sbjct: 545 LSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEE 604
Query: 620 RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
++ LDW KR +I+ GIARG+LYLHQDSRLRIIHRDLKASNILLD +M P+ISDFG AR+
Sbjct: 605 QRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARI 664
Query: 680 FGGEEILAITKRVVGT 695
FGG ++ T RVVGT
Sbjct: 665 FGGNQMEGCTSRVVGT 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 737 bits (1902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/680 (53%), Positives = 486/680 (71%), Gaps = 10/680 (1%)
Query: 18 QISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVAN 77
Q S +TI SQ +KDGDVI S K +A GFFS GNS RYVGIWY Q+S+ T++WVAN
Sbjct: 17 QSCYSDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVAN 76
Query: 78 RNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEA-SAGNTVAQLLDTGNLVLVR 136
R++PINDTSG++ + +GNL ++ T P+W ++ + VA+L D GNLVL+
Sbjct: 77 RDHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLD 136
Query: 137 NDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFP 196
TG++ W+SF+HPT+T+LP M+FG+ +++G++R +T+W+SP DPGSGN ++ ++ GFP
Sbjct: 137 PVTGKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFP 196
Query: 197 QPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARM 256
Q ++YK WR G WTGQR+SG PEMT FIFNI++++N DEV + G+ D S RM
Sbjct: 197 QMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRM 256
Query: 257 ILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
+LNETG LQRF WN RD++WIG+W+AP ++CD Y HCG N C+ T+ FEC+CLPG+E
Sbjct: 257 VLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYE 316
Query: 317 PKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEK 376
PK P++WFLRD S GC R + S C EGF KL+R+K+P+TS A NVDMN+ LK CE++
Sbjct: 317 PKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTS-AVNVDMNITLKECEQR 375
Query: 377 CLSNCSCVAYASASAETNRGI-GCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNN 435
CL NCSCVAYASA E+ G GCL +HG++ DTR Y ++GQD ++R + +ELA N
Sbjct: 376 CLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNG 435
Query: 436 SKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRF 495
+ K+RL LI+++++ V+LL + F R+ R + R R+ F SS F
Sbjct: 436 ASG----KKRLVLILISLIAVVMLLLISFHCYLRKRRQRT-QSNRLRKAPSSFAPSS--F 488
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI 555
++ I + + R ++ FELST+ AT+NF+ NKLG GGFGPVYKG L NG EI
Sbjct: 489 DLEDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEI 548
Query: 556 AVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI 615
AVKRLS +SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E ML+YE++PNKSLDYFI
Sbjct: 549 AVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFI 608
Query: 616 FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
F E ++ LDW KR II GI RG+LYLHQDSRLRIIHRDLKASN+LLD +M P+I+DFG
Sbjct: 609 FHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFG 668
Query: 676 TARVFGGEEILAITKRVVGT 695
AR+FGG +I T RVVGT
Sbjct: 669 LARIFGGNQIEGSTNRVVGT 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 593 bits (1528), Expect = e-168, Method: Compositional matrix adjust.
Identities = 321/689 (46%), Positives = 436/689 (63%), Gaps = 36/689 (5%)
Query: 20 STSIDTISLSQP--IKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVAN 77
S S +T+S S+ I + IVS ++ LGFF PG + Y+GIWY IS+ T +WVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 78 RNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNT-VAQLLDTGNLVL-- 134
R+ P++ + G L ++ +VL +QS PVW N++ + VA+LLD GN VL
Sbjct: 86 RDTPLSSSIGTLKISDSNLVVL---DQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD 142
Query: 135 VRNDTGE-TLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLA 193
+N + LWQSFD PTDT+LP M+ GWD +TG NR++ +WKSPDDP SG+FSF L+
Sbjct: 143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202
Query: 194 GFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMT--RTFIFNITYIDNQDEVYLCDGLNDLS 251
GFP+ L+ + +++R+GPW G RFSG PEM +FN T +++EV +
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFT--TSKEEVTYSFRITKSD 260
Query: 252 TIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTC 311
+R+ ++ +G LQRFTW + W +W AP ++CD Y CG C+ N + C C
Sbjct: 261 VYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSP--VCNC 318
Query: 312 LPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLK 371
+ GF+P+ P+ W LRDGS GC RK S C G+GF++L++MKLPDT+ A+ VD +G+K
Sbjct: 319 IKGFKPRNPQVWGLRDGSDGCVRKTLLS-CGGGDGFVRLKKMKLPDTTTAS-VDRGIGVK 376
Query: 372 ACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAE 431
CE+KCL +C+C A+A+ + G GC+ + G+L D R Y GQDL+VR A +L
Sbjct: 377 ECEQKCLRDCNCTAFANTDIRGS-GSGCVTWTGELFDIRNYAKGGQDLYVRLAATDL--- 432
Query: 432 ALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFL-----RRRLATRIGERKRQRRREL 486
K NR+ K + I V+++L LL FFL +R + Q R
Sbjct: 433 ---EDKRNRSAKIIGSSIGVSVLL---LLSFIIFFLWKRKQKRSILIETPIVDHQLRSRD 486
Query: 487 LFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYK 546
L +N S R IS + N + +++ E + AT+NFS +NKLGQGGFG VYK
Sbjct: 487 LLMNEVVISSRRH--ISRENNTD--DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYK 542
Query: 547 GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606
GKL +GQE+AVKRLS TS QG +E KNEV LIA+LQH NLV+LL CC++ E MLIYE++
Sbjct: 543 GKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYL 602
Query: 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666
N SLD +FD+SR L+W+ RFDII GIARG+LYLHQDSR RIIHRDLKASNILLD+
Sbjct: 603 ENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKY 662
Query: 667 MNPRISDFGTARVFGGEEILAITKRVVGT 695
M P+ISDFG AR+FG +E A T++VVGT
Sbjct: 663 MTPKISDFGMARIFGRDETEANTRKVVGT 691
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 561 bits (1446), Expect = e-159, Method: Compositional matrix adjust.
Identities = 313/699 (44%), Positives = 422/699 (60%), Gaps = 84/699 (12%)
Query: 7 LLNTLLFFQFSQI--STSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWY 64
+L+ L+ FS I + + D + +Q +KDGD IVS + +GFFSPG S RY+GIWY
Sbjct: 6 VLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWY 65
Query: 65 NQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVL-HERNQSTVPVW----QANISEASA 119
+IS T++WVANR++P+ D SG L V+ G+L L ++RN +W + +AS
Sbjct: 66 KKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHI---IWSSSSSPSSQKASL 122
Query: 120 GNTVAQLLDTGNLVLVRN--DTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKS 177
N + Q+LDTGNLV VRN D + +WQS D+P D LP M++G + TGLNR++T+W++
Sbjct: 123 RNPIVQILDTGNLV-VRNSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRA 181
Query: 178 PDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDN 237
DDP +GN++ +D G PQ L K+ V ++R GPW G RF+G P + I+ Y+
Sbjct: 182 IDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFT 241
Query: 238 QDEVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNS 297
++EVY L + S + RM LN G LQR+TW + + W Y +A + CD Y CG
Sbjct: 242 EEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYG 301
Query: 298 NCNLNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGE-GFIKLERMKLP 356
+CN+N + C CL GF K P+ W D S GC R+ C KGE GF+K+ ++KLP
Sbjct: 302 SCNINESPA--CRCLKGFVAKTPQAWVAGDWSEGCVRRVKLD-CGKGEDGFLKISKLKLP 358
Query: 357 DTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAG 416
DT + D N+ L C++ CL NC+C AY+ + G GC+++ GDL D R+Y G
Sbjct: 359 DTRTSW-YDKNMDLNECKKVCLRNCTCSAYSPFDIR-DGGKGCILWFGDLIDIREYNENG 416
Query: 417 QDLFVRANAAELAAEALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIG 476
QDL+VR ++E+ E L +R ++R+
Sbjct: 417 QDLYVRLASSEI--ETL-----------------------------------QRESSRVS 439
Query: 477 ERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKL 536
RK+ E +++ F +L T+ AT FS NKL
Sbjct: 440 SRKQ----------------------------EEEDLELPFLDLDTVSEATSGFSAGNKL 471
Query: 537 GQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596
GQGGFGPVYKG L+ GQE+AVKRLS TS QG+EE KNE+ LIAKLQHRNLVK+LG C++E
Sbjct: 472 GQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDE 531
Query: 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL 656
+E MLIYE+ PNKSLD FIFD+ R++ LDW KR +II GIARG+LYLH+DSRLRIIHRDL
Sbjct: 532 EERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDL 591
Query: 657 KASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
KASN+LLD MN +ISDFG AR GG+E A T RVVGT
Sbjct: 592 KASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGT 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 550 bits (1418), Expect = e-155, Method: Compositional matrix adjust.
Identities = 308/687 (44%), Positives = 421/687 (61%), Gaps = 37/687 (5%)
Query: 20 STSIDTISLSQP--IKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVAN 77
S S +T+S ++ I I+S +I+ LGFF+P +S + Y+GIWY I T +WVAN
Sbjct: 24 SVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVAN 83
Query: 78 RNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVA-QLLDTGNLVLVR 136
R+NP++ ++G L ++ NLV+ + QS PVW NI+ + VA +LLD GN +L R
Sbjct: 84 RDNPLSSSNGTLKIS-GNNLVIFD--QSDRPVWSTNITGGDVRSPVAAELLDNGNFLL-R 139
Query: 137 NDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFP 196
+ LWQSFD PTDT+L M+ GWD++TG NR + +WK+ DDP SG FS L+ + FP
Sbjct: 140 DSNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFP 199
Query: 197 QPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARM 256
+ + + L+R+GPW G RFS P + + +++EV +N + +R+
Sbjct: 200 EFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRL 259
Query: 257 ILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
LN G LQR TW + W W +P + CD Y CG C+ N C C+ GF+
Sbjct: 260 YLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPN--CYCIKGFK 317
Query: 317 PKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEK 376
P + W LRDGS GC RK S C +GF +L+RMKLPDT+ A VD +GLK C+E+
Sbjct: 318 PVNEQAWDLRDGSAGCMRKTRLS-CDGRDGFTRLKRMKLPDTT-ATIVDREIGLKVCKER 375
Query: 377 CLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNS 436
CL +C+C A+A+A N G GC+++ ++ D R Y GQDL+VR AAEL + + N
Sbjct: 376 CLEDCNCTAFANADIR-NGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNE 434
Query: 437 KSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFS 496
K I+ +GV +L L F + +RK++R + N S
Sbjct: 435 K------------IIGSSIGVSILLLLSFVI-----FHFWKRKQKRSITIQTPNVDQVRS 477
Query: 497 E----REASISTKG----NKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK 548
+ + +S +G K+ +++ EL L AT+NFS NKLGQGGFG VYKG+
Sbjct: 478 QDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGR 537
Query: 549 LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608
L +G+EIAVKRLS S QG +E NEV LIAKLQH NLV+LLGCC+++ E MLIYE++ N
Sbjct: 538 LLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLEN 597
Query: 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN 668
SLD +FD++R L+W+KRFDII GIARG+LYLHQDSR RIIHRDLKASN+LLD+ M
Sbjct: 598 LSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMT 657
Query: 669 PRISDFGTARVFGGEEILAITKRVVGT 695
P+ISDFG AR+FG EE A T+RVVGT
Sbjct: 658 PKISDFGMARIFGREETEANTRRVVGT 684
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 549 bits (1415), Expect = e-155, Method: Compositional matrix adjust.
Identities = 303/706 (42%), Positives = 447/706 (63%), Gaps = 44/706 (6%)
Query: 6 LLLNTLLFFQFSQISTSIDTISLSQP--IKDGDVIVSSRKIYALGFFSPGNSVKRYVGIW 63
LL+ ++ +S I+T+S ++ I +VS I+ +GFF + + Y+G+W
Sbjct: 16 LLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFFRTNS--RWYLGMW 73
Query: 64 YNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASA-GNT 122
Y ++S T +WVANR+NP+++ G L ++ NLVL + S PVW N++ +
Sbjct: 74 YKKVSDRTYVWVANRDNPLSNAIGTLKIS-GNNLVLLD--HSNKPVWWTNLTRGNERSPV 130
Query: 123 VAQLLDTGNLVL---VRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPD 179
VA+LL GN V+ ND E LWQSFD+PTDT+LP M+ G++ +TGLNR++T+W+S D
Sbjct: 131 VAELLANGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSD 190
Query: 180 DPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQD 239
DP SGNFS+ L+ P+ L +++ + R+GPW G RFSG PE + +I+N +
Sbjct: 191 DPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNE 250
Query: 240 EVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAE-RCDYYGHCGPNSN 298
EV + + S +R+ L G+ QR TW R W +W++P + +CD Y CGP +
Sbjct: 251 EVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAY 310
Query: 299 CNLNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDT 358
C++N + C C+ GF P+ ++W R +GGC R+ S G+GF ++++MKLP+T
Sbjct: 311 CDVNTSP--VCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC--SGDGFTRMKKMKLPET 366
Query: 359 SVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKY-TNA-- 415
++A VD ++G+K C+++C+S+C+C A+A+A N G GC+++ L D R Y T+A
Sbjct: 367 TMAT-VDRSIGVKECKKRCISDCNCTAFANADIR-NGGSGCVIWTERLEDIRNYATDAID 424
Query: 416 GQDLFVRANAAELAAEALNNSKSNRARKRRLALIIVAIVLGV-ILLGLCFFFL-----RR 469
GQDL+VR AA++A +KR + I+++ +GV +LL L F L +R
Sbjct: 425 GQDLYVRLAAADIA------------KKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKR 472
Query: 470 RLATRIGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDN 529
A+ I QR + L +N S+RE S G + ++++ E+ T++ AT+N
Sbjct: 473 AKASAISIANTQRNQNLP-MNEMVLSSKREFS----GEYKFEELELPLIEMETVVKATEN 527
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
FS+ NKLGQGGFG VYKG+L +G+EIAVKRLS TS QG +E NEV LIA+LQH NLV++
Sbjct: 528 FSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQV 587
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
LGCC+E DE MLIYE++ N SLD ++F ++R+ L+W +RFDI G+ARG+LYLHQDSR
Sbjct: 588 LGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRF 647
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
RIIHRDLK SNILLD+ M P+ISDFG AR+F +E A T +VVGT
Sbjct: 648 RIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGT 693
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 547 bits (1410), Expect = e-155, Method: Compositional matrix adjust.
Identities = 308/694 (44%), Positives = 419/694 (60%), Gaps = 57/694 (8%)
Query: 24 DTISLSQPIKDGD--VIVSSRKIYALGFFSPGNSVKR--YVGIWYNQISQLTLLWVANRN 79
D I+ S PIKD + ++ I+ GFF+P NS R YVGIWY +I T++WVAN++
Sbjct: 31 DRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANKD 90
Query: 80 NPINDTSGVLSVNIQGNLVLHE-RNQSTVPVWQANISEASAGN-TVAQLLDTGNLVLVRN 137
+PINDTSGV+S+ GNL + + RN+ VW N+S A N T QL+D+GNL+L N
Sbjct: 91 SPINDTSGVISIYQDGNLAVTDGRNRL---VWSTNVSVPVAPNATWVQLMDSGNLMLQDN 147
Query: 138 -DTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFP 196
+ GE LW+SF HP D+ +P M G D RTG N +T+W S DDP +GN++ + FP
Sbjct: 148 RNNGEILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFP 207
Query: 197 QPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFI---FNITYIDNQDEVYLCDGLNDLSTI 253
+ L++K++V WR+GPW GQ F G P M FN+ DNQ + + ND S +
Sbjct: 208 ELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNS-DNQGTISMSYA-ND-SFM 264
Query: 254 ARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLP 313
L+ G + + W+ R W P CD YG CG +C+ + C C+
Sbjct: 265 YHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAG--ENPPCKCVK 322
Query: 314 GFEPKYPKEWFLRDGSGGCKRK-----------QGTSTCQKGEGFIKLERMKLPDTSVAA 362
GF PK EW + S GC RK K +GF+KL++MK+P ++ +
Sbjct: 323 GFVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAERS 382
Query: 363 NVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVR 422
+ C + CL NCSC AYA +RGIGC+++ GDL D + + +G DLF+R
Sbjct: 383 EASE----QVCPKVCLDNCSCTAYA-----YDRGIGCMLWSGDLVDMQSFLGSGIDLFIR 433
Query: 423 ANAAELAAEALNNSKSNRARKRRLALIIVAIVLGVILLG-LCFFFLRRRLATRIGERKRQ 481
+EL + LA++I A V+GV+L+ +C R+ R K
Sbjct: 434 VAHSELKTHS------------NLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAK-D 480
Query: 482 RRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGF 541
R EL+F S+ E++ + +I+ ++ FE L +TD+FS NKLGQGGF
Sbjct: 481 RSAELMFKRMEALTSDNESA-----SNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGF 535
Query: 542 GPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601
GPVYKGKL GQEIAVKRLS SGQG+EEL NEV++I+KLQHRNLVKLLGCC+E +E ML
Sbjct: 536 GPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERML 595
Query: 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 661
+YE+MP KSLD ++FD ++++LDWK RF+I+ GI RG+LYLH+DSRL+IIHRDLKASNI
Sbjct: 596 VYEYMPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNI 655
Query: 662 LLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
LLDE +NP+ISDFG AR+F E A T+RVVGT
Sbjct: 656 LLDENLNPKISDFGLARIFRANEDEANTRRVVGT 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 545 bits (1405), Expect = e-154, Method: Compositional matrix adjust.
Identities = 305/692 (44%), Positives = 420/692 (60%), Gaps = 49/692 (7%)
Query: 16 FSQISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWV 75
F +S + + S + D + IVSS + + GFFSP NS RY GIWYN +S T++WV
Sbjct: 20 FLSVSLAQERAFFSGKLNDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYNSVSVQTVIWV 79
Query: 76 ANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANIS-EASAGNTVAQLLDTGNLVL 134
AN++ PIND+SGV+SV+ GNLV+ + + + W N+S +ASA +TVA+LLD+GNLVL
Sbjct: 80 ANKDKPINDSSGVISVSQDGNLVVTDGQRRVL--WSTNVSTQASANSTVAELLDSGNLVL 137
Query: 135 VRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGL-NRYVTAWKSPDDPGSGNFSFTLDLA 193
+ LW+SF +PTD+ LPNM G + R G N +T+WKSP DP G+++ L LA
Sbjct: 138 KEASSDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGSYTAALVLA 197
Query: 194 GFPQPLLYKDDVK---LWRAGPWTGQRFSGTPEM-TRTFIFNITYIDNQDEVYLCDGLND 249
+P+ + ++ +WR+GPW GQ F+G P++ F++ D+ + ND
Sbjct: 198 AYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTNGSVTMSYAND 257
Query: 250 LSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFEC 309
ST+ ++ G + R W+ R W PA CD Y CG + CN C
Sbjct: 258 -STLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFATCNPRKNP--LC 314
Query: 310 TCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQK------GEGFIKLERMKLPDTSVAAN 363
+C+ GF P+ EW + SGGC R+ C++ +GF++L RMKLPD + +
Sbjct: 315 SCIRGFRPRNLIEWNNGNWSGGCTRRVPLQ-CERQNNNGSADGFLRLRRMKLPDFARRSE 373
Query: 364 VDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRA 423
C CL CSC+A A G GC++++G L D+++ + +G DL++R
Sbjct: 374 ASE----PECLRTCLQTCSCIAAAHG-----LGYGCMIWNGSLVDSQELSASGLDLYIRL 424
Query: 424 NAAELAAEALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRR 483
+E+ + + +R LI + G+ ++ C L RR+ + +K+ R
Sbjct: 425 AHSEI-----------KTKDKRPILIGTILAGGIFVVAACVL-LARRIVMKKRAKKKGRD 472
Query: 484 RELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGP 543
E +F ER +++ GNK K ++ FE L AAT+NFS NKLGQGGFGP
Sbjct: 473 AEQIF--------ERVEALA-GGNKGKLK-ELPLFEFQVLAAATNNFSLRNKLGQGGFGP 522
Query: 544 VYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603
VYKGKL GQEIAVKRLS SGQG+EEL NEV++I+KLQHRNLVKLLGCC+ +E ML+Y
Sbjct: 523 VYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVY 582
Query: 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663
EFMP KSLDY++FD R +LLDWK RF+II GI RG+LYLH+DSRLRIIHRDLKASNILL
Sbjct: 583 EFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILL 642
Query: 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
DE + P+ISDFG AR+F G E A T+RVVGT
Sbjct: 643 DENLIPKISDFGLARIFPGNEDEANTRRVVGT 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 544 bits (1401), Expect = e-153, Method: Compositional matrix adjust.
Identities = 300/678 (44%), Positives = 416/678 (61%), Gaps = 35/678 (5%)
Query: 29 SQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGV 88
S I I+S +I+ LGFF+P +S + Y+GIWY I T +WVANR+NP++ ++G
Sbjct: 35 SLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGT 94
Query: 89 LSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVA-QLLDTGNLVL---VRNDTGETLW 144
L ++ NLV+ + QS PVW NI+ + VA +LLD GN VL N LW
Sbjct: 95 LKIS-DNNLVIFD--QSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLW 151
Query: 145 QSFDHPTDTVLPNMRFGWDKRTG-LNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKD 203
QSFD PTDT+L +M+ GWD ++G NR + +WK+ DDP SG+FS L +GFP+ +Y
Sbjct: 152 QSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNK 211
Query: 204 DVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNETGF 263
+ +R+GPW G RFS P M + ++ +N +V +N + + + L+ TG
Sbjct: 212 ESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGL 271
Query: 264 LQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKYPKEW 323
LQR TW + W W +P + CD Y CG C+ N + C C+ GFEP ++
Sbjct: 272 LQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSP--ICNCIKGFEP-MNEQA 328
Query: 324 FLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNCSC 383
LRD S GC RK S C +GF++L++M+LPDT+ +VD +GLK CEE+CL C+C
Sbjct: 329 ALRDDSVGCVRKTKLS-CDGRDGFVRLKKMRLPDTT-ETSVDKGIGLKECEERCLKGCNC 386
Query: 384 VAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSNRARK 443
A+A+ N G GC+++ G L D R Y GQDL+VR A +L + R +
Sbjct: 387 TAFANTDIR-NGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDL--------EDKRIKS 437
Query: 444 RRLALIIVAIVLGVILLGLCFFFLRRR------LATRIGERKRQRRRELLFLNSSTRFSE 497
+++ + + + ++L + F F +R+ + T I + R + + L ++R
Sbjct: 438 KKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASR--- 494
Query: 498 REASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAV 557
S ++K NK +++ E L AT+NFST NKLGQGGFG VYKG L +G+EIAV
Sbjct: 495 ---SYTSKENK-TDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAV 550
Query: 558 KRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617
KRLS S QG +E NEV LIAKLQH NLV+LLGCC+++ E MLIYE++ N SLD +FD
Sbjct: 551 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 610
Query: 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
++R L+W+KRFDII GIARG+LYLHQDSR RIIHRDLKASN+LLD+ M P+ISDFG A
Sbjct: 611 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 670
Query: 678 RVFGGEEILAITKRVVGT 695
R+FG EE A T+RVVGT
Sbjct: 671 RIFGREETEANTRRVVGT 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 530 bits (1365), Expect = e-149, Method: Compositional matrix adjust.
Identities = 301/691 (43%), Positives = 412/691 (59%), Gaps = 47/691 (6%)
Query: 16 FSQISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWV 75
F +S + + S + D + IVSS + + GFFSP NS RY GIWYN I T++WV
Sbjct: 20 FLSVSLAHERALFSGTLNDSETIVSSFRTFRFGFFSPVNSTNRYAGIWYNSIPVQTVIWV 79
Query: 76 ANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANIS-EASAGNTVAQLLDTGNLVL 134
AN++ PIND+SGV+S++ GNLV+ + + + W N+S ASA +TVA+LL++GNLVL
Sbjct: 80 ANKDTPINDSSGVISISEDGNLVVTDGQRRVL--WSTNVSTRASANSTVAELLESGNLVL 137
Query: 135 VRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGL-NRYVTAWKSPDDPGSGNFSFTLDLA 193
+T LW+SF +PTD+ LPNM G + RTG N +T+W +P DP G+++ L LA
Sbjct: 138 KDANTDAYLWESFKYPTDSWLPNMLVGTNARTGGGNITITSWTNPSDPSPGSYTAALVLA 197
Query: 194 GFPQPLLYKDD---VKLWRAGPWTGQRFSGTPEM-TRTFIFNITYIDNQDEVYLCDGLND 249
+P+ ++ ++ +WR+GPW G F+G P++ F++ D+ + ND
Sbjct: 198 PYPELFIFNNNDNNATVWRSGPWNGLMFNGLPDVYPGLFLYRFKVNDDTNGSATMSYAND 257
Query: 250 LSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFEC 309
ST+ + L+ GF R W+ R W PA CD Y CG + CN C
Sbjct: 258 -STLRHLYLDYRGFAIRRDWSEARRNWTLGSQVPATECDIYSRCGQYTTCNPRKNP--HC 314
Query: 310 TCLPGFEPKYPKEWFLRDGSGGCKRK---QGTSTCQKGEG--FIKLERMKLPDTSVAANV 364
+C+ GF P+ EW + SGGC RK Q KG F+KL+RMK+PD + +
Sbjct: 315 SCIKGFRPRNLIEWNNGNWSGGCIRKLPLQCERQNNKGSADRFLKLQRMKMPDFARRSEA 374
Query: 365 DMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRAN 424
C CL +CSC+A+A G GC++++ L D++ + +G DL +R
Sbjct: 375 SE----PECFMTCLQSCSCIAFAHG-----LGYGCMIWNRSLVDSQVLSASGMDLSIRLA 425
Query: 425 AAELAAEALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRR 484
+E + + RR LI ++ G+ ++ C LA RI +KR +++
Sbjct: 426 HSEF-----------KTQDRRPILIGTSLAGGIFVVATCVL-----LARRIVMKKRAKKK 469
Query: 485 ELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPV 544
++ F EA G++E K ++ FE L ATDNFS SNKLGQGGFGPV
Sbjct: 470 GT---DAEQIFKRVEAL--AGGSREKLK-ELPLFEFQVLATATDNFSLSNKLGQGGFGPV 523
Query: 545 YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604
YKG L GQEIAVKRLS SGQG+EEL EV++I+KLQHRNLVKL GCC+ +E ML+YE
Sbjct: 524 YKGMLLEGQEIAVKRLSQASGQGLEELVTEVVVISKLQHRNLVKLFGCCIAGEERMLVYE 583
Query: 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664
FMP KSLD++IFD +LLDW RF+II GI RG+LYLH+DSRLRIIHRDLKASNILLD
Sbjct: 584 FMPKKSLDFYIFDPREAKLLDWNTRFEIINGICRGLLYLHRDSRLRIIHRDLKASNILLD 643
Query: 665 EKMNPRISDFGTARVFGGEEILAITKRVVGT 695
E + P+ISDFG AR+F G E A T+RVVGT
Sbjct: 644 ENLIPKISDFGLARIFPGNEDEANTRRVVGT 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 695 | ||||||
| 356527947 | 838 | PREDICTED: G-type lectin S-receptor-like | 0.971 | 0.805 | 0.535 | 0.0 | |
| 297843970 | 842 | hypothetical protein ARALYDRAFT_471279 [ | 0.958 | 0.790 | 0.535 | 0.0 | |
| 255555113 | 1480 | Negative regulator of the PHO system, pu | 0.949 | 0.445 | 0.556 | 0.0 | |
| 297849512 | 820 | hypothetical protein ARALYDRAFT_471270 [ | 0.972 | 0.824 | 0.530 | 0.0 | |
| 334182463 | 901 | putative S-locus lectin protein kinase [ | 0.951 | 0.733 | 0.534 | 0.0 | |
| 322510108 | 833 | RecName: Full=G-type lectin S-receptor-l | 0.951 | 0.793 | 0.534 | 0.0 | |
| 4008008 | 829 | receptor-like protein kinase [Arabidopsi | 0.943 | 0.791 | 0.533 | 0.0 | |
| 224076623 | 793 | predicted protein [Populus trichocarpa] | 0.920 | 0.807 | 0.529 | 0.0 | |
| 359496273 | 1576 | PREDICTED: G-type lectin S-receptor-like | 0.949 | 0.418 | 0.530 | 0.0 | |
| 334182470 | 845 | putative S-locus lectin protein kinase [ | 0.964 | 0.792 | 0.536 | 0.0 |
| >gi|356527947|ref|XP_003532567.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1997), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/695 (53%), Positives = 500/695 (71%), Gaps = 20/695 (2%)
Query: 5 KLLLNTLLFFQFSQISTSID-TISLSQPIKDGDVIVSS-RKIYALGFFSPGNSVKRYVGI 62
+ L + L+ F S+D TI+++ PI+DGDV+VS+ +ALGFFSP NS RYVGI
Sbjct: 8 EFLSSFLVLMFFYPFCHSLDNTITINHPIRDGDVLVSNGLGNFALGFFSPRNSTNRYVGI 67
Query: 63 WYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTV-PVWQANISEASAGN 121
WYN+IS+ T++WVANR+ P+NDTSGVL ++ GNLVLH+ + ++ PVW +N+S S N
Sbjct: 68 WYNKISEQTVVWVANRDTPLNDTSGVLKISNNGNLVLHDNSTRSLNPVWSSNVSIESTNN 127
Query: 122 TVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDP 181
A+LLDTGNLVL++ + LWQSFD+P +T+LP M+ G +++TGL+R++ +WKSP+DP
Sbjct: 128 ISAKLLDTGNLVLIQTNNNNILWQSFDYPGNTMLPFMKLGLNRKTGLDRFLVSWKSPNDP 187
Query: 182 GSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEV 241
G+GN ++ +D GFPQ LYKD + LWR G WTGQR+SG PEMT FIF + Y++N+ EV
Sbjct: 188 GTGNMTYKIDPTGFPQLFLYKDKIPLWRVGSWTGQRWSGVPEMTPNFIFTVNYVNNESEV 247
Query: 242 YLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNL 301
+ G+ D S +RM+L+E+G + R TW + RW W AP E CD + CG N+NC+
Sbjct: 248 SIMYGVKDPSVFSRMVLDESGHVARSTWQAHEHRWFQIWDAPKEECDNFRRCGSNANCDP 307
Query: 302 NLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVA 361
D FEC CLPGFEPK+ +EWFLRDGSGGC RK STC+ GEGF+++ R+K+PDTS
Sbjct: 308 YHADKFECECLPGFEPKFEREWFLRDGSGGCVRKSNVSTCRSGEGFVEVTRVKVPDTS-K 366
Query: 362 ANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFV 421
A V +G++ C+E+CL +CSCVAY SA+ + G GC+ +HG++ DTR Y GQ LFV
Sbjct: 367 ARVAATIGMRECKERCLRDCSCVAYTSANESS--GSGCVTWHGNMEDTRTYMQVGQSLFV 424
Query: 422 RANAAELAAEALNNSKSNRARKRRLALIIVAIVLGVIL-LGLCFFFLRRRLATRIGERKR 480
R + ELA A + + +K +A++ AI L ++L + ++F++ R R G R+
Sbjct: 425 RVDKLELAKYA-KHPYGSLGKKGMVAVLTAAIFLFLLLAITFVYWFVKTR---RQGIRRD 480
Query: 481 QRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGG 540
++ L + ST E + + + D+ FFELS++ AATDNFS +NKLGQGG
Sbjct: 481 RKYSFRLTFDDSTDLQEFDTT---------KNSDLPFFELSSIAAATDNFSDANKLGQGG 531
Query: 541 FGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600
FG VYKG L NG EIAVKRLS SGQGIEE KNEV+LI+KLQHRNLV++LGCC++ +E M
Sbjct: 532 FGSVYKGLLINGMEIAVKRLSKYSGQGIEEFKNEVVLISKLQHRNLVRILGCCIQGEEKM 591
Query: 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660
LIYE++PNKSLD IFDES++ LDWKKRFDII G+ARG+LYLHQDSRLRIIHRDLKASN
Sbjct: 592 LIYEYLPNKSLDSLIFDESKRSQLDWKKRFDIICGVARGMLYLHQDSRLRIIHRDLKASN 651
Query: 661 ILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+L+D +NP+I+DFG AR+FGG++I A T RVVGT
Sbjct: 652 VLMDSSLNPKIADFGMARIFGGDQIAANTNRVVGT 686
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843970|ref|XP_002889866.1| hypothetical protein ARALYDRAFT_471279 [Arabidopsis lyrata subsp. lyrata] gi|297335708|gb|EFH66125.1| hypothetical protein ARALYDRAFT_471279 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1939), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/681 (53%), Positives = 485/681 (71%), Gaps = 15/681 (2%)
Query: 18 QISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVAN 77
Q S +TI Q +KDGDVI S K +A GFFS GNS RYVGIWY Q+S+ T++WVAN
Sbjct: 17 QSCYSDNTILRRQSLKDGDVIFSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTVVWVAN 76
Query: 78 RNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEA-SAGNTVAQLLDTGNLVLVR 136
R++PINDTSG++ + +GNL ++ T P+W ++ + VA+L D GNLVL+
Sbjct: 77 RDHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLTDLGNLVLLD 136
Query: 137 NDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFP 196
TG++ W+SF+HPT+T+LP M+ G+ ++ G++R +T+W+SP DPGSGN ++ ++ GFP
Sbjct: 137 PVTGKSFWESFNHPTNTLLPFMKLGFTRQNGVDRIMTSWRSPGDPGSGNITYRIERRGFP 196
Query: 197 QPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARM 256
Q ++YK WR G WTGQR+SG PEMT FIFNI+++ N DEV + G+ D S I RM
Sbjct: 197 QMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVSNPDEVSITYGVFDASVITRM 256
Query: 257 ILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
+LNETG LQRF WN RD++WIG+W+AP ++CD Y HCG N C+ TD FEC+CLPG+E
Sbjct: 257 VLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDPTSTDKFECSCLPGYE 316
Query: 317 PKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEK 376
PK P++WFLRD S GC R + S C EGF KL+R+K+P+TS A NVDMN+ LK CE++
Sbjct: 317 PKTPRDWFLRDASDGCTRIKAASICNGKEGFAKLKRVKIPNTS-AVNVDMNITLKECEQR 375
Query: 377 CLSNCSCVAYASASAETNRGI-GCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNN 435
CL NCSCVAYASA E+ G GCL +HG++ DTR Y ++GQD ++R + +EL N
Sbjct: 376 CLKNCSCVAYASAYHESENGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELVRWNGNG 435
Query: 436 SKSNRARKRRLALIIVAIVLGVILLGLCFF-FLRRRLATRIGERKRQRRRELLFLNSSTR 494
S K RL LI+++++ V+LL + F F+R+R R+ +R R+ +
Sbjct: 436 SSG----KMRLFLILISLLAVVMLLMISLFCFIRKR-------RQFKRLRKAPSSFAPCS 484
Query: 495 FSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQE 554
F ++ I + + R ++ FELST+ AAT+NF+ NKLG GGFGPVYKG L NG E
Sbjct: 485 FDLEDSFILEELEDKSRTRELPLFELSTIAAATNNFAFQNKLGAGGFGPVYKGVLQNGME 544
Query: 555 IAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF 614
IAVKRLS +SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E ML+YE++PNKSLDYF
Sbjct: 545 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 604
Query: 615 IFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674
IF++ + LDW KR II GIARG+LYLHQDSRLRIIHRDLKASN+LLD +M P+I+DF
Sbjct: 605 IFNDEHRVELDWPKRMGIIRGIARGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 664
Query: 675 GTARVFGGEEILAITKRVVGT 695
G AR+FGG +I T RVVGT
Sbjct: 665 GLARIFGGNQIEGSTNRVVGT 685
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555113|ref|XP_002518594.1| Negative regulator of the PHO system, putative [Ricinus communis] gi|223542439|gb|EEF43981.1| Negative regulator of the PHO system, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 749 bits (1935), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/677 (55%), Positives = 489/677 (72%), Gaps = 17/677 (2%)
Query: 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSP-GNSVKRYVGIWYNQISQLTLLWVANRNNP 81
IDTI+ IKDGD++VSS + +ALGFFSP GN +RYVGIWYN++++ T++WVANR+NP
Sbjct: 665 IDTITSRNSIKDGDILVSSGQGFALGFFSPAGNPARRYVGIWYNKVTEKTVVWVANRDNP 724
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEAS--AGNTVAQLLDTGNLVLVRNDT 139
INDTSGVL++N +GNLVL+ NQ T+PVW AN+S +S N++ QLL+TGNL+L++ D+
Sbjct: 725 INDTSGVLAINSKGNLVLYGHNQ-TIPVWSANVSLSSLNKNNSIVQLLETGNLLLLQQDS 783
Query: 140 GETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPL 199
LWQSFDHPTDT+LP M+ G D++TG N ++++WKS DDPG+GN + +D G+PQ
Sbjct: 784 NTVLWQSFDHPTDTMLPYMKLGLDRKTGKNWFLSSWKSKDDPGTGNIFYRIDPTGYPQLF 843
Query: 200 LYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTI-ARMIL 258
LYK ++ WR GPWTGQR+SG PEMTR +IFN ++++ +DEV++ GL +TI +RM++
Sbjct: 844 LYKGSLRWWRGGPWTGQRWSGVPEMTRNYIFNASFVNTEDEVFITYGLTTNATIFSRMMV 903
Query: 259 NETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPK 318
NE+G +QR TWN+RD RWIG+W+AP E CD YG CG NSNC+ +D F C CLPGF PK
Sbjct: 904 NESGTVQRATWNDRDGRWIGFWSAPKEPCDNYGECGANSNCDPYDSDNFICKCLPGFYPK 963
Query: 319 YPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCL 378
P W+LRDGS GC RK G STC+ GEGF++L +K+PDT+ A V+M+L LKACE++CL
Sbjct: 964 SPGSWYLRDGSDGCNRKAGVSTCRDGEGFVRLALVKVPDTA-TARVNMSLSLKACEQECL 1022
Query: 379 SNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKS 438
NCSC AY SA GIGCL ++GDL D R Y++ GQD++VR +A ELA + S
Sbjct: 1023 RNCSCTAYTSA---YESGIGCLTWYGDLVDIRTYSSVGQDIYVRVDAVELAKYGKSKS-- 1077
Query: 439 NRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSER 498
R K A++I ++ + L + L ++ R+ + F S T +
Sbjct: 1078 -RLTKGVQAILIASVSVASFLAVFVVYCLVKKRRKARDRRRSKSL--FSFTQSPTDLGDS 1134
Query: 499 EASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVK 558
KGN E D+ FF+LS + AT NFS NKLG+GGFG VYKG L G+EIAVK
Sbjct: 1135 HGG---KGNDEDGIPDLPFFDLSAIATATSNFSDDNKLGEGGFGSVYKGLLHGGKEIAVK 1191
Query: 559 RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE 618
RLS SGQG EE KNEV LIAKLQHRNLV+++G C++E E MLIYE++PNKSLD FIFDE
Sbjct: 1192 RLSRYSGQGTEEFKNEVALIAKLQHRNLVRMIGYCVQEPEKMLIYEYLPNKSLDSFIFDE 1251
Query: 619 SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+++ LLDW R II GIARG+LYLHQDSRLRIIHRDLKASN+LLD MNP+ISDFG AR
Sbjct: 1252 AKRSLLDWSIRHSIICGIARGILYLHQDSRLRIIHRDLKASNVLLDASMNPKISDFGMAR 1311
Query: 679 VFGGEEILAITKRVVGT 695
+ G ++I A T RVVGT
Sbjct: 1312 IVGVDQIEANTNRVVGT 1328
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297849512|ref|XP_002892637.1| hypothetical protein ARALYDRAFT_471270 [Arabidopsis lyrata subsp. lyrata] gi|297338479|gb|EFH68896.1| hypothetical protein ARALYDRAFT_471270 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/692 (53%), Positives = 486/692 (70%), Gaps = 16/692 (2%)
Query: 7 LLNTLLFFQFSQISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQ 66
++ + FF Q S+DTI Q ++DGDVI S K +A GFFS G+S RYVGIWY Q
Sbjct: 3 IIVIIFFFSLFQSCISVDTIMRRQSLRDGDVIHSVGKRFAFGFFSLGDSKLRYVGIWYAQ 62
Query: 67 ISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNT-VAQ 125
I+Q T++WVANR++PINDTSG++ + + NL ++ + T P+W N+S++ T VA+
Sbjct: 63 ITQQTIVWVANRDHPINDTSGLIKFSNRCNLCVYASDNGTEPIWSTNVSDSILETTLVAR 122
Query: 126 LLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGN 185
L D GNLVL+ TG + W+SFDHPTDT LP MR G+ ++ GL+R++T+WKS DPG G+
Sbjct: 123 LSDLGNLVLLDPVTGRSFWESFDHPTDTFLPFMRMGFTRKDGLDRFLTSWKSHGDPGCGD 182
Query: 186 FSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCD 245
+ ++ GFPQ +LYK V WR G WTG R+SG PEM +IFN ++++N+DEV
Sbjct: 183 LTLRMERRGFPQLILYKGRVPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTY 242
Query: 246 GLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTD 305
G+ D S I R ++NETG + RFTW RD+RW +W+ P E+CD Y HCGPN C+ +
Sbjct: 243 GVTDDSVITRTMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDPPSSK 302
Query: 306 GFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVD 365
FECTCLPGFEPK+P+ WFLRD SGGC +K+G S C + +GF+KL+RMK+PDTS A+VD
Sbjct: 303 TFECTCLPGFEPKFPRHWFLRDSSGGCTKKKGASRCSEKDGFVKLKRMKIPDTS-DASVD 361
Query: 366 MNLGLKACEEKCLSNCSCVAYASASAETNRG-IGCLMYHGDLNDTRKYTNAGQDLFVRAN 424
MN+ K C+++CL NCSCVAYASA E+ RG IGCL +H + D R Y ++GQD ++R +
Sbjct: 362 MNITFKECKQRCLRNCSCVAYASAYHESKRGAIGCLTWHSGMLDARTYLSSGQDFYIRVD 421
Query: 425 AAELAAEALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRR 484
+L AL N K + KRR+ LI++++V V+LL + F + R ER++ R
Sbjct: 422 KEKL---ALWNRKG-LSGKRRVLLILISLVAAVMLLTVILFCVVR-------ERRKSNRH 470
Query: 485 ELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPV 544
N + E S + +K R ++ FF+L+T+ AA +NFS+ NKLG GGFGPV
Sbjct: 471 RSSSANFVPVPFDFEESFRFEQDKA-RNRELPFFDLNTIAAAANNFSSQNKLGAGGFGPV 529
Query: 545 YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604
YKG L NG EIAVKRLS SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E MLIYE
Sbjct: 530 YKGVLQNGMEIAVKRLSKNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLIYE 589
Query: 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664
++PNKSLDYFIF E ++ LDW KR +II GIARG+LYLHQDS+LRIIHRDLKASNILLD
Sbjct: 590 YLPNKSLDYFIFHEEQRAELDWPKRMEIIRGIARGILYLHQDSKLRIIHRDLKASNILLD 649
Query: 665 EKMNPRISDFGTARVFGGEEILAITKR-VVGT 695
+M P+ISDFG AR+FGG +I T R + GT
Sbjct: 650 SEMIPKISDFGMARIFGGNQIEGCTSRWIYGT 681
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334182463|ref|NP_172601.2| putative S-locus lectin protein kinase [Arabidopsis thaliana] gi|332190599|gb|AEE28720.1| putative S-locus lectin protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/676 (53%), Positives = 481/676 (71%), Gaps = 15/676 (2%)
Query: 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNP 81
S+DTI Q ++DG+VI+S+ K +A GFFS G+S RYVGIWY QISQ T++WVANR++P
Sbjct: 86 SVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHP 145
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNT-VAQLLDTGNLVLVRNDTG 140
INDTSG++ + +GNL ++ + T +W N+S++ T VA L D GNLVL TG
Sbjct: 146 INDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTG 205
Query: 141 ETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLL 200
+ W+SFDHPTDT LP MR G+ ++ GL+R +T+WKS DPGSG+ ++ GFPQ +L
Sbjct: 206 RSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLIL 265
Query: 201 YKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNE 260
YK WR G WTG R+SG PEM +IFN ++++N+DEV G+ D S I R ++NE
Sbjct: 266 YKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNE 325
Query: 261 TGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKYP 320
TG + RFTW RD+RW +W+ P E+CD Y HCGPN C+ + FECTCLPGFEPK+P
Sbjct: 326 TGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFP 385
Query: 321 KEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSN 380
+ WFLRD SGGC +K+ S C + +GF+KL+RMK+PDTS A+VDMN+ LK C+++CL N
Sbjct: 386 RHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTS-DASVDMNITLKECKQRCLKN 444
Query: 381 CSCVAYASASAETNRG-IGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSN 439
CSCVAYASA E+ RG IGCL +HG + D R Y N+GQD ++R + ELA +++
Sbjct: 445 CSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARW----NRNG 500
Query: 440 RARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSERE 499
+ KRR+ LI+++++ V+LL + F + R ER++ R N + + +
Sbjct: 501 LSGKRRVLLILISLIAAVMLLTVILFCVVR-------ERRKSNRHRSSSANFAPVPFDFD 553
Query: 500 ASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR 559
S + +K R ++ F+L+T++AAT+NFS+ NKLG GGFGPVYKG L N EIAVKR
Sbjct: 554 ESFRFEQDKA-RNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKR 612
Query: 560 LSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES 619
LS SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E ML+YE++PNKSLDYFIF E
Sbjct: 613 LSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEE 672
Query: 620 RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
++ LDW KR +I+ GIARG+LYLHQDSRLRIIHRDLKASNILLD +M P+ISDFG AR+
Sbjct: 673 QRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARI 732
Query: 680 FGGEEILAITKRVVGT 695
FGG ++ T RVVGT
Sbjct: 733 FGGNQMEGCTSRVVGT 748
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|322510108|sp|Q9ZT07.3|RKS1_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase RKS1; AltName: Full=Receptor-like protein kinase 1; Flags: Precursor | Back alignment and taxonomy information |
|---|
Score = 745 bits (1923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/676 (53%), Positives = 481/676 (71%), Gaps = 15/676 (2%)
Query: 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNP 81
S+DTI Q ++DG+VI+S+ K +A GFFS G+S RYVGIWY QISQ T++WVANR++P
Sbjct: 18 SVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHP 77
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNT-VAQLLDTGNLVLVRNDTG 140
INDTSG++ + +GNL ++ + T +W N+S++ T VA L D GNLVL TG
Sbjct: 78 INDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTG 137
Query: 141 ETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLL 200
+ W+SFDHPTDT LP MR G+ ++ GL+R +T+WKS DPGSG+ ++ GFPQ +L
Sbjct: 138 RSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLIL 197
Query: 201 YKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNE 260
YK WR G WTG R+SG PEM +IFN ++++N+DEV G+ D S I R ++NE
Sbjct: 198 YKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNE 257
Query: 261 TGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKYP 320
TG + RFTW RD+RW +W+ P E+CD Y HCGPN C+ + FECTCLPGFEPK+P
Sbjct: 258 TGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFP 317
Query: 321 KEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSN 380
+ WFLRD SGGC +K+ S C + +GF+KL+RMK+PDTS A+VDMN+ LK C+++CL N
Sbjct: 318 RHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTS-DASVDMNITLKECKQRCLKN 376
Query: 381 CSCVAYASASAETNRG-IGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSN 439
CSCVAYASA E+ RG IGCL +HG + D R Y N+GQD ++R + ELA +++
Sbjct: 377 CSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARW----NRNG 432
Query: 440 RARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSERE 499
+ KRR+ LI+++++ V+LL + F + R ER++ R N + + +
Sbjct: 433 LSGKRRVLLILISLIAAVMLLTVILFCVVR-------ERRKSNRHRSSSANFAPVPFDFD 485
Query: 500 ASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR 559
S + +K R ++ F+L+T++AAT+NFS+ NKLG GGFGPVYKG L N EIAVKR
Sbjct: 486 ESFRFEQDKA-RNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKR 544
Query: 560 LSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES 619
LS SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E ML+YE++PNKSLDYFIF E
Sbjct: 545 LSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEE 604
Query: 620 RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
++ LDW KR +I+ GIARG+LYLHQDSRLRIIHRDLKASNILLD +M P+ISDFG AR+
Sbjct: 605 QRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARI 664
Query: 680 FGGEEILAITKRVVGT 695
FGG ++ T RVVGT
Sbjct: 665 FGGNQMEGCTSRVVGT 680
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4008008|gb|AAC95352.1| receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/677 (53%), Positives = 481/677 (71%), Gaps = 21/677 (3%)
Query: 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNP 81
S+DTI Q ++DG+VI+S+ K +A GFFS G+S RYVGIWY QISQ T++WVANR++P
Sbjct: 18 SVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHP 77
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNT-VAQLLDTGNLVLVRNDTG 140
INDTSG++ + +GNL ++ + T +W N+S++ T VA L D GNLVL TG
Sbjct: 78 INDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTG 137
Query: 141 ETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLL 200
+ W+SFDHPTDT LP MR G+ ++ GL+R +T+WKS DPGSG+ ++ GFPQ +L
Sbjct: 138 RSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLIL 197
Query: 201 YKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNE 260
YK WR G WTG R+SG PEM +IFN ++++N+DEV G+ D S I R ++NE
Sbjct: 198 YKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNE 257
Query: 261 TGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKYP 320
TG + RFTW RD+RW +W+ P E+CD Y HCGPN C+ + FECTCLPGFEPK+P
Sbjct: 258 TGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFP 317
Query: 321 KEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSN 380
+ WFLRD SGGC +K+ S C + +GF+KL+RMK+PDTS A+VDMN+ LK C+++CL N
Sbjct: 318 RHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTS-DASVDMNITLKECKQRCLKN 376
Query: 381 CSCVAYASASAETNRG-IGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSN 439
CSCVAYASA E+ RG IGCL +HG + D R Y N+GQD ++R + ELA +++
Sbjct: 377 CSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARW----NRNG 432
Query: 440 RARKRRLALIIVAIVLGVILLGLCFF-FLRRRLATRIGERKRQRRRELLFLNSSTRFSER 498
+ KRR+ LI+++++ V+LL + F +R R + + + R + + S RF +
Sbjct: 433 LSGKRRVLLILISLIAAVMLLTVILFCVVRERRSIEVFGKLRPVPFD---FDESFRFEQD 489
Query: 499 EASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVK 558
+A R ++ F+L+T++AAT+NFS+ NKLG GGFGPVYKG L N EIAVK
Sbjct: 490 KA----------RNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVK 539
Query: 559 RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE 618
RLS SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E ML+YE++PNKSLDYFIF E
Sbjct: 540 RLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHE 599
Query: 619 SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
++ LDW KR +I+ GIARG+LYLHQDSRLRIIHRDLKASNILLD +M P+ISDFG AR
Sbjct: 600 EQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMAR 659
Query: 679 VFGGEEILAITKRVVGT 695
+FGG ++ T RVVGT
Sbjct: 660 IFGGNQMEGCTSRVVGT 676
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076623|ref|XP_002304971.1| predicted protein [Populus trichocarpa] gi|222847935|gb|EEE85482.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1913), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/697 (52%), Positives = 475/697 (68%), Gaps = 57/697 (8%)
Query: 1 MNPAKLLLNTLLFFQFSQISTSIDTISLSQPIKDGDVIVSS-RKIYALGFFSPG-NSVKR 58
MNP + L+ L F SID I+ +Q IKDGDV+VSS + Y LGFFS G + +R
Sbjct: 1 MNPIERFLSALFLFLVFSSCLSIDIIAPNQSIKDGDVLVSSGSQSYELGFFSSGIDYTRR 60
Query: 59 YVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEAS 118
YVGIWY ++S+ T++WVANR+NPIN TSGVL++N QGNLV++E N+S+VPVW N++ +S
Sbjct: 61 YVGIWYRKVSERTVVWVANRDNPINGTSGVLAINKQGNLVIYENNRSSVPVWSTNVAASS 120
Query: 119 AGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSP 178
N AQL D+GNLVLV+ D+ LWQSFDH TDT+LP M+ G D + GLNR +++WKS
Sbjct: 121 MTNCTAQLQDSGNLVLVQQDSKRVLWQSFDHATDTLLPGMKLGLDLKIGLNRSLSSWKSK 180
Query: 179 DDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQ 238
DDPG+G +D +GFPQ LYK + WR GPWTG R+SG P+M T+IF T++ +
Sbjct: 181 DDPGTGTIVLGIDPSGFPQLFLYKSQTRRWRVGPWTGLRWSGVPQMATTYIFGNTFVSSV 240
Query: 239 DEVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSN 298
DEV +N+ S I+RM++NE+G +QR TWN+ D++W G W AP E CD YG CGPNSN
Sbjct: 241 DEVSYSYSINNPSLISRMVVNESGVVQRLTWNDPDKQWFGIWYAPKEPCDTYGQCGPNSN 300
Query: 299 CNLNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDT 358
C+ T+ F C CLPGFEPK P+EW+LR+GS GC RK STC GEGF+KL R+K+PDT
Sbjct: 301 CDPYQTNNFMCKCLPGFEPKSPQEWYLREGSRGCVRKPNVSTCHGGEGFVKLARVKVPDT 360
Query: 359 SVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQD 418
S+A+ +M+L LK C +CL NCSC AYASA RG+GCL ++GDL DTR +++ GQ+
Sbjct: 361 SMAS-ANMSLRLKECARECLRNCSCTAYASAD---ERGLGCLRWYGDLVDTRTFSDVGQE 416
Query: 419 LFVRANAAELAAEALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGER 478
+++R + AEL EA+N +L+ C F R L +
Sbjct: 417 IYIRVDRAEL--EAMN-------------------WFNKVLIVFCRCFGWRDLPIK---- 451
Query: 479 KRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQ 538
F E S D+ F+LS + AAT+NFS +NKLG+
Sbjct: 452 ---------------EFEEGTTS-----------SDLPLFDLSVVAAATNNFSGANKLGE 485
Query: 539 GGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598
GGFG VYKG L +G+EIAVKRL+ SGQGI E +NEV LIAKLQHRNLV++LGCC++ E
Sbjct: 486 GGFGSVYKGLLHDGKEIAVKRLAKYSGQGINEFRNEVELIAKLQHRNLVRILGCCIQGRE 545
Query: 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658
MLIYE++PNKSLD FIF+E R+ LDW R +II GIARG+LYLH+DSRLRIIHRDLKA
Sbjct: 546 KMLIYEYLPNKSLDSFIFNEPRRSQLDWSTRHNIICGIARGILYLHEDSRLRIIHRDLKA 605
Query: 659 SNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
SN+LLD MNP+ISDFG AR+FG ++I A T RVVGT
Sbjct: 606 SNVLLDASMNPKISDFGMARIFGVDQIEANTNRVVGT 642
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496273|ref|XP_002270694.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/677 (53%), Positives = 479/677 (70%), Gaps = 17/677 (2%)
Query: 19 ISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANR 78
I S DTI+ +QP +DGD++VS + +ALGFFSP NS RY+G+WYN I + T++WV NR
Sbjct: 765 ICISTDTITPNQPFRDGDLLVSKQSRFALGFFSPRNSTLRYIGVWYNTIREQTVVWVLNR 824
Query: 79 NNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRND 138
++PINDTSGVLS+N GNL+LH N VW N+S +S TVAQLLDTGNLVL+ N
Sbjct: 825 DDPINDTSGVLSINTSGNLLLHRGNTH---VWSTNVSISSVNPTVAQLLDTGNLVLIHNG 881
Query: 139 TGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQP 198
+WQ FD+PTD+ LP M+ G ++RTG NR++T+WKSP DPG+G +S +++G PQ
Sbjct: 882 DKRVVWQGFDYPTDSWLPYMKLGLNRRTGFNRFLTSWKSPTDPGTGKYSLGFNVSGSPQI 941
Query: 199 LLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMIL 258
LY+ LWR G W G R+SG P M I +++NQDE+ + + S + R+ +
Sbjct: 942 FLYQGSEPLWRTGNWNGLRWSGLPVMKYIIQHKIIFLNNQDEISEMFTMANASFLERVTV 1001
Query: 259 NETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPK 318
+ G+LQR W R+ +W ++TAP +RCD YG CGPNSNC+ + + FECTCL GFEPK
Sbjct: 1002 DHDGYLQRNMWQEREDKWFSFYTAPRDRCDRYGLCGPNSNCDDSQAE-FECTCLAGFEPK 1060
Query: 319 YPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCL 378
P++WFL+DGS GC RK+G C GEGF+K+ R K PDTSVA V+MN+ ++AC E+CL
Sbjct: 1061 SPRDWFLKDGSAGCLRKEGAKVCGNGEGFVKVGRAKPPDTSVA-RVNMNISMEACREECL 1119
Query: 379 SNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKS 438
CSC YA+A+ + G GCL +HGDL DTR + GQDL+VR +A L A SK
Sbjct: 1120 KECSCSGYAAANV-SGSGSGCLSWHGDLVDTRVFPEGGQDLYVRVDAITLGMLA---SKG 1175
Query: 439 NRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSER 498
A+K +A+++V + ++LL F+FLR+++ R + R +L S E
Sbjct: 1176 FLAKKGMMAVLVVGAAVIMVLLVSSFWFLRKKMKGRQNKMLYNSRPGATWLQDSLGAKEH 1235
Query: 499 EASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVK 558
+ S + N E++ FF+L+T++AAT+NFS N+LG+GGFG VYKG+L NGQEIAVK
Sbjct: 1236 DESTT---NSELQ-----FFDLNTIVAATNNFSFENELGRGGFGSVYKGQLYNGQEIAVK 1287
Query: 559 RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE 618
+LS SGQG EE KNEV LIAKLQH NLV+LLGCC++E+E ML+YE++PNKSLD FIFDE
Sbjct: 1288 KLSKDSGQGKEEFKNEVTLIAKLQHVNLVRLLGCCIQEEEKMLVYEYLPNKSLDSFIFDE 1347
Query: 619 SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+++ LLDW+KRF+II+GIARG+LYLH+DSRLRIIHRDLKASN+LLD +M P+ISDFG AR
Sbjct: 1348 TKRSLLDWRKRFEIIVGIARGILYLHEDSRLRIIHRDLKASNVLLDAEMLPKISDFGLAR 1407
Query: 679 VFGGEEILAITKRVVGT 695
+FGG ++ T RVVGT
Sbjct: 1408 IFGGNQMEGNTNRVVGT 1424
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334182470|ref|NP_172608.2| putative S-locus lectin protein kinase [Arabidopsis thaliana] gi|322510094|sp|Q9LPZ3.3|Y1141_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410; Flags: Precursor gi|332190612|gb|AEE28733.1| putative S-locus lectin protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/680 (53%), Positives = 486/680 (71%), Gaps = 10/680 (1%)
Query: 18 QISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVAN 77
Q S +TI SQ +KDGDVI S K +A GFFS GNS RYVGIWY Q+S+ T++WVAN
Sbjct: 17 QSCYSDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVAN 76
Query: 78 RNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEA-SAGNTVAQLLDTGNLVLVR 136
R++PINDTSG++ + +GNL ++ T P+W ++ + VA+L D GNLVL+
Sbjct: 77 RDHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLD 136
Query: 137 NDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFP 196
TG++ W+SF+HPT+T+LP M+FG+ +++G++R +T+W+SP DPGSGN ++ ++ GFP
Sbjct: 137 PVTGKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFP 196
Query: 197 QPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARM 256
Q ++YK WR G WTGQR+SG PEMT FIFNI++++N DEV + G+ D S RM
Sbjct: 197 QMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRM 256
Query: 257 ILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
+LNETG LQRF WN RD++WIG+W+AP ++CD Y HCG N C+ T+ FEC+CLPG+E
Sbjct: 257 VLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYE 316
Query: 317 PKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEK 376
PK P++WFLRD S GC R + S C EGF KL+R+K+P+TS A NVDMN+ LK CE++
Sbjct: 317 PKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTS-AVNVDMNITLKECEQR 375
Query: 377 CLSNCSCVAYASASAETNRGI-GCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNN 435
CL NCSCVAYASA E+ G GCL +HG++ DTR Y ++GQD ++R + +ELA N
Sbjct: 376 CLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNG 435
Query: 436 SKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRF 495
+ K+RL LI+++++ V+LL + F R+ R + R R+ F SS F
Sbjct: 436 ASG----KKRLVLILISLIAVVMLLLISFHCYLRKRRQRT-QSNRLRKAPSSFAPSS--F 488
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI 555
++ I + + R ++ FELST+ AT+NF+ NKLG GGFGPVYKG L NG EI
Sbjct: 489 DLEDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEI 548
Query: 556 AVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI 615
AVKRLS +SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E ML+YE++PNKSLDYFI
Sbjct: 549 AVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFI 608
Query: 616 FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
F E ++ LDW KR II GI RG+LYLHQDSRLRIIHRDLKASN+LLD +M P+I+DFG
Sbjct: 609 FHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFG 668
Query: 676 TARVFGGEEILAITKRVVGT 695
AR+FGG +I T RVVGT
Sbjct: 669 LARIFGGNQIEGSTNRVVGT 688
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 695 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.576 | 0.471 | 0.431 | 5.5e-156 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.585 | 0.519 | 0.422 | 6.3e-155 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.582 | 0.480 | 0.409 | 1.1e-148 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.585 | 0.480 | 0.398 | 5.4e-145 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.582 | 0.496 | 0.359 | 2.4e-138 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.579 | 0.485 | 0.362 | 1.9e-136 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.575 | 0.471 | 0.347 | 4.6e-135 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.581 | 0.479 | 0.349 | 3.7e-131 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.256 | 0.220 | 0.688 | 8.9e-128 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.284 | 0.246 | 0.671 | 1.9e-127 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 5.5e-156, Sum P(2) = 5.5e-156
Identities = 181/419 (43%), Positives = 259/419 (61%)
Query: 12 LFFQFSQISTSIDTISLSQP--IKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQ 69
L F S S +T+S S+ I + IVS ++ LGFF PG + Y+GIWY IS+
Sbjct: 18 LLILFPAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISK 77
Query: 70 LTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNT-VAQLLD 128
T +WVANR+ P++ + G L ++ NLV+ + QS PVW N++ + VA+LLD
Sbjct: 78 RTYVWVANRDTPLSSSIGTLKIS-DSNLVVLD--QSDTPVWSTNLTGGDVRSPLVAELLD 134
Query: 129 TGNLVL--VRNDTGE-TLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGN 185
GN VL +N + LWQSFD PTDT+LP M+ GWD +TG NR++ +WKSPDDP SG+
Sbjct: 135 NGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGD 194
Query: 186 FSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMT--RTFIFNITYIDNQDEVYL 243
FSF L+ GFP+ L+ + +++R+GPW G RFSG PEM +FN T +++EV
Sbjct: 195 FSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFT--TSKEEVTY 252
Query: 244 CDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNL 303
+ +R+ ++ +G LQRFTW + W +W AP ++CD Y CG C+ N
Sbjct: 253 SFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNT 312
Query: 304 TDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAAN 363
+ C C+ GF+P+ P+ W LRDGS GC RK S C G+GF++L++MKLPDT+ A+
Sbjct: 313 SP--VCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLS-CGGGDGFVRLKKMKLPDTTTAS- 368
Query: 364 VDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVR 422
VD +G+K CE+KCL +C+C A+A+ + G GC+ + G+L D R Y GQDL+VR
Sbjct: 369 VDRGIGVKECEQKCLRDCNCTAFANTDIRGS-GSGCVTWTGELFDIRNYAKGGQDLYVR 426
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 864 (309.2 bits), Expect = 6.3e-155, Sum P(2) = 6.3e-155
Identities = 180/426 (42%), Positives = 258/426 (60%)
Query: 7 LLNTLLFFQFSQI--STSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWY 64
+L+ L+ FS I + + D + +Q +KDGD IVS + +GFFSPG S RY+GIWY
Sbjct: 6 VLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWY 65
Query: 65 NQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVL-HERNQSTVPVWQANIS----EASA 119
+IS T++WVANR++P+ D SG L V+ G+L L ++RN +W ++ S +AS
Sbjct: 66 KKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHI---IWSSSSSPSSQKASL 122
Query: 120 GNTVAQLLDTGNLVLVRN--DTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKS 177
N + Q+LDTGNLV VRN D + +WQS D+P D LP M++G + TGLNR++T+W++
Sbjct: 123 RNPIVQILDTGNLV-VRNSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRA 181
Query: 178 PDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDN 237
DDP +GN++ +D G PQ L K+ V ++R GPW G RF+G P + I+ Y+
Sbjct: 182 IDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFT 241
Query: 238 QDEVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNS 297
++EVY L + S + RM LN G LQR+TW + + W Y +A + CD Y CG
Sbjct: 242 EEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYG 301
Query: 298 NCNLNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGE-GFIKLERMKLP 356
+CN+N + C CL GF K P+ W D S GC R+ C KGE GF+K+ ++KLP
Sbjct: 302 SCNINESPA--CRCLKGFVAKTPQAWVAGDWSEGCVRRVKLD-CGKGEDGFLKISKLKLP 358
Query: 357 DTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAG 416
DT + D N+ L C++ CL NC+C AY+ G GC+++ GDL D R+Y G
Sbjct: 359 DTRTSW-YDKNMDLNECKKVCLRNCTCSAYSPFDIRDG-GKGCILWFGDLIDIREYNENG 416
Query: 417 QDLFVR 422
QDL+VR
Sbjct: 417 QDLYVR 422
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.1e-148, Sum P(2) = 1.1e-148
Identities = 172/420 (40%), Positives = 248/420 (59%)
Query: 6 LLLNTLLFFQFSQISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYN 65
+ L +LF FS +S + + + S I I+S +I+ LGFF+P +S + Y+GIWY
Sbjct: 13 IFLILILFLAFS-VSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYK 71
Query: 66 QISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVA- 124
I T +WVANR+NP++ ++G L ++ NLV+ + QS PVW NI+ + VA
Sbjct: 72 IIPIRTYVWVANRDNPLSSSNGTLKIS-GNNLVIFD--QSDRPVWSTNITGGDVRSPVAA 128
Query: 125 QLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSG 184
+LLD GN +L R+ LWQSFD PTDT+L M+ GWD++TG NR + +WK+ DDP SG
Sbjct: 129 ELLDNGNFLL-RDSNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSG 187
Query: 185 NFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRT--FIFNITYIDNQDEVY 242
FS L+ + FP+ + + L+R+GPW G RFS P + ++N T +++EV
Sbjct: 188 EFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTA--SKEEVT 245
Query: 243 LCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLN 302
+N + +R+ LN G LQR TW + W W +P + CD Y CG C+ N
Sbjct: 246 YSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSN 305
Query: 303 LTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAA 362
C C+ GF+P + W LRDGS GC RK S C +GF +L+RMKLPDT+ A
Sbjct: 306 SLPN--CYCIKGFKPVNEQAWDLRDGSAGCMRKTRLS-CDGRDGFTRLKRMKLPDTT-AT 361
Query: 363 NVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVR 422
VD +GLK C+E+CL +C+C A+A+A N G GC+++ ++ D R Y GQDL+VR
Sbjct: 362 IVDREIGLKVCKERCLEDCNCTAFANADIR-NGGSGCVIWTREILDMRNYAKGGQDLYVR 420
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 816 (292.3 bits), Expect = 5.4e-145, Sum P(2) = 5.4e-145
Identities = 168/422 (39%), Positives = 243/422 (57%)
Query: 6 LLLNTLLFFQFSQISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYN 65
+L +LF FS +++ S I I+S +I+ LGFF+P +S + Y+GIWY
Sbjct: 13 ILFIIILFLAFSVYASNFSATE-SLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYK 71
Query: 66 QISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVA- 124
I T +WVANR+NP++ ++G L ++ NLV+ + QS PVW NI+ + VA
Sbjct: 72 IIPIRTYVWVANRDNPLSSSNGTLKIS-DNNLVIFD--QSDRPVWSTNITGGDVRSPVAA 128
Query: 125 QLLDTGNLVL---VRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTG-LNRYVTAWKSPDD 180
+LLD GN VL N LWQSFD PTDT+L +M+ GWD ++G NR + +WK+ DD
Sbjct: 129 ELLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDD 188
Query: 181 PGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDE 240
P SG+FS L +GFP+ +Y + +R+GPW G RFS P M + ++ +N +
Sbjct: 189 PSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQ 248
Query: 241 VYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCN 300
V +N + + + L+ TG LQR TW + W W +P + CD Y CG C+
Sbjct: 249 VVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCD 308
Query: 301 LNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSV 360
N + C C+ GFEP ++ LRD S GC RK S C +GF++L++M+LPDT+
Sbjct: 309 ANTSP--ICNCIKGFEPMN-EQAALRDDSVGCVRKTKLS-CDGRDGFVRLKKMRLPDTT- 363
Query: 361 AANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLF 420
+VD +GLK CEE+CL C+C A+A+ N G GC+++ G L D R Y GQDL+
Sbjct: 364 ETSVDKGIGLKECEERCLKGCNCTAFANTDIR-NGGSGCVIWSGGLFDIRNYAKGGQDLY 422
Query: 421 VR 422
VR
Sbjct: 423 VR 424
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 2.4e-138, Sum P(2) = 2.4e-138
Identities = 155/431 (35%), Positives = 249/431 (57%)
Query: 7 LLNTLLFFQFSQISTSID--TISLSQPIKDGDVIVSSRKIYALGFFSPGNSVK---RYVG 61
L + LF S +S ++D I+ + +KDGD + S +++ LGFFS + R++G
Sbjct: 7 LFSLSLFLISSSLSVALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLG 66
Query: 62 IWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANIS--EAS- 118
+WY + ++WVANRNNP+ TSG L+++ G+L L + + W ++ S +AS
Sbjct: 67 LWY--MEPFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKAL--WSSSSSSTKASK 122
Query: 119 -AGNTVAQLLDTGNLVLVRNDTGET-LWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWK 176
A N + ++ +GNL+ +D E LWQSFD+P +T+L M+ G + +T + +++WK
Sbjct: 123 TANNPLLKISCSGNLI--SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWK 180
Query: 177 SPDDPGSGNFSFTLDLAGFPQPLLYK--DDVKLWRAGPWTGQRFSGTPEMTR-TFIFNIT 233
+ DP G+F+ +LD G PQ +L K D +R G W G F+G P M R +F+
Sbjct: 181 TLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYK 240
Query: 234 YIDNQDEV-YLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGH 292
+ + EV Y + + ++R++LN TG L RF ++ +WI TAP + CDYY
Sbjct: 241 FTSSAQEVNYSWTPRHRI--VSRLVLNNTGKLHRFI-QSKQNQWILANTAPEDECDYYSI 297
Query: 293 CGPNSNCNLNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLER 352
CG + C +N + C+CL GF+PK ++W + G+ GC + T+ C+K + F+K
Sbjct: 298 CGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTN-CEKKDAFVKFPG 356
Query: 353 MKLPDTSVA-ANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRK 411
+KLPDTS + + + L+ C+ KC SNCSC AYA+ G GCL++ GDL D R+
Sbjct: 357 LKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREG-GKGCLLWFGDLVDMRE 415
Query: 412 YTNAGQDLFVR 422
Y++ GQD+++R
Sbjct: 416 YSSFGQDVYIR 426
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 1.9e-136, Sum P(2) = 1.9e-136
Identities = 156/430 (36%), Positives = 242/430 (56%)
Query: 6 LLLNTLLFFQFSQISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYN 65
+LL TL+ F ++ + D I+ S +D + +VS+ + GFFSP NS RY GIW+N
Sbjct: 6 ILLLTLICFSL-RLCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFN 64
Query: 66 QISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTV-A 124
I T++WVAN N+PIND+SG++S++ +GNLV+ + + V W N+ A NT A
Sbjct: 65 NIPVQTVVWVANSNSPINDSSGMVSISKEGNLVVMD-GRGQVH-WSTNVLVPVAANTFYA 122
Query: 125 QLLDTGNLVLV-RNDTG-ETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPG 182
+LL+TGNLVL+ +TG E LW+SF+HP + LP M D +TG + + +WKSP DP
Sbjct: 123 RLLNTGNLVLLGTTNTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPS 182
Query: 183 SGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMT-RTFIFNITYI-DNQDE 240
G +S L FP+ +++KDD+ +WR+GPW GQ F G P M R +F +T DN+
Sbjct: 183 PGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNRGS 242
Query: 241 VYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCN 300
V + N L + +L+ G + + WN + W + P+ +CD Y CG ++C
Sbjct: 243 VSMSYAGNTL--LYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCR 300
Query: 301 LNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRK--------QGTSTCQKGEGFIKLER 352
N C C+ GF+P+ EW + + GC RK +K +GF+++++
Sbjct: 301 FNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQK 360
Query: 353 MKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKY 412
MK+P + + + C E CL NCSC AY+ +RGIGCL++ G+L D +++
Sbjct: 361 MKVPHNPQRSGANE----QDCPESCLKNCSCTAYSF-----DRGIGCLLWSGNLMDMQEF 411
Query: 413 TNAGQDLFVR 422
+ G ++R
Sbjct: 412 SGTGVVFYIR 421
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 677 (243.4 bits), Expect = 4.6e-135, Sum P(2) = 4.6e-135
Identities = 151/434 (34%), Positives = 232/434 (53%)
Query: 6 LLLNTLLFFQFSQISTSIDTISLSQPIKDG---DVIVSSRKIYALGFFSPGNSVKRYVGI 62
L L+ L+F + S + +TI + ++DG +VS +K + LGFFSPG+S R++GI
Sbjct: 9 LYLSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGI 68
Query: 63 WYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNT 122
WY I ++WVANR PI+D SGVL ++ GNLVL + TV W +NI ++ N
Sbjct: 69 WYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITV--WSSNIESSTTNNN 126
Query: 123 --VAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDD 180
V + DTGN VL DT +W+SF+HPTDT LP MR + +TG N +W+S D
Sbjct: 127 NRVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETD 186
Query: 181 PGSGNFSFTLDLAGFPQPLLYKDD-VKLWRAGPWTGQRFSGTPEMT--RTFIFNITYIDN 237
P GN+S +D +G P+ +L++ + + WR+G W F+G P M+ +++
Sbjct: 187 PSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSP 246
Query: 238 QDE---VYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCG 294
DE VY +D S + R + G + WN ++W + + P CD Y CG
Sbjct: 247 PDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCG 306
Query: 295 PNSNCNLNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQK----GEG-FIK 349
C++ ++G C+C+ G+E W S GC+R+ C++ GE F+
Sbjct: 307 KFGICDMKGSNGI-CSCIHGYEQVSVGNW-----SRGCRRRTPLK-CERNISVGEDEFLT 359
Query: 350 LERMKLPDTSVAANVDMNL-GLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLND 408
L+ +KLPD + + NL + C E+CL NCSC AY+ GIGC++++ DL D
Sbjct: 360 LKSVKLPDFEIPEH---NLVDPEDCRERCLRNCSCNAYSLVG-----GIGCMIWNQDLVD 411
Query: 409 TRKYTNAGQDLFVR 422
+++ G L +R
Sbjct: 412 LQQFEAGGSSLHIR 425
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 664 (238.8 bits), Expect = 3.7e-131, Sum P(2) = 3.7e-131
Identities = 151/432 (34%), Positives = 227/432 (52%)
Query: 7 LLNTLLFFQ--FSQISTSI-DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIW 63
L+ TLL F S +S S ++ + + I++GD ++S + + LGFF+P NS RYVGIW
Sbjct: 10 LVTTLLIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIW 69
Query: 64 YNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTV 123
Y I T++WVANR P+ D G L + GNLV+ T+ W N+ E + NTV
Sbjct: 70 YKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETI--WSTNV-EPESNNTV 126
Query: 124 AQLLDTGNLVLVRN-DTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPG 182
A L TG+LVL + D + W+SF++PTDT LP MR + G NR WKS DP
Sbjct: 127 AVLFKTGDLVLCSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPS 186
Query: 183 SGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTR--TFIFNITYI---DN 237
G +S +D G + ++++ + + WR+GPW F+G P+M R +I+ D
Sbjct: 187 PGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDR 246
Query: 238 QDEVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRW-IGYWTAPAERCDYYGHCGPN 296
VY +D S R + G ++F WN R W + W P+ C+ Y CG
Sbjct: 247 DGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWK-PSTECEKYNRCGNY 305
Query: 297 SNCNLNLT-DGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQK---GE--GFIKL 350
S C+ + D +C+C+ GFEP + +W RD SGGC+R+ + Q G+ GF L
Sbjct: 306 SVCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVL 365
Query: 351 ERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTR 410
+ +K+PD +V ++ + C++ C +CSC AYA GIGC+++ DL D
Sbjct: 366 KGIKVPDFG---SVVLHNNSETCKDVCARDCSCKAYALVV-----GIGCMIWTRDLIDME 417
Query: 411 KYTNAGQDLFVR 422
+ G + +R
Sbjct: 418 HFERGGNSINIR 429
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 647 (232.8 bits), Expect = 8.9e-128, Sum P(2) = 8.9e-128
Identities = 124/180 (68%), Positives = 152/180 (84%)
Query: 517 FFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVL 576
FF++ T+ AT+NFS SNKLGQGGFGPVYKGKL +G+EIAVKRLS++SGQG EE NE++
Sbjct: 481 FFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIV 540
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL-LDWKKRFDIILG 635
LI+KLQH+NLV++LGCC+E +E +LIYEFM N SLD F+FD SRK+L +DW KR DII G
Sbjct: 541 LISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFD-SRKRLEIDWPKRLDIIQG 599
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
IARG+ YLH+DS L++IHRDLK SNILLDEKMNP+ISDFG AR++ G E T+RVVGT
Sbjct: 600 IARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGT 659
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 672 (241.6 bits), Expect = 1.9e-127, Sum P(2) = 1.9e-127
Identities = 137/204 (67%), Positives = 165/204 (80%)
Query: 497 EREASISTKGNK-EIRKVDVT---FFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNG 552
E A IS K +++ DV FF++ T+ AT+NFS SNKLGQGGFG VYKGKL +G
Sbjct: 454 EHIAHISKDAWKNDLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDG 513
Query: 553 QEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612
+EIAVKRLS++SGQG EE NE++LI+KLQHRNLV++LGCC+EE+E +LIYEFM NKSLD
Sbjct: 514 KEIAVKRLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLD 573
Query: 613 YFIFDESRKQL-LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671
F+FD SRK+L +DW KRFDII GIARG+LYLH DSRLR+IHRDLK SNILLDEKMNP+I
Sbjct: 574 TFLFD-SRKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKI 632
Query: 672 SDFGTARVFGGEEILAITKRVVGT 695
SDFG AR++ G E T+RVVGT
Sbjct: 633 SDFGLARMYQGTEYQDNTRRVVGT 656
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9ZT07 | RKS1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5340 | 0.9510 | 0.7935 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00010713001 | SubName- Full=Chromosome undetermined scaffold_278, whole genome shotgun sequence; (815 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 695 | |||
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 3e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-36 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 6e-32 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-24 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-21 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 5e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-07 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd00054 | 38 | cd00054, EGF_CA, Calcium-binding EGF-like domain, | 0.001 | |
| COG1718 | 268 | COG1718, RIO1, Serine/threonine protein kinase inv | 0.002 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.002 | |
| smart00179 | 39 | smart00179, EGF_CA, Calcium-binding EGF-like domai | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.003 | |
| cd00053 | 36 | cd00053, EGF, Epidermal growth factor domain, foun | 0.003 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.004 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.004 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.004 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 46/111 (41%), Positives = 66/111 (59%), Gaps = 2/111 (1%)
Query: 208 WRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNETGFLQRF 267
WR+GPW G RFSG PEM + + + +N +EVY + + S +R+ L+ G L+RF
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 268 TWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPK 318
TW + W +W+AP ++CD YG CGP C++N T C C+ GF PK
Sbjct: 61 TWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVN-TSPK-CNCIKGFVPK 109
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 63/150 (42%), Positives = 81/150 (54%), Gaps = 10/150 (6%)
Query: 535 KLGQGGFGPVYKGKLSNG-----QEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
KLG+G FG VYKG L E+AVK L S Q IEE E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
LLG C EE+ M++ E+MP L ++ +R + L L IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IHRDL A N L+ E + +ISDFG +R
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 9e-39
Identities = 61/150 (40%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 535 KLGQGGFGPVYKGKL-----SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
KLG+G FG VYKGKL E+AVK L S Q IEE E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
LLG C EE+ ++ E+M L ++ + L L IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IHRDL A N L+ E + +ISDFG +R
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 57/156 (36%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 534 NKLGQGGFGPVYKGKLSNGQ----EIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
KLG+G FG VYKGKL E+AVK L S + ++ E ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFI------FDESRKQLLDWKKRFDIILGIARGVLY 642
LLG C EE+ L+ E+M L ++ F K L K + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
L + +HRDL A N L+ E + +ISDFG +R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 55/150 (36%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 535 KLGQGGFGPVYKGKL-----SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
KLG+G FG VYKG L ++AVK L S + EE E ++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
LLG C + + ++ E+MP L F+ + L K + L IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+HRDL A N L+ E + +ISDFG +R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 8e-36
Identities = 57/163 (34%), Positives = 88/163 (53%), Gaps = 10/163 (6%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLST-TSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
LG+GGFG VY + G+++A+K + S +EEL E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
+E+ L+ E+ SL + + + L + I+L I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 654 RDLKASNILLDEK-MNPRISDFGTARVFGGEEILAITKRVVGT 695
RDLK NILLD +++DFG +++ ++ L K +VGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 53/114 (46%), Positives = 71/114 (62%), Gaps = 5/114 (4%)
Query: 69 QLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLD 128
T++WVANR NP+ D+S L + GNLVL++ N VW +N S VA L D
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGR--VVWSSNTSG-KGSGCVAVLQD 57
Query: 129 TGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPG 182
GNLVL +++G+ LWQSFDHPTDT+LP + G + G +R +T+WKS DP
Sbjct: 58 DGNLVL-YDNSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 54/151 (35%), Positives = 78/151 (51%), Gaps = 9/151 (5%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
KLG G FG VYK K G+ +AVK L + + + + E+ ++ +L H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
++D L+ E+ L ++ SR L + I L I RG+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGG 682
IHRDLK NILLDE +I+DFG A+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK 150
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 54/168 (32%), Positives = 85/168 (50%), Gaps = 11/168 (6%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHRNLV 587
+ KLG+G FG VY + G+ +A+K + + E + E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L +ED+ L+ E+ L + + R +L + + RF + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
I+HRDLK NILLDE + +++DFG AR E L VGT
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 56/177 (31%), Positives = 86/177 (48%), Gaps = 31/177 (17%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
LG+G FG VY G+ +AVK LS S + +E L+ E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 591 GCCLEEDENML-IY-EFMPNKSLDYFI-----FDESR-----KQLLDWKKRFDIILGIAR 638
G +E++N L I+ E++ SL + E +Q+L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-------------E 112
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
G+ YLH I+HRD+K +NIL+D +++DFG A+ G E T V GT
Sbjct: 113 GLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 52/122 (42%), Positives = 73/122 (59%), Gaps = 6/122 (4%)
Query: 29 SQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGV 88
S P+ G +VSS ++ LGFF + Y I Y S+ T++WVANR+NP + +S
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSR-TVVWVANRDNP-SGSSCT 58
Query: 89 LSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFD 148
L++ GNLV++ + S VW +N + + GN V LLD GNLVL +D G LWQSFD
Sbjct: 59 LTLQSDGNLVIY--DGSGTVVWSSNTTRVN-GNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114
Query: 149 HP 150
+P
Sbjct: 115 YP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 50/121 (41%), Positives = 71/121 (58%), Gaps = 7/121 (5%)
Query: 29 SQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGV 88
S + G +VS ++ LGFF+ Y I Y S+ T++WVANR+NP++D S
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSR-TVVWVANRDNPVSD-SCT 57
Query: 89 LSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFD 148
L++ GNLVL+ + VW +N + A+ GN V LLD GNLV+ +D G LWQSFD
Sbjct: 58 LTLQSDGNLVLY--DGDGRVVWSSNTTGAN-GNYVLVLLDDGNLVIYDSD-GNFLWQSFD 113
Query: 149 H 149
+
Sbjct: 114 Y 114
|
Length = 114 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 20/156 (12%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
F K+G+GGFG VYK + G+E+A+K + S + E++ NE+ ++ K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLD-WKKRFD------IILGIARGVL 641
G L++DE ++ EF SL K LL + + + +G+
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
YLH IIHRD+KA+NILL ++ DFG +
Sbjct: 113 YLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 52/179 (29%), Positives = 88/179 (49%), Gaps = 29/179 (16%)
Query: 529 NFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRN 585
N+ + +G+G FG VYKG L G +A+K++S + ++ + E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD---------IILGI 636
+VK +G D +I E+ N SL +Q++ K+F + +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL---------RQII---KKFGPFPESLVAVYVYQV 108
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+G+ YLH+ +IHRD+KA+NIL + +++DFG A + VVGT
Sbjct: 109 LQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-24
Identities = 38/69 (55%), Positives = 50/69 (72%), Gaps = 3/69 (4%)
Query: 341 CQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCL 400
C G+GF++L MKLPDT+ AA VD ++GLK CE++CLSNCSC AY A A+ G GCL
Sbjct: 1 CGGGDGFLRLPNMKLPDTT-AAIVDRSIGLKECEQRCLSNCSCTAY--AYADIRGGSGCL 57
Query: 401 MYHGDLNDT 409
++ G+L D
Sbjct: 58 IWTGELVDM 66
|
Length = 66 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 49/159 (30%), Positives = 83/159 (52%), Gaps = 20/159 (12%)
Query: 536 LGQGGFGPVYKG-----KLSNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG VYKG +A+K L + + +E+ +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQ 645
LG CL + LI + MP L ++ + + LL+W + IA+G+ YL +
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
R++HRDL A N+L+ + +I+DFG A++ +E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTSG-QGIEELKNEVLLIAKL 581
+ +LG+G FG V + G+++AVK L+ + Q + + E+ ++ L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 582 QHRNLVKLLGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
H N+VK G C + LI E++P+ SL ++ + L F I +G
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKG 121
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+ YL R IHRDL A NIL++ + +ISDFG A+V
Sbjct: 122 MDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 55/149 (36%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
KLG G FG V+ G + ++AVK L T S E E ++ KL+H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 593 CLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
C EE+ ++ E+M SL D+ E +K L + D+ IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE---SRNY 124
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVF 680
IHRDL A NIL+ E + +I+DFG AR+
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 55/163 (33%), Positives = 82/163 (50%), Gaps = 23/163 (14%)
Query: 536 LGQGGFGPVYKGKL------SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
LG+G FG VYKG+L + +A+K L + +E + E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIF-------------DESRKQLLDWKKRFDIILG 635
LLG C +E +++E++ + L F+ DE+ K LD I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IA G+ YL S +HRDL A N L+ E + +ISDFG +R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 55/174 (31%), Positives = 85/174 (48%), Gaps = 25/174 (14%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
++G+G FG VY + S+G+ +K LS S + E+ NEV ++ KL H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFI---------FDESRKQLLDWKKRFDIILGIARGVL 641
E+ + ++ E+ L I F E +Q+LDW + + +
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE--EQILDW------FVQLCLALK 117
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
YLH SR +I+HRD+K NI L ++ DFG ++V LA T VVGT
Sbjct: 118 YLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 4/150 (2%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
F+ KLG G FG V++G N +A+K L + ++ + EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
C + +I E M SL F+ Q+L D+ +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARV 679
IHRDL A NIL+ E + +++DFG AR+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 21/176 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
+ + K+G+G G VYK G+E+A+K++ Q E + NE+L++ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL---- 641
+V L DE ++ E+M SL I ++ ++ + I + R VL
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNE-----PQIAYVCREVLQGLE 130
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
YLH +IHRD+K+ NILL + + +++DFG F + +KR VVGT
Sbjct: 131 YLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 14/169 (8%)
Query: 530 FSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
F KLG+G +G VYK GQ +A+K + ++E+ E+ ++ + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQD 646
G + + ++ E+ S + D + + L ++ I+ +G+ YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS- 117
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ IHRD+KA NILL+E+ +++DFG + +A V+GT
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 536 LGQGGFGPVYKGKLSNGQE------IAVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVK 588
LG+G FG V+ G+ + + +AVK L T S ++ + E L+ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYF-----------IFDESRKQLLDWKKRFDIILGIA 637
G C E D ++++E+M + L+ F +S L + I + IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
G++YL + +HRDL N L+ + +I DFG +R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 39/179 (21%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNL 586
++G+G +G VYK + G+ +A+K++ + I E+K L+ KL+H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLRHPNI 60
Query: 587 VKLLGCCLEEDEN--MLIYEFMPN--KSLDY---FIFDESR-----KQLLDWKKRFDIIL 634
V+L + + +++E+M + L F ES+ KQLL
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---------- 110
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
G+ YLH + I+HRD+K SNIL++ +++DFG AR + T RV+
Sbjct: 111 ---EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-21
Identities = 34/88 (38%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 338 TSTCQKGE---GFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETN 394
C GF+KL +KLPD + A + L+ C E CLSNCSC AYA N
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI---TAISLEECREACLSNCSCTAYAY----NN 54
Query: 395 RGIGCLMYHGDLNDTRKYTNAGQDLFVR 422
GCL+++G LN+ R ++ G L++R
Sbjct: 55 GSGGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 6e-21
Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 22/168 (13%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLIAKLQHRN 585
KLG+G +G VYK + G+ +A+K++ ++ + E+ L+ +L+H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKELKHPN 59
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+VKLL E + L++E+ + L ++ + R L I+ + RG+ Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
RI+HRDLK NIL++ +++DFG AR F G + T VV
Sbjct: 117 H---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 7e-21
Identities = 51/153 (33%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 534 NKLGQGGFGPVYKG--KLSNGQEI--AVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVK 588
+LG G FG V KG + +G+E+ AVK L G +E E ++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
L+G C E ML+ E P L ++ + D K ++ +A G+ YL
Sbjct: 61 LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLESK-- 114
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+HRDL A N+LL + +ISDFG +R G
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALG 146
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.9 bits (229), Expect = 4e-20
Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH-R 584
++ KLG+G FG VY + + + +A+K L+ + + +E E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+VKL +E L+ E++ SL+ + RK L + I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 645 QDSRLRIIHRDLKASNILLDEKMN-PRISDFGTARVFGGE----EILAITKRVVGT 695
IIHRD+K NILLD ++ DFG A++ I A+ VGT
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 48/145 (33%), Positives = 77/145 (53%), Gaps = 10/145 (6%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE 595
+G+G FG V G GQ++AVK L S + E ++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 596 EDENMLIYEFMPNKSL-DYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
+ ++ E+M SL DY SR + ++ ++ L + G+ YL + +H
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 654 RDLKASNILLDEKMNPRISDFGTAR 678
RDL A N+L+ E + ++SDFG A+
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 58/177 (32%), Positives = 87/177 (49%), Gaps = 37/177 (20%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRLS-----TTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG VY+G L +G AVK +S T + +++L+ E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 590 LGCCLEEDENMLIY-EFMPNKSL-----DYFIFDES-----RKQLLDWKKRFDIILGIAR 638
LG EED N+ I+ E +P SL Y F E +Q+L
Sbjct: 68 LGTEREED-NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
G+ YLH +HRD+K +NIL+D +++DFG A+ + K G+
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGS 164
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 56/161 (34%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ KLG G FG V+ G + ++A+K L S E E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 588 KLLGCCLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+L +E +I E+M N SL D+ E K L K D+ IA G+ ++
Sbjct: 65 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE-- 119
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687
R IHRDL+A+NIL+ E + +I+DFG AR+ E A
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ ++G G FG V+ G +++A+K + E+ E ++ KL H LV
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L G C E L++EFM + L ++ +++ + + L + G+ YL +
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+IHRDL A N L+ E ++SDFG R
Sbjct: 121 ---VIHRDLAARNCLVGENQVVKVSDFGMTRF 149
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 58/154 (37%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
KLG G FG V+ G +N ++AVK L + ++ E L+ LQH LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 595 EEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
+E+ +I E+M SL D+ DE K LL K D IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687
RDL+A+N+L+ E + +I+DFG ARV E A
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
KLG G FG V++G +N +AVK L + + L E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA-EAQIMKKLRHPKLIQLYAVCT 71
Query: 595 EEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
E+ ++ E M SL +Y R L + D+ +A G+ YL + IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGEE 684
RDL A N+L+ E +++DFG ARV +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 60/163 (36%), Positives = 78/163 (47%), Gaps = 26/163 (15%)
Query: 536 LGQGGFGPVYKGKL-------SNGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRN 585
LG G FG VY+G S +AVK L G +E K E L++ H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQ-----LLDWKKRFDIILGIARGV 640
+VKLLG CL + +I E M L ++ D +R + LL K+ DI L +A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRD-ARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPR-----ISDFGTAR 678
+YL Q + IHRDL A N L+ EK I DFG AR
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 53/158 (33%), Positives = 91/158 (57%), Gaps = 11/158 (6%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS-GQGIEELK-NEVLLIAKLQHRN 585
+++ K+G+G +G VYKG+ GQ +A+K++ S +G+ E+ L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES--RKQLLDWKKRFDIILGIARGVLYL 643
+V L ++E LI+EF+ S+D + +S + Q +D + + I +G+L+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
H R++HRDLK N+L+D K +++DFG AR FG
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLST---TSGQGIEELKNEVLLIAKL-Q 582
D+F +G+G F V K +E A+K L + ++ +K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIA 637
H ++KL +E+ + E+ PN L +I DE + I
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAAEIL 112
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
+ YLH IIHRDLK NILLD+ M+ +I+DFGTA+V
Sbjct: 113 LALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 53/146 (36%), Positives = 77/146 (52%), Gaps = 8/146 (5%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
K+G+G FG VYKG L E+AVK R + + L+ +L + H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
C+++ ++ E +P SL F+ +K L KK + L A G+ YL + I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 653 HRDLKASNILLDEKMNPRISDFGTAR 678
HRDL A N L+ E +ISDFG +R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQHRNLVKLLG 591
K+G+G +G VYK + G+ +A+K++ E+ L+ +L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+ + L++EFM + L I D R L + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGG 682
+HRDLK N+L++ + +++DFG AR FG
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGS 150
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 15/173 (8%)
Query: 529 NFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRN 585
+F NK+G+G FG V+K + ++ + A+K+ LS + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLD---WKKRFDIILGIARGVLY 642
+++ L++ + ++ E+ N L + + + L + W+ I+LG+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
LH +I+HRD+K+ N+ LD N +I D G A++ A T +VGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 19/175 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKG--KLSNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHR 584
+ LGQG G VYK K + G+ A+K++ + ++L E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPT-GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL--- 641
+VK G +E E ++ E+M SL + K++ + ++ IAR +L
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP--VLAYIARQILKGL 112
Query: 642 -YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
YLH IIHRD+K SN+L++ K +I+DFG ++V E L VGT
Sbjct: 113 DYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 52/151 (34%), Positives = 81/151 (53%), Gaps = 16/151 (10%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKR-----LSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LGQG FG VY + G+E+AVK+ S + + + L+ E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 590 LGCCLEEDENMLIY-EFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
GC L +DE + I+ E+MP S+ D + + + K I+ GV YLH +
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN- 123
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
I+HRD+K +NIL D N ++ DFG ++
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 55/159 (34%), Positives = 90/159 (56%), Gaps = 20/159 (12%)
Query: 536 LGQGGFGPVYKGK-LSNGQEI----AVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG VYKG + G+ + A+K L+ T+G + E +E L++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQ 645
LG CL L+ + MP+ L ++ + + LL+W + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
R++HRDL A N+L+ + +I+DFG AR+ G+E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRL-STTSGQGI-EELKNEVLLIAKLQHRNLVKLLG 591
++G+G G V+K K G+ +A+K++ GI + E+ + QH +VKLL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+L+ E+MP+ L + DE R K + +L +GV Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHA---NGI 120
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
+HRDLK +N+L+ +I+DFG AR+F EE + +V
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 536 LGQGGFGPVYKG--KLSNGQEI--AVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKL 589
+G G FG V +G KL +EI A+K L S Q ++ L E ++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLT-EASIMGQFDHPNIIRL 70
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
G + M+I E+M N SLD F+ + ++ GIA G+ YL S +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+HRDL A NIL++ + ++SDFG +R E
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 53/152 (34%), Positives = 83/152 (54%), Gaps = 17/152 (11%)
Query: 536 LGQGGFGPVYKGKL--SNGQEI--AVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+G+G FG VY G L S+GQ+I AVK L+ T + +E+ E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 591 GCCL-EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII---LGIARGVLYLHQD 646
G CL E +++ +M + L FI E+ + D+I L +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLASK 117
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ +HRDL A N +LDE +++DFG AR
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 56/164 (34%), Positives = 71/164 (43%), Gaps = 28/164 (17%)
Query: 535 KLGQGGFGPVYKG--KLSNGQEI--AVKRLSTTSGQGI-EELKNEVLLIAKLQHRNLVKL 589
KLG G FG V +G S G+ I AVK L + I ++ E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQ---------LLDWKKRFDIILGIARGV 640
G L M++ E P SL D RK L D+ + IA G+
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYA------VQIANGM 110
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
YL R IHRDL A NILL +I DFG R E
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 52/158 (32%), Positives = 84/158 (53%), Gaps = 26/158 (16%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQG---------IEELKNEVLLIAKLQHRN 585
+G G FG VY G S+G+ +AVK++ S ++ L E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIARGV 640
+V+ LG L+ D + E++P S+ +Y F+E+ + + + I +G+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
YLH IIHRD+K +NIL+D K +ISDFG ++
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 50/158 (31%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 536 LGQGGFGPVYKGKLSNG----QEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+G FG V +G+LS ++AVK +L + IEE +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 590 LGCCLEEDEN------MLIYEFMPNKSLDYFIFD---ESRKQLLDWKKRFDIILGIARGV 640
+G C E M+I FM + L F+ + L + ++ IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
YL S IHRDL A N +L E M ++DFG ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 32/161 (19%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLS------TTSGQGIEELKNEVLLIAKLQHRNLV 587
LG+G +G VY G + GQ IAVK++ + + E+L+ EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 588 KLLGCCLEEDENMLIYEFMPNKS----LDYF------IFDESRKQLLDWKKRFDIILGIA 637
+ LG CL+++ + EF+P S L+ F +F + KQ+LD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
GV YLH + ++HRD+K +N++L ++ DFG AR
Sbjct: 114 -GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 48/151 (31%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
LG+G +G VY + LS IA+K + + ++ L E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 595 EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQDSRLRII 652
E + E +P SL + S+ L ++ I I G+ YLH +I+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 653 HRDLKASNILLDEKMNP-RISDFGTARVFGG 682
HRD+K N+L++ +ISDFGT++ G
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 39/180 (21%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKL 581
++ KLG+G FG VYK ++ G+ +A+K++ + G I L+ E+ ++ KL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 582 QHRNLVKLLGCCLEEDENML-----IYEFMPNKSLDY--------FIFDESR-----KQL 623
+H N+V L+ +E + +Y P D ES+ QL
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 624 LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683
L+ G+ YLH++ I+HRD+KA+NIL+D + +I+DFG AR + G
Sbjct: 125 LE-------------GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIE-ELKNEVLLIAKLQHRN 585
+ ++LG+G G V K +L N I A+K ++T ++ ++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 586 LVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL-- 641
+VK G L+E + + E+ SLD I+ + +K+ ++ ++ IA VL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEK--VLGKIAESVLKG 117
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
YLH +IIHRD+K SNILL K ++ DFG + GE + ++ GT
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGT 166
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 534 NKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+KLG G +G VY+G +AVK L + +EE E ++ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 593 CLEEDENMLIYEFMPNKS-LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
C E +I EFM + LDY E +Q ++ + I+ + YL + +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGE 683
IHRDL A N L+ E +++DFG +R+ G+
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 4e-17
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 20/168 (11%)
Query: 536 LGQGGFGPVYK-GKLSNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+G FG V K G+ A+K L + +E E +++++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 592 CCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQDS 647
+ +E + L+ E+ P L + + + + RF +I+L + YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALE----YLH--- 110
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
L II+RDLK NILLD + +++DFG A+ E T GT
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 17/167 (10%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKGKLSNG------QEIAVKRL-STTSGQGIEELKNEVLLI 578
D+ + LG G FG VY+G ++AVK L + S Q + E L++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIIL 634
+K H+N+V+L+G E ++ E M L F+ + R L K
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR---ISDFGTAR 678
+A+G YL ++ IHRD+ A N LL K R I+DFG AR
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 48/146 (32%), Positives = 73/146 (50%), Gaps = 12/146 (8%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
LG G FG V+ GK ++A+K + + + IEE K ++ KL H NLV+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAK----VMMKLSHPNLVQLYGV 67
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
C ++ ++ E+M N L ++ RK L + D+ + + YL + I
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122
Query: 653 HRDLKASNILLDEKMNPRISDFGTAR 678
HRDL A N L+ E ++SDFG AR
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 14/152 (9%)
Query: 536 LGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
LG+G FG V + + G+ +AVK+L ++ + + + + E+ ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 591 GCCLEEDEN--MLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
G C L+ E++P SL DY R LD +K I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
R +HRDL NIL++ + +I DFG +V
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKV 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQ-HRNLVKLL 590
+LG G FG VY + G+ +A+K++ EE N EV + KL H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
E DE ++E+M +L Y + + + + II I +G+ ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTAR 678
HRDLK N+L+ +I+DFG AR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 54/181 (29%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 529 NFSTSNKLGQGGFGPVYK-GKLSNGQEI-AVKRLSTT----------SGQGIEELKNEVL 576
++ LG G FG VYK K +NGQ + A+K ++ + I ++ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 577 LIAK-LQHRNLVKLLGCCLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIIL 634
+I + L+H N+V+ LE D ++ + + L ++F + +KQ ++ ++I +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ + YLH++ R I+HRDL +NI+L E I+DFG A+ E L VVG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVG 175
Query: 695 T 695
T
Sbjct: 176 T 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 60/160 (37%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 536 LGQGGFGPV--YKGKLSN---GQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHRNLVKL 589
LG+G FG V Y +N G+ +AVK L GQ K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 590 LGCCLEEDEN--MLIYEFMPNKSL-DYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQ 645
GCC E+ LI E++P SL DY + + QLL + ++ I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYLHS 125
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VFGGEE 684
IHRDL A N+LLD +I DFG A+ V G E
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 10/157 (6%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELK-NEVLLIAKLQHR 584
NF K+G+G +G VYK + G+ +A+K RL T + +G+ E+ L+ +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+VKLL E++ L++EF+ ++ L F+ D S + + + +G+ + H
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
R++HRDLK N+L++ + +++DFG AR FG
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 31/178 (17%)
Query: 530 FSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLV 587
F+ +G+G FG VYK Q +A+K + + IE+++ E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 588 KLLGCCLEEDENMLIYEFMPNKS----LDYFIFDESRKQLLDWKKRFDIILGIARGVL-- 641
K G L+ + +I E+ S L DE I I R VL
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE------------TYIAFILREVLLG 110
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
YLH++ IHRD+KA+NILL E+ + +++DFG + G+ ++KR VGT
Sbjct: 111 LEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGT 161
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 23/164 (14%)
Query: 535 KLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSGQGI-EELKNEVLLIAKLQHRNLV 587
+LG+ FG VYKG L Q +A+K L + + EE K+E ++ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIF-------------DESRKQLLDWKKRFDIIL 634
LLG +E +I+ + + L F+ D++ K L+ I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IA G+ +L S ++H+DL N+L+ +K+N +ISD G R
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 40/166 (24%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRL----------STTSGQGIEELKNEVLLIAKLQH 583
K+G+G +G VYK + G+ +A+K++ ST I E+ L+ +L H
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA----IREIS----LLKELNH 57
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF----DIILG---- 635
N+V+LL E++ L++EF+ D K+ +D +I
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQ 107
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+ +G+ Y H R++HRDLK N+L+D + +++DFG AR FG
Sbjct: 108 LLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 47/155 (30%), Positives = 88/155 (56%), Gaps = 6/155 (3%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELK-NEVLLIAKLQHRNL 586
NF KLG+G + VYKG+ + G+ +A+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
V+L E++ ML++E+M +K L ++ + LD + +G+ + H++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
R++HRDLK N+L++++ +++DFG AR FG
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-16
Identities = 54/165 (32%), Positives = 88/165 (53%), Gaps = 20/165 (12%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEI----AVKRL-STTSGQGIEELKNEVLLIAKLQH 583
F LG G FG VYKG + G+++ A+K L TS + +E+ +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSL-DYFIFDESR---KQLLDWKKRFDIILGIARG 639
++ +LLG CL LI + MP L DY + + LL+W + IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ YL + R++HRDL A N+L+ + +I+DFG A++ G +E
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 51/147 (34%), Positives = 74/147 (50%), Gaps = 12/147 (8%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELK----NEVLLIAKLQHRNLVKLLG 591
LG+G FG V+KG L + +AVK T +ELK +E ++ + H N+VKL+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVK---TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
C + ++ E +P D+ F +K L K+ L A G+ YL +
Sbjct: 60 VCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 652 IHRDLKASNILLDEKMNPRISDFGTAR 678
IHRDL A N L+ E +ISDFG +R
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 55/170 (32%), Positives = 87/170 (51%), Gaps = 16/170 (9%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRN 585
FS ++G G FG VY + + N + +A+K++S + Q E+ ++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
++ GC L E L+ E+ + D E K+ L + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ +IHRD+KA NILL E ++ DFG+A I+A VGT
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 51/153 (33%), Positives = 80/153 (52%), Gaps = 6/153 (3%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
KLGQG FG V+ G + +A+K L + E E ++ KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 595 EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 654
E+ ++ E+M SL F+ E K L + D+ IA G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 655 DLKASNILLDEKMNPRISDFGTARVFGGEEILA 687
DL+A+NIL+ E + +++DFG AR+ E A
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 49/155 (31%), Positives = 83/155 (53%), Gaps = 20/155 (12%)
Query: 536 LGQGGFGPVYKG--KLSNGQEIAVKRLSTTSGQGIEELKNEVL----LIAKLQHRNLVKL 589
+G G FG V++G K+ +E+AV + T E+ + + L ++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVA-IKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIARGVLYLHQ 645
G + M+I E+M N +LD ++ D S QL+ ++ GIA G+ YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYL-- 123
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
S + +HRDL A NIL++ + ++SDFG +RV
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 49/155 (31%), Positives = 82/155 (52%), Gaps = 24/155 (15%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLS----TTSGQG--IEELKNEVLLIAKLQHRNLVK 588
LG G F Y+ + + G +AVK+++ T+S Q +E L+ E+ L+A+L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 589 LLGCCLEEDENMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
+LG E+ L E+M S+ Y F E+ + + RG+ YL
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI--------INYTEQLLRGLSYL 119
Query: 644 HQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTA 677
H++ +IIHRD+K +N+L+D RI+DFG A
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 54/175 (30%), Positives = 95/175 (54%), Gaps = 18/175 (10%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-TTSGQGI-EELKNEVLLIAKLQ---H 583
+ ++G+G +G VYK + L+ G+ +A+K++ S +GI E+ L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 584 RNLVKLLGCCL-----EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
N+V+LL C E + L++E + ++ L ++ + L + D++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
GV +LH RI+HRDLK NIL+ +I+DFG AR++ E +A+T VV
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSVVV 168
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 57/154 (37%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
KLG G FG V+ + ++AVK + S +E E ++ LQH LVKL
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 595 EEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
+E +I EFM SL D+ DE KQ L K D IA G+ ++ Q + IH
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687
RDL+A+NIL+ + +I+DFG ARV E A
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 34/165 (20%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLIAKLQHR 584
KLG+G + VYK + G+ +A+K++ +E K+ E+ L+ +L+H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGE---RKEAKDGINFTALREIKLLQELKHP 62
Query: 585 NLVKLLGCCLEEDENMLIYEFMP--------NKSLDYFIFDESRKQLLDWKKRFDIILGI 636
N++ LL + L++EFM +KS+ D K +L
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVL--------TPADIKS---YMLMT 111
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
RG+ YLH I+HRDLK +N+L+ +++DFG AR FG
Sbjct: 112 LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 23/164 (14%)
Query: 535 KLGQGGFGPVYKGKL-----SNGQEIAVKRLST-TSGQGIEELKNEVLLIAKLQHRNLVK 588
+LG+ FG +YKG L + Q +A+K L + Q E + E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIF--------------DESRKQLLDWKKRFDIIL 634
LLG +E +++E++ L F+ D + K LD I +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IA G+ YL S +H+DL A NIL+ E+++ +ISD G +R
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 18/156 (11%)
Query: 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRN 585
F+ ++G G FG VY + + +A+K++S + Q E+ ++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL---- 641
++ GC L E L+ E+ + D I + +K L + I I G L
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPL-----QEVEIAAICHGALQGLA 129
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
YLH R IHRD+KA NILL E +++DFG+A
Sbjct: 130 YLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 48/154 (31%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKN---EVLLIAKLQHRN 585
F+ ++G G FG VY + E+ A+K++S + Q E+ ++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
++ GC L E L+ E+ + D E K+ L + I G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+ +IHRD+KA NILL E +++DFG+A +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 33/160 (20%)
Query: 533 SNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQG--IEELKNEVLLIAKLQHRNLVKL 589
NK+G G FG VY L G+ +AVK + I+E+ +E+ ++ L+H NLVK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 590 LGCCLE-EDENMLIY-EFMPNKSLDYF-----IFDES-----RKQLLDWKKRFDIILGIA 637
G +E E + I+ E+ +L+ I DE QLL
Sbjct: 65 YG--VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL------------- 109
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
G+ YLH I+HRD+K +NI LD ++ DFG A
Sbjct: 110 EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 27/159 (16%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRL---STTSGQG-------IEELKNEVLLIAKLQHR 584
+G+G +G VY ++ G+ +AVK++ +T +G+ ++ L++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIARG 639
N+V+ LG E+ + E++P S+ Y F+E + + + G
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEG 120
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ YLH I+HRDLKA N+L+D +ISDFG ++
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 29/177 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK---LSNGQE---IAVKRLST-TSGQGIEELKNEVLLIAK 580
+N +GQG FG V++ + L + +AVK L S + + E L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL----------------- 623
H N+VKLLG C L++E+M L+ F+ S +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 624 --LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
L ++ I +A G+ YL S + +HRDL N L+ E M +I+DFG +R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 523 LLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL 581
L T F +G+G +G VYK + GQ +A+K + EE+K E ++ K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59
Query: 582 -QHRNLVKLLGCCL------EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD--- 631
H N+ G + +D+ L+ E S+ + K L KR
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEW 114
Query: 632 ---IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
I+ RG+ YLH++ ++IHRD+K NILL + ++ DFG +
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 52/153 (33%), Positives = 80/153 (52%), Gaps = 6/153 (3%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
KLGQG FG V+ G + ++A+K L + E E ++ KL+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAV-V 70
Query: 595 EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 654
E+ ++ EFM SL F+ E + L + D+ IA G+ Y+ R+ IHR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 655 DLKASNILLDEKMNPRISDFGTARVFGGEEILA 687
DL+A+NIL+ + + +I+DFG AR+ E A
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 43/155 (27%), Positives = 81/155 (52%), Gaps = 14/155 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+++ ++G G +G VYK + ++ G+ +A+K + G E ++ E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR----GVLY 642
V G L D+ ++ E+ SL I+ +R L + I + R G+ Y
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-----LQIAYVCRETLKGLAY 116
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
LH+ IHRD+K +NILL E + +++DFG +
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 54/151 (35%), Positives = 80/151 (52%), Gaps = 20/151 (13%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLST-TSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
+G+G FG V +G+ + GQ++AVK + + Q E E ++ KL H+NLV+LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLGVI 68
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRK-----QLLDWKKRFDIILGIARGVLYLHQDSR 648
L ++ E M +L F+ R QLL +F L +A G+ YL
Sbjct: 69 LHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLL----QFS--LDVAEGMEYLESK-- 119
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+++HRDL A NIL+ E ++SDFG ARV
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARV 149
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKN---EVLLIAKLQHRN 585
F +++G G FG VY S+ E+ AVK++S + Q E+ ++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
++ GC L+E L+ E+ + D E K+ L + I G +G+ YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+ +IHRD+KA NILL E +++DFG+A
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 44/150 (29%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
D + +LG G FG VYK + G A K + S + +E+ E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+V L E++ ++ EF +LD I E + L + + R+ + + + +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHS 121
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFG 675
++IHRDLKA NILL + +++DFG
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFG 148
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 54/151 (35%), Positives = 84/151 (55%), Gaps = 13/151 (8%)
Query: 536 LGQGGFGPV----YKGKLSN-GQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLVKL 589
LG+G FG V Y + N G+++AVK L SG I +LK E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 590 LGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
G C E+ N LI EF+P+ SL ++ K ++ K++ + I +G+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
R + +HRDL A N+L++ + +I DFG +
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 11/164 (6%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEE---LKNEVLLIAKLQHRNLVKLLGC 592
+G+G FG V+ + Q++ + + +E +NE ++ L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
LE+ M++ E+ P +L +I LLD + I + ++H I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---IL 123
Query: 653 HRDLKASNILLDE-KMNPRISDFGTARVFGGEEILAITKRVVGT 695
HRDLK NILLD+ KM +I DFG +++ + A T VVGT
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYT--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 535 KLGQGGFGPVYKGKLSN---GQE---IAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
+LG+G FG V+ + N Q+ +AVK L S ++ + E L+ LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYF---------IFDESRKQL---LDWKKRFDIILGI 636
G C E ++++E+M + L+ F I L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
A G++YL + L +HRDL N L+ + + +I DFG +R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 43/174 (24%), Positives = 83/174 (47%), Gaps = 10/174 (5%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLST---TSGQGIEELKNEVLLIAKLQ 582
NF K+G+G F VYK L +G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-FDESRKQLLDWKKRFDIILGIARGVL 641
H N++K L +E +E ++ E L I + +K+L+ + + + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
++H RI+HRD+K +N+ + ++ D G R F + A + VGT
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 8/163 (4%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
++ KLG G FG V+ G + ++AVK L + E E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLH 644
LV+L + E+ ++ E+M SL F+ D E R L D+ +A G+ Y+
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAYIE 119
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687
R+ IHRDL+++NIL+ + + +I+DFG AR+ E A
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 14/148 (9%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
+LG G FG VYK K G A K + T S + +E+ E+ ++A H +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL----YLHQDSRL 649
+ + ++ EF P ++D + + LD I I R +L YLH +
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLHS---M 129
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTA 677
+IIHRDLKA N+LL + +++DFG +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 24/177 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR-- 584
D+ +LG G G V K G+ +AVK + E ++ ++L + H+
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN---EAIQKQILRELDILHKCN 57
Query: 585 --NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL- 641
+V G + + E+M SLD I E + ++ + I+ IA VL
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPE-----RILGKIAVAVLK 111
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
YLH + +IIHRD+K SNIL++ + ++ DFG + G+ + ++ K VGT
Sbjct: 112 GLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGT 162
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQE------IAVKRLSTTSGQGIE-ELKNEVLLIAKL 581
N LG+G FG V+ K +E + VK L T + ++ E + E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI------FDESRKQLLDWKKRFDIILG 635
H+N+V+LLG C E + + +I E+ L F+ ++ + L K++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IA G+ +L S R +HRDL A N L+ + ++S ++
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+G G VY L N +++A+KR+ ++EL+ EV +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI--------FDESRKQLLDWKKRFDIILGIARGVL-- 641
+ DE L+ ++ SL + DE+ II + + VL
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA------------IIATVLKEVLKG 114
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGT 695
YLH + + IHRD+KA NILL E + +I+DFG + GG+ + K VGT
Sbjct: 115 LEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 51/164 (31%), Positives = 87/164 (53%), Gaps = 20/164 (12%)
Query: 536 LGQGGFGPVYKGKLSNGQEI---AVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
LG+G FG V +G+L+ I AVK +++ + +E+ +E + + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 591 GCCLEEDEN------MLIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGV 640
G CL+ E+ ++I FM + L F+ SR Q L + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG-TARVFGGE 683
YL S IHRDL A N +L+E MN ++DFG + +++ G+
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 37/172 (21%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-IAVKRLS-TTSGQGIEELK-NEVLLIAKLQHR 584
D + K+G+G +G VYK + E IA+K++ +G+ E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------------- 631
N+V+L E L++E+ LD LD KK D
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LD-----------LDLKKHMDSSPDFAKNPRLIK 105
Query: 632 -IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTARVFG 681
+ I RG+ Y H R++HRDLK N+L+D + N +++DFG AR FG
Sbjct: 106 TYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 19/166 (11%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSN---GQE---IAVKRLSTTSGQGIEELKNEVLLIAKLQ 582
N +LG+G FG V+ + N Q+ +AVK L S ++ E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL----------LDWKKRFDI 632
H ++VK G C+E D ++++E+M + L+ F+ + L + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IA G++YL + +HRDL N L+ E + +I DFG +R
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 44/166 (26%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 536 LGQGGFGP--VYKGKLSNGQ----EIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+G FG +Y+ + E+ + RLS + + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
++++ ++ E+ +L Y + QL + + + I V Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
I+HRD+K NI L + ++ DFG +++ G E +A T VVGT
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 53/176 (30%), Positives = 90/176 (51%), Gaps = 21/176 (11%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRN 585
+F KLG+G +G VYK K LS+ Q A+K L + S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 586 LVK-----LLGCCLEEDENMLIYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARG 639
++ L G L ++ E+ P L I + ++L+ ++ + I + + RG
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ LH+ +I+HRDLK++NILL +I D G ++V + K +GT
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 22/166 (13%)
Query: 529 NFSTSNKLGQGGFGPVYK-GKLSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHR 584
+F +G+G FG V K + A+K ++ + + NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 585 NLVKLLGCCLEEDENM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIAR 638
LV L +++ENM L+ + + L Y + F E + + I I
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIVL 111
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ YLH IIHRD+K NILLDE+ + I+DF A +
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 31/176 (17%)
Query: 530 FSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
F+ LG+G FG V + +L + Q++AVK L S IEE E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 584 RNLVKLLGCCLEEDEN------MLIYEFMPNKSLDYFI---------FDESRKQLLDWKK 628
N++KL+G L M+I FM + L F+ F + L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VFGGE 683
RF ++ IA G+ YL S IHRDL A N +L+E M ++DFG ++ ++ G+
Sbjct: 117 RF--MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 529 NFSTSNKLGQGGFGPVY--KGKLSNGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHR 584
+ K+G+G FG +Y K K S+ + +K + T + E K EV+L+AK++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE-----SRKQLLDWKKRFDIILGIARG 639
N+V E ++ E+ L I + S Q+L W + I+ G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLG 113
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVFGGEEILAITKRVVGT 695
+ ++H +I+HRD+K+ NI L + M ++ DFG AR LA T VGT
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 22/167 (13%)
Query: 536 LGQGGFGPVYKG--KLSNGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRNLVKLL 590
+G G FG V G KL +EI V + +G ++ ++ E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL------GIARGVLYLH 644
G + M++ E+M N SLD F+ RK +F +I GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL----RKH----DGQFTVIQLVGMLRGIASGMKYL- 122
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691
S + +HRDL A NIL++ + ++SDFG +RV + A T R
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 535 KLGQGGFGPVYKGKLSNGQEI-AVKRLSTTS-GQGIEELK-NEVLLIAKLQHRNLVKLLG 591
K+G+G +G V+K K EI A+KR+ +G+ E+ L+ +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+ + L++E+ YF +S +D + + + +G+ + H +
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFG 681
+HRDLK N+L+++ +++DFG AR FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 22/176 (12%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLS--TTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+G+G FG V K + S+G+ + K + + + ++L +EV ++ +L+H N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 591 GCCLEEDENMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARGVL---- 641
++ N +Y E+ L I + +K+ +K + I I +L
Sbjct: 66 DRIIDR-SNQTLYIVMEYCEGGDLAQLI-QKCKKE----RKYIEEEFIWRILTQLLLALY 119
Query: 642 YLH--QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
H D ++HRDLK +NI LD N ++ DFG A++ G + A T VGT
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 55/172 (31%), Positives = 87/172 (50%), Gaps = 39/172 (22%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTS---GQGIEELKNEVLLIAKLQHR 584
F N++G+G +G VY+ + + EI A+K++ + G I L+ E+ L+ L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 585 NLVKLL---------------GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKR 629
N+V+L C E+D L+ MP F ES+ +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDN-MPTP------FSESQVKC------ 112
Query: 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
++L + RG+ YLH++ IIHRDLK SN+LL +K +I+DFG AR +G
Sbjct: 113 --LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 53/159 (33%), Positives = 87/159 (54%), Gaps = 20/159 (12%)
Query: 536 LGQGGFGPVYKGK-LSNGQEI----AVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG VYKG + +G+ + A+K L TS + +E+ +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 590 LGCCLEEDENMLIYEFMPNKSL-DYFIFDESR---KQLLDWKKRFDIILGIARGVLYLHQ 645
LG CL L+ + MP L DY ++ R + LL+W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE 127
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+R++HRDL A N+L+ + +I+DFG AR+ +E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+LG G FG V+ GK ++A+K + + + IEE K ++ KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQLYG 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR----GVLYLHQDS 647
C ++ ++ EFM N L ++ + + +L D++L + + G+ YL ++S
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL-RQRQGKL-----SKDMLLSMCQDVCEGMEYLERNS 120
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IHRDL A N L+ ++SDFG R
Sbjct: 121 ---FIHRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 26/178 (14%)
Query: 533 SNKLGQGGFGPVYKGK-LSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVK 588
K+GQG FG V+K + Q +A+K++ + G I L+ E+ ++ L+H N+V
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN 75
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFD---ESRKQLLDWKK-RFD------IILGIAR 638
L+ C + K Y +F+ LL K +F ++ +
Sbjct: 76 LIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA---ITKRVV 693
G+ Y+H R +I+HRD+KA+NIL+ + +++DFG AR F + T RVV
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 18/152 (11%)
Query: 536 LGQGGFGPVYKGKLS----NGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+G G FG V +G+L +A+K L S + + + +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGIARGVLYLHQD 646
G + M+I EFM N +LD F+ + QL+ ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYL--- 122
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
S + +HRDL A NIL++ + ++SDFG +R
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 28/165 (16%)
Query: 535 KLGQGGFGPVYKGKLSN---GQEIAVKRL--STTSGQGIEELK-NEVLLIAKLQHRNLVK 588
+G+G +G VYK K N G+E A+K+ GI + E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFD---------ESRKQLLDWKKRFDIILGIARG 639
L+ LE + +Y DY D ++++ + ++ I G
Sbjct: 67 LVEVFLE-HADKSVYLL-----FDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 640 VLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTARVF 680
V YLH + ++HRDLK +NIL+ E+ +I D G AR+F
Sbjct: 121 VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN----EVLLIAKLQ 582
+ + +G+G +G V K + + G+ +A+K+ + E++K EV ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H N+V L + L++E++ L+ E+ L I + + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
H IIHRD+K NIL+ E ++ DFG AR
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 52/172 (30%), Positives = 89/172 (51%), Gaps = 19/172 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
DNF K+G+G G V S G+++AVK++ Q E L NEV+++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
V++ L DE ++ EF+ +L D I +R ++ ++ + L + + + +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTD--IVTHTR---MNEEQIATVCLAVLKALSFLHA 133
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
+IHRD+K+ +ILL ++SDFG F + + +R +VGT
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 40/172 (23%), Positives = 72/172 (41%), Gaps = 31/172 (18%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLS--TTSGQGIEELKNEVLLIA 579
+ + +LGQG FG VY+G +A+K ++ + + IE L NE ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFL-NEASVMK 64
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFM-------------PNKSLDYFIFDESRKQLLDW 626
+ ++V+LLG +++ E M P + + + ++ +
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 627 KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IA G+ YL + +HRDL A N ++ E + +I DFG R
Sbjct: 125 ------AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 24/163 (14%)
Query: 529 NFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRL-----STTSGQGIEELKNEVLLIAKLQ 582
N+ LGQG FG VY G+E+AVK++ S + + + L+ E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 583 HRNLVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL-----G 635
H +V+ GC + E L E MP S+ + QL + + +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSI--------KDQLKSYGALTENVTRKYTRQ 114
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
I GV YLH + I+HRD+K +NIL D N ++ DFG ++
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 29/171 (16%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELK-NEVL-------LIAKLQHRNL 586
+LG+G FG VY + + + +A +RL + EL NE + L++KL H +
Sbjct: 7 RLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRK--------QLLDWKKRFDIILGIAR 638
VK LE D +I E+ + LD +E + Q+ +W + +
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLD-CKLEELKHTGKTLSENQVCEW------FIQLLL 117
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
GV Y+HQ RI+HRDLKA NI L + +I DFG +R+ G LA T
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 53/176 (30%), Positives = 95/176 (53%), Gaps = 22/176 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQH 583
D + N++ +G +G VY+ + G+ +A+K+L G I L+ E+ ++ KLQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 584 RNLVKL----LGCCLEEDENMLIYEFMPN--KSLDYFIFDESRKQLLDWKKRFDIILGIA 637
N+V + +G L D+ ++ E++ + KSL + ++ L + + ++L +
Sbjct: 64 PNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSL----METMKQPFLQSEVKC-LMLQLL 116
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
GV +LH + I+HRDLK SN+LL+ + +I DFG AR + G + T+ VV
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV 168
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 48/151 (31%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+LG G FG V GK ++A+K + S + + IEE K ++ KL H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMKLSHEKLVQLYG 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGIARGVLYLHQDS 647
C ++ ++ E+M N L ++ + ++ QLL+ K + G+ YL
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------DVCEGMAYLESK- 119
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ IHRDL A N L+D++ ++SDFG +R
Sbjct: 120 --QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 43/181 (23%)
Query: 535 KLGQGGFGPVYKGKLSNGQE-----------------IAVKRLSTTSGQGIE-ELKNEVL 576
KLG+G FG V+ ++ N Q+ +AVK L + + + EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLD----------- 625
++++L+ N+++LLG C++ED +I E+M N L+ F+ S L D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 626 --------WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
+ + L IA G+ YL S L +HRDL N L+ E + +I+DFG +
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 678 R 678
R
Sbjct: 186 R 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 440 RARKRRLALIIVAIVLGVILL----GLCFFFLRRRLATRIGERKRQRRR----ELLFLNS 491
R RK + LG L+ F F+R R E KR EL F +S
Sbjct: 621 RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR---NNLELKRVENEDGTWELQFFDS 677
Query: 492 STRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LS 550
+ S+ SI+ L + + N + +G G YKGK +
Sbjct: 678 --KVSK---SITIND---------------ILSSLKEE----NVISRGKKGASYKGKSIK 713
Query: 551 NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610
NG + VK ++ + I +E+ + KLQH N+VKL+G C E LI+E++ K+
Sbjct: 714 NGMQFVVKEINDVNS--IPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769
Query: 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670
L + + L W++R I +GIA+ + +LH ++ +L I++D K P
Sbjct: 770 LSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH 823
Query: 671 I 671
+
Sbjct: 824 L 824
|
Length = 968 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 24/163 (14%)
Query: 529 NFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRL-----STTSGQGIEELKNEVLLIAKLQ 582
N+ LG+G FG VY G+E+AVK++ S + + + L+ E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 583 HRNLVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESRKQL-----LDWKKRFDIILG 635
H +V+ GC + +E L E+MP S+ + QL L
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTRRYTRQ 114
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
I +GV YLH + I+HRD+K +NIL D N ++ DFG ++
Sbjct: 115 ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 47/193 (24%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQH 583
D F ++G+G +G VYK + + G+ +A+K++ + G I ++ E+ ++ +L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD----------ESR------------- 620
RN+V L ++ + + +F +K Y +F+ ES
Sbjct: 66 RNIVNLKEIVTDKQDAL---DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 621 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
KQLL+ G+ Y H+ + L HRD+K SNILL+ K +++DFG AR++
Sbjct: 123 KQLLE-------------GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 681 GGEEILAITKRVV 693
EE T +V+
Sbjct: 167 NSEESRPYTNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 43/146 (29%), Positives = 76/146 (52%), Gaps = 16/146 (10%)
Query: 535 KLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
K+GQG G VY ++ GQE+A+K+++ E + NE+L++ + +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL----YLHQDSRL 649
L DE ++ E++ SL + + + I + R L +LH +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVCRECLQALEFLHSN--- 134
Query: 650 RIIHRDLKASNILLDEKMNPRISDFG 675
++IHRD+K+ NILL + +++DFG
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 42/163 (25%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKL 581
D + S+ L +G FG ++ G L +E+ VK + + + + L E L+ L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 582 QHRNLVKLLGCCLEE-DENMLIYEFMPNKSLDYF-----IFDESRKQLLDWKKRFDIILG 635
H+N++ +L C+E+ + ++Y +M +L F + + + Q L ++ + +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IA G+ YLH + +IH+D+ A N ++DE++ +I+D +R
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 5e-12
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 41/170 (24%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN------EVLLIAKLQHRNLVK 588
+G G +G V G+++A+K++S ++L + E+ L+ L+H N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV----FDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 589 LLGCCLEEDENMLIYEFMPNKSLD----YFIFD----------ESRKQLLDWKKRFDIIL 634
LL ++L P D Y + + +S + L D ++ +
Sbjct: 64 LL--------DILR----PPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY-FLY 110
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
I RG+ YLH +IHRDLK SNIL++ + +I DFG AR +E
Sbjct: 111 QILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 43/171 (25%), Positives = 84/171 (49%), Gaps = 13/171 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
++F ++G G +G VYK + ++ G+ A+K + G+ ++ E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
V G L D+ + EF SL Y + + + + R + +G+ YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ +HRD+K +NILL + + +++DFG + +A K +GT
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGT 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 33/172 (19%)
Query: 536 LGQGGFGPVYKGK------LSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLVK 588
LG+G FG V K + +AVK L + + +L +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRK----------------------QLLDW 626
L G C ++ +LI E+ SL F+ ESRK + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFL-RESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 627 KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
I+RG+ YL + ++++HRDL A N+L+ E +ISDFG +R
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 34/161 (21%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRL-----STTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LGQG FG VY + G+E+A K++ S + + + L+ E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 590 LGCCLEEDENML--IYEFMPNKSLD-----YFIFDES-----RKQLLDWKKRFDIILGIA 637
GC + E L E+MP S+ Y ES +Q+L+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE------------ 117
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
G+ YLH + I+HRD+K +NIL D N ++ DFG ++
Sbjct: 118 -GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 7e-12
Identities = 44/150 (29%), Positives = 81/150 (54%), Gaps = 9/150 (6%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLV 587
F+ K+G+G FG V+KG + Q++ A+K + + IE+++ E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
K G L++ + +I E++ S D LD + I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTA 677
+ IHRD+KA+N+LL E +++DFG A
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 46/146 (31%), Positives = 73/146 (50%), Gaps = 12/146 (8%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE 595
+G+G FG V G G ++AVK + + + E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 596 EDENMLIY-EFMPNKSL-DYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
E + I E+M SL DY SR + +L L + + YL ++ +
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 653 HRDLKASNILLDEKMNPRISDFGTAR 678
HRDL A N+L+ E ++SDFG +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 535 KLGQGGFGPVYKGKLSN-GQEIAVKR-LSTTSGQGIEELK-NEVLLIAKLQHRNLVKLLG 591
+G+G +G V K K GQ +A+K+ L + + ++++ E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+ L++EF+ + LD E LD + + I RG+ + H + I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGG 682
IHRD+K NIL+ + ++ DFG AR
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 9e-12
Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLV 587
F +G G +G VYKG+ + GQ A+K + T G EE+K E+ ++ K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 66
Query: 588 KLLGCCLE------EDENMLIYEFMPNKSLDYFIFDESRKQLL-DWKKRFDIILGIARGV 640
G ++ +D+ L+ EF S+ I + L +W I I RG+
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
+LHQ ++IHRD+K N+LL E ++ DFG +
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 43/150 (28%), Positives = 82/150 (54%), Gaps = 9/150 (6%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLV 587
F+ ++G+G FG VYKG + +E+ A+K + + IE+++ E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+ G L+ + +I E++ S D + L+ I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTA 677
R IHRD+KA+N+LL E+ + +++DFG A
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 12/148 (8%)
Query: 536 LGQGGFGPVYKGK-LSNGQEI----AVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG V+KG + G I A+K + SG Q +E+ + +L + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
LG C L+ + P SL + + LD ++ + + IA+G+ YL +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTA 677
R++HR+L A NILL +I+DFG A
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 535 KLGQGGFGPVYKGKLSNGQE---------------IAVKRL-STTSGQGIEELKNEVLLI 578
KLG+G FG V+ + E +AVK L + + + E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-ESRKQL--------LDWKKR 629
++L++ N+++LLG C+ +D +I E+M N L+ F+ E +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
+ + IA G+ YL + L +HRDL N L+ +I+DFG +R + I
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 690 KRVV 693
R V
Sbjct: 189 GRAV 192
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 13/149 (8%)
Query: 535 KLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL----QHRNLVKL 589
++G+G FG V+ G+L ++ +AVK T +LK + L A++ H N+V+L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRL 58
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+G C ++ ++ E + + D+ F + L K+ ++ A G+ YL
Sbjct: 59 IGVCTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH-- 114
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTAR 678
IHRDL A N L+ EK +ISDFG +R
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 43/161 (26%), Positives = 87/161 (54%), Gaps = 11/161 (6%)
Query: 519 ELSTLLAATD---NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNE 574
+L T+++ D ++ K+GQG G V+ ++ GQE+A+K+++ E + NE
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE 66
Query: 575 VLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 634
+L++ +L++ N+V L L DE ++ E++ SL D + +D + +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+ + +LH + ++IHRD+K+ N+LL + +++DFG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 536 LGQGGFGPVY------KGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ +++ KRL G+ + + ++L K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL--EKVSSRFIVSL 58
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQD 646
+D+ L+ M L Y I++ + + F II G+ +LHQ
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL----EHLHQ- 113
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
RI++RDLK N+LLD+ N RISD G A
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 49/149 (32%), Positives = 82/149 (55%), Gaps = 12/149 (8%)
Query: 534 NKLGQGGFGPVYKG--KLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
+KLG+G + VYKG KL++ +A+K RL G ++ EV L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
E L++E++ +K L ++ D + K F + + RG+ Y H R
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RR 123
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTAR 678
+++HRDLK N+L++E+ +++DFG AR
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL----STT--SGQGIEELK 572
T+ T+ + +G G FG V + GQ +A+K++ ST + + ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 573 NEVLLIAKLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESR---KQLLDWKK 628
L+ L+H N++ L + E++ + E + D SR KQ + +
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQY-- 112
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+ I RG+ Y+H ++HRDLK SNIL++E + +I DFG AR+
Sbjct: 113 ---FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 26/174 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRLS-TTSGQGIEELKNEVLLI 578
D LG+G FG V + + +AVK L + + + +L +E+ L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 579 AKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----------FD--ESRKQLL 624
+ +H+N++ LLG C +E +I E+ +L F+ FD + ++ L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+K +ARG+ YL +SR R IHRDL A N+L+ E +I+DFG AR
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 26/173 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKG------KLSNGQEIAVKRL-STTSGQGIEELKNEVLLIAK 580
D + LG+G FG V K + +AVK L + + + +L +E+ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG---- 635
+ +H+N++ LLG C +E ++ E+ + +L F+ R
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLT 130
Query: 636 ----------IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ARG+ +L + IHRDL A N+L+ E +I+DFG AR
Sbjct: 131 QKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 42/150 (28%), Positives = 82/150 (54%), Gaps = 9/150 (6%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLV 587
F+ ++G+G FG V+KG + Q++ A+K + + IE+++ E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
K G L+ + +I E++ S D R D + ++ I +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTA 677
+ IHRD+KA+N+LL E+ + +++DFG A
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHR 584
D++ KLG+G + VYKGK NG+ +A+K RL G ++ E L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLL-DWKKRFDIILGIARGVLYL 643
N+V L ++ L++E++ Y D+ L + K F + + RG+ Y+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLF--LFQLLRGLSYI 119
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
HQ I+HRDLK N+L+ + +++DFG AR
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 22/163 (13%)
Query: 535 KLGQGGFGPVYKGKLSN------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
+LG+G FG V+ + N +AVK L + ++ + E L+ LQH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYF----------IFDESRKQL---LDWKKRFDIILG 635
G C + D ++++E+M + L+ F + D +Q L + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IA G++YL + +HRDL N L+ + +I DFG +R
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 11/149 (7%)
Query: 535 KLGQGGFGPVYKG--KLSNGQEI--AVKRLSTTSGQGIEEL-KNEVLLIAKLQHRNLVKL 589
+G+G FG VY+G ++I AVK + + E E ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+G E+ ++ E P L ++ + K LD ++ + YL
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTAR 678
R +HRD+ A N+L+ ++ DFG +R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 18/170 (10%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQ---HRNLVK 588
++G G +G VYK + +G +A+K + + + L EV L+ +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 589 LLGCCL-----EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
L+ C E + L++E + Y D+ L + D++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
H + I+HRDLK NIL+ +++DFG AR++ + +A+T VV
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVV 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 48/149 (32%), Positives = 80/149 (53%), Gaps = 12/149 (8%)
Query: 534 NKLGQGGFGPVYKG--KLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
KLG+G + V+KG KL+ +A+K RL G ++ EV L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+ L++E++ +K L ++ D + K F + I RG+ Y H R
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RR 123
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTAR 678
+++HRDLK N+L++E+ +++DFG AR
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 28/155 (18%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
+LG G FG VYK + G A K + T S + +E+ E+ ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESR-----------KQLLDWKKRFDIILGIARGVLY 642
E+ ++ EF ++D + + R KQ L+ + Y
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE-------------ALNY 118
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
LH++ +IIHRDLKA NIL + +++DFG +
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 24/168 (14%)
Query: 536 LGQGGFGPVYKGKLSNG---QEIAVKRLSTTSGQGIE-ELKNEVLLIAKL-QHRNLVKLL 590
+G+G FG V K ++ + A+KR+ + + + E+ ++ KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 591 GCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFDIILGIA 637
G C L E+ P+ +L D+ F S L ++ +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
RG+ YL Q + IHRDL A NIL+ E +I+DFG +R G+E+
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEV 176
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 43/154 (27%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 535 KLGQGGFGPVYKG--KLSNGQ-EIAVKRLSTTSGQGI-EELKNEVLLIAKLQHRNLVKLL 590
+LG G FG V KG K+ Q ++A+K L + + + +E+ E ++ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
G C E + ML+ E L+ F+ +K + +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+HRDL A N+LL + +ISDFG ++ G ++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 38/176 (21%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKR-LSTTSGQGIEELK-NEVLLIAKLQHR 584
D + K+G+G +G VYK + + G+ +A+K+ +GI E+ L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 585 N-LVKLLGCCLEEDENMLIYEFMPNKSLDYFIF---DESRKQLLDWKKR----------- 629
+V+LL +E E K Y +F D K+ +D R
Sbjct: 61 IYIVRLL--DVEHVEEK------NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 630 ----FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVF 680
+ ++ G+A + H + ++HRDLK N+L+D +K +I+D G R F
Sbjct: 113 KSFMYQLLKGVA----HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQH---RNLVKLL 590
+G+G +G VY+GK + G+ +A+K ++ T + +++ EV L+++L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL----YLHQD 646
G L+ +I E+ S+ + + K I I R VL Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTL----MKAGPIAEK----YISVIIREVLVALKYIHKV 120
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
+IHRD+KA+NIL+ N ++ DFG A
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 19/153 (12%)
Query: 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRNLVKLLG 591
+G G +G V + G+++A+K+LS Q K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 592 C-----CLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
LE+ +++ L+ M L+ + ++L D +F ++ I RG+ Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLM-GADLNNIV---KCQKLSDDHIQF-LVYQILRGLKYIHS 136
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IIHRDLK SNI ++E +I DFG AR
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 45/177 (25%), Positives = 72/177 (40%), Gaps = 35/177 (19%)
Query: 531 STSNKLGQGGFGPVYKGKLSNGQEI-----------------AVKRL-STTSGQGIEELK 572
+ KLG+G FG V+ + Q+ AVK L S E+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 573 NEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD- 631
EV ++++L N+ +LLG C + +I E+M N L+ F+ + +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL---QKHVAETSGLACNS 124
Query: 632 ----------IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ IA G+ YL L +HRDL N L+ + +I+DFG +R
Sbjct: 125 KSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQH-R 584
D+ +LG+G +G V K + + G +AVKR+ +T + Q + L ++ + +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIAR 638
V G E + + E M + SLD F K++ D I + I +
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVK 114
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+ YLH S+L +IHRD+K SN+L++ ++ DFG
Sbjct: 115 ALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG 149
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 46/145 (31%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 536 LGQGGFGPVYKGKLSN-GQEIAVKRL-STTSGQGIEELKNEVLLIAKLQH-RNLVKLLGC 592
+G+G FG V K G +AVKR+ ST + + L ++ ++ + +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 593 CLEEDENMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
E + + E M + SLD Y E K ++ + I + + + YL ++ L+
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LK 128
Query: 651 IIHRDLKASNILLDEKMNPRISDFG 675
IIHRD+K SNILLD N ++ DFG
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFG 153
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLL 577
+LS L F +G G +G VYKG+ + GQ A+K + T + EE+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINM 65
Query: 578 IAKL-QHRNLVKLLGCCLE------EDENMLIYEFMPNKSLDYFIFDESRKQLL-DWKKR 629
+ K HRN+ G ++ +D+ L+ EF S+ + + L DW
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
I I RG+ +LH ++IHRD+K N+LL E ++ DFG +
Sbjct: 126 --ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIE-ELKNEVLLIAKLQHRNLVKLLG 591
N++G G G VYK G+ A+K + + ++ E+ ++ + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 592 CCLEEDENMLIYEFMPNKSLD-YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
E ++ EFM SL+ I DE + L D ++ I+ GIA YLH R
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADE--QFLADVARQ--ILSGIA----YLH---RRH 188
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARV 679
I+HRD+K SN+L++ N +I+DFG +R+
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 37/153 (24%), Positives = 78/153 (50%), Gaps = 18/153 (11%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQ-HRNLVKL 589
K+G+G F V K + G+ A+K + + +E++ N E+ + +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 590 LGCCLEEDEN--MLIYEFMPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+ + L++E M D +++ + RK+ L K+ + + + + ++H+
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ I HRD+K NIL+ + +++DFG+ R
Sbjct: 119 NG---IFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 43/172 (25%), Positives = 86/172 (50%), Gaps = 10/172 (5%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHR 584
NF K+G+G F VY+ L + + +A+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-FDESRKQLLDWKKRFDIILGIARGVLYL 643
N++K L +E++E ++ E L I + + +K+L+ + + + + V ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
H SR R++HRD+K +N+ + ++ D G R F + A +VGT
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 41/147 (27%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 530 FSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
++ K+GQG G VY ++ GQE+A+K+++ E + NE+L++ + ++ N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
L L DE ++ E++ SL D + +D + + + + +LH +
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN-- 134
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFG 675
++IHRD+K+ NILL + +++DFG
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 42/142 (29%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 535 KLGQGGFGPV-YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
K+G+G G V + G+++AVK++ Q E L NEV+++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
L DE ++ EF+ +L D ++ ++ + L + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 654 RDLKASNILLDEKMNPRISDFG 675
RD+K+ +ILL ++SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 41/176 (23%), Positives = 78/176 (44%), Gaps = 49/176 (27%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-----TTSGQGIEELKNEVLLIAKL 581
+ + +G+G +G V G ++A+K++S T + + E+K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 582 QHRNLVKLLGCCLEED-ENM----LIYEFMP-------------NKSLDYFIFDESRKQL 623
+H N++ +L E+ ++ E M N + YF++ Q+
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-----QI 115
Query: 624 LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
L RG+ Y+H + ++HRDLK SN+LL+ + +I DFG AR+
Sbjct: 116 L-------------RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 32/158 (20%)
Query: 535 KLGQGGFGPVYKGKLS-NGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
KLG+G + VYKG+ GQ +A+K RL G ++ E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKR-----------FDIILGIARGV 640
+ L++E++ D KQ +D F ++ RG+
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGL 116
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
Y HQ R++HRDLK N+L+ E+ +++DFG AR
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEE---LKNEVLLIAKLQHRN 585
F ++GQGG+G V+ K + EI A+KR+ + + E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 586 LVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
LVKLL ++DE + L E++P D+ + L + RF + V LH
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH 118
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
L IHRDLK N L+D + +++DFG ++ I+ VVG+
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGS 161
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 53/154 (34%), Positives = 73/154 (47%), Gaps = 22/154 (14%)
Query: 536 LGQGGFGPVY------KGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GKL +++ KRL +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 590 LGCCLEEDENM-LIYEFMPNKSLDYFIF--DESRKQLLDWKKRF---DIILGIARGVLYL 643
+ ++ L+ M L Y I+ DE + + F II G+ +L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLE----HL 113
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
HQ RII+RDLK N+LLD N RISD G A
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 4e-10
Identities = 40/147 (27%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 530 FSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
++ K+GQG G VY ++ GQE+A+++++ E + NE+L++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
L L DE ++ E++ SL D + +D + + + + +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFG 675
++IHRD+K+ NILL + +++DFG
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 39/152 (25%), Positives = 74/152 (48%), Gaps = 11/152 (7%)
Query: 529 NFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
++ ++G G +G VYK L G+ AVK + G ++ E+ ++ + +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
G L ++ + E+ SL Y + + + + R + +G+ YLH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHS 124
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
++ HRD+K +NILL + + +++DFG A
Sbjct: 125 KGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 535 KLGQGGFGPVYKGK-LSNGQE-IAVKRLST-TSGQGIE-ELKNEVLLIAKLQ---HRNLV 587
++G+G +G V+K + L NG +A+KR+ T +G+ EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 588 KLLGCCL-----EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
+L C E + L++E + Y D+ + + + D++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688
LH R++HRDLK NIL+ +++DFG AR++ + L
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 168
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 6e-10
Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 38/165 (23%)
Query: 534 NKLGQGGFGPVYKG-KLSNGQEIAVKRL-----STTSGQGIEELKNEVLLIAKL-QHRNL 586
KLG+G +G V+K + +A+K++ + T Q E++ + +L H N+
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ---RTFREIMFLQELGDHPNI 69
Query: 587 VKLLGCCLEEDENM----LIYEFMPNKSLDYFIFDES------RKQLL-DWKKRFDIILG 635
VKLL + + EN L++E+M E+ R +L D KR+ I+
Sbjct: 70 VKLLN--VIKAENDKDIYLVFEYM-----------ETDLHAVIRANILEDVHKRY-IMYQ 115
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
+ + + Y+H S +IHRDLK SNILL+ +++DFG AR
Sbjct: 116 LLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 534 NKLGQGGFGPVYKGKLS-NGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+KLG+G + V+KG+ +A+K RL G ++ EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
E L++E++ + Y ++ L+ + + RG+ Y H + +
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTAR 678
I+HRDLK N+L++EK +++DFG AR
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 45/146 (30%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 535 KLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIE-ELKNEVLLIAKLQHRNLVKLLGC 592
KLG+G + VYKG NGQ +A+K +S + +G+ E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
++ ++E+M Y I + L + R + + RG+ Y+H I+
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHIL 125
Query: 653 HRDLKASNILLDEKMNPRISDFGTAR 678
HRDLK N+L+ +++DFG AR
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 9/150 (6%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIA---VKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKL 589
+++G G FG V G+ G A VK L ++ + EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQDS 647
LG C+E +L+ EF P L ++ +K + +A G+L+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTA 677
IH DL N L ++ +I D+G A
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
DNF K+G+G G V + S+G+ +AVK++ Q E L NEV+++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
V++ L DE ++ EF+ +L D ++ ++ + L + + + LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFG 675
+IHRD+K+ +ILL ++SDFG
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 26/176 (14%)
Query: 526 ATDNFSTSNKLGQGGFGPVY--------KGKLSNGQEIAVKRL-STTSGQGIEELKNEVL 576
D LG+G FG V K K + ++AVK L S + + + +L +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 577 LIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIF-------------DESRKQ 622
++ + +H+N++ LLG C ++ +I E+ +L ++ + ++
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 623 LLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
L +K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRL--------STTSGQGIEE------LKNEVLLI 578
LG+G +G V K G+ +A+K++ T Q + E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------I 632
+++H N++ L+ +E D L+ + M K+++D K R I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVKCI 124
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+L I G+ LH+ +HRDL +NI ++ K +I+DFG AR +G
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170
|
Length = 335 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 50/159 (31%), Positives = 73/159 (45%), Gaps = 12/159 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK---LSNGQ---EIAVKRL-STTSGQGIEELKNEVLLIAK 580
+N S LG G FG V + LS ++AVK L T E L +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
L H N+V LLG C ++I E+ L F+ R+ L + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ +L + IHRDL A N+LL +I DFG AR
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 535 KLGQGGFGPVYKG--KLSNGQE-IAVKRLSTTSGQGIEELKNEVLLIAK----LQHRNLV 587
+LG G FG V KG K+ ++ +AVK L + LK+E+L A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+++G C E + ML+ E L+ F+ + K + + K +++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTE-KNITELVHQVSMGMKYLEETN 115
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+HRDL A N+LL + +ISDFG ++ G +E
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 38/160 (23%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH 583
D+ +G G FG V+ + + A+K ++ + + + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 584 RNLVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIAR 638
+++L E D+ L + E++P L F + + + + F +I+ +
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCALE- 115
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
YLH I++RDLK NILLD++ + +++DFG A+
Sbjct: 116 ---YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 13/157 (8%)
Query: 536 LGQGGFGPV------YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ +++ KRL SG+ + L+ E+L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+ L+ M L Y I++ + L + ++ I G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTA-RVFGGEEI 685
I++RD+K N+LLD++ N R+SD G A + G+ I
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 26/174 (14%)
Query: 528 DNFSTSNKLGQGGFGPVY--------KGKLSNGQEIAVKRLS-TTSGQGIEELKNEVLLI 578
D + LG+G FG V K K +AVK L + + + +L +E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 579 AKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----------FDESR--KQLL 624
+ +H+N++ LLG C ++ +I E+ +L ++ +D +R + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 24/161 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTT----SGQGIEELKNEVLLIAKLQ 582
D+F +G+G FG V+ + + ++ A+K L + Q I ++ E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 583 HRNLVKLLGCCLEEDENM-LIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGI 636
+VKL +++E++ L+ E+MP L +F E + + + I
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----I 107
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
A VL L +L IHRD+K NIL+D + +++DFG
Sbjct: 108 AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 43/177 (24%), Positives = 77/177 (43%), Gaps = 29/177 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-----------------IAVKRLSTTSGQGIE- 569
+ KLG+G FG V+ + ++ +AVK L + +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 570 ELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-ESRKQLLDWKK 628
+ E+ ++++L+ N+++LL C+ D +I E+M N L+ F+ E ++
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 629 RF-------DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ IA G+ YL S L +HRDL N L+ + +I+DFG +R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 28/110 (25%), Positives = 50/110 (45%), Gaps = 16/110 (14%)
Query: 574 EVLLIAKLQHRNLVKLLGCCLEEDENMLIYE-----FMPNKSLDYFIFDESRKQLLDWKK 628
E +L+ + H +++++ + L+ +P+ S D + + R + L +
Sbjct: 107 EAMLLQNVNHPSVIRMK--------DTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
I I G+ YLH RIIHRD+K NI +++ I D G A+
Sbjct: 159 ALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 535 KLGQGGFGPVYKGKLSNG---QEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLL 590
++G G FG V G++++G ++ VK L ++ Q + E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLL--DWKKRFDIILGIARGVLYLHQDSR 648
G C E +L+ EF P L ++ + +L+ D + IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTA 677
IH DL N LL + +I D+G +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 43/172 (25%), Positives = 83/172 (48%), Gaps = 10/172 (5%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLST---TSGQGIEELKNEVLLIAKLQHR 584
NF K+G+G F VY+ L +G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYL 643
N++K +E++E ++ E L I + +K+L+ K + + + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
H SR R++HRD+K +N+ + ++ D G R F + A +VGT
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 23/168 (13%)
Query: 536 LGQGGFGPVYKGKLSN---------GQEIAVKRLSTTSGQGI-EELKNEVLLIAKLQHRN 585
LGQG F +YKG L GQE++V S L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
LVKL G C+ DEN+++ E++ LD F+ E L WK D+ +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 646 DSRLRIIHRDLKASNILL-----DEKMNP--RISDFGTARVFGGEEIL 686
+++H ++ NIL+ +E P ++SD G E
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 536 LGQGGFGPVY--------KGKLSNGQEIAVKRLST-TSGQGIEELKNEVLLIAKL-QHRN 585
LG+G FG V K K + +AVK L + + + +L +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----------FDESR--KQLLDWKKRFDI 632
++ LLG C ++ ++ E+ +L ++ FD + ++ L +K
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ARG+ YL + + IHRDL A N+L+ E +I+DFG AR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 9e-09
Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 32/167 (19%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTT----SGQGIEELKNEVLLIAKLQ 582
D+F LG G FG V + + A+K LS Q +E + NE ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD----------I 632
H LV L G ++ L+ E++P L F RK RF +
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRK-----SGRFPEPVARFYAAQV 110
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+L + YLH L I++RDLK N+LLD +I+DFG A+
Sbjct: 111 VLALE----YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR 150
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 53/171 (30%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 520 LSTLLAATDNFSTSNKLGQGGFGPVYK-GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLI 578
L +L TD + +G+G +G VYK +G AVK L S EE++ E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 579 AKL-QHRNLVKLLGCCLEEDENM-----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFD- 631
L H N+VK G + D+ + L+ E S+ + K LL +R D
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127
Query: 632 -----IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
I+ G G+ +LH + RIIHRD+K +NILL + ++ DFG +
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 42/142 (29%), Positives = 77/142 (54%), Gaps = 8/142 (5%)
Query: 535 KLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
K+G+G G V + +G+++AVK + Q E L NEV+++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
L +E ++ EF+ +L I ++R L+ ++ + + + + YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD-IVSQTR---LNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 654 RDLKASNILLDEKMNPRISDFG 675
RD+K+ +ILL ++SDFG
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFG 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-08
Identities = 26/79 (32%), Positives = 38/79 (48%), Gaps = 8/79 (10%)
Query: 346 GFIKLERMKLPDTSVAANVDMNLGLKACEEKCL-SNCSCVAYASASAETNRGIGCLMYH- 403
F++L KLP S +L + C KCL SNCSC ++ N GCL++
Sbjct: 5 CFVRLPNTKLPGFSRIVISVASL--EECASKCLNSNCSCRSFTY----NNGTKGCLLWSE 58
Query: 404 GDLNDTRKYTNAGQDLFVR 422
L D R + + G DL+ +
Sbjct: 59 SSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 25/170 (14%)
Query: 536 LGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEE-LKNEVLLIAKLQHRNLVKLLG 591
LG GGFG V K+ S + A+K + G +E + +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 592 CCLEEDEN---MLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQ 645
+D+ ML+ E+ L + D R ++ RF ++L YLH
Sbjct: 60 -RTFKDKKYIYMLM-EYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFE----YLH- 110
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
II+RDLK N+LLD ++ DFG A+ + T GT
Sbjct: 111 --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKG------KLSNGQEIAVKRLSTTSG--QGIEELKNEVLL 577
A + + S +LGQG FG VY+G K +A+K ++ + + IE L NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASV 62
Query: 578 IAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIF-------DESRKQLLDWKKRF 630
+ + ++V+LLG + ++I E M L ++ + + KK
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ IA G+ YL+ + + +HRDL A N ++ E +I DFG R
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 536 LGQGGFGPV------YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ +++ KR+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+D L+ M L + I+ + + F I G+ LHQ+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQE--- 121
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTA 677
RI++RDLK NILLD+ + RISD G A
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 41/153 (26%), Positives = 80/153 (52%), Gaps = 13/153 (8%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKR-LSTTSGQGIEELK-NEVLLIAKLQHRNLVKLLG 591
K+G+G +G V+K + GQ +A+K+ + + I+++ E+ ++ +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRK--QLLDWKKRFDIILGIARGVLYLHQDSRL 649
+ + L++E+ D+ + +E K + + II + V + H+
Sbjct: 68 VFRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK---H 119
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682
IHRD+K NIL+ ++ ++ DFG AR+ G
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 51/181 (28%), Positives = 73/181 (40%), Gaps = 53/181 (29%)
Query: 538 QGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596
+G FG VY K S G A+K L + +IAK Q N+ E
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSD------------MIAKNQVTNV-------KAE 46
Query: 597 DENMLIYEFMPNKSLDYFIFD-----------------ESRKQLL-----DWKKRFDIIL 634
M+I P + Y+ F S + L DW K++ I
Sbjct: 47 RAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IA 104
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ GV LHQ IIHRD+K N+L+D+ + +++DFG +R G K+ VG
Sbjct: 105 EVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GL----ENKKFVG 155
Query: 695 T 695
T
Sbjct: 156 T 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 40/171 (23%)
Query: 528 DNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLS------TTSGQGIEELKNEVLLIAK 580
+ +G G +G V +G+++A+K++ T + + + ELK ++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRH 60
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD---YFIFD----------ESRKQLLDWK 627
+H N++ + P + Y + D S + L +
Sbjct: 61 FKHDNIIAIRDI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEH 108
Query: 628 KRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
R+ + + RG+ Y+H + +IHRDLK SN+L++E RI DFG AR
Sbjct: 109 IRY-FLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 32/178 (17%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQG---IEELKNEVLLIAKLQHRNLVKLLG 591
+ +G +G V+ K S G A+K + ++++ E ++++ Q +VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 592 CCLEEDENM-LIYEFMPN---KSL--DYFIFDESRKQLLDWKKRF--DIILGIARGVLYL 643
+ +N+ L+ E++P SL + DE D + + +I+L + YL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVARIYIAEIVLALE----YL 109
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV-FGGEEILAI-----TKRVVGT 695
H IIHRDLK NIL+D + +++DFG ++V +I KR+VGT
Sbjct: 110 HS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 49/155 (31%), Positives = 70/155 (45%), Gaps = 26/155 (16%)
Query: 536 LGQGGFGPV------YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ +++ KR+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-------FDESRKQLLDWKKRFDIILGIARGVLY 642
+D L+ M L + I FDE R + I G+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE--------ITCGLED 117
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
LH R RI++RDLK NILLD+ + RISD G A
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 536 LGQGGFGP--VYKGKLSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+G+G FG + + S+ Q+ A+K + S +E+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRK-----QLLDWKKRFDIILGIARGVLYLHQDS 647
+ ++ E+ L I + K +L W + + GV ++H+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK- 119
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
R++HRD+K+ NI L + ++ DFG+AR+ A T VGT
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGT 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 43/166 (25%)
Query: 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQHRNLVKLLGC 592
+G+G +G V K S +++A+K+++ I+ + E+ L+ L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 593 CLEEDENM-----LIYEFM---------PNKSL-----DYFIFDESRKQLLDWKKRFDII 633
++YE M +++L YF++ QLL
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY-----QLL--------- 118
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
RG+ Y+H + ++HRDLK SN+LL+ + +I DFG AR
Sbjct: 119 ----RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 522 TLLAATDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKN---EVLL 577
T+ + + + +G G +G V G +AVK+LS Q I K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRL 69
Query: 578 IAKLQHRNLVKLL-----GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDI 632
+ ++H N++ LL LEE ++ + + L+ + ++L D +F +
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-L 125
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
I I RG+ Y+H IIHRDLK SN+ ++E +I DFG AR
Sbjct: 126 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 24/168 (14%)
Query: 536 LGQGGFGPVYKG---KLSNGQEIAVKRLST-TSGQGIEELKNEVLLIAKL-QHRNLVKLL 590
+G+G FG V + K A+K L S + E+ ++ KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 591 GCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFDIILGIA 637
G C + E+ P +L D+ F + L ++ +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
G+ YL S + IHRDL A N+L+ E + +I+DFG +R GEE+
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEV 171
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 16/148 (10%)
Query: 536 LGQGGFGPVYKG--KLSNGQEIAVK----RLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG + +G KL + +E+ V R + Q L E L + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRL 71
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQ--LLDWKKRFDIILGIARGVLYLHQDS 647
G + M++ E+M N +LD F+ RK L + ++ G+A G+ YL S
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYL---S 124
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFG 675
+ +H+ L A +L++ + +IS F
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 536 LGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL---- 590
LG G G V+ S+ + +AVK++ T Q ++ E+ +I +L H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 591 --GCCLEEDENML-----IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
G L ED L +Y D E + + F L RG+ Y+
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL--LRGLKYI 130
Query: 644 HQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARV 679
H + ++HRDLK +N+ ++ E + +I DFG AR+
Sbjct: 131 HSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 48/155 (30%), Positives = 68/155 (43%), Gaps = 26/155 (16%)
Query: 536 LGQGGFGPV------YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ +++ KR+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-------FDESRKQLLDWKKRFDIILGIARGVLY 642
+D L+ M L + I FDE R I A
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----------IFYAAELCCG 114
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
L R RI++RDLK NILLD++ + RISD G A
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIE-ELKNEVLLIAKLQHRNLVKLLGCC 593
K+G+G +G VYK K +G++ L G GI E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 594 LEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY-----LHQD 646
L + L++++ + F + K KK + G+ + +LY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 647 SRLRIIHRDLKASNILL----DEKMNPRISDFGTARVF 680
++HRDLK +NIL+ E+ +I+D G AR+F
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 45/170 (26%), Positives = 84/170 (49%), Gaps = 21/170 (12%)
Query: 535 KLGQGGFG-PVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLG 591
K+G+G FG + +G++ +K ++ + S + EE + EV +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 592 CCLEEDENM-LIYEFMPNKSLDYFIFDE-----SRKQLLDWKKRFDIILGIARGVLYLHQ 645
EE+ N+ ++ ++ L I + Q+LDW + I + ++H
Sbjct: 67 S-FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVHD 119
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+I+HRD+K+ NI L + ++ DFG ARV LA T +GT
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 21/154 (13%)
Query: 536 LGQGGFGPV---YKGKLSNGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQHRNLVKLL 590
+G G +G V Y +L Q++AVK+LS I + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 591 -----GCCLEE-DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
+E +E L+ M L+ + ++L D +F +I + RG+ Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM-GADLNNIV---KCQKLSDEHVQF-LIYQLLRGLKYIH 135
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IIHRDLK SN+ ++E RI DFG AR
Sbjct: 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 47/154 (30%), Positives = 68/154 (44%), Gaps = 28/154 (18%)
Query: 536 LGQGGFGPV----YKGKLSNGQEIAVKRLS---TTSGQGIEELKNE--VLLIA-KLQHRN 585
LG+G FG V YK G+ A+K L + +E L E + A +H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGIARGVL 641
LV L C ED + E+ L I F E R ++LG+
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY----AACVVLGLQ---- 115
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
YLH++ +I++RDLK N+LLD + +I+DFG
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG 146
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-07
Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 15/88 (17%)
Query: 339 STCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSN---CSCVAYASASAETNR 395
C+ + +K+ T C +C N SC A+ A A
Sbjct: 3 EFCKSAGTTLIKIALKIKTTKANT-------ADECANRCEKNGLPFSCKAFVFAKARK-- 53
Query: 396 GIGCLMYH-GDLNDTRKYTNAGQDLFVR 422
CL + ++ RK + G DL+
Sbjct: 54 --QCLWFPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIE-ELKNEVLLIAKLQHRNLVKLLGCC 593
K+G+G +G VYK K +G++ L G GI E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 594 LEEDENM--LIYEFMPNKSLDYFIF---DESRKQLLDWKKRF--DIILGIARGVLYLHQD 646
L + L++++ + F ++ K+ + + ++ I G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 647 SRLRIIHRDLKASNILL----DEKMNPRISDFGTARVF 680
++HRDLK +NIL+ E+ +I+D G AR+F
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 37/150 (24%)
Query: 552 GQEIAVKRLS------TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605
GQ +A+K+LS T + + EL L+ + H+N++ LL F
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNV------------F 84
Query: 606 MPNKSLDYF--------IFDESRKQ----LLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
P KSL+ F + D + Q LD ++ ++ + G+ +LH IIH
Sbjct: 85 TPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIH 141
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGE 683
RDLK SNI++ +I DFG AR G
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 10/164 (6%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLS--TTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+G+G +G V + ++G++ +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 593 CLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
ED + ++ F L Y E + +LL + + + IA + YLH+ I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HI 123
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+HRDLK N+ L ++ D G ARV + +A T ++GT
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR-- 584
++ T + LG G G V K K + G +A K ++ ++L ++ H
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKK---VVHIGAKSSVRKQILRELQIMHECR 61
Query: 585 --NLVKLLGCCLEEDENMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGV 640
+V G L E+ + EFM SLD Y ++L I + + G+
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGL 116
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
YL+ + RI+HRD+K SNIL++ + ++ DFG + GE I +I VGT
Sbjct: 117 TYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGT 165
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 35/154 (22%), Positives = 62/154 (40%), Gaps = 21/154 (13%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
+ K K +AVK+ L + S + ++ L+ E++ +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 594 LEEDENMLIYEFMPNKSLDYFI---FDESRKQLLDWKKRFDIILGIARGVL----YLHQD 646
+ + E ++ M S + + F E +L I I + VL Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--------IAFILKDVLNALDYIHS- 119
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
IHR +KAS+ILL +S +
Sbjct: 120 --KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 536 LGQGGFGPV------YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ + + KR+ G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+D L+ M L + I++ + + F I G+ LH+++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAAEILCGLEDLHREN-- 122
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTA-RVFGGEEI 685
++RDLK NILLD+ + RISD G A ++ GE I
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 23/154 (14%)
Query: 536 LGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNE--VLLIAKLQHRNLVKL 589
LG+G FG V +L +G+ AVK L +E E +L +A+ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYLH 644
C D + EF+ L + I FDE+R + + I +++LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLH 113
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
II+RDLK N+LLD + + +++DFG +
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG G G VYK L + +AVK + T Q +++ +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIGFYG 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
E+ + EFM SLD ++ + + +L I + + +G+ YL L+I
Sbjct: 67 AFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKI 116
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+HRD+K SN+L++ + ++ DFG + + + +I K VGT
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGT 156
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 23/146 (15%)
Query: 550 SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609
+ + KR+ S I+ L+NE+L + +L H N++K+ E +M +
Sbjct: 190 PKCERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKIEEILRSEA-----NTYMITQ 243
Query: 610 SLDY----FIFDESRKQLLDWKKR------FDIILGIARGVLYLHQDSRLRIIHRDLKAS 659
D+ F++DE+ DWK R I+ + V Y+H ++IHRD+K
Sbjct: 244 KYDFDLYSFMYDEA----FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLE 296
Query: 660 NILLDEKMNPRISDFGTARVFGGEEI 685
NI L+ + DFGTA F E
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKERE 322
|
Length = 501 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 24/168 (14%)
Query: 536 LGQGGFGPVYKGKLSNG---QEIAVKRLSTTSGQGI-EELKNEVLLIAKL-QHRNLVKLL 590
+G+G FG V K ++ + A+KR+ + + + E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 591 GCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFDIILGIA 637
G C L E+ P+ +L D+ F S L ++ +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
RG+ YL S+ + IHRDL A NIL+ E +I+DFG +R G+E+
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV 164
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 23/168 (13%)
Query: 536 LGQGGFGPVYKGKLSN----GQ----EIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
LGQG F ++KG G+ E+ +K L + E ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY-LHQD 646
G C+ DE++++ E++ SLD ++ + WK L +A+ + + LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHFL 116
Query: 647 SRLRIIHRDLKASNILL-----DEKMNP---RISDFGTARVFGGEEIL 686
+ H ++ A N+LL + NP ++SD G + +EIL
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 49/189 (25%), Positives = 79/189 (41%), Gaps = 37/189 (19%)
Query: 504 TKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLST 562
K K D + ++LS +F LG G FG V K G+ A+K L
Sbjct: 1 MKAAYMFTKPDTSSWKLS-------DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK 53
Query: 563 TS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES 619
+ ++ + E ++ +L H +V ++ +E+ + EF+ L F
Sbjct: 54 REILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL----FTHL 109
Query: 620 RKQLLDWKKRF----------DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669
RK RF +++L YLH II+RDLK N+LLD K +
Sbjct: 110 RK-----AGRFPNDVAKFYHAELVLAFE----YLHS---KDIIYRDLKPENLLLDNKGHV 157
Query: 670 RISDFGTAR 678
+++DFG A+
Sbjct: 158 KVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 33/156 (21%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEV----LLIAKLQHRNLVKLL 590
+G+G FG V K ++G+ AVK L + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFD-----------ESRKQLLDWKKRFDIILGIARG 639
Y F L YF+ D + + + + RF IA
Sbjct: 63 ------------YSFQTADKL-YFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASA 108
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+ YLH L II+RDLK NILLD + + ++DFG
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFG 141
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 49/159 (30%), Positives = 69/159 (43%), Gaps = 36/159 (22%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLL---IAKLQHR--NLVKL 589
+G G G VYK + G +AVK++ T + EE K +L+ + H +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENK-RILMDLDVVLKSHDCPYIVKC 79
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLD-WKKRF-----DIILG-----IAR 638
G I + D FI E LD KR + ILG I +
Sbjct: 80 YGY--------FITDS------DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
+ YL + +IHRD+K SNILLD N ++ DFG +
Sbjct: 126 ALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 32/149 (21%), Positives = 61/149 (40%), Gaps = 19/149 (12%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV--KLLGC 592
L G VY + + +K + + + EV ++ L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLAS 61
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQDSRLR 650
+ + L+ E++ ++LD + +E ++ + + L +A+ LHQ L
Sbjct: 62 GESDGWSYLLMEWIEGETLD-EVSEEEKEDIAE-------QLAELLAK----LHQLPLLV 109
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARV 679
+ H DL NIL+D+ I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 50/154 (32%), Positives = 73/154 (47%), Gaps = 29/154 (18%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
LG+G FG V +L E+ AVK L +E E VL +A +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 641
C +D + E++ L + I FDE R RF +I+LG+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA-------RFYAAEIVLGL----Q 110
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+LH+ II+RDLK N+LLD + + +I+DFG
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFG 141
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 19/159 (11%)
Query: 535 KLGQGGFGPVYKG------KLSNGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNL 586
+LGQG FG VY+G K +AVK ++ ++ + IE L NE ++ ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHV 71
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIF-------DESRKQLLDWKKRFDIILGIARG 639
V+LLG + +++ E M + L ++ + + ++ + IA G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ YL+ + +HRDL A N ++ +I DFG R
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 24/58 (41%), Positives = 34/58 (58%), Gaps = 3/58 (5%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
I RG+ YLH I+HRD+K N+L++ +I DFG ARV +E +T+ VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 28/161 (17%)
Query: 528 DNFSTSNKLGQGGFGPV-YKGKLSNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQ 582
D+F + +G+G FG V K G A+K+L + Q + ++ E ++A+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59
Query: 583 HRNLVKLLGCCLEEDENM-LIYEFMPNKSL-------DYFIFDESRKQLLDWKKRFDIIL 634
+ +VKL +++ + LI E++P + D F +E+R
Sbjct: 60 NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR-------------F 105
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
IA +L + +L IHRD+K N+LLD K + ++SDFG
Sbjct: 106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 22/154 (14%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGI--EELKNEVLLIAKLQHRNLVKLLGC 592
+G G +G V G+++A+K+LS I + E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 593 CLEE---DENMLIYEFMPNKSLDY-----FIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
DE Y MP D E + Q L + + G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL--------VYQMLCGLKYIH 134
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IIHRDLK N+ ++E +I DFG AR
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 45/139 (32%), Positives = 67/139 (48%), Gaps = 25/139 (17%)
Query: 552 GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611
G +AVK+LS +N+ AK +R LV LL C ++ L+ F P KSL
Sbjct: 46 GINVAVKKLS-------RPFQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95
Query: 612 DYF--------IFDESRKQL----LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKAS 659
+ F + D + Q+ LD ++ ++ + G+ +LH IIHRDLK S
Sbjct: 96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152
Query: 660 NILLDEKMNPRISDFGTAR 678
NI++ +I DFG AR
Sbjct: 153 NIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 20/162 (12%)
Query: 528 DNFSTSNKLGQGGFGPV-YKGKLSNGQEIAVKRLSTTSGQGIEEL---KNEVLLIAKLQH 583
++F T +G+G FG V K G+ A+K L + ++L K E ++A+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIAR 638
+V L + LI EF+P L Y F E RF +A
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-------VTRF----YMAE 109
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
VL + +L IHRD+K NIL+D + ++SDFG + F
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQ--EIAVKRLSTTS---GQGIEELKNEVLLIAKLQ 582
++F+ LG G FG V N +A+KR + + ++ + +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI---ARG 639
H V L G +E L+ EF+ ++F F L KRF +G A+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTF-------LRRNKRFPNDVGCFYAAQI 140
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
VL L I++RDLK N+LLD+ +++DFG A+V
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 48/150 (32%), Positives = 76/150 (50%), Gaps = 14/150 (9%)
Query: 536 LGQGGFGPVY-----KGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVK 588
LGQG FG V+ G + GQ A+K L +T + K E ++A++ H +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDA-GQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
L E + LI +F+ L F K+++ ++ D+ +A L L
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEE--DVKFYLAELALALDHLHS 116
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTAR 678
L II+RDLK NILLDE+ + +++DFG ++
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 536 LGQGGFGPV-YKGKLSNGQEIAVKRLST--TSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+G G +G V G ++A+K+L S + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 593 CLEEDENM-------LIYEFMPN---KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
D ++ L+ FM K + + E R Q L ++ + +G+ Y
Sbjct: 83 -FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ--------MLKGLKY 133
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+H IIHRDLK N+ ++E +I DFG AR
Sbjct: 134 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 8e-06
Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 35/182 (19%)
Query: 514 DVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLST--TSGQGIEEL 571
D TF T+L N QG Y L + +A+K+LS + +
Sbjct: 10 DSTF----TVLKRYQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRA 63
Query: 572 KNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF--------IFDESRKQL 623
E++L+ + H+N++ LL F P KSL+ F + D + Q+
Sbjct: 64 YRELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQV 111
Query: 624 ----LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
LD ++ ++ + G+ +LH IIHRDLK SNI++ +I DFG AR
Sbjct: 112 IQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168
Query: 680 FG 681
G
Sbjct: 169 AG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 38/154 (24%), Positives = 67/154 (43%), Gaps = 24/154 (15%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIA---VKRLSTTSGQGIEE--LKN-EVLLIAKLQHRNLVK 588
++G G FG V ++ +A VK L + + L+ + I LQH N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI--LQHPNILQ 59
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL-------GIARGVL 641
LG C+E +L++E+ L ++ E W +R +L IA GV
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVT 113
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
++H + +H DL N L + ++ D+G
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYG 144
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 35/182 (19%)
Query: 514 DVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLST--TSGQGIEEL 571
D TF T+L N QG Y L + +A+K+LS + +
Sbjct: 17 DSTF----TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRA 70
Query: 572 KNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF--------IFDESRKQL 623
E++L+ + H+N++ LL F P KSL+ F + D + Q+
Sbjct: 71 YRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQV 118
Query: 624 ----LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
LD ++ ++ + G+ +LH IIHRDLK SNI++ +I DFG AR
Sbjct: 119 IQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175
Query: 680 FG 681
G
Sbjct: 176 AG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 27/156 (17%)
Query: 536 LGQGGFGPVYK-GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC-- 592
+G+GGFG VY K G+ A+K L + I+ + E L + + +LV C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 593 --CLE-----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKK-RF---DIILGIARGVL 641
C+ D+ I + M L Y + S+ + K+ RF +IILG+
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLE---- 111
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
H +R +++RDLK +NILLDE + RISD G A
Sbjct: 112 --HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 35/160 (21%)
Query: 536 LGQGGFGPVYK-GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC-- 592
+G+GGFG VY K G+ A+K L + I+ + E L + + +LV C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 593 --CLE-----EDENMLIYEFMPNKSLDYF-----IFDESRKQLLDWKKRF---DIILGIA 637
C+ D+ I + M L Y +F E+ + RF +IILG+
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-------EMRFYAAEIILGLE 111
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
H +R +++RDLK +NILLDE + RISD G A
Sbjct: 112 ------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 47/179 (26%), Positives = 73/179 (40%), Gaps = 36/179 (20%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTSGQGIEELKNEVLL----- 577
D+F KLG+G FG VYK L N + +K+ +T G +E NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 578 -IAKLQHRNLVKLLGCCLEEDENMLI---------YEFMPNKSLDY----FIFDESRKQL 623
A + L + +EDE L+ + M +K Y ++ + +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 624 LDWKKRFDIILGIARGVLY----LHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTA 677
++ II I R +L+ LH I+HRD+K NI+ E +I D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 31/180 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL------STTSGQGIEELKNEVLLIAKL 581
D+F ++LG G G V K + I ++L Q I EL+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF-DIILG----- 635
+V G + E + E M SLD Q+L KR + ILG
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKEAKRIPEEILGKVSIA 111
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ RG+ YL + + +I+HRD+K SNIL++ + ++ DFG + G+ I ++ VGT
Sbjct: 112 VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 165
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 49/176 (27%), Positives = 68/176 (38%), Gaps = 43/176 (24%)
Query: 535 KLGQGGFGPVYKG-KLSNGQEIAVKR----LSTTSGQGIEELKNEVLLIAK----LQHRN 585
+G+GG G VY + +A+K+ LS LK L AK L H
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPG 63
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLD--WKKR-------------- 629
+V + C + D +Y MP +I + K LL W+K
Sbjct: 64 IVPVYSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 630 -FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
I I + Y+H S+ ++HRDLK NILL I D+G A EE
Sbjct: 115 FLSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167
|
Length = 932 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 46/166 (27%), Positives = 73/166 (43%), Gaps = 47/166 (28%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLI-----AKLQHRNLVKL- 589
LG+G FG V +L T I+ LK +V+L + R ++ L
Sbjct: 3 LGKGSFGKVMLAELKG----------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALA 52
Query: 590 --------LGCCLEEDENML-IYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DI 632
L C + E++ + E++ L + I FDE+R RF +I
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA-------RFYAAEI 105
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
I G+ +LH+ II+RDLK N+LLD+ + +I+DFG +
Sbjct: 106 ICGLQ----FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 61/213 (28%), Positives = 83/213 (38%), Gaps = 76/213 (35%)
Query: 536 LGQGGFGPVYK------GKLSNGQEIAVKRL---STTSGQG--IEELKNEVLLIAKLQHR 584
LG+G FG V + K ++ + +AVK L +T S + ELK +LI H
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK---ILIHIGHHL 71
Query: 585 NLVKLLGCCLE-EDENMLIYE-----------------FMPNK----SLDYFIFDESRKQ 622
N+V LLG C + M+I E F P + E +KQ
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131
Query: 623 LLD-------------------------------WKKRF---DII---LGIARGVLYLHQ 645
LD +K+ D+I +ARG+ +L
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL-- 189
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
SR + IHRDL A NILL E +I DFG AR
Sbjct: 190 ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 39/168 (23%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
D+F +G+G FG V K+ + + I A+K L+ K E+L A+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN----------KWEMLKRAET----- 45
Query: 587 VKLLGCCLEEDENMLI-----------YEFMPNKSL----DYFIFDESRKQLLDWKKRFD 631
C E+ N+L+ Y F L DY++ + L ++ R
Sbjct: 46 -----ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP 100
Query: 632 IILG---IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676
+ IA VL +H +L +HRD+K N+LLD + R++DFG+
Sbjct: 101 EDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGS 148
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 20/169 (11%)
Query: 534 NKLGQGGFGPVYKGKLS-NGQEIAVK--RLSTTSGQGIEELK-NEVLLIAKLQHR----N 585
++LG+G +G VYK G +A+K RL ++E K N++++ + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPY 60
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+V G E + E+M SLD + + I + +G+ +L +
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ IIHRD+K +N+L++ ++ DFG + G + ++ K +G
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIG 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 21/127 (16%)
Query: 558 KRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC-------CLEEDENMLIYEFMPNKS 610
K++ + G + E+ ++ + HR ++ L+ C+ MP
Sbjct: 120 KKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCM----------VMPKYK 169
Query: 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670
D F + + R L ++ I + + YLH IIHRD+K NI LDE N
Sbjct: 170 CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAV 225
Query: 671 ISDFGTA 677
+ DFG A
Sbjct: 226 LGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 20/171 (11%)
Query: 525 AATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK-LQ 582
+ ++ N +G G FG VY+ + +++A+K++ + KN LLI K L
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN 117
Query: 583 HRNLVKL-----LGCCLEEDENM---LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 634
H N++ L C + ++N+ ++ EF+P Y L
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTAR-VFGGE 683
+ R + Y+H I HRDLK N+L+D + ++ DFG+A+ + G+
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
|
Length = 440 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 21/164 (12%)
Query: 529 NFSTSNKLGQGGFGPVYKGK---LSNGQEIAVKRLSTTSGQGI------EELKNEVLLIA 579
+ +LGQG +G V + S + +A+K+++ + I ELK LL
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELK---LLRH 57
Query: 580 KLQHRNLVKLLGCCLEEDEN---MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
H+N+ L + N + +YE + L I S + L D + I I
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQS-FIYQI 114
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
G+ Y+H + ++HRDLK N+L++ +I DFG AR F
Sbjct: 115 LCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 23/176 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL------STTSGQGIEELKNEVLLIAKL 581
D+F ++LG G G V+K I ++L Q I EL+ ++ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR--KQLLDWKKRFDIILGIARG 639
+V G + E + E M SLD + R +Q+L + + + +G
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKG 115
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ YL + + +I+HRD+K SNIL++ + ++ DFG + G+ I ++ VGT
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 165
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 41/169 (24%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
D+F +G+G FG V K+ N ++ A+K L+ K E+L A+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN----------KWEMLKRAET----- 45
Query: 587 VKLLGCCLEEDENMLI-----------YEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIIL 634
C E+ ++L+ Y F +L Y + D LL +F+ L
Sbjct: 46 -----ACFREERDVLVNGDRRWITNLHYAFQDENNL-YLVMDYYVGGDLLTLLSKFEDRL 99
Query: 635 G-------IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676
+A VL + +L +HRD+K N+LLD+ + R++DFG+
Sbjct: 100 PEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGS 148
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 11/69 (15%)
Query: 616 FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
F ES ++ IA VL L +L II+RD+K NILLD + + ++DFG
Sbjct: 102 FTESEVRVY-----------IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFG 150
Query: 676 TARVFGGEE 684
++ F EE
Sbjct: 151 LSKEFLAEE 159
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 528 DNFSTSNKLGQGGFGPV-YKGKLSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH 583
D+F + +G+G FG V K G A+K L + + ++ E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
+VK+ ++ LI EF+P D + L + +F IA VL +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQF----YIAETVLAI 114
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+L IHRD+K N+LLD K + ++SDFG
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 47/156 (30%), Positives = 70/156 (44%), Gaps = 33/156 (21%)
Query: 536 LGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEV----LLIAKLQHRNLVKLL 590
+G+G FG V K S+G AVK L + +E + + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFD-----------ESRKQLLDWKKRFDIILGIARG 639
Y F + L YF+ D + + L+ + RF +A
Sbjct: 63 ------------YSFQTAEKL-YFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASA 108
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+ YLH L II+RDLK NILLD + + ++DFG
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFG 141
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 23/151 (15%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEEL-----KNEVLLIAKLQHRNLVKL 589
LG+G FG V +L E+ A+K L +++ + +L +A +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYLH 644
C +D + E++ L + I FDE R RF + +++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-------RF-YAAEVTLALMFLH 113
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+ +I+RDLK NILLD + + +++DFG
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFG 141
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 25/155 (16%)
Query: 536 LGQGGFGPVYKGKLS-NGQEIAVKRLS---TTSGQGIE--ELKNEVLLIAKLQHRNLVKL 589
LG+G FG V+ +L Q A+K L +E ++ VL +A +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61
Query: 590 LGCCLEEDENML-IYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYL 643
C + EN+ + E++ L + I FD R +II G+ +L
Sbjct: 62 Y-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICGLQ----FL 112
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
H I++RDLK NILLD + +I+DFG +
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 38/156 (24%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKN----EVLLIAKLQ 582
+ F +G+G +G V K + +EI A+K+ + EE+K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLK 58
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
N+V+L + L++E++ L+ + +E + K R I + + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVR-SYIYQLIKAIHW 115
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
H++ I+HRD+K N+L+ ++ DFG AR
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 19/156 (12%)
Query: 536 LGQGGFGPVYKGKLS-NGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+G FG V +L G+ AVK L +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 592 CCLEEDENML-IYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQDS 647
C + E++ + EF+ L + I D+ R L ++ F +I+ G+ +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCGLQ----FLHSKG 116
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTAR--VFG 681
II+RDLK N++LD + +I+DFG + VFG
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 25/171 (14%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEVLLIAK----LQHRN--LVK 588
LG+G FG V + E+ A+K L I++ E ++ K L + L +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQ 65
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQD 646
L C D + E++ L Y I +Q+ +K+ + IA G+ +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTAR--VFGGEEILAITKRVVGT 695
II+RDLK N++LD + + +I+DFG + +FGG T+ GT
Sbjct: 121 G---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGT 164
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 57/226 (25%), Positives = 84/226 (37%), Gaps = 78/226 (34%)
Query: 528 DNFSTSNKLGQGGFGPVYK------GKLSNGQEIAVKRL-STTSGQGIEELKNEVLLIAK 580
DN LG G FG V + GK N +AVK L ++ E L +E+ +++
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 581 L-QHRNLVKLLG--------------CCL--------EEDENMLIY----EFMPNKSLDY 613
L QH+N+V LLG CC ++ E L + + S DY
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157
Query: 614 --------FIFDES-------------------------RKQLLD----WKKRFDIILG- 635
+I +S K D W D +L
Sbjct: 158 KNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRF 217
Query: 636 ---IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+A+G+ +L + IHRD+ A N+LL + +I DFG AR
Sbjct: 218 SSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 19/110 (17%)
Query: 574 EVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDI- 632
E ++ + H ++++L G LI +P D + + L K+ I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCY-------LAAKRNIAIC 182
Query: 633 -ILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
IL I R VL YLH++ RIIHRD+KA NI ++ + + DFG A
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 528 DNFSTSNKLGQGGFGPV-YKGKLSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH 583
++F + +G+G FG V K G A+K L + + ++ E ++ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
+VK+ ++ LI EF+P + + + L + + +F IA VL +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQF----YIAETVLAI 114
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+L IHRD+K N+LLD K + ++SDFG
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 25/169 (14%)
Query: 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKN---- 573
++ L +++ +G+G FG V + + Q++ A+K LS E +K
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSK-----FEMIKRSDSA 88
Query: 574 ---EVLLIAKLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFI--FDESRKQLLDWK 627
E I + V L C ++D+ + ++ E+MP L + +D K W
Sbjct: 89 FFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WA 144
Query: 628 KRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676
K + A VL L + +IHRD+K N+LLD+ + +++DFGT
Sbjct: 145 KFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT 188
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 22/164 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYK-GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HR 584
+D + +G+G +G V+K NG + AVK L EE++ E ++ L H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75
Query: 585 NLVKLLGCCLEEDEN-----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------II 633
N+VK G ++D L+ E S+ + K L +R + I+
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAYIL 130
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
G+ +LH + + IHRD+K +NILL + ++ DFG +
Sbjct: 131 HEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 21/98 (21%)
Query: 604 EFMPNKSLDYFIFDESRKQLLDWKKRF-DIILG-----IARGVLYLHQDSRLRIIHRDLK 657
E M SLD Q+L R + ILG + RG+ YL + + +I+HRD+K
Sbjct: 79 EHMDGGSLD---------QVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVK 127
Query: 658 ASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
SNIL++ + ++ DFG + G+ I ++ VGT
Sbjct: 128 PSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 161
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 536 LGQGGFGPVYKGKL----SNGQEIAVKRLS----TTSGQGIEELKNEVLLIAKLQHRNLV 587
LG+GG+G V++ + G+ A+K L + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLH 644
L+ + LI E++ L F+ E ++ F +I L + +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALE----HLH 117
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
Q II+RDLK NILLD + + +++DFG
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFG 145
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEV----LLIAKLQHRNLVKLL 590
+G+G FG V K +G+ AVK L +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
++ + +F+ L F + + + + RF IA + YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLHS---IN 116
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTAR 678
I++RDLK NILLD + + ++DFG +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEV----LLIAKLQHRNLVKLL 590
+G+G FG V + ++ AVK L + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
D+ + +++ L Y + + + L+ + RF IA + YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-YAAEIASALGYLHS---LN 116
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTAR 678
I++RDLK NILLD + + ++DFG +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 57/211 (27%), Positives = 79/211 (37%), Gaps = 71/211 (33%)
Query: 536 LGQGGFGPVYKG------KLSNGQEIAVKRL---STTSGQG--IEELKNEVLLIAKLQHR 584
LG G FG V + K S+ +AVK L +T S + ELK +LI H
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELK---ILIHIGNHL 71
Query: 585 NLVKLLGCCLEEDEN-MLIYEFMPNKSLDYFI------FDESRKQLLDWKKRFDIILGIA 637
N+V LLG C + + M+I EF +L F+ F R++ + RF ++ +
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131
Query: 638 RG-------------------------------------------VLYLHQDSR------ 648
R + Y Q +R
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA 191
Query: 649 -LRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ IHRDL A NILL E +I DFG AR
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.001
Identities = 8/33 (24%), Positives = 13/33 (39%), Gaps = 1/33 (3%)
Query: 287 CDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKY 319
C C C +N + C+C PG+ +
Sbjct: 5 CASGNPCQNGGTC-VNTVGSYRCSCPPGYTGRN 36
|
Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. Length = 38 |
| >gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 34/210 (16%)
Query: 496 SEREASISTKGNKEIRKV-DVTFFE--LSTLLAATDNFSTSNKLGQGGFGP---VYKGKL 549
E + + +KE RKV D F + L TL + +G G VY +
Sbjct: 10 READKREKREKDKEDRKVVDEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAET 69
Query: 550 SNGQEIAVK--RLSTTSGQGIEEL--------------KNEVLLIAKLQHRNLVKLLGCC 593
+G+ +AVK R ST+ + I + V A+ + RNL +
Sbjct: 70 GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG 129
Query: 594 ------LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+ N+L+ EF+ + L + +L + + ++ ++ R LY
Sbjct: 130 VRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMR-RLY----K 184
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTA 677
++H DL NIL+ + P I D A
Sbjct: 185 EAGLVHGDLSEYNILVHDG-EPYIIDVSQA 213
|
Length = 268 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQHR 584
+F+ LG+G FG V + E+ A+K L +E E ++A
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 585 NLVKLLGCCLEE-DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVL 641
+ L C + D + E++ L Y I +Q+ +K+ + I+ G+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVGLF 115
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+LH+ II+RDLK N++LD + + +I+DFG +
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 16/38 (42%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
YLH+ IIHRDLK N+L+ + + +++DFG ++V
Sbjct: 119 YLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
++ ++ H+++V L G C+ + EN+++ EF+ LD F+ +S WK F + +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQL 114
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILL 663
A + YL +D L +H ++ NILL
Sbjct: 115 ASALSYL-EDKDL--VHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 37/175 (21%)
Query: 519 ELSTLLAATDNFSTSNKLGQGGFGPVY--KGKLSNGQEIAVKRLSTTSGQGIEELK---- 572
+++ L ++F +G+G FG V + K S Q A+K LS E +K
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSK-QVYAMKLLSK-----FEMIKRSDS 87
Query: 573 ----NEVLLIAKLQHRNLVKLLGCCLEEDENML--IYEFMPNKSL-----DYFIFDESRK 621
E ++A +V+L +D+ L + E+MP L +Y I +
Sbjct: 88 AFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---- 141
Query: 622 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676
W + + A VL L + IHRD+K N+LLD+ + +++DFGT
Sbjct: 142 ---KWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|214542 smart00179, EGF_CA, Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
Score = 36.1 bits (84), Expect = 0.002
Identities = 8/30 (26%), Positives = 11/30 (36%), Gaps = 1/30 (3%)
Query: 287 CDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
C C C +N + C C PG+
Sbjct: 5 CASGNPCQNGGTC-VNTVGSYRCECPPGYT 33
|
Length = 39 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+A+G+ +L SR + IHRDL A NILL E +I DFG AR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 48/171 (28%)
Query: 552 GQEIAVKRLSTTSGQGIEE---LKNEVLLIAKLQHRNLVKLL--GCCLEEDENMLIYEFM 606
G E+A+K L T + + + + E L A+L H N+V LL G ++E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR--------------II 652
P ++L +++L A G L + RL I+
Sbjct: 62 PGRTL---------REVLA-----------ADGALPAGETGRLMLQVLDALACAHNQGIV 101
Query: 653 HRDLKASNILL---DEKMNPRISDFGTARVFGG-----EEILAITKRVVGT 695
HRDLK NI++ + + ++ DFG + G L T V+GT
Sbjct: 102 HRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|238010 cd00053, EGF, Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
Score = 35.5 bits (82), Expect = 0.003
Identities = 8/30 (26%), Positives = 11/30 (36%), Gaps = 1/30 (3%)
Query: 287 CDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
C C C +N + C C PG+
Sbjct: 2 CAASNPCSNGGTC-VNTPGSYRCVCPPGYT 30
|
Length = 36 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 41/168 (24%), Positives = 73/168 (43%), Gaps = 39/168 (23%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
++F +G+G FG V KL N ++ A+K L+ K E+L A+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN----------KWEMLKRAET----- 45
Query: 587 VKLLGCCLEEDENMLI-----------YEFMPNKSL----DYFIFDESRKQLLDWKKRFD 631
C E+ ++L+ Y F +L DY++ + L ++ R
Sbjct: 46 -----ACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP 100
Query: 632 IILG---IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676
+ +A V+ + +L +HRD+K NIL+D + R++DFG+
Sbjct: 101 EDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 148
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 18/42 (42%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
R + Y+H + + HRDLK NIL + +I DFG ARV
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 15/166 (9%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQE----IAVKRLSTTS----GQGIEELKNEVLLIAK 580
NF LG G +G V+ + +G + A+K L + + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 581 LQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
++ + L + D + LI +++ L F R++ K ++ +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERF----KEQEVQIYSGEI 114
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
VL L +L II+RD+K NILLD + ++DFG ++ F +E+
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYL 643
L +L C D + E++ L Y I +Q+ +K+ + IA G+ +L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
H II+RDLK N++LD + + +I+DFG +
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 695 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.94 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.94 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.94 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.93 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.92 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.92 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.92 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.92 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.91 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.91 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.91 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.91 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.91 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.91 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.91 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.9 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.9 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.9 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.9 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.9 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.9 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.9 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.9 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.9 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.9 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.9 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.9 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.9 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.9 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.9 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.9 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.9 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.9 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.9 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.89 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.89 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.89 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.89 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.89 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.89 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.89 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.89 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.89 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.89 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.89 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.89 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.89 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.89 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.89 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.89 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.89 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.89 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.89 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.89 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.89 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.88 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.88 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.88 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.88 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.88 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.88 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.88 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.88 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.88 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.88 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.88 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.88 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.88 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.88 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.88 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.88 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.88 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.87 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.87 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.87 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.87 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.87 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.87 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.87 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.87 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.87 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.87 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.87 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.87 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.87 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.87 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.87 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.87 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.87 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.87 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.87 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.87 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.87 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.87 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.87 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.87 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.87 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.87 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.87 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.87 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.86 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.86 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.86 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.86 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.86 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.86 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.86 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.86 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.86 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.86 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.86 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.86 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.86 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.86 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.86 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.86 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.86 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.86 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.86 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.86 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.86 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.86 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.86 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.85 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.85 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.85 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.85 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.85 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.85 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.85 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.85 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.85 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.85 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.85 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.85 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.85 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.85 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.85 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.85 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.85 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.85 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.85 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.85 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.85 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.85 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.85 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.85 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.84 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.84 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.84 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.84 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.84 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.84 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.84 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.84 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.84 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.84 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.84 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.84 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.84 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.84 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.83 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.83 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.83 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.83 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.83 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.83 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.83 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.83 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.83 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.83 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.83 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.83 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.83 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.82 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.82 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.82 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.82 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.82 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.82 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.82 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.82 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.82 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.82 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.82 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.82 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.81 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.81 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.81 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.81 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.81 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.81 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.81 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.81 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.81 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.81 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.81 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.81 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.81 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.81 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.8 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.8 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.8 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.8 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.8 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.8 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.8 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.8 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.8 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.8 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.8 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.79 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.79 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.79 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.78 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.78 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.78 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.77 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.77 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.77 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.76 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.76 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.75 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.75 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.72 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.72 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.7 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.64 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.64 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.62 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.61 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.58 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.58 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.48 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.27 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.95 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.93 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.64 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.56 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.44 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.38 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.29 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.22 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.14 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.11 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.05 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.03 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.75 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.7 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.66 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.64 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.63 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.58 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.52 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.48 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.45 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.32 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.15 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.93 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.92 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.71 | |
| PLN02236 | 344 | choline kinase | 96.69 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.62 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.18 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.11 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.08 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.98 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.79 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.61 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.55 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.5 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.19 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.08 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.86 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.68 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.63 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=327.83 Aligned_cols=168 Identities=52% Similarity=0.856 Sum_probs=154.9
Q ss_pred ccceecHHHHHHhcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEE
Q 005471 514 DVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593 (695)
Q Consensus 514 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 593 (695)
....|.+.++..||++|+..+.||+|+||.||+|.+++++.||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56679999999999999999999999999999999999999999998765443156799999999999999999999999
Q ss_pred EeCC-eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 594 LEED-ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 594 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
.+.+ +.+||||||++|+|+++|+..... .++|..|++||.++|+||+|||+.+.++||||||||+|||||+++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999876554 78999999999999999999999998899999999999999999999999
Q ss_pred eeccceeecC
Q 005471 673 DFGTARVFGG 682 (695)
Q Consensus 673 DFGla~~~~~ 682 (695)
|||||+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999976543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=271.88 Aligned_cols=152 Identities=32% Similarity=0.549 Sum_probs=135.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.+|...+.||+|+|++||+|+++ ++.+||||.+.+. .....+.+..|+.+|+.++|||||+|++++..++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46777788999999999999975 5789999999765 44556678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC------CceEEEeeccce
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK------MNPRISDFGTAR 678 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~------~~~kl~DFGla~ 678 (695)
||.+|+|.+||+... .+++.....++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+||
T Consensus 90 yC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999997654 4889999999999999999999998 9999999999999864 568999999999
Q ss_pred eecCCcc
Q 005471 679 VFGGEEI 685 (695)
Q Consensus 679 ~~~~~~~ 685 (695)
.+.+...
T Consensus 164 ~L~~~~~ 170 (429)
T KOG0595|consen 164 FLQPGSM 170 (429)
T ss_pred hCCchhH
Confidence 9986554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=270.04 Aligned_cols=149 Identities=39% Similarity=0.620 Sum_probs=132.5
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc--cHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-eeEEEEEcCCC
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ--GIEELKNEVLLIAKLQHRNLVKLLGCCLEED-ENMLIYEFMPN 608 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~~~ 608 (695)
..+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+|+|+|.+.. ..+||||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34679999999999999975555999999765322 2569999999999999999999999999988 78999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-ceEEEeeccceeecCC
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGE 683 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 683 (695)
|+|.++++.. +...+++..+++++.+||+||.|||++.+ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999775 44569999999999999999999999864 99999999999999997 9999999999987654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=259.49 Aligned_cols=159 Identities=29% Similarity=0.455 Sum_probs=134.6
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcc-------cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQ-------GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
+.|.+.+.||+|+||.|-+|.- ++|+.||||.+.+.... ....+++|+++|++|+|||||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 4566779999999999999965 57999999999764221 223457999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CceEEEeecc
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK---MNPRISDFGT 676 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGl 676 (695)
|||||||++|+|.+++.... .+.+..-.-++.|++.|+.|||+.+ |+||||||+||||..+ ..+||+||||
T Consensus 252 YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999986543 3556666679999999999999998 9999999999999755 8899999999
Q ss_pred ceeecCCcceeccccccCC
Q 005471 677 ARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 677 a~~~~~~~~~~~~~~~~GT 695 (695)
|+..+... ..+++.||
T Consensus 326 AK~~g~~s---fm~TlCGT 341 (475)
T KOG0615|consen 326 AKVSGEGS---FMKTLCGT 341 (475)
T ss_pred hhccccce---ehhhhcCC
Confidence 99987433 35667777
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=266.21 Aligned_cols=160 Identities=29% Similarity=0.451 Sum_probs=143.9
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+.+.+||+|.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4578889999999999999997 78999999999763 3445677899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+|++++|.++++ +++.+++.+...+..||+.||.|||++. |||||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999985 4556999999999999999999999987 999999999999999999999999999999876
Q ss_pred cceeccccccCC
Q 005471 684 EILAITKRVVGT 695 (695)
Q Consensus 684 ~~~~~~~~~~GT 695 (695)
+-+..| +.||
T Consensus 172 ~Erk~T--lCGT 181 (592)
T KOG0575|consen 172 GERKKT--LCGT 181 (592)
T ss_pred ccccce--ecCC
Confidence 554433 7787
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=266.44 Aligned_cols=151 Identities=37% Similarity=0.616 Sum_probs=136.4
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
..+.||+|-||+|+.|.+.....||||.++.. ....+.|.+|+++|++|+|+|||+|+|+|..++..+||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 45899999999999999988789999999764 45567899999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCccee
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 687 (695)
.++|... ....+.-.+.+.++.|||+||+||+++. +|||||.++||||+++..+||+||||||.+..++..+
T Consensus 289 l~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 289 LDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred HHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999763 3345788999999999999999999987 9999999999999999999999999999777666543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=251.57 Aligned_cols=157 Identities=28% Similarity=0.409 Sum_probs=135.7
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-eeEEEEEcC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-ENMLIYEFM 606 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~ 606 (695)
+..++.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++.+.+||+||+++|+|.... ...|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344589999999999999985 5788999998543 3445678999999999999999999999999999 499999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcce
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 686 (695)
++|+|+.++... ..+++...-.|+.+|++||.|||+.. +||||||||+||||+..|++||||||.++.+.+.
T Consensus 161 DgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999999654 33789999999999999999999742 4999999999999999999999999999988654
Q ss_pred eccccccCC
Q 005471 687 AITKRVVGT 695 (695)
Q Consensus 687 ~~~~~~~GT 695 (695)
..++.+||
T Consensus 233 -~a~tfvGT 240 (364)
T KOG0581|consen 233 -IANTFVGT 240 (364)
T ss_pred -hccccccc
Confidence 33446676
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=258.76 Aligned_cols=160 Identities=28% Similarity=0.445 Sum_probs=137.4
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 602 (695)
+.|+.+++||+|.||.||||+. .+|+.||+|++.... .....-..+||.||++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4566778999999999999974 679999999987543 33445567899999999999999999999987 679999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+|||++ +|.-++... ...++..+...++.|++.||+|||.++ |+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999984 666666432 234889999999999999999999998 99999999999999999999999999999988
Q ss_pred Ccceecccccc
Q 005471 683 EEILAITKRVV 693 (695)
Q Consensus 683 ~~~~~~~~~~~ 693 (695)
+.....|++|+
T Consensus 271 ~~~~~~T~rVv 281 (560)
T KOG0600|consen 271 SGSAPYTSRVV 281 (560)
T ss_pred CCCcccccceE
Confidence 88776777765
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=228.85 Aligned_cols=111 Identities=43% Similarity=0.728 Sum_probs=81.0
Q ss_pred CCeEEEEecCCCCCCCC--CceEEEEecCCeeeeccCCCceeEEee-ccccCCCCccEEEEccCCCEEEEeCCCCceEEe
Q 005471 69 QLTLLWVANRNNPINDT--SGVLSVNIQGNLVLHERNQSTVPVWQA-NISEASAGNTVAQLLDTGNLVLVRNDTGETLWQ 145 (695)
Q Consensus 69 ~~tvVW~Anr~~p~~~~--~~~l~~~~~G~l~l~~~~~~~~~~Wss-~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWq 145 (695)
++||||+|||+.|+... .+.|.|+.||+|+|+|..++ .+|++ ++...+..+..|+|+|+|||||++. .+.+|||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~--~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-~~~~lW~ 77 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGS--VIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-SGNVLWQ 77 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTE--EEEE--S-TTSS-SSEEEEEETTSEEEEEET-TSEEEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCC--EEEEecccCCccccCeEEEEeCCCCEEEEee-cceEEEe
Confidence 46999999999999543 47899999999999998877 89999 5442222478999999999999986 7889999
Q ss_pred ecCCCCCCcCCCceeccccCCCceeeEEEccCCCCCC
Q 005471 146 SFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPG 182 (695)
Q Consensus 146 SFd~PtDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps 182 (695)
||||||||+||||+|+.+..+|.+..++||++.+|||
T Consensus 78 Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 78 SFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp STTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred ecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999999988887777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=250.52 Aligned_cols=161 Identities=28% Similarity=0.426 Sum_probs=140.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
.++|+++++||+|+||+||.++.. +++.+|+|++++.. ....+..+.|..+|.+++||.||+|+-.|++.++.|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357889999999999999999764 58899999998753 23456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+||+.||.|..+|.++. .+++....-++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999996543 3778877779999999999999998 99999999999999999999999999997654
Q ss_pred CcceeccccccCC
Q 005471 683 EEILAITKRVVGT 695 (695)
Q Consensus 683 ~~~~~~~~~~~GT 695 (695)
+.. .+.++.||
T Consensus 178 ~~~--~t~tfcGT 188 (357)
T KOG0598|consen 178 DGD--ATRTFCGT 188 (357)
T ss_pred CCC--ccccccCC
Confidence 443 35557887
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=215.99 Aligned_cols=110 Identities=48% Similarity=1.140 Sum_probs=104.9
Q ss_pred EEeCCCCCceeecccccceeeeeeEEEeecCCeeEEEEeecCCCeEEEEEECccCceEEEEEeCCCCcEEEEEEccCCCC
Q 005471 208 WRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERC 287 (695)
Q Consensus 208 ~~~g~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~w~~p~~~C 287 (695)
||+|+|+|..|+++|+|.....+.+.|+.+++|++++|...+.+.++|++||.+|++++|.|++..+.|...|++|.|+|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 89999999999999999987889999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccCCCCCcccccCCCCCCCC
Q 005471 288 DYYGHCGPNSNCNLNLTDGFECTCLPGFEPKY 319 (695)
Q Consensus 288 ~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~~~ 319 (695)
|+|+.||+||+|+.+.. +.|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~--~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNS--PKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCC--CceECCCCcCCCc
Confidence 99999999999987766 8899999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-29 Score=270.15 Aligned_cols=157 Identities=29% Similarity=0.497 Sum_probs=138.0
Q ss_pred CCCCccceeeeeCceeEEEEEcCC----CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
....+.++||.|.||+|++|+++- ...||||.|+... +....+|..|+.||++.+||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 445677999999999999998752 3479999998753 34466899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+|||+||+|+.||.....+ +.+.+..-+.++||.||.||-+.+ +|||||.++||||+.+..+||+||||+|.+..
T Consensus 709 TEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999776544 888999999999999999999887 99999999999999999999999999998877
Q ss_pred Ccceecc
Q 005471 683 EEILAIT 689 (695)
Q Consensus 683 ~~~~~~~ 689 (695)
+.....+
T Consensus 784 d~~~~yt 790 (996)
T KOG0196|consen 784 DPEAAYT 790 (996)
T ss_pred CCCcccc
Confidence 6643333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=254.17 Aligned_cols=155 Identities=28% Similarity=0.505 Sum_probs=136.1
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCccc-HHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+.+...+.++||+|.||+|..++...+.+||||.++..+... ..+|.+||++|.+++|||||+|+|+|..++..++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 445566779999999999999999888999999998765444 5899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
||++|+|..|+..+.... +.-....+|+.|||.||+||.+.. +|||||.++|||++.++++||+|||++|-+=..+
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999997654332 455566779999999999999876 9999999999999999999999999999553333
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=268.58 Aligned_cols=150 Identities=33% Similarity=0.556 Sum_probs=133.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
.+....+.||+|+||+||+|+.. +.+.||||.++..+.. ..++|++|+++++.++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455689999999999999853 3467999999876554 6789999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 601 LIYEFMPNKSLDYFIFDESR-----------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
||+|||..|+|.+||..... ...|+..+.+.||.|||.||+||-+++ +|||||.++|+||.+++.+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999964321 234888999999999999999999887 9999999999999999999
Q ss_pred EEEeeccceee
Q 005471 670 RISDFGTARVF 680 (695)
Q Consensus 670 kl~DFGla~~~ 680 (695)
||+||||+|-+
T Consensus 643 KIsDfGLsRdi 653 (774)
T KOG1026|consen 643 KISDFGLSRDI 653 (774)
T ss_pred Eecccccchhh
Confidence 99999999954
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=253.02 Aligned_cols=153 Identities=29% Similarity=0.435 Sum_probs=135.3
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC---CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 601 (695)
.++|..++.||+|+|++|++|+. ..++++|||++.+. .....+.+..|-.+|.+| .||.|++|+-.|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 35688889999999999999975 46899999998764 233455677899999999 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|+||+++|+|.++|.... .+++.....++.+|+.||+|||.++ ||||||||+|||||++|++||+|||-|+++.
T Consensus 152 vLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999997653 3778777889999999999999998 9999999999999999999999999999997
Q ss_pred CCcc
Q 005471 682 GEEI 685 (695)
Q Consensus 682 ~~~~ 685 (695)
+.+.
T Consensus 226 ~~~~ 229 (604)
T KOG0592|consen 226 PSQK 229 (604)
T ss_pred hhhc
Confidence 5543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=249.04 Aligned_cols=159 Identities=30% Similarity=0.479 Sum_probs=134.6
Q ss_pred CCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHc--CCCCceeeeEeEEEeCC----eeEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK--LQHRNLVKLLGCCLEED----ENMLI 602 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~lV 602 (695)
.....++||+|+||.||||++.+ +.||||++.. +..+.|.+|-.|... |+|+||++++++-.... +.+||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34456899999999999999964 9999999864 445667777666654 68999999999977665 78999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD------SRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
+||.+.|+|.++|.. ..++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+.+.|+||||
T Consensus 287 t~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999954 4689999999999999999999985 456899999999999999999999999999
Q ss_pred ceeecCCcceeccccccCC
Q 005471 677 ARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 677 a~~~~~~~~~~~~~~~~GT 695 (695)
|.++...+...-+---+||
T Consensus 363 Al~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred eEEecCCCCCcchhhhhhh
Confidence 9999877666444445666
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=230.38 Aligned_cols=150 Identities=32% Similarity=0.595 Sum_probs=131.0
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcc-c-HHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQ-G-IEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~-~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|...++||+|.||.||+|+. .+|+.||||+++..... + .....+||+.|+.++|+||+.|+++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3567779999999999999985 57999999999765322 2 2345679999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+ -+|...+++. ...+.-.....++.++++||+|||++. |+||||||.|+|+++++.+||+||||||.++..
T Consensus 82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 997 6898888654 345778888899999999999999987 999999999999999999999999999999754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-28 Score=236.36 Aligned_cols=149 Identities=23% Similarity=0.420 Sum_probs=128.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHH-HHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIE-ELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~-~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+.|+.+.++|+|+||.|||++.+ +|+.||||++..... ...+ -..+||++|++++|+|+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45677789999999999999986 589999999865432 2233 34689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|++.--|+++-.. ...++.....+++.|+++|+.|+|.+. ||||||||+||||+.++.+||||||+||.+..
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9997766655322 223788888899999999999999998 99999999999999999999999999999973
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=239.99 Aligned_cols=150 Identities=25% Similarity=0.508 Sum_probs=135.5
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+|.+.+.||+|.||+|-++.. ..|++||||.+++.. .++.-.+++||+||..|+||||+.++.+|+..+...||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 566678999999999999975 679999999987753 4555678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
|..+|.|.+|+.+.. .|++.+..++++||..|+.|+|.+. ++|||||.+|||||.++.+||+||||+.++..+.
T Consensus 134 YaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 134 YASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred ecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999996543 4899999999999999999999987 9999999999999999999999999999886554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-28 Score=236.37 Aligned_cols=165 Identities=27% Similarity=0.492 Sum_probs=139.9
Q ss_pred CCCccceeeeeCceeEEEEE-cCCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEe-EEEeCCe-eEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLG-CCLEEDE-NMLIY 603 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g-~~~~~~~-~~lV~ 603 (695)
+|.++++||+|.||+|||++ +.+|..+|.|.+.-. +....+.+..|+.+|++|+|||||+.++ -+.++.+ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46677999999999999996 578999999988632 3445667889999999999999999999 4555555 78999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDS-RLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||+..|+|...++.-+ .++.++++..++++.|+++||..+|..- +..|+||||||.||+|+.+|.+||.||||+|.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999987543 3556899999999999999999999842 2349999999999999999999999999999998
Q ss_pred CCcceeccccccCC
Q 005471 682 GEEILAITKRVVGT 695 (695)
Q Consensus 682 ~~~~~~~~~~~~GT 695 (695)
.+...+ ...+||
T Consensus 180 s~~tfA--~S~VGT 191 (375)
T KOG0591|consen 180 SKTTFA--HSLVGT 191 (375)
T ss_pred chhHHH--HhhcCC
Confidence 776654 447887
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=226.67 Aligned_cols=157 Identities=29% Similarity=0.416 Sum_probs=137.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|+..+.||.|+||.|..++.+ +|.-+|+|++++... ...+...+|..+|+.+.||.+++|++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999875 578899999987543 23455678999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|.|..+|.... .+++....-++.+|+.||+|||+.. |++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999996543 3788888889999999999999988 999999999999999999999999999988643
Q ss_pred cceeccccccCC
Q 005471 684 EILAITKRVVGT 695 (695)
Q Consensus 684 ~~~~~~~~~~GT 695 (695)
|-++.||
T Consensus 198 -----T~TlCGT 204 (355)
T KOG0616|consen 198 -----TWTLCGT 204 (355)
T ss_pred -----EEEecCC
Confidence 3335665
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=204.22 Aligned_cols=115 Identities=43% Similarity=0.735 Sum_probs=101.2
Q ss_pred CccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeeccCCCceeE
Q 005471 30 QPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPV 109 (695)
Q Consensus 30 ~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~~~ 109 (695)
+.|.+|++|+|++|.|++|||.+......+.+|||++.+ .++||.||++.| ....+.|.|+.||+|+|+|.+|. ++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~--~v 77 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGT--VV 77 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCc--EE
Confidence 578899999999999999999997643489999999876 789999999998 44668899999999999998888 89
Q ss_pred EeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCC
Q 005471 110 WQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHP 150 (695)
Q Consensus 110 Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~P 150 (695)
|+|++.. +.+..+|+|+|+|||||++. .+.+||||||||
T Consensus 78 W~S~~~~-~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~P 116 (116)
T cd00028 78 WSSNTTR-VNGNYVLVLLDDGNLVLYDS-DGNFLWQSFDYP 116 (116)
T ss_pred EEecccC-CCCceEEEEeCCCCEEEECC-CCCEEEcCCCCC
Confidence 9999863 35567899999999999987 478999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=247.71 Aligned_cols=152 Identities=32% Similarity=0.485 Sum_probs=133.2
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHH--HHHHHHHHcCC-CCceeeeEeEEEeCC-eeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEEL--KNEVLLIAKLQ-HRNLVKLLGCCLEED-ENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~--~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~l 601 (695)
.++|...++||.|.||.||+|+- .++..||||++++.-.. .++. .+|++.|.+|. |||||+|.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45788889999999999999974 56889999999875333 3332 47999999998 999999999999988 8999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|||||+ -+|.++++++ ..++++....+|+.||++||+|+|.++ ++||||||+|||+.....+||+||||||.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999996 5788888765 567999999999999999999999998 9999999999999988899999999999886
Q ss_pred CCcc
Q 005471 682 GEEI 685 (695)
Q Consensus 682 ~~~~ 685 (695)
..+.
T Consensus 162 SkpP 165 (538)
T KOG0661|consen 162 SKPP 165 (538)
T ss_pred cCCC
Confidence 5544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=249.59 Aligned_cols=150 Identities=34% Similarity=0.537 Sum_probs=131.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC--C--cE-EEEEEccc---CCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN--G--QE-IAVKRLST---TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~--g--~~-vAvK~l~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 598 (695)
.++....++||+|+||+||+|++.. + .. ||||..+. .......+|.+|+++|.+++|||||+|+|++....+
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455556899999999999998743 2 23 89998874 234567799999999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.++|||+|+||+|+++|..... .++..+++.++.+.|+||+|||++. +|||||.++|+|++.+..+||+||||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999976433 5899999999999999999999998 9999999999999999999999999998
Q ss_pred eec
Q 005471 679 VFG 681 (695)
Q Consensus 679 ~~~ 681 (695)
.-.
T Consensus 311 ~~~ 313 (474)
T KOG0194|consen 311 AGS 313 (474)
T ss_pred CCc
Confidence 543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=235.17 Aligned_cols=164 Identities=29% Similarity=0.445 Sum_probs=134.1
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--------------cccHHHHHHHHHHHHcCCCCceeeeE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--------------GQGIEELKNEVLLIAKLQHRNLVKLL 590 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--------------~~~~~~~~~Ei~~l~~l~H~nIv~l~ 590 (695)
..++|.+.+.||+|.||.|-+|+. .+++.||||++.+.. ....+..++||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 346788999999999999999986 468999999986532 11245788999999999999999999
Q ss_pred eEEEeC--CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005471 591 GCCLEE--DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN 668 (695)
Q Consensus 591 g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 668 (695)
.+..+. +..|||+|||..|.+...- .....+.+.+...|++++..||+|||.++ ||||||||+|+||++++.
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 998765 4689999999999875432 12222889999999999999999999998 999999999999999999
Q ss_pred eEEEeeccceeecCC---cceeccccccCC
Q 005471 669 PRISDFGTARVFGGE---EILAITKRVVGT 695 (695)
Q Consensus 669 ~kl~DFGla~~~~~~---~~~~~~~~~~GT 695 (695)
+||+|||.+..+... ...+...+.+||
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGT 278 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGT 278 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCC
Confidence 999999999987322 222344456776
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=239.37 Aligned_cols=151 Identities=26% Similarity=0.380 Sum_probs=135.3
Q ss_pred HhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
...++|+.+.+||+|+||.||.++-+ +|..+|+|++++.. ....+.++.|-.+|...++|.||+|+..|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35678999999999999999999864 58999999998753 334567889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|||||+|||++..+|.. ...|++.....++.+++.|++-||+.+ +|||||||+|+|||..|++||+||||+.-+
T Consensus 218 LiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999954 346888888889999999999999988 999999999999999999999999999755
Q ss_pred c
Q 005471 681 G 681 (695)
Q Consensus 681 ~ 681 (695)
.
T Consensus 292 ~ 292 (550)
T KOG0605|consen 292 D 292 (550)
T ss_pred h
Confidence 3
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=242.39 Aligned_cols=159 Identities=26% Similarity=0.482 Sum_probs=140.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|.+.+.||+|+||.||||+-+ +.+.||||.+.+.. ..+.+.+++|++|+++++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56778899999999999999754 57899999997653 3446678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
|+.+ +|..+|.... .++++....|+.++..||.|||+.. |+|||+||.||||+..+.+|+||||+||.++.+.
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9986 9999996543 3899999999999999999999987 9999999999999999999999999999987654
Q ss_pred ceeccccccCC
Q 005471 685 ILAITKRVVGT 695 (695)
Q Consensus 685 ~~~~~~~~~GT 695 (695)
+ +.+++.||
T Consensus 155 ~--vltsikGt 163 (808)
T KOG0597|consen 155 S--VLTSIKGT 163 (808)
T ss_pred e--eeeeccCc
Confidence 3 46667776
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=231.59 Aligned_cols=150 Identities=31% Similarity=0.494 Sum_probs=132.0
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC--eeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--ENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E 604 (695)
.+|...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|...... ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 356677999999999999998754 8999999887654333677999999999999999999999855554 5889999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 682 (695)
|+++|+|.+++..... .+++.....+..||++||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999976543 4899999999999999999999987 999999999999999 79999999999998874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=236.78 Aligned_cols=149 Identities=28% Similarity=0.452 Sum_probs=131.9
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC----Cc-ccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT----SG-QGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 599 (695)
..+|...+.||+|+||+|+.|.. .++..||||.+... .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 45788889999999999999975 46899999976553 11 23456778999999998 99999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CceEEEeeccce
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTAR 678 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~ 678 (695)
++||||+.+|+|.+++... ..+.+.....++.|++.|++|||+++ |+||||||+||||+.+ +.+||+|||++.
T Consensus 96 ~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999763 23778888899999999999999987 9999999999999999 999999999999
Q ss_pred eec
Q 005471 679 VFG 681 (695)
Q Consensus 679 ~~~ 681 (695)
...
T Consensus 170 ~~~ 172 (370)
T KOG0583|consen 170 ISP 172 (370)
T ss_pred ccC
Confidence 884
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-26 Score=216.47 Aligned_cols=150 Identities=29% Similarity=0.436 Sum_probs=132.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|.||.||.|+.+ ++-.||+|++.+.. .+-..++++|++|-..|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56888899999999999999864 57789999987642 234568999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||.+.|+|...|.+.. ...+++.....++.|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||-+..-.
T Consensus 102 Eya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999997433 234677778889999999999999987 9999999999999999999999999997643
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=228.40 Aligned_cols=153 Identities=30% Similarity=0.522 Sum_probs=130.9
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-----------------CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-----------------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKL 589 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l 589 (695)
++|.+.++||+|+||.||++...+ +..||||.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778999999999999997532 3469999987643 2335678999999999999999999
Q ss_pred EeEEEeCCeeEEEEEcCCCCCHHHHHhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 005471 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDES----------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653 (695)
Q Consensus 590 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 653 (695)
++++.+.+..++||||+++|+|.+++.... ....++|.....++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1124788889999999999999999987 999
Q ss_pred cCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 654 RDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 654 rDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|||||+|||+++++.+||+|||+++.+...
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~ 191 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAG 191 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccC
Confidence 999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=223.19 Aligned_cols=149 Identities=29% Similarity=0.518 Sum_probs=127.0
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc-c-cHHHHHHHHHHHHcCCCCc-eeeeEeEEEeCC------e
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG-Q-GIEELKNEVLLIAKLQHRN-LVKLLGCCLEED------E 598 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~-~-~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~------~ 598 (695)
.|...++||+|.||+||+|+. .+|+.||+|++..... + -.....+|+.++++++|+| ||+|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455568899999999999985 4688999999876533 2 2334578999999999999 999999999887 7
Q ss_pred eEEEEEcCCCCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRK-QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
.+||+||++ -+|..++...... ..++-.....++.||++||+|||+++ |+||||||.||||++++.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 889999995 6898888654422 34666788899999999999999987 999999999999999999999999999
Q ss_pred eeec
Q 005471 678 RVFG 681 (695)
Q Consensus 678 ~~~~ 681 (695)
+.++
T Consensus 168 ra~~ 171 (323)
T KOG0594|consen 168 RAFS 171 (323)
T ss_pred HHhc
Confidence 9776
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=220.99 Aligned_cols=150 Identities=29% Similarity=0.476 Sum_probs=125.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcc-c-HHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-G-IEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~-~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 602 (695)
+.|..++.|++|.||.||+|+.. +++.||+|+++..... + .---.+||.+|.+++|||||.+..+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45677799999999999999874 5788999999764321 1 11235799999999999999999987753 578999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||||+ -+|..++.... ..+...+..-++.|+++|++|||... |+||||||+|+|++..|.+||+||||||.++.
T Consensus 156 Me~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99997 47888886554 34667777789999999999999987 99999999999999999999999999999976
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 230 p 230 (419)
T KOG0663|consen 230 P 230 (419)
T ss_pred C
Confidence 5
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=234.44 Aligned_cols=154 Identities=32% Similarity=0.479 Sum_probs=129.8
Q ss_pred hcCCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 597 (695)
..++|.+.++||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++.++ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788889999999999999974 2356899999875432 3346788999999999 8999999999988654
Q ss_pred -eeEEEEEcCCCCCHHHHHhccCC--------------------------------------------------------
Q 005471 598 -ENMLIYEFMPNKSLDYFIFDESR-------------------------------------------------------- 620 (695)
Q Consensus 598 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 620 (695)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 621 ---KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 621 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
...+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 124788888999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=238.21 Aligned_cols=150 Identities=33% Similarity=0.595 Sum_probs=132.1
Q ss_pred HHHHhcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 522 TLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 522 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
+..+..+.+.+.+.||+|+||+||||++. ..||||+++... .+..++|++|+..+++-+|.||+-+.|+|..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 33344455667799999999999999985 479999997653 3467899999999999999999999999998877
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
.||+.+|++-+|..+|+... ..++-.+..+|+.|||+||.|||.+. |||||||..||+|.+++.|||.||||+..
T Consensus 463 AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999997654 34788889999999999999999998 99999999999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=253.75 Aligned_cols=151 Identities=36% Similarity=0.642 Sum_probs=133.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC--Cc----EEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN--GQ----EIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~--g~----~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
.++....+.||+|.||.||+|.+.+ +. .||||.+++. +.+...+|.+|..+|++++|||||+|+|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455667899999999999998743 33 4999999875 456678999999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeec
Q 005471 600 MLIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 675 (695)
++++|||++|+|..||.+.. +...|.-.+.+.|+.|||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997642 2345888999999999999999999987 9999999999999999999999999
Q ss_pred cceee
Q 005471 676 TARVF 680 (695)
Q Consensus 676 la~~~ 680 (695)
|||-+
T Consensus 848 lArDi 852 (1025)
T KOG1095|consen 848 LARDI 852 (1025)
T ss_pred hhHhh
Confidence 99944
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=193.05 Aligned_cols=113 Identities=41% Similarity=0.723 Sum_probs=99.4
Q ss_pred CccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeeccCCCceeE
Q 005471 30 QPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPV 109 (695)
Q Consensus 30 ~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~~~ 109 (695)
+.|..|++|+|++|.|++|||.+.. +..+.+|||++.+ .++||+|||+.|+... +.|.|+.||+|+|+|.+|. ++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~-q~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~--~v 76 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIM-QNDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGR--VV 76 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCC-CCCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCC--EE
Confidence 4678899999999999999999864 4688999999876 7899999999998653 8899999999999999888 89
Q ss_pred EeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCC
Q 005471 110 WQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDH 149 (695)
Q Consensus 110 Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~ 149 (695)
|+|++. .+.+..+|+|+|+|||||++. .+.++||||||
T Consensus 77 W~S~t~-~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~ 114 (114)
T smart00108 77 WSSNTT-GANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY 114 (114)
T ss_pred EEeccc-CCCCceEEEEeCCCCEEEECC-CCCEEeCCCCC
Confidence 999975 345567899999999999986 56799999997
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=241.92 Aligned_cols=149 Identities=33% Similarity=0.557 Sum_probs=130.3
Q ss_pred ccceeeeeCceeEEEEEc-CCCc----EEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 532 TSNKLGQGGFGPVYKGKL-SNGQ----EIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~-~~g~----~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
..++||+|+||+||||.+ +.|+ +||||++... ..+..+++..|+.+|++|+||||+||+|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 458999999999999975 4443 6899988764 3455678999999999999999999999998776 8899999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
||.|.|.++++.+.. .+.-...+.+..|||+||.|||++. ++||||.++||||.+-..+||+|||+|+++..++.
T Consensus 779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999976533 3677888999999999999999886 99999999999999999999999999999987765
Q ss_pred e
Q 005471 686 L 686 (695)
Q Consensus 686 ~ 686 (695)
+
T Consensus 854 e 854 (1177)
T KOG1025|consen 854 E 854 (1177)
T ss_pred c
Confidence 4
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=234.45 Aligned_cols=159 Identities=33% Similarity=0.501 Sum_probs=142.0
Q ss_pred CCCCccceeeeeCceeEEEEE-cCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
..|...++||+|+.|.||.++ ..+++.||||++........+-+.+|+.+|+..+|+|||+++..+...++.+.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 346666899999999999996 4578899999998876666667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcce
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 686 (695)
++|+|.+.+.. ..+++.+...|++++++||+|||.++ |||||||.+||||+.++.+||+|||++..+..++..
T Consensus 353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 99999988743 24889999999999999999999998 999999999999999999999999999999888765
Q ss_pred eccccccCC
Q 005471 687 AITKRVVGT 695 (695)
Q Consensus 687 ~~~~~~~GT 695 (695)
. .+++||
T Consensus 426 R--~TmVGT 432 (550)
T KOG0578|consen 426 R--STMVGT 432 (550)
T ss_pred c--ccccCC
Confidence 4 347887
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=223.21 Aligned_cols=148 Identities=25% Similarity=0.426 Sum_probs=126.5
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHc--CCCCceeeeEeEEEeCC----eeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK--LQHRNLVKLLGCCLEED----ENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~l 601 (695)
.+..+.+.||+|.||+|++|.++ |+.||||++...+ ++...+|.+|... |+|+||+.+++.-..+. +.+|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 45667799999999999999996 7899999997543 3455666666654 69999999999755443 4789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-----DSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
|++|.++|||.+||.. ..++-...++++..+|.||++||. ++++.|.|||||++|||+.+++.+.|+|+||
T Consensus 287 vTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 9999999999999954 468889999999999999999997 4778899999999999999999999999999
Q ss_pred ceeecCC
Q 005471 677 ARVFGGE 683 (695)
Q Consensus 677 a~~~~~~ 683 (695)
|-....+
T Consensus 363 Av~h~~~ 369 (513)
T KOG2052|consen 363 AVRHDSD 369 (513)
T ss_pred eEEeccc
Confidence 9988655
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=230.64 Aligned_cols=148 Identities=24% Similarity=0.372 Sum_probs=131.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|+..+.||+|+||+||+++.. +++.||||++.+.. ......+++|+.++.+++||||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888899999999999999764 58899999986532 223456788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999998643 34789999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=218.69 Aligned_cols=152 Identities=24% Similarity=0.382 Sum_probs=135.8
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.+.|++.+.||.|.-++||+|+. +.+..||||++.-.. ..+.+++++|++.|..++||||++.+..|..+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35688889999999999999974 567999999987543 3346899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||.+|++.++++..... .+++..+..|.+++++||.|||.++ .||||||+.||||+++|.+||+|||.+..+-.
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999765433 3889999999999999999999998 99999999999999999999999999887743
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=230.15 Aligned_cols=150 Identities=21% Similarity=0.279 Sum_probs=132.0
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
..++|+..+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4467888999999999999999875 5789999998642 22334567889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++|+|.+++... .+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999988532 3678888899999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 005471 682 G 682 (695)
Q Consensus 682 ~ 682 (695)
.
T Consensus 194 ~ 194 (370)
T cd05621 194 E 194 (370)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=230.90 Aligned_cols=147 Identities=25% Similarity=0.349 Sum_probs=129.9
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.++||+|+||+||+++. .+++.||||++.+.. ....+.+++|++++.+++|||||++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688889999999999999975 468899999886532 233567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999988543 34788888889999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=230.26 Aligned_cols=149 Identities=25% Similarity=0.383 Sum_probs=132.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|+..+.||+|+||+||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888899999999999999874 58899999986532 233456788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999998643 24788999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=226.32 Aligned_cols=149 Identities=25% Similarity=0.387 Sum_probs=131.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++..++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999875 58899999987532 233456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999998543 34788888999999999999999987 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=230.81 Aligned_cols=146 Identities=23% Similarity=0.338 Sum_probs=129.4
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.|..++.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999976 467899999986532 2335678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+++|+|.+++... ..+++.....++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999998643 34788888889999999999999987 999999999999999999999999998755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=219.13 Aligned_cols=149 Identities=29% Similarity=0.416 Sum_probs=130.2
Q ss_pred CCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 530 FSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
|+..+.||+|+||.||++.. .+++.||||.+.... ......+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999986 468999999886532 22334678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++|+|..++.... ...+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999988875432 234789999999999999999999987 99999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=229.95 Aligned_cols=154 Identities=31% Similarity=0.462 Sum_probs=131.9
Q ss_pred cCCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCe
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 598 (695)
.++|.+.++||+|+||.||+|+. .++..||||+++... ....+.+.+|+.++..+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688889999999999999963 245689999987543 23456788999999999 89999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccCC----------------------------------------------------------
Q 005471 599 NMLIYEFMPNKSLDYFIFDESR---------------------------------------------------------- 620 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 620 (695)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998864211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 621 --------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 621 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
...++|.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=234.45 Aligned_cols=160 Identities=29% Similarity=0.472 Sum_probs=135.9
Q ss_pred CCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------eeEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ENML 601 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~l 601 (695)
|...+.||+|+||.||+|+. .+|+.||||.+++.. ....+...+|+++|++++|||||++++.=.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34458899999999999995 579999999987753 334566778999999999999999999755433 4689
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--C--CCceEEEeeccc
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--E--KMNPRISDFGTA 677 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~--~~~~kl~DFGla 677 (695)
|||||++|+|...|.+......|++.+.+.+..+++.||.|||+++ |+||||||.||++- + ...-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988777778999999999999999999999887 99999999999994 3 234699999999
Q ss_pred eeecCCcceeccccccCC
Q 005471 678 RVFGGEEILAITKRVVGT 695 (695)
Q Consensus 678 ~~~~~~~~~~~~~~~~GT 695 (695)
|-+..++ ..+.++||
T Consensus 172 rel~d~s---~~~S~vGT 186 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGT 186 (732)
T ss_pred ccCCCCC---eeeeecCc
Confidence 9987666 34558887
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=219.96 Aligned_cols=149 Identities=32% Similarity=0.479 Sum_probs=118.6
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe-----eEEEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE-----NMLIY 603 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~~lV~ 603 (695)
|...+++|.|+||.||+|.+. ++++||||+.-.... .-.+|+++|++++|||||+|+-+|....+ ..|||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 444589999999999999875 468999998765332 22369999999999999999999886543 35899
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 681 (695)
|||| -+|...+.+-. .+..++.....-+..||.+||.|||+.+ |+||||||.|+|+|. .+.+||||||-|+.+.
T Consensus 102 eymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred Hhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 9998 57777775421 1223555555568999999999999976 999999999999995 4999999999999997
Q ss_pred CCcce
Q 005471 682 GEEIL 686 (695)
Q Consensus 682 ~~~~~ 686 (695)
.++..
T Consensus 178 ~~epn 182 (364)
T KOG0658|consen 178 KGEPN 182 (364)
T ss_pred cCCCc
Confidence 65543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=224.71 Aligned_cols=149 Identities=26% Similarity=0.375 Sum_probs=131.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46778899999999999999875 57899999986532 233467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999988643 24778888889999999999999987 99999999999999999999999999997754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=234.33 Aligned_cols=151 Identities=17% Similarity=0.240 Sum_probs=131.6
Q ss_pred CCccceeeeeCceeEEEEEcC-C-CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-N-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
|.+.+.||+|+||.||++... + ++.||+|.+..........+++|+.+++.++|||||++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 677799999999999999753 3 57889998765444445678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 608 NKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 608 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+|+|.+++... .....+++.....++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999888643 22345788899999999999999999987 999999999999999999999999999987644
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-24 Score=230.43 Aligned_cols=150 Identities=28% Similarity=0.418 Sum_probs=133.4
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
-|++++.||+|+-|.|-.|+. .+|+.+|||.+.+.. ......+.+||.+|+-+.||||++|++++.+..+.|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 477789999999999999986 579999999987652 2334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
|+++|.|.++|.... .+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||.+..+||+|||||.+-.++.
T Consensus 93 yv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred ecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999996543 4788999999999999999999987 9999999999999999999999999998765443
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=225.59 Aligned_cols=149 Identities=26% Similarity=0.354 Sum_probs=130.8
Q ss_pred CCCCccceeeeeCceeEEEEEcCC--CcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN--GQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~--g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|...+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 467888999999999999998643 3689999886432 23355788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999998643 24788899999999999999999987 99999999999999999999999999997753
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-24 Score=222.48 Aligned_cols=149 Identities=22% Similarity=0.341 Sum_probs=131.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999875 68899999986432 233456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999998543 24788888999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-24 Score=229.96 Aligned_cols=162 Identities=27% Similarity=0.408 Sum_probs=137.6
Q ss_pred HhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCee
Q 005471 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 599 (695)
...++|..+++||+|.||+|+++.++ +++.+|||.+++.. ..+.+..+.|.+|+... +||.|++|+.+|+..++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999986 47789999998864 34567778888888777 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||+.||++..+. ....+++....-++..|+.||.|||+++ |||||||.+|||||.+|.+||+||||+|.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999943222 2345889988889999999999999998 99999999999999999999999999997
Q ss_pred ecCCcceeccccccCC
Q 005471 680 FGGEEILAITKRVVGT 695 (695)
Q Consensus 680 ~~~~~~~~~~~~~~GT 695 (695)
-..... .|.++.||
T Consensus 518 ~m~~g~--~TsTfCGT 531 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGT 531 (694)
T ss_pred cCCCCC--ccccccCC
Confidence 543333 46668887
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=223.48 Aligned_cols=152 Identities=20% Similarity=0.309 Sum_probs=133.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||+||+++.. +++.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999864 68899999987532 234556889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.+++.... ..+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999986542 34889999999999999999999987 999999999999999999999999999987544
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 156 ~ 156 (330)
T cd05601 156 K 156 (330)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=230.65 Aligned_cols=153 Identities=31% Similarity=0.506 Sum_probs=136.7
Q ss_pred CCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
....++||-|-||.||.|.++. .-.||||.++. +....++|..|+.+|+.++|||+|+|+|+|..+...|||+|||..
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 3445899999999999999864 46799999976 456788999999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCccee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 687 (695)
|+|.+||.+..+. .++-...+.++.||+.||+||..++ +|||||.++|+|+.++..+||+||||+|++.++...+
T Consensus 348 GNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 348 GNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred ccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999999876554 4666777889999999999999987 9999999999999999999999999999998876544
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=229.06 Aligned_cols=146 Identities=23% Similarity=0.359 Sum_probs=128.9
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.|..+++||+|+||.||+|+. .+++.||||++.+.. ....+.+.+|++++++++|||||++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 577889999999999999986 467899999986532 2334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999988543 34778888889999999999999987 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=222.60 Aligned_cols=150 Identities=23% Similarity=0.297 Sum_probs=131.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+++.. +++.||||.+.+. .....+.+++|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999864 5889999998642 2233456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++|+|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998543 234788888899999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=222.23 Aligned_cols=141 Identities=23% Similarity=0.309 Sum_probs=124.9
Q ss_pred ceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 534 NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
+.||+|+||.||+++. .+++.||||.+.... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999986 468899999987532 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+|..++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 998888543 35789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=222.00 Aligned_cols=151 Identities=21% Similarity=0.268 Sum_probs=131.9
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+++.. +++.||||.+.+. .....+.+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999865 5788999998642 1223455788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|..++.... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999986532 24788888889999999999999987 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=220.21 Aligned_cols=155 Identities=30% Similarity=0.477 Sum_probs=130.3
Q ss_pred cceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 533 SNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
.+.||.|-||+||-|+. ++|+.||||++.+. .......+++|+.||.+++||.||.|.-.|+..+..+.|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 38999999999999987 47999999999764 33455789999999999999999999999999999999999996 5
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CceEEEeeccceeecCCcce
Q 005471 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK---MNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~~~ 686 (695)
++.+.|..... ..|+++...-++.||+.||.|||.++ |+|+||||+||||.+. -.+||||||+||++++...+
T Consensus 648 DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 55455433322 23778777778999999999999998 9999999999999743 46999999999999877664
Q ss_pred eccccccCC
Q 005471 687 AITKRVVGT 695 (695)
Q Consensus 687 ~~~~~~~GT 695 (695)
+.|+||
T Consensus 724 ---rsVVGT 729 (888)
T KOG4236|consen 724 ---RSVVGT 729 (888)
T ss_pred ---hhhcCC
Confidence 447887
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=227.06 Aligned_cols=146 Identities=22% Similarity=0.346 Sum_probs=129.1
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+|++.+.||+|+||.||+++.. +++.||||.+.+.. ....+.+.+|++++.+++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5888899999999999999864 58899999986532 2234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999998543 34788888889999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=221.59 Aligned_cols=141 Identities=24% Similarity=0.329 Sum_probs=125.2
Q ss_pred ceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 534 NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
+.||+|+||.||+++. .+++.||||.+.+.. ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 468899999987532 234567788999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 998887543 34789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=227.23 Aligned_cols=154 Identities=31% Similarity=0.487 Sum_probs=130.9
Q ss_pred cCCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCe
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 598 (695)
.++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.+++.+ +|+|||+++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34688889999999999999873 234579999997543 23345688999999999 89999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccC-----------------------------------------------------------
Q 005471 599 NMLIYEFMPNKSLDYFIFDES----------------------------------------------------------- 619 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 619 (695)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885421
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 620 --------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 620 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
....+++.....|+.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..+
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 0124788889999999999999999987 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=220.36 Aligned_cols=140 Identities=23% Similarity=0.280 Sum_probs=124.4
Q ss_pred eeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 536 LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
||+|+||.||+++.. +++.||||.+... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 5789999998643 233456778899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
.+++... ..+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 9988643 24788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-24 Score=236.53 Aligned_cols=151 Identities=27% Similarity=0.450 Sum_probs=132.4
Q ss_pred CCCCccceeeeeCceeEEEEEcCCC-cEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeE-EEeC------Ce
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNG-QEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGC-CLEE------DE 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g-~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~-~~~~------~~ 598 (695)
.+..+.+.|.+|||+.||.+++..+ .++|+|++-..+.+..+.+++||++|++|+ |+|||.+++. .... -+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3456679999999999999998766 999999998778888999999999999997 9999999993 2221 25
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.+|.||||++|.|-+++..+.... |.+.+.++|+.++++|+.+||... +||||||||.|||||+.++..||||||-|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 789999999999999987554443 899999999999999999999974 789999999999999999999999999987
Q ss_pred ee
Q 005471 679 VF 680 (695)
Q Consensus 679 ~~ 680 (695)
-.
T Consensus 195 t~ 196 (738)
T KOG1989|consen 195 TK 196 (738)
T ss_pred cc
Confidence 43
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=226.46 Aligned_cols=154 Identities=29% Similarity=0.437 Sum_probs=131.4
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEED 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~ 597 (695)
..++|.+.++||+|+||.||+|+.. .+..||||++..... ...+.+.+|+++++++. |||||+++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888899999999999999752 234799999975432 33467899999999996 999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccCC---------------------------------------------------------
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESR--------------------------------------------------------- 620 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 620 (695)
..+|||||+++|+|.++|.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998854210
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005471 621 ------------------------------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (695)
Q Consensus 621 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 664 (695)
...+++..+..++.||++||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788888999999999999999987 99999999999999
Q ss_pred CCCceEEEeeccceeecC
Q 005471 665 EKMNPRISDFGTARVFGG 682 (695)
Q Consensus 665 ~~~~~kl~DFGla~~~~~ 682 (695)
+++.+||+|||+++.+..
T Consensus 272 ~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 272 QGKIVKICDFGLARDIMH 289 (400)
T ss_pred CCCEEEEEeCCcceeccc
Confidence 999999999999997644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=221.36 Aligned_cols=141 Identities=23% Similarity=0.319 Sum_probs=124.7
Q ss_pred ceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 534 NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
+.||+|+||.||+++. .+++.||+|.+.... ......+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999986 468999999987532 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 998887543 34789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=226.76 Aligned_cols=151 Identities=23% Similarity=0.284 Sum_probs=131.3
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
..++|...++||+|+||.||+++.. +++.||||.+.+. .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457888899999999999999864 5889999998642 12334557789999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++|+|.+++... .++......++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988542 3677778889999999999999987 9999999999999999999999999998875
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 194 ~~ 195 (370)
T cd05596 194 AN 195 (370)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=225.14 Aligned_cols=154 Identities=22% Similarity=0.269 Sum_probs=133.4
Q ss_pred HHHhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe
Q 005471 523 LLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 523 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 598 (695)
+....++|.+.+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3444578999999999999999999875 5789999998642 12234567889999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.++||||+++|+|..++... .++......++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999988532 3677888889999999999999987 9999999999999999999999999999
Q ss_pred eecCC
Q 005471 679 VFGGE 683 (695)
Q Consensus 679 ~~~~~ 683 (695)
.+...
T Consensus 191 ~~~~~ 195 (371)
T cd05622 191 KMNKE 195 (371)
T ss_pred EcCcC
Confidence 87543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=224.45 Aligned_cols=151 Identities=25% Similarity=0.405 Sum_probs=134.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||+||+++.. +++.||||++.... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999875 68899999987532 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++++|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998654 35788999999999999999999976 999999999999999999999999999987544
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 155 ~ 155 (350)
T cd05573 155 K 155 (350)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-23 Score=218.11 Aligned_cols=142 Identities=24% Similarity=0.304 Sum_probs=124.3
Q ss_pred ceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 534 NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
+.||+|+||.||+++. .+++.||+|.+.... .....++..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 468899999987532 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+|..++... ..+++.....++.||+.||.|||+ .+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 998887543 348899999999999999999997 45 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=219.65 Aligned_cols=150 Identities=21% Similarity=0.261 Sum_probs=130.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.++||+|+||.||+++.. +++.+|+|.+.+.. ....+.+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46788899999999999999875 46789999986421 223445788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++|+|.+++.... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999996532 24788888899999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=220.09 Aligned_cols=148 Identities=24% Similarity=0.327 Sum_probs=128.6
Q ss_pred CCCccceeeeeCceeEEEEEc----CCCcEEEEEEcccCC----cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCee
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 599 (695)
+|++.+.||+|+||.||+++. .+++.||+|++.+.. ....+.+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467789999999999999875 357899999986431 22345678899999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999988543 34788999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005471 680 FGG 682 (695)
Q Consensus 680 ~~~ 682 (695)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=224.83 Aligned_cols=162 Identities=26% Similarity=0.457 Sum_probs=141.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe-eEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE-NMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~lV~ 603 (695)
++|..++++|+|+||.++..+.+ +++.+++|.+.... ....+....|+.++++++|||||...+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999988764 56789999886542 3334466789999999999999999999999998 89999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||++||+|.+.|.... ...++++..+.++.|++.|+.|||++. |+|||||+.||+++.+..+||.|||+||.++.+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997654 456899999999999999999999876 999999999999999999999999999999887
Q ss_pred cceeccccccCC
Q 005471 684 EILAITKRVVGT 695 (695)
Q Consensus 684 ~~~~~~~~~~GT 695 (695)
... ..+++||
T Consensus 160 ~~~--a~tvvGT 169 (426)
T KOG0589|consen 160 DSL--ASTVVGT 169 (426)
T ss_pred hhh--hheecCC
Confidence 743 4447887
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-23 Score=215.40 Aligned_cols=148 Identities=28% Similarity=0.486 Sum_probs=128.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|...++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999864 67899999986532 22345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++ ++|.+++.... ..+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 98 48888875432 34788888999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=218.56 Aligned_cols=150 Identities=30% Similarity=0.578 Sum_probs=129.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCc----EEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
.+|+..+.||+|+||.||+|++. +++ .||||.++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888899999999999999863 333 48999987543 34456788999999999999999999998764 5789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|+||+++|+|.+++.... ..+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999986543 24788899999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
.+
T Consensus 161 ~~ 162 (316)
T cd05108 161 AD 162 (316)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=213.57 Aligned_cols=148 Identities=24% Similarity=0.426 Sum_probs=130.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC----CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|++.+.||+|+||.||+|.+. .+..||+|.++.... ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46778899999999999999753 356899999876432 3345788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|||+++|+|++++.... ..+++...+.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||++...
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999986532 35789999999999999999999887 999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=218.79 Aligned_cols=141 Identities=27% Similarity=0.394 Sum_probs=123.6
Q ss_pred ceeeeeCceeEEEEEc----CCCcEEEEEEcccCC----cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 534 NKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++||+|+||.||+++. .+++.||||.+.... ......+..|+.++..++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 357899999986531 22345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+++++|.+++... ..+.+.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 9999999988543 34678888889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=218.05 Aligned_cols=144 Identities=30% Similarity=0.333 Sum_probs=126.2
Q ss_pred ceeeeeCceeEEEEEc----CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 534 NKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~----~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
+.||+|+||.||+++. .+++.+|||++.... ......+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999874 357899999987532 2234467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+|+|.+++... ..+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 99999988543 34889999999999999999999987 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=221.19 Aligned_cols=159 Identities=30% Similarity=0.471 Sum_probs=138.3
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcc---cHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQ---GIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~l 601 (695)
.+.|.+.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|.++. |||||.+.+.+......++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4567788999999999999998765 999999999775433 3468999999999998 9999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CceEEEeeccc
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK----MNPRISDFGTA 677 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla 677 (695)
|||++.+|.|.+.+... . +++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+|
T Consensus 114 vmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999998765 2 889999999999999999999987 9999999999999733 57999999999
Q ss_pred eeecCCcceeccccccCC
Q 005471 678 RVFGGEEILAITKRVVGT 695 (695)
Q Consensus 678 ~~~~~~~~~~~~~~~~GT 695 (695)
+.+..++ ....++||
T Consensus 187 ~~~~~~~---~~~~~~Gt 201 (382)
T KOG0032|consen 187 KFIKPGE---RLHTIVGT 201 (382)
T ss_pred eEccCCc---eEeeecCC
Confidence 9988732 23446776
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=212.85 Aligned_cols=148 Identities=29% Similarity=0.497 Sum_probs=126.7
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEccc--CCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe-----CCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLST--TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-----EDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~~ 599 (695)
..|...+.||+|+||.|..+.. .+|+.||||++.. ......++..+|+++|+.++|+||+.+++.+.. -...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 3455568999999999999986 4689999999873 244556778899999999999999999999876 3457
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
|+|+|+| .-+|...++.. ..|......-++.||++||.|+|+.+ |+||||||+|+|++.+..+||+||||||.
T Consensus 102 YiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 9999999 47888888543 23777777779999999999999987 99999999999999999999999999999
Q ss_pred ecC
Q 005471 680 FGG 682 (695)
Q Consensus 680 ~~~ 682 (695)
...
T Consensus 175 ~~~ 177 (359)
T KOG0660|consen 175 LDK 177 (359)
T ss_pred ccc
Confidence 864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-23 Score=215.53 Aligned_cols=149 Identities=29% Similarity=0.463 Sum_probs=128.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++|.+.++||+|+||.||+|+.. +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999875 688999999875432 233467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|++ ++|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 6777776543 234788888899999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-23 Score=222.17 Aligned_cols=148 Identities=25% Similarity=0.382 Sum_probs=130.9
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|+..+.||+|+||.||+++.. +++.||||.+.... ....+.++.|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999864 58899999986432 233557888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999998543 34788888999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=213.16 Aligned_cols=152 Identities=34% Similarity=0.548 Sum_probs=131.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-----CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
+.|+..++||+|+||.||+|.. ..++.||+|.+.... .+...++.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3566779999999999999974 346789999987533 3345678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 005471 602 IYEFMPNKSLDYFIFDESR--------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~ 667 (695)
||||+++++|.+++..... ...+++.....++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 234788999999999999999999987 99999999999999999
Q ss_pred ceEEEeeccceeecC
Q 005471 668 NPRISDFGTARVFGG 682 (695)
Q Consensus 668 ~~kl~DFGla~~~~~ 682 (695)
.+||+|||+++.+..
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (283)
T cd05090 162 HVKISDLGLSREIYS 176 (283)
T ss_pred cEEeccccccccccC
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-24 Score=193.75 Aligned_cols=148 Identities=27% Similarity=0.497 Sum_probs=125.7
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|...++||+|.||+||+|+.. +++.||+|+++..+ ..-.....+||.+++.++|+|||+|++....+...-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556689999999999999865 47789999876432 22244567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+. -+|.++...... .++-.....++.|+++||.|+|+++ ++||||||.|.||+.++++|++||||||.++-
T Consensus 83 cd-qdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred hh-HHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 95 567777644332 4777888889999999999999998 99999999999999999999999999998864
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=212.92 Aligned_cols=148 Identities=24% Similarity=0.301 Sum_probs=130.8
Q ss_pred CCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+|+.++.||+|.-|+||++++.+ +..+|+|++.+.. .....+.+.|-+||+.++||.++.||+.++.++..+||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45567899999999999999865 4789999998753 2334566789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
||+||+|..+++.+.. +.+++....-++.+|+.||+|||..+ ||.|||||+||||.++|++.|+||-|+...
T Consensus 158 yCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred cCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999988876543 45788888889999999999999987 999999999999999999999999999865
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=209.71 Aligned_cols=149 Identities=29% Similarity=0.467 Sum_probs=132.4
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|+..+.||+|+||.||+++..++..+|+|.+... ....+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 346777899999999999999988889999988643 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 999999886432 24789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=209.55 Aligned_cols=151 Identities=30% Similarity=0.496 Sum_probs=135.3
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.++|++.+.||+|+||.||+|...+++.||||.++... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45678889999999999999998888899999987543 34577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++++|.+++.... ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999986543 235799999999999999999999987 99999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=221.63 Aligned_cols=144 Identities=29% Similarity=0.455 Sum_probs=125.0
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+|...++||+|+||.||+++.. +++.||||.+..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3556689999999999999864 689999999865432 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++++|... ....+.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 155 ~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 155 DGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99998542 12456777889999999999999987 99999999999999999999999999998753
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=210.20 Aligned_cols=145 Identities=39% Similarity=0.677 Sum_probs=125.9
Q ss_pred cceeeeeCceeEEEEEcC-----CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 533 SNKLGQGGFGPVYKGKLS-----NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~-----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.+.||.|.||.||+|++. .+..|+||.++... ....++|.+|++.+.+++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 478999999999999876 25689999996543 334788999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++|+|.++|.... ...+++..+..|+.||++||.|||+.. |+|+||+++|||+++++.+||+|||+++...
T Consensus 84 ~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 84 PGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 9999999997652 335899999999999999999999987 9999999999999999999999999999873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=216.78 Aligned_cols=151 Identities=24% Similarity=0.357 Sum_probs=132.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++|+..+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888899999999999999875 57889999887542 2335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+++++|.+++... ..+++.....++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999998543 24788899999999999999999853 399999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-24 Score=205.21 Aligned_cols=159 Identities=31% Similarity=0.482 Sum_probs=134.9
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC----ccc----HHHHHHHHHHHHcC-CCCceeeeEeEEEeCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS----GQG----IEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~----~~~----~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 597 (695)
+.|...+.||+|..+.|.++.. .+++++|+|++.... ... .++-.+|+.||+++ .||+|++|.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3566678999999999998876 468899999886432 111 33456899999998 6999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++|+|.|+.|.|.++|.. .-.++++...+|+.|+.+|++|||... ||||||||+|||+|+++.+||+|||+|
T Consensus 97 F~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 99999999999999999943 345889999999999999999999998 999999999999999999999999999
Q ss_pred eeecCCcceeccccccCC
Q 005471 678 RVFGGEEILAITKRVVGT 695 (695)
Q Consensus 678 ~~~~~~~~~~~~~~~~GT 695 (695)
..+.+++- ...+.||
T Consensus 171 ~~l~~Gek---LrelCGT 185 (411)
T KOG0599|consen 171 CQLEPGEK---LRELCGT 185 (411)
T ss_pred eccCCchh---HHHhcCC
Confidence 99987664 2334555
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=220.83 Aligned_cols=152 Identities=32% Similarity=0.456 Sum_probs=134.0
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
...|.+...||+|.|++|..++.. ++.+||||.+.+... ...+.+.+|+++|..+.|||||+|+.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456788899999999999999864 689999999987532 23345889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+.+|.+.+++....+ +.......++.|+.+|++|||.+. |+|||||++||||+.++.+||+|||++..+..+
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999977655 344667779999999999999998 999999999999999999999999999998754
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 209 ~ 209 (596)
T KOG0586|consen 209 L 209 (596)
T ss_pred c
Confidence 4
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=216.61 Aligned_cols=141 Identities=23% Similarity=0.364 Sum_probs=123.6
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+|+||.||+++.. +++.||+|.+++. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 5789999998753 223345677899988877 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+|..++... ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9998887543 34789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=217.08 Aligned_cols=150 Identities=23% Similarity=0.361 Sum_probs=131.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++|+..++||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888999999999999999875 57889999876542 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|+++++|.+++... ..+++.....++.++++||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999998643 24788888899999999999999753 39999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=209.44 Aligned_cols=150 Identities=33% Similarity=0.531 Sum_probs=134.3
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++.+...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 567888999999999999999888889999988653 3345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++|.+++.... ...+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999986543 234788899999999999999999986 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=211.50 Aligned_cols=150 Identities=29% Similarity=0.556 Sum_probs=131.3
Q ss_pred CCCCccceeeeeCceeEEEEEc-----CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 600 (695)
++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|++++.+++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999974 35789999998766555667899999999999999999999987643 4578
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 234899999999999999999999987 999999999999999999999999999976
Q ss_pred cC
Q 005471 681 GG 682 (695)
Q Consensus 681 ~~ 682 (695)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=222.99 Aligned_cols=154 Identities=29% Similarity=0.453 Sum_probs=130.9
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEED 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~ 597 (695)
..++|.+.++||+|+||.||+|++. .++.||||+++.... ...+.+.+|++++.++. |||||+++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456777899999999999999853 346899999975432 23457889999999997 999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccC----------------------------------------------------------
Q 005471 598 ENMLIYEFMPNKSLDYFIFDES---------------------------------------------------------- 619 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 619 (695)
..++||||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999986421
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005471 620 -------------------------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 662 (695)
Q Consensus 620 -------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 662 (695)
....+++.....|+.||+.||.|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124678888999999999999999876 999999999999
Q ss_pred EcCCCceEEEeeccceeecC
Q 005471 663 LDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 663 l~~~~~~kl~DFGla~~~~~ 682 (695)
+++++.+||+|||+++.+..
T Consensus 272 l~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMR 291 (401)
T ss_pred EeCCCEEEEEecCcceeccc
Confidence 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=215.60 Aligned_cols=146 Identities=27% Similarity=0.365 Sum_probs=126.3
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCC-CceeeeEeEEEeCCeeEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH-RNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~ 603 (695)
+|.+.+.||+|+||.||+|+.. +++.||||++.+. .....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677899999999999999865 4678999998753 22345677889999999976 56889999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 999999999888543 24788999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=217.07 Aligned_cols=144 Identities=28% Similarity=0.434 Sum_probs=123.8
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHH---HcCCCCceeeeEeEEEeCCeeEEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLI---AKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
|.+.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|++++ .+++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999999864 68899999987532 22345566676655 567899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|||+++++|..++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999888743 24899999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=210.84 Aligned_cols=143 Identities=18% Similarity=0.342 Sum_probs=124.7
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCccc---HHHHHHHHHHHHcCCCCceeeeEeEEEe----CCeeEEEEEcC
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG---IEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENMLIYEFM 606 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~ 606 (695)
..||+|++|.||+|.+ +++.||||+++...... .+.|.+|+.+|.+++|||||+++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6899999999999998 68999999987643322 4678899999999999999999999987 34678999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++|+|.+++... ..+++.....++.+++.||.|||... .++||||||+|||+++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 999999998643 34789999999999999999999842 278999999999999999999999999987644
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=212.55 Aligned_cols=149 Identities=21% Similarity=0.393 Sum_probs=129.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999875 57889999987542 2335677899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|++++.+..+... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9998877655422 234788899999999999999999887 99999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=215.00 Aligned_cols=142 Identities=27% Similarity=0.379 Sum_probs=121.5
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
++||+|+||.||+|+.. +++.||||.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999874 57889999987532 23344556677777654 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 9999888543 24788888899999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=214.91 Aligned_cols=147 Identities=27% Similarity=0.349 Sum_probs=126.6
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
+|...+.||+|+||.||+|+.. +++.||||.+.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677899999999999999865 57799999987532 22344567788888777 6899999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999999888543 24788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=210.81 Aligned_cols=145 Identities=32% Similarity=0.424 Sum_probs=125.9
Q ss_pred eeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 536 LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
||+|+||+||+++.. +++.||||.+.... ....+.+..|++++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 68899999986532 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 612 DYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 612 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
..++.... ....+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 88875432 2345899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=215.35 Aligned_cols=141 Identities=26% Similarity=0.398 Sum_probs=123.2
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
++||+|+||.||+|+.. +++.||||.+.... ....+.+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 57899999987532 23345677889988876 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence 9998888543 24788888999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=215.79 Aligned_cols=140 Identities=24% Similarity=0.368 Sum_probs=123.9
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+|+||.||+++.. +++.||||.+++.. ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999864 57899999987532 23345678899999998 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 9998887543 34899999999999999999999987 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=207.67 Aligned_cols=149 Identities=28% Similarity=0.498 Sum_probs=132.5
Q ss_pred CCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+|...+.||+|+||.||+|+..++..+|||.+... ....+++.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46677899999999999999877778999988753 33456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+|||+++++.+||+|||+++.+..+
T Consensus 84 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 84 GCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999865322 4899999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=210.17 Aligned_cols=154 Identities=28% Similarity=0.465 Sum_probs=131.5
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 598 (695)
..++|+..+.||+|+||.||+|... .+..||||++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888999999999999998753 34679999886432 2334578899999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEE
Q 005471 599 NMLIYEFMPNKSLDYFIFDESR-------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 671 (695)
.++||||+++++|.+++..... ...+++.....++.|+++||.|||+.+ ++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864321 224678889999999999999999976 999999999999999999999
Q ss_pred EeeccceeecC
Q 005471 672 SDFGTARVFGG 682 (695)
Q Consensus 672 ~DFGla~~~~~ 682 (695)
+|||+++.+..
T Consensus 161 ~dfg~~~~~~~ 171 (277)
T cd05062 161 GDFGMTRDIYE 171 (277)
T ss_pred CCCCCccccCC
Confidence 99999986643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=228.44 Aligned_cols=155 Identities=23% Similarity=0.305 Sum_probs=132.1
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----- 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 597 (695)
..++|.+.++||+|+||+||+++. .+++.||||++... .......+.+|+.++..++|+||++++..+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 446888999999999999999975 46899999998653 2344567889999999999999999988876543
Q ss_pred ---eeEEEEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEe
Q 005471 598 ---ENMLIYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (695)
Q Consensus 598 ---~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 673 (695)
..++||||+++|+|.+++.... ....+++.....++.|++.||.|||+.+ |+||||||+||||++++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 2579999999999999986532 2345888999999999999999999986 99999999999999999999999
Q ss_pred eccceeecCC
Q 005471 674 FGTARVFGGE 683 (695)
Q Consensus 674 FGla~~~~~~ 683 (695)
||+++.+...
T Consensus 187 FGls~~~~~~ 196 (496)
T PTZ00283 187 FGFSKMYAAT 196 (496)
T ss_pred cccCeecccc
Confidence 9999987543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=210.98 Aligned_cols=150 Identities=30% Similarity=0.414 Sum_probs=130.4
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+|+..++||+|+||+||++... +++.||||.+.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3667799999999999999864 68899999986532 1223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+++|+|.+++.... ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999998875432 235889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=210.37 Aligned_cols=152 Identities=31% Similarity=0.555 Sum_probs=133.1
Q ss_pred CCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|.+.+.||+|+||+||++.. .++..+|+|.+........+.+.+|++++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677789999999999999974 2345689999876655556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEE
Q 005471 602 IYEFMPNKSLDYFIFDES----------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 671 (695)
||||+++++|.+++.... ....+++...+.++.|++.||+|||+++ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1234899999999999999999999987 999999999999999999999
Q ss_pred EeeccceeecC
Q 005471 672 SDFGTARVFGG 682 (695)
Q Consensus 672 ~DFGla~~~~~ 682 (695)
+|||+++.+..
T Consensus 162 ~dfg~~~~~~~ 172 (288)
T cd05093 162 GDFGMSRDVYS 172 (288)
T ss_pred ccCCccccccC
Confidence 99999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=220.69 Aligned_cols=141 Identities=21% Similarity=0.318 Sum_probs=124.9
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
..+|++.++||+|+||.||++.. .+++.||||.... +.+.+|++++++++|||||++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999986 4688999996532 3567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+. ++|..++... ..+++.....|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 95 7888777543 24789999999999999999999987 999999999999999999999999999764
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=208.45 Aligned_cols=145 Identities=28% Similarity=0.428 Sum_probs=123.2
Q ss_pred ceeeeeCceeEEEEEcCC---CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 534 NKLGQGGFGPVYKGKLSN---GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~---g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
++||+|+||.||+|+..+ ...+|+|.+.... .....++.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468888876433 233457889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 610 SLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 610 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccc
Confidence 99999865432 223567788899999999999999987 9999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=207.36 Aligned_cols=149 Identities=30% Similarity=0.521 Sum_probs=131.8
Q ss_pred CCCCccceeeeeCceeEEEEEcCC----CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|+..+.||+|+||.||+|++.. ...||||.+.... .....+|.+|+.++.+++||||+++++.+.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 467888999999999999998742 4579999887543 33456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|||+++++|.+++..... .+++.....++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999865332 5789999999999999999999977 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=214.40 Aligned_cols=141 Identities=27% Similarity=0.345 Sum_probs=120.7
Q ss_pred ceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHH-HHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVL-LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
++||+|+||+||+++. .+++.+|||++.+.. .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999986 468899999986531 223345555654 46779999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+|..++... ..+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9998887542 34788999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=215.56 Aligned_cols=146 Identities=25% Similarity=0.440 Sum_probs=125.0
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----eeE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----ENM 600 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 600 (695)
+|.+.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677899999999999999864 6899999998643 2233456889999999999999999999986543 479
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||++ ++|.+++... ..+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 6888887533 24889999999999999999999987 999999999999999999999999999865
Q ss_pred c
Q 005471 681 G 681 (695)
Q Consensus 681 ~ 681 (695)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=207.07 Aligned_cols=146 Identities=29% Similarity=0.422 Sum_probs=124.7
Q ss_pred ceeeeeCceeEEEEEcCC---CcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 534 NKLGQGGFGPVYKGKLSN---GQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~---g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
+.||+|+||.||+|+..+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997643 45799998876432 33457888999999999999999999999999999999999999
Q ss_pred CHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 610 SLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 610 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+|.+++..... ....++.....++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccC
Confidence 99999865322 234677788889999999999999987 99999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=214.54 Aligned_cols=146 Identities=26% Similarity=0.360 Sum_probs=126.2
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 604 (695)
|...+.||+|+||.||+++.. +++.||||.+.+.. ....+.+..|+.++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 566789999999999999864 68899999987531 233456778999998885 6788889999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 82 y~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 82 YVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999888543 34889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=232.30 Aligned_cols=150 Identities=22% Similarity=0.325 Sum_probs=131.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.++||+|+||.||+|+.. +++.||||++..... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999864 588999999875322 23457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeec
Q 005471 604 EFMPNKSLDYFIFDES--------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 675 (695)
||+++++|.+++.... ....+++...+.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1223567788899999999999999987 9999999999999999999999999
Q ss_pred cceee
Q 005471 676 TARVF 680 (695)
Q Consensus 676 la~~~ 680 (695)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99987
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=213.54 Aligned_cols=141 Identities=28% Similarity=0.358 Sum_probs=120.6
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHH-HHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVL-LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+|+||+||+|+.. +++.||||++.... ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999874 68899999986532 122334455544 56789999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+|..++... ..+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999888543 34788888899999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=211.28 Aligned_cols=151 Identities=27% Similarity=0.472 Sum_probs=129.5
Q ss_pred CCCCccceeeeeCceeEEEEEcCC---------------CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEe
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN---------------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLG 591 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~---------------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g 591 (695)
++|.+.++||+|+||.||+++... ...||||.+.... ....+.+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987532 2358999987542 233457899999999999999999999
Q ss_pred EEEeCCeeEEEEEcCCCCCHHHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005471 592 CCLEEDENMLIYEFMPNKSLDYFIFDESR---------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 662 (695)
Q Consensus 592 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 662 (695)
++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 123688999999999999999999987 999999999999
Q ss_pred EcCCCceEEEeeccceeec
Q 005471 663 LDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 663 l~~~~~~kl~DFGla~~~~ 681 (695)
+++++.+||+|||+++.+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EcCCCcEEecccccccccc
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=210.49 Aligned_cols=153 Identities=25% Similarity=0.447 Sum_probs=130.3
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 598 (695)
..++|++.++||+|+||.||+|... .+..||+|.+.... .....++.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888999999999999999653 24589999886543 2234567889999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEE
Q 005471 599 NMLIYEFMPNKSLDYFIFDESR-------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 671 (695)
.++||||+++|+|.+++..... ...+.+.....++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964321 234577788899999999999999987 999999999999999999999
Q ss_pred Eeeccceeec
Q 005471 672 SDFGTARVFG 681 (695)
Q Consensus 672 ~DFGla~~~~ 681 (695)
+|||+++.+.
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=209.21 Aligned_cols=152 Identities=32% Similarity=0.531 Sum_probs=137.0
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
..+|...++||+|+||.||+|...+++.+|+|.+.........++..|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34677889999999999999998889999999998765555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999997543 335799999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=222.56 Aligned_cols=145 Identities=22% Similarity=0.296 Sum_probs=126.6
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 456888899999999999999875 478899995422 3456899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+. ++|..++.... ..++|..+..|+.||++||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 95 78888775432 35899999999999999999999987 999999999999999999999999999987543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=205.81 Aligned_cols=148 Identities=25% Similarity=0.453 Sum_probs=132.8
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|++.++||+|+||.||+|+. .+++.||+|++........+.+++|+.++.+++||||+++++.+...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999986 568899999987654455667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++++|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999988543 34788999999999999999999986 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=206.05 Aligned_cols=148 Identities=29% Similarity=0.471 Sum_probs=131.5
Q ss_pred CCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+|...+.||+|+||.||+++..++..+|+|.+... ....+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 46677999999999999999887788999988653 23345788899999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++|.+++..... .+++.....++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999864332 5789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=213.33 Aligned_cols=141 Identities=28% Similarity=0.438 Sum_probs=123.3
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+|+||.||+++.. +++.||||.+.+. .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 5789999998653 223445677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+|..++... ..+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999888543 24788999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=207.98 Aligned_cols=150 Identities=31% Similarity=0.520 Sum_probs=126.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCc----EEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|+..+.||+|+||.||+|... +++ .+++|.+..... ....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35677799999999999999863 344 478888754322 33467888999999999999999999875 456789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++||+++|+|.+++.... ..+++.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999986533 34899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 161 ~~ 162 (279)
T cd05111 161 PD 162 (279)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=216.12 Aligned_cols=152 Identities=31% Similarity=0.485 Sum_probs=128.1
Q ss_pred cCCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC-
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED- 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~- 597 (695)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788899999999999999963 356789999987543 23345688999999999 7899999999887654
Q ss_pred eeEEEEEcCCCCCHHHHHhccCC---------------------------------------------------------
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESR--------------------------------------------------------- 620 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 620 (695)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999854210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 621 -------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 621 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
...+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 123688888999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=212.86 Aligned_cols=141 Identities=23% Similarity=0.346 Sum_probs=124.2
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
++||+|+||+||+++.. +++.||||++.+.. ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 57899999987542 23345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9998887543 34889999999999999999999987 999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=206.00 Aligned_cols=149 Identities=31% Similarity=0.571 Sum_probs=124.9
Q ss_pred CccceeeeeCceeEEEEEcCCC-c--EEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC------Cee
Q 005471 531 STSNKLGQGGFGPVYKGKLSNG-Q--EIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------DEN 599 (695)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~~g-~--~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 599 (695)
.+.++||+|+||.||+|+..+. . .+|||.++.. .....+.+..|++++++++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568999999999999987543 2 6899988653 234456788999999999999999999988643 246
Q ss_pred EEEEEcCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 600 MLIYEFMPNKSLDYFIFDES---RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
+++|||+++|+|..++.... ....+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874321 2335889999999999999999999986 99999999999999999999999999
Q ss_pred ceeecC
Q 005471 677 ARVFGG 682 (695)
Q Consensus 677 a~~~~~ 682 (695)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=208.54 Aligned_cols=151 Identities=28% Similarity=0.518 Sum_probs=132.2
Q ss_pred CCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
+|...+.||+|+||.||+++. .++..+++|.+........+.+.+|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 466678999999999999974 23567999998766555567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 603 YEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999986432 1234789999999999999999999987 9999999999999999999
Q ss_pred EEEeeccceeecC
Q 005471 670 RISDFGTARVFGG 682 (695)
Q Consensus 670 kl~DFGla~~~~~ 682 (695)
||+|||+++....
T Consensus 163 ~l~dfg~a~~~~~ 175 (291)
T cd05094 163 KIGDFGMSRDVYS 175 (291)
T ss_pred EECCCCcccccCC
Confidence 9999999986644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=207.95 Aligned_cols=152 Identities=30% Similarity=0.559 Sum_probs=132.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|.+.+.||+|+||.||+|+.. +++.||||.++..... ..+.+.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777799999999999999863 3478999998765433 4578999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 601 LIYEFMPNKSLDYFIFDES-----------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
+||||+++++|.+++.... ....+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986532 1234788999999999999999999987 9999999999999999999
Q ss_pred EEEeeccceeecC
Q 005471 670 RISDFGTARVFGG 682 (695)
Q Consensus 670 kl~DFGla~~~~~ 682 (695)
||+|||+++.+..
T Consensus 162 kl~d~g~~~~~~~ 174 (280)
T cd05049 162 KIGDFGMSRDVYT 174 (280)
T ss_pred EECCcccceeccc
Confidence 9999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=212.39 Aligned_cols=141 Identities=27% Similarity=0.349 Sum_probs=119.7
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHH-HHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVL-LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
++||+|+||.||+++.. +++.||+|.+.+.. .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999874 57899999986532 122334555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
++|...+... ..+++.....++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9998887543 34677888889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=207.72 Aligned_cols=151 Identities=26% Similarity=0.515 Sum_probs=123.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC--CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcC---CCCceeeeEeEEEe-----
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS--NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKL---QHRNLVKLLGCCLE----- 595 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~----- 595 (695)
++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++..+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 467899998864322 2234556677777665 69999999999863
Q ss_pred CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeec
Q 005471 596 EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (695)
Q Consensus 596 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 675 (695)
....++||||++ ++|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999997 68888885432 234789999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCC
Q 005471 676 TARVFGGE 683 (695)
Q Consensus 676 la~~~~~~ 683 (695)
+++.+...
T Consensus 156 ~~~~~~~~ 163 (290)
T cd07862 156 LARIYSFQ 163 (290)
T ss_pred ceEeccCC
Confidence 99877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=211.18 Aligned_cols=141 Identities=27% Similarity=0.402 Sum_probs=122.1
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+|+||+||+|+.. +++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 47899999987531 23344566788888764 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+|..++... ..+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999988543 34788899999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=205.35 Aligned_cols=150 Identities=32% Similarity=0.543 Sum_probs=128.0
Q ss_pred CCccceeeeeCceeEEEEEcCC----CcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe-----
Q 005471 530 FSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE----- 598 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 598 (695)
|.+.+.||+|+||.||+|.... +..||||+++... ....+++.+|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 3679999987532 2345678999999999999999999999877654
Q ss_pred -eEEEEEcCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEee
Q 005471 599 -NMLIYEFMPNKSLDYFIFDES---RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (695)
Q Consensus 599 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 674 (695)
.++++||+++|+|..++.... ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999885432 2235889999999999999999999987 999999999999999999999999
Q ss_pred ccceeecC
Q 005471 675 GTARVFGG 682 (695)
Q Consensus 675 Gla~~~~~ 682 (695)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99997643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=207.56 Aligned_cols=150 Identities=35% Similarity=0.614 Sum_probs=130.1
Q ss_pred CCCccceeeeeCceeEEEEEcCC------CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
+|++.+.||+|+||.||+|.... .+.||+|.+.... .....++.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57778999999999999998643 2579999986543 2335678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005471 602 IYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN 668 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 668 (695)
+|||+++++|.+++..... ...+++.....++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999865321 135788999999999999999999987 999999999999999999
Q ss_pred eEEEeeccceeec
Q 005471 669 PRISDFGTARVFG 681 (695)
Q Consensus 669 ~kl~DFGla~~~~ 681 (695)
+||+|||+++.+.
T Consensus 163 ~~L~dfg~~~~~~ 175 (283)
T cd05048 163 VKISDFGLSRDIY 175 (283)
T ss_pred EEECCCcceeecc
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=208.14 Aligned_cols=153 Identities=28% Similarity=0.469 Sum_probs=132.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC-----------------CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN-----------------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVK 588 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~ 588 (695)
.++|.+.++||+|+||.||+++..+ +..||+|.+.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999987542 2468999987543 234567899999999999999999
Q ss_pred eEeEEEeCCeeEEEEEcCCCCCHHHHHhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 005471 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDES--------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660 (695)
Q Consensus 589 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N 660 (695)
+++++...+..++|+||+++++|..++.... ....+++.....++.|+++||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543 1225899999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeeccceeecC
Q 005471 661 ILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 661 ILl~~~~~~kl~DFGla~~~~~ 682 (695)
|++++++.+||+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eeecCCCceEEccccceeeccc
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=210.55 Aligned_cols=148 Identities=26% Similarity=0.488 Sum_probs=128.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|...++||+|+||.||+|+.. +++.||||.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999865 578899999875432 2334677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++ +|..++... ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 985 787777543 234788888899999999999999987 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=211.58 Aligned_cols=141 Identities=28% Similarity=0.412 Sum_probs=122.2
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
++||+|+||.||+++.. +++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999875 57899999987532 23345667788888764 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+|..++... ..+++.....++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999888543 24788888899999999999999987 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=208.56 Aligned_cols=141 Identities=23% Similarity=0.363 Sum_probs=120.1
Q ss_pred eeeeeCceeEEEEEcCC-------------------------CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeee
Q 005471 535 KLGQGGFGPVYKGKLSN-------------------------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 589 (695)
+||+|+||.||+|.+.. ...||+|.+.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998876544445678889999999999999999
Q ss_pred EeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC--
Q 005471 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-- 667 (695)
Q Consensus 590 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-- 667 (695)
+++|.+....++||||+++|+|+.++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999885432 34788999999999999999999886 99999999999998643
Q ss_pred -----ceEEEeeccceee
Q 005471 668 -----NPRISDFGTARVF 680 (695)
Q Consensus 668 -----~~kl~DFGla~~~ 680 (695)
.+|++|||+++..
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3899999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=204.76 Aligned_cols=155 Identities=28% Similarity=0.396 Sum_probs=133.7
Q ss_pred HHhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 524 LAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
+.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345667777789999999999999864 5778999998776556677899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCceEEEeeccceeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFG 681 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 681 (695)
+||+++++|..++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999865422212277888889999999999999886 999999999999986 6799999999998764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=205.64 Aligned_cols=151 Identities=28% Similarity=0.508 Sum_probs=131.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC----CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
.+|++.+.||+|+||.||+|+.. .+..+|+|.++... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777899999999999999863 23479999886532 23356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++++|.+++.... ..+++...+.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999986543 34789999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=231.12 Aligned_cols=150 Identities=24% Similarity=0.380 Sum_probs=132.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.++||+|+||.||+|... +++.||||++.... ....+.+..|+.+++.++||||+++++++...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999875 68899999986532 223467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++++|..++... ..+++.....|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.....
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 999999999998543 24788888999999999999999986 999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=208.40 Aligned_cols=152 Identities=26% Similarity=0.460 Sum_probs=130.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-----------------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-----------------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKL 589 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-----------------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l 589 (695)
++|++.++||+|+||.||++... ++..+|+|++.... ....+.+.+|+.++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998532 23468999987542 3345678999999999999999999
Q ss_pred EeEEEeCCeeEEEEEcCCCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 005471 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESR--------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 661 (695)
Q Consensus 590 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI 661 (695)
++++...+..++||||+++++|.+++..... ...+++.....++.||+.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 124778899999999999999999987 99999999999
Q ss_pred EEcCCCceEEEeeccceeecC
Q 005471 662 LLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 662 Ll~~~~~~kl~DFGla~~~~~ 682 (695)
|+++++.+||+|||+++.+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred EEcCCCCEEeccCcccccccC
Confidence 999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=206.96 Aligned_cols=155 Identities=27% Similarity=0.473 Sum_probs=133.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC-----CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEe-CCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 599 (695)
.++|.+.+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999998765 6889999887542 3345678899999999999999999999877 4678
Q ss_pred EEEEEcCCCCCHHHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRK-----QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 674 (695)
++++||+++++|..++...... ..+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 45899999999999999999999886 999999999999999999999999
Q ss_pred ccceeecCCc
Q 005471 675 GTARVFGGEE 684 (695)
Q Consensus 675 Gla~~~~~~~ 684 (695)
|+++.+...+
T Consensus 162 g~~~~~~~~~ 171 (280)
T cd05043 162 ALSRDLFPMD 171 (280)
T ss_pred CCcccccCCc
Confidence 9999765433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-24 Score=208.47 Aligned_cols=157 Identities=26% Similarity=0.475 Sum_probs=138.5
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
|.++++||+|+||.||++..+ .|+.+|||++.. ..+.+++..|+.+|.+.+.|++|+.||.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556789999999999999875 589999998865 34678999999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcceec
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 688 (695)
|++.+++.. ++++|.+.+...|+...++||+|||... -||||||+.||||+.+|.+||+|||.|-.+...--+
T Consensus 113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-- 185 (502)
T KOG0574|consen 113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-- 185 (502)
T ss_pred CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh--
Confidence 999999854 4557999999999999999999999875 799999999999999999999999999988654433
Q ss_pred cccccCC
Q 005471 689 TKRVVGT 695 (695)
Q Consensus 689 ~~~~~GT 695 (695)
-++|+||
T Consensus 186 RNTVIGT 192 (502)
T KOG0574|consen 186 RNTVIGT 192 (502)
T ss_pred hCccccC
Confidence 3447887
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=211.62 Aligned_cols=141 Identities=26% Similarity=0.349 Sum_probs=118.7
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHH-HHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEV-LLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+|+||.||+++.. +++.||+|.+.... .....++..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999875 56789999986532 12233444444 456788999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
++|.+++... ..+.+.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999988543 23667777889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=214.31 Aligned_cols=153 Identities=31% Similarity=0.478 Sum_probs=128.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcC-CCCceeeeEeEEEeC-C
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE-D 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-~ 597 (695)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 356888899999999999999642 347899999875332 2345677899999999 899999999988765 4
Q ss_pred eeEEEEEcCCCCCHHHHHhccCC---------------------------------------------------------
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESR--------------------------------------------------------- 620 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 620 (695)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998854211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 621 -KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 621 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
...++|..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 125789999999999999999999886 99999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=216.08 Aligned_cols=148 Identities=26% Similarity=0.436 Sum_probs=127.5
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----eeE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----ENM 600 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 600 (695)
+|+..++||+|+||.||++.. .+++.||||++... .....+++.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 367789999999999999986 46899999998653 2234567889999999999999999999998876 789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+|+||++ ++|.+.+.. ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 577777643 234889999999999999999999987 999999999999999999999999999876
Q ss_pred cCC
Q 005471 681 GGE 683 (695)
Q Consensus 681 ~~~ 683 (695)
...
T Consensus 154 ~~~ 156 (372)
T cd07853 154 EPD 156 (372)
T ss_pred ccC
Confidence 543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=209.13 Aligned_cols=153 Identities=28% Similarity=0.518 Sum_probs=131.3
Q ss_pred cCCCCccceeeeeCceeEEEEEc--------CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE 596 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~--------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 596 (695)
.++|.+.+.||+|+||.||+++. .++..||+|.+.... ....+++.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 34677789999999999999963 134579999886532 34456788999999999 899999999999999
Q ss_pred CeeEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005471 597 DENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 663 (695)
...++||||+++|+|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999865321 234788999999999999999999987 9999999999999
Q ss_pred cCCCceEEEeeccceeecC
Q 005471 664 DEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 664 ~~~~~~kl~DFGla~~~~~ 682 (695)
++++.+||+|||+++.+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 171 TENNVMKIADFGLARDVNN 189 (304)
T ss_pred cCCCcEEECCCccceeccc
Confidence 9999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=208.55 Aligned_cols=155 Identities=29% Similarity=0.507 Sum_probs=132.7
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 597 (695)
..++|+..+.||+|+||.||++... ....+|+|.+.... .....++.+|+.++.++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456788899999999999999863 23679999887532 23445688999999999 8999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDE-------------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 664 (695)
..+++|||+++|+|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 12345889999999999999999999886 99999999999999
Q ss_pred CCCceEEEeeccceeecCC
Q 005471 665 EKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 665 ~~~~~kl~DFGla~~~~~~ 683 (695)
+++.+||+|||+++.+...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~ 185 (293)
T cd05053 167 EDHVMKIADFGLARDIHHI 185 (293)
T ss_pred CCCeEEeCccccccccccc
Confidence 9999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=203.14 Aligned_cols=143 Identities=30% Similarity=0.504 Sum_probs=126.5
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999874 68899999876432 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
.+++... ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 9998543 234789999999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=239.55 Aligned_cols=142 Identities=30% Similarity=0.555 Sum_probs=123.3
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
..+...+.||+|+||.||+|+. .+++.||||++...... ...|++++++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999986 57899999998754322 234688999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
++|+|.+++.. ++|..+.+|+.|||+||+|||..+..+|+||||||+||+++.++.+++. ||++...
T Consensus 766 ~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 766 EGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999842 7899999999999999999997766779999999999999999998886 7776543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=205.87 Aligned_cols=152 Identities=28% Similarity=0.495 Sum_probs=132.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
.++...++||+|+||.||+++.. ++..+|+|.+........+.+.+|++++.+++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35666799999999999999632 356899999877665667789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 602 IYEFMPNKSLDYFIFDESR------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
+|||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 134789999999999999999999887 9999999999999999999
Q ss_pred EEEeeccceeecC
Q 005471 670 RISDFGTARVFGG 682 (695)
Q Consensus 670 kl~DFGla~~~~~ 682 (695)
||+|||+++.+..
T Consensus 162 kL~dfg~~~~~~~ 174 (280)
T cd05092 162 KIGDFGMSRDIYS 174 (280)
T ss_pred EECCCCceeEcCC
Confidence 9999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=206.76 Aligned_cols=150 Identities=31% Similarity=0.501 Sum_probs=128.6
Q ss_pred CCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
+|.+.+.||+|+||.||+|+.. ....+|+|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667799999999999999752 23578999886543 2345678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 005471 602 IYEFMPNKSLDYFIFDES---------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N 660 (695)
++||+++++|.+++.... ....+++...+.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885421 1134789999999999999999999886 9999999999
Q ss_pred EEEcCCCceEEEeeccceeec
Q 005471 661 ILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 661 ILl~~~~~~kl~DFGla~~~~ 681 (695)
||+++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-22 Score=207.72 Aligned_cols=150 Identities=33% Similarity=0.508 Sum_probs=128.7
Q ss_pred CCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
|.+.++||+|+||.||+|... .++.||||++...... ..+.+..|+.++.+++||||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 556689999999999999863 2578999998754332 245688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 603 YEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
+||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 99999999999985321 1234788889999999999999999987 9999999999999999999
Q ss_pred EEEeeccceeecC
Q 005471 670 RISDFGTARVFGG 682 (695)
Q Consensus 670 kl~DFGla~~~~~ 682 (695)
||+|||+++.+..
T Consensus 164 kl~Dfg~~~~~~~ 176 (283)
T cd05091 164 KISDLGLFREVYA 176 (283)
T ss_pred Eeccccccccccc
Confidence 9999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-22 Score=205.86 Aligned_cols=154 Identities=25% Similarity=0.436 Sum_probs=132.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... .....++.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 356778899999999999999864 24689999986543 23345788999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 600 MLIYEFMPNKSLDYFIFDESR-------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
++||||+++++|.+++..... ...++|...+.++.||+.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865321 224788999999999999999999886 9999999999999999999999
Q ss_pred eeccceeecCC
Q 005471 673 DFGTARVFGGE 683 (695)
Q Consensus 673 DFGla~~~~~~ 683 (695)
|||+++.+...
T Consensus 162 dfg~~~~~~~~ 172 (277)
T cd05032 162 DFGMTRDIYET 172 (277)
T ss_pred CcccchhhccC
Confidence 99999876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=204.05 Aligned_cols=150 Identities=31% Similarity=0.515 Sum_probs=130.7
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|.+.++||+|+||.||+|+..+...||+|++... ....+++.+|++++.+++||||+++++.+. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 467888999999999999999877778999998753 234567899999999999999999999874 456899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+|+|.+++.... ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999986532 235789999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-23 Score=217.71 Aligned_cols=137 Identities=32% Similarity=0.508 Sum_probs=121.4
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHH
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 612 (695)
++-||.|+.|.||+|++. ++.||||+++... ..+|+-|++|+||||+.+.|+|....-.+||||||+.|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 468999999999999996 5899999876422 35788999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
..|+.. ..+.-....++..+||.||.|||.+. |||||||.-||||..+-.+||+|||-++.+...
T Consensus 201 ~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 201 EVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred HHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 999653 23566777889999999999999986 999999999999999999999999999987644
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=204.95 Aligned_cols=149 Identities=32% Similarity=0.585 Sum_probs=129.9
Q ss_pred CCCccceeeeeCceeEEEEEc-----CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENM 600 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 600 (695)
.|++.++||+|+||.||+++. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467789999999999999974 357889999987543 33456789999999999999999999999875 4678
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999985432 24799999999999999999999987 999999999999999999999999999877
Q ss_pred cC
Q 005471 681 GG 682 (695)
Q Consensus 681 ~~ 682 (695)
..
T Consensus 160 ~~ 161 (284)
T cd05079 160 ET 161 (284)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-22 Score=209.82 Aligned_cols=141 Identities=29% Similarity=0.414 Sum_probs=123.9
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+|+||+||+++.. +++.||||.+.+.. ....+.+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47899999987532 23455677899999888 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9998888543 24889999999999999999999987 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=202.58 Aligned_cols=152 Identities=34% Similarity=0.538 Sum_probs=135.8
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
..++|.+.++||+|+||.||++...+++.+|||.+... ....+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34678888999999999999999888889999998753 34457899999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999986543 235899999999999999999999987 99999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-22 Score=204.35 Aligned_cols=149 Identities=30% Similarity=0.522 Sum_probs=130.2
Q ss_pred CCCccceeeeeCceeEEEEEcCC-C---cEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSN-G---QEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-g---~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
.|++.+.||+|+||.||+|+... + ..||||.+... .....++|..|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46677999999999999998743 2 36999998754 2334568999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999986532 34789999999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=199.91 Aligned_cols=143 Identities=31% Similarity=0.505 Sum_probs=127.2
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHH
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 612 (695)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988889999999876432 23446889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 9885432 34789999999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=203.27 Aligned_cols=144 Identities=28% Similarity=0.425 Sum_probs=124.4
Q ss_pred eeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 536 LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
||+|+||.||+++.. +|+.+|+|++.... ....+.+..|++++.+++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 58999999986421 12234556799999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++..+...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 88875433 234789999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=204.90 Aligned_cols=148 Identities=29% Similarity=0.399 Sum_probs=129.0
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
|...++||+|+||+||++... +++.+|+|.+..... ...+.+.+|++++.+++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556689999999999999864 688999999865321 2234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++++|..++.... ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999998886432 235899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=201.89 Aligned_cols=149 Identities=31% Similarity=0.526 Sum_probs=131.3
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|++.++||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++.+++|+||+++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4677889999999999999998888899999987643 34567899999999999999999999874 566899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999986532 234789999999999999999999987 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=207.50 Aligned_cols=149 Identities=25% Similarity=0.343 Sum_probs=130.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|+..+.||+|+||.||+++.. ++..+|+|.+.... ....+++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999864 57889999876532 23345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++++|.+++... ..+++.....++.||++||.|||+.. +++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999998643 34788889999999999999999742 39999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=201.44 Aligned_cols=149 Identities=30% Similarity=0.557 Sum_probs=133.4
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|+..+.||+|+||.||++... ++.||||.+..... ..+++.+|+.++.+++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46777899999999999999875 78999999876533 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++|.+++..... ..+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccc
Confidence 9999999865432 25899999999999999999999987 99999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=202.78 Aligned_cols=143 Identities=24% Similarity=0.413 Sum_probs=122.7
Q ss_pred ceeeeeCceeEEEEEcCC-------------CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 534 NKLGQGGFGPVYKGKLSN-------------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-------------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
+.||+|+||.||+|+... ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998532 2358899887654445567888999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-------eEEEe
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN-------PRISD 673 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~kl~D 673 (695)
+||||+++++|+.++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998875432 34789999999999999999999987 999999999999987654 89999
Q ss_pred eccceeec
Q 005471 674 FGTARVFG 681 (695)
Q Consensus 674 FGla~~~~ 681 (695)
||++..+.
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=201.74 Aligned_cols=150 Identities=33% Similarity=0.522 Sum_probs=132.2
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.+.|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 35678889999999999999999889999999987543 3456889999999999999999999986 456789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999886543 235789999999999999999999876 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=204.15 Aligned_cols=149 Identities=29% Similarity=0.537 Sum_probs=128.0
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCc----EEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQ----EIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|...++||+|+||.||+|+. .+++ .||+|.+.... ....+++.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4677889999999999999975 3444 48999886542 3345678899999999999999999999875 45789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++||+++|+|.+++.... ..+++...+.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999986532 34889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 005471 682 G 682 (695)
Q Consensus 682 ~ 682 (695)
.
T Consensus 161 ~ 161 (279)
T cd05109 161 I 161 (279)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=203.12 Aligned_cols=150 Identities=31% Similarity=0.529 Sum_probs=132.5
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
.|...+.||+|+||.||+|... .++.||+|.+... ....+++.+|++++.+++||||+++++++...+..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4666789999999999999865 4789999998753 3446788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++|.+++.... ...+++..++.++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++.+...
T Consensus 86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999986533 335799999999999999999999886 999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=207.09 Aligned_cols=151 Identities=31% Similarity=0.484 Sum_probs=131.2
Q ss_pred CCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 599 (695)
++|...+.||+|+||.||++.. ..+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4678889999999999999974 234579999887543 23346788999999999 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||+++|+|.+++.... ...+++.....++.+|+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999986432 234799999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005471 680 FGG 682 (695)
Q Consensus 680 ~~~ 682 (695)
+..
T Consensus 191 ~~~ 193 (302)
T cd05055 191 IMN 193 (302)
T ss_pred ccC
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=202.49 Aligned_cols=142 Identities=27% Similarity=0.470 Sum_probs=123.0
Q ss_pred ceeeeeCceeEEEEEcCCCc-----------EEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 534 NKLGQGGFGPVYKGKLSNGQ-----------EIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~-----------~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999876432 5788877654332 6788999999999999999999999988 788999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-------ceEEEeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-------NPRISDFG 675 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~kl~DFG 675 (695)
|||+++|+|++++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999865432 5789999999999999999999876 99999999999999887 79999999
Q ss_pred cceeecC
Q 005471 676 TARVFGG 682 (695)
Q Consensus 676 la~~~~~ 682 (695)
+++.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9997644
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=205.34 Aligned_cols=150 Identities=31% Similarity=0.455 Sum_probs=133.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.+.|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 356888899999999999999875 4789999998776656677889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++++|..++.... ..+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999988875432 24789999999999999999999876 9999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.6e-22 Score=202.27 Aligned_cols=145 Identities=34% Similarity=0.595 Sum_probs=127.6
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccH--HHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGI--EELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~--~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
|+..+.||+|+||+||+++.. +++.+|+|.+........ ....+|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456689999999999999875 466899999987643332 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
++++|.+++. ....+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||++..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999996 2334789999999999999999999987 999999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=207.95 Aligned_cols=151 Identities=29% Similarity=0.514 Sum_probs=130.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC--------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 597 (695)
++|.+.+.||+|+||.||+++.. +...+|+|.+.... .....++..|+.++.++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46788899999999999999742 23579999987542 33456788899999999 7999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 664 (695)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999965321 134889999999999999999999876 99999999999999
Q ss_pred CCCceEEEeeccceeec
Q 005471 665 EKMNPRISDFGTARVFG 681 (695)
Q Consensus 665 ~~~~~kl~DFGla~~~~ 681 (695)
+++.+||+|||+++.+.
T Consensus 175 ~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 175 EDNVMKIADFGLARDIH 191 (307)
T ss_pred CCCcEEECCCccccccc
Confidence 99999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=206.42 Aligned_cols=151 Identities=23% Similarity=0.391 Sum_probs=131.8
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++.+++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777899999999999999875 6889999988653 2233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++++|..++........+++.....++.+++.||.|||+.. +|+||||||+||++++++.+||+|||+++.+.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999998865433345899999999999999999999742 39999999999999999999999999998663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.35 Aligned_cols=149 Identities=33% Similarity=0.577 Sum_probs=130.2
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3677799999999999999874 68899999886432 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++ ++|.+++........+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888765444456899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=203.87 Aligned_cols=142 Identities=23% Similarity=0.404 Sum_probs=120.5
Q ss_pred eeeeeCceeEEEEEcCCC---cEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCC
Q 005471 535 KLGQGGFGPVYKGKLSNG---QEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~g---~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 610 (695)
.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975443 346677665433 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 611 LDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 611 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
|.+++..... ....++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9999865422 234567777889999999999999886 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=200.60 Aligned_cols=143 Identities=28% Similarity=0.538 Sum_probs=123.0
Q ss_pred eeeeeCceeEEEEEcC---CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCC
Q 005471 535 KLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~~---~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 610 (695)
.||+|+||.||+|.+. .+..||||.+..... ...+++.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 355799999875432 33467899999999999999999999875 457899999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|.+++... ...+++..+..++.|+++||.|||+++ ++||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 99988643 235899999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=214.01 Aligned_cols=153 Identities=25% Similarity=0.496 Sum_probs=131.9
Q ss_pred CCCCccceeeeeCceeEEEEEcCC---C--cEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN---G--QEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~---g--~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
+.....++||+|-||.||+|...+ | -.||||..+.. .....+.|..|..+|++++|||||+|+|+|.+. ..+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 344556899999999999998633 2 25899988774 455678899999999999999999999999764 7899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|||.++-|.|.+||...+ ..|+......++.||..||.|||+.. +|||||.++|||+.+.-.+||+||||+|-+.
T Consensus 468 vmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 999999999999997643 34788888899999999999999987 9999999999999999999999999999887
Q ss_pred CCcce
Q 005471 682 GEEIL 686 (695)
Q Consensus 682 ~~~~~ 686 (695)
.+...
T Consensus 543 d~~yY 547 (974)
T KOG4257|consen 543 DDAYY 547 (974)
T ss_pred ccchh
Confidence 65544
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=203.56 Aligned_cols=149 Identities=30% Similarity=0.403 Sum_probs=129.0
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
|+..++||+|+||.||++... +++.||||.+..... ...+.+..|+.++.+++|+||+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566689999999999999864 688999998865322 2234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999998885432 234788999999999999999999876 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.9e-22 Score=216.07 Aligned_cols=146 Identities=23% Similarity=0.348 Sum_probs=126.6
Q ss_pred cCCCCccceeeeeCceeEEEEEcC---CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
..+|.+.+.||+|+||.||++... .++.||||.+... +.+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 356888999999999999999753 3578999987643 24567999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|++. ++|.+++. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 67878773 2345899999999999999999999987 999999999999999999999999999877544
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 239 ~ 239 (392)
T PHA03207 239 P 239 (392)
T ss_pred c
Confidence 3
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=205.59 Aligned_cols=149 Identities=28% Similarity=0.451 Sum_probs=133.7
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688889999999999999985 578999999987655555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..+
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999998843 24788899999999999999999986 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=204.69 Aligned_cols=152 Identities=31% Similarity=0.519 Sum_probs=132.0
Q ss_pred cCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
.++|+..+.||+|+||.||++... ++..||+|.+.... ....+++.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888899999999999999853 46789999987542 23456789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 005471 600 MLIYEFMPNKSLDYFIFDES-------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N 660 (695)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 1124788899999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeeccceeec
Q 005471 661 ILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 661 ILl~~~~~~kl~DFGla~~~~ 681 (695)
||+++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=201.50 Aligned_cols=150 Identities=29% Similarity=0.550 Sum_probs=131.0
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-C---cEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-G---QEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g---~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|+..+.||+|+||.||+|+... + ..+|||.+.... ....+++..|++++.+++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 456777999999999999998742 3 379999987542 33456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++++|..++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999986532 34789999999999999999999987 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=201.14 Aligned_cols=152 Identities=23% Similarity=0.455 Sum_probs=132.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.++||+|+||.||+|+.. +++.||||.+... .......+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999864 6889999987542 2233456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++++|..++.... ....+++.....++.||++||.|||+.+ |+|+||||+|||++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345788889999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=206.09 Aligned_cols=149 Identities=28% Similarity=0.526 Sum_probs=128.1
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-C--cEEEEEEcccC-CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-G--QEIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g--~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467788999999999999998753 3 34788888743 233456789999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 603 YEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
+||+++++|.+++.... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986432 1124789999999999999999999986 9999999999999999999
Q ss_pred EEEeecccee
Q 005471 670 RISDFGTARV 679 (695)
Q Consensus 670 kl~DFGla~~ 679 (695)
||+|||+++.
T Consensus 159 kl~dfg~~~~ 168 (297)
T cd05089 159 KIADFGLSRG 168 (297)
T ss_pred EECCcCCCcc
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=202.33 Aligned_cols=147 Identities=30% Similarity=0.453 Sum_probs=130.6
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++..++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456688999999999999875 4778899998765555667889999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++|..++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9998887542 235899999999999999999999987 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-23 Score=200.80 Aligned_cols=152 Identities=30% Similarity=0.457 Sum_probs=129.7
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++.|++.+.||+|.|+.||++.. ++|+.+|+|.+... ...+.+++.+|+.|...|+|||||+|.....+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 35677779999999999999864 57899999877543 4457889999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCceEEEeeccceee
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTARVF 680 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~ 680 (695)
|+|.+++|..-|... ...++...-+.+.||+++|.|+|.++ |||||+||+|+||-+ .--+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999996655432 34667777889999999999999987 999999999999963 345899999999999
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
+..+
T Consensus 164 ~~g~ 167 (355)
T KOG0033|consen 164 NDGE 167 (355)
T ss_pred CCcc
Confidence 8443
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=209.53 Aligned_cols=139 Identities=24% Similarity=0.319 Sum_probs=118.6
Q ss_pred eeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcC---CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKL---QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 536 LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
||+|+||+||+|+.. +++.||||++.+... .....+..|..++.+. +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 588999999864321 2233445566666655 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+|..++... ..+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999888543 34788999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=203.12 Aligned_cols=150 Identities=29% Similarity=0.446 Sum_probs=131.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|+..+.||+|+||.||+|+.. +.+.|++|.+...... ..+++.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778899999999999999853 3467999988654333 4568999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEee
Q 005471 601 LIYEFMPNKSLDYFIFDESRK------QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 674 (695)
+||||+++++|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654321 25899999999999999999999987 999999999999999999999999
Q ss_pred ccceee
Q 005471 675 GTARVF 680 (695)
Q Consensus 675 Gla~~~ 680 (695)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=205.00 Aligned_cols=150 Identities=27% Similarity=0.428 Sum_probs=134.3
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|.+.+.||+|+||.||++... +++.+|+|.+........+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999874 5789999998766555667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++++|..++.... ..+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999885432 34889999999999999999999987 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=207.19 Aligned_cols=149 Identities=32% Similarity=0.563 Sum_probs=128.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCc--EEEEEEcccC-CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ--EIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~--~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|++.+.||+|+||.||+|+.. ++. .+|+|++... .....+++.+|++++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777899999999999999864 343 4688877643 233456788999999999 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 603 YEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
|||+++++|.+++.... ....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235789999999999999999999887 9999999999999999999
Q ss_pred EEEeecccee
Q 005471 670 RISDFGTARV 679 (695)
Q Consensus 670 kl~DFGla~~ 679 (695)
||+|||+++.
T Consensus 164 kl~dfg~~~~ 173 (303)
T cd05088 164 KIADFGLSRG 173 (303)
T ss_pred EeCccccCcc
Confidence 9999999974
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=201.80 Aligned_cols=144 Identities=24% Similarity=0.378 Sum_probs=126.9
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+|+..++||+|+||.||+|.. .+++.||||.+... .....+++.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567789999999999999985 56889999988654 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999996542 2578888899999999999999987 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=199.72 Aligned_cols=149 Identities=32% Similarity=0.518 Sum_probs=129.7
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|.+.++||+|+||.||++....+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3577778999999999999998777789999886532 34567889999999999999999999875 566899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999986532 234789999999999999999999887 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=207.22 Aligned_cols=152 Identities=31% Similarity=0.522 Sum_probs=130.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC--------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 597 (695)
++|.+.++||+|+||.||+++.. ....+|+|.+.... .....++..|++++.++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46777899999999999999742 24579999887542 33456788999999999 6999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 664 (695)
..++||||+++|+|.+++.... ....+++.....++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986532 1235889999999999999999999886 99999999999999
Q ss_pred CCCceEEEeeccceeecC
Q 005471 665 EKMNPRISDFGTARVFGG 682 (695)
Q Consensus 665 ~~~~~kl~DFGla~~~~~ 682 (695)
+++.+||+|||+++.+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (314)
T cd05099 169 EDNVMKIADFGLARGVHD 186 (314)
T ss_pred CCCcEEEccccccccccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=217.31 Aligned_cols=149 Identities=24% Similarity=0.423 Sum_probs=121.7
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--------
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-------- 596 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-------- 596 (695)
...+|...++||+|+||.||+|... +++.||||++.... ....+|+.++++++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999864 68899999885432 2345799999999999999999987542
Q ss_pred CeeEEEEEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CceEEEee
Q 005471 597 DENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDF 674 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DF 674 (695)
...++||||+++ +|..++... .....+++.....++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 666665432 22345889999999999999999999987 9999999999999965 47999999
Q ss_pred ccceeecC
Q 005471 675 GTARVFGG 682 (695)
Q Consensus 675 Gla~~~~~ 682 (695)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99997754
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=202.16 Aligned_cols=145 Identities=34% Similarity=0.526 Sum_probs=126.1
Q ss_pred CccceeeeeCceeEEEEEc-----CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC--eeEEE
Q 005471 531 STSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--ENMLI 602 (695)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV 602 (695)
+..+.||+|+||+||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7779999999999988653 357789999987543 234567889999999999999999999987643 57899
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++++|.+++... .+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999998542 3899999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=199.22 Aligned_cols=152 Identities=24% Similarity=0.465 Sum_probs=133.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|+..++||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999876 7899999988642 2233567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++++|..++.... ....+++.....++.++++||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886432 2345789999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=202.39 Aligned_cols=151 Identities=32% Similarity=0.523 Sum_probs=130.5
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeC------C
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE------D 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~------~ 597 (695)
+++.|...+.||+|+||.||+|... +++.||||.+... .....++..|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4566788899999999999999864 5788999998654 34456788999999998 799999999998863 3
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++||||+++++|.+++... ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 578999999999999998653 2335889999999999999999999987 999999999999999999999999999
Q ss_pred eeec
Q 005471 678 RVFG 681 (695)
Q Consensus 678 ~~~~ 681 (695)
+.+.
T Consensus 159 ~~~~ 162 (272)
T cd06637 159 AQLD 162 (272)
T ss_pred eecc
Confidence 8764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9e-23 Score=216.08 Aligned_cols=149 Identities=32% Similarity=0.519 Sum_probs=128.7
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcc---cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQ---GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.|..++.||.|+||.||.++. .+.+.||||++.-...+ ....+..|+..|.+++|||+|...|+|......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 356678999999999999986 46788999999754333 35578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||- |+-.+++.-. ++++.+..+..|..+.+.||.|||++. .||||||+.||||.+.+.+||+|||.|.++.+.
T Consensus 107 YCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 995 6666666433 335788888899999999999999987 899999999999999999999999999987653
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=216.45 Aligned_cols=154 Identities=31% Similarity=0.497 Sum_probs=129.3
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEE--Eccc--CCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe--eEEEEEcC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVK--RLST--TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE--NMLIYEFM 606 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK--~l~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~lV~Ey~ 606 (695)
++||+|+|-+||||.+. +|.+||-- ++.+ .+....+.|..|+++|+.|+|||||+++..+.+... ..+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 78999999999999874 47777732 2222 134456889999999999999999999999998776 67999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEEeeccceeecCCcc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~ 685 (695)
..|+|..|+.+..+ ++.+...++++||++||.|||.+. +||||||||-+||+|+ ..|.+||.|+|||.++....
T Consensus 126 TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 99999999976543 677888899999999999999986 6899999999999998 56899999999999886433
Q ss_pred eeccccccCC
Q 005471 686 LAITKRVVGT 695 (695)
Q Consensus 686 ~~~~~~~~GT 695 (695)
.+.++||
T Consensus 201 ---aksvIGT 207 (632)
T KOG0584|consen 201 ---AKSVIGT 207 (632)
T ss_pred ---cceeccC
Confidence 3447887
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=207.44 Aligned_cols=140 Identities=21% Similarity=0.259 Sum_probs=113.5
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC--CCcEEEEEEcccCC-----cccHHHHHHHHHHHHcCCCCceee-eEeEEEeCC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS--NGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQHRNLVK-LLGCCLEED 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~-l~g~~~~~~ 597 (695)
..++|...+.||+|+||+||+|... +++.+|||++.... ....+.|.+|+++|.+++|+|++. +++ .+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence 3467889999999999999999864 57778999875331 123456899999999999999995 443 24
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCceEEEeecc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL-KASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DFGl 676 (695)
..+|||||+++++|... . .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~---~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R---PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHh-C---cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 67999999999999632 1 10 1 1357889999999999987 999999 99999999999999999999
Q ss_pred ceeecC
Q 005471 677 ARVFGG 682 (695)
Q Consensus 677 a~~~~~ 682 (695)
|+.+..
T Consensus 159 A~~~~~ 164 (365)
T PRK09188 159 ASVFRR 164 (365)
T ss_pred ceeccc
Confidence 998754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.96 Aligned_cols=148 Identities=26% Similarity=0.482 Sum_probs=131.8
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|...++||+|+||.||+|+. .+++.||+|.++.........+.+|+.++..++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3567778999999999999986 468899999987654455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++++|.+++... ..+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+.
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999988543 24789999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=201.56 Aligned_cols=150 Identities=25% Similarity=0.434 Sum_probs=130.9
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46778899999999999999875 58899999886432 2234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|++++.|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99999888776432 24799999999999999999999976 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=201.90 Aligned_cols=152 Identities=32% Similarity=0.519 Sum_probs=130.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC------CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568888999999999999998753 5679999886543 33345788999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---ceEEE
Q 005471 600 MLIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM---NPRIS 672 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~ 672 (695)
++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865421 235899999999999999999999987 99999999999998654 69999
Q ss_pred eeccceeec
Q 005471 673 DFGTARVFG 681 (695)
Q Consensus 673 DFGla~~~~ 681 (695)
|||+++.+.
T Consensus 162 dfg~~~~~~ 170 (277)
T cd05036 162 DFGMARDIY 170 (277)
T ss_pred cCccccccC
Confidence 999998764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=202.30 Aligned_cols=150 Identities=30% Similarity=0.554 Sum_probs=129.4
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-C----cEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-G----QEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g----~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
.+|...+.||+|+||.||+|...+ + ..+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 456778999999999999998642 3 2689998876533 345678899999999999999999999987 78899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++|+|.+++..... .+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999865322 3889999999999999999999976 9999999999999999999999999999775
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 161 ~~ 162 (279)
T cd05057 161 VD 162 (279)
T ss_pred Cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.5e-23 Score=210.87 Aligned_cols=159 Identities=28% Similarity=0.447 Sum_probs=138.9
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.|...+.||+|.||.||||.. ..++.||||.+... .....+++++|+.+++.++|+||.+.+|.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466678999999999999986 46889999999754 3445678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcce
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 686 (695)
.+|++.+.|... ..+++....-|++++..||.|||.+. .+|||||+.||||.+++.+||+|||+|..+.....+
T Consensus 94 ~gGsv~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLLKSG---NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhhccC---CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999988433 33466666778999999999999987 999999999999999999999999999999877766
Q ss_pred eccccccCC
Q 005471 687 AITKRVVGT 695 (695)
Q Consensus 687 ~~~~~~~GT 695 (695)
. .+++||
T Consensus 168 r--~tfvGT 174 (467)
T KOG0201|consen 168 R--KTFVGT 174 (467)
T ss_pred c--cccccc
Confidence 4 557887
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=197.92 Aligned_cols=149 Identities=32% Similarity=0.482 Sum_probs=131.2
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-----cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666789999999999999876 78999999886532 22456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+||+++++|.+++... ..+++.....++.||++||.|||+.+ |+|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998543 24789999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 155 ~ 155 (258)
T cd06632 155 F 155 (258)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=202.72 Aligned_cols=150 Identities=29% Similarity=0.402 Sum_probs=132.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|...+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36778899999999999999865 58899999886532 233567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||+++++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998554 34788999999999999999999987 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=208.37 Aligned_cols=152 Identities=28% Similarity=0.500 Sum_probs=130.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC--------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 597 (695)
.+|.+.+.||+|+||.||+++.. ....||+|.+.... ....+++.+|+.++.++ +||||++++++|.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35778899999999999999742 12368999887532 33456889999999999 7999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 664 (695)
..+++|||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1234789999999999999999999987 99999999999999
Q ss_pred CCCceEEEeeccceeecC
Q 005471 665 EKMNPRISDFGTARVFGG 682 (695)
Q Consensus 665 ~~~~~kl~DFGla~~~~~ 682 (695)
+++.+||+|||+++.+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 169 EDNVMKIADFGLARDVHN 186 (334)
T ss_pred CCCcEEECCcccceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=204.07 Aligned_cols=148 Identities=26% Similarity=0.449 Sum_probs=132.7
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677889999999999999985 468899999987655555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++++|.+++.. ..+++.....++.|++.||.|||..+ |+||||||+|||+++++.+||+|||+++....
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999998843 23788899999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=197.89 Aligned_cols=147 Identities=37% Similarity=0.615 Sum_probs=130.7
Q ss_pred ceeeeeCceeEEEEEcCC----CcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+|+||.||++.... +..+|||.+...... ..+++.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 778999998765333 367889999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 609 KSLDYFIFDESR------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 609 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++|.+++..... ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999876421 245899999999999999999999987 99999999999999999999999999998765
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=197.61 Aligned_cols=151 Identities=26% Similarity=0.446 Sum_probs=132.9
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|...+.||+|+||.||+++.. +++.|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999874 6889999987643 334566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++++|.+++.... ...+++.....++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999986542 345889999999999999999999886 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=208.39 Aligned_cols=145 Identities=20% Similarity=0.314 Sum_probs=125.6
Q ss_pred HhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
....+|.+.+.||+|+||.||+|+.. +++.||+|..... ....|+.++.+++||||+++++++.+....++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999875 4678999975432 2346899999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||+. ++|..++... ...+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 6888877543 235899999999999999999999987 9999999999999999999999999998543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=203.37 Aligned_cols=148 Identities=32% Similarity=0.516 Sum_probs=130.1
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcc-----cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-----GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
+|+..+.||+|+||.||+|... +++.||||++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667789999999999999864 6889999998754322 234567899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+ +++|.+++.... ..+++.....++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999986533 25899999999999999999999987 99999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=202.29 Aligned_cols=158 Identities=27% Similarity=0.382 Sum_probs=133.2
Q ss_pred HHHHHhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEe---
Q 005471 521 STLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE--- 595 (695)
Q Consensus 521 ~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~--- 595 (695)
..+..+.++|++.+.||+|+||.||+++.. +++.+|+|.+.... ....++.+|+.++.++ +||||+++++++..
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 444557789999999999999999999864 57899999876532 2345788899999999 69999999999853
Q ss_pred --CCeeEEEEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 596 --EDENMLIYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 596 --~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
++..++||||+++++|.+++.... ....+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 356899999999999998875422 2345788889999999999999999986 9999999999999999999999
Q ss_pred eeccceeecC
Q 005471 673 DFGTARVFGG 682 (695)
Q Consensus 673 DFGla~~~~~ 682 (695)
|||+++.+..
T Consensus 167 dfg~~~~~~~ 176 (286)
T cd06638 167 DFGVSAQLTS 176 (286)
T ss_pred cCCceeeccc
Confidence 9999987653
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=199.09 Aligned_cols=144 Identities=33% Similarity=0.493 Sum_probs=127.7
Q ss_pred ceeeeeCceeEEEEEcCC--C--cEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLSN--G--QEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~--g--~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998643 2 3699999987655 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++|.+++..... ..+++.....++.|+++||.|||..+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999866432 45899999999999999999999987 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=198.78 Aligned_cols=150 Identities=32% Similarity=0.498 Sum_probs=132.1
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.++|.+.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4567888999999999999999877888999988753 3345678899999999999999999999887 7789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999986543 334788999999999999999999876 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=196.65 Aligned_cols=152 Identities=24% Similarity=0.415 Sum_probs=133.0
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|+..+.||+|+||.||.++. .+++.+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477789999999999999875 45889999987643 234456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
+++++|.+++.... ...+++.....++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999986542 335789999999999999999999886 9999999999999999999999999999875433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=203.77 Aligned_cols=148 Identities=28% Similarity=0.498 Sum_probs=128.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|...++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46788899999999999999864 57899999886432 23345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++ ++|..++.... ..+++.....++.||++||.|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 58888875432 34788889999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=200.81 Aligned_cols=149 Identities=31% Similarity=0.522 Sum_probs=130.7
Q ss_pred CCCccceeeeeCceeEEEEEcC-----CCcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEe--CCeeE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-----NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENM 600 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-----~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~ 600 (695)
.|...+.||+|+||.||+++.. +++.+|||.+...... ..+++.+|++++++++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999853 3678999998765432 46789999999999999999999999887 55789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+
T Consensus 85 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999865432 4899999999999999999999987 999999999999999999999999999987
Q ss_pred cC
Q 005471 681 GG 682 (695)
Q Consensus 681 ~~ 682 (695)
..
T Consensus 160 ~~ 161 (284)
T cd05038 160 PE 161 (284)
T ss_pred cc
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=197.66 Aligned_cols=149 Identities=32% Similarity=0.518 Sum_probs=130.8
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-----cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|...+.||+|+||.||++.. .+++++|+|.+.... ....+.+.+|++++.+++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688889999999999999986 468899999876432 1224568899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988543 34788888999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 005471 682 G 682 (695)
Q Consensus 682 ~ 682 (695)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=198.87 Aligned_cols=146 Identities=33% Similarity=0.555 Sum_probs=129.3
Q ss_pred CCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC------cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS------GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
+|...+.||+|+||+||+|...+++.+|||.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367779999999999999998889999999886432 12234688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.+
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999998543 24788888999999999999999887 999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=200.73 Aligned_cols=152 Identities=23% Similarity=0.456 Sum_probs=132.6
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|++.+.||+|+||.||+++. .+++.+|||.+.... ....+++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577789999999999999985 578999999876432 233457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++++|.+++.... ....+++.....++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 2345899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-22 Score=192.02 Aligned_cols=154 Identities=31% Similarity=0.395 Sum_probs=136.9
Q ss_pred hcCCCCccceeeeeCceeEEEEE-cCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----ee
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----EN 599 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~ 599 (695)
..++|.+.++||+|||..||.++ +.+++.+|+|++.-...++.+..++|++..++++||||++++++...+. +.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34678889999999999999998 5778999999998766777888999999999999999999999876544 48
Q ss_pred EEEEEcCCCCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 600 MLIYEFMPNKSLDYFIFDESRK-QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
||++.|...|+|.+.+.....+ ..+++.+.+.|+.+|++||++||+.. ++..||||||.|||+.+.+.++|.|||-+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999998765443 36899999999999999999999986 579999999999999999999999999987
Q ss_pred ee
Q 005471 679 VF 680 (695)
Q Consensus 679 ~~ 680 (695)
..
T Consensus 178 ~a 179 (302)
T KOG2345|consen 178 QA 179 (302)
T ss_pred cc
Confidence 54
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-22 Score=215.98 Aligned_cols=150 Identities=33% Similarity=0.525 Sum_probs=131.4
Q ss_pred CccceeeeeCceeEEEEEcC--CCc--EEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 531 STSNKLGQGGFGPVYKGKLS--NGQ--EIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~--~g~--~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
...++||+|.||.|++|.+. +|+ .||||.++.... .....|.+|+.+|.+|+|||+++|||+..+ ...+||+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34589999999999999874 344 689999987543 367899999999999999999999999877 678999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
++.|+|.+.|.+ ..+..+--.....++.|||.||.||..+. +|||||.++|+||-..-.+||+||||.|-++.++.
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999987 34445777888899999999999999987 99999999999999999999999999999976554
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=197.54 Aligned_cols=142 Identities=30% Similarity=0.530 Sum_probs=123.2
Q ss_pred eeeeeCceeEEEEEc---CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 535 KLGQGGFGPVYKGKL---SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~---~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
+||+|+||.||+|.+ .+++.+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 357889999986543 233567899999999999999999999875 45678999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 999998543 24789999999999999999999987 999999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=203.92 Aligned_cols=144 Identities=29% Similarity=0.479 Sum_probs=118.8
Q ss_pred cceeeeeCceeEEEEEcC---CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe--CCeeEEEEEcCC
Q 005471 533 SNKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENMLIYEFMP 607 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~ 607 (695)
.++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|+.++.+++||||+++++++.. ....++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 46789999986532 23457789999999999999999999865 345789999986
Q ss_pred CCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCceEEEeeccc
Q 005471 608 NKSLDYFIFDES------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTA 677 (695)
Q Consensus 608 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla 677 (695)
++|.+++.... ....+++.....++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57777764321 1224788889999999999999999987 9999999999999 46678999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+.+..
T Consensus 160 ~~~~~ 164 (317)
T cd07868 160 RLFNS 164 (317)
T ss_pred eccCC
Confidence 98754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=198.46 Aligned_cols=143 Identities=33% Similarity=0.575 Sum_probs=123.2
Q ss_pred ceeeeeCceeEEEEEcCC-Cc--EEEEEEcccC-CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLSN-GQ--EIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-g~--~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+|+||.||+|+..+ +. .+|+|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999998754 33 5788888753 234456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeec
Q 005471 609 KSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (695)
Q Consensus 609 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 675 (695)
|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1234789999999999999999999976 9999999999999999999999999
Q ss_pred ccee
Q 005471 676 TARV 679 (695)
Q Consensus 676 la~~ 679 (695)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=196.94 Aligned_cols=151 Identities=26% Similarity=0.473 Sum_probs=134.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|...+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888899999999999999864 5788999998765555677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++++|.+++.... ..+++.....++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999885432 34788999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-21 Score=194.93 Aligned_cols=143 Identities=36% Similarity=0.558 Sum_probs=128.0
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHH
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 612 (695)
++||+|+||.||++...+++.||+|.+...... ..+++.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999988764333 4568899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++.... ..+++.....++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 9985432 24788999999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=196.02 Aligned_cols=148 Identities=28% Similarity=0.524 Sum_probs=131.4
Q ss_pred CCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+|+..+.||+|+||.||++...+++.+|+|.+... .....++.+|++++.+++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 56677999999999999998877889999988653 33456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++|.+++.... ..+++.....++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 84 GCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999886432 24789999999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=198.24 Aligned_cols=147 Identities=27% Similarity=0.443 Sum_probs=127.9
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc----------ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG----------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~----------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 597 (695)
+|...+.||+|+||.||+|.. .+++.+|||.++.... ...+.+..|+.++.+++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 356678999999999999975 4688999998753211 01346788999999999999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998654 34788888999999999999999986 999999999999999999999999999
Q ss_pred eeec
Q 005471 678 RVFG 681 (695)
Q Consensus 678 ~~~~ 681 (695)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=208.63 Aligned_cols=147 Identities=29% Similarity=0.414 Sum_probs=124.1
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 597 (695)
.++|...+.||+|+||.||++... +++.||||++... .....+++.+|+.++..++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467889999999999999999864 5889999998643 2234567789999999999999999999987543
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++||||+++ +|...+.. .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 46999999975 45555422 2678888889999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+....
T Consensus 171 ~~~~~ 175 (359)
T cd07876 171 RTACT 175 (359)
T ss_pred ccccc
Confidence 86543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-21 Score=196.02 Aligned_cols=148 Identities=27% Similarity=0.494 Sum_probs=128.5
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe-CCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~ 606 (695)
++|.+.+.||+|+||.||++... +..+|+|.++.. ...+.+.+|+.++++++|+|++++++++.. .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46778899999999999999875 788999988653 235678899999999999999999998654 45689999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++++|.+++.... ...+++.....++.||+.||.|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999986543 234789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=197.64 Aligned_cols=148 Identities=31% Similarity=0.494 Sum_probs=127.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-----cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--Cee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 599 (695)
.+|...++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788899999999999999864 58899999875321 12345788899999999999999999998764 457
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988543 23678888999999999999999987 99999999999999999999999999986
Q ss_pred ec
Q 005471 680 FG 681 (695)
Q Consensus 680 ~~ 681 (695)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=203.04 Aligned_cols=149 Identities=34% Similarity=0.643 Sum_probs=126.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCc----EEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|+..+.||+|+||.||+|+.. ++. .+|+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677789999999999999863 343 578998865432 2344788999999999999999999998754 5679
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++||+++|+|.+++.... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999986532 24788999999999999999999987 9999999999999999999999999999775
Q ss_pred C
Q 005471 682 G 682 (695)
Q Consensus 682 ~ 682 (695)
.
T Consensus 161 ~ 161 (303)
T cd05110 161 G 161 (303)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-22 Score=205.07 Aligned_cols=162 Identities=30% Similarity=0.410 Sum_probs=139.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
.+.|..-++||+|+||+||-++.. +|+.+|+|++.+. ..++..-..+|-++|.++..+.||.|--++...+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 355777799999999999999864 6889999988653 234555667899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+..|.||+|..+|..... ..+++.+..-++.+|+.||++||.+. ||.|||||+|||||++|+++|+|.|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999988876544 46889998899999999999999987 99999999999999999999999999999977
Q ss_pred CcceeccccccCC
Q 005471 683 EEILAITKRVVGT 695 (695)
Q Consensus 683 ~~~~~~~~~~~GT 695 (695)
.+.. ..| +||
T Consensus 340 g~~~--~~r-vGT 349 (591)
T KOG0986|consen 340 GKPI--RGR-VGT 349 (591)
T ss_pred CCcc--ccc-cCc
Confidence 6653 233 565
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-21 Score=200.10 Aligned_cols=150 Identities=29% Similarity=0.441 Sum_probs=127.7
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++++|...+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.+++|+||+++++++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 356788899999999999999986 4688999999865432 22346778999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||++ ++|..++.... ..+.+.....++.||+.||.|||..+ |+|+||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 67766664332 24678888889999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=200.67 Aligned_cols=147 Identities=29% Similarity=0.497 Sum_probs=128.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|...+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56788899999999999999875 678999999865322 2234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+++ +|..++..... .+++.....++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 984 89888764332 4788899999999999999999987 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-21 Score=196.74 Aligned_cols=147 Identities=33% Similarity=0.565 Sum_probs=128.9
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcc---------cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ---------GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~---------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 598 (695)
+|.+...||+|+||.||+|... +++.+|+|.+...... ..+.+++|+.++.+++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 5789999988653221 12568899999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.++||||+++++|..++... ..+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999998543 34788888999999999999999987 9999999999999999999999999998
Q ss_pred eec
Q 005471 679 VFG 681 (695)
Q Consensus 679 ~~~ 681 (695)
.+.
T Consensus 155 ~~~ 157 (267)
T cd06628 155 KLE 157 (267)
T ss_pred ccc
Confidence 775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=198.53 Aligned_cols=150 Identities=24% Similarity=0.433 Sum_probs=128.7
Q ss_pred CCCCccceeeeeCceeEEEEEcCC----CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|...++||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 456777999999999999998643 2468999886544 3445688999999999999999999998865 567899
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.+..
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999986432 24799999999999999999999887 99999999999999999999999999987654
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
+
T Consensus 160 ~ 160 (270)
T cd05056 160 E 160 (270)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=201.64 Aligned_cols=149 Identities=28% Similarity=0.467 Sum_probs=130.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|+..++||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36778899999999999999875 588999998865322 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+++++|..+.... ..+++.....++.||++||.|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999998776432 23789999999999999999999986 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.4e-21 Score=201.52 Aligned_cols=146 Identities=19% Similarity=0.333 Sum_probs=129.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|...+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+.++..++||||+++++.+..+++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999864 57899999887543 223457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
||+++++|.+++... ..+++.....++.++++||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999998543 24788888899999999999999986 99999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-21 Score=199.21 Aligned_cols=151 Identities=26% Similarity=0.409 Sum_probs=126.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHH-HHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLL-IAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|++.+.||+|+||.||+++.. +|+.||||+++... .....++..|+.+ ++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999875 68999999987542 2333455566665 566789999999999999999999999
Q ss_pred cCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|++ |+|..++... .....+++.....++.||+.||.|||++. +++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 7887777542 22346899999999999999999999862 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=193.69 Aligned_cols=150 Identities=24% Similarity=0.433 Sum_probs=131.2
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+|++.++||+|+||.||+++.. +++.+|+|.++.. .....+.+..|+.++++++||||+++++.+...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3667799999999999999864 6889999988643 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++++|.+++... ....+++.....++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999887543 2334788889999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=201.30 Aligned_cols=149 Identities=27% Similarity=0.474 Sum_probs=133.4
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|...+.||.|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4578889999999999999975 568999999987655555678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++++|..++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..+
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999998843 24789999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=196.82 Aligned_cols=150 Identities=33% Similarity=0.533 Sum_probs=125.7
Q ss_pred CCccceeeeeCceeEEEEEcC----CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 597 (695)
|.+.++||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456689999999999999753 3688999988653 2334567889999999999999999999987643
Q ss_pred eeEEEEEcCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEee
Q 005471 598 ENMLIYEFMPNKSLDYFIFDES---RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 674 (695)
..++++||+++|+|..++.... ....+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378999999999988875322 1224788899999999999999999987 999999999999999999999999
Q ss_pred ccceeecC
Q 005471 675 GTARVFGG 682 (695)
Q Consensus 675 Gla~~~~~ 682 (695)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99997653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-22 Score=216.20 Aligned_cols=150 Identities=30% Similarity=0.454 Sum_probs=133.7
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCc-EEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQ-EIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~-~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+.|.++..||.|+||+||++..++.. ..|.|.+...+....+.+.-||+||+..+||+||+|++.|...+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34666788999999999999876544 45678888777888889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+||-.+.++....+ .|.+..+.-++++++.||.|||++. |||||||+.|||++-+|.++|+|||.+.....
T Consensus 112 ~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred CCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh
Confidence 99999998866543 5899999999999999999999987 99999999999999999999999999876543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=206.61 Aligned_cols=148 Identities=30% Similarity=0.432 Sum_probs=126.1
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC------C
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------D 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 597 (695)
.++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46788899999999999999986 467899999986532 22345677899999999999999999988643 3
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++++|++ +++|..++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 468999988 7888877742 24889999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+....
T Consensus 166 ~~~~~ 170 (343)
T cd07878 166 RQADD 170 (343)
T ss_pred eecCC
Confidence 97654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=196.25 Aligned_cols=143 Identities=33% Similarity=0.556 Sum_probs=121.4
Q ss_pred ceeeeeCceeEEEEEcC----CCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEe-CCeeEEEEEcCC
Q 005471 534 NKLGQGGFGPVYKGKLS----NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDENMLIYEFMP 607 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~----~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~ 607 (695)
+.||+|+||.||+|... +...+|||++... .....+.+.+|+.++++++||||+++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999988643 23445678899999999999999999998764 456789999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++|.+++.... ..+.+...+.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999986432 23677888889999999999999886 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=198.03 Aligned_cols=149 Identities=30% Similarity=0.573 Sum_probs=130.6
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+|+..++||+|++|.||+|+.. +++.||||.+..... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4777899999999999999975 588999999875432 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++ +|.+++........+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 88888765444456899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-21 Score=200.07 Aligned_cols=144 Identities=24% Similarity=0.417 Sum_probs=123.7
Q ss_pred ceeeeeCceeEEEEEcCC--------CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 534 NKLGQGGFGPVYKGKLSN--------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+.||+|+||.||+|.... ..++|+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997532 235888888655445566888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------eEEEeeccc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN--------PRISDFGTA 677 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~kl~DFGla 677 (695)
+++|+|..++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999865432 4789999999999999999999987 999999999999987665 699999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
..+..
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 86654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=199.70 Aligned_cols=160 Identities=31% Similarity=0.426 Sum_probs=135.4
Q ss_pred ecHHHHHHhcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEe
Q 005471 518 FELSTLLAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE 595 (695)
Q Consensus 518 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 595 (695)
+...++..++++|...+.||+|+||.||++.. .+++.+|+|.+.... ...+++.+|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 33445556678899999999999999999987 468899999986532 2345778899999999 89999999999876
Q ss_pred CC-----eeEEEEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 596 ED-----ENMLIYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 596 ~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
.+ ..++||||+++++|.+++.... ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 5799999999999999885422 2345889999999999999999999886 9999999999999999999
Q ss_pred EEEeeccceeec
Q 005471 670 RISDFGTARVFG 681 (695)
Q Consensus 670 kl~DFGla~~~~ 681 (695)
||+|||+++.+.
T Consensus 168 kl~dfg~~~~~~ 179 (291)
T cd06639 168 KLVDFGVSAQLT 179 (291)
T ss_pred EEeecccchhcc
Confidence 999999998764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=200.80 Aligned_cols=143 Identities=30% Similarity=0.486 Sum_probs=118.1
Q ss_pred ceeeeeCceeEEEEEcC---CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe--CCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~ 608 (695)
.+||+|+||.||+|+.. ++..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 68999999999999864 35789999886532 23467889999999999999999999864 4567899999875
Q ss_pred CCHHHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCceEEEeeccce
Q 005471 609 KSLDYFIFDE------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTAR 678 (695)
Q Consensus 609 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~ 678 (695)
+|.+++... .....+++.....++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665421 12234788889999999999999999987 9999999999999 567899999999999
Q ss_pred eecC
Q 005471 679 VFGG 682 (695)
Q Consensus 679 ~~~~ 682 (695)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07867 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-21 Score=194.52 Aligned_cols=149 Identities=27% Similarity=0.490 Sum_probs=133.8
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|+..+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++||||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999998764 78999999875432 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++++|.+++... ...+++.....++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999998543 235899999999999999999999987 999999999999999999999999999977543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=209.52 Aligned_cols=149 Identities=24% Similarity=0.400 Sum_probs=128.0
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-C-----CceeeeEeEEEeCCeeEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-H-----RNLVKLLGCCLEEDENML 601 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~l 601 (695)
+|.+.+.||+|.||.|.||.. .+++.||||+++... ....+-..|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 678889999999999999975 568999999998753 34455567999999986 4 399999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCceEEEeecccee
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--KMNPRISDFGTARV 679 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~ 679 (695)
|+|.+. -+|.++|+.... ..++......|+.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999995 789999976543 34888999999999999999999887 999999999999974 45799999999987
Q ss_pred ecCC
Q 005471 680 FGGE 683 (695)
Q Consensus 680 ~~~~ 683 (695)
..+.
T Consensus 341 ~~q~ 344 (586)
T KOG0667|consen 341 ESQR 344 (586)
T ss_pred cCCc
Confidence 6543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=193.43 Aligned_cols=141 Identities=26% Similarity=0.403 Sum_probs=127.2
Q ss_pred ceeeeeCceeEEEEE-cCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
+.||+|+|+.|--+. +.+|+++|||++.+...+....+.+|++++...+ |+||++|+.+|+++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 789999999999885 6789999999999988888889999999999995 99999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CceEEEeeccceee
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK---MNPRISDFGTARVF 680 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~ 680 (695)
...|..+ +.+.+.+.-++..+|+.||.|||.++ |.||||||+|||-.+. .-+||+||.|+.-+
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 8888643 34788888999999999999999998 9999999999999754 34899999988654
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=196.73 Aligned_cols=148 Identities=29% Similarity=0.532 Sum_probs=129.4
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc------ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
+|+..+.||+|+||.||++.. .+++.+|+|.+..... ...+.+++|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467789999999999999985 5688999998864321 134678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-ceEEEeeccceee
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVF 680 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 680 (695)
|+||+++++|.+++... ..+++.....++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998643 34788999999999999999999987 99999999999998765 6999999999877
Q ss_pred cC
Q 005471 681 GG 682 (695)
Q Consensus 681 ~~ 682 (695)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.9e-21 Score=202.54 Aligned_cols=145 Identities=19% Similarity=0.292 Sum_probs=125.2
Q ss_pred ccceeeee--CceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 532 TSNKLGQG--GFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 532 ~~~~LG~G--~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+.++||+| +|++||+++. .+++.||||++.... ....+.+++|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34789999 7899999976 468999999987542 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++||+.+..+
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 99999999864322 24789999999999999999999987 999999999999999999999999875543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-22 Score=225.34 Aligned_cols=169 Identities=21% Similarity=0.268 Sum_probs=144.4
Q ss_pred HHHHHHhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEccc---CCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe
Q 005471 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLST---TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE 595 (695)
Q Consensus 520 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 595 (695)
..++....++|.++++||+|+||.|..++.+ +++.||+|++.+ ........|+.|-.+|..-+.+-||+|.-+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3445555678999999999999999999875 578899999987 334556779999999999999999999999999
Q ss_pred CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeec
Q 005471 596 EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (695)
Q Consensus 596 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 675 (695)
..++|||||||+||+|-.++.... .+++.-...++..|+.||.-||+.+ +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999986544 3677777778999999999999887 9999999999999999999999999
Q ss_pred cceeecCCcceeccccccCC
Q 005471 676 TARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 676 la~~~~~~~~~~~~~~~~GT 695 (695)
-+-.+..+..-. ...-+||
T Consensus 221 sClkm~~dG~V~-s~~aVGT 239 (1317)
T KOG0612|consen 221 SCLKMDADGTVR-SSVAVGT 239 (1317)
T ss_pred hHHhcCCCCcEE-eccccCC
Confidence 999998655433 3335787
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=193.70 Aligned_cols=149 Identities=40% Similarity=0.644 Sum_probs=131.0
Q ss_pred CccceeeeeCceeEEEEEcCC-----CcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 531 STSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~~-----g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.+.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456899999999999998754 378999999765333 56788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+++++|.+++...... .+++.....++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999998653321 2789999999999999999999987 999999999999999999999999999877644
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-21 Score=202.92 Aligned_cols=151 Identities=25% Similarity=0.335 Sum_probs=132.7
Q ss_pred CCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 530 FSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
|.+.+.||+|-|..|-+++. -+|..||||++.+..- .....+.+|++.|+.++|||||+||.+.......|||+|.=
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 55568999999999999975 4799999999987643 34557888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEEeeccceeecCCcc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~ 685 (695)
.+|+|.+||..+... +.+....+++.||+.|+.|+|+.+ +|||||||+||++- +-|-+||+|||++..+.+++.
T Consensus 100 D~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred CCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 999999999766543 788888999999999999999987 99999999998875 568899999999999877653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-22 Score=196.02 Aligned_cols=151 Identities=29% Similarity=0.483 Sum_probs=123.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC---C--CcEEEEEEcccCCc-cc-HHHHHHHHHHHHcCCCCceeeeEeEEEe-CCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS---N--GQEIAVKRLSTTSG-QG-IEELKNEVLLIAKLQHRNLVKLLGCCLE-EDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~---~--g~~vAvK~l~~~~~-~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 599 (695)
..|+....||+|.||.||++.-. + .+++|||+++..+. .+ ....-+|+.+++.++||||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 35777889999999999999532 2 23799999876422 12 1234579999999999999999999988 6678
Q ss_pred EEEEEcCCCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CceEEEe
Q 005471 600 MLIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK----MNPRISD 673 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~D 673 (695)
+|++||.+. +|-.+|+.+ .....++-....+|+.||+.|+.|||++- |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999975 666666433 23346888888999999999999999987 9999999999999866 9999999
Q ss_pred eccceeecC
Q 005471 674 FGTARVFGG 682 (695)
Q Consensus 674 FGla~~~~~ 682 (695)
||+||++..
T Consensus 180 lGlaR~~~~ 188 (438)
T KOG0666|consen 180 LGLARLFNN 188 (438)
T ss_pred ccHHHHhhc
Confidence 999999864
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=193.65 Aligned_cols=152 Identities=28% Similarity=0.450 Sum_probs=134.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|++.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999854 67899999986532 33567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++++|.+++........+++.....++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999999865433345889999999999999999999887 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-21 Score=195.06 Aligned_cols=148 Identities=30% Similarity=0.512 Sum_probs=132.0
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677899999999999999864 688999999876543 3567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++++|.+++... ..+++..+..++.++++||.|||+.+ |+|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 9999999998643 24788889999999999999999987 99999999999999999999999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=197.48 Aligned_cols=149 Identities=28% Similarity=0.508 Sum_probs=122.2
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcC---CCCceeeeEeEEEeC-----C
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKL---QHRNLVKLLGCCLEE-----D 597 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~-----~ 597 (695)
+|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.++.++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4677899999999999999865 688999998865322 1233456677777665 799999999998753 3
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++||||++ ++|..++.... ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999998 48888875432 234789999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=206.71 Aligned_cols=148 Identities=28% Similarity=0.412 Sum_probs=124.6
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----- 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 597 (695)
..++|...+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468889999999999999999864 57899999987532 233456778999999999999999999986543
Q ss_pred -eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 598 -ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 598 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
..++||||+++ +|...+.. .+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999975 56555532 3788888899999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 005471 677 ARVFGG 682 (695)
Q Consensus 677 a~~~~~ 682 (695)
++....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=197.40 Aligned_cols=149 Identities=30% Similarity=0.482 Sum_probs=132.1
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677899999999999999864 68899999987543 23356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999886543 45899999999999999999999987 999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=193.26 Aligned_cols=143 Identities=33% Similarity=0.543 Sum_probs=123.9
Q ss_pred ceeeeeCceeEEEEEcCC----CcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999876543 24567899999999999999999999875 5568999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||||+|||++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 99999996543 4789999999999999999999887 999999999999999999999999999977543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=221.31 Aligned_cols=157 Identities=25% Similarity=0.379 Sum_probs=129.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 601 (695)
.++|.+.++||+|+||+||+++.. .++.+|+|.+... .......|..|+.++.+|+|||||++++++... ...+|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 457888899999999999999864 4678899988643 233456788999999999999999999998654 46899
Q ss_pred EEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCEEEcC-----------
Q 005471 602 IYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSR----LRIIHRDLKASNILLDE----------- 665 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiHrDlkp~NILl~~----------- 665 (695)
||||+++|+|..+|.... ....+++...+.|+.||+.||.|||..+. .+||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 999999999999986532 22458999999999999999999998542 34999999999999964
Q ss_pred ------CCceEEEeeccceeecCC
Q 005471 666 ------KMNPRISDFGTARVFGGE 683 (695)
Q Consensus 666 ------~~~~kl~DFGla~~~~~~ 683 (695)
...+||+|||+++.+...
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~ 195 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIE 195 (1021)
T ss_pred ccccCCCCceEEccCCcccccccc
Confidence 335899999999877543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=198.06 Aligned_cols=148 Identities=25% Similarity=0.324 Sum_probs=128.8
Q ss_pred CCCccceeeeeCceeEEEEEc----CCCcEEEEEEcccCC----cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCee
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 599 (695)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999975 368899999986532 22346778899999999 699999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||+++++|.+++... ..+++.....++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998643 34778888889999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005471 680 FGG 682 (695)
Q Consensus 680 ~~~ 682 (695)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-21 Score=194.30 Aligned_cols=146 Identities=33% Similarity=0.578 Sum_probs=127.0
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|.+.+.||+|+||.||++.. +++.||+|.+... ...+.+.+|+.++.+++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577789999999999999975 5788999988643 2346788999999999999999999998754 5799999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999986543 234789999999999999999999876 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=199.91 Aligned_cols=150 Identities=25% Similarity=0.325 Sum_probs=132.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|+..+.||+|+||.||++... +++.+|||.+..... ...+.+..|++++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36778899999999999999875 488999999875432 24567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||+++++|.+++.... ...+++.....++.||++||.|||..+ ++|+||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 9999999999886432 345889999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=193.90 Aligned_cols=148 Identities=30% Similarity=0.495 Sum_probs=127.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-----cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--Cee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 599 (695)
.+|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999864 58899999886432 12345688999999999999999999998763 567
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++++||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999988543 23788888999999999999999876 99999999999999999999999999986
Q ss_pred ec
Q 005471 680 FG 681 (695)
Q Consensus 680 ~~ 681 (695)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=200.06 Aligned_cols=150 Identities=29% Similarity=0.480 Sum_probs=126.6
Q ss_pred CCCccceeeeeCceeEEEEEcC---CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENM 600 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~---~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 600 (695)
+|...++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3667789999999999999874 47899999987632 23345678899999999999999999999988 7899
Q ss_pred EEEEcCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC----CCceEEEee
Q 005471 601 LIYEFMPNKSLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE----KMNPRISDF 674 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DF 674 (695)
+||||+++ +|..++..... ...+++.....++.||+.||.|||+.+ |+||||||+|||+++ ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666543221 235788899999999999999999987 999999999999999 999999999
Q ss_pred ccceeecC
Q 005471 675 GTARVFGG 682 (695)
Q Consensus 675 Gla~~~~~ 682 (695)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=196.89 Aligned_cols=149 Identities=27% Similarity=0.391 Sum_probs=132.5
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677899999999999999875 58899999987532 2346788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+++++|.+++... ..+++.....++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998543 35788999999999999999999887 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=192.99 Aligned_cols=150 Identities=29% Similarity=0.419 Sum_probs=134.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|+..+.||+|++|.||+++.. +++.|+||++..... ...+++.+|+.++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 35778899999999999999876 489999999876543 4467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++++|.+++... ..+++.....++.|+++||.|||+ .+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999998653 457899999999999999999998 76 999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-21 Score=201.51 Aligned_cols=144 Identities=28% Similarity=0.460 Sum_probs=128.0
Q ss_pred ccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCC
Q 005471 532 TSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 610 (695)
....||+|+||.||++... ++..||||++........+.+.+|+.++.+++||||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3467999999999999864 578999999876555556678899999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 106 L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 106 LTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 9998743 23788999999999999999999987 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=205.30 Aligned_cols=147 Identities=27% Similarity=0.407 Sum_probs=124.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 597 (695)
.++|...+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468899999999999999999864 57899999987532 233457788999999999999999999876533
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++||||+++ +|...+.. .+++.....++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 46999999975 66666532 3778888899999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+....
T Consensus 174 ~~~~~ 178 (364)
T cd07875 174 RTAGT 178 (364)
T ss_pred cccCC
Confidence 87644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-20 Score=194.42 Aligned_cols=146 Identities=29% Similarity=0.492 Sum_probs=129.2
Q ss_pred CCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
|+..+.||+|+||.||+|.. .+++.+|||.+.... ....+.+.+|+.++.+++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 56678999999999999976 467899999876432 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++|.+++.. ..+++.....++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 86 ~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 86 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999988843 24789999999999999999999987 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=194.57 Aligned_cols=148 Identities=27% Similarity=0.485 Sum_probs=130.8
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC-CcccHHHHHHHHHHHHcCC---CCceeeeEeEEEeCCeeEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~ 603 (695)
.|+..+.||+|+||.||+|.. .+++.+|||.+... .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999986 56889999988654 2344567889999999996 999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++++|.+++... .+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988432 5889999999999999999999987 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=198.81 Aligned_cols=146 Identities=27% Similarity=0.486 Sum_probs=128.6
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455688999999999999864 57889999886443 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++|.+++.. ..+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 86 GGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999988743 34788999999999999999999886 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=195.02 Aligned_cols=161 Identities=24% Similarity=0.297 Sum_probs=135.2
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcc---cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQ---GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
.++|..+++||+|.||+|..++- .+++.+|||++++.-.. ....-..|-++|...+||.+..|.-.|+..+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788889999999999999975 46899999999875333 333456799999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||..+|.|..+|.+ ...+++....-+...|..||.|||++. ||.||||.+|.|||++|++||+||||.+.-..
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999877743 445777777778999999999999987 99999999999999999999999999985322
Q ss_pred CcceeccccccCC
Q 005471 683 EEILAITKRVVGT 695 (695)
Q Consensus 683 ~~~~~~~~~~~GT 695 (695)
..+.+++..||
T Consensus 321 --~g~t~kTFCGT 331 (516)
T KOG0690|consen 321 --YGDTTKTFCGT 331 (516)
T ss_pred --ccceeccccCC
Confidence 12345667776
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=195.00 Aligned_cols=149 Identities=28% Similarity=0.433 Sum_probs=132.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|+..+.||.|+||.||+|+.. +++.||+|.+.... .....++.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35777899999999999999865 58899999886543 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++++|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999988543 5889999999999999999999987 999999999999999999999999999988643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=191.59 Aligned_cols=150 Identities=25% Similarity=0.432 Sum_probs=131.3
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|+..+.||+|+||.||+++.. +++.||+|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4777899999999999999864 6889999988643 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++++|.+++.... ...+++.....++.|++.||.|||+.+ ++|+||+|+|||++.++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 99999999885432 234788999999999999999999986 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=197.74 Aligned_cols=149 Identities=28% Similarity=0.465 Sum_probs=132.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5678889999999999999975 467899999986544445667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||++..+...
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999998853 23788899999999999999999987 999999999999999999999999998866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=196.29 Aligned_cols=150 Identities=28% Similarity=0.467 Sum_probs=127.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCe-----
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDE----- 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~----- 598 (695)
++|+..+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46788899999999999999864 68899999876532 22345788899999999 46999999999987766
Q ss_pred eEEEEEcCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCceEEEeec
Q 005471 599 NMLIYEFMPNKSLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFG 675 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFG 675 (695)
.++||||+++ +|..++..... ...+++.....++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78888754322 245799999999999999999999987 999999999999998 8999999999
Q ss_pred cceeec
Q 005471 676 TARVFG 681 (695)
Q Consensus 676 la~~~~ 681 (695)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=197.17 Aligned_cols=150 Identities=29% Similarity=0.462 Sum_probs=129.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 602 (695)
++|+..+.||+|+||.||+|+.. +++.+|||.++.... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777899999999999999875 578999999865322 2234567899999999999999999999887 789999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||++ ++|.+++.... ..+++.....++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99998 58988875432 25899999999999999999999987 99999999999999999999999999997754
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=194.64 Aligned_cols=148 Identities=27% Similarity=0.467 Sum_probs=130.7
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.|+..+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+++++++.||||+++++.+.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666789999999999999864 57899999887542 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 99999998843 24788888999999999999999886 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=200.55 Aligned_cols=155 Identities=28% Similarity=0.405 Sum_probs=128.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc-------ccHHHHHHHHHHHHcCCCCceeeeEeEEEeC-Ce
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG-------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-DE 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~-------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~ 598 (695)
++|-.+++||+|||++||++.. ...+-||||+-..... ...+...+|-+|-+.|+||.||++|+++.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4566778999999999999964 4567889997543211 1123456799999999999999999998754 56
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCceEEEeec
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFG 675 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFG 675 (695)
.+-|+||+++.+|+.+|+. .+.+++++...|+.||+.||.||.+.. +||||-||||.||||. ..|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7899999999999999954 345889999999999999999999874 7899999999999996 45789999999
Q ss_pred cceeecCCcce
Q 005471 676 TARVFGGEEIL 686 (695)
Q Consensus 676 la~~~~~~~~~ 686 (695)
|++++..+...
T Consensus 619 LSKIMdddSy~ 629 (775)
T KOG1151|consen 619 LSKIMDDDSYN 629 (775)
T ss_pred hhhhccCCccC
Confidence 99999766543
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.7e-21 Score=200.24 Aligned_cols=142 Identities=28% Similarity=0.442 Sum_probs=127.0
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHH
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 612 (695)
..||+|+||.||++... +++.||||.+........+.+.+|+.++..++||||+++++.+..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 57999999999999864 68899999987654455667889999999999999999999999999999999999999998
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
.++.. ..+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 107 ~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 107 DIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred HHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 87743 24789999999999999999999987 99999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=197.65 Aligned_cols=148 Identities=26% Similarity=0.387 Sum_probs=129.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|++.+.||+|+||+||++... +++.||+|.+.... ....+.+.+|++++..++||||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677799999999999999864 58899999876532 33456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+++++|..++... ..+++.....++.+++.||.|||+.. +|+||||||+||++++++.++|+|||+++.+
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 9999999887542 34789999999999999999999742 3999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=195.40 Aligned_cols=146 Identities=40% Similarity=0.605 Sum_probs=125.1
Q ss_pred ceeeeeCceeEEEEEcCC-------CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 534 NKLGQGGFGPVYKGKLSN-------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+.||+|+||.||+|+..+ ++.+|||.+.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2579999876543 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-----ceEEEeecc
Q 005471 606 MPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-----NPRISDFGT 676 (695)
Q Consensus 606 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kl~DFGl 676 (695)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++++. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234789999999999999999999876 99999999999999877 899999999
Q ss_pred ceeecC
Q 005471 677 ARVFGG 682 (695)
Q Consensus 677 a~~~~~ 682 (695)
++.+..
T Consensus 158 ~~~~~~ 163 (269)
T cd05044 158 ARDIYK 163 (269)
T ss_pred cccccc
Confidence 986643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=196.82 Aligned_cols=148 Identities=30% Similarity=0.503 Sum_probs=127.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
+.|...+.||+|+||.||+|+.. +++.||+|.+..... ...+++.+|++++++++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777899999999999999864 688999998864322 23457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++...
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9997 57766664322 34899999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.5e-21 Score=197.66 Aligned_cols=148 Identities=25% Similarity=0.492 Sum_probs=127.5
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|+..+.||+|+||.||+|+.. +|+.+|+|++.... ......+.+|++++.+++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999874 68899999886432 22235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++ ++|.+++.... ..+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 97 57777765432 34899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=196.26 Aligned_cols=148 Identities=29% Similarity=0.542 Sum_probs=128.7
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777899999999999999864 68899999886432 22345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++ ++|..++.... ...+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 68888875433 335889999999999999999999886 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.7e-21 Score=204.99 Aligned_cols=157 Identities=29% Similarity=0.443 Sum_probs=131.2
Q ss_pred ceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHH
Q 005471 534 NKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 612 (695)
-+||+|.||+||.|+..+ ...+|||.+.....+..+-+..||.+-+.|+|+|||+.+|.+.+++..-+.||-+|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999999754 5579999998877777788999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEEeeccceeecCCcceecccc
Q 005471 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEILAITKR 691 (695)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~ 691 (695)
.+|...=..-.-.+...--+-.||++||.|||+.. |||||||-.||||+ -.|.+||+|||-+|.+.+=.. .|.+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc--cccc
Confidence 99964322211145555567899999999999987 99999999999998 578999999999998754222 3444
Q ss_pred ccCC
Q 005471 692 VVGT 695 (695)
Q Consensus 692 ~~GT 695 (695)
+.||
T Consensus 736 FTGT 739 (1226)
T KOG4279|consen 736 FTGT 739 (1226)
T ss_pred cccc
Confidence 5565
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=208.80 Aligned_cols=153 Identities=23% Similarity=0.376 Sum_probs=121.0
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-----------------CCCcEEEEEEcccCCcccHH--------------HHHHH
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-----------------SNGQEIAVKRLSTTSGQGIE--------------ELKNE 574 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-----------------~~g~~vAvK~l~~~~~~~~~--------------~~~~E 574 (695)
..++|++.++||+|+||.||+|.. ..++.||||++........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999964 23567999998653322222 23347
Q ss_pred HHHHHcCCCCce-----eeeEeEEEe--------CCeeEEEEEcCCCCCHHHHHhccCC---------------------
Q 005471 575 VLLIAKLQHRNL-----VKLLGCCLE--------EDENMLIYEFMPNKSLDYFIFDESR--------------------- 620 (695)
Q Consensus 575 i~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 620 (695)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888877655 678888764 3567999999999999998864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 621 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 621 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
...++|..+..++.|+++||.|||..+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123567888899999999999999987 9999999999999999999999999998654
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-20 Score=189.46 Aligned_cols=150 Identities=25% Similarity=0.410 Sum_probs=129.1
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-eeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-ENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E 604 (695)
+|.+.+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+...+ ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3677899999999999999864 57889999986432 234567889999999999999999999876544 5789999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+++++|.+++.... ...+++.....++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999886532 335799999999999999999999987 99999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.1e-20 Score=186.93 Aligned_cols=150 Identities=34% Similarity=0.573 Sum_probs=134.6
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+||+++++.+......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 566789999999999999875 6889999999775545667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
++|.+++.... ..+++..+..++.+++.||.|||..+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 99999886542 35899999999999999999999976 9999999999999999999999999999876543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=194.84 Aligned_cols=150 Identities=25% Similarity=0.419 Sum_probs=130.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|+..++||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 35778899999999999999875 5789999988653 23345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|++++.+..++.. ...+++.....++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777665533 233789999999999999999999987 999999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-21 Score=185.85 Aligned_cols=142 Identities=18% Similarity=0.169 Sum_probs=108.9
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc--c-------HHH-----------------HHHHHHHHHcCCCCce
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ--G-------IEE-----------------LKNEVLLIAKLQHRNL 586 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~H~nI 586 (695)
...||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999888999999998653211 1 112 2349999999988776
Q ss_pred eeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEEEcC
Q 005471 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL-HQDSRLRIIHRDLKASNILLDE 665 (695)
Q Consensus 587 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp~NILl~~ 665 (695)
....... ....+|||||++++++...+.. ...++......++.|++.+|.|| |+.+ |+||||||+|||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 4433322 2234899999998877544322 22478888999999999999999 6766 999999999999984
Q ss_pred CCceEEEeeccceeecCC
Q 005471 666 KMNPRISDFGTARVFGGE 683 (695)
Q Consensus 666 ~~~~kl~DFGla~~~~~~ 683 (695)
+.++|+|||+|......
T Consensus 154 -~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 154 -GKLYIIDVSQSVEHDHP 170 (190)
T ss_pred -CcEEEEEccccccCCCc
Confidence 78999999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=191.48 Aligned_cols=148 Identities=30% Similarity=0.507 Sum_probs=127.5
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC-----CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--Cee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-----SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 599 (695)
.+|.+.+.||+|+||.||+|+. .+++.||+|.+... ..+..+.+++|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4678889999999999999986 45889999987432 123345788999999999999999999998764 457
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++|+||+++++|.+++... ..+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999988543 23788888899999999999999887 99999999999999999999999999987
Q ss_pred ec
Q 005471 680 FG 681 (695)
Q Consensus 680 ~~ 681 (695)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=191.72 Aligned_cols=153 Identities=29% Similarity=0.518 Sum_probs=128.1
Q ss_pred CCCccceeeeeCceeEEEEEcCC--CcEEEEEEcccCC----------cccHHHHHHHHHHHHc-CCCCceeeeEeEEEe
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSN--GQEIAVKRLSTTS----------GQGIEELKNEVLLIAK-LQHRNLVKLLGCCLE 595 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~--g~~vAvK~l~~~~----------~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~ 595 (695)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777999999999999999764 6789999875321 1234457788888875 799999999999999
Q ss_pred CCeeEEEEEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEee
Q 005471 596 EDENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (695)
Q Consensus 596 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 674 (695)
.+..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.. +++|+||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887542 22345888999999999999999999632 3999999999999999999999999
Q ss_pred ccceeecCC
Q 005471 675 GTARVFGGE 683 (695)
Q Consensus 675 Gla~~~~~~ 683 (695)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-20 Score=187.85 Aligned_cols=149 Identities=30% Similarity=0.488 Sum_probs=132.9
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|+..+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++.+++|||++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667799999999999999765 578999999876543 4556889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998543 35899999999999999999999887 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-20 Score=187.90 Aligned_cols=150 Identities=30% Similarity=0.505 Sum_probs=134.0
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLIY 603 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 603 (695)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999876 688999999876532 4567889999999999999999999999988 8899999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++++|.+++.... .+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986543 5899999999999999999999976 999999999999999999999999999988655
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=193.83 Aligned_cols=151 Identities=28% Similarity=0.392 Sum_probs=129.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC--eeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--ENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~ 603 (695)
++|...+.||+|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.... ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777899999999999999874 578999998875432 34567899999999999999999999987543 679999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||+++++|.+++.... ....+++.....++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999998875422 2344788889999999999999999987 9999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=213.36 Aligned_cols=152 Identities=28% Similarity=0.429 Sum_probs=118.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC--CcEEEEE------------------EcccCCcccHHHHHHHHHHHHcCCCCce
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN--GQEIAVK------------------RLSTTSGQGIEELKNEVLLIAKLQHRNL 586 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~--g~~vAvK------------------~l~~~~~~~~~~~~~Ei~~l~~l~H~nI 586 (695)
.++|.+.++||+|+||+||++..+. +...++| ++.. .......+++|+.+|.+++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999987532 2222222 1111 12234568899999999999999
Q ss_pred eeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005471 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (695)
Q Consensus 587 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 664 (695)
|++++++...+..++|+|++. ++|.+++..... ...........|+.||+.||.|||+++ ||||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 566666643221 111234556679999999999999987 99999999999999
Q ss_pred CCCceEEEeeccceeecCC
Q 005471 665 EKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 665 ~~~~~kl~DFGla~~~~~~ 683 (695)
.++.+||+|||+|+.+...
T Consensus 302 ~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCEEEEeCCCceecCcc
Confidence 9999999999999987543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=192.73 Aligned_cols=151 Identities=28% Similarity=0.472 Sum_probs=134.7
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++.|...+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|++++++++|+||+++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566777899999999999999876 688999999876443 56778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+++++|.+++.... ..+++..+..++.+++.||.|||..+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999996543 35899999999999999999999976 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=195.14 Aligned_cols=151 Identities=26% Similarity=0.477 Sum_probs=128.6
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----- 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 597 (695)
..++|++.+.||+|+||.||+|... +++.||||+++... ......+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567888999999999999999875 57899999986532 223456778999999999999999999988755
Q ss_pred -----eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 598 -----ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 598 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
..++|+||+++ ++..++... ...+++.....++.||+.||.|||+.+ |+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 666666433 235899999999999999999999987 9999999999999999999999
Q ss_pred eeccceeecC
Q 005471 673 DFGTARVFGG 682 (695)
Q Consensus 673 DFGla~~~~~ 682 (695)
|||+++.+..
T Consensus 159 dfg~~~~~~~ 168 (302)
T cd07864 159 DFGLARLYNS 168 (302)
T ss_pred cccccccccC
Confidence 9999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=192.11 Aligned_cols=141 Identities=27% Similarity=0.406 Sum_probs=125.8
Q ss_pred eeeeCceeEEEEEcCC-CcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 536 LGQGGFGPVYKGKLSN-GQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 536 LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|++++.+++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999865432 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
.+++.... .+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 99986533 5889999999999999999999987 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=188.72 Aligned_cols=150 Identities=26% Similarity=0.470 Sum_probs=130.2
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|...+.||+|+||.||++.. .+++.+|||.+... .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 467789999999999999976 46789999988653 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 682 (695)
+++++|.+++.... ...+++.....++.++++||.|||+++ |+|+||||+||+++++ ..+||+|||+++.+..
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999986532 334789999999999999999999987 9999999999999854 5689999999997754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=192.63 Aligned_cols=148 Identities=25% Similarity=0.375 Sum_probs=131.1
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+|+..+.||+|+||.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5667789999999999999875 58899999887643 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++++|.+++.... ..+++.....++.|+++||.|||+ .+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999986542 457888889999999999999998 65 9999999999999999999999999998664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=193.10 Aligned_cols=156 Identities=31% Similarity=0.485 Sum_probs=131.4
Q ss_pred HHHHHhcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEe---
Q 005471 521 STLLAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE--- 595 (695)
Q Consensus 521 ~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~--- 595 (695)
.++..+.+.|+..+.||+|+||.||+|+. .+++.+|+|.+... .....++..|+.++.++ +||||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 34444557788889999999999999987 45789999988653 23446788899999998 79999999999864
Q ss_pred ---CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 596 ---EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 596 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
.+..+++|||+++|+|.+++.... ...+++.....++.||+.||.|||+.+ |+|+||||+||++++++.+||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 456799999999999999886532 234788888899999999999999987 9999999999999999999999
Q ss_pred eeccceeec
Q 005471 673 DFGTARVFG 681 (695)
Q Consensus 673 DFGla~~~~ 681 (695)
|||+++.+.
T Consensus 164 dfg~~~~~~ 172 (282)
T cd06636 164 DFGVSAQLD 172 (282)
T ss_pred eCcchhhhh
Confidence 999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=191.53 Aligned_cols=152 Identities=28% Similarity=0.477 Sum_probs=132.0
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC------
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~------ 597 (695)
++++|.+.+.||+|+||.||+|... +++.+++|.+.... ...+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999874 57889999887543 3456789999999999 7999999999998755
Q ss_pred eeEEEEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
..++||||+++++|.+++.... ....+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 3799999999999999886432 2345889999999999999999999987 99999999999999999999999999
Q ss_pred ceeec
Q 005471 677 ARVFG 681 (695)
Q Consensus 677 a~~~~ 681 (695)
+....
T Consensus 160 ~~~~~ 164 (275)
T cd06608 160 SAQLD 164 (275)
T ss_pred ceecc
Confidence 98654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=192.34 Aligned_cols=142 Identities=32% Similarity=0.442 Sum_probs=124.2
Q ss_pred eeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 536 LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
||+|+||+||++... +++.+|+|.+.... ....+.+..|++++.+++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 68899999886432 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 998865432 35789999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.2e-20 Score=191.79 Aligned_cols=149 Identities=28% Similarity=0.505 Sum_probs=125.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|+..+.||+|++|.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46788899999999999999875 68899999886532 2234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 681 (695)
|++ ++|..++.... ...+++.....++.||+.||.|||+.+ |+||||+|+||++++ +..+||+|||+++.+.
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 57777764332 223577888889999999999999986 999999999999985 5679999999998764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=181.03 Aligned_cols=144 Identities=20% Similarity=0.243 Sum_probs=112.9
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc---------------------c-----HHHHHHHHHHHHcCCCCce
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ---------------------G-----IEELKNEVLLIAKLQHRNL 586 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~---------------------~-----~~~~~~Ei~~l~~l~H~nI 586 (695)
...||+|+||.||+|+..+|+.||||+++..... . ...++.|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999888999999998754211 0 1123578999999999988
Q ss_pred eeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcC
Q 005471 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDE 665 (695)
Q Consensus 587 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~ 665 (695)
.....+... ..+|||||++++++....... ..++......++.+++.+|.|||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 654444333 358999999988654332221 236677888999999999999999 76 99999999999999
Q ss_pred CCceEEEeeccceeecCCcc
Q 005471 666 KMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 666 ~~~~kl~DFGla~~~~~~~~ 685 (695)
++.++|+|||+|+.+..+..
T Consensus 153 ~~~~~liDFG~a~~~~~~~~ 172 (190)
T cd05145 153 DGKPYIIDVSQAVELDHPNA 172 (190)
T ss_pred CCCEEEEEcccceecCCCCH
Confidence 78999999999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=191.59 Aligned_cols=148 Identities=26% Similarity=0.458 Sum_probs=128.9
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeEEEEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLIYE 604 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E 604 (695)
|++.++||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|+.++.+++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456789999999999999875 47899999987653 23345688999999999999999999999988 78999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+++ +|..++.... ..+++..+..++.||++||.|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9984 8888875432 35889999999999999999999987 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=198.94 Aligned_cols=148 Identities=29% Similarity=0.532 Sum_probs=126.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC--eeE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED--ENM 600 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~--~~~ 600 (695)
.++|...+.||+|+||.||+|... +++.+|||++... .......+.+|+.++.++ +||||+++++++...+ ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 356788899999999999999875 5789999988542 223345677899999999 9999999999987543 579
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||++ ++|..++... .++|..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 5888887432 5788999999999999999999986 999999999999999999999999999876
Q ss_pred cC
Q 005471 681 GG 682 (695)
Q Consensus 681 ~~ 682 (695)
..
T Consensus 158 ~~ 159 (337)
T cd07852 158 SE 159 (337)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.6e-20 Score=188.95 Aligned_cols=142 Identities=27% Similarity=0.346 Sum_probs=126.0
Q ss_pred eeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 536 LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 48899999986532 23456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9998543 24788889999999999999999976 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-21 Score=218.08 Aligned_cols=150 Identities=30% Similarity=0.489 Sum_probs=121.9
Q ss_pred HhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC------
Q 005471 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------ 596 (695)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------ 596 (695)
+...+|..++.||+||||.||+++.+ ||+.||||+|.-.. ......+.+|+.++++|+|||||+.+..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888899999999999999864 89999999997653 33345788999999999999999877633110
Q ss_pred --------------------------------------------------------------------------------
Q 005471 597 -------------------------------------------------------------------------------- 596 (695)
Q Consensus 597 -------------------------------------------------------------------------------- 596 (695)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005471 597 ---------------------------------DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643 (695)
Q Consensus 597 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL 643 (695)
-..||-||||+.-.+.+++.+..... .-...++++++|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 11367889998888888875433211 3456678999999999999
Q ss_pred HhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 644 H~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
|+.+ ||||||||.||+||++..+||.|||||..
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 9988 99999999999999999999999999997
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.2e-20 Score=190.77 Aligned_cols=146 Identities=28% Similarity=0.454 Sum_probs=129.2
Q ss_pred CCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.++..++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 34447999999999999985 46889999988655445566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++|.+++.. ..+++.....++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++....
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999998854 24788999999999999999999987 99999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=190.86 Aligned_cols=141 Identities=30% Similarity=0.383 Sum_probs=117.4
Q ss_pred eeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHH---HHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 535 KLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLL---IAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~---l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
.||+|+||.||++... +++.+|||.+.+... .....+.+|..+ +...+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 588999998865321 112233444433 334479999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 99999888543 34899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-20 Score=188.63 Aligned_cols=156 Identities=24% Similarity=0.451 Sum_probs=129.9
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLIY 603 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 603 (695)
+|+..+.||+|+||.||++.. .+++.+|+|.+... .....+++..|++++++++||||+++++++... ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366778999999999999975 46789999988643 233456788999999999999999999988653 4578999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 604 EFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDS--RLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
||+++++|.+++.... ....+++.....++.+|+.||.|||..+ ..+|+|+||||+||++++++.+||+|||+++.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999986532 2345899999999999999999999332 334999999999999999999999999999987
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
....
T Consensus 161 ~~~~ 164 (265)
T cd08217 161 GHDS 164 (265)
T ss_pred cCCc
Confidence 5443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=192.97 Aligned_cols=142 Identities=29% Similarity=0.455 Sum_probs=127.1
Q ss_pred ceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHH
Q 005471 534 NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 612 (695)
.+||+|+||.||++.. .+++.||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 6899999999999987 468899999986554455667889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 88743 23788999999999999999999986 99999999999999999999999999887644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.4e-20 Score=190.84 Aligned_cols=147 Identities=29% Similarity=0.537 Sum_probs=128.0
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
|+..++||+|++|.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456789999999999999864 68999999886542 223456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+ ++|.+++..... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 689888855432 35899999999999999999999986 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=192.65 Aligned_cols=147 Identities=30% Similarity=0.528 Sum_probs=126.4
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
|...+.||+|+||.||+++.. +++.+|+|++..... ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566789999999999999864 688999999864322 2345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++ |+|.+++... ...+++..+..++.+|+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 107 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 97 5777766433 234899999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.2e-20 Score=193.35 Aligned_cols=150 Identities=31% Similarity=0.519 Sum_probs=127.6
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 601 (695)
.++|+..+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457888899999999999999874 588999998864322 2233566899999999999999999998765 46799
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||++ ++|.+++.... ..+++..+..++.||++||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999997 47887775432 35899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 005471 682 G 682 (695)
Q Consensus 682 ~ 682 (695)
.
T Consensus 160 ~ 160 (309)
T cd07845 160 L 160 (309)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-20 Score=196.57 Aligned_cols=149 Identities=26% Similarity=0.436 Sum_probs=127.3
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----- 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 597 (695)
..++|+..+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456798999999999999999975 468899999886432 223456889999999999999999999987654
Q ss_pred -eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 598 -ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 598 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
..++||||+ +++|..++.. ..+++.....++.||++||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999 6788887743 24789999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 005471 677 ARVFGG 682 (695)
Q Consensus 677 a~~~~~ 682 (695)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07880 165 ARQTDS 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=200.47 Aligned_cols=148 Identities=21% Similarity=0.353 Sum_probs=128.7
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
..-|..++.||-|+||+|.+++- ++...+|+|.|++.+ ......++.|-.||+..+.+-||+|+--|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 35577889999999999999964 456689999998754 23455678899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|||++||++-.+|.+. ..+.+.....++..++.|+++.|..+ +|||||||+|||||.+|++||+||||+.-+
T Consensus 708 MdYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EeccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999988654 34677777778889999999999887 999999999999999999999999998644
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-20 Score=192.38 Aligned_cols=150 Identities=33% Similarity=0.484 Sum_probs=132.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 602 (695)
++|...+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|++++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778899999999999999875 68999999886532 233467889999999998 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999998543 25899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=188.57 Aligned_cols=151 Identities=26% Similarity=0.473 Sum_probs=130.6
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|...+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677899999999999999875 57899999886531 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-ceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 683 (695)
+++++|.+++..... ..+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||++..+...
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999998865332 34789999999999999999999987 99999999999999875 5699999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=205.91 Aligned_cols=150 Identities=23% Similarity=0.312 Sum_probs=120.1
Q ss_pred HHHhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCC------CceeeeEeEEEe
Q 005471 523 LLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH------RNLVKLLGCCLE 595 (695)
Q Consensus 523 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H------~nIv~l~g~~~~ 595 (695)
+...+++|.+.++||+|+||+||+|... .++.||||+++... ....++..|+.++.+++| ++|+++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345678999999999999999999864 57889999986532 233456667777777654 458999999876
Q ss_pred C-CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCC------
Q 005471 596 E-DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKM------ 667 (695)
Q Consensus 596 ~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~------ 667 (695)
. .+.++|||++ +++|.+++... ..+++.....|+.||+.||.|||.+ + ||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 5 4678999988 67788877543 3488999999999999999999974 5 99999999999998665
Q ss_pred ----------ceEEEeeccceee
Q 005471 668 ----------NPRISDFGTARVF 680 (695)
Q Consensus 668 ----------~~kl~DFGla~~~ 680 (695)
.+||+|||++...
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccCCCCceEEECCCCccccC
Confidence 4999999998643
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-20 Score=192.36 Aligned_cols=149 Identities=27% Similarity=0.484 Sum_probs=125.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe------
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE------ 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------ 598 (695)
++|+..++||+|+||.||+++.. +++.||||.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999864 68899999886432 2223456789999999999999999999887543
Q ss_pred --eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 599 --NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 599 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
.++||||++ ++|..++.... ..+++.....++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 499999997 47777764332 24789999999999999999999986 99999999999999999999999999
Q ss_pred ceeecC
Q 005471 677 ARVFGG 682 (695)
Q Consensus 677 a~~~~~ 682 (695)
++.+..
T Consensus 166 ~~~~~~ 171 (310)
T cd07865 166 ARAFSL 171 (310)
T ss_pred cccccC
Confidence 987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.4e-20 Score=196.83 Aligned_cols=148 Identities=29% Similarity=0.452 Sum_probs=125.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 597 (695)
.++|+..+.||+|+||.||++... +++.||||.+... .....+++.+|+.++.+++||||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 467888999999999999999864 6889999998643 2233456778999999999999999999986543
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++||||++ ++|...+... +++.....++.|++.||.|||..+ |+||||||+|||+++++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 4699999996 5777776422 788888899999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 005471 678 RVFGGE 683 (695)
Q Consensus 678 ~~~~~~ 683 (695)
+.....
T Consensus 166 ~~~~~~ 171 (353)
T cd07850 166 RTAGTS 171 (353)
T ss_pred eeCCCC
Confidence 977543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=201.19 Aligned_cols=170 Identities=29% Similarity=0.463 Sum_probs=142.2
Q ss_pred cHHHHHHhcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEe-
Q 005471 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE- 595 (695)
Q Consensus 519 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~- 595 (695)
.++.+...++.|.+.+.||+|.+|.||+++. ++++.+|||++... ....++++.|..+++.. +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444445667788899999999999999985 56888999988764 34456778889999887 79999999999986
Q ss_pred ----CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEE
Q 005471 596 ----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (695)
Q Consensus 596 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 671 (695)
++.++||||||.+|+.-++++... ...+.|....-|+..++.||.+||... +||||||=.||||+.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 457899999999999999987665 445899999999999999999999986 999999999999999999999
Q ss_pred EeeccceeecCCcceeccccccCC
Q 005471 672 SDFGTARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~GT 695 (695)
.|||++..+...--+. ++.+||
T Consensus 165 vDFGvSaQldsT~grR--nT~iGt 186 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRR--NTFIGT 186 (953)
T ss_pred eeeeeeeeeecccccc--cCcCCC
Confidence 9999999886544433 335665
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-20 Score=195.85 Aligned_cols=148 Identities=26% Similarity=0.457 Sum_probs=126.0
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----ee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----EN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~ 599 (695)
.++|.+.++||+|+||.||+|+. .+++.||||.+.... ......+..|+.++.+++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46788999999999999999975 468899999986432 233456788999999999999999999876543 47
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++|+||++ ++|..++.. ..+++.....++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999997 477766632 24889999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005471 680 FGG 682 (695)
Q Consensus 680 ~~~ 682 (695)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-20 Score=191.01 Aligned_cols=147 Identities=25% Similarity=0.334 Sum_probs=127.2
Q ss_pred CCccceeeeeCceeEEEEEc----CCCcEEEEEEcccCC----cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeE
Q 005471 530 FSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 600 (695)
|+..+.||+|+||.||+++. .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 66778999999999999874 356889999886432 22345678899999999 6999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++++|..++... ..+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+
T Consensus 82 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 999999999999888542 34788888899999999999999876 999999999999999999999999999876
Q ss_pred cC
Q 005471 681 GG 682 (695)
Q Consensus 681 ~~ 682 (695)
..
T Consensus 156 ~~ 157 (288)
T cd05583 156 LA 157 (288)
T ss_pred cc
Confidence 44
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=188.30 Aligned_cols=146 Identities=23% Similarity=0.393 Sum_probs=123.1
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCC-CCceeeeEeEEEeC--CeeEEEEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEE--DENMLIYE 604 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E 604 (695)
|++.++||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456789999999999999864 68899999887532 222234457899999885 99999999999987 88999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|++ ++|.+.+.... ..+++.....++.||+.||.|||+.+ |+||||||+||++++ +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 57777775432 35899999999999999999999987 999999999999999 9999999999987743
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-19 Score=183.72 Aligned_cols=152 Identities=24% Similarity=0.442 Sum_probs=133.9
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|...+.||+|+||.||++... +++.+++|++..... ...+++.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677799999999999999875 588999999875432 4566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++++|.+++.... ....+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999986542 1345899999999999999999999986 999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=193.73 Aligned_cols=153 Identities=29% Similarity=0.432 Sum_probs=128.9
Q ss_pred HHHHHhcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC-
Q 005471 521 STLLAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE- 596 (695)
Q Consensus 521 ~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~- 596 (695)
.++...+++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34556778999999999999999999975 568899999987532 22345678899999999999999999988653
Q ss_pred -----CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEE
Q 005471 597 -----DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (695)
Q Consensus 597 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 671 (695)
...++++|++ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 2367888876 7889887743 23789999999999999999999987 999999999999999999999
Q ss_pred Eeeccceeec
Q 005471 672 SDFGTARVFG 681 (695)
Q Consensus 672 ~DFGla~~~~ 681 (695)
+|||+++...
T Consensus 162 ~dfg~~~~~~ 171 (345)
T cd07877 162 LDFGLARHTD 171 (345)
T ss_pred eccccccccc
Confidence 9999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=187.12 Aligned_cols=141 Identities=30% Similarity=0.363 Sum_probs=117.6
Q ss_pred eeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHH---HHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 535 KLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEV---LLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei---~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
.||+|+||.||++... +++.||||.+.+... .....+..|. .++....||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999998865321 1122233443 34445689999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++|..++... ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 99999888532 35899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.6e-20 Score=195.18 Aligned_cols=148 Identities=24% Similarity=0.453 Sum_probs=126.9
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEe----CCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~ 600 (695)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57888899999999999999864 68999999987542 2345667889999999999999999998764 34679
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+. ++|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999996 6888887432 34889999999999999999999987 999999999999999999999999999876
Q ss_pred cC
Q 005471 681 GG 682 (695)
Q Consensus 681 ~~ 682 (695)
..
T Consensus 158 ~~ 159 (334)
T cd07855 158 SS 159 (334)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=184.30 Aligned_cols=142 Identities=27% Similarity=0.350 Sum_probs=119.6
Q ss_pred ceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHH-HcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLI-AKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+|+||.||+|... +++.||||.+..... .....+..|..++ ...+|+||+++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 588999999865421 1223344555444 455899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++|..++... ..+++.....++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 9999998543 24788888999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-20 Score=196.35 Aligned_cols=153 Identities=25% Similarity=0.361 Sum_probs=130.0
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCc--------ccHHHHHHHHHHHHcCC---CCceeeeEeEEEe
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSG--------QGIEELKNEVLLIAKLQ---HRNLVKLLGCCLE 595 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~--------~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~ 595 (695)
..|..++.||+|+||.|..+.++. ..+|+||.+.+... ...-.+-.||.||+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358888999999999999998754 56899998876421 11223456999999997 9999999999999
Q ss_pred CCeeEEEEEcC-CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEee
Q 005471 596 EDENMLIYEFM-PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (695)
Q Consensus 596 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 674 (695)
++..||+||-. ++.+|.++|.. ++.+++.+..-|+.||+.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999977 56778888843 445889998899999999999999998 999999999999999999999999
Q ss_pred ccceeecCCcce
Q 005471 675 GTARVFGGEEIL 686 (695)
Q Consensus 675 Gla~~~~~~~~~ 686 (695)
|-|.....++..
T Consensus 715 gsaa~~ksgpfd 726 (772)
T KOG1152|consen 715 GSAAYTKSGPFD 726 (772)
T ss_pred cchhhhcCCCcc
Confidence 999987766654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=188.16 Aligned_cols=148 Identities=30% Similarity=0.437 Sum_probs=127.3
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEcC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
|.+.+.||+|+||+||+|+.. +++.|+||++..... .......+|+..+.+++ ||||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456789999999999999975 478899999865422 22334457999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+|+|.+++.... ...+++..+..++.|++++|.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 789988876543 235799999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=192.65 Aligned_cols=147 Identities=27% Similarity=0.409 Sum_probs=125.3
Q ss_pred CCCCc-cceeeeeCceeEEEEEcC-CCcEEEEEEcccCCccc--------------HHHHHHHHHHHHcCCCCceeeeEe
Q 005471 528 DNFST-SNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQG--------------IEELKNEVLLIAKLQHRNLVKLLG 591 (695)
Q Consensus 528 ~~f~~-~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~nIv~l~g 591 (695)
++|.. .+.||+|+||.||+|... +++.||||.+....... ...+.+|++++.+++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34443 467999999999999864 68899999886532211 124678999999999999999999
Q ss_pred EEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEE
Q 005471 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (695)
Q Consensus 592 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 671 (695)
++...+..++||||++ ++|.+++... ..+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 6888888532 34788899999999999999999987 999999999999999999999
Q ss_pred Eeeccceeec
Q 005471 672 SDFGTARVFG 681 (695)
Q Consensus 672 ~DFGla~~~~ 681 (695)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998776
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=192.25 Aligned_cols=150 Identities=27% Similarity=0.482 Sum_probs=127.5
Q ss_pred HHhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEe-CCee
Q 005471 524 LAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDEN 599 (695)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 599 (695)
...+++|+..+.||+|+||.||++... +++.||||++.+. .....+.+..|++++.+++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345778999999999999999999754 7889999987642 22334677889999999999999999999876 4578
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++|+||+ +++|..++.. ..+++.....++.|+++||.|||+.+ |+||||+|+|||+++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 4688887743 23677888889999999999999987 99999999999999999999999999986
Q ss_pred ec
Q 005471 680 FG 681 (695)
Q Consensus 680 ~~ 681 (695)
..
T Consensus 158 ~~ 159 (328)
T cd07856 158 QD 159 (328)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=189.21 Aligned_cols=149 Identities=25% Similarity=0.418 Sum_probs=124.9
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCC-cccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|...+.||+|+||.||+|...+ ++.||||.+.... .....++..|+.++.+.. ||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567778999999999999999864 8899999987543 223455667887777775 9999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|++ ++|..++.... ..+++..+..++.||++||.|||+.. +|+||||+|+||++++++.+||+|||+++.+.
T Consensus 95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 985 46776664422 25889999999999999999999742 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=190.75 Aligned_cols=143 Identities=20% Similarity=0.219 Sum_probs=122.7
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
+.+|.|+++.||+++. +++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4555666666666665 6899999998654 344567899999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
.+++..... ..+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 87 ~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 87 EDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 999865422 34788888899999999999999987 9999999999999999999999999997663
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=185.21 Aligned_cols=152 Identities=30% Similarity=0.509 Sum_probs=132.0
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|++.++||+|+||.||+++. .+++.+|+|.+.... .....++..|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 467789999999999999975 467899999986532 23355778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++++|..++.+.. ....+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999886532 2345889999999999999999999987 999999999999999999999999999887554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=193.35 Aligned_cols=148 Identities=26% Similarity=0.479 Sum_probs=126.6
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----ee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----EN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~ 599 (695)
++|...+.||+|+||.||+++. .+++.||||.+... .......+.+|+.++..++||||+++++++.... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5688889999999999999986 46889999998653 2333456778999999999999999999887543 47
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||+. ++|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 99999996 6888877532 34889999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005471 680 FGG 682 (695)
Q Consensus 680 ~~~ 682 (695)
...
T Consensus 158 ~~~ 160 (337)
T cd07858 158 TSE 160 (337)
T ss_pred cCC
Confidence 654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=208.01 Aligned_cols=158 Identities=30% Similarity=0.455 Sum_probs=134.6
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC--------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEe
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE 595 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 595 (695)
..++..+.+.||+|.||.|++|.+. ....||||.++... ....+.+..|+++|..+ +|+||+.|+|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3445556679999999999999753 14579999998653 34567899999999998 69999999999999
Q ss_pred CCeeEEEEEcCCCCCHHHHHhccC------CC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005471 596 EDENMLIYEFMPNKSLDYFIFDES------RK-------QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 662 (695)
Q Consensus 596 ~~~~~lV~Ey~~~gsL~~~l~~~~------~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 662 (695)
.+..++|+||++.|+|.++|.... .. ..+.....+.++.|||.||+||++.. +|||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999997654 00 23888999999999999999999986 999999999999
Q ss_pred EcCCCceEEEeeccceeecCCcce
Q 005471 663 LDEKMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 663 l~~~~~~kl~DFGla~~~~~~~~~ 686 (695)
|.++..+||+||||||.....+..
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y 474 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYY 474 (609)
T ss_pred ecCCCEEEEccccceeccCCCCce
Confidence 999999999999999976655544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-21 Score=188.53 Aligned_cols=149 Identities=28% Similarity=0.575 Sum_probs=119.3
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEccc---CCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-------
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLST---TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------- 597 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------- 597 (695)
.|....+||+|.||+||+++.. +++.||+|++-. ...... ...+|+++|..++|+|++.|+..|....
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpi-talreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPI-TALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcH-HHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3445579999999999999875 477889886532 122223 3456999999999999999999887532
Q ss_pred -eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 598 -ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 598 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
..+||+++++. +|.-+|.... ..++..++.+++.++..||.|+|... |+|||+||+|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 36899999974 6777775433 33677888889999999999999876 99999999999999999999999999
Q ss_pred ceeecCCc
Q 005471 677 ARVFGGEE 684 (695)
Q Consensus 677 a~~~~~~~ 684 (695)
||.+...+
T Consensus 171 ar~fs~~~ 178 (376)
T KOG0669|consen 171 ARAFSTSK 178 (376)
T ss_pred ccceeccc
Confidence 99886443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-20 Score=173.07 Aligned_cols=152 Identities=28% Similarity=0.413 Sum_probs=126.9
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC-CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
.+....++.||+|+||.|-+-++ .+|+.+|+|++... ..+..+++..|+.+..+. ..|.+|.++|...+....++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34455568899999999988775 57999999999764 345566777888887665 7999999999999999999999
Q ss_pred EcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|.|. -+|+.+-.+- .....+++...-+|+..|.+||.|||++ +.+||||+||+||||+.+|++||||||++-.+.
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9995 6787775432 2344578888889999999999999996 469999999999999999999999999998774
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.6e-19 Score=182.50 Aligned_cols=146 Identities=23% Similarity=0.314 Sum_probs=119.8
Q ss_pred cCCCCcccee--eeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEE
Q 005471 527 TDNFSTSNKL--GQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 527 ~~~f~~~~~L--G~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 602 (695)
.++|.+.+.+ |+|+||.||+++. .+++.+|+|.+....... . |+.....+ +||||+++++.+...+..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 4556666666 9999999999986 467889999876532111 1 22222222 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-ceEEEeeccceeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFG 681 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 681 (695)
|||+++++|.+++.... .+++.....++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++.+.
T Consensus 88 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999985432 5899999999999999999999987 99999999999999988 99999999998765
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 162 ~~ 163 (267)
T PHA03390 162 TP 163 (267)
T ss_pred CC
Confidence 43
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=186.04 Aligned_cols=148 Identities=29% Similarity=0.505 Sum_probs=128.9
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
|...+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455689999999999999874 688999998865432 23567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++ +|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 8887775532 35889999999999999999999987 999999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=191.43 Aligned_cols=141 Identities=24% Similarity=0.333 Sum_probs=122.2
Q ss_pred ceeeee--CceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQG--GFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G--~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.||+| +||+||+++. .+++.||||.+.... ....+.+++|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467776 8999999986 478999999986432 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
++|.+++.... ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+|++||+.+.
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 99999886543 234788998999999999999999886 9999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=192.79 Aligned_cols=148 Identities=29% Similarity=0.465 Sum_probs=129.4
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----eeE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----ENM 600 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 600 (695)
+|.+.+.||+|+||.||+|+.. +++.+|||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677899999999999999875 48899999987643 334567889999999999999999999998875 789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||++ ++|..++... ..+++.....++.+|+.||.|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 5788877543 25889999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 005471 681 GGE 683 (695)
Q Consensus 681 ~~~ 683 (695)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.6e-19 Score=184.24 Aligned_cols=149 Identities=30% Similarity=0.518 Sum_probs=124.4
Q ss_pred CCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCc--ccHHHHHHHHHHHHcC---CCCceeeeEeEEEeCCe-----
Q 005471 530 FSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSG--QGIEELKNEVLLIAKL---QHRNLVKLLGCCLEEDE----- 598 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~----- 598 (695)
|++.+.||+|+||.||+|+... ++++|||++..... .....+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567899999999999999864 89999999864322 1234566787777655 69999999999998877
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.+++|||++ ++|.+++..... ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 478888754332 24899999999999999999999987 9999999999999999999999999998
Q ss_pred eecCC
Q 005471 679 VFGGE 683 (695)
Q Consensus 679 ~~~~~ 683 (695)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-21 Score=185.68 Aligned_cols=150 Identities=29% Similarity=0.395 Sum_probs=123.4
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+.+.+..||.|+||+|+|-.+ +.|+.+|||+++.... .+.+++..|.++..+- +.||||+++|++..++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 444567899999999999876 4689999999986543 5567788888876665 799999999999999999999999
Q ss_pred CCCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|. .+|+.+.+.- -++..+++...-.|.....+||.||-++. .|||||+||+|||||..|.+||||||++-.+.
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 95 6777665321 12334778777788888999999998754 69999999999999999999999999987653
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=190.34 Aligned_cols=147 Identities=27% Similarity=0.414 Sum_probs=122.4
Q ss_pred CCCccceeeeeCceeEEEEEcC-C--CcEEEEEEcccCC--cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeC----Ce
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-N--GQEIAVKRLSTTS--GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE----DE 598 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~--g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~ 598 (695)
+|.+.+.||+|+||.||+++.. . ++.||||++.... ....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667789999999999999864 3 6789999886432 22345678899999999 599999999976543 34
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.++++||++ ++|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688889886 688888743 234889999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 005471 679 VFGG 682 (695)
Q Consensus 679 ~~~~ 682 (695)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 7653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.3e-19 Score=186.20 Aligned_cols=145 Identities=32% Similarity=0.528 Sum_probs=124.3
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
|...+.||+|+||+||+|+.. +++.|+||++..... ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 455578999999999999864 578999999864322 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
++ +++.+++... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 5776766433 234889999999999999999999987 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=186.67 Aligned_cols=150 Identities=29% Similarity=0.429 Sum_probs=123.0
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+|...++||+|+||.||++... +++.+|||.+.... ......+..|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455688999999999999864 57899999987542 234567889999999996 99999999999999999999999
Q ss_pred CCCCCHHHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++ +++..+... ......+++.....++.+++.||+|||+.. +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 86 455443321 112245889999999999999999999752 39999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=185.96 Aligned_cols=147 Identities=31% Similarity=0.516 Sum_probs=129.0
Q ss_pred CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
|+..+.||+|+||.||+|+.. +++.+|+|.+.... ....+.+..|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 445688999999999999875 48999999987643 333467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+ ++|.+++.... ..+++..+..++.++++||.|||+.+ |+||||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58999886542 34889999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.5e-19 Score=184.78 Aligned_cols=147 Identities=20% Similarity=0.287 Sum_probs=109.5
Q ss_pred CCCCccceeeeeCceeEEEEEcCCC----cEEEEEEcccCCcccH-----------HHHHHHHHHHHcCCCCceeeeEeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNG----QEIAVKRLSTTSGQGI-----------EELKNEVLLIAKLQHRNLVKLLGC 592 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g----~~vAvK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~nIv~l~g~ 592 (695)
++|.+.++||+|+||.||+|+..+. ..+|+|.......... .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788889999999999999987543 4566665332211110 111233445566789999999998
Q ss_pred EEeCC----eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005471 593 CLEED----ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN 668 (695)
Q Consensus 593 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 668 (695)
+.... ..++++|++. .++.+.+... ...++.....|+.|+++||.|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 76654 3467888764 3555555332 22467888899999999999999986 999999999999999999
Q ss_pred eEEEeeccceeec
Q 005471 669 PRISDFGTARVFG 681 (695)
Q Consensus 669 ~kl~DFGla~~~~ 681 (695)
+||+|||+|+.+.
T Consensus 165 ~~l~DFGla~~~~ 177 (294)
T PHA02882 165 GYIIDYGIASHFI 177 (294)
T ss_pred EEEEEcCCceeec
Confidence 9999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-19 Score=187.11 Aligned_cols=148 Identities=32% Similarity=0.529 Sum_probs=126.1
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.|+..+.||+|+||.||+|+.. +++.+|||.+... .....+++.+|++++++++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3556689999999999999864 5788999988642 22334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+. |++..++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+..
T Consensus 96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 997 67777664332 34788999999999999999999886 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-20 Score=212.95 Aligned_cols=152 Identities=27% Similarity=0.416 Sum_probs=131.2
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
.+-+|.....||.|.||.||-+.. .+|...|||-+... .........+|+.++..|+|||+|+.+|+-.+++..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345677789999999999999974 56888999977543 234456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||||++|+|.+.+.... .+++.....+-.|++.|+.|||+++ ||||||||+||+|+.+|.+|+.|||.|+.+.+
T Consensus 1313 MEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999985432 2455555668889999999999998 99999999999999999999999999999876
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 1387 ~ 1387 (1509)
T KOG4645|consen 1387 N 1387 (1509)
T ss_pred c
Confidence 4
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=188.31 Aligned_cols=150 Identities=30% Similarity=0.503 Sum_probs=125.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 597 (695)
.++|.+.++||+|+||.||+|+.. +++.+|||++..... .....+.+|++++.+++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888899999999999999864 588999998864322 22346778999999999999999999876544
Q ss_pred --eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeec
Q 005471 598 --ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (695)
Q Consensus 598 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 675 (695)
..++|+||++. +|...+... ...+++.....++.|+++||.|||+.+ |+|+||||+|||+++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999974 666666432 235899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecC
Q 005471 676 TARVFGG 682 (695)
Q Consensus 676 la~~~~~ 682 (695)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.4e-19 Score=189.48 Aligned_cols=146 Identities=27% Similarity=0.446 Sum_probs=123.3
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 597 (695)
.++|...+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++.+++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788889999999999999986 468999999986532 223456788999999999999999999987653
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++|+||+.. +|..++. ..+++.....++.|+++||.|||..+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 6765541 24788999999999999999999987 999999999999999999999999999
Q ss_pred eeec
Q 005471 678 RVFG 681 (695)
Q Consensus 678 ~~~~ 681 (695)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.6e-19 Score=178.98 Aligned_cols=142 Identities=30% Similarity=0.397 Sum_probs=125.9
Q ss_pred eeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 536 LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
||+|+||.||++... +++.+|+|.+..... ...+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 588999998875432 2456788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
.+++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9998543 24789999999999999999999976 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.6e-19 Score=190.57 Aligned_cols=146 Identities=26% Similarity=0.457 Sum_probs=125.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC----------
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE---------- 596 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~---------- 596 (695)
.+|...+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788889999999999999986 45889999998765555667788999999999999999999876654
Q ss_pred ----CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEE
Q 005471 597 ----DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRI 671 (695)
Q Consensus 597 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl 671 (695)
...++||||++ ++|..++.. ..+++.....++.||++||.|||+.+ |+||||||+||+++ ++..+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 588877743 24788999999999999999999987 99999999999998 5667999
Q ss_pred Eeeccceeec
Q 005471 672 SDFGTARVFG 681 (695)
Q Consensus 672 ~DFGla~~~~ 681 (695)
+|||+++.+.
T Consensus 157 ~dfg~~~~~~ 166 (342)
T cd07854 157 GDFGLARIVD 166 (342)
T ss_pred CCcccceecC
Confidence 9999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=182.52 Aligned_cols=150 Identities=31% Similarity=0.474 Sum_probs=123.7
Q ss_pred CCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccC-----CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTT-----SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46777999999999999998643 344555554432 122334567899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 603 YEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|||+++++|..++... .....+++.....++.|+++||.|||+.+ ++|+||||+||++++ ..+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888642 22345899999999999999999999986 999999999999986 469999999998774
Q ss_pred C
Q 005471 682 G 682 (695)
Q Consensus 682 ~ 682 (695)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=171.87 Aligned_cols=139 Identities=21% Similarity=0.305 Sum_probs=107.4
Q ss_pred CccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-----CCCceeeeEeEEEeCC---eeE-E
Q 005471 531 STSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-----QHRNLVKLLGCCLEED---ENM-L 601 (695)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~~~-l 601 (695)
...++||+|+||.||. ...++.. +||++........+.+.+|+.++..+ .||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457999999999996 3233444 79988765445567899999999999 5799999999999874 333 7
Q ss_pred EEEc--CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCEEEcC----CCceEEEee
Q 005471 602 IYEF--MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV-LYLHQDSRLRIIHRDLKASNILLDE----KMNPRISDF 674 (695)
Q Consensus 602 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DF 674 (695)
|+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ ||||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5689999999542 24444 35678888888 8999987 999999999999974 347999994
Q ss_pred ccceee
Q 005471 675 GTARVF 680 (695)
Q Consensus 675 Gla~~~ 680 (695)
+-++.+
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 444433
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-19 Score=187.56 Aligned_cols=161 Identities=24% Similarity=0.357 Sum_probs=136.9
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEccc--CCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLST--TSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~--~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 604 (695)
..|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+..|.+|+ |.+||+|++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 34677899999999999999998889999987653 34566788999999999995 9999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
|= .-+|..+|...... ..+| .+..+-.||+.++.++|+++ |||.||||.|+|+-+ |.+||+|||+|..+..+.
T Consensus 441 ~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 84 57899998665433 3456 45568999999999999998 999999999999985 589999999999998887
Q ss_pred ceeccccccCC
Q 005471 685 ILAITKRVVGT 695 (695)
Q Consensus 685 ~~~~~~~~~GT 695 (695)
........+||
T Consensus 514 TsI~kdsQvGT 524 (677)
T KOG0596|consen 514 TSIVKDSQVGT 524 (677)
T ss_pred cceeeccccCc
Confidence 77666666776
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-20 Score=182.56 Aligned_cols=151 Identities=27% Similarity=0.475 Sum_probs=123.8
Q ss_pred cceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----eeEEEEE
Q 005471 533 SNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----ENMLIYE 604 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~E 604 (695)
.+.||=|+||.||..+. ++|+.||.|++... .-...+.+.+|+++|.-.+|.|++.+++..+-.. +.|.++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 47899999999999987 47999999988643 1234567888999999999999999999876543 4578888
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
.|. .+|.+++... ..|+-....-+..||++||.|||+.+ |+||||||.|.|++++..+|||||||||....++
T Consensus 138 LmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 885 5677766432 33555666668899999999999987 9999999999999999999999999999988777
Q ss_pred ceeccc
Q 005471 685 ILAITK 690 (695)
Q Consensus 685 ~~~~~~ 690 (695)
...+|-
T Consensus 211 ~~hMTq 216 (449)
T KOG0664|consen 211 RLNMTH 216 (449)
T ss_pred hhhhHH
Confidence 765554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-19 Score=172.52 Aligned_cols=147 Identities=24% Similarity=0.462 Sum_probs=125.0
Q ss_pred cCCCCccceeeeeCceeEEEEE-cCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCe--eEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDE--NMLI 602 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~--~~lV 602 (695)
.++|++.+++|+|.|++||.|. ..+.++++||.+++. ..+.+++|+++|..|. ||||++|++...++.. ..||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678888999999999999997 456788999999764 3567899999999997 9999999999887653 5799
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEEeeccceeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFG 681 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~ 681 (695)
+||+.+-+...+. +.|+-....-++.++++||.|+|+.+ |+|||+||.|++|| +.-.++|+|+|||.++-
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998886654 12555566678999999999999988 99999999999999 55679999999999987
Q ss_pred CCcc
Q 005471 682 GEEI 685 (695)
Q Consensus 682 ~~~~ 685 (695)
+.+.
T Consensus 185 p~~e 188 (338)
T KOG0668|consen 185 PGKE 188 (338)
T ss_pred CCce
Confidence 6543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.4e-19 Score=188.27 Aligned_cols=148 Identities=30% Similarity=0.463 Sum_probs=127.2
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe-----
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE----- 598 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 598 (695)
.++|...+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 467888899999999999999875 5789999988643 22234567789999999999999999998876655
Q ss_pred -eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 599 -NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 599 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
.++|+||+ +++|.+++.. ..+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 5789888753 34889999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+.+..
T Consensus 166 ~~~~~ 170 (343)
T cd07851 166 RHTDD 170 (343)
T ss_pred ccccc
Confidence 87643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-19 Score=184.87 Aligned_cols=160 Identities=28% Similarity=0.362 Sum_probs=131.9
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 602 (695)
.+|..+.+||+|+||+|.++.-+. .+.+|||++++.- ..+.+--+.|-++|+.. +-|.+++|..+++..+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 367788999999999999997653 5679999998742 23344556788888876 678999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+.+|+|-..+.+-.+ +.++...-+|..||-||-+||+++ ||.||||..|||||.++++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999988865443 567777889999999999999998 99999999999999999999999999985332
Q ss_pred CcceeccccccCC
Q 005471 683 EEILAITKRVVGT 695 (695)
Q Consensus 683 ~~~~~~~~~~~GT 695 (695)
+. ..|++..||
T Consensus 503 ~~--~TTkTFCGT 513 (683)
T KOG0696|consen 503 DG--VTTKTFCGT 513 (683)
T ss_pred CC--cceeeecCC
Confidence 22 235556666
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.5e-18 Score=169.59 Aligned_cols=149 Identities=32% Similarity=0.487 Sum_probs=132.4
Q ss_pred CCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
|...+.||+|++|.||++...+ ++.+|||.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556899999999999999865 889999998765444 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++|.+++...... +++.....++.+++.+|.|||..+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 99999998653321 788999999999999999999986 999999999999999999999999999988654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-18 Score=174.73 Aligned_cols=133 Identities=23% Similarity=0.179 Sum_probs=115.1
Q ss_pred eCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhc
Q 005471 539 GGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617 (695)
Q Consensus 539 G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 617 (695)
|.||.||+++. .+++.+|+|++.... ++.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999986 468899999987542 234455666667899999999999999999999999999999998854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 618 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
. ..+++.....++.|+++||.|||+.+ |+||||||+||++++++.+|++|||+++.+..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 3 23889999999999999999999987 99999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=196.81 Aligned_cols=149 Identities=26% Similarity=0.357 Sum_probs=105.7
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCC-----CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeE------EE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC------CL 594 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-----g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~------~~ 594 (695)
..++|...++||+|+||.||+|++.+ +..||||++..... .+....| .+....|.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 35678899999999999999998754 68999998764321 1111111 1222223333322221 24
Q ss_pred eCCeeEEEEEcCCCCCHHHHHhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 005471 595 EEDENMLIYEFMPNKSLDYFIFDESRK-----------------QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 657 (695)
Q Consensus 595 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 657 (695)
.....+|||||+++++|.+++...... ..........|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999988643210 00112334578999999999999987 9999999
Q ss_pred CCCEEEcC-CCceEEEeeccceeec
Q 005471 658 ASNILLDE-KMNPRISDFGTARVFG 681 (695)
Q Consensus 658 p~NILl~~-~~~~kl~DFGla~~~~ 681 (695)
|+|||+++ ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999995 6899999999998664
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-19 Score=174.24 Aligned_cols=146 Identities=27% Similarity=0.347 Sum_probs=120.8
Q ss_pred cCCCCcc-ceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeC----Cee
Q 005471 527 TDNFSTS-NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE----DEN 599 (695)
Q Consensus 527 ~~~f~~~-~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~~ 599 (695)
+++|++. ++||-|-.|+|..+..+ +++.+|+|++... ...++|+++--+. .|||||++++++... .-+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4455442 68999999999998764 6889999988653 3456788776555 699999999998753 346
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCceEEEeecc
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGT 676 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGl 676 (695)
++|||.|+||.|...+.++. ...+++++.-.|+.||+.|+.|||+.. |.||||||+|+|.. .+..+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 79999999999999987654 446899999999999999999999987 99999999999997 466799999999
Q ss_pred ceeec
Q 005471 677 ARVFG 681 (695)
Q Consensus 677 a~~~~ 681 (695)
|+.-.
T Consensus 211 AK~t~ 215 (400)
T KOG0604|consen 211 AKETQ 215 (400)
T ss_pred ccccC
Confidence 99754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-18 Score=189.02 Aligned_cols=149 Identities=29% Similarity=0.437 Sum_probs=118.9
Q ss_pred CCccceeeeeCce-eEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 530 FSTSNKLGQGGFG-PVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 530 f~~~~~LG~G~fG-~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
|...+.+|.|+-| .||+|.+. |++||||++-.. ..+-..+||..|..- +||||||.++.-.++...||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4445788999887 57999994 789999998542 334557899999888 69999999998888889999999995
Q ss_pred CCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCceEEEeeccceeec
Q 005471 608 NKSLDYFIFDESRK-QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-----KMNPRISDFGTARVFG 681 (695)
Q Consensus 608 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~~~~ 681 (695)
-+|++++...... ....-.....+..|+++||++||+.. ||||||||.||||+. ...++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 7999999663111 11111334568899999999999976 999999999999975 3579999999999998
Q ss_pred CCcce
Q 005471 682 GEEIL 686 (695)
Q Consensus 682 ~~~~~ 686 (695)
.+++.
T Consensus 663 ~~~sS 667 (903)
T KOG1027|consen 663 GGKSS 667 (903)
T ss_pred CCcch
Confidence 77655
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-18 Score=169.80 Aligned_cols=146 Identities=25% Similarity=0.413 Sum_probs=120.1
Q ss_pred ccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 532 TSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
.+..||.|..|.|++.+.. .|..+|||.+.... .++.+++...+.++.+-+ .|.||+.+|+|..+....+.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 4578999999999999875 58899999997653 344556667777777664 8999999999999999999999984
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
--++.++... ..++++...-++...+.+||.||.+++ .|||||+||+|||+|+.|.+|+||||++-.+..
T Consensus 175 ~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 175 TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 2344555432 234778777788899999999999876 699999999999999999999999999988753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.74 E-value=5e-17 Score=159.78 Aligned_cols=143 Identities=36% Similarity=0.626 Sum_probs=126.9
Q ss_pred eeeeCceeEEEEEcCC-CcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHHH
Q 005471 536 LGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDY 613 (695)
Q Consensus 536 LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 613 (695)
||+|.+|.||+++... ++++++|++...... ..+.+.+|++.+.+++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 889999998764332 35678999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCceEEEeeccceeecCC
Q 005471 614 FIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFGGE 683 (695)
Q Consensus 614 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~ 683 (695)
++.... ..+++..+..++.+++++|.|||+.+ ++|+||+|.||+++. +..++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 986432 34789999999999999999999986 999999999999999 899999999999977543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=164.67 Aligned_cols=136 Identities=20% Similarity=0.297 Sum_probs=114.7
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc--------cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ--------GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+.||+|++|.||+|.. .+..++||+....... ....+.+|+.++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 6778999976532211 123577899999999999998888888888889999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++++|.+++... .+ .+..++.+++.+|.+||..+ ++|+|++|+|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988432 12 77889999999999999987 99999999999999 7899999999998643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.8e-18 Score=170.27 Aligned_cols=161 Identities=24% Similarity=0.358 Sum_probs=133.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 601 (695)
.++|.++++||+|+|.+|..+++. +.+.+|+|++++. ..++.+-.+.|-.+.... +||.+|.|..+|+.+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457888999999999999999875 5678999998764 334455677788877766 79999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|.||+++|+|--++ .++..|+++...-+...|..||.|||+.+ ||.||||..|+|||..+.+||+|+|+.+.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999996554 34445888888889999999999999998 9999999999999999999999999998643
Q ss_pred CCcceeccccccCC
Q 005471 682 GEEILAITKRVVGT 695 (695)
Q Consensus 682 ~~~~~~~~~~~~GT 695 (695)
.+. ..|.+..||
T Consensus 403 ~~g--d~tstfcgt 414 (593)
T KOG0695|consen 403 GPG--DTTSTFCGT 414 (593)
T ss_pred CCC--cccccccCC
Confidence 322 234556665
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=162.42 Aligned_cols=146 Identities=18% Similarity=0.184 Sum_probs=112.4
Q ss_pred HHHhcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc----------------------cHHHHHHHHHHHHc
Q 005471 523 LLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ----------------------GIEELKNEVLLIAK 580 (695)
Q Consensus 523 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~----------------------~~~~~~~Ei~~l~~ 580 (695)
+......|...+.||+|+||.||++...+|+.||||++...... ....+..|..++.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333346777999999999999999888999999986542100 01235678999999
Q ss_pred CCCCc--eeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005471 581 LQHRN--LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658 (695)
Q Consensus 581 l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp 658 (695)
+.|++ +...++ ....++||||+++++|...... .....++.++++++.++|+.+ |+||||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 98874 444444 2456899999999998765321 223468899999999999976 99999999
Q ss_pred CCEEEcCCCceEEEeeccceeecCCc
Q 005471 659 SNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 659 ~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
+||++++++.+||+|||++..+..+.
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCCcc
Confidence 99999999999999999998776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-17 Score=164.28 Aligned_cols=141 Identities=15% Similarity=0.145 Sum_probs=115.8
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHH---------HHHHHHHHHHcCCCCceeeeEeEEEeC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIE---------ELKNEVLLIAKLQHRNLVKLLGCCLEE 596 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~---------~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 596 (695)
..++|...++||+|+||.||.... +++.+|||.+.+....... .+++|+..+.++.||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999766 5778999999754332222 267899999999999999999986643
Q ss_pred --------CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005471 597 --------DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN 668 (695)
Q Consensus 597 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 668 (695)
...+|||||++|.+|.++.. ++. ....+|+.+|..||+.+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977631 222 24568999999999987 99999999999999988
Q ss_pred eEEEeeccceeecC
Q 005471 669 PRISDFGTARVFGG 682 (695)
Q Consensus 669 ~kl~DFGla~~~~~ 682 (695)
++|+|||..+....
T Consensus 173 i~liDfg~~~~~~e 186 (232)
T PRK10359 173 LRIIDLSGKRCTAQ 186 (232)
T ss_pred EEEEECCCcccccc
Confidence 99999999987743
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=164.35 Aligned_cols=138 Identities=32% Similarity=0.471 Sum_probs=123.9
Q ss_pred CceeEEEEEcC-CCcEEEEEEcccCCccc-HHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhc
Q 005471 540 GFGPVYKGKLS-NGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617 (695)
Q Consensus 540 ~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 617 (695)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999987654444 67899999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 618 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
... +++.....++.+++++|.|||..+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 332 788999999999999999999986 999999999999999999999999999988654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-18 Score=188.27 Aligned_cols=151 Identities=26% Similarity=0.447 Sum_probs=134.9
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|.....+|.|.||.|||++.. .++..|||.++.......+-++.|+-+++..+|||||.++|-+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457778899999999999999864 5888999999877777778888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+.+|+|++.-+.. .++++.+...+++...+||+|||..+ -+|||||-.|||+++.+.+|++|||.+..++..
T Consensus 94 cgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred cCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999998876543 34788888888999999999999987 799999999999999999999999999887653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=9e-19 Score=183.35 Aligned_cols=158 Identities=25% Similarity=0.317 Sum_probs=133.2
Q ss_pred CCCccceeeeeCceeEEEEEcCCCc-EEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSNGQ-EIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~g~-~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+++.+..||-|+||.|=+++..... .+|+|.+++. +....+.+..|-.+|...+.|.||+||-.|.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4455578999999999998876543 3788887764 33445677899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
-|-+|.|=..|.+.. .++.....-++..+.+|++|||.++ ||.|||||+|+|||.+|-+||.|||+|+.++..+
T Consensus 501 aClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999988886543 3666776778899999999999998 9999999999999999999999999999997665
Q ss_pred ceeccccccCC
Q 005471 685 ILAITKRVVGT 695 (695)
Q Consensus 685 ~~~~~~~~~GT 695 (695)
- |-+..||
T Consensus 575 K---TwTFcGT 582 (732)
T KOG0614|consen 575 K---TWTFCGT 582 (732)
T ss_pred c---eeeecCC
Confidence 2 4556666
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=185.70 Aligned_cols=139 Identities=17% Similarity=0.266 Sum_probs=113.1
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEE-cccCCc-------ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR-LSTTSG-------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~-l~~~~~-------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
..|...++||+|+||.||+|.+.... +++|+ +.+... ...+.+.+|++++.+++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34456789999999999999876543 34443 222111 1235688999999999999999988888888888
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ +++.++|+|||+|+.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988873 34568999999999999987 9999999999999 677999999999997
Q ss_pred ecC
Q 005471 680 FGG 682 (695)
Q Consensus 680 ~~~ 682 (695)
...
T Consensus 477 ~~~ 479 (535)
T PRK09605 477 SDL 479 (535)
T ss_pred CCc
Confidence 654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=157.61 Aligned_cols=149 Identities=26% Similarity=0.406 Sum_probs=123.5
Q ss_pred cCCCCccceeeeeCceeEEEEE-cCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCC-CceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 604 (695)
...|.++++||.|+||.+|.|. +.+|.+||||.-+....+ -++..|.++...|+| ..|..+.-+..+.....||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3578889999999999999997 567999999987654333 356778888888864 688888888899999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~~ 681 (695)
.+ +.+|.++..-..+. ++-.+.+.++-|++.-++|+|.++ +|||||||+|+|+. ....+.++|||||+.+-
T Consensus 92 LL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 68888876444333 677888889999999999999998 99999999999996 33568899999999885
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
.-
T Consensus 166 d~ 167 (341)
T KOG1163|consen 166 DI 167 (341)
T ss_pred cc
Confidence 43
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.1e-17 Score=160.65 Aligned_cols=132 Identities=23% Similarity=0.344 Sum_probs=108.6
Q ss_pred eeeeeCceeEEEEEcCCCcEEEEEEcccCCc--------ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG--------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.||+|+||.||+|.. ++..+++|....... ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 568899998543211 11356778999999999988766666666777789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++++|.+++..... .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99999888743210 68999999999999987 99999999999999 7899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.2e-17 Score=165.25 Aligned_cols=146 Identities=19% Similarity=0.187 Sum_probs=112.0
Q ss_pred CCCccceeeeeCceeEEEEE--cCCCcEEEEEEcccCCcc------------------------cHHHHHHHHHHHHcCC
Q 005471 529 NFSTSNKLGQGGFGPVYKGK--LSNGQEIAVKRLSTTSGQ------------------------GIEELKNEVLLIAKLQ 582 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~--~~~g~~vAvK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~ 582 (695)
.|.+.+.||+|+||.||+|. ..+|+.||||.+...... ....+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778999999999999998 578999999988643210 0123568999999997
Q ss_pred CCc--eeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 005471 583 HRN--LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660 (695)
Q Consensus 583 H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N 660 (695)
|.. +.++++. ...+|||||+++.+|...+... ..+.......++.||+.+|.|||..+ .|+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 533 3444443 2458999999998886654221 22445556789999999999999875 39999999999
Q ss_pred EEEcCCCceEEEeeccceeecCCc
Q 005471 661 ILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 661 ILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
|+++ ++.++|+|||+|+..+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCCcc
Confidence 9999 8899999999999776544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.6e-17 Score=157.34 Aligned_cols=133 Identities=20% Similarity=0.175 Sum_probs=106.2
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEEcccCCccc----HHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEcC
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG----IEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~----~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
....|++|+||+||.+.- .+.+++.+.+....... ...+++|+++|.+|+ |++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 57788888776543211 125789999999995 5889999886 4569999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL-KASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++.+|...+.. ....++.|++++|.++|+.+ |+|||| ||+|||+++++.++|+|||+|.....
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 99988644311 11347789999999999987 999999 79999999999999999999996543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.4e-17 Score=166.11 Aligned_cols=159 Identities=25% Similarity=0.365 Sum_probs=133.7
Q ss_pred HHHHHHhcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeE
Q 005471 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGC 592 (695)
Q Consensus 520 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 592 (695)
..++....+++....++-+|.||.||+|.+. +.++|-||.++... ......+..|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455666778888899999999999999653 34567788776543 3445678889999999999999999999
Q ss_pred EEeCC-eeEEEEEcCCCCCHHHHHh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 005471 593 CLEED-ENMLIYEFMPNKSLDYFIF-----DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666 (695)
Q Consensus 593 ~~~~~-~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~ 666 (695)
+.+.. ..+.+|.++.-|+|+.||. +......+.-.+...++.|++.||+|||.++ |||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 98754 5789999999999999997 3344456777788889999999999999987 9999999999999999
Q ss_pred CceEEEeeccceeec
Q 005471 667 MNPRISDFGTARVFG 681 (695)
Q Consensus 667 ~~~kl~DFGla~~~~ 681 (695)
..+||+|=.|+|-+-
T Consensus 433 LqVkltDsaLSRDLF 447 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLF 447 (563)
T ss_pred eeEEeccchhccccC
Confidence 999999999999653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-17 Score=160.62 Aligned_cols=146 Identities=21% Similarity=0.385 Sum_probs=120.3
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeE-EEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGC-CLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~E 604 (695)
+.|.+.+.||+|.||.+-+++++. .+.+++|-+... ....++|.+|..---.| .|.||+.-++. |+..+...+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 467788999999999999999864 668899987653 34567899998765555 69999987665 666777889999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--EKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~ 681 (695)
|+|.|+|.+-+.. ..+.+.....++.|+++||.|||++. +||||||.+||||- +...+||||||+.+..+
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999877633 23667777889999999999999998 99999999999994 45689999999998765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.1e-17 Score=174.67 Aligned_cols=146 Identities=26% Similarity=0.346 Sum_probs=122.5
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++.|.....+|.|+|+.|-++.. .+++..+||++.+.. .+..+|+.++.+. +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56778888899999999999976 467899999997652 2234567666665 79999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-cCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL-DEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~ 683 (695)
.+.++.+.+.+.... ..-..+..|+.+|+.|+.|||+++ ||||||||+|||+ ++.+.++|+|||.++...++
T Consensus 397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999998877764332 122667789999999999999987 9999999999999 59999999999999988765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-16 Score=156.65 Aligned_cols=150 Identities=24% Similarity=0.372 Sum_probs=124.2
Q ss_pred CCCccceeeeeCceeEEEEE-cCCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+|.+.++||+|.||.++.|+ +-+++.||||.-...+ ..-+++.|-+..+.| ..++|...+-+-.++.+..||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68889999999999999997 4578999999654322 234567777777777 5789999999999999999999998
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCceEEEeeccceeec
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-----KMNPRISDFGTARVFG 681 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~~~~ 681 (695)
+.+|+++..-..+. ++-++...||.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||||+.+.
T Consensus 107 -GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 68888876444443 788899999999999999999998 999999999999963 3468999999999986
Q ss_pred CCcce
Q 005471 682 GEEIL 686 (695)
Q Consensus 682 ~~~~~ 686 (695)
..+..
T Consensus 181 Dp~Tk 185 (449)
T KOG1165|consen 181 DPKTK 185 (449)
T ss_pred Ccccc
Confidence 55443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9e-16 Score=163.47 Aligned_cols=145 Identities=28% Similarity=0.395 Sum_probs=120.3
Q ss_pred CCCccceeeeeCceeEEEEEcCCC--cEEEEEEcccCCcccHHHHHHHHHHHHcCCC----CceeeeEeEE-EeCCeeEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSNG--QEIAVKRLSTTSGQGIEELKNEVLLIAKLQH----RNLVKLLGCC-LEEDENML 601 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~g--~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~l 601 (695)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 688899999999999999986553 4788887765433332377889999988873 5888999988 47778899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-----CceEEEeecc
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-----MNPRISDFGT 676 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kl~DFGl 676 (695)
||+.+ +.+|.++..... ...++-.+.+.|+.|++.+|++||+.+ +|||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 789988775444 445888999999999999999999988 9999999999999854 4699999999
Q ss_pred ce
Q 005471 677 AR 678 (695)
Q Consensus 677 a~ 678 (695)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.4e-16 Score=162.04 Aligned_cols=144 Identities=25% Similarity=0.458 Sum_probs=125.4
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCC----CcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 600 (695)
..+.|..+++||+|.|++||++.+.. .+.||+|.+...+ ....+.+|+++|..+ -|.||+++.+++..++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 45678889999999999999998643 5689999987643 446789999999999 5999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEEeecccee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARV 679 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~ 679 (695)
+|+||+++-...+++.. ++......++..+..||.++|..+ ||||||||+|+|.+ ..+.-.|.|||||..
T Consensus 112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999888743 556777789999999999999998 99999999999998 556789999999985
Q ss_pred e
Q 005471 680 F 680 (695)
Q Consensus 680 ~ 680 (695)
.
T Consensus 183 ~ 183 (418)
T KOG1167|consen 183 Y 183 (418)
T ss_pred H
Confidence 4
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.7e-16 Score=157.86 Aligned_cols=154 Identities=19% Similarity=0.252 Sum_probs=126.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCC------ceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR------NLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~------nIv~l~g~~~~~~~~ 599 (695)
+++|.+..++|+|.||.|-.+... .+..||||+++.... ..++-+-|++++.+|.+. -+|.+.+++...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999999764 368899999986543 344556799999999432 478899999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------------
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-------------- 665 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-------------- 665 (695)
+||+|.| +.++.++|.... -.+++......|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 458889986533 335788888999999999999999987 999999999999831
Q ss_pred ------CCceEEEeeccceeecCCcce
Q 005471 666 ------KMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 666 ------~~~~kl~DFGla~~~~~~~~~ 686 (695)
...+||+|||-|+.-.+..+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~hs~ 268 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHHST 268 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCcce
Confidence 345899999999987666544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=141.23 Aligned_cols=137 Identities=23% Similarity=0.212 Sum_probs=116.1
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCC--CceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH--RNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
+.+.||+|.++.||++...+ ..++||....... ...+..|+.++..++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34789999999999999855 7899998865433 5678899999999976 59999999988888899999999987
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
.+..+ +......++.+++++|.+||.....+++|+|++|+|||+++.+.++++|||+++...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 76432 456667789999999999998755569999999999999998999999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-15 Score=148.28 Aligned_cols=140 Identities=21% Similarity=0.240 Sum_probs=99.5
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc--cHHH----------------------HHHHHHHHHcCCCCc--e
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ--GIEE----------------------LKNEVLLIAKLQHRN--L 586 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~--~~~~----------------------~~~Ei~~l~~l~H~n--I 586 (695)
.+.||+|+||.||+|...++++||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999987653211 1111 134566666654432 4
Q ss_pred eeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcC
Q 005471 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDE 665 (695)
Q Consensus 587 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~ 665 (695)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 346899999999554221111100 11 4556789999999999998 65 99999999999999
Q ss_pred CCceEEEeeccceeecCCc
Q 005471 666 KMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 666 ~~~~kl~DFGla~~~~~~~ 684 (695)
++.++|+|||+|+.+..++
T Consensus 150 ~~~~~liDfg~a~~~~~~~ 168 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHPN 168 (187)
T ss_pred CCcEEEEECcccccccCcc
Confidence 8999999999998776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.8e-16 Score=156.15 Aligned_cols=146 Identities=29% Similarity=0.404 Sum_probs=117.4
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------e
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------E 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~ 598 (695)
.+|..+..+|.|.- .|..+-. -.++.||+|++... .....+.-.+|..++..+.|+||++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666677888877 4555432 35789999987543 2334566778999999999999999999998654 4
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.|+|||||. .+|...+.. .++..+...|..|++.|+.|||+.+ |+||||||+||++..++.+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 689999995 678777752 2677778889999999999999987 9999999999999999999999999999
Q ss_pred eecCC
Q 005471 679 VFGGE 683 (695)
Q Consensus 679 ~~~~~ 683 (695)
.-+.+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 65443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.3e-16 Score=161.38 Aligned_cols=155 Identities=21% Similarity=0.300 Sum_probs=131.1
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCC------CCceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ------HRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~l~g~~~~~~~~ 599 (695)
-.+|.+....|+|-|++|.+|... .|++||||+|...... .+.=..|+++|.+|. .-++++|+-.|...+++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 456888888999999999999864 4789999999875332 233456999999995 34899999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CceEEEeeccce
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTAR 678 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~ 678 (695)
+||+|-+ .-+|.++|..-.+...|.......++.|+.-||..|-..+ |+|.||||.|||+++. ..+||||||-|.
T Consensus 510 ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 510 CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccc
Confidence 9999987 4789999987776666888888899999999999999887 9999999999999964 678999999999
Q ss_pred eecCCcce
Q 005471 679 VFGGEEIL 686 (695)
Q Consensus 679 ~~~~~~~~ 686 (695)
..+.++..
T Consensus 586 ~~~eneit 593 (752)
T KOG0670|consen 586 FASENEIT 593 (752)
T ss_pred cccccccc
Confidence 88877653
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-15 Score=121.37 Aligned_cols=66 Identities=53% Similarity=1.001 Sum_probs=56.3
Q ss_pred ccCCCcEEEeecccCCCCcccccccCCCChHHHHHHhhccCCccceeccccCCCCCcceeeeccccccc
Q 005471 341 CQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDT 409 (695)
Q Consensus 341 C~~~~~f~~~~~~~~p~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~w~~~l~~~ 409 (695)
|+.+|+|+++++|++|++. ...+..+.++++|++.||+||||+||+|.++. ++.+|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~-~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~--~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFD-NAIVDSSVSLEECEKACLSNCSCTAYAYSNLS--GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCc-ceeeecCCCHHHHHhhcCCCCCEeeEEeeccC--CCCEEEEEcCEeecC
Confidence 5457999999999999987 44455679999999999999999999997644 357899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.6e-14 Score=148.76 Aligned_cols=150 Identities=32% Similarity=0.498 Sum_probs=127.4
Q ss_pred CCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc---cHHHHHHHHHHHHcCCCC-ceeeeEeEEEeCCeeEEEEEc
Q 005471 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ---GIEELKNEVLLIAKLQHR-NLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~Ey 605 (695)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+.+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 456688999999999999887 78999988765332 367889999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-ceEEEeeccceeecCCc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGEE 684 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 684 (695)
+.++++..++........+.......++.|++.++.|+|..+ ++|||+||+||+++... .+|++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966644321124778888999999999999999987 99999999999999988 79999999999775544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.6e-15 Score=154.43 Aligned_cols=134 Identities=25% Similarity=0.355 Sum_probs=109.3
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-----C---CceeeeEeEEEeCC-
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-----H---RNLVKLLGCCLEED- 597 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---~nIv~l~g~~~~~~- 597 (695)
.+|.+.++||-|-|++||++.. .+.+-||+|+.+. ..+..+.-..||++|++++ | ..||+|++.|...+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788899999999999999975 4567899998865 3445566778999999883 3 37999999998744
Q ss_pred ---eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 005471 598 ---ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666 (695)
Q Consensus 598 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~ 666 (695)
+.+||+|++ |-+|..+|.... -+-++.....+|+.||+.||.|||.++ +|||-||||+||||-.+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 789999999 456666665432 234788889999999999999999988 69999999999999643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.4e-14 Score=144.29 Aligned_cols=136 Identities=19% Similarity=0.241 Sum_probs=106.5
Q ss_pred ceee-eeCceeEEEEEcCCCcEEEEEEcccCC-------------cccHHHHHHHHHHHHcCCCCce--eeeEeEEEeCC
Q 005471 534 NKLG-QGGFGPVYKGKLSNGQEIAVKRLSTTS-------------GQGIEELKNEVLLIAKLQHRNL--VKLLGCCLEED 597 (695)
Q Consensus 534 ~~LG-~G~fG~Vy~g~~~~g~~vAvK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~nI--v~l~g~~~~~~ 597 (695)
..|| .|+.|+||+.... +..++||+..... ......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5788 8999999999885 6788998774311 1223467889999999998875 67777755433
Q ss_pred e----eEEEEEcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 598 E----NMLIYEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 598 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
. .++||||+++ .+|.+++... .++.. .+.+|+.+|.+||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 6898887432 23332 4678999999999987 9999999999999998899999
Q ss_pred eeccceeec
Q 005471 673 DFGTARVFG 681 (695)
Q Consensus 673 DFGla~~~~ 681 (695)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998865
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-13 Score=151.58 Aligned_cols=143 Identities=22% Similarity=0.280 Sum_probs=101.2
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccH----------------------------------------HHHHH
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGI----------------------------------------EELKN 573 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~----------------------------------------~~~~~ 573 (695)
+.||.|++|.||+|++.+|+.||||+.++...... -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999999865321100 02344
Q ss_pred HHHHHHcC----CCCceeeeEeEEE-eCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 005471 574 EVLLIAKL----QHRNLVKLLGCCL-EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR-GVLYLHQDS 647 (695)
Q Consensus 574 Ei~~l~~l----~H~nIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 647 (695)
|+..+.++ +|.+-+.+-..+. .....+|||||+++++|.++....... . .+..++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 55555554 2333333333332 244679999999999998876432111 1 23456666666 467788876
Q ss_pred CCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 648 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
++|+|+||.||++++++.++++|||+++.+.++.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~~ 311 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEED 311 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHHH
Confidence 9999999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.2e-14 Score=161.54 Aligned_cols=146 Identities=23% Similarity=0.348 Sum_probs=115.7
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC---CCceeeeEeEEEeCCeeEEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV 602 (695)
..+.|.+.+.||+|+||+||+|...+|+.||+|.-+...... |.-=.+++.+|+ -+-|+.+..+..-.+.-+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 345677889999999999999999889999999877654332 111122233333 23455666666677888999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-------CCCceEEEeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-------EKMNPRISDFG 675 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-------~~~~~kl~DFG 675 (695)
+||.+.|+|.+++. ..+.++|...+.++.|+++-++.||..+ |||+||||+|.||. +...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999985 4456899999999999999999999987 99999999999994 34569999999
Q ss_pred cceee
Q 005471 676 TARVF 680 (695)
Q Consensus 676 la~~~ 680 (695)
-|.-|
T Consensus 847 ~siDm 851 (974)
T KOG1166|consen 847 RSIDM 851 (974)
T ss_pred cceee
Confidence 98755
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.8e-13 Score=112.70 Aligned_cols=71 Identities=25% Similarity=0.408 Sum_probs=62.0
Q ss_pred ccCCCcEEEeecccCCCCcccccccCCCChHHHHHHhhc---cCCccceeccccCCCCCcceeeecccc-ccceeeccCC
Q 005471 341 CQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLS---NCSCVAYASASAETNRGIGCLMYHGDL-NDTRKYTNAG 416 (695)
Q Consensus 341 C~~~~~f~~~~~~~~p~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~~~~~~~~~C~~w~~~l-~~~r~~~~~~ 416 (695)
|..+.+|+++.+|++|++. . .++++|+++|++ ||||+||+|.+. +.+|++|.++| .|++.++..+
T Consensus 5 ~~~~g~fl~~~~~klpd~~-~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~----~~gC~~W~~~l~~d~~~~~~~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTK-A------NTADECANRCEKNGLPFSCKAFVFAKA----RKQCLWFPFNSMSGVRKEFSHG 73 (80)
T ss_pred eecCCeEEEeecccCCccc-c------cCHHHHHHHHhcCCCCCCceeeeccCC----CCCeEEecCcchhhHHhccCCC
Confidence 4556789999999999887 2 689999999999 999999999753 35899999999 9999888888
Q ss_pred cchhhh
Q 005471 417 QDLFVR 422 (695)
Q Consensus 417 ~~~yvr 422 (695)
.++|+|
T Consensus 74 ~~Ly~r 79 (80)
T cd00129 74 FDLYEN 79 (80)
T ss_pred ceeEeE
Confidence 999987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.1e-12 Score=119.84 Aligned_cols=131 Identities=21% Similarity=0.167 Sum_probs=98.1
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCcee-eeEeEEEeCCeeEEEEEcCCCCCHH
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV-KLLGCCLEEDENMLIYEFMPNKSLD 612 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 612 (695)
+.|+.|.++.||+++.. ++.+++|....... ....+..|++++..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 67899999999999875 77899998754321 233567899999988665554 455443 33468999999998875
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS--RLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
.. . . ....++.+++++|..||... +..++|+|++|.||+++ ++.++++|||.|..-
T Consensus 80 ~~-------~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TE-------D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cc-------c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 32 0 0 01235678999999999876 33469999999999999 668999999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.7e-12 Score=143.31 Aligned_cols=148 Identities=18% Similarity=0.215 Sum_probs=94.1
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcc----------------------------------cHH---
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQ----------------------------------GIE--- 569 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~----------------------------------~~~--- 569 (695)
..|+. +.||.|++|.||+|++++ |++||||++++.... ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44665 789999999999999987 999999998754110 001
Q ss_pred ---HHHHHHHHHHcC----CCCceeeeEeEEEe-CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHH-H
Q 005471 570 ---ELKNEVLLIAKL----QHRNLVKLLGCCLE-EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG-V 640 (695)
Q Consensus 570 ---~~~~Ei~~l~~l----~H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L 640 (695)
++.+|+.-+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++..-.... .+.. .++...++. +
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHHH
Confidence 133344444443 24444443343333 34678999999999997642111111 1111 122221111 1
Q ss_pred HHHHhCCCCCeEecCCCCCCEEEcCCC----ceEEEeeccceeecCCc
Q 005471 641 LYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFGTARVFGGEE 684 (695)
Q Consensus 641 ~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGla~~~~~~~ 684 (695)
.-++..+ ++|+|+||.||+++.++ .+++.|||++..+.++.
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~~ 318 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKED 318 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHHH
Confidence 2233444 99999999999999888 99999999999886543
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.9e-12 Score=106.54 Aligned_cols=80 Identities=41% Similarity=0.852 Sum_probs=64.2
Q ss_pred CCccccCC---CcEEEeecccCCCCcccccccCCCChHHHHHHhhccCCccceeccccCCCCCcceeeeccccccceeec
Q 005471 337 GTSTCQKG---EGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYT 413 (695)
Q Consensus 337 ~l~~C~~~---~~f~~~~~~~~p~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~w~~~l~~~r~~~ 413 (695)
+++ |... +.|+.++++++|+..+. . ..+++++|++.|++||+|+||+|.+ ++.+|++|.+.+.+.+...
T Consensus 2 ~~~-C~~~~~~~~f~~~~~~~~~~~~~~--~-~~~s~~~C~~~Cl~nCsC~a~~~~~----~~~~C~~~~~~~~~~~~~~ 73 (84)
T cd01098 2 PLN-CGGDGSTDGFLKLPDVKLPDNASA--I-TAISLEECREACLSNCSCTAYAYNN----GSGGCLLWNGLLNNLRSLS 73 (84)
T ss_pred Ccc-cCCCCCCCEEEEeCCeeCCCchhh--h-ccCCHHHHHHHHhcCCCcceeeecC----CCCeEEEEeceecceEeec
Confidence 344 7543 68999999999987632 2 6789999999999999999999975 2458999999999987655
Q ss_pred cCCcchhhhhh
Q 005471 414 NAGQDLFVRAN 424 (695)
Q Consensus 414 ~~~~~~yvr~~ 424 (695)
..+..+|||++
T Consensus 74 ~~~~~~yiKv~ 84 (84)
T cd01098 74 SGGGTLYLRLA 84 (84)
T ss_pred CCCcEEEEEeC
Confidence 55688999873
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.6e-11 Score=146.56 Aligned_cols=95 Identities=20% Similarity=0.298 Sum_probs=74.2
Q ss_pred cCCC-CceeeeEeEE-------EeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005471 580 KLQH-RNLVKLLGCC-------LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651 (695)
Q Consensus 580 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 651 (695)
.++| +||++++++| .+.+..++++||+ .++|.++|... ...+++...+.|+.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5888888887 3334567888987 56999999643 234899999999999999999999987 9
Q ss_pred EecCCCCCCEEEcC-------------------CCceEEEeeccceee
Q 005471 652 IHRDLKASNILLDE-------------------KMNPRISDFGTARVF 680 (695)
Q Consensus 652 iHrDlkp~NILl~~-------------------~~~~kl~DFGla~~~ 680 (695)
|||||||+||||+. ++.+||+|||+++..
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~ 149 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRRE 149 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccc
Confidence 99999999999954 455667777777653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.6e-10 Score=113.18 Aligned_cols=143 Identities=17% Similarity=0.232 Sum_probs=110.1
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCC--CceeeeEeEEEeCC---eeEEEEEcCC
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQH--RNLVKLLGCCLEED---ENMLIYEFMP 607 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~Ey~~ 607 (695)
+.|+.|..+.||+++..+|+.+++|....... ....++..|++++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999987778999998765322 135678899999999975 45677888766543 5689999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS---------------------------------------- 647 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 647 (695)
+.++...+.. ..++...+..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888654421 23566677778888888888888521
Q ss_pred -------------CCCeEecCCCCCCEEEcC--CCceEEEeeccceee
Q 005471 648 -------------RLRIIHRDLKASNILLDE--KMNPRISDFGTARVF 680 (695)
Q Consensus 648 -------------~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~ 680 (695)
+..++|+|++|.|||++. +..+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245899999999999998 677899999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.6e-11 Score=136.05 Aligned_cols=144 Identities=28% Similarity=0.364 Sum_probs=109.5
Q ss_pred ccceeeeeCceeEEEEEcC-CCcEEEEEEcc----cC-Cc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 532 TSNKLGQGGFGPVYKGKLS-NGQEIAVKRLS----TT-SG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~----~~-~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
..+.+|.|++|.|+..... ..+..+.|... .. .. .....+..|..+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3478999999977776532 22333333221 11 11 111225567778888999999988888887777777799
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|++. +|..++... ..+.-.++..++.|+..|+.|||..+ |.|||||++|+|+..++.+||+|||.+..+.-
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 998888654 23566677789999999999999988 99999999999999999999999999998743
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-09 Score=106.72 Aligned_cols=138 Identities=14% Similarity=0.131 Sum_probs=98.6
Q ss_pred ceeeeeCceeEEEEEcCC-------CcEEEEEEcccCC----------------------cccHHHHH----HHHHHHHc
Q 005471 534 NKLGQGGFGPVYKGKLSN-------GQEIAVKRLSTTS----------------------GQGIEELK----NEVLLIAK 580 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-------g~~vAvK~l~~~~----------------------~~~~~~~~----~Ei~~l~~ 580 (695)
..||.|.-+.||.|.-.+ +..+|||..+... ....+.++ +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999997653 4799999654210 00122333 79999988
Q ss_pred CC--CCceeeeEeEEEeCCeeEEEEEcCCCCCHHH-HHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCC
Q 005471 581 LQ--HRNLVKLLGCCLEEDENMLIYEFMPNKSLDY-FIFDESRKQLLDWKKRFDIILGIARGVLYL-HQDSRLRIIHRDL 656 (695)
Q Consensus 581 l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDl 656 (695)
+. .-++.+++++ ...+|||||+.+..+.. .+.+ ..++......+..+++.+|..| |..+ |||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 85 3566666664 56789999998654422 2211 1234445567789999999999 7766 999999
Q ss_pred CCCCEEEcCCCceEEEeeccceeecCC
Q 005471 657 KASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 657 kp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++.|||+++ +.+.|+|||.|......
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~hp 177 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCCCC
Confidence 999999974 68999999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-09 Score=102.59 Aligned_cols=137 Identities=22% Similarity=0.286 Sum_probs=103.3
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEE-cccCC-------cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKR-LSTTS-------GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~-l~~~~-------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
..+.+|+-..+|.+.+.+ .++.+|. +.+.- ....+...+|+.+|.+++--.|..-+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 467899999999997753 4455553 32211 01123566899999998766665555566788888999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
+++-.|.+.+... +..++..|-.-+.-||..+ |+|+||.++||++..+. +.++||||++.-...+.
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~Ed 146 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVED 146 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccHHh
Confidence 9999998888433 2457788888889999987 99999999999999775 99999999996544443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.5e-11 Score=132.38 Aligned_cols=145 Identities=26% Similarity=0.293 Sum_probs=116.3
Q ss_pred eeeeeCceeEEEEE----cCCCcEEEEEEcccCCcc--cHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 535 KLGQGGFGPVYKGK----LSNGQEIAVKRLSTTSGQ--GIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~----~~~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
.+|+|.||.|+.++ ...+..+|+|.+++.... .......|..++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999764 345678899988764321 1114456888899997 9999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
+|.|...+... ...+......+...++-+++++|... |+|||+|++||+++.+|.+|+.|||+++..-..+.
T Consensus 81 gg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99997766432 23455555556778999999999987 99999999999999999999999999998765443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.4e-09 Score=99.38 Aligned_cols=150 Identities=25% Similarity=0.285 Sum_probs=110.1
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEE-cccC-------CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKR-LSTT-------SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~-l~~~-------~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
....|-||+-+.|+++.++ |+...||. ..+. .....+..++|++++++++--.|..-.-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999985 67767774 3221 1123456778999999987666666556677778889999
Q ss_pred EcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---eEEEeecccee
Q 005471 604 EFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDFGTARV 679 (695)
Q Consensus 604 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~ 679 (695)
||+++ .++.+++.........+. .....+..|-+.+.-||... |||+||..+||+|..++. +-++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~-~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDE-GLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccch-hHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99986 467777765433322222 22568889999999999988 999999999999975543 57999999986
Q ss_pred ecCCcce
Q 005471 680 FGGEEIL 686 (695)
Q Consensus 680 ~~~~~~~ 686 (695)
-..++.+
T Consensus 166 s~~~EDK 172 (229)
T KOG3087|consen 166 SRLPEDK 172 (229)
T ss_pred ccCcccc
Confidence 5544443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2e-10 Score=112.72 Aligned_cols=138 Identities=25% Similarity=0.458 Sum_probs=113.1
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
...+|.+.-.|+.|+|++. |..+++|++... ...-.+.|..|.-.|+-..||||+.++|.|..+.+..++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3467888889999999996 455666766532 2233457888888899899999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
+|...|++.. .-..+-.+..+++.+||+||+|||+..+ -|..--|.+..+++|++.+++|+
T Consensus 273 slynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 273 SLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee
Confidence 9999997654 3456788889999999999999999863 25555688999999999998884
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.9e-09 Score=106.25 Aligned_cols=147 Identities=24% Similarity=0.346 Sum_probs=96.5
Q ss_pred ccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCC----------CceeeeEeEEE---
Q 005471 532 TSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH----------RNLVKLLGCCL--- 594 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H----------~nIv~l~g~~~--- 594 (695)
..+.||.|+++.||.++.. +++++|||..... .....+++++|...+..+.+ -.++--++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3478999999999999985 4899999976432 23446777777766655433 12222122211
Q ss_pred ------eCC--------eeEEEEEcCCCCCHHHHHhc---cCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 005471 595 ------EED--------ENMLIYEFMPNKSLDYFIFD---ESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL 656 (695)
Q Consensus 595 ------~~~--------~~~lV~Ey~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl 656 (695)
... +.+++|+-+ -++|..++.. ... ...+....++.+-.|+++.+++||..+ ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 111 235677777 4788777532 211 123455667778899999999999998 999999
Q ss_pred CCCCEEEcCCCceEEEeeccceeecC
Q 005471 657 KASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 657 kp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+|++++++|.++|.||+.....+.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc
Confidence 99999999999999999998887654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3e-09 Score=116.22 Aligned_cols=100 Identities=30% Similarity=0.517 Sum_probs=90.3
Q ss_pred HHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 005471 578 IAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 657 (695)
Q Consensus 578 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 657 (695)
|+.+.|.|+.+++|.+.++...+.|.+|++.|+|.+.+..... .++|.-...++++|++||.|||.-. . ..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 3568999999999999999999999999999999999976433 4899999999999999999999854 2 3999999
Q ss_pred CCCEEEcCCCceEEEeeccceeec
Q 005471 658 ASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 658 p~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++|+++|....+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-07 Score=96.96 Aligned_cols=141 Identities=18% Similarity=0.129 Sum_probs=99.4
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCc-----------ccHHHHHHHHHHHHcCCC--CceeeeEeEEEe-----
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG-----------QGIEELKNEVLLIAKLQH--RNLVKLLGCCLE----- 595 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~-----------~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~----- 595 (695)
+.+-+-.-..|++.++ +|+.+.||+...... .....+.+|...+.++.. -....++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444444677766 577899997643221 111247788888888743 333455556543
Q ss_pred CCeeEEEEEcCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-------CC
Q 005471 596 EDENMLIYEFMPNK-SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-------KM 667 (695)
Q Consensus 596 ~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-------~~ 667 (695)
....+||+|++++- +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23468999999986 7988874321 122445666789999999999999998 999999999999985 57
Q ss_pred ceEEEeecccee
Q 005471 668 NPRISDFGTARV 679 (695)
Q Consensus 668 ~~kl~DFGla~~ 679 (695)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999999965
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.1e-09 Score=125.49 Aligned_cols=142 Identities=17% Similarity=0.228 Sum_probs=110.8
Q ss_pred CCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC-cccHHHHHHHHHH--HHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS-GQGIEELKNEVLL--IAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~--l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++...+.||++.|=+|.+++.++|. |+||++-+.. ....+.|+++++- ...++|||.+.+.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4556689999999999999998887 8899876554 3445555544443 4556899999988776666677888888
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.. -+|.+.|. .++.|...+..-|+.|++.||.-+|..+ |.|+|||.+||||+.=.-+.|+||.--|
T Consensus 103 vk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 75 35666552 2344556666679999999999999987 9999999999999998899999997765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.6e-08 Score=95.05 Aligned_cols=128 Identities=25% Similarity=0.305 Sum_probs=82.9
Q ss_pred eEEEEEcCCCcEEEEEEcccCC--------------c------------ccHHHHHHHHHHHHcCCCC--ceeeeEeEEE
Q 005471 543 PVYKGKLSNGQEIAVKRLSTTS--------------G------------QGIEELKNEVLLIAKLQHR--NLVKLLGCCL 594 (695)
Q Consensus 543 ~Vy~g~~~~g~~vAvK~l~~~~--------------~------------~~~~~~~~Ei~~l~~l~H~--nIv~l~g~~~ 594 (695)
.||.|...+|.++|||.-+... . ......++|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999899999999654210 0 0122456799999999765 56666654
Q ss_pred eCCeeEEEEEcCC--CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEEEcCCCceEE
Q 005471 595 EEDENMLIYEFMP--NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL-HQDSRLRIIHRDLKASNILLDEKMNPRI 671 (695)
Q Consensus 595 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp~NILl~~~~~~kl 671 (695)
....|||||++ +..+..+.... +.......++.+++..+..+ |..+ |||+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 25589999998 55554433211 11122345677777766664 5665 9999999999999988 9999
Q ss_pred EeeccceeecCC
Q 005471 672 SDFGTARVFGGE 683 (695)
Q Consensus 672 ~DFGla~~~~~~ 683 (695)
+|||.|.....+
T Consensus 148 IDf~qav~~~~p 159 (188)
T PF01163_consen 148 IDFGQAVDSSHP 159 (188)
T ss_dssp --GTTEEETTST
T ss_pred EecCcceecCCc
Confidence 999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.7e-08 Score=104.35 Aligned_cols=89 Identities=24% Similarity=0.457 Sum_probs=67.8
Q ss_pred CCCceeeeEeEEEeC---------------------------CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHH
Q 005471 582 QHRNLVKLLGCCLEE---------------------------DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 634 (695)
Q Consensus 582 ~H~nIv~l~g~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 634 (695)
+|||||++.++|.+. ...|+||.-.+ -+|.+++.... .+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 699999999988652 12467877654 57777775432 33445556889
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCC--ceEEEeeccce
Q 005471 635 GIARGVLYLHQDSRLRIIHRDLKASNILLD--EKM--NPRISDFGTAR 678 (695)
Q Consensus 635 ~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~--~~kl~DFGla~ 678 (695)
|+++|+.|||.++ |.|||||++||||. +|. .+.|+|||.+-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999987 99999999999994 443 46789999863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.2e-09 Score=120.20 Aligned_cols=151 Identities=25% Similarity=0.339 Sum_probs=118.1
Q ss_pred CCCCccceeeeeCceeEEEEEcCC--CcEEEEEEcccCC--cccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN--GQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~--g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 602 (695)
..|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 346667889999999998876533 3456777665432 233344556777777776 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCEEEcCCC-ceEEEeeccceee
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH-QDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVF 680 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 680 (695)
.||..++++...+..... ...+....-.+..|+..++.|+| ..+ +.|||+||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999877732111 12344455568999999999999 666 99999999999999999 9999999999988
Q ss_pred cC
Q 005471 681 GG 682 (695)
Q Consensus 681 ~~ 682 (695)
..
T Consensus 176 ~~ 177 (601)
T KOG0590|consen 176 RN 177 (601)
T ss_pred cc
Confidence 76
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.9e-07 Score=97.08 Aligned_cols=140 Identities=22% Similarity=0.310 Sum_probs=111.8
Q ss_pred eeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe----CCeeEEEEEcCCC-CCHHHHH
Q 005471 542 GPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENMLIYEFMPN-KSLDYFI 615 (695)
Q Consensus 542 G~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~l 615 (695)
.+.||+.. .||..|..||+.....+.......-+++++++.|+|||.|..++.. +...+|||+|.|+ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56788864 4799999999954433333334456888999999999999999884 3457899999985 6676665
Q ss_pred hccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 616 FDES------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 616 ~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+... .....++...+.++.|++.||.++|+.+ +.-+-|.|++||++.+.+++|+..|+..++..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 1234678889999999999999999987 777999999999999999999999999998877
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
+
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 6
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.1e-07 Score=100.03 Aligned_cols=121 Identities=17% Similarity=0.242 Sum_probs=97.6
Q ss_pred CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHH
Q 005471 550 SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKR 629 (695)
Q Consensus 550 ~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~ 629 (695)
.++.+|.|...+.......+...+-++.|+.++||||++++......+..|||+|-+. .|..++.... ....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------KEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------HHHH
Confidence 4677888887766544334557788899999999999999999999999999999874 5666664332 2233
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 630 ~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
.-.+.||+.||.|||+.+ .++|++|.-..|++++.|+.||.+|-++...
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 346789999999999776 4999999999999999999999999888654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.5e-06 Score=86.43 Aligned_cols=108 Identities=24% Similarity=0.267 Sum_probs=84.2
Q ss_pred HHHHHHHHHHHHcCC--CCceeeeEeEEEeCC----eeEEEEEcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 005471 568 IEELKNEVLLIAKLQ--HRNLVKLLGCCLEED----ENMLIYEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640 (695)
Q Consensus 568 ~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 640 (695)
.....+|...+..+. .-...+.+++..... ..+||+|++++ -+|.+++..... ++...+..++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 345677888777774 344556677766533 34899999987 479888865322 44556678999999999
Q ss_pred HHHHhCCCCCeEecCCCCCCEEEcCCC---ceEEEeeccceeec
Q 005471 641 LYLHQDSRLRIIHRDLKASNILLDEKM---NPRISDFGTARVFG 681 (695)
Q Consensus 641 ~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~~~ 681 (695)
.-||+.+ |+|+|+++.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999998 99999999999999887 89999999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.8e-07 Score=100.12 Aligned_cols=143 Identities=18% Similarity=0.226 Sum_probs=93.1
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc--------------------------c----HHH----------HHH
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ--------------------------G----IEE----------LKN 573 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~--------------------------~----~~~----------~~~ 573 (695)
+.|+.++-|.||+|++++|++||||+.++.-.. . .++ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 789999999999999999999999987653111 0 011 223
Q ss_pred HHHHHHcC----C-CCceeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCC
Q 005471 574 EVLLIAKL----Q-HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL-YLHQDS 647 (695)
Q Consensus 574 Ei~~l~~l----~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~ 647 (695)
|..-+.++ + .+++.--.=+..-.....|+|||++|-.+.+...... ...+-+. |+..++++.- -+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 44434333 2 3443322223333567899999999999988753222 1234222 3333333221 122233
Q ss_pred CCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 648 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
++|.|.+|.||+++.++.+-+.|||+...+.++.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 9999999999999999999999999999886543
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.44 E-value=5.7e-07 Score=80.34 Aligned_cols=87 Identities=29% Similarity=0.470 Sum_probs=60.6
Q ss_pred eEEEEecCCeeeeccC-CCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccCC
Q 005471 88 VLSVNIQGNLVLHERN-QSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (695)
Q Consensus 88 ~l~~~~~G~l~l~~~~-~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (695)
.+.++.||+||+++.. +. ++|++++.........+.|+++|||||++. .+.++|+| +|
T Consensus 23 ~~~~q~dgnlV~~~~~~~~--~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S-----~t------------- 81 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRT--VVWVANRDNPVSDSCTLTLQSDGNLVLYDG-DGRVVWSS-----NT------------- 81 (114)
T ss_pred ccCCCCCEEEEEEECCCCc--EEEECCCCCCCCCCEEEEEeCCCCEEEEeC-CCCEEEEe-----cc-------------
Confidence 3445679999999765 35 899999753323346789999999999986 46789997 11
Q ss_pred CceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcC-CeeEEEe
Q 005471 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKD-DVKLWRA 210 (695)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~-~~~y~~~ 210 (695)
....|.|.+.++++|...+ ++. ..+.|.+
T Consensus 82 -------------~~~~~~~~~~L~ddGnlvl--~~~~~~~~W~S 111 (114)
T smart00108 82 -------------TGANGNYVLVLLDDGNLVI--YDSDGNFLWQS 111 (114)
T ss_pred -------------cCCCCceEEEEeCCCCEEE--ECCCCCEEeCC
Confidence 0134567888999998544 432 3567765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.8e-06 Score=86.61 Aligned_cols=139 Identities=22% Similarity=0.219 Sum_probs=95.3
Q ss_pred CCccceeeeeCceeEEEEEcCCCcEEEEEEcccC--------------------C--cccHHHHHHHHHHHHcCCCC--c
Q 005471 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--------------------S--GQGIEELKNEVLLIAKLQHR--N 585 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~--------------------~--~~~~~~~~~Ei~~l~~l~H~--n 585 (695)
..+.++||-|.-+.||.|..+.|.++|||.-+.. + .......++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3455899999999999999999999999943211 0 00122356799999998654 6
Q ss_pred eeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 005471 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 665 (695)
Q Consensus 586 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~ 665 (695)
|.+.+++ +...+||||+++-.|...- ++-...-.|+..|++-+.-+-..+ |||+|+.+=|||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666654 4568999999987664321 111112223344444333333444 999999999999999
Q ss_pred CCceEEEeeccceeecCC
Q 005471 666 KMNPRISDFGTARVFGGE 683 (695)
Q Consensus 666 ~~~~kl~DFGla~~~~~~ 683 (695)
++.+.++||--+...+.+
T Consensus 238 dg~~~vIDwPQ~v~~~hp 255 (304)
T COG0478 238 DGDIVVIDWPQAVPISHP 255 (304)
T ss_pred CCCEEEEeCcccccCCCC
Confidence 999999999887765433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2e-07 Score=102.13 Aligned_cols=151 Identities=21% Similarity=0.299 Sum_probs=119.2
Q ss_pred CCCccceeee--eCceeEEEEEc---CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeE
Q 005471 529 NFSTSNKLGQ--GGFGPVYKGKL---SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 529 ~f~~~~~LG~--G~fG~Vy~g~~---~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 600 (695)
.|...+.+|. |.+|.||.+.. .++..+|+|+-+.. ..+....=.+|+...++++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556688999 99999999987 35788999974332 2232233346777777774 999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCEEEcCC-CceEEEeec
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR----GVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFG 675 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFG 675 (695)
+-+|++. .+|..+.+.... .++......+..+..+ ||.++|... |+|-|+||.||++.++ ..+++.|||
T Consensus 195 iqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999985 778777754332 3555666667777777 999999987 9999999999999999 999999999
Q ss_pred cceeecCCcc
Q 005471 676 TARVFGGEEI 685 (695)
Q Consensus 676 la~~~~~~~~ 685 (695)
+...++....
T Consensus 269 ~v~~i~~~~~ 278 (524)
T KOG0601|consen 269 LVSKISDGNF 278 (524)
T ss_pred eeEEccCCcc
Confidence 9999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-07 Score=102.87 Aligned_cols=148 Identities=24% Similarity=0.286 Sum_probs=119.3
Q ss_pred hcCCCCccceeeeeCceeEEEEEc--CCCcEEEEEEcccCCcccHHHH--HHHHHHHHcC-CCCceeeeEeEEEeCCeeE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL--SNGQEIAVKRLSTTSGQGIEEL--KNEVLLIAKL-QHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~g~~vAvK~l~~~~~~~~~~~--~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 600 (695)
.+.+|..+..||.|.|+.|++... .++..+++|.+.+.......++ ..|+.+...+ .|.++++....+.+..+.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 456788889999999999999864 3577899998766543333332 3466666666 5899999888888888889
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CceEEEeecccee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARV 679 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~ 679 (695)
+--||++++++...+ .-...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999987665 22334777888899999999999999876 9999999999999876 8899999999864
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.2e-06 Score=78.59 Aligned_cols=88 Identities=30% Similarity=0.453 Sum_probs=61.1
Q ss_pred EEEEe-cCCeeeeccC-CCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccCC
Q 005471 89 LSVNI-QGNLVLHERN-QSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (695)
Q Consensus 89 l~~~~-~G~l~l~~~~-~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (695)
+.++. ||+|++++.. +. ++|++|+.........+.|.++|||||++. .+.++|+|=-
T Consensus 24 ~~~q~~dgnlv~~~~~~~~--~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S~~------------------ 82 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRT--VVWVANRDNPSGSSCTLTLQSDGNLVIYDG-SGTVVWSSNT------------------ 82 (116)
T ss_pred CCCCCCeEEEEEEeCCCCe--EEEECCCCCCCCCCEEEEEecCCCeEEEcC-CCcEEEEecc------------------
Confidence 34455 8999999765 35 899999863223456789999999999986 4678998710
Q ss_pred CceeeEEEccCCCCCCCcceeeeecCCCCCceEEEc-CCeeEEEeCC
Q 005471 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYK-DDVKLWRAGP 212 (695)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~-~~~~y~~~g~ 212 (695)
....+.+.+.|+++|... +++ ...+.|.+..
T Consensus 83 -------------~~~~~~~~~~L~ddGnlv--l~~~~~~~~W~Sf~ 114 (116)
T cd00028 83 -------------TRVNGNYVLVLLDDGNLV--LYDSDGNFLWQSFD 114 (116)
T ss_pred -------------cCCCCceEEEEeCCCCEE--EECCCCCEEEcCCC
Confidence 012467888899999844 443 2456787643
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.6e-07 Score=104.46 Aligned_cols=111 Identities=25% Similarity=0.406 Sum_probs=76.9
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
..+|..+++|-.|+||.||..+++. .+.+|+| +.+..- -+++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc---cccccCCccee------------------
Confidence 3578888999999999999998864 5678884 332110 0111 23333444444
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|+-...++.... ++- +++.+++|||+.+ |+|||+||+|.||..-|.+|++||||+++.
T Consensus 136 ---gDc~tllk~~g~---lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP---LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhcccCCC---Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 444444432211 211 2378999999987 999999999999999999999999999864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.5e-05 Score=78.09 Aligned_cols=141 Identities=16% Similarity=0.130 Sum_probs=103.3
Q ss_pred eeeeeCceeEEEEEcCCCcEEEEEEcccCC------cccHHHHHHHHHHHHcCC--CCceeeeEeEEEeCC----eeEEE
Q 005471 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTS------GQGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEED----ENMLI 602 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~------~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~----~~~lV 602 (695)
--|+||.+.|++-.+. |+.+-+|+-...- +.+...|.+|...|.+|. .-.+.+...+..... ..+||
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 3467899999998875 4478899865221 345678999999999885 333455553222222 35899
Q ss_pred EEcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--eEEEeecccee
Q 005471 603 YEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN--PRISDFGTARV 679 (695)
Q Consensus 603 ~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~ 679 (695)
+|-+++ -+|.+++.+... ...+...+..+..+|++.+.-||..+ +.|+|+-+.|||++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 678888754322 23466677789999999999999988 999999999999986666 99999987765
Q ss_pred e
Q 005471 680 F 680 (695)
Q Consensus 680 ~ 680 (695)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-05 Score=81.36 Aligned_cols=139 Identities=17% Similarity=0.195 Sum_probs=85.6
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCc--eeeeEeEEEeCCeeEEEEEcCCCCC-
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGCCLEEDENMLIYEFMPNKS- 610 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gs- 610 (695)
.+||+|..+.||+. .+..+++|..... .......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 68999999999984 2456778876542 23456788999998886443 3567777777777789999999863
Q ss_pred HHHHH---------------------hccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHh-CCCCCeEecCC
Q 005471 611 LDYFI---------------------FDESRKQLLDWKKRFD-IIL----------GIAR-GVLYLHQ-DSRLRIIHRDL 656 (695)
Q Consensus 611 L~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~-~~~~~iiHrDl 656 (695)
+...+ +.... .......+.. +-. .+.+ ...+|.. ..+..++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 11000 0011111000 000 0111 1222221 12335789999
Q ss_pred CCCCEEEcCCCceEEEeecccee
Q 005471 657 KASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 657 kp~NILl~~~~~~kl~DFGla~~ 679 (695)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.22 E-value=3e-06 Score=81.48 Aligned_cols=62 Identities=23% Similarity=0.188 Sum_probs=53.7
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+|.+++... ...++|..+..|+.||++||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 6888888643 235899999999999999999999874 999999999999999 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.2e-06 Score=70.60 Aligned_cols=73 Identities=34% Similarity=0.724 Sum_probs=54.3
Q ss_pred CCcEEEeecccCCCCcccccccCCCChHHHHHHhhc-cCCccceeccccCCCCCcceeeec-cccccceeeccCCcchhh
Q 005471 344 GEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLS-NCSCVAYASASAETNRGIGCLMYH-GDLNDTRKYTNAGQDLFV 421 (695)
Q Consensus 344 ~~~f~~~~~~~~p~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~~~~~~~~~~C~~w~-~~l~~~r~~~~~~~~~yv 421 (695)
...|..++++.+++.. .. .....++++|++.|++ +|+|.||.|.+ ++.+|.+|. +.+.+.......+.++|.
T Consensus 3 ~~~f~~~~~~~l~~~~-~~-~~~~~s~~~C~~~C~~~~~~C~s~~y~~----~~~~C~l~~~~~~~~~~~~~~~~~~~y~ 76 (78)
T smart00473 3 DDCFVRLPNTKLPGFS-RI-VISVASLEECASKCLNSNCSCRSFTYNN----GTKGCLLWSESSLGDARLFPSGGVDLYE 76 (78)
T ss_pred CceeEEecCccCCCCc-ce-eEcCCCHHHHHHHhCCCCCceEEEEEcC----CCCEEEEeeCCccccceecccCCceeEE
Confidence 3569999999999655 22 2456799999999999 99999999974 245899999 777777644444455554
Q ss_pred h
Q 005471 422 R 422 (695)
Q Consensus 422 r 422 (695)
|
T Consensus 77 ~ 77 (78)
T smart00473 77 K 77 (78)
T ss_pred e
Confidence 3
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.14 E-value=8.6e-06 Score=79.47 Aligned_cols=106 Identities=23% Similarity=0.241 Sum_probs=83.6
Q ss_pred HHHHHHHHcCCC-CceeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 005471 572 KNEVLLIAKLQH-RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650 (695)
Q Consensus 572 ~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 650 (695)
..|..++..+++ +++.+++|.| ..++|.||.+.+++.........-...+|..|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 6999999999 45889999997765321000011123589999999999999999999865556
Q ss_pred eEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 651 IIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 651 iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+.-.|++|+|+-+++++.+|++|...+-...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999998876553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.6e-06 Score=88.09 Aligned_cols=97 Identities=25% Similarity=0.303 Sum_probs=79.5
Q ss_pred HHHHHcCCCCceeeeEeEEEeCC-----eeEEEEEcCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005471 575 VLLIAKLQHRNLVKLLGCCLEED-----ENMLIYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSR 648 (695)
Q Consensus 575 i~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 648 (695)
..-|-.+.|.|||+++.|+.+.. +..+++|||..|++..+|++..+ ...+......+++.||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 44456677999999999987644 46899999999999999976543 234555666679999999999999976
Q ss_pred CCeEecCCCCCCEEEcCCCceEEE
Q 005471 649 LRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 649 ~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
++|+|+++.-+-|++..++-+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred CccccCCcchhheeecCCceEEec
Confidence 679999999999999999888874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1e-05 Score=90.04 Aligned_cols=142 Identities=16% Similarity=0.220 Sum_probs=88.2
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCccc---------------------------HH----------HHHHHHH
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG---------------------------IE----------ELKNEVL 576 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~---------------------------~~----------~~~~Ei~ 576 (695)
+.||.-+.|.||+|++++|+.||||+.++.-... .+ .|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999866531110 00 1223333
Q ss_pred HH----HcCCCCc---eeeeEeEEEe-CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005471 577 LI----AKLQHRN---LVKLLGCCLE-EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648 (695)
Q Consensus 577 ~l----~~l~H~n---Iv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 648 (695)
-. ..+.|-+ =|.+=.++.+ ...+.|+||||+|..+.+...-... .++-. .|+..+.++...+=- .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~---~i~~~l~~~~~~qIf--~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPH---DILNKLVEAYLEQIF--K 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHH---HHHHHHHHHHHHHHH--h
Confidence 22 2334555 1112222222 3467999999999888666432221 13333 344333333322111 1
Q ss_pred CCeEecCCCCCCEEEcC----CCceEEEeeccceeecC
Q 005471 649 LRIIHRDLKASNILLDE----KMNPRISDFGTARVFGG 682 (695)
Q Consensus 649 ~~iiHrDlkp~NILl~~----~~~~kl~DFGla~~~~~ 682 (695)
.+++|+|-+|.||++.. +..+.+-|||+.+.+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 13999999999999993 67899999999987754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.3e-05 Score=78.82 Aligned_cols=141 Identities=16% Similarity=0.159 Sum_probs=86.7
Q ss_pred eeeeeCc-eeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEcCCCCCHH
Q 005471 535 KLGQGGF-GPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (695)
Q Consensus 535 ~LG~G~f-G~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 612 (695)
.|-.|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4445555 789999775 4678888775432 345677888888873 444567788777666789999999998876
Q ss_pred HHH-------------------hccCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 005471 613 YFI-------------------FDESR-KQLLD--WKKRFDIIL--------------------GIARGVLYLHQ----D 646 (695)
Q Consensus 613 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~ 646 (695)
... +.... ..... ...+..... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 11000 00011 001110000 01111222211 1
Q ss_pred CCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 647 ~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
.++.++|+|+.|.|||++++....|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999988889999998874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.4e-05 Score=76.67 Aligned_cols=145 Identities=19% Similarity=0.199 Sum_probs=87.0
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCC--ceeeeEeEEEeC---CeeEEEEEcCC
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR--NLVKLLGCCLEE---DENMLIYEFMP 607 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~g~~~~~---~~~~lV~Ey~~ 607 (695)
++.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... -+.+++...... ...+++||+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999877 68999986543 4556788898888887533 355677655333 34689999999
Q ss_pred CCCHHH----------------HH---hcc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 005471 608 NKSLDY----------------FI---FDE-SRKQLLDWKKR---------FDI------------ILGIAR-GVLYLHQ 645 (695)
Q Consensus 608 ~gsL~~----------------~l---~~~-~~~~~l~~~~~---------~~i------------~~~ia~-gL~yLH~ 645 (695)
+..+.. .+ +.. .......+... ... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 01011111110 000 011222 2333332
Q ss_pred ----CCCCCeEecCCCCCCEEEc-CCCceEEEeeccceee
Q 005471 646 ----DSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVF 680 (695)
Q Consensus 646 ----~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~ 680 (695)
..+..++|+|+.|.|||++ +++.+.|+||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666789999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1e-06 Score=95.12 Aligned_cols=146 Identities=21% Similarity=0.231 Sum_probs=98.8
Q ss_pred cceeeeeCceeEEEEEcCCC----cEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEe-------EEEe-----C
Q 005471 533 SNKLGQGGFGPVYKGKLSNG----QEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG-------CCLE-----E 596 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g----~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g-------~~~~-----~ 596 (695)
.+..++.+++.++..+...+ ..+..|+.............+++-.+....|-+..-+.. .... .
T Consensus 249 ~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~ 328 (516)
T KOG1033|consen 249 SKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKK 328 (516)
T ss_pred cccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccc
Confidence 35666677777766554322 234444443322122233334555554444433333322 1111 1
Q ss_pred CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
...++.|+++.-.+|.++|.+.......++.....++.|++.|++| ++ .+|||+||.||....+..+||.||||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 2467999999999999999766555567888899999999999999 44 89999999999999999999999999
Q ss_pred ceeecCCc
Q 005471 677 ARVFGGEE 684 (695)
Q Consensus 677 a~~~~~~~ 684 (695)
.......+
T Consensus 403 ~ts~~~~~ 410 (516)
T KOG1033|consen 403 VTSQDKDE 410 (516)
T ss_pred eeecccCC
Confidence 98876655
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.7e-05 Score=67.85 Aligned_cols=100 Identities=27% Similarity=0.415 Sum_probs=68.2
Q ss_pred CEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEe-cCCCCCCCCCceEEEEecCCeeeeccCCCceeEEeecc
Q 005471 36 DVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVA-NRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANI 114 (695)
Q Consensus 36 ~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~A-nr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~~~Wss~~ 114 (695)
+.+.+.+|.+.|-|...|+ | +.|+. ..++||.. +...+.. ..+.+.|..+|||||+|..+. ++|+|..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----L-vl~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~--~lW~Sf~ 80 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----L-VLYDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGN--VLWQSFD 80 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----E-EEEET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSE--EEEESTT
T ss_pred cccccccccccceECCCCe-----E-EEEcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecce--EEEeecC
Confidence 4566656999999998886 4 34443 35779999 4444432 457899999999999998777 9999853
Q ss_pred ccCCCCccEEEEcc--CCCEEEEeCCCCceEEeecCCCC
Q 005471 115 SEASAGNTVAQLLD--TGNLVLVRNDTGETLWQSFDHPT 151 (695)
Q Consensus 115 ~~~~~~~~~a~L~d--~GNlVl~~~~~~~~lWqSFd~Pt 151 (695)
. .....+.+++ .||++ +.. ...+.|.|=+.|+
T Consensus 81 ~---ptdt~L~~q~l~~~~~~-~~~-~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 Y---PTDTLLPGQKLGDGNVT-GKN-DSLTSWSSNTDPS 114 (114)
T ss_dssp S---SS-EEEEEET--TSEEE-EES-TSSEEEESS----
T ss_pred C---CccEEEeccCcccCCCc-ccc-ceEEeECCCCCCC
Confidence 2 3456677777 89999 653 3568999877664
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.5e-05 Score=74.54 Aligned_cols=139 Identities=15% Similarity=0.168 Sum_probs=89.9
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHH---------HHHHHHHHHcCC---CCceeeeEeEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEE---------LKNEVLLIAKLQ---HRNLVKLLGCC 593 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~---------~~~Ei~~l~~l~---H~nIv~l~g~~ 593 (695)
...+|...+.+-....-.|.+-.. +++.+.+|..+.......+. ..+++..+.+++ --..+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356677777777766666766666 46888888765533222222 223444444443 22333333333
Q ss_pred Ee-----CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 005471 594 LE-----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN 668 (695)
Q Consensus 594 ~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 668 (695)
.. ....+|+|||++|-.|.++.. ++. .++..++++|.-||..+ ++|+|..|.|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 22 234568999999988755431 222 25566788899999987 9999999999999965 4
Q ss_pred eEEEeeccceee
Q 005471 669 PRISDFGTARVF 680 (695)
Q Consensus 669 ~kl~DFGla~~~ 680 (695)
++++||+..+..
T Consensus 173 i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 IRIIDTQGKRMS 184 (229)
T ss_pred EEEEECcccccc
Confidence 999999988754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0002 Score=85.99 Aligned_cols=147 Identities=15% Similarity=0.314 Sum_probs=92.5
Q ss_pred cceeeeeCceeEEEEEcCCC---cEEEEEEcccCC-cccHHHHHHHHHHHHcCC-CCce--eeeEeEEEeC---CeeEEE
Q 005471 533 SNKLGQGGFGPVYKGKLSNG---QEIAVKRLSTTS-GQGIEELKNEVLLIAKLQ-HRNL--VKLLGCCLEE---DENMLI 602 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g---~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV 602 (695)
.+.|+.|.+..+|+.+..++ ..+++|+..... ......+.+|.++|..+. |++| .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887654 367777754322 123457889999999995 6665 7888888764 457899
Q ss_pred EEcCCCCCHHH--------------------H---HhccCCC--------CCCC--------HHHHHHH---------HH
Q 005471 603 YEFMPNKSLDY--------------------F---IFDESRK--------QLLD--------WKKRFDI---------IL 634 (695)
Q Consensus 603 ~Ey~~~gsL~~--------------------~---l~~~~~~--------~~l~--------~~~~~~i---------~~ 634 (695)
|||+++..+.+ . |+..... .... |...+.- ..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999764321 0 1111000 0111 1111110 11
Q ss_pred HHHHHHHHHHhCCC--------CCeEecCCCCCCEEEcC-C-CceEEEeecccee
Q 005471 635 GIARGVLYLHQDSR--------LRIIHRDLKASNILLDE-K-MNPRISDFGTARV 679 (695)
Q Consensus 635 ~ia~gL~yLH~~~~--------~~iiHrDlkp~NILl~~-~-~~~kl~DFGla~~ 679 (695)
.+.+.+.+|..+-+ ..+||+|+++.|||++. + ...-|.||.++.+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 23344667754322 34999999999999984 2 3467999999874
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00021 Score=71.22 Aligned_cols=152 Identities=19% Similarity=0.225 Sum_probs=93.6
Q ss_pred HHHHHhcCCCCcccee---eeeCceeEEEEEcCCCcEEEEEEcccCCccc-------------------HHH-----HHH
Q 005471 521 STLLAATDNFSTSNKL---GQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG-------------------IEE-----LKN 573 (695)
Q Consensus 521 ~~l~~~~~~f~~~~~L---G~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~-------------------~~~-----~~~ 573 (695)
+.+.....+..+.+.. ..|.-..||+|.-.++..+|||+.+...... .++ .+.
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k 117 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK 117 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence 3333344444444444 4677779999998889999999875432111 110 123
Q ss_pred HHHHHHcCC--CCceeeeEeEEEeCCeeEEEEEcCCCCCH-HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 005471 574 EVLLIAKLQ--HRNLVKLLGCCLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650 (695)
Q Consensus 574 Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 650 (695)
|..-|.++. +-.+.+-+++. +..|||||+..... .-.|.+ ..+.......+..++++.|.-|-... +
T Consensus 118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a--~ 187 (268)
T COG1718 118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA--G 187 (268)
T ss_pred HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc--C
Confidence 555555552 33444444432 45799999965421 111111 11122245556777888887776633 4
Q ss_pred eEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 651 iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+||+||..=|||+. ++.+.|+|||-|.....+
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 99999999999999 889999999999877543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.0003 Score=68.60 Aligned_cols=125 Identities=26% Similarity=0.412 Sum_probs=89.5
Q ss_pred CCCCccceeeeeCc-eeEEEEEcCCCcEEEEEEccc---C---------Cc---------ccHHHHHHHHHHHHcCC---
Q 005471 528 DNFSTSNKLGQGGF-GPVYKGKLSNGQEIAVKRLST---T---------SG---------QGIEELKNEVLLIAKLQ--- 582 (695)
Q Consensus 528 ~~f~~~~~LG~G~f-G~Vy~g~~~~g~~vAvK~l~~---~---------~~---------~~~~~~~~Ei~~l~~l~--- 582 (695)
.+++.++.||.|.- |.||++++. |+.+|+|..+. . .. ....-|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 999999995 68999998321 0 00 11235778999888885
Q ss_pred CCce--eeeEeEEEeCC------------------eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 005471 583 HRNL--VKLLGCCLEED------------------ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642 (695)
Q Consensus 583 H~nI--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y 642 (695)
+.++ |+.+||..-.. ...||.||++... .....-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4466 89999874331 1247777775432 1112245677788888
Q ss_pred HHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 643 LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
+|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99877 999999999976 4589999865
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00062 Score=66.82 Aligned_cols=134 Identities=17% Similarity=0.286 Sum_probs=90.1
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCC----------------cccHHHHHHHHHHHHcCC------CCceeeeE
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS----------------GQGIEELKNEVLLIAKLQ------HRNLVKLL 590 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------H~nIv~l~ 590 (695)
...||+|+.-.||. +++.....||++.... ....++..+|+.-...+. +..|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 47899999999985 4455567788776543 122455666666555544 88999999
Q ss_pred eEEEeCCeeEEEEEcCCC------CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005471 591 GCCLEEDENMLIYEFMPN------KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (695)
Q Consensus 591 g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 664 (695)
|+.+++...-+|+|.+.+ -+|.+++.+. .++. . +...+-+-..||-+++ |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999888999997743 3466666332 2343 2 3333344455666665 99999999999996
Q ss_pred CC---C-ceEEEe-ecccee
Q 005471 665 EK---M-NPRISD-FGTARV 679 (695)
Q Consensus 665 ~~---~-~~kl~D-FGla~~ 679 (695)
.. . .+.|+| ||-...
T Consensus 153 ~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred ecCCCceEEEEEeCCCCccc
Confidence 32 2 577777 565544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00067 Score=71.38 Aligned_cols=76 Identities=12% Similarity=0.108 Sum_probs=56.3
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCC---CceeeeEeEEEeC---CeeEEEEEcC
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH---RNLVKLLGCCLEE---DENMLIYEFM 606 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~g~~~~~---~~~~lV~Ey~ 606 (695)
.+.||+|..+.||+....++ .+.+|..+. ......+..|.+.|+.|.- ..+.+++++|... +..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 36899999999999987665 466666432 1133578899999988843 4677888887643 5689999999
Q ss_pred CCCCH
Q 005471 607 PNKSL 611 (695)
Q Consensus 607 ~~gsL 611 (695)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00025 Score=71.92 Aligned_cols=140 Identities=17% Similarity=0.197 Sum_probs=76.7
Q ss_pred ceeeeeCce-eEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCC---ceeeeEeEEEeC---CeeEEEEEcC
Q 005471 534 NKLGQGGFG-PVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR---NLVKLLGCCLEE---DENMLIYEFM 606 (695)
Q Consensus 534 ~~LG~G~fG-~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~g~~~~~---~~~~lV~Ey~ 606 (695)
+.|+.|+.. .||+. +..+.+|.-.. ......+.+|.+++..+... -+.+.++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777766 58875 23566775443 22345788899998877421 233444433322 2348899999
Q ss_pred CCCCHHHH------------------HhccCCCC--C-----------C-CHHHHH--HHH-------HHHHHH-HHH-H
Q 005471 607 PNKSLDYF------------------IFDESRKQ--L-----------L-DWKKRF--DII-------LGIARG-VLY-L 643 (695)
Q Consensus 607 ~~gsL~~~------------------l~~~~~~~--~-----------l-~~~~~~--~i~-------~~ia~g-L~y-L 643 (695)
+|.++... |+...... . + .|.... .+. .+.... ++. +
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98776321 11110000 0 0 121110 010 011111 111 1
Q ss_pred Hh--CCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 644 HQ--DSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 644 H~--~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
+. ..+..++|+|+.+.|||++++...-|+||+.|..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1234489999999999999876678999998864
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00063 Score=68.82 Aligned_cols=141 Identities=21% Similarity=0.253 Sum_probs=81.5
Q ss_pred ceeeeeCceeEEEEEcCC--CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCc-eeeeEeEEEeCCeeEEEEEcCCCCC
Q 005471 534 NKLGQGGFGPVYKGKLSN--GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN-LVKLLGCCLEEDENMLIYEFMPNKS 610 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~--g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~~~gs 610 (695)
+.|..|-...+|+....+ ++.+.+|........ .....+|+.++..+...+ ..++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999998764 678888876543221 123346888888874333 344444332 248999999877
Q ss_pred HHHH-----------------HhccCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 005471 611 LDYF-----------------IFDESRK--------QLL-DWKKRFDIIL----------------------GIARGVLY 642 (695)
Q Consensus 611 L~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~gL~y 642 (695)
+... ++..... ... .|.....+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 1111110 001 1221111110 11111112
Q ss_pred H----HhC-CCCCeEecCCCCCCEEEcC-CCceEEEeecccee
Q 005471 643 L----HQD-SRLRIIHRDLKASNILLDE-KMNPRISDFGTARV 679 (695)
Q Consensus 643 L----H~~-~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~ 679 (695)
| ... .+..++|+|+.+.|||+++ +..+.|+||-.|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 2346999999999999997 57899999998864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00055 Score=64.69 Aligned_cols=129 Identities=21% Similarity=0.281 Sum_probs=86.2
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceee-eEeEEEeCCeeEEEEEcCCCCC
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK-LLGCCLEEDENMLIYEFMPNKS 610 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~lV~Ey~~~gs 610 (695)
..+.|++|.+|.||+|.+. +.++|+|+-+.. .....++.|+++|..+.-.++.. ++.+- +..+.|||+.+..
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 3478999999999999996 458899876643 34567889999999988766653 44442 3356699999888
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-CCCEEEcCCCceEEEeeccceee
Q 005471 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK-ASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk-p~NILl~~~~~~kl~DFGla~~~ 680 (695)
|.+.-... +-.. ...+++.---|-.. +|-|..|. |..++|-.+..+.|+||--|+.-
T Consensus 99 L~~~~~~~------~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIGG------DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcc------cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 86654211 1122 23344442223322 37787775 55555555569999999999843
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0016 Score=70.89 Aligned_cols=75 Identities=13% Similarity=0.227 Sum_probs=54.7
Q ss_pred ceeeeeCceeEEEEEcCCC-cEEEEEEcccC-----C--cccHHHHHHHHHHHHcCC---CCceeeeEeEEEeCCeeEEE
Q 005471 534 NKLGQGGFGPVYKGKLSNG-QEIAVKRLSTT-----S--GQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g-~~vAvK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV 602 (695)
+.||.|.+..||+....+| +.+.||.-.+. . ....+.+..|.+.|..+. -..+.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6799999999999999877 48999974321 1 124566777888887752 3457777776 44567899
Q ss_pred EEcCCCCC
Q 005471 603 YEFMPNKS 610 (695)
Q Consensus 603 ~Ey~~~gs 610 (695)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00074 Score=69.44 Aligned_cols=139 Identities=17% Similarity=0.146 Sum_probs=78.1
Q ss_pred eeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCce-eeeEeEEEeCCeeEEEEEcCCCCCHHH
Q 005471 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYEFMPNKSLDY 613 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 613 (695)
.+..|-...+|+... +++.+++|........-.-...+|.+++..+....+ .+++... ...+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 355677788998874 567788887544322111135678888888754333 3344432 2479999999876532
Q ss_pred H-----------------HhccCC-CCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEecCCCCCC
Q 005471 614 F-----------------IFDESR-KQLLDWKKR-FDIILG---------IARGVLYLHQD-----SRLRIIHRDLKASN 660 (695)
Q Consensus 614 ~-----------------l~~~~~-~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~iiHrDlkp~N 660 (695)
. |+.... ...++...+ .....+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111111 111222111 111111 11112222211 12358999999999
Q ss_pred EEEcCCCceEEEeecccee
Q 005471 661 ILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 661 ILl~~~~~~kl~DFGla~~ 679 (695)
||+++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0031 Score=66.24 Aligned_cols=143 Identities=17% Similarity=0.167 Sum_probs=87.3
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCc--eeeeEeE------EEeCCeeEEEEE
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGC------CLEEDENMLIYE 604 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~------~~~~~~~~lV~E 604 (695)
.+.|..|....+|+....+ ..+++|+... ...+++..|+.++..+.+.+ +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987654 4688887754 23456677888887774332 4444432 123445689999
Q ss_pred cCCCCCHHH----H----------HhccC--------CCCCCCHHHHHH----------HHHHHHHHHHHHHh----CCC
Q 005471 605 FMPNKSLDY----F----------IFDES--------RKQLLDWKKRFD----------IILGIARGVLYLHQ----DSR 648 (695)
Q Consensus 605 y~~~gsL~~----~----------l~~~~--------~~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~ 648 (695)
|++|..+.. . ++... ......|..... ....+..++.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 1 11100 001123332211 11223445555553 123
Q ss_pred CCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 649 LRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 649 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
..++|+|+.|.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987789999988763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0025 Score=67.13 Aligned_cols=142 Identities=26% Similarity=0.331 Sum_probs=83.5
Q ss_pred ceeeeeCceeEEEEEcCC-------CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCce-eeeEeEEEeCCeeEEEEEc
Q 005471 534 NKLGQGGFGPVYKGKLSN-------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey 605 (695)
+.|..|-...+|+.+..+ ++.+++|...... .......+|.+++..+....+ .++++.+. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456666677899988765 4788888865432 223455678888877743333 35555543 2368999
Q ss_pred CCCCCHHHH-----------------HhccCCCC------C--CCHHHHHH--------------------------HHH
Q 005471 606 MPNKSLDYF-----------------IFDESRKQ------L--LDWKKRFD--------------------------IIL 634 (695)
Q Consensus 606 ~~~gsL~~~-----------------l~~~~~~~------~--l~~~~~~~--------------------------i~~ 634 (695)
++|..+... ++...... . .-|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 11111110 0 01111100 011
Q ss_pred HHHHHHHHHHh------CCCCCeEecCCCCCCEEEcCC----CceEEEeeccceee
Q 005471 635 GIARGVLYLHQ------DSRLRIIHRDLKASNILLDEK----MNPRISDFGTARVF 680 (695)
Q Consensus 635 ~ia~gL~yLH~------~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~~ 680 (695)
.+..-+.+|.. ..+..++|+|+.|.|||++++ ..++++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22223334432 244578999999999999974 88999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.015 Score=61.74 Aligned_cols=141 Identities=18% Similarity=0.173 Sum_probs=76.6
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCC--ceeeeEe------EEEeCCeeEEEEEc
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR--NLVKLLG------CCLEEDENMLIYEF 605 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~g------~~~~~~~~~lV~Ey 605 (695)
+.|..|....+|+.+..+| .+.+|+... ...+.+..|+.++..|... .+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5566777789999887655 688887652 1233444455555544211 1223332 11234567899999
Q ss_pred CCCCCHHH-----------HH---hccCC--------CCCCCH-HHHHHHH-------------HHHHHHHHHHHhC---
Q 005471 606 MPNKSLDY-----------FI---FDESR--------KQLLDW-KKRFDII-------------LGIARGVLYLHQD--- 646 (695)
Q Consensus 606 ~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~i~-------------~~ia~gL~yLH~~--- 646 (695)
++|..+.. .| +.... ...+.| .....-. ..+...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875411 11 11000 001112 2211111 1111122233211
Q ss_pred -CCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 647 -SRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 647 -~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
-+..+||+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999977666899999885
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.014 Score=61.72 Aligned_cols=143 Identities=20% Similarity=0.213 Sum_probs=82.9
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCC--ceeeeEeEE------EeCCeeEEEEE
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR--NLVKLLGCC------LEEDENMLIYE 604 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~g~~------~~~~~~~lV~E 604 (695)
.+.++.|--..+|+.+..++ .+.+|+..... ..+++..|++++..|... .+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777789999876555 57778764421 234556677777666322 234443321 12345689999
Q ss_pred cCCCCCHH----H-------H---HhccCC------C---CCCCHHHHHH------------HHHHHHHHHHHHHh----
Q 005471 605 FMPNKSLD----Y-------F---IFDESR------K---QLLDWKKRFD------------IILGIARGVLYLHQ---- 645 (695)
Q Consensus 605 y~~~gsL~----~-------~---l~~~~~------~---~~l~~~~~~~------------i~~~ia~gL~yLH~---- 645 (695)
|++|..+. . . ++.... . ..-.|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99986542 0 0 111000 0 0112222110 11223445555543
Q ss_pred CCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 646 ~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
..+..++|+|+++.||+++++..+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234569999999999999988877999999984
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0015 Score=53.06 Aligned_cols=50 Identities=10% Similarity=0.398 Sum_probs=35.9
Q ss_pred eecccCCCCcccccccCCCChHHHHHHhhccCCccceeccccCCCCCcceeeeccc
Q 005471 350 LERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGD 405 (695)
Q Consensus 350 ~~~~~~p~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~w~~~ 405 (695)
++++.+++.+.. .....+.++|++.|+.+|+|.||.|.. ....|+++.+.
T Consensus 9 ~~~~~~~g~d~~--~~~~~s~~~Cq~~C~~~~~C~afT~~~----~~~~C~lk~~~ 58 (73)
T cd01100 9 GSNVDFRGGDLS--TVFASSAEQCQAACTADPGCLAFTYNT----KSKKCFLKSSE 58 (73)
T ss_pred cCCCccccCCcc--eeecCCHHHHHHHcCCCCCceEEEEEC----CCCeEEcccCC
Confidence 345666665522 223568999999999999999999974 23479997664
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.013 Score=63.11 Aligned_cols=142 Identities=19% Similarity=0.253 Sum_probs=80.5
Q ss_pred ceeeeeCceeEEEEEcCC-----CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCcee-eeEeEEEeCCeeEEEEEcCC
Q 005471 534 NKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV-KLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-----g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~ 607 (695)
+.|-.|-.-.+|+....+ ++.+.+|........... -.+|..++..+...++. ++++.+.. + .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345456777888887532 367888877554332222 25688888777544443 45565432 2 6899998
Q ss_pred CCCHHHH-----------------HhccCC---CCCCCHHHHHHHHH-----------------HHHHHHHHH----Hh-
Q 005471 608 NKSLDYF-----------------IFDESR---KQLLDWKKRFDIIL-----------------GIARGVLYL----HQ- 645 (695)
Q Consensus 608 ~gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~-----------------~ia~gL~yL----H~- 645 (695)
+.++... +|.... .....|.+...+.. .+...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 111110 00111222222211 111122222 21
Q ss_pred CCCCCeEecCCCCCCEEEcC-CCceEEEeeccceee
Q 005471 646 DSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVF 680 (695)
Q Consensus 646 ~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~ 680 (695)
..+..++|+|+++.|||+++ +..++|+||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 23346899999999999986 578999999988753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.013 Score=60.84 Aligned_cols=32 Identities=31% Similarity=0.506 Sum_probs=26.6
Q ss_pred CCeEecCCCCCCEEEcCCCc-eEEEeeccceee
Q 005471 649 LRIIHRDLKASNILLDEKMN-PRISDFGTARVF 680 (695)
Q Consensus 649 ~~iiHrDlkp~NILl~~~~~-~kl~DFGla~~~ 680 (695)
..++|+|++|.|||+++++. .-|.||+.+.+-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997554 579999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.037 Score=57.72 Aligned_cols=73 Identities=19% Similarity=0.278 Sum_probs=47.6
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcC---CCCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL---QHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
.+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.| .--.+.+.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4678889999999988 5678899997652 2334677787777777 3456778999988888889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.049 Score=57.32 Aligned_cols=128 Identities=18% Similarity=0.308 Sum_probs=76.0
Q ss_pred CcEEEEEEccc--CCcccHHHHHHHHHHHHcCCC--CceeeeEeEEEeCC--eeEEEEEcCCCCCH---------H----
Q 005471 552 GQEIAVKRLST--TSGQGIEELKNEVLLIAKLQH--RNLVKLLGCCLEED--ENMLIYEFMPNKSL---------D---- 612 (695)
Q Consensus 552 g~~vAvK~l~~--~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~Ey~~~gsL---------~---- 612 (695)
++++.+. ... ..........+|.++|+.+.- .-+.+.++.|.++. ..+.||||+++..+ .
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 6777777 321 122334556678888877642 23445677777666 66999999987322 1
Q ss_pred -----HHHhc---c--------------CCCCCCCHHHHHHHHH--------HHHHHHHHHHhC-----CCCCeEecCCC
Q 005471 613 -----YFIFD---E--------------SRKQLLDWKKRFDIIL--------GIARGVLYLHQD-----SRLRIIHRDLK 657 (695)
Q Consensus 613 -----~~l~~---~--------------~~~~~l~~~~~~~i~~--------~ia~gL~yLH~~-----~~~~iiHrDlk 657 (695)
++|.. - ...+.-.|...+..+. ....-..+|+++ .+..++|+|++
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 11110 0 0011122333332111 223345566544 33569999999
Q ss_pred CCCEEEcCCCceEEEeeccceee
Q 005471 658 ASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 658 p~NILl~~~~~~kl~DFGla~~~ 680 (695)
+.||+++.+..+-|.||+++.+=
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccC
Confidence 99999998888999999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.00074 Score=78.81 Aligned_cols=148 Identities=16% Similarity=0.208 Sum_probs=102.9
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
.+.+.+.+-+-+|.++.++..+-. .|...++|..... .....+..+.+-.++-..+||-+++..--+......+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 456666778888999999877543 2333333332221 112233344444444455678888776666677888999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
++|..+++|...|+... .++..-....+..+..+++|||... ++|||++|.|+|...++..+++|||+.+..
T Consensus 883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999988886543 2333333345667888999999865 899999999999999999999999965544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.00077 Score=74.87 Aligned_cols=140 Identities=18% Similarity=0.111 Sum_probs=95.9
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCc-eeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN-LVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~ 606 (695)
..+...+.++++++++++|.+..-.+....+.+... ...+-++++|.+++||| .++-++-+..++...++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 334444678999999999987644444445544322 45566899999999999 777777777777889999999
Q ss_pred CCC-C-HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNK-S-LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~g-s-L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
..+ + ...... ....+...+...+.+.-+++++|||+.. =+||| |||..+ ...|..||+.+..+.+.
T Consensus 317 s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 317 STGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred cCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 877 2 111100 0111223333445666778999999854 48998 887776 58899999999877654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.056 Score=57.78 Aligned_cols=73 Identities=12% Similarity=0.191 Sum_probs=47.7
Q ss_pred eeeeeCceeEEEEEcCCC-cEEEEEEcccC------C-cccHHHHHHHHHHHHcCC--CC-ceeeeEeEEEeCCeeEEEE
Q 005471 535 KLGQGGFGPVYKGKLSNG-QEIAVKRLSTT------S-GQGIEELKNEVLLIAKLQ--HR-NLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~g-~~vAvK~l~~~------~-~~~~~~~~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~lV~ 603 (695)
.||.|....||++..+++ +.|+||.-.+. + ....++...|.+.|.... -| .+.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998755 58999953211 1 233445556777776542 23 44455543 555667999
Q ss_pred EcCCCC
Q 005471 604 EFMPNK 609 (695)
Q Consensus 604 Ey~~~g 609 (695)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.1 Score=56.73 Aligned_cols=73 Identities=11% Similarity=0.085 Sum_probs=50.2
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccC----Cc---ccHHHHHHHHHHHHcCC---CCceeeeEeEEEeCCeeEEE
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT----SG---QGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~----~~---~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV 602 (695)
.+.||.|.--.||+.... ++.+.||+-... .. .....-..|...|..+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 368899999999998874 567889975421 11 23344445666665553 357888888876 456889
Q ss_pred EEcCCC
Q 005471 603 YEFMPN 608 (695)
Q Consensus 603 ~Ey~~~ 608 (695)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.2 Score=52.85 Aligned_cols=29 Identities=28% Similarity=0.366 Sum_probs=25.4
Q ss_pred CCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 649 LRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 649 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
..++|+|+.+.|||++. ..+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46899999999999998 578999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.013 Score=60.77 Aligned_cols=133 Identities=17% Similarity=0.221 Sum_probs=87.0
Q ss_pred CCccceeeeeCceeEEEEEcCCCcEEEEEEccc--C---------------C-c--ccH--HHHHHHHHHHHcCC-CC-c
Q 005471 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLST--T---------------S-G--QGI--EELKNEVLLIAKLQ-HR-N 585 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~--~---------------~-~--~~~--~~~~~Ei~~l~~l~-H~-n 585 (695)
++..++||-|.-+.||.+-..+|++.++|.-+. . . . ... -...+|...|+.|. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 567799999999999999999999999883211 0 0 0 001 12345777777774 32 2
Q ss_pred eeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 005471 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 665 (695)
Q Consensus 586 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~ 665 (695)
+.+.++ .+..++|||++.+-.|...-+ ..+-+..+ ..+..-+.-|..++ +||+|..-=||++++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeee------cCChHHHH---HHHHHHHHHHHHcC---ceecccchheeEEec
Confidence 333333 345689999998887744321 12223322 22333334455555 999999999999999
Q ss_pred CCceEEEeeccce
Q 005471 666 KMNPRISDFGTAR 678 (695)
Q Consensus 666 ~~~~kl~DFGla~ 678 (695)
+..++++||--..
T Consensus 238 d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 238 DDKIVVIDFPQMV 250 (465)
T ss_pred CCCEEEeechHhh
Confidence 9999999996543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.096 Score=55.70 Aligned_cols=136 Identities=21% Similarity=0.284 Sum_probs=81.0
Q ss_pred CceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCc------eeeeEeE----EEeCCeeEEEEEcCCCC
Q 005471 540 GFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN------LVKLLGC----CLEEDENMLIYEFMPNK 609 (695)
Q Consensus 540 ~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~g~----~~~~~~~~lV~Ey~~~g 609 (695)
.-..||+....+|+. ++|..... ....++..|+..|..|.-.. |..+=|- .......+-++||++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445688888877766 77776653 45567777888777663211 2222222 11123678899999998
Q ss_pred CHHH-H--------------Hhc----c-----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhC----CC
Q 005471 610 SLDY-F--------------IFD----E-----SRKQLLDWKK-------------RFDIILGIARGVLYLHQD----SR 648 (695)
Q Consensus 610 sL~~-~--------------l~~----~-----~~~~~l~~~~-------------~~~i~~~ia~gL~yLH~~----~~ 648 (695)
.+.. . |+. - .......|.. ......++...+..+.+. -+
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8862 1 110 0 0111244541 011223444455555442 11
Q ss_pred C-C--eEecCCCCCCEEEcCCCc-eEEEeeccce
Q 005471 649 L-R--IIHRDLKASNILLDEKMN-PRISDFGTAR 678 (695)
Q Consensus 649 ~-~--iiHrDlkp~NILl~~~~~-~kl~DFGla~ 678 (695)
. + +||+|+.|.|||++.+.. +.+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 2 999999999999998874 8999999876
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.12 Score=55.21 Aligned_cols=141 Identities=18% Similarity=0.252 Sum_probs=77.5
Q ss_pred ceeeeeCceeEEEEEcCC----CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCcee-eeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV-KLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
+.|-.|=.-.+|+....+ +..|.+|......... -.-.+|..++..+...++. ++++++. .+ +|.||+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345446667788876543 2378888765433222 2235688888877655553 5566552 22 58999987
Q ss_pred CCHHHH-----------------HhccCC---CCCCCHHHHHHHHHH----------------------HHHHHHHHH--
Q 005471 609 KSLDYF-----------------IFDESR---KQLLDWKKRFDIILG----------------------IARGVLYLH-- 644 (695)
Q Consensus 609 gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~----------------------ia~gL~yLH-- 644 (695)
..|..- +|.... ...--|....++..+ +.+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765221 111110 001123322222111 111111111
Q ss_pred --h-CCCCCeEecCCCCCCEEEcC-CCceEEEeecccee
Q 005471 645 --Q-DSRLRIIHRDLKASNILLDE-KMNPRISDFGTARV 679 (695)
Q Consensus 645 --~-~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~ 679 (695)
. ..+.-+.|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 12234789999999999974 57899999988864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.09 Score=56.91 Aligned_cols=74 Identities=12% Similarity=0.140 Sum_probs=49.6
Q ss_pred cceeeeeCceeEEEEEcCC-CcEEEEEEccc---C--C-cccHHHHHHHHHHHHcCC--CC-ceeeeEeEEEeCCeeEEE
Q 005471 533 SNKLGQGGFGPVYKGKLSN-GQEIAVKRLST---T--S-GQGIEELKNEVLLIAKLQ--HR-NLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~---~--~-~~~~~~~~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~lV 602 (695)
.+.||.|.-..||++...+ ++.|+||.-.+ . + ....++...|.+.|.... -| .+.+++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3689999999999999753 56899995321 1 1 234556666777776652 33 45556554 55567899
Q ss_pred EEcCCC
Q 005471 603 YEFMPN 608 (695)
Q Consensus 603 ~Ey~~~ 608 (695)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999964
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.31 Score=51.54 Aligned_cols=32 Identities=28% Similarity=0.395 Sum_probs=28.5
Q ss_pred CCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 648 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
+..++|+|+.+.|||+++++.+.|+||-.+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44699999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.53 Score=50.22 Aligned_cols=72 Identities=11% Similarity=0.046 Sum_probs=45.0
Q ss_pred eCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCC--Cceeee---Ee--EEEeCCeeEEEEEcCCCCCH
Q 005471 539 GGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH--RNLVKL---LG--CCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 539 G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l---~g--~~~~~~~~~lV~Ey~~~gsL 611 (695)
+.-..||+....++..+++|..+.. .....++..|++.+..|.. -.++.. -| ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 3446799998888888999977532 3345667778877766631 112221 12 12234567889999987653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.5 Score=58.23 Aligned_cols=141 Identities=18% Similarity=0.241 Sum_probs=78.0
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-------CCCceeeeE-----eEEEe-CC--e
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-------QHRNLVKLL-----GCCLE-ED--E 598 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-------~H~nIv~l~-----g~~~~-~~--~ 598 (695)
+.|+ |..-.+|+.+..+|+.+++|+.+... ...++..|..+|..| .-|.+++-. ..... .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4454 45677899888888899999987642 233444455555433 233333321 11111 22 4
Q ss_pred eEEEEEcCCCCCHHHH-----------------Hhc------c-CCCCCCCHHH-----------------HHHHHHHHH
Q 005471 599 NMLIYEFMPNKSLDYF-----------------IFD------E-SRKQLLDWKK-----------------RFDIILGIA 637 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~-----------------l~~------~-~~~~~l~~~~-----------------~~~i~~~ia 637 (695)
.+.+++|++|..+.+. ++. . .....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999877541 000 0 0011233422 112222222
Q ss_pred HHHH-----HHHhCCCCCeEecCCCCCCEEEcCCC--ce-EEEeeccce
Q 005471 638 RGVL-----YLHQDSRLRIIHRDLKASNILLDEKM--NP-RISDFGTAR 678 (695)
Q Consensus 638 ~gL~-----yLH~~~~~~iiHrDlkp~NILl~~~~--~~-kl~DFGla~ 678 (695)
+... .|. .-+..+||.|+.+.|||++.+. .+ -|+|||.+.
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 2221 121 2234599999999999999775 44 499999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 695 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-26 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 3e-91
Identities = 74/197 (37%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 509 EIRKVDVTFFELSTLLAATDNFS------TSNKLGQGGFGPVYKGKLSNGQEIAVKRLST 562
E+ F L T+NF NK+G+GGFG VYKG + N +AVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 563 ----TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE 618
T+ + ++ E+ ++AK QH NLV+LLG + D+ L+Y +MPN SL +
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 619 SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
L W R I G A G+ +LH++ IHRD+K++NILLDE +ISDFG AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 679 VFGGEEILAITKRVVGT 695
+T R+VGT
Sbjct: 182 ASEKFAQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 5e-89
Identities = 82/197 (41%), Positives = 116/197 (58%), Gaps = 3/197 (1%)
Query: 501 SISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL 560
+ + + E+ + F L L A+DNFS N LG+GGFG VYKG+L++G +AVKRL
Sbjct: 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 561 STTSGQGIE-ELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES 619
QG E + + EV +I+ HRNL++L G C+ E +L+Y +M N S+ + +
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 620 RKQL-LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
Q LDW KR I LG ARG+ YLH +IIHRD+KA+NILLDE+ + DFG A+
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 679 VFGGEEILAITKRVVGT 695
+ + +T V GT
Sbjct: 183 LM-DYKDTHVTTAVRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 1e-82
Identities = 71/206 (34%), Positives = 113/206 (54%), Gaps = 4/206 (1%)
Query: 491 SSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLS 550
S + + + + L L AT+NF +G G FG VYKG L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 551 NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610
+G ++A+KR + S QGIEE + E+ ++ +H +LV L+G C E +E +LIY++M N +
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 611 LDYFIFDESRKQL-LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669
L ++ + + W++R +I +G ARG+ YLH + IIHRD+K+ NILLDE P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 670 RISDFGTARVFGGEEILAITKRVVGT 695
+I+DFG ++ + ++ V GT
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 8e-61
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 17/189 (8%)
Query: 518 FELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLL 577
L + +G FG V+K +L + +AVK Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 578 IAKLQHRNLVKLLGCCLE----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 633
+ ++H N+++ +G + + LI F SL F+ + ++ W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 634 LGIARGVLYLHQD-------SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
+ARG+ YLH+D + I HRD+K+ N+LL + I+DFG A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 687 AITKRVVGT 695
T VGT
Sbjct: 188 GDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-53
Identities = 49/196 (25%), Positives = 80/196 (40%), Gaps = 25/196 (12%)
Query: 518 FELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG-IEELKNEVL 576
S DN +G+G +G VYKG L + + +AVK S + Q I E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK--NIY 59
Query: 577 LIAKLQHRNLVKLLGCCLEEDEN-----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD 631
+ ++H N+ + + + +L+ E+ PN SL ++ DW
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCR 115
Query: 632 IILGIARGVLYLHQD------SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
+ + RG+ YLH + + I HRDL + N+L+ ISDFG + G +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 686 LAI------TKRVVGT 695
+ VGT
Sbjct: 176 VRPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 46/164 (28%), Positives = 87/164 (53%), Gaps = 6/164 (3%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
K+G G FG V++ + +G ++AVK L + + E EV ++ +L+H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+ ++ E++ SL + ++ LD ++R + +A+G+ YLH I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+HR+LK+ N+L+D+K ++ DFG +R+ + +K GT
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGT 202
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
+G+G FG V K K +++A+K++ S + E+ ++++ H N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
L + L+ E+ SL + L ++GV YLH +IH
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 654 RDLKASNILLDEKMN-PRISDFGTARV 679
RDLK N+LL +I DFGTA
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACD 155
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-44
Identities = 55/158 (34%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRL----STTSGQGIEELKNEVLLIAKLQHRNLVKL 589
+G GGFG VY+ G E+AVK Q IE ++ E L A L+H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
G CL+E L+ EF L+ + + + + + IARG+ YLH ++ +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 650 RIIHRDLKASNILLDEKMNPR--------ISDFGTARV 679
IIHRDLK+SNIL+ +K+ I+DFG AR
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 4e-44
Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 7/151 (4%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
KL + G ++KG+ G +I VK L S + + E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 592 CCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
C LI +MP SL + + + + D + L +ARG+ +LH L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTLEPL 133
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVF 680
I L + ++++DE M RIS F
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-43
Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 23/175 (13%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-------IEELKNEVLLIAKLQHRN 585
++G+GGFG V+KG+ + + +A+K L +G +E + EV +++ L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+VKL G ++ EF+P L + + D++ + W + ++L IA G+ Y+
Sbjct: 85 IVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQN 140
Query: 646 DSRLRIIHRDLKASNILLDEK-----MNPRISDFGTARVFGGEEILAITKRVVGT 695
I+HRDL++ NI L + +++DFG ++ ++G
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGN 189
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 6/159 (3%)
Query: 534 NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
LG+G FG K G+ + +K L + EV ++ L+H N++K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
++ I E++ +L I + W +R IA G+ YLH + II
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 653 HRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691
HRDL + N L+ E N ++DFG AR+ E+ R
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 12/165 (7%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
++G G FG VYKGK ++AVK L + + Q ++ KNEV ++ K +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 592 CCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
+ ++ ++ SL + + K + KK DI ARG+ YLH
Sbjct: 88 YSTAP--QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KS 140
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
IIHRDLK++NI L E +I DFG A +++ G+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+G+G FG VY G+ E+A++ + + ++ K EV+ + +H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
C+ +I ++L + K +LD K I I +G+ YLH I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFG 681
+H+DLK+ N+ D I+DFG + G
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISG 180
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 21/175 (12%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNE--VLLIAKLQHRNLVKLLG 591
+G+G +G V++G G+ +AVK S+ + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 592 CCLEEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+ + LI + SL ++ + LD I+L IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 648 RLR-----IIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGT 695
I HRDLK+ NIL+ + I+D G A + ++ VGT
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 21/175 (12%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNE--VLLIAKLQHRNLVKLLG 591
++G+G +G V+ GK G+++AVK T E + ++H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 592 CCLEEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
++ + LI ++ N SL ++ + LD K + G+ +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 648 RLR-----IIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGT 695
I HRDLK+ NIL+ + I+D G A F E+ VGT
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNE--VLLIAKLQHRNLVKLLG 591
+G+G FG V++GK G+E+AVK S+ + E + L+H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 592 CCLEEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD- 646
+++ L+ ++ + SL ++ + + + + L A G+ +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 647 ----SRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGT 695
+ I HRDLK+ NIL+ + I+D G A + I VGT
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRN 585
++ ++G+G FG V+ G+L ++ +AVK T + E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+V+L+G C ++ ++ E + F+ + L K ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
IHRDL A N L+ EK +ISDFG +R
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 20/167 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-----IAVKRL-STTSGQGIEELKNEVLLIAKL 581
F LG G FG VYKG E +A+K L TS + +E+ +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIA 637
+ ++ +LLG CL LI + MP L ++ + + LL+W + IA
Sbjct: 75 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+G+ YL R++HRDL A N+L+ + +I+DFG A++ G EE
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 534 NKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
+LG+G FG V + + G+ +AVK+L ++ + + + + E+ ++ LQH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 589 LLGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
G C LI E++P SL ++ + K+ +D K I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
R IHRDL NIL++ + +I DFG +V ++
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 49/159 (30%), Positives = 83/159 (52%), Gaps = 13/159 (8%)
Query: 534 NKLGQGGFGPVYKGKL-----SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLV 587
LG+G FG V + + G+++AVK L + G I +LK E+ ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 588 KLLGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
K G C E+ N LI EF+P+ SL ++ K ++ K++ + I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 142
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ +HRDL A N+L++ + +I DFG + ++
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 48/215 (22%), Positives = 91/215 (42%), Gaps = 27/215 (12%)
Query: 477 ERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKL 536
++ + ++ + + + + F + +L
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQ---------------QL 49
Query: 537 GQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
G+G FG V + + G+ +AVK+L ++ + + + + E+ ++ LQH N+VK G
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 109
Query: 592 CCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
C LI E++P SL ++ + K+ +D K I +G+ YL
Sbjct: 110 VCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---GTK 164
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
R IHRDL NIL++ + +I DFG +V ++
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 534 NKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
++LG+G FG V + + G +AVK+L + + + E+ ++ L +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 589 LLGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
G L+ E++P+ L F+ + + LD + I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
R +HRDL A NIL++ + + +I+DFG A++ ++
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 15/159 (9%)
Query: 534 NKLGQGGFGPVYKGKLSN-----GQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLV 587
LG+G FG V G+ +AVK L + Q K E+ ++ L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 588 KLLGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
K GCC + L+ E++P SL ++ + + + I G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
IHRDL A N+LLD +I DFG A+
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRN 585
+ ++G G FG V+ G N ++A+K + S E+ E ++ KL H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPK 64
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
LV+L G CLE+ L+ EFM + L ++ +++ L + + L + G+ YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL-- 120
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+IHRDL A N L+ E ++SDFG R ++
Sbjct: 121 -EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 19/175 (10%)
Query: 516 TFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNE 574
+F+ ++ ++ KLG+GGF V + L +G A+KR+ Q EE + E
Sbjct: 17 LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76
Query: 575 VLLIAKLQHRNLVKLLGCCLEEDENM----LIYEFMPNKSLDYFIFDESRKQLLDWKKRF 630
+ H N+++L+ CL E L+ F +L I ++L D
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFL 131
Query: 631 D------IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
++LGI RG+ +H HRDLK +NILL ++ P + D G+
Sbjct: 132 TEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-31
Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 8/152 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+G+G FG V G G ++AVK + + + E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 588 KLLGCCLEEDEN-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+LLG +EE ++ E+M SL ++ R +L L + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+HRDL A N+L+ E ++SDFG +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 20/167 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-----IAVKRL-STTSGQGIEELKNEVLLIAKL 581
F LG G FG VYKG E +A+K L TS + +E+ +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIA 637
+ ++ +LLG CL LI + MP L ++ + + LL+W + IA
Sbjct: 75 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+G+ YL R++HRDL A N+L+ + +I+DFG A++ G EE
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRN 585
+ + +LG G FG V GK ++AVK + + S +E E + KL H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPK 64
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
LVK G C +E ++ E++ N L ++ S + L+ + ++ + G+ +L
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL-- 120
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ IHRDL A N L+D + ++SDFG R ++
Sbjct: 121 -ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 23/166 (13%)
Query: 534 NKLGQGGFGPVYKGKLSNG------QEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNL 586
+LG+ FG VYKG L Q +A+K L G EE ++E +L A+LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYF-------------IFDESRKQLLDWKKRFDII 633
V LLG ++ +I+ + + L F D + K L+ ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
IA G+ YL S ++H+DL N+L+ +K+N +ISD G R
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRN 585
+ + +LG G FG V GK ++A+K + + S +E E ++ L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 80
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
LV+L G C ++ +I E+M N L ++ + ++ ++ + + YL
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL-- 136
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ +HRDL A N L++++ ++SDFG +R +E
Sbjct: 137 -ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 534 NKLGQGGFGPVYKGKLSNGQE-----IAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLV 587
LG G FG V+KG E + +K + SG Q + + + +L I L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIARGVLYL 643
+LLG C L+ +++P SL + + LL+W + IA+G+ YL
Sbjct: 79 RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 131
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
++HR+L A N+LL +++DFG A + ++
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 16/166 (9%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
+F LGQG FG V K + + + A+K++ T + + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFI---------FD--ESRKQLLDWKKRFDIIL 634
+V+ LE + + KS + +D S + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
I + Y+H IIHRDLK NI +DE N +I DFG A+
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 12/161 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI--AVKRL--STTSGQGIEELKNEVLLIAKLQH 583
+ + +KLG G +G VY+G + AVK L T +EE E ++ +++H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKH 68
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
NLV+LLG C E +I EFM +L ++ E +Q + + I+ + YL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ IHRDL A N L+ E +++DFG +R+ G+
Sbjct: 128 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 21/168 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKG--KLSNGQEI--AVKRL---STTSGQGIEELKNEVLLIAK 580
+ KLG G FG V +G +G+ + AVK L + + +++ EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGI 636
L HRNL++L G L ++ E P SL + L + + +
Sbjct: 78 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQV 130
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
A G+ YL R IHRDL A N+LL + +I DFG R +
Sbjct: 131 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 8/152 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+G+G FG V G G ++AVK + + + E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 588 KLLGCCLEEDEN-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+LLG +EE ++ E+M SL ++ + +L L + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+HRDL A N+L+ E ++SDFG +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 534 NKLGQGGFGPVYKGKLSNGQE------IAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+LG+G FG V+ + N +AVK L S ++ + E L+ LQH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYF------------IFDESRKQLLDWKKRFDIILG 635
+ G C E ++++E+M + L+ F ++ L + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+A G++YL + L +HRDL N L+ + + +I DFG +R
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 43/171 (25%), Positives = 79/171 (46%), Gaps = 9/171 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHR 584
+ + K+G+G FG K +G++ +K +S S + EE + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+V+ E ++ ++ L I + + L + D + I + ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+I+HRD+K+ NI L + ++ DFG ARV LA +GT
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 535 KLGQGGFGPVYKGKLSNGQE---IAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+LG G FG V +G ++ +A+K L T EE+ E ++ +L + +V+L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
G C E ML+ E L F+ +++ + +++ ++ G+ YL
Sbjct: 77 GVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+HRDL A N+LL + +ISDFG ++ G ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 534 NKLGQGGFGPVYKGKL----SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
+G G G V G+L +A+K L + + + + +E ++ + H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
L G M++ E+M N SLD F+ + + ++ G+ G+ YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SD 169
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
L +HRDL A N+L+D + ++SDFG +RV +
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 534 NKLGQGGFGPVYKGKLSNGQE----IAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
+G+G FG VY G+ + + A+K L T Q +E E LL+ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 589 LLGCCLEEDE-NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
L+G L + ++ +M + L FI R K L +ARG+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL---A 141
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+ +HRDL A N +LDE +++DFG AR
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 534 NKLGQGGFGPVYKGKLSNG----QEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
+G+G FG VY G L + AVK L T + + E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 589 LLGCCLEEDEN-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
LLG CL + + +++ +M + L FI + K L +A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ +HRDL A N +LDEK +++DFG AR
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 17/165 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE----IAVKRL--STTSGQGIEELKNEVLLIAKL 581
+ LG+G FG V +G L +AVK + +S + IEE +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 582 QHRNLVKLLGCCLEED-----ENMLIYEFMPNKSLDYFI---FDESRKQLLDWKKRFDII 633
H N+++LLG C+E + M+I FM L ++ E+ + + + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ IA G+ YL S +HRDL A N +L + M ++DFG ++
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 535 KLGQGGFGPVYKGKLSNG---QEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKL 589
+LG G FG V KG + +AVK L +EL E ++ +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKKRFDIILGIARGVLYLHQD 646
+G C E ML+ E L+ ++ K +++ + ++ G+ YL
Sbjct: 84 IGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYL--- 133
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+HRDL A N+LL + +ISDFG ++ +E
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 48/166 (28%), Positives = 71/166 (42%), Gaps = 18/166 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNG----QEIAVKRL--STTSGQGIEELKNEVLLIAKL 581
F+ LG+G FG V + +L ++AVK L + IEE E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 582 QHRNLVKLLGCCLEEDEN------MLIYEFMPNKSLDYFIFD---ESRKQLLDWKKRFDI 632
H ++ KL+G L M+I FM + L F+ L +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
++ IA G+ YL S IHRDL A N +L E M ++DFG +R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 534 NKLGQGGFGPVYKGKLSNG------QEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+LG+G FG V+ + N +AVK L + ++ + E L+ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYF-------------IFDESRKQLLDWKKRFDIIL 634
K G C + D ++++E+M + L+ F K L + I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IA G++YL + +HRDL N L+ + +I DFG +R
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 40/178 (22%), Positives = 77/178 (43%), Gaps = 20/178 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQH 583
NF K+G+G F VY+ L +G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILG----IA 637
N++K +E++E ++ E L I K K+ + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWKYFVQLC 146
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ ++H R++HRD+K +N+ + ++ D G R F + A + +VGT
Sbjct: 147 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 60/267 (22%), Positives = 114/267 (42%), Gaps = 30/267 (11%)
Query: 438 SNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSE 497
+ RR A + I++ GL L+T ++ E L+ +
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELST---SLYKKAGSENLYFQGANTVHI 66
Query: 498 REASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNG----Q 553
++++ + + ++ V + L + +G+G FG VY G L +
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHF--------NEVIGRGHFGCVYHGTLLDNDGKKI 118
Query: 554 EIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN-MLIYEFMPNKSL 611
AVK L T + + E +++ H N++ LLG CL + + +++ +M + L
Sbjct: 119 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 612 DYFIFDESR----KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667
FI +E+ K L+ L +A+G+ +L + + +HRDL A N +LDEK
Sbjct: 179 RNFIRNETHNPTVKDLIG------FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF 229
Query: 668 NPRISDFGTARVFGGEEILAITKRVVG 694
+++DFG AR +E ++ +
Sbjct: 230 TVKVADFGLARDMYDKEFDSVHNKTGA 256
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-30
Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 6/152 (3%)
Query: 534 NKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+KLG G +G VY+G +AVK L + + +EE E ++ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
C E +I EFM +L ++ E +Q + + I+ + YL + I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 653 HRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
HR+L A N L+ E +++DFG +R+ G+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-30
Identities = 50/157 (31%), Positives = 72/157 (45%), Gaps = 6/157 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
++ KLG G FG V+ + ++AVK + S E E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLV 246
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
KL +E +I EFM SL F+ K D IA G+ ++
Sbjct: 247 KLHAVVTKE-PIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ IHRDL+A+NIL+ + +I+DFG ARV E
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 28/185 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+F +G GGFG V+K K +G+ +KR+ + E+ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 587 VKLLGCCLEEDENM----------------LIYEFMPNKSLDYFIFDESRKQLLDWKKRF 630
V GC D + + EF +L+ +I ++ R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK 690
++ I +GV Y+H ++I+RDLK SNI L + +I DFG +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--- 179
Query: 691 RVVGT 695
R GT
Sbjct: 180 RSKGT 184
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 41/174 (23%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRLSTTSGQGIEELKNEVLLIA 579
++ + LGQG F ++KG + E+ +K L E +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
KL H++LV G C+ DEN+L+ EF+ SLD ++ + K ++ + ++ +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPR--------ISDFGTARVFGGEEI 685
+ +L +IH ++ A NILL + + + +SD G + ++I
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 17/165 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE------IAVKRL-STTSGQGIEELKNEVLLIAK 580
+ + S +LGQG FG VY+G + +A+K + S + E NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF-------IFDESRKQLLDWKKRFDII 633
++V+LLG + ++I E M L + + + K +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
IA G+ YL + + +HRDL A N ++ E +I DFG R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 21/163 (12%)
Query: 534 NKLGQGGFGPVYKGKLSNGQE---IAVKRL-STTSGQGIEELKNEVLLIAKL-QHRNLVK 588
+ +G+G FG V K ++ A+KR+ S + E+ ++ KL H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYF-------------IFDESRKQLLDWKKRFDIILG 635
LLG C L E+ P+ +L F S L ++
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ARG+ YL S+ + IHRDL A NIL+ E +I+DFG +R
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 10/176 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHR 584
+++ +G G +G K + S+G+ + K + + + L +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 585 NLVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESRK-QLLDWKKRFDIILGIARGVL 641
N+V+ ++ L + E+ L I +++ Q LD + ++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 642 YLHQ--DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
H+ D ++HRDLK +N+ LD K N ++ DFG AR+ + A T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 11/163 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-----IAVKRL-STTSGQGIEELKNEVLLIAKL 581
+ +G G FG VYKG L +A+K L + + + + E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL 641
H N+++L G + M+I E+M N +LD F+ + + ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
YL + + +HRDL A NIL++ + ++SDFG +RV +
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 52/169 (30%), Positives = 82/169 (48%), Gaps = 10/169 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKG--KLSNGQEI--AVKRL-STTSGQGIEELKNEVLLIAKLQ 582
N S +G G FG V G KL + +EI A+K L + + + E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H N+++L G + M++ E+M N SLD F+ + ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691
L S + +HRDL A NIL++ + ++SDFG RV + A T R
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL--SNGQEI--AVKRL-STTSGQGIEELKNEVLLIAKLQ 582
++ + LG+G FG VY+G G++I AVK + E+ +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGIAR 638
H ++VKL+G EE +I E P L +++ L+ + L I +
Sbjct: 72 HPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY------SLQICK 124
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ YL + +HRD+ NIL+ ++ DFG +R E+
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ +LG G FG V+ G + ++AVK L S + E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L +E +I E+M N SL F+ L K D+ IA G+ ++
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
IHRDL+A+NIL+ + ++ +I+DFG AR+ E
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 40/162 (24%), Positives = 67/162 (41%), Gaps = 11/162 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKG--KLSNGQEI--AVKRL-STTSGQGIEELKNEVLLIAKLQ 582
+ +G+G FG V++G + A+K + TS E+ E L + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H ++VKL+G E +I E L F+ + RK LD ++ + Y
Sbjct: 75 HPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
L R +HRD+ A N+L+ ++ DFG +R
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 17/176 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQHRN 585
+F LG+GGFG V++ K + A+KR+ E++ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 586 LVKLLGCCLEEDE---------NMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDII 633
+V+ LE++ + +Y + ++L ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
L IA V +LH ++HRDLK SNI ++ DFG +E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-29
Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 535 KLGQGGFGPVYKGKLSNGQE---IAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+LG G FG V +G ++ +A+K L T EE+ E ++ +L + +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
G C E ML+ E L F+ +++ + +++ ++ G+ YL
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+HR+L A N+LL + +ISDFG ++ G ++
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 51/165 (30%), Positives = 71/165 (43%), Gaps = 17/165 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNG------QEIAVKRL-STTSGQGIEELKNEVLLIAK 580
N + LG G FG VY+G++S ++AVK L S Q + E L+I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGI 636
H+N+V+ +G L+ ++ E M L F+ S+ L + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR---ISDFGTAR 678
A G YL IHRD+ A N LL R I DFG AR
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
LG+G +G VY G+ LSN IA+K + + + L E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 595 EEDENMLIYEFMPNKSLD--------YFIFDESR-----KQLLDWKKRFDIILGIARGVL 641
E + E +P SL +E KQ+L G+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-------------EGLK 136
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGEEILAITKRVVGT 695
YLH + +I+HRD+K N+L++ +ISDFGT++ G I T+ GT
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGT 186
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
++ KLGQG FG V+ G + +A+K L + E E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 325
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L EE ++ E+M SL F + L + D+ IA G+ Y+
Sbjct: 326 QLYAVVSEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
R+ +HRDL+A+NIL+ E + +++DFG AR+ E
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
++ KLGQG FG V+ G + +A+K L + E E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 242
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L EE ++ E+M SL F + L + D+ IA G+ Y+
Sbjct: 243 QLYAVVSEE-PIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
R+ +HRDL+A+NIL+ E + +++DFG AR+ E
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 34/203 (16%)
Query: 490 NSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKL 549
N + F+ + +SIS KE+ + ++T LG G FG VY+G++
Sbjct: 50 NPNYCFAGKTSSISDL--KEVPRKNITLIR---------------GLGHGAFGEVYEGQV 92
Query: 550 SNG------QEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602
S ++AVK L S Q + E L+I+K H+N+V+ +G L+ ++
Sbjct: 93 SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152
Query: 603 YEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658
E M L F+ S+ L + IA G YL IHRD+ A
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAA 209
Query: 659 SNILLDEKMNPR---ISDFGTAR 678
N LL R I DFG AR
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 31/179 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNG------QEIAVKRL-STTSGQGIEELKNEVLLIAK 580
N LG+G FG V K + +AVK L S + +L +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSL-DY--------------------FIFDES 619
+ H +++KL G C ++ +LI E+ SL + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 620 RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
++ L I++G+ YL + ++++HRDL A NIL+ E +ISDFG +R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 16/177 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRN 585
+ S+ LGQG V++G+ G A+K + S + ++ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 586 LVKLLGCCLEEDENMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
+VKL EE EF P SL + + S L + ++ + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 643 LHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
L + I+HR++K NI+ D + +++DFG AR +E + GT
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGT 178
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 45/173 (26%), Positives = 71/173 (41%), Gaps = 31/173 (17%)
Query: 534 NKLGQGGFGPVYKGKLSNG------QEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNL 586
+G+G FG V++ + +AVK L S + + E L+A+ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYF---------------------IFDESRKQLLD 625
VKLLG C L++E+M L+ F L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 626 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
++ I +A G+ YL S + +HRDL N L+ E M +I+DFG +R
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 48/167 (28%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 534 NKLGQGGFGPVYKGKLSN------GQEIAVKRL-STTSGQGIEELKNEVLLIAKL-QHRN 585
LG+G FG V + + +AVK L + L +E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 586 LVKLLGCCLEEDE-NMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFD 631
+V LLG C + M+I EF +L Y ++ K L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 632 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+A+G+ +L + + IHRDL A NILL EK +I DFG AR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRL-STTSGQGIEELKNEVLLI 578
D + LG+G FG V + +AVK L + + + +L +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 579 AKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRKQLL 624
+ +H+N++ LLG C ++ +I E+ +L +Y + + ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 50/237 (21%), Positives = 96/237 (40%), Gaps = 34/237 (14%)
Query: 473 TRIGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATD---- 528
++ +R RR+ + SS+ + + +S D
Sbjct: 18 HKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWE 77
Query: 529 ----NFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRL-STTSGQGIEELKNEV 575
+ LG+G FG V + +AVK L + + + +L +E+
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 576 LLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRK 621
++ + +H+N++ LLG C ++ +I E+ +L +Y + + +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 622 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ + +K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 40/162 (24%), Positives = 67/162 (41%), Gaps = 11/162 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKG--KLSNGQEI--AVKRL-STTSGQGIEELKNEVLLIAKLQ 582
+ +G+G FG V++G + A+K + TS E+ E L + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H ++VKL+G E +I E L F+ + RK LD ++ + Y
Sbjct: 450 HPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
L R +HRD+ A N+L+ ++ DFG +R
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 48/174 (27%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE------IAVKRL-STTSGQGIEELKNEVLLIAK 580
+ S LG G FG V + + +AVK L + E L +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF---------------IFDESRKQLL 624
L H N+V LLG C ++I E+ L F E + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
D + +A+G+ +L + IHRDL A NILL +I DFG AR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 16/173 (9%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRNL 586
+S ++G GG V++ Q A+K L Q ++ +NE+ + KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 587 --VKLLGCCLEEDENMLIYEFM--PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
++L E + IY M N L+ ++ +K+ +D +R + V
Sbjct: 89 KIIRLYDY--EITDQY-IYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 142
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+HQ I+H DLK +N L+ ++ DFG A + + VGT
Sbjct: 143 IHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 16/177 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRN 585
+ S+ LGQG V++G+ G A+K + S + ++ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 586 LVKLLGCCLEEDENMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
+VKL EE EF P SL + + S L + ++ + G+ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 643 LHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
L + I+HR++K NI+ D + +++DFG AR +E + GT
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGT 178
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 49/180 (27%), Positives = 87/180 (48%), Gaps = 30/180 (16%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
++ K+GQG G VY ++ GQE+A+++++ E + NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGIARGVL 641
+V L L DE ++ E++ SL + DE I + R L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE------------GQIAAVCRECL 126
Query: 642 ----YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
+LH + ++IHRD+K+ NILL + +++DFG F + +KR +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 45/170 (26%), Positives = 68/170 (40%), Gaps = 22/170 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRL-STTSGQGIEELKNEVLLIAK 580
+N LG G FG V + ++AVK L ST E L +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSL-----------DYFIFDESRKQLLDWKK 628
L QH N+V LLG C ++I E+ L + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+A+G+ +L + IHRD+ A N+LL +I DFG AR
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 39/220 (17%)
Query: 490 NSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATD---NFSTSNKLGQGGFGPVYK 546
+++ + L ++ D + K+G+G G V
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKA------ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCL 63
Query: 547 GK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605
+ +G+++AVK + Q E L NEV+++ QH N+V++ L +E ++ EF
Sbjct: 64 AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 606 MPNKSLDYFI----FDESRKQLLDWKKRFDIILGIARGVL----YLHQDSRLRIIHRDLK 657
+ +L + +E + I + VL YLH +IHRD+K
Sbjct: 124 LQGGALTDIVSQVRLNE------------EQIATVCEAVLQALAYLHAQ---GVIHRDIK 168
Query: 658 ASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
+ +ILL ++SDFG F + + KR +VGT
Sbjct: 169 SDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGT 204
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 54/176 (30%), Positives = 86/176 (48%), Gaps = 20/176 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
+ + +LG G FG VYK K G A K + T S + +E+ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL---- 641
+VKLLG + + ++ EF P ++D I E + L + I + R +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTE-----PQIQVVCRQMLEALN 131
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
+LH RIIHRDLKA N+L+ + + R++DFG + + + KR +GT
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGT 180
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 16/173 (9%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRNL 586
+S ++G GG V++ Q A+K L Q ++ +NE+ + KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 587 --VKLLGCCLEEDENMLIYEFM--PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
++L E + IY M N L+ ++ +K+ +D +R + V
Sbjct: 70 KIIRLYDY--EITDQY-IYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 123
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+HQ I+H DLK +N L+ ++ DFG A + + VGT
Sbjct: 124 IHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 26/168 (15%)
Query: 534 NKLGQGGFGPVYKGKL--------SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKL-QH 583
LG+G FG V + + ++AVK L S + + + +L +E+ ++ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRF 630
+N++ LLG C ++ +I E+ +L +Y + + ++ L K
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ARG+ YL + + IHRDL A N+L+ E +I+DFG AR
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 47/220 (21%), Positives = 75/220 (34%), Gaps = 36/220 (16%)
Query: 491 SSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-L 549
SS + T+ N+ + + + ++G+G FG V++ K
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 550 SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609
G + AVK++ E++ A L +V L G E + E +
Sbjct: 81 QTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135
Query: 610 SL-----DYFIFDESR-----KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKAS 659
SL E R Q L G+ YLH RI+H D+KA
Sbjct: 136 SLGQLIKQMGCLPEDRALYYLGQAL-------------EGLEYLHTR---RILHGDVKAD 179
Query: 660 NILLDEKMNP-RISDFGTARVFGGEEILAITKR---VVGT 695
N+LL + + DFG A + + + GT
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 41/173 (23%), Positives = 72/173 (41%), Gaps = 16/173 (9%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRNL 586
+S ++G GG V++ Q A+K L Q ++ +NE+ + KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 587 --VKLLGCCLEEDENMLIYEFM--PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
++L E + IY M N L+ ++ +K+ +D +R + V
Sbjct: 117 KIIRLYDY--EITDQY-IYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 170
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+HQ I+H DLK +N L+ ++ DFG A + + VG
Sbjct: 171 IHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 16/169 (9%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
++G+G F VYKG E+A + + + K E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 592 CCL---EEDENMLIY-EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+ + +++ E M + +L ++ R +++ K I +G+ +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 648 RLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGEEILAITKRVVGT 695
IIHRDLK NI + + +I D G A + K V+GT
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 193
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-26
Identities = 43/176 (24%), Positives = 71/176 (40%), Gaps = 20/176 (11%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEV-LLIAKLQHRNLV 587
+F + LG G G + + + +++AVKR+ + EV LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 588 KLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+ C E+D + E +Y E + + ++ G+ +LH
Sbjct: 82 RYF--CTEKDRQFQYIAIELCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 646 DSRLRIIHRDLKASNILLDEK-----MNPRISDFGTARVF-GGEEILAITKRVVGT 695
L I+HRDLK NIL+ + ISDFG + G + V GT
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 16/147 (10%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+GGF ++ + A K + E++ E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 592 CCLEEDENM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
E+++ + ++ E +SL + RK L + + R+ + I G YLH+
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR--- 159
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFG 675
R+IHRDLK N+ L+E + +I DFG
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFG 186
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQE 554
S + ++++K+D E S + F KLG+G +G VYK GQ
Sbjct: 1 SLETVQLRNPPRRQLKKLD----EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQI 56
Query: 555 IAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF 614
+A+K++ ++E+ E+ ++ + ++VK G + + ++ E+ S+
Sbjct: 57 VAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI 114
Query: 615 IFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674
I R + L + I+ +G+ YLH R IHRD+KA NILL+ + + +++DF
Sbjct: 115 I--RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADF 169
Query: 675 GTARVFGGEEILAITKR--VVGT 695
G G+ + KR V+GT
Sbjct: 170 G----VAGQLTDTMAKRNTVIGT 188
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 41/147 (27%), Positives = 70/147 (47%), Gaps = 16/147 (10%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+GGF ++ + A K + E++ E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 592 CCLEEDENM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
E+++ + ++ E +SL + RK L + + R+ + I G YLH R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLH---R 133
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFG 675
R+IHRDLK N+ L+E + +I DFG
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFG 160
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 44/173 (25%), Positives = 68/173 (39%), Gaps = 31/173 (17%)
Query: 534 NKLGQGGFGPVYKGKLSNGQE------IAVKRL-STTSGQGIEELKNEVLLIAKL-QHRN 585
LG G FG V + +AVK L E L +E+ ++ +L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSL-DY-------------------FIFDESRKQLLD 625
+V LLG C LI+E+ L +Y + +E +L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 626 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
++ +A+G+ +L +HRDL A N+L+ +I DFG AR
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 15/179 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRN 585
D++ +G G V +++A+KR++ Q ++EL E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD--IILGIARGVL-- 641
+V + +DE L+ + + S+ I + D I I R VL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG-TARVFGGEEILAITKR--VVGT 695
YLH++ IHRD+KA NILL E + +I+DFG +A + G +I R VGT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 20/175 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG---IEELKNEVLLIAKLQ 582
FS ++G G FG VY + + N + +A+K++S + Q +++ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H N ++ GC L E L+ E+ + D E K+ L + + G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
LH +IHRD+KA NILL E ++ DFG + VGT
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASI----MAPANSFVGT 213
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 22/161 (13%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGC 592
L +GGF VY+ + + +G+E A+KRL + + + EV + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDE-SRKQLLDW------KKRF------DIILGIARG 639
E ++ + E + QL+++ + I R
Sbjct: 95 ASIGKEES------DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
V ++H+ + IIHRDLK N+LL + ++ DFG+A
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 15/173 (8%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHR 584
+ F+ K+G+G FG V+KG + +A+K + + IE+++ E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
+ K G L++ + +I E++ S D LD + I+ I +G+ YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
+ + IHRD+KA+N+LL E +++DFG A G+ KR VGT
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGT 182
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEE-LKNEVLLIAKLQH 583
++F N LG+G F VY+ + + G E+A+K + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 584 RNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGI 636
++++L E+ + L+ E N + + + K F + I
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNR----VKPFSENEARHFMHQI 121
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
G+LYLH I+HRDL SN+LL MN +I+DFG
Sbjct: 122 ITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFG 157
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 55/182 (30%), Positives = 83/182 (45%), Gaps = 29/182 (15%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
+ ++ LG+G FG V K K QE AVK ++ + + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 584 RNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGI 636
N++KL E+ + ++ E L FDE K +KRF II +
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIKQV 130
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVV 693
G+ Y+H+ I+HRDLK NILL ++ + +I DFG + F + K +
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI 184
Query: 694 GT 695
GT
Sbjct: 185 GT 186
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 53/174 (30%), Positives = 86/174 (49%), Gaps = 21/174 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKN--------EVLLIA 579
+ + K+G+G +G VYK K S G+ +A+KR+ ++ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
+L H N+V L+ E L++EFM K L + + K L + + + RG
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRG 131
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
V + HQ RI+HRDLK N+L++ +++DFG AR F G + + T VV
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 43/186 (23%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLI 578
+NF K+G+G +G VYK + G+ +A+K++ ++ E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPN------KSLDYFIFDESR-----KQLLDWK 627
+L H N+VKLL E++ L++EF+ + QLL
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 628 KRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687
+G+ + H R++HRDLK N+L++ + +++DFG AR F G +
Sbjct: 114 ----------QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRT 159
Query: 688 ITKRVV 693
T VV
Sbjct: 160 YTHEVV 165
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 20/180 (11%)
Query: 524 LAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-----IEELKNEVLL 577
++++ F KLG G + VYKG + G +A+K + S +G I E+ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----L 56
Query: 578 IAKLQHRNLVKLLGCCLEEDENMLIYEFMPN--KSL--DYFIFDESRKQLLDWKKRFDII 633
+ +L+H N+V+L E++ L++EFM N K + + R L+ K F
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF--Q 114
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
+ +G+ + H++ +I+HRDLK N+L++++ ++ DFG AR F G + + VV
Sbjct: 115 WQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 14/176 (7%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHR 584
D F KLG G FG V+ + S+G E +K ++ Q +E+++ E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 585 NLVKLLGCCLEEDENM-LIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
N++K+ E+ NM ++ E L + + ++R + L +++ + + Y
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 643 LHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
H ++H+DLK NIL +I DFG A +F +E GT
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 43/214 (20%), Positives = 74/214 (34%), Gaps = 17/214 (7%)
Query: 487 LFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYK 546
L+ S + R +S +G + +F ++LG G +G V+K
Sbjct: 18 LYFQSMHQLQPRR--VSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFK 75
Query: 547 G-KLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602
+G+ AVK + EV K+ QH V+L EE + +
Sbjct: 76 VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGILYL 134
Query: 603 Y-EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 661
E SL E+ L + + + + +LH ++H D+K +NI
Sbjct: 135 QTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANI 188
Query: 662 LLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
L + ++ DFG G + G
Sbjct: 189 FLGPRGRCKLGDFGLLVELGTAG---AGEVQEGD 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 55/182 (30%), Positives = 83/182 (45%), Gaps = 29/182 (15%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
+ ++ LG+G FG V K K QE AVK ++ + + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 584 RNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGI 636
N++KL E+ + ++ E L FDE K +KRF II +
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIKQV 130
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVV 693
G+ Y+H+ I+HRDLK NILL ++ + +I DFG + F + K +
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI 184
Query: 694 GT 695
GT
Sbjct: 185 GT 186
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
D + +LG G FG V++ + G+ K ++T +KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 586 LVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLY 642
L+ L E+ M LI EF+ L FD + + + + + G+ +
Sbjct: 110 LINLHDAF-EDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPR--ISDFGTARVFGGEEILAITKRVVGT 695
+H+ I+H D+K NI+ + K I DFG A +EI+ K T
Sbjct: 165 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTAT 213
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 41/181 (22%), Positives = 70/181 (38%), Gaps = 29/181 (16%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
++ N +G+G +G V A K++ + ++ K E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 586 LVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIA 637
+++L ED L+ E L F+ K+ F I+ +
Sbjct: 68 IIRLYETF--EDNTDIYLVMELCTGGEL----FERVVH-----KRVFRESDAARIMKDVL 116
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVG 694
V Y H+ L + HRDLK N L ++ DFG A F +++ + VG
Sbjct: 117 SAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVG 170
Query: 695 T 695
T
Sbjct: 171 T 171
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 29/182 (15%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
++ + KLG G +G V + E A+K + T S +L EV ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 584 RNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGI 636
N++KL E+ N L+ E L FDE + +F II +
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGEL----FDEIIH-----RMKFNEVDAAVIIKQV 145
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVV 693
GV YLH+ I+HRDLK N+LL ++ +I DFG + VF ++ + K +
Sbjct: 146 LSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERL 199
Query: 694 GT 695
GT
Sbjct: 200 GT 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 40/186 (21%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLI 578
D + KLG+G +G VYK + +A+KR+ +E + EV L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------I 632
+LQHRN+++L LI+E+ + K+ +D
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSF 137
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR-----ISDFGTARVFGGEEILA 687
+ + GV + H R +HRDLK N+LL I DFG AR F G I
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 688 ITKRVV 693
T ++
Sbjct: 194 FTHEII 199
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 4e-23
Identities = 41/175 (23%), Positives = 84/175 (48%), Gaps = 22/175 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLI 578
+ K+G+G +G V+K K + +A+KR+ +++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
+L+H+N+V+L + + L++EF + L + +S LD + + + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLK 112
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
G+ + H ++HRDLK N+L++ ++++FG AR F G + + VV
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 19/175 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLI 578
+ + LG+G F VYK + + Q +A+K++ E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
+L H N++ LL + L+++FM L+ I D S K + +L +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQ 123
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
G+ YLHQ I+HRDLK +N+LLDE +++DFG A+ F G A T +VV
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV 174
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 5e-23
Identities = 44/174 (25%), Positives = 86/174 (49%), Gaps = 21/174 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKN--------EVLLIA 579
+ + K+G+G +G VYK + + G+ A+K++ +E+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
+L+H N+VKL + +L++E + + L + + + L+ +L + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNG 112
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
+ Y H R++HRDLK N+L++ + +I+DFG AR F G + T +V
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 17/173 (9%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
S + LG G FG V+K + + G ++A K + T + EE+KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 588 KLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLH 644
+L E ++ L+ E++ L FD L + I G+ ++H
Sbjct: 150 QLYD-AFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVFGGEEILAITKRVVGT 695
Q + I+H DLK NIL + +I DFG AR + E L K GT
Sbjct: 205 Q---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGT 251
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 5e-23
Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 16/173 (9%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHR 584
+ +LG GGFG V + G+++A+K+ E E+ ++ KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 585 NLVKLLGCCLEEDENM-------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIA 637
N+V + + + L E+ L ++ L ++ I+
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVFGGEEILA 687
+ YLH+ RIIHRDLK NI+L +++ +I D G A+ E+
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 50/228 (21%), Positives = 92/228 (40%), Gaps = 15/228 (6%)
Query: 473 TRIGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFST 532
ERKR+R ++ R +S +I K D++
Sbjct: 102 IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDI 161
Query: 533 SNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+LG G FG V++ + G A K + T E ++ E+ ++ L+H LV L
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+++E ++IYEFM L F++ + + + + + +G+ ++H+
Sbjct: 222 AFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---N 274
Query: 650 RIIHRDLKASNILLDEKMNPRI--SDFGTARVFGGEEILAITKRVVGT 695
+H DLK NI+ K + + DFG ++ + K GT
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGT 319
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 31/179 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-----IEELKNEVLLIAKL 581
+ + +KLG+G + VYKGK +A+K + +G I E+ L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKR-FD------IIL 634
+H N+V L E L++E++ D+ KQ LD + +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL----------DKDLKQYLDDCGNIINMHNVKLFLF 107
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
+ RG+ Y H+ +++HRDLK N+L++E+ +++DFG AR VV
Sbjct: 108 QLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV 162
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 59/183 (32%), Positives = 82/183 (44%), Gaps = 30/183 (16%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLST---TSGQGIEELKNEVLLIAKLQ 582
+D + LG+G FG V K GQE AVK +S E L EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 583 HRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILG 635
H N++KL E+ L+ E L FDE +KRF II
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGEL----FDEIIS-----RKRFSEVDAARIIRQ 134
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRV 692
+ G+ Y+H+ +I+HRDLK N+LL + N RI DFG + F + + K
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDK 188
Query: 693 VGT 695
+GT
Sbjct: 189 IGT 191
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 37/165 (22%), Positives = 72/165 (43%), Gaps = 25/165 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL----------STTSGQGIEELKNEVL 576
+ + K+G+G +G V+K + GQ +A+K+ + E++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA----LREIR---- 54
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
++ +L+H NLV LL + L++E+ + L + ++ + I
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQT 111
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+ V + H+ IHRD+K NIL+ + ++ DFG AR+
Sbjct: 112 LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 19/181 (10%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK-----RLSTTSGQGIEELKNEVLLIAK 580
D + +G+G F V + GQ+ AVK + +++ G E+LK E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 581 LQHRNLVKLLGCCLEEDENM--LIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIA 637
L+H ++V+LL + M +++EFM L + + + I
Sbjct: 83 LKHPHIVELLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVFGGEEILAITKRVVG 694
+ Y H IIHRD+K +LL K N ++ FG A G + VG
Sbjct: 141 EALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVG 195
Query: 695 T 695
T
Sbjct: 196 T 196
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEE-LKNEVLLIAKLQH 583
++F LG+G FG VY + + +A+K L + G+E L+ EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGIA 637
N+++L G + LI E+ P ++ + E +K +FD I +A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKL-----SKFDEQRTATYITELA 119
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+ Y H R+IHRD+K N+LL +I+DFG
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 154
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 17/176 (9%)
Query: 527 TDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
+DN+ +LG+G F V + + G E A K ++T S + ++L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLY 642
N+V+L EE + L+++ + L F++ ++ I I + Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVFGGEEILAITKRVVGT 695
H I+HR+LK N+LL K +++DFG A E GT
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGT 170
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 25/165 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL----------STTSGQGIEELKNEVL 576
+ + +G+G +G V K + G+ +A+K+ + E+K
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA----MREIK---- 76
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
L+ +L+H NLV LL C ++ L++EF+ + LD E LD++ + I
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQI 133
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
G+ + H IIHRD+K NIL+ + ++ DFG AR
Sbjct: 134 INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 2e-22
Identities = 47/191 (24%), Positives = 71/191 (37%), Gaps = 33/191 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEV-LLIAKLQHRNL 586
+ + LG G G V G+ +AVKR+ + E+ LL H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 587 VKLLGCCLEEDENM--LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARG 639
++ C E + + E N +L + DE+ K ++ ++ IA G
Sbjct: 72 IRYY--CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASG 127
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPR-------------ISDFGTARVFGGEE-- 684
V +LH L+IIHRDLK NIL+ ISDFG + +
Sbjct: 128 VAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 685 ILAITKRVVGT 695
GT
Sbjct: 185 FRTNLNNPSGT 195
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 17/157 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSG-QGIEELKNEV-LLIAKLQHR 584
D+ +LG+G +G V K + + +GQ +AVKR+ T Q + L ++ + + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARGVL- 641
V G E + + E M + SLD F KQ++D + DI+ IA ++
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+LH S+L +IHRD+K SN+L++ ++ DFG
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG 155
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 34/175 (19%), Positives = 74/175 (42%), Gaps = 18/175 (10%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
+ + + LG+G FG V++ S+ + K + G +K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 586 LVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLY 642
++ L E E + +I+EF+ + F+ + L+ ++ + + + +
Sbjct: 63 ILHLHESF-ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNP--RISDFGTARVFGGEEILAITKRVVGT 695
LH I H D++ NI+ + + +I +FG AR + + +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTA 166
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 21/180 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHR 584
F +G G +G VYKG+ + GQ A+K + T G EE+K E+ ++ K HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHR 81
Query: 585 NLVKLLGC------CLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIA 637
N+ G +D+ L+ EF S+ D + ++ L + I I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEWIAYICREIL 139
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
RG+ +LHQ ++IHRD+K N+LL E ++ DFG + + + +R +GT
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGT 192
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 22/181 (12%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGI---------EELKNEVL 576
+N+ LG+G V + +E AVK + T G E EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 577 LIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIIL 634
++ K+ H N+++L L+++ M L FD + K L K+ I+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMR 131
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ + LH+ L I+HRDLK NILLD+ MN +++DFG + E L + V G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCG 185
Query: 695 T 695
T
Sbjct: 186 T 186
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
+DN+ +LG+G F V + + G E A K ++T S + ++L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 584 RNLVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGV 640
N+V+L ++E+ L+++ + L F++ ++ I I +
Sbjct: 88 PNIVRLHDSI--QEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESI 141
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVFGGEEILAITKRVVGT 695
Y H I+HR+LK N+LL K +++DFG A E GT
Sbjct: 142 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGT 193
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-22
Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 33/186 (17%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG--------IEELKNEVLL 577
+ + +G+G V + + G E AVK + T+ + E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 578 IAKL-QHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF----- 630
+ ++ H +++ L+ E M L+++ M L FD + K
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGEL----FDYLTE-----KVALSEKET 202
Query: 631 -DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
I+ + V +LH I+HRDLK NILLD+ M R+SDFG + E L
Sbjct: 203 RSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--- 256
Query: 690 KRVVGT 695
+ + GT
Sbjct: 257 RELCGT 262
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 7e-22
Identities = 36/174 (20%), Positives = 65/174 (37%), Gaps = 31/174 (17%)
Query: 520 LSTLLAATDNFSTSNKLGQG--GFGPVYKGK-LSNGQEIAVKR--LSTTSGQGIEELKNE 574
+S+ L + +G+G V + G+ + V+R L S + + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 575 VLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-------FDESRKQLLDWK 627
+ + H N+V + ++E ++ FM S I +E
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE--------- 127
Query: 628 KRFDIILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
I I +GVL Y+H +HR +KAS+IL+ +S +
Sbjct: 128 ---LAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 7e-22
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 23/176 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRN 585
D+F ++LG G G V+K +G +A K + ++ E+ ++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARGVL-- 641
+V G + E + E M SLD Q+L R I+ ++ V+
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRIPEQILGKVSIAVIKG 143
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
YL + +I+HRD+K SNIL++ + ++ DFG + G+ I ++ VGT
Sbjct: 144 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 193
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHR 584
++ ++G+G +G V K +GQ +AVKR+ +T + ++L ++ ++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARGVL- 641
+V+ G E + + E M + S D F + +I+ I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV-VGT 695
+L L+IIHRD+K SNILLD N ++ DFG + G+ + +I K G
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGC 188
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 52/196 (26%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLI 578
+ K+GQG FG V+K + GQ++A+K++ +E K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 579 AKLQHRNLVKLLGCCLEEDENM--------LIYEFMPN---KSLD--YFIFDESR----- 620
L+H N+V L+ C + L+++F + L F S
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 621 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
+ LL G+ Y+H++ +I+HRD+KA+N+L+ +++DFG AR F
Sbjct: 131 QMLL-------------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 681 G---GEEILAITKRVV 693
+ T RVV
Sbjct: 175 SLAKNSQPNRYTNRVV 190
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 43/169 (25%), Positives = 65/169 (38%), Gaps = 20/169 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKL-Q 582
T F K+G G FG V+K K +G A+KR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 583 HRNLVKLLGCCLEEDENMLIY-EFMPNKSLDYFIFDESRKQLLDWKKRFD------IILG 635
H ++V+ ED++MLI E+ SL I + F ++L
Sbjct: 70 HSHVVRYFSAW-AEDDHMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAELKDLLLQ 123
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ RG+ Y+H ++H D+K SNI + P +
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 53/182 (29%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLST------TSGQGIEELKNEVLLIA 579
D + +LG G F V K + S G E A K + G EE++ EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 580 KLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIA 637
++ H N++ L E ++ LI E + L FD ++K+ L ++ I I
Sbjct: 71 QVLHHNVITLHDVY-ENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQIL 125
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNP----RISDFGTARVFGGEEILAITKRVV 693
GV YLH +I H DLK NI+L +K P ++ DFG A K +
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF 179
Query: 694 GT 695
GT
Sbjct: 180 GT 181
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT------SGQGIEELKNEVLLIA 579
D++ +LG G F V K + G+E A K + G EE++ EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 580 KLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIA 637
+++H N++ L E ++ LI E + L FD + K+ L + + I
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQIL 118
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNP----RISDFGTARVFGGEEILAITKRVV 693
GV YLH RI H DLK NI+L +K P ++ DFG A K +
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF 172
Query: 694 GT 695
GT
Sbjct: 173 GT 174
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 39/170 (22%), Positives = 74/170 (43%), Gaps = 25/170 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLS-----------------TTSGQGIEE 570
+++ L QG F + + + + A+K+ + ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 571 LKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL-DY----FIFDESRKQLLD 625
KNE+ +I +++ + G DE +IYE+M N S+ + F+ D++ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 626 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+ II + Y+H + I HRD+K SNIL+D+ ++SDFG
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFG 197
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 22/181 (12%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS------GQGIEELKNEVLLIA 579
D + +LG G F V K + S G E A K + G EE++ EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIAR 638
++ H N++ L + +LI E + L FD ++K+ L ++ I I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNP----RISDFGTARVFGGEEILAITKRVVG 694
GV YLH +I H DLK NI+L +K P ++ DFG A K + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFG 180
Query: 695 T 695
T
Sbjct: 181 T 181
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 39/203 (19%), Positives = 79/203 (38%), Gaps = 36/203 (17%)
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI 555
+ + + + V + T ++ +G G FG V++ KL E+
Sbjct: 8 APLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV 67
Query: 556 AVKRLSTTSGQGIEELKN-EVLLIAKLQHRNLVKLLGCCLEEDENM------LIYEFMPN 608
A+K++ + KN E+ ++ ++H N+V L + L+ E++P
Sbjct: 68 AIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP- 121
Query: 609 KSLDYFIFDESRKQLLDWKKRFDIILG----------IARGVLYLHQDSRLRIIHRDLKA 658
E+ + + + + R + Y+H + I HRD+K
Sbjct: 122 ---------ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKP 169
Query: 659 SNILLDEKMNP-RISDFGTARVF 680
N+LLD ++ DFG+A++
Sbjct: 170 QNLLLDPPSGVLKLIDFGSAKIL 192
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 499 EASISTKGNKEIRKVDVTFFELSTLLAA-TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIA 556
E ++S NK D+T + S A D + S LG G G V +++A
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 557 VKRLST--------TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM-LIYEFMP 607
++ +S ++ E+ ++ KL H ++K+ + E+ ++ E M
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLELME 222
Query: 608 NKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666
L FD+ + L + V YLH+ IIHRDLK N+LL +
Sbjct: 223 GGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQ 275
Query: 667 MNP---RISDFGTARVFGGEEILAITKRVVGT 695
+I+DFG +++ G ++ + + GT
Sbjct: 276 EEDCLIKITDFGHSKILGETSLM---RTLCGT 304
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 40/193 (20%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-------------TTSGQGIEELK 572
+++ KLG G +G V K + E A+K + + EE+
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 573 NEVLLIAKLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF- 630
NE+ L+ L H N++KL E+ + L+ EF L F++ + + +F
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGEL----FEQ-----IINRHKFD 144
Query: 631 -----DIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGG 682
+I+ I G+ YLH+ I+HRD+K NILL + +N +I DFG + F
Sbjct: 145 ECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 683 EEILAITKRVVGT 695
+ L + +GT
Sbjct: 202 DYKL---RDRLGT 211
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 53/182 (29%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT------SGQGIEELKNEVLLIA 579
D + T +LG G F V K + S G + A K + G E+++ EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 580 KLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIA 637
++QH N++ L E ++ LI E + L FD + K+ L ++ + + I
Sbjct: 70 EIQHPNVITLHEVY-ENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQIL 124
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNP----RISDFGTARVFGGEEILAITKRVV 693
GV YLH L+I H DLK NI+L ++ P +I DFG A K +
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF 178
Query: 694 GT 695
GT
Sbjct: 179 GT 180
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 26/160 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEE-LKNEVLLIAKLQH 583
D+F LG+G FG VY + N +A+K L S +G+E L+ E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 584 RNLVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILG 635
N++++ D L+ EF P L + E +K RFD +
Sbjct: 74 PNILRMYNYF--HDRKRIYLMLEFAPRGEL----YKELQKH-----GRFDEQRSATFMEE 122
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+A + Y H ++IHRD+K N+L+ K +I+DFG
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG 159
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (233), Expect = 7e-21
Identities = 27/240 (11%), Positives = 55/240 (22%), Gaps = 37/240 (15%)
Query: 475 IGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSN 534
+R EL+ E A + + + S L
Sbjct: 10 FMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQ-NAETTVDSLLSQGERKLKLVE 68
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLL 590
L G V+ + + ++ A+K + S +E L A+L + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 591 GCC-----------------------LEEDENMLIYEFMPNKSLDYFIFDE------SRK 621
++ MP S+D + +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 622 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+ + R L ++H N+ + + D G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 9e-21
Identities = 43/187 (22%), Positives = 69/187 (36%), Gaps = 42/187 (22%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
F LG G F V+ K G+ A+K + + L+NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-----ESRKQLLDW---KKRF------D 631
+V L E Y + E L D + +
Sbjct: 68 IVTLEDIY--ESTTHY-----------YLVMQLVSGGE----LFDRILERGVYTEKDASL 110
Query: 632 IILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAI 688
+I + V YLH+ I+HRDLK N+L +E I+DFG +++ +
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--- 164
Query: 689 TKRVVGT 695
GT
Sbjct: 165 -STACGT 170
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 34/179 (18%), Positives = 70/179 (39%), Gaps = 20/179 (11%)
Query: 506 GNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS 564
++ A ++ ++G G G V+K + G IAVK++ +
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62
Query: 565 G-QGIEELKNEV-LLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQ 622
+ + + ++ +++ +V+ G + + + E M + K
Sbjct: 63 NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--------KL 113
Query: 623 LLDWKKRF--DIILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+ I+ + ++ YL + +IHRD+K SNILLDE+ ++ DFG
Sbjct: 114 KKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFG 170
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 9e-21
Identities = 26/171 (15%), Positives = 56/171 (32%), Gaps = 22/171 (12%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK------LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK 580
+ + LG+G F VY+ N Q+ +K + + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI--FDESRKQLLDWKKRFDIILGIAR 638
+K L ++ ++L+ E +L I + + ++++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 639 GVLYLHQDSRLRIIHRDLKASNILL-----------DEKMNPRISDFGTAR 678
+ +H IIH D+K N +L D + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 26/183 (14%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE--------LKNEVLL 577
D + S LG G G V +++A+K +S ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 578 IAKLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILG 635
+ KL H ++K+ + E+ ++ E M L FD+ + L
Sbjct: 69 LKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ 122
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRV 692
+ V YLH IIHRDLK N+LL +E +I+DFG +++ G ++ + +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTL 176
Query: 693 VGT 695
GT
Sbjct: 177 CGT 179
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 535 KLGQGGFGPVYKGK---LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
K+G+G +G VYK K + ++ A+K++ T G + + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACR-EIALLRELKHPNVISLQK 85
Query: 592 CCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGIARGVLYL 643
L + L++++ L + I + + ++ I G+ YL
Sbjct: 86 VFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPR----ISDFGTARVFG 681
H + ++HRDLK +NIL+ + R I+D G AR+F
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 41/218 (18%), Positives = 66/218 (30%), Gaps = 54/218 (24%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK-----RLSTTSGQGIEELKNEVLLIAK 580
+ +GQG +G V A+K ++ + + +E +K EV L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 581 LQHRNLVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRF-------- 630
L H N+ +L EDE L+ E L +
Sbjct: 85 LHHPNIARLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 631 -----------------------------DIILGIARGVLYLHQDSRLRIIHRDLKASNI 661
+I+ I + YLH I HRD+K N
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENF 199
Query: 662 LL--DEKMNPRISDFGTARVF--GGEEILAITKRVVGT 695
L ++ ++ DFG ++ F GT
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 32/176 (18%)
Query: 525 AATDNFSTS---------NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNE 574
+TD+FS + LG+G V L QE AVK + G + E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 575 VLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--- 630
V ++ + Q HRN+++L+ EED L++E M S+ K ++ F
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHK-----RRHFNEL 111
Query: 631 ---DIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVF 680
++ +A + +LH I HRDLK NIL ++ +I DF
Sbjct: 112 EASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 4e-20
Identities = 34/194 (17%), Positives = 63/194 (32%), Gaps = 38/194 (19%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH-------- 583
LGQ + G+ V T I+++K EVL + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 584 --------RNLVKLLGCC-----LEEDENMLI---YEFMPNKSLDYFIFDE------SRK 621
+LVK ++ +M + + P + F E S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 622 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+ L R + L + R + LH ++H L+ +I+LD++ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 682 GEEILAITKRVVGT 695
G ++ R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 5e-20
Identities = 30/182 (16%), Positives = 59/182 (32%), Gaps = 41/182 (22%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQ--------- 582
LGQ + G+ V T I+++K EVL + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 583 ----------------HRNLVKLLGCCLEEDENM----LIYEFMPNKSLDYF--IFDESR 620
+ ++++ E D + +Y M + + + S
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 621 KQ-LLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
L R + L + R + LH ++H L+ +I+LD++ ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 680 FG 681
G
Sbjct: 256 DG 257
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-20
Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 42/189 (22%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
T+ + +LG+G F V + + GQE A ++T S + ++L+ E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-----ESRKQLLDW---KKRF----- 630
N+V+L +E Y IFD E L + ++ +
Sbjct: 70 PNIVRLHDSI--SEEGHH-----------YLIFDLVTGGE----LFEDIVAREYYSEADA 112
Query: 631 -DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVFGGEEIL 686
I I VL+ HQ + ++HR+LK N+LL K+ +++DFG A GE+
Sbjct: 113 SHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-- 167
Query: 687 AITKRVVGT 695
GT
Sbjct: 168 QAWFGFAGT 176
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 21/182 (11%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN-----EVLLIA 579
AT + ++G G +G VYK + +G +A+K + +G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 580 KLQ---HRNLVKLLGCCLEEDEN-----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD 631
+L+ H N+V+L+ C + L++E + ++ L ++ D++ L + D
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 632 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691
++ RG+ +LH + I+HRDLK NIL+ +++DFG AR++ + +A+T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPV 179
Query: 692 VV 693
VV
Sbjct: 180 VV 181
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 45/185 (24%), Positives = 92/185 (49%), Gaps = 33/185 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK--LSNGQEIAVKRL----------STTSGQGIEELKNEV 575
+ ++G+G +G V+K + + G+ +A+KR+ +T I E+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST----IREVA--- 63
Query: 576 LL--IAKLQHRNLVKLLGCCLEEDEN-----MLIYEFMPNKSLDYFIFDESRKQLLDWKK 628
+L + +H N+V+L C + L++E + ++ L ++ D+ + + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTET 121
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688
D++ + RG+ +LH R++HRDLK NIL+ +++DFG AR++ + +A+
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MAL 176
Query: 689 TKRVV 693
T VV
Sbjct: 177 TSVVV 181
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 46/172 (26%), Positives = 71/172 (41%), Gaps = 22/172 (12%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHR-NLVKLL 590
+LG+G F V + S GQE A K L E+ +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 591 GCCLEEDENM-LIYEFMPNKSLDYFIFD---ESRKQLLDWKKRFDIILGIARGVLYLHQD 646
E + LI E+ + F +++ +I I GV YLHQ
Sbjct: 96 EVY-ENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ- 149
Query: 647 SRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
I+H DLK NILL + +I DFG +R G L + ++GT
Sbjct: 150 --NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIMGT 196
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 43/224 (19%)
Query: 490 NSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK- 548
+ F + ++ V + + S A +D F ++LG+G VY+ K
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 549 LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608
+ A+K L T + ++ E+ ++ +L H N++KL E +
Sbjct: 75 KGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF--ETPTEI------- 123
Query: 609 KSLDYFIFD-----ESRKQLLDW---KKRF------DIILGIARGVLYLHQDSRLRIIHR 654
+ + E L D K + D + I V YLH+ I+HR
Sbjct: 124 ----SLVLELVTGGE----LFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHR 172
Query: 655 DLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
DLK N+L +I+DFG +++ + ++ K V GT
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGT 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 39/192 (20%), Positives = 70/192 (36%), Gaps = 49/192 (25%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--------RLSTTSGQGIEELKNEVLLIA 579
+ST + LG G FG V+ +E+ VK + ++ E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI----------FDESRKQLLDWKKR 629
+++H N++K+ + N+ + F +D R
Sbjct: 85 RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFA-----FIDRHPR 126
Query: 630 FDIILG------IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683
D L + V YL IIHRD+K NI++ E ++ DFG+A
Sbjct: 127 LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 684 EILAITKRVVGT 695
++ GT
Sbjct: 184 KLF---YTFCGT 192
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 45/180 (25%), Positives = 73/180 (40%), Gaps = 28/180 (15%)
Query: 527 TDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
TD + +G G + + + E AVK + + EE++ +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIARG 639
++ L + ++ E M L D+ + +K F ++ I +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILR-----QKFFSEREASAVLFTITKT 128
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNP----RISDFGTARVFGGEEILAITKRVVGT 695
V YLH ++HRDLK SNIL ++ RI DFG A+ E L +T T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 37/173 (21%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKN-EVLLIAKLQHR 584
+++ + +G G FG VY+ KL +G+ +A+K++ + KN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 585 NLVKLLGCCLEEDENM------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--- 635
N+V+L E L+ +++P E+ ++ R L
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----------ETVYRVARHYSRAKQTLPVIY 157
Query: 636 -------IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTARVF 680
+ R + Y+H I HRD+K N+LLD ++ DFG+A+
Sbjct: 158 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 48/237 (20%), Positives = 71/237 (29%), Gaps = 72/237 (30%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQHRN 585
+F +G+GGFG V++ K + A+KR+ E++ EV +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE--------------------------- 618
+V+ LE E D
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 619 ------------------SRKQLLDWKKR------------FDIILGIARGVLYLHQDSR 648
++ L DW R I + IA V +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK----------RVVGT 695
++HRDLK SNI ++ DFG +E VGT
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 41/175 (23%), Positives = 74/175 (42%), Gaps = 27/175 (15%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQ 582
D F GQG FG V GK G +A+K++ + ++ ++ +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVLH 77
Query: 583 HRNLVKLLGCCLEEDEN-------MLIYEFMP---NKSLDYFIFDESRKQLL--DWKKRF 630
H N+V+L E ++ E++P ++ + R+ K F
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY---RRQVAPPPILIKVF 134
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTARVFGGEE 684
+ + R + LH S + + HRD+K N+L++E ++ DFG+A+ E
Sbjct: 135 --LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 28/172 (16%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHRNLVKLLGCC 593
LG+G +G V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 594 LEEDENMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLYL 643
E + L E+ L D ++++ QL+ GV+YL
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------------GVVYL 121
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
H + I HRD+K N+LLDE+ N +ISDFG A VF + ++ GT
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 34/163 (20%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLS----TTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
LG+G +G V + AVK L G +K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 591 GCCLEEDENM--LIYEFMPNKSLDYFIF--------DESRK---QLLDWKKRFDIILGIA 637
E++ ++ E+ + ++ QL+D
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID------------ 120
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
G+ YLH I+H+D+K N+LL +IS G A
Sbjct: 121 -GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 28/172 (16%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHRNLVKLLGCC 593
LG+G +G V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 594 LEEDENMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLYL 643
E + L E+ L D ++++ QL+ GV+YL
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------------GVVYL 121
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
H + I HRD+K N+LLDE+ N +ISDFG A VF + ++ GT
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 46/178 (25%), Positives = 73/178 (41%), Gaps = 56/178 (31%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG G FG V G+ G ++AVK R S + ++K E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI---------FD-----------ESRK---QLLDWKK 628
Y+ + + + + FD E+R+ Q+L
Sbjct: 77 -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS--- 122
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
V Y H R ++HRDLK N+LLD MN +I+DFG + + E L
Sbjct: 123 ----------AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 55/177 (31%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+G FG V Q++A+K R ++ E+ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI--------FD-----------ESRK---QLLDWKKR 629
Y+ + + + FD E R+ Q++
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIIC---- 119
Query: 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
+ Y H R +I+HRDLK N+LLD+ +N +I+DFG + + L
Sbjct: 120 ---------AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 62/196 (31%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLS--------------------------TTSGQGI 568
+G+G +G V ++ A+K LS I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 569 EELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM--PNKSLDYFIFDESRK-QLLD 625
E++ E+ ++ KL H N+VKL E + PN+ Y +F+ + +++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 626 --WKKRF----------DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673
K D+I GI YLH +IIHRD+K SN+L+ E + +I+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 674 FGTARVFGGEEILAIT 689
FG + F G + L
Sbjct: 181 FGVSNEFKGSDALLSN 196
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 49/178 (27%), Positives = 74/178 (41%), Gaps = 56/178 (31%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG G FG V GK G ++AVK R S + +++ E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI---------FD-----------ESRK---QLLDWKK 628
Y+ + S + + FD ESR+ Q+L
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--- 127
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
GV Y H R ++HRDLK N+LLD MN +I+DFG + + E L
Sbjct: 128 ----------GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 29/164 (17%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+G+G F V + + G+E+A+K + + + +++L EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 593 CLEEDENMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLY 642
E LI E+ + DY + E+R Q++ V Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-------------AVQY 129
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
H + RI+HRDLKA N+LLD MN +I+DFG + F L
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 43/178 (24%), Positives = 70/178 (39%), Gaps = 32/178 (17%)
Query: 531 STSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVK 588
LG+G F K + Q AVK +S + E+ + + H N+VK
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 589 LLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIARGV 640
L D+ L+ E + L F+ +K KK F I+ + V
Sbjct: 71 LHEVF--HDQLHTFLVMELLNGGEL----FERIKK-----KKHFSETEASYIMRKLVSAV 119
Query: 641 LYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
++H + ++HRDLK N+L ++ + +I DFG AR+ + T T
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 53/180 (29%), Positives = 81/180 (45%), Gaps = 26/180 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
++F LG+G F V + + +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILG 635
VKL ++++ + N L +I FDE+ RF +I+
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAEIVSA 142
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ YLH IIHRDLK NILL+E M+ +I+DFGTA+V E A VGT
Sbjct: 143 LE----YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
KLG GG VY + ++A+K + + ++ + EV ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
E+D L+ E++ +L +I L + I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
I+HRD+K NIL+D +I DFG A+ E L T V+GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGT 175
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 39/183 (21%), Positives = 66/183 (36%), Gaps = 41/183 (22%)
Query: 532 TSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEV-LLIAKLQHRNLVKL 589
TS LG G G V + ++ A+K L + + EV L Q ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRI 120
Query: 590 LGCCLEEDENM------LIYEFMPNKSLDYFIFD--ESRKQLLDWKKRF------DIILG 635
+ E+ ++ E + L F + R + F +I+
Sbjct: 121 VDVY--ENLYAGRKCLLIVMECLDGGEL----FSRIQDRGD-----QAFTEREASEIMKS 169
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRV 692
I + YLH + I HRD+K N+L +++DFG A+ L
Sbjct: 170 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTP 223
Query: 693 VGT 695
T
Sbjct: 224 CYT 226
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 35/166 (21%), Positives = 64/166 (38%), Gaps = 37/166 (22%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRL------STTSGQGIEELKNEVLLIAKLQHR--NL 586
LG GGFG VY G +S+ +A+K + + EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFD--ESRKQLLDW---KKRFDIILG------ 635
++L ++ I + E + L D+ + L
Sbjct: 111 IRL-------------LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVF 680
+ V + H ++HRD+K NIL+D + ++ DFG+ +
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 7e-16
Identities = 40/221 (18%), Positives = 83/221 (37%), Gaps = 23/221 (10%)
Query: 476 GERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNK 535
G + + S + + K + + D + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIE------ELKNEVLLIAKLQHRNLVK 588
+G G +G V + + +A+K++ I+ E+ ++ +L H ++VK
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILNRLNHDHVVK 116
Query: 589 LLGCCLEED-ENM----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
+L + +D E ++ E + L + + ++ + GV Y+
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT-LLYNLLVGVKYV 172
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
H S I+HRDLK +N L+++ + ++ DFG AR E
Sbjct: 173 H--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 37/181 (20%), Positives = 68/181 (37%), Gaps = 38/181 (20%)
Query: 532 TSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEV-LLIAKLQHRNLVKL 589
+ LG G G V + GQ+ A+K L + + + EV ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 590 LGCCLEEDENM------LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIA 637
L E+ + +I E M L F +++ + F +I+ I
Sbjct: 88 LDVY--ENMHHGKRCLLIIMECMEGGEL----FSRIQER---GDQAFTEREAAEIMRDIG 138
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ +LH I HRD+K N+L ++ +++DFG A+ + +
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCY 191
Query: 695 T 695
T
Sbjct: 192 T 192
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 31/163 (19%), Positives = 60/163 (36%), Gaps = 39/163 (23%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRL------STTSGQGIEELKNEV----LLIAKLQHR 584
LG+GGFG V+ G L++ ++A+K + + EV + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFI--FDESRKQLLDW---KKRFD------II 633
+++L ++ + + + L D+ K
Sbjct: 99 GVIRL-------------LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFG 675
+ + + H ++HRD+K NIL+D + ++ DFG
Sbjct: 146 GQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFG 185
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 49/174 (28%), Positives = 70/174 (40%), Gaps = 35/174 (20%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHRNLVKLLGCC 593
+G G FG + + +AVK + G I+E ++ E++ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE--RGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 594 LEEDENMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLYL 643
L +I E+ L + DE+R QLL GV Y
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-------------GVSYC 132
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPR--ISDFGTARVFGGEEILAITKRVVGT 695
H ++I HRDLK N LLD PR I DFG ++ K VGT
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT 180
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 39/170 (22%), Positives = 69/170 (40%), Gaps = 15/170 (8%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
LG GG V+ + L + +++AVK L + E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 591 GCCLEEDENMLIY----EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
E + E++ +L + E + K+ ++I + + + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH-- 133
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI-LAITKRVVGT 695
+ IIHRD+K +NI++ ++ DFG AR + T V+GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIE-ELKNEVLLIAKLQHR 584
D++ KLG+G + V++ ++N +++ VK L + I+ E+K +L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK---ILENLRGGP 91
Query: 585 NLVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
N++ L + L++E + N + L D+ RF + I + + Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKALDY 145
Query: 643 LHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEILAITKRVV 693
H S I+HRD+K N+++D E R+ D+G A + + RV
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVA 192
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 42/202 (20%), Positives = 72/202 (35%), Gaps = 30/202 (14%)
Query: 502 ISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLS 561
+ KG +R + + ++ + G +G V G S G +A+KR+
Sbjct: 2 MQAKGEAAMRDLIAELHAM------QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVF 55
Query: 562 TTSGQGIEELKNEVLLIAK-----------LQHRNLVKLLGCCL-EEDENM----LIYEF 605
T G + K H N++ L + E+ M L+ E
Sbjct: 56 NTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL 115
Query: 606 MPNKSLD-YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664
M D + + R + ++ + I G+ LH+ ++HRDL NILL
Sbjct: 116 MRT---DLAQVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLA 168
Query: 665 EKMNPRISDFGTARVFGGEEIL 686
+ + I DF AR +
Sbjct: 169 DNNDITICDFNLAREDTADANK 190
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 4e-14
Identities = 29/201 (14%), Positives = 61/201 (30%), Gaps = 46/201 (22%)
Query: 524 LAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL--------STTSGQGIEELKNEV 575
T+ K+G+G FG V++ + +A+K + + + + EE+ E+
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 576 LLIAKLQ---------HRNLVKLLGCCL-------------------EEDENMLIYEFMP 607
++ +L + L + N F
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 608 NKSLDYFIF-------DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660
++ F ++ R +L I+ + + LR HRDL N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 661 ILLDEKMNPRISDFGTARVFG 681
+LL + ++ +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSST 213
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 35/162 (21%), Positives = 60/162 (37%), Gaps = 38/162 (23%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEV-LLIAKLQHRNLVKLLGC 592
LG G G V + ++ A+K L + + EV L Q ++V+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 79
Query: 593 CLEEDENM------LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRF------DIILGIAR 638
E+ ++ E + L F R + F +I+ I
Sbjct: 80 Y--ENLYAGRKCLLIVMECLDGGEL----FSRIQDRGD-----QAFTEREASEIMKSIGE 128
Query: 639 GVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTA 677
+ YLH + I HRD+K N+L +++DFG A
Sbjct: 129 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 8e-14
Identities = 36/171 (21%), Positives = 68/171 (39%), Gaps = 27/171 (15%)
Query: 535 KLGQGGFGPVYKGK--LSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLVKLL- 590
+ GG G +Y NG+ + +K L + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 591 -GCCLEEDENMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ + + Y E++ +SL S+ Q L + +L I + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
+ +++ DLK NI+L E+ ++ D G I + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--------RINSFGYLYGT 240
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 46/196 (23%), Positives = 84/196 (42%), Gaps = 32/196 (16%)
Query: 501 SISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKR 559
S+ K + V+ T +EL + + +G G +G V +G+++A+K+
Sbjct: 3 SLIRKKGFYKQDVNKTAWEL------PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK 56
Query: 560 LS-----TTSGQGI-EELKNEVLLIAKLQHRNLVKLL-----GCCLEEDENM-LIYEFMP 607
LS + EL L+ +QH N++ LL L + L+ FM
Sbjct: 57 LSRPFQSEIFAKRAYRELL----LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ 112
Query: 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667
L + + + K ++ ++ + +G+ Y+H ++HRDLK N+ ++E
Sbjct: 113 -TDLQKIM----GLKFSEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDC 163
Query: 668 NPRISDFGTARVFGGE 683
+I DFG AR E
Sbjct: 164 ELKILDFGLARHADAE 179
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 9e-14
Identities = 53/183 (28%), Positives = 83/183 (45%), Gaps = 33/183 (18%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VL-LIAK 580
++FS +G+GGFG VY + ++ ++ A+K L QG NE +L L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DI 632
+V + D+ I + M L Y + F E+ RF +I
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAEI 301
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692
ILG+ ++H +++RDLK +NILLDE + RISD G A F ++
Sbjct: 302 ILGLE----HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHAS 350
Query: 693 VGT 695
VGT
Sbjct: 351 VGT 353
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 44/198 (22%), Positives = 76/198 (38%), Gaps = 55/198 (27%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKN-EVLLIAKLQHR 584
+ +S LG G FG V + +G+ A+K++ KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60
Query: 585 NLVKLLGCCLEEDENM--------------------------------------LIYEFM 606
N++KL+ + +I E++
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 607 P---NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663
P +K L FI S + + I + R V ++H L I HRD+K N+L+
Sbjct: 121 PDTLHKVLKSFI--RSGRSIPMNLISI-YIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 664 DEKMNP-RISDFGTARVF 680
+ K N ++ DFG+A+
Sbjct: 175 NSKDNTLKLCDFGSAKKL 192
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
+ F LG+GGFG V ++ ++ A K+L +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGV 640
R +V L +D L+ M L + I+ + + + F +I G+
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE--- 300
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
LH R RI++RDLK NILLD+ + RISD G
Sbjct: 301 -DLH---RERIVYRDLKPENILLDDHGHIRISDLG 331
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 21/170 (12%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKL- 589
+G+GG G VY+ + + +A+K +S ++ ++ E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 590 -LGCCLEEDENMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
G E + L Y + L + + L + I+ I + H
Sbjct: 101 DFG----EIDGQL-YVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHA 152
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
HRD+K NIL+ + DFG A +E L VGT
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGT 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 53/184 (28%), Positives = 78/184 (42%), Gaps = 32/184 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
D F LG+GGFG V+ ++ ++ A K+L+ +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI---------FDESRKQLLDWKKRF---D 631
R +V L + + L+ M + Y I F E R F
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTAQ 297
Query: 632 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691
I+ G+ +LHQ II+RDLK N+LLD+ N RISD G A + TK
Sbjct: 298 IVSGLE----HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKG 348
Query: 692 VVGT 695
GT
Sbjct: 349 YAGT 352
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 34/199 (17%)
Query: 503 STKGNKEIRKVDV--TFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKR 559
+K + + V+V + F + + +G G G V + +A+K+
Sbjct: 41 KSKVDNQFYSVEVGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK 94
Query: 560 LS-----TTSGQGI-EELKNEVLLIAKLQHRNLVKLL-----GCCLEEDENM-LIYEFMP 607
LS T + EL L+ + H+N++ LL LEE +++ L+ E M
Sbjct: 95 LSRPFQNQTHAKRAYRELV----LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD 150
Query: 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667
L I + +L + + ++ + G+ +LH IIHRDLK SNI++
Sbjct: 151 AN-LCQVI----QMELDHERMSY-LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC 201
Query: 668 NPRISDFGTARVFGGEEIL 686
+I DFG AR G ++
Sbjct: 202 TLKILDFGLARTAGTSFMM 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 37/191 (19%), Positives = 81/191 (42%), Gaps = 29/191 (15%)
Query: 506 GNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS--- 561
G + + + + DN+ + +G+G +G VY + + +A+K+++
Sbjct: 10 GRENLYFQGIKNVHV------PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF 63
Query: 562 --TTSGQGI-EELKNEVLLIAKLQHRNLVKLLGCCLEEDENM-----LIYEFMPNKSLDY 613
+ I E+ ++ +L+ +++L + +D ++ E L
Sbjct: 64 EDLIDCKRILREIT----ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKK 118
Query: 614 FIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673
++ L + + I+ + G ++H IIHRDLK +N LL++ + ++ D
Sbjct: 119 LF--KTPIFLTEEHIKT-ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCD 172
Query: 674 FGTARVFGGEE 684
FG AR E+
Sbjct: 173 FGLARTINSEK 183
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 43/195 (22%), Positives = 87/195 (44%), Gaps = 31/195 (15%)
Query: 502 ISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL 560
++ V F++ ++ + +G+G +G V N +A+K++
Sbjct: 7 MAAAAAAGPEMVRGQVFDV------GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60
Query: 561 S----TTSGQGI-EELKNEVLLIAKLQHRNLVKLLGC----CLEEDENM-LIYEFMPNKS 610
S T Q E+K ++ + +H N++ + +E+ +++ ++ + M
Sbjct: 61 SPFEHQTYCQRTLREIK----ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TD 115
Query: 611 LDYFIFDESRKQLL-DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669
L + + Q L + + + I RG+ Y+H S ++HRDLK SN+LL+ +
Sbjct: 116 LYKLL----KTQHLSNDHICY-FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDL 167
Query: 670 RISDFGTARVFGGEE 684
+I DFG ARV +
Sbjct: 168 KICDFGLARVADPDH 182
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 44/180 (24%), Positives = 76/180 (42%), Gaps = 40/180 (22%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-----TTSGQGI-EELKNEVLLIA 579
+ +G G G V + +A+K+LS T + EL L+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD-----YFIFD--ES------RKQLLDW 626
+ H+N++ LL N+ F P KSL+ Y + + ++ + +L
Sbjct: 80 CVNHKNIIGLL--------NV----FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 127
Query: 627 KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
+ + ++ + G+ +LH IIHRDLK SNI++ +I DFG AR G ++
Sbjct: 128 RMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 23/165 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL----STTSGQGI-EELKNEVLLIAK 580
+ +F + LG+G +G V G+ +A+K++ E+K ++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 581 LQHRNLVKLLGC----CLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG 635
+H N++ + E + +I E M L I S + L D ++ I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI---STQMLSDDHIQY-FIYQ 120
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
R V LH + +IHRDLK SN+L++ + ++ DFG AR+
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 41/188 (21%), Positives = 79/188 (42%), Gaps = 30/188 (15%)
Query: 513 VDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGI 568
+++ F+L + LG GG G V+ + +A+K++ S +
Sbjct: 2 MNIHGFDL------GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA 55
Query: 569 -EELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD-YFIFD--ES----- 619
E+K +I +L H N+VK+ + + Y + + E+
Sbjct: 56 LREIK----IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV 111
Query: 620 --RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGT 676
+ LL+ R + + RG+ Y+H + ++HRDLK +N+ ++ E + +I DFG
Sbjct: 112 LEQGPLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 677 ARVFGGEE 684
AR+
Sbjct: 168 ARIMDPHY 175
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-11
Identities = 21/123 (17%), Positives = 44/123 (35%), Gaps = 18/123 (14%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
D ++ + G + Y + N V +W + N +
Sbjct: 2 DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNLVLYDNN---------RAVWASGTNGKAS 50
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
VL + GNLV++ ++ +W +N + GN L N+V+ +++ +
Sbjct: 51 GC--VLKMQNDGNLVIYSGSR---AIWASNTN-RQNGNYYLILQRDRNVVI-YDNSNNAI 103
Query: 144 WQS 146
W +
Sbjct: 104 WAT 106
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 25/170 (14%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-----TTSGQGI-EELKNEVLLIA 579
+ +G G +G V G ++A+K+L + EL+ L+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 580 KLQHRNLVKLLGCCL--EEDENM----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 633
++H N++ LL E ++ L+ FM L + ++L + + +F ++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQF-LV 134
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683
+ +G+ Y+H IIHRDLK N+ ++E +I DFG AR E
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 31/185 (16%)
Query: 512 KVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL-----STTSG 565
+++ T +E+ + + + +G G +G V G +AVK+L S
Sbjct: 19 ELNKTIWEV------PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72
Query: 566 QGI-EELKNEVLLIAKLQHRNLVKLL-----GCCLEEDENM-LIYEFMPNKSLDYFIFDE 618
+ EL+ L+ ++H N++ LL LEE ++ L+ M L+ +
Sbjct: 73 KRTYRELR----LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--- 124
Query: 619 SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
++L D +F +I I RG+ Y+H IIHRDLK SN+ ++E +I DFG AR
Sbjct: 125 KCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 679 VFGGE 683
E
Sbjct: 181 HTADE 185
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 42/180 (23%), Positives = 77/180 (42%), Gaps = 46/180 (25%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIE------ELKNEVLLIA 579
+ KLG+G +G V+K G+ +AVK++ + E+ +L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 580 KLQHRNLVKLLGCCLEEDEN--MLIYEFMP--------NKSLD-----YFIFDESRKQLL 624
H N+V LL +++ L++++M L+ Y ++ QL+
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY-----QLI 119
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ + YLH S ++HRD+K SNILL+ + + +++DFG +R F
Sbjct: 120 -------------KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 7e-11
Identities = 20/126 (15%), Positives = 41/126 (32%), Gaps = 19/126 (15%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ ++ + + G + Y N V W +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNLVLYDHSTSV---------WASNTGILGK 50
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
+ GN V+++ +W ++ S GN V L + GN+V+ +D +
Sbjct: 51 KGC-KAVLQSDGNFVVYDAEGR--SLWASH-SVRGNGNYVLVLQEDGNVVIYGSD----I 102
Query: 144 WQSFDH 149
W + +
Sbjct: 103 WSTGTY 108
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 39/165 (23%), Positives = 73/165 (44%), Gaps = 27/165 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RN 585
+ + K+G G FG +Y G ++ G+E+A+K + L E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL- 641
+ + C E D N+++ E + SL+ L ++ ++F + +L +A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE---------DLFNFCSRKFSLKTVLLLADQMIS 116
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVF 680
Y+H + IHRD+K N L+ I DFG A+ +
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 38/202 (18%), Positives = 77/202 (38%), Gaps = 30/202 (14%)
Query: 508 KEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TT 563
++ + L + D+F +G+G F V K+ ++ A+K ++
Sbjct: 41 DFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML 100
Query: 564 SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFI------F 616
+ + E ++ R + +L +++ + L+ E+ L +
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159
Query: 617 DESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673
RF +I++ I +H+ L +HRD+K NILLD + R++D
Sbjct: 160 PAEMA-------RFYLAEIVMAID----SVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 674 FGTARVFGGEEILAITKRVVGT 695
FG+ + + VGT
Sbjct: 206 FGSCLKLRADG-TVRSLVAVGT 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 34/157 (21%), Positives = 58/157 (36%), Gaps = 19/157 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRL-STTSGQGIEELKNEVLLIAK 580
D LG+G FG V + + + +AVK L + L +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 581 L-QHRNLVKLLGCCLEEDE-NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
+ H N+V LLG C + M+I EF +L ++ KR + + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
G + + I DLK + + S F
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+A+G+ +L + + IHRDL A NILL EK +I DFG AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-10
Identities = 23/124 (18%), Positives = 43/124 (34%), Gaps = 19/124 (15%)
Query: 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPI 82
++++S + G + Y L N V G W +N
Sbjct: 1 VNSLSSPNSLFTGHSLEVGPS-YRLIMQGDCNFVLYDSGKPV---------WASNTGGLG 50
Query: 83 NDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGET 142
+ L N GNLV+++++ +WQ + + V L N+V+ G
Sbjct: 51 SGCRLTLHNN--GNLVIYDQSNR--VIWQTKTN-GKEDHYVLVLQQDRNVVIY----GPV 101
Query: 143 LWQS 146
+W +
Sbjct: 102 VWAT 105
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 51/204 (25%), Positives = 80/204 (39%), Gaps = 27/204 (13%)
Query: 491 SSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLS 550
++ + SE+E S+ K + S A D F LG G FG V K
Sbjct: 5 AAKKGSEQE-SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 551 NGQEI-AVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606
A+K L + IE NE ++ + LVKL + ++ E++
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 607 PNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKA 658
+ + F E RF I+L YLH L +I+RDLK
Sbjct: 124 AGGEMFSHLRRIGRFSEPHA-------RFYAAQIVLTFE----YLHS---LDLIYRDLKP 169
Query: 659 SNILLDEKMNPRISDFGTARVFGG 682
N+L+D++ +++DFG A+ G
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKG 193
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 30/171 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLS----TTSGQGIEELKNEVLLIAKLQ 582
D+F +G+G FG V K + A+K ++ + + + E+ ++ L+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLE 73
Query: 583 HRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DII 633
H LV L +++E+M ++ + + L Y + F E + +++
Sbjct: 74 HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-------KLFICELV 125
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ + YL RIIHRD+K NILLDE + I+DF A + E
Sbjct: 126 MALD----YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 37/165 (22%), Positives = 72/165 (43%), Gaps = 27/165 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+ F K+G G FG +Y G + +E+A+K + + +L E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 587 V-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL- 641
+ + +E D N+L+ + + SL+ L ++ ++ + +L +A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE---------DLFNFCSRKLSLKTVLMLADQMIN 114
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNPR---ISDFGTARVF 680
++H S +HRD+K N L+ I DFG A+ +
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 28/163 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTS----GQGIEELKNEVLLIAKLQ 582
+F LG G FG V+ + + A+K L Q +E +E L+++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIIL 634
H ++++ G + + +I +++ L + F +F ++ L
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAEVCL 117
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
+ YLH II+RDLK NILLD+ + +I+DFG A
Sbjct: 118 ALE----YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 40/197 (20%), Positives = 81/197 (41%), Gaps = 26/197 (13%)
Query: 510 IRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSG 565
+ + T ++ L +++ +G+G FG V + + +++ A+K LS
Sbjct: 51 LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 110
Query: 566 QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN----KSLDYFIFDESRK 621
E ++A +V+L ++ ++ E+MP + + E
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA 170
Query: 622 QLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
RF +++L + +H + IHRD+K N+LLD+ + +++DFGT
Sbjct: 171 -------RFYTAEVVLALD----AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 679 VFGGEEILAITKRVVGT 695
E ++ VGT
Sbjct: 217 KMNKEGMVR-CDTAVGT 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 48/209 (22%), Positives = 78/209 (37%), Gaps = 37/209 (17%)
Query: 479 KRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQ 538
K+Q E+ F + S + + K +V + FE LL G+
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLL------------GK 158
Query: 539 GGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
G FG V K A+K L + + E ++ +H L L
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218
Query: 595 EEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQD 646
D + E+ L + + F E R RF +I+ + YLH
Sbjct: 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAEIVSALD----YLH-- 265
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFG 675
S +++RDLK N++LD+ + +I+DFG
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFG 294
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 35/167 (20%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RN 585
++ ++G+G FG +++G L N Q++A+K S L++E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL- 641
+ + E N+L+ + + SL+ LLD ++F + + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLE---------DLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNPR-----ISDFGTARVF 680
+H+ S +++RD+K N L+ + + DFG + +
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 40/182 (21%), Positives = 74/182 (40%), Gaps = 30/182 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
++F +G+G FG V KL N ++ A+K L+ + E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 584 RNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFI------FDESRKQLLDWKKRF---DII 633
+ + L ++D N+ L+ ++ L + E RF +++
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-------RFYLAEMV 185
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
+ I +HQ L +HRD+K NIL+D + R++DFG+ + + V
Sbjct: 186 IAID----SVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAV 237
Query: 694 GT 695
GT
Sbjct: 238 GT 239
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 1e-09
Identities = 23/123 (18%), Positives = 40/123 (32%), Gaps = 20/123 (16%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ + Q + + + Y L + N VK G W +N +
Sbjct: 3 NVLLSGQTLHADHSLQAGA--YTLTIQNKCNLVKYQNGRQI---------WASNTDR--R 49
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
+ L++ GNLV+++ N + V + G L G V+ G L
Sbjct: 50 GSGCRLTLLSDGNLVIYDHNNNDV---WGSACWGDNGKYALVLQKDGRFVIY----GPVL 102
Query: 144 WQS 146
W
Sbjct: 103 WSL 105
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 29/166 (17%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RNL 586
NF K+G G FG + GK L + +A+K S +L E +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL-- 641
++ N ++ E + SL+ L D + F + +L IA ++
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLE---------DLFDLCDRTFSLKTVLMIAIQLISR 117
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPR-----ISDFGTARVF 680
Y+H + +I+RD+K N L+ N I DF A+ +
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 32/167 (19%), Positives = 67/167 (40%), Gaps = 28/167 (16%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIA---VKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
K+G GGFG +Y + ++ A VK +G L +E+ ++ ++ +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP----LFSELKFYQRVAKKDCIKKW 99
Query: 591 GCCLEEDE----NMLIYEFMPNKSLDY--FIFD---ESRKQLLDWKKRFDI--ILGIARG 639
+ D K Y + + +++ F +L +
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIR 159
Query: 640 VL----YLHQDSRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVF 680
+L Y+H++ +H D+KA+N+LL K ++ +D+G + +
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 14/150 (9%), Positives = 46/150 (30%), Gaps = 16/150 (10%)
Query: 535 KLGQGGFGPVYKG---KLSNGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVK 588
G ++ L +++A+ + ++E + L ++++ + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
+L +++ E++ SL ++ + +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA--DTS---PSPVGAIRAMQSLAAAADAAH---R 147
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+ S + + + ++ T
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 32/179 (17%), Positives = 68/179 (37%), Gaps = 37/179 (20%)
Query: 529 NFSTSNKLGQGGFGPVYKGK---------LSNGQEIAVKRLSTTSGQGIEELK------- 572
+ + + G +Y+ Q+ ++K L G+ E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 573 -NEVLLIAKLQHRNLV---KLLGCCLEEDE-NMLIYEFMPNKSLDYFIFDESRKQLLDWK 627
+V KL L+ +G + +D+ L+ + +SL D S K +L +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSER 159
Query: 628 KRFDIILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVF 680
+L +A +L +LH++ +H ++ A NI +D + ++ + +G A +
Sbjct: 160 ----SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 39/174 (22%)
Query: 535 KLGQGGFGPVYKGKLSNGQEI------AVKRLSTTSGQGIEELK-----NEVLLIAKLQH 583
+GQGGFG +Y +++ + + VK + +G ELK + I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 584 RNLVKLLG-----CCLEEDENMLIYEFMPNKSLDYFIFD---ESRKQLLDW-KKRFDI-- 632
+K LG D+N Y FM I D +++ + KRF
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFM--------IMDRFGSDLQKIYEANAKRFSRKT 153
Query: 633 ILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVF 680
+L ++ +L Y+H+ +H D+KASN+LL+ K ++ D+G A +
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 41/194 (21%)
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI 555
E + G ++ + FE +L G+G FG V ++ ++
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVL------------GKGSFGKVMLARVKETGDL 50
Query: 556 -AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609
AVK L +E E +L +A+ H L +L C D + EF+
Sbjct: 51 YAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLFCCFQTPDRLFFVMEFVNGG 109
Query: 610 SLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNI 661
L + I FDE+R RF +II + +LH II+RDLK N+
Sbjct: 110 DLMFHIQKSRRFDEARA-------RFYAAEIISALM----FLHD---KGIIYRDLKLDNV 155
Query: 662 LLDEKMNPRISDFG 675
LLD + + +++DFG
Sbjct: 156 LLDHEGHCKLADFG 169
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 40/194 (20%)
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVY---KGKLSNG 552
S +E +I+ + K D + FEL +L GQG FG V+ K S+
Sbjct: 4 SIKEIAITHHVKEGHEKADPSQFELLKVL------------GQGSFGKVFLVKKISGSDA 51
Query: 553 QEI-AVKRLS--TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609
+++ A+K L T + K E ++ ++ H +VKL E + LI +F+
Sbjct: 52 RQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG 111
Query: 610 SLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNI 661
L + F E +F ++ L + +LH L II+RDLK NI
Sbjct: 112 DLFTRLSKEVMFTEEDV-------KFYLAELALALD----HLHS---LGIIYRDLKPENI 157
Query: 662 LLDEKMNPRISDFG 675
LLDE+ + +++DFG
Sbjct: 158 LLDEEGHIKLTDFG 171
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 44/193 (22%), Positives = 78/193 (40%), Gaps = 41/193 (21%)
Query: 497 EREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI- 555
E+EA + + K + + F+L ++ G+G + V +L I
Sbjct: 33 EKEAMNTRESGKASSSLGLQDFDLLRVI------------GRGSYAKVLLVRLKKTDRIY 80
Query: 556 AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610
A++ + + I+ ++ E V A H LV L C E + E++
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGLHSCFQTESRLFFVIEYVNGGD 139
Query: 611 LDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNIL 662
L + + E RF +I L + YLH+ II+RDLK N+L
Sbjct: 140 LMFHMQRQRKLPEEHA-------RFYSAEISLALN----YLHE---RGIIYRDLKLDNVL 185
Query: 663 LDEKMNPRISDFG 675
LD + + +++D+G
Sbjct: 186 LDSEGHIKLTDYG 198
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 43/162 (26%), Positives = 66/162 (40%), Gaps = 29/162 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKL 581
+F+ LG+G FG V + E+ AVK L +E E VL +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-G 399
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DII 633
+ L +L C D + E++ L Y I F E F +I
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAEIA 452
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+G+ +L II+RDLK N++LD + + +I+DFG
Sbjct: 453 IGLF----FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG 487
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 35/152 (23%), Positives = 60/152 (39%), Gaps = 26/152 (17%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+G FG V + A+K L + + E ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYL 643
D + E+ L + + F E R RF +I+ + YL
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RFYGAEIVSALE----YL 121
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
H +++RD+K N++LD+ + +I+DFG
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFG 150
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 47/191 (24%), Positives = 81/191 (42%), Gaps = 42/191 (21%)
Query: 501 SISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVY---KGKLSNGQEI-A 556
S T N+ K+ FEL +L G+GG+G V+ K +N +I A
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVL------------GKGGYGKVFQVRKVTGANTGKIFA 49
Query: 557 VKRLS----TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612
+K L + + K E ++ +++H +V L+ + LI E++ L
Sbjct: 50 MKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF 109
Query: 613 YFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664
+ F E F +I + + +LHQ II+RDLK NI+L+
Sbjct: 110 MQLEREGIFMEDTA-------CFYLAEISMALG----HLHQ---KGIIYRDLKPENIMLN 155
Query: 665 EKMNPRISDFG 675
+ + +++DFG
Sbjct: 156 HQGHVKLTDFG 166
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 5e-08
Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 29/154 (18%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
+G+G + V +L I A+K + + I+ ++ E V A H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 75
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 641
C E + E++ L + + E RF +I L +
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEISLALN---- 124
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
YLH+ II+RDLK N+LLD + + +++D+G
Sbjct: 125 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG 155
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 5e-08
Identities = 23/123 (18%), Positives = 41/123 (33%), Gaps = 20/123 (16%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ + + + G+ + + R Y N V V W N
Sbjct: 2 NILYSGETLSPGEFLNNGR--YVFIMQEDCNLVLYDVDKPI---------WATNTGGLDR 50
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
+ + GNLV++ + P+W +N + GN V L N+V+ G
Sbjct: 51 RCHLSMQSD--GNLVVY--SPRNNPIWASN-TGGENGNYVCVLQKDRNVVIY----GTAR 101
Query: 144 WQS 146
W +
Sbjct: 102 WAT 104
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 7e-08
Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 29/154 (18%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
LG+G FG V+ + + A+K L +E E VL +A +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 83
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 641
++ + E++ L Y I FD SR F +IILG+
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TFYAAEIILGLQ---- 132
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+LH I++RDLK NILLD+ + +I+DFG
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFG 163
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 42/154 (27%), Positives = 63/154 (40%), Gaps = 29/154 (18%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
LG+G FG V + E+ AVK L +E E VL + + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQL 86
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 641
C D + E++ L Y I F E F +I +G+
Sbjct: 87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAEIAIGLF---- 135
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
+L II+RDLK N++LD + + +I+DFG
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG 166
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 29/154 (18%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
+G+G FG V + + AVK L + + + +E VLL ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-VKHPFLVGL 104
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 641
D+ + +++ L Y + F E R RF +I +
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAEIASALG---- 153
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
YLH L I++RDLK NILLD + + ++DFG
Sbjct: 154 YLHS---LNIVYRDLKPENILLDSQGHIVLTDFG 184
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 40/186 (21%), Positives = 66/186 (35%), Gaps = 54/186 (29%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
KLG G F V+ K + N +A+K + + +E +KLL
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----------------IKLL 69
Query: 591 GCCLEEDENMLIYEFMPN--KSLDYFIFDESRKQ------------LLDWKKRF------ 630
+ D + K LD+F LL K++
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 631 -DIILGIAR----GVLYLHQDSRLRIIHRDLKASNILLDEKMNP------RISDFGTARV 679
+ I++ G+ Y+H R IIH D+K N+L++ +P +I+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC- 186
Query: 680 FGGEEI 685
+ E
Sbjct: 187 WYDEHY 192
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 46/204 (22%), Positives = 76/204 (37%), Gaps = 45/204 (22%)
Query: 490 NSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVY---K 546
+ + + KV + FEL +L G G +G V+ K
Sbjct: 28 GGEQLLTVKHELRTANLTGHAEKVGIENFELLKVL------------GTGAYGKVFLVRK 75
Query: 547 GKLSNGQEI-AVKRLS----TTSGQGIEELKNE--VLLIAKLQHRNLVKLLGCCLEEDEN 599
+ ++ A+K L + E + E VL + Q LV L E +
Sbjct: 76 ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQTETKL 134
Query: 600 MLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRI 651
LI +++ L + F E + +I+L + +LH+ L I
Sbjct: 135 HLILDYINGGELFTHLSQRERFTEHEV-------QIYVGEIVLALE----HLHK---LGI 180
Query: 652 IHRDLKASNILLDEKMNPRISDFG 675
I+RD+K NILLD + ++DFG
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFG 204
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-07
Identities = 23/109 (21%), Positives = 37/109 (33%), Gaps = 18/109 (16%)
Query: 38 IVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNL 97
I+ +Y + N V +W N N + G L
Sbjct: 25 ILFGTHVYRFIMQTDCNLVLYDNN---------NPIWATNTGGLGNGCR--AVLQPDGVL 73
Query: 98 VLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146
V+ V VWQ+ ++ AG+ V L N+V+ G+ LW +
Sbjct: 74 VVI--TNENVTVWQSPVA-GKAGHYVLVLQPDRNVVI----YGDALWAT 115
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 39/169 (23%), Positives = 61/169 (36%), Gaps = 51/169 (30%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRL---STTSGQGIEELK--------------NEVLL 577
+G+G FG V K Q +A+K + Q EE++ N + +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 578 IAKLQHRN---LV-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKKRF 630
+ RN + +LL L YE + F R +L
Sbjct: 165 LENFTFRNHICMTFELLSMNL--------YELIKKNKFQGFSLPLVRKFAHSILQ----- 211
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP--RISDFGTA 677
+ LH + RIIH DLK NILL ++ ++ DFG++
Sbjct: 212 --------CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 41/179 (22%), Positives = 64/179 (35%), Gaps = 50/179 (27%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELK--------------NEV 575
+ +G+G FG V K + +A+K Q E++ V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 576 LLIAKLQHRN---LV-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKK 628
L RN LV ++L L Y+ + N + + +R +Q+
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSYNL--------YDLLRNTNFRGVSLNLTRKFAQQMCT--- 168
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP--RISDFGTARVFGGEEI 685
+L+L L IIH DLK NILL +I DFG++ G+ I
Sbjct: 169 ----------ALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI 215
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 5e-06
Identities = 21/128 (16%), Positives = 43/128 (33%), Gaps = 21/128 (16%)
Query: 19 ISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANR 78
I + + + Q + + + + L N V W +N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTAKN--HQLVMQGDCNLVLYGGKY----------GWQSNT 49
Query: 79 NNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRND 138
+ N L +N +G L++ + +W + S + G V L D G V+
Sbjct: 50 HG--NGEHCFLRLNHKGELIIK--DDDFKTIWSSR-SSSKQGEYVLILQDDGFGVIY--- 101
Query: 139 TGETLWQS 146
G ++++
Sbjct: 102 -GPAIFET 108
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-05
Identities = 23/125 (18%), Positives = 44/125 (35%), Gaps = 23/125 (18%)
Query: 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNP 81
+ + Q + + + + L N V Y G W + N
Sbjct: 2 GTNYLLSGQTLDTEGHLKNGD--FDLVMQDDCNLV-LYNGNWQS-------------NTA 45
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGE 141
N L++ G LV+ N VW++ +++ GN A + G LV+ G
Sbjct: 46 NNGRDCKLTLTDYGELVIK--NGDGSTVWKSG-AQSVKGNYAAVVHPDGRLVVF----GP 98
Query: 142 TLWQS 146
++++
Sbjct: 99 SVFKI 103
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 57/381 (14%), Positives = 102/381 (26%), Gaps = 129/381 (33%)
Query: 20 STSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVG---------IW------Y 64
ID I I D + + +++ V+++V +
Sbjct: 48 KEEIDHI-----IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102
Query: 65 NQISQLTLLWVANRNNPIND------------------TSGVLSVNIQGNLVLHERNQST 106
Q S +T +++ R+ ND +L + N+++
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID------ 156
Query: 107 VPVWQANISEASAGNTV--AQLLDTGNLVLVRNDTGETLWQSF---DHPTDTV--LPNMR 159
+G T + + + + + W + + P + L +
Sbjct: 157 --------GVLGSGKTWVALDVCLSYKVQCKMD--FKIFWLNLKNCNSPETVLEMLQKLL 206
Query: 160 FGWDKR-TGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDV---KLWRA----- 210
+ D T + + + K L + LL +V K W A
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266
Query: 211 ---------------GPWTGQRFSG-------TPEMTRTFIFNITYIDNQD---EVYLCD 245
T S TP+ ++ + QD EV +
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN 326
Query: 246 GLNDLSTIARMILNETGFLQRFTWNNRDR--RWIGYWTAPAERCDYYGHCGPNSNCNLNL 303
LS IA I RD W D + H NC+ L
Sbjct: 327 PRR-LSIIAESI--------------RDGLATW-----------DNWKH----VNCD-KL 355
Query: 304 TDGFECTCLPGFEPKYPKEWF 324
T E + L EP ++ F
Sbjct: 356 TTIIE-SSLNVLEPAEYRKMF 375
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 8e-05
Identities = 33/229 (14%), Positives = 68/229 (29%), Gaps = 58/229 (25%)
Query: 471 LATRIGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFEL-STLLAATDN 529
L + I +RQ + + E+ + N+ K +V+ + L A
Sbjct: 94 LMSPIKTEQRQPSMM------TRMYIEQRDRLYN-DNQVFAKYNVSRLQPYLKLRQALLE 146
Query: 530 FSTSNKL---GQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+ + G G G K + + +V L K+Q +
Sbjct: 147 LRPAKNVLIDGVLGSG---------------K--TW--------VALDVCLSYKVQCKMD 181
Query: 587 VKL----LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
K+ L C + + + + L + D + D + + + L
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQ-----KL-LYQIDPNWTSRSDHSSNIKLRIHSIQAEL- 234
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE-EILAITK 690
RL + + + ++L N + F +IL T+
Sbjct: 235 ----RRL-LKSKPYENCLLVLLNVQNAKA-----WNAFNLSCKILLTTR 273
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.7 bits (104), Expect = 5e-05
Identities = 38/280 (13%), Positives = 69/280 (24%), Gaps = 31/280 (11%)
Query: 20 STSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSV--KRYVGIWYNQISQLTLLWVAN 77
+ Q + G ++S + + L GN V +W Q +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPL 70
Query: 78 RNNPINDTSGVLSVNIQGNLVL--HERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLV 135
RN L+ +Q L + R + + S T L D GN+V
Sbjct: 71 RNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIV-- 123
Query: 136 RNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGF 195
LW + L + V G + L G
Sbjct: 124 -LVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV---------YGAGASKLVFQGD 173
Query: 196 PQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIAR 255
+ Y + G+ G N+ + V ++ A
Sbjct: 174 GNLVAYGPNGAATWNAGTQGK---GAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHAS-AV 229
Query: 256 MILNETGFL----QRFTWNNRDRRWIGYWTAPAERCDYYG 291
+ L G + ++ W + + +
Sbjct: 230 LRLQANGSIAILDEKPVWARFG--FQPTYRHIRKINPDQK 267
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 36/181 (19%), Positives = 63/181 (34%), Gaps = 48/181 (26%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELK-------------NEVLL 577
K+G G FG V + + N + AVK + + E N V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101
Query: 578 IAKLQHRN---LV-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKKRF 630
K + + L+ + LG L YE + + + F ++ + ++L
Sbjct: 102 HGKFMYYDHMCLIFEPLGPSL--------YEIITRNNYNGFHIEDIKLYCIEIL------ 147
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK 690
+ + YL ++ + H DLK NILLD+ + G + + TK
Sbjct: 148 -------KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 691 R 691
Sbjct: 198 S 198
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 38/153 (24%), Positives = 61/153 (39%), Gaps = 40/153 (26%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
KLG G F V+ + + +A+K + ++ E +E+ +LL
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEI------------RLLKSV 90
Query: 594 LEEDENMLIYEFMPNKSLDYF------------IFDESRKQLLDWKKRFD---------- 631
D N E + + LD F +F+ LL W + +
Sbjct: 91 RNSDPNDPNREMVV-QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 632 -IILGIARGVLYLHQDSRLRIIHRDLKASNILL 663
II + +G+ YLH ++ RIIH D+K NILL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILL 180
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 33/157 (21%), Positives = 53/157 (33%), Gaps = 50/157 (31%)
Query: 535 KLGQGGFGPVYKGK--LSNGQEIAVK--R---------------LSTTSGQGIEELKNEV 575
LG+G FG V + + G+ +AVK + L + V
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 576 LLIAKLQHRN---LV-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKK 628
++ +H +V +LLG Y+F+ F D R Q+
Sbjct: 81 QMLEWFEHHGHICIVFELLGLST--------YDFIKENGFLPFRLDHIRKMAYQIC---- 128
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 665
+ V +LH ++ H DLK NIL +
Sbjct: 129 ---------KSVNFLH---SNKLTHTDLKPENILFVQ 153
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 3e-04
Identities = 23/102 (22%), Positives = 30/102 (29%), Gaps = 18/102 (17%)
Query: 45 YALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQ 104
Y L + N V W N VL N G + +
Sbjct: 152 YRLSMETDCNLVLFDRDDRV---------WSTNTAGKGTGCRAVLQPN--GRMDV--LTN 198
Query: 105 STVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146
+ VW + S SAG V L NL + G LW +
Sbjct: 199 QNIAVWTSGNS-RSAGRYVFVLQPDRNLAIY----GGALWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 6e-04
Identities = 22/181 (12%), Positives = 45/181 (24%), Gaps = 35/181 (19%)
Query: 62 IWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGN 121
I + + + + + +S ++ NLVL + + VW +N + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDV---RVWASNTA--GATG 57
Query: 122 TVAQLLDTGNLVLVRNDTGETLWQS-----------------------------FDHPTD 152
A L G LV++ W S
Sbjct: 58 CRAVLQSDGLLVILTAQN-TIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKG 116
Query: 153 TVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212
+V+ + + L + +L+ D ++W
Sbjct: 117 SVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNT 176
Query: 213 W 213
Sbjct: 177 A 177
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 35/188 (18%), Positives = 55/188 (29%), Gaps = 69/188 (36%)
Query: 535 KLGQGGFGPVYKG--KLSNGQEIAVK--R---------------LSTTSGQGIEELKNEV 575
LG+G FG V + ++A+K R L + E V
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 576 LLIAKLQHRN---LV-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKK 628
L+ + +LLG +EF+ + + R QL
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKNT--------FEFLKENNFQPYPLPHVRHMAYQLC---- 133
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP------------------- 669
+ +LH ++ H DLK NIL
Sbjct: 134 ---------HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 670 RISDFGTA 677
R++DFG+A
Sbjct: 182 RVADFGSA 189
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 6e-04
Identities = 18/123 (14%), Positives = 37/123 (30%), Gaps = 18/123 (14%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ + SQ + D + + Y+L N V +W + +
Sbjct: 7 NVLFSSQVMYDNAQLATRD--YSLVMRDDCNLVLTKGSKTNI-------VWESGTSG--R 55
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
+ + G L + + V+ +N G+ V L G V+ +
Sbjct: 56 GQHCFMRLGHSGELDIT--DDRLNTVFVSNTV-GQEGDYVLILQINGQAVVYGPA----V 108
Query: 144 WQS 146
W +
Sbjct: 109 WST 111
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 695 | |||
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.98 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.94 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.94 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.93 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.93 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.93 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.93 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.93 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.93 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.93 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.93 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.93 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.93 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.93 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.93 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.93 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.93 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.93 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.93 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.92 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.92 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.92 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.92 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.92 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.92 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.92 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.92 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.92 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.92 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.92 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.92 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.92 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.92 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.92 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.92 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.92 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.92 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.92 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.92 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.92 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.92 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.92 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.92 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.92 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.92 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.92 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.92 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.92 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.92 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.92 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.92 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.92 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.92 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.92 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.92 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.92 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.92 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.92 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.92 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.91 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.91 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.91 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.91 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.91 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.91 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.91 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.91 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.91 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.91 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.91 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.91 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.91 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.91 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.91 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.91 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.91 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.91 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.91 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.91 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.91 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.91 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.91 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.91 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.91 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.91 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.91 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.91 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.91 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.91 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.91 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.91 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.91 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.91 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.91 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.91 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.91 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.91 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.91 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.91 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.91 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.91 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.91 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.9 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.9 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.9 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.9 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.9 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.9 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.9 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.9 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.9 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.9 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.9 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.9 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.9 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.9 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.9 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.9 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.9 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.9 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.9 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.9 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.9 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.9 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.9 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.9 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.9 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.9 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.9 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.9 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.9 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.9 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.9 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.9 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.9 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.9 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.9 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.9 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.9 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.9 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.9 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.9 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.9 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.9 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.9 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.9 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.9 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.9 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.9 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.9 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.9 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.9 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.9 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.9 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.9 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.9 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.9 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.9 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.9 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.9 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.89 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.89 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.89 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.89 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.89 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.89 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.89 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.89 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.89 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.89 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.89 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.89 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.89 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.89 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.89 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.89 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.89 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.89 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.89 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.89 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.89 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.88 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.88 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.88 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.88 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.88 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.88 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.88 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.88 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.88 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.88 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.88 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.88 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.88 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.87 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.87 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.87 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.87 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.87 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.87 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.87 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.87 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.87 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.86 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.86 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.86 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.86 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.85 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.84 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.81 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.75 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.7 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.67 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.63 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.61 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.57 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.55 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.51 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.25 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.23 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.04 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.97 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.86 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.76 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.49 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.96 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.62 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.16 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.14 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.03 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.0 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.99 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.87 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.85 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.53 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.06 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.71 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.28 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.42 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 83.5 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.34 |
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=372.62 Aligned_cols=232 Identities=17% Similarity=0.250 Sum_probs=180.4
Q ss_pred cccccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCC----CceEEEEecC
Q 005471 20 STSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDT----SGVLSVNIQG 95 (695)
Q Consensus 20 ~~~~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~----~~~l~~~~~G 95 (695)
+++.|+|++|++|++|++|+|++|.|+||||.++ ++|| |+ +.+ |||+|||++|+.++ +++|+|+.||
T Consensus 11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 4567999999999999999999999999999543 5677 77 667 99999999999875 7899999999
Q ss_pred Ceee--eccCCCceeEEeeccccCC----CCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccCCCce
Q 005471 96 NLVL--HERNQSTVPVWQANISEAS----AGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLN 169 (695)
Q Consensus 96 ~l~l--~~~~~~~~~~Wss~~~~~~----~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~tg~~ 169 (695)
+|+| .|+++. +||+|+++... .++++|+|+|+|||||++ +.+|||| ||||||||||||+.+.++|..
T Consensus 82 ~Lvl~~~~~~~~--~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~---~~~lWqS--~ptdtlLpg~~~~~~l~~g~~ 154 (276)
T 3m7h_A 82 QYGAFLDDYSRR--RVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD---SLALWNG--TPAIPLVPGAIDSLLLAPGSE 154 (276)
T ss_dssp SSSEEEEEGGGT--EEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---EEEEEES--CTTSCCCCSCTTCEEECSSEE
T ss_pred cEEEEEeCCCCC--EEEEeCCCcccccccCCceEEEEeCCCCEEecC---CceeeCc--ccccccccccccccccccCcc
Confidence 9999 777777 99999975211 235789999999999997 5799999 999999999999998888865
Q ss_pred eeEEEccCCCCCCCcceeeeecCCCCCceEEEcC-CeeEEEeCCCCCceeecccccceeeeeeEEEeecCC-eeEEEEee
Q 005471 170 RYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKD-DVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQD-EVYLCDGL 247 (695)
Q Consensus 170 ~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~-~~~y~~~g~~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 247 (695)
| ++.+||++|.|++.++++|. ++++++ ..+||++|+|++.... -.+.... .+.+.++++ .+++++..
T Consensus 155 --L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~--l~l~~dG--nLvl~d~~~~~vWsS~t~ 223 (276)
T 3m7h_A 155 --L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVR--AVFQGDG--NLVVYGAGNAVLWHSHTG 223 (276)
T ss_dssp --E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCE--EEECTTS--CEEEECTTSCEEEECSCT
T ss_pred --c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEE--EEEcCCC--eEEEEeCCCcEEEEecCC
Confidence 6 57899999999999999995 556654 5899999999764311 1122111 233344433 44444432
Q ss_pred cCCCeEEEEEECccCceEEEEEeCCCCcEEEEEEcc
Q 005471 248 NDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAP 283 (695)
Q Consensus 248 ~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~w~~p 283 (695)
. ...+|++|+.||+|++|.| ...|...|.+|
T Consensus 224 ~--~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P 254 (276)
T 3m7h_A 224 G--HASAVLRLQANGSIAILDE---KPVWARFGFQP 254 (276)
T ss_dssp T--CTTCEEEECTTSCEEEEEE---EEEEESSSCCT
T ss_pred C--CCCEEEEEcCCccEEEEcC---CCeEEccCccC
Confidence 2 2347999999999999998 23455555544
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=317.40 Aligned_cols=217 Identities=13% Similarity=0.177 Sum_probs=168.2
Q ss_pred ccccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeee
Q 005471 21 TSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLH 100 (695)
Q Consensus 21 ~~~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~ 100 (695)
++.|+|.+|++|++|++| ++|.|+|||+.+++ + ++|.. +|+||+|||+.| ..+.|+|+.||+|||+
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l-~ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----L-VLFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----E-EEEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----E-EEEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 556999999999999999 59999999998776 2 34543 699999999998 4688999999999999
Q ss_pred ccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCc-CCCceecccc-CCCc-----eeeEE
Q 005471 101 ERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTV-LPNMRFGWDK-RTGL-----NRYVT 173 (695)
Q Consensus 101 ~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtl-Lpg~~l~~~~-~tg~-----~~~l~ 173 (695)
|.+|. +||+|++. ...+..+|+|+|+|||||++. ++||||||||||+ |||| +.+. .+|+ ++.|+
T Consensus 72 d~~~~--~vW~s~~~-~~~~~~~~~l~d~Gnlvl~~~----~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 72 TAQNT--IRWSSGTK-GSIGNYVLVLQPDRTVTIYGP----GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp CTTTC--CSCCCCCC-CCSSCCEEEECSSSCEEEECS----EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred cCCCc--EEEeCCcc-ccCCcEEEEEeCCCCEEEecC----CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 99888 89999975 223346899999999999942 8999999999877 5554 4443 4444 46787
Q ss_pred EccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCCCCCceeecccccceeeeeeEEEeecCCeeEEEEeecCCCeE
Q 005471 174 AWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTI 253 (695)
Q Consensus 174 Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (695)
+.+||++|.|+|.++++| +++++++..+||++++|++. +...+++.....+ +.+..++++++.++..... ..
T Consensus 143 ---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~-~~ 214 (236)
T 1dlp_A 143 ---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRSA-GR 214 (236)
T ss_dssp ---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEEETTTEEEEECCCCCSS-SC
T ss_pred ---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEEeCCCcEEEEeCCCCCC-CC
Confidence 578999999999999999 68888888899999999653 5566666544321 2222234455555544333 45
Q ss_pred EEEEECccCceEEEE
Q 005471 254 ARMILNETGFLQRFT 268 (695)
Q Consensus 254 ~rl~L~~~G~l~~~~ 268 (695)
.|++||+||++++|.
T Consensus 215 ~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 215 YVFVLQPDRNLAIYG 229 (236)
T ss_dssp CEEEECSSSCEEEEC
T ss_pred EEEEEcCCCcEEEeC
Confidence 799999999999993
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=306.73 Aligned_cols=165 Identities=28% Similarity=0.496 Sum_probs=141.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 35667799999999999999863 467899999987666667889999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEE
Q 005471 602 IYEFMPNKSLDYFIFDES----------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 671 (695)
|||||++|+|.++|.... ....++|..++.|+.|||+||.|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 2346999999999999999999999987 999999999999999999999
Q ss_pred EeeccceeecCCcceeccccccCC
Q 005471 672 SDFGTARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~GT 695 (695)
+|||+|+.+........+....||
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEEC
T ss_pred CCcccceecCCCCceeecCceecC
Confidence 999999987665544444444554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=308.03 Aligned_cols=164 Identities=25% Similarity=0.464 Sum_probs=132.8
Q ss_pred CCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
+|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+||
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4566689999999999999864 4788999999877666778899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceE
Q 005471 603 YEFMPNKSLDYFIFDESR------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 670 (695)
||||++|+|.++|..... ...++|..++.|+.|||+||.|||+.+ ||||||||+||||++++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEE
Confidence 999999999999975421 235899999999999999999999987 99999999999999999999
Q ss_pred EEeeccceeecCCcceeccccccCC
Q 005471 671 ISDFGTARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 671 l~DFGla~~~~~~~~~~~~~~~~GT 695 (695)
|+|||+|+.+...+.....++..||
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp ECCCC----------------CCCC
T ss_pred EcccccceeccCCCcceecCccccc
Confidence 9999999988665544444455565
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.87 Aligned_cols=163 Identities=31% Similarity=0.489 Sum_probs=138.8
Q ss_pred CCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
+++.++||+|+||+||+|++. +++.||||+++... ....++|++|+.++++++|||||+|+|+|.+.+..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445689999999999999863 46789999997543 34467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 603 YEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
||||++|+|.++|..... ...++|..+++|+.|||+||.|||+++ ||||||||+||||++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 999999999999965321 235899999999999999999999987 9999999999999999999
Q ss_pred EEEeeccceeecCCcceeccccccCC
Q 005471 670 RISDFGTARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 670 kl~DFGla~~~~~~~~~~~~~~~~GT 695 (695)
||+|||+|+.+...+....+....||
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred EECCcccceeccCCCceeEecccccC
Confidence 99999999988665544444445565
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=296.70 Aligned_cols=161 Identities=30% Similarity=0.481 Sum_probs=131.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.+++.+.++||+|+||+||+|++. ..||||+++.. .....++|.+|+.+|++++|||||+++|+|.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 356777899999999999999985 36999998753 23456789999999999999999999998754 57899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
||++|+|.++|.... ..++|..++.|+.|||+||.|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 112 y~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999996543 34899999999999999999999987 9999999999999999999999999999886554
Q ss_pred ceeccccccCC
Q 005471 685 ILAITKRVVGT 695 (695)
Q Consensus 685 ~~~~~~~~~GT 695 (695)
....++...||
T Consensus 187 ~~~~~~~~~GT 197 (307)
T 3omv_A 187 GSQQVEQPTGS 197 (307)
T ss_dssp -------CCCC
T ss_pred cceeecccccC
Confidence 44445556776
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.69 Aligned_cols=162 Identities=30% Similarity=0.406 Sum_probs=144.3
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|++.++||+|+||+||+|+. .+++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688899999999999999986 56899999999753 2334677999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.+++... ..+++.....++.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999653 34899999999999999999999987 999999999999999999999999999999766
Q ss_pred cceeccccccCC
Q 005471 684 EILAITKRVVGT 695 (695)
Q Consensus 684 ~~~~~~~~~~GT 695 (695)
.....+..++||
T Consensus 186 ~~~~~~~~~~GT 197 (311)
T 4aw0_A 186 SKQARANSFVGT 197 (311)
T ss_dssp TTCCCBCCCCSC
T ss_pred CCcccccCcccC
Confidence 555556667887
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.32 Aligned_cols=159 Identities=28% Similarity=0.427 Sum_probs=141.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45788899999999999999864 68999999997665556677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcce
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 686 (695)
++|+|.+++.. ..+++.....|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.+..+...
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999854 23899999999999999999999987 999999999999999999999999999988655432
Q ss_pred eccccccCC
Q 005471 687 AITKRVVGT 695 (695)
Q Consensus 687 ~~~~~~~GT 695 (695)
.+.++||
T Consensus 227 --~~~~~GT 233 (346)
T 4fih_A 227 --RKSLVGT 233 (346)
T ss_dssp --BCCCCSC
T ss_pred --ccccccC
Confidence 3446777
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.71 Aligned_cols=163 Identities=25% Similarity=0.428 Sum_probs=135.6
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
.++|.++++||+|+||+||+|+. .+|+.||||++... .....+.+++|+++|++++|||||++++++.+++..||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999986 46899999999754 2334568999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.++|.... ...+++.....|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999996543 335789999999999999999999987 999999999999999999999999999987643
Q ss_pred cceeccccccCC
Q 005471 684 EILAITKRVVGT 695 (695)
Q Consensus 684 ~~~~~~~~~~GT 695 (695)
.. .++.++||
T Consensus 179 ~~--~~~~~~GT 188 (350)
T 4b9d_A 179 VE--LARACIGT 188 (350)
T ss_dssp HH--HHHHHHSC
T ss_pred cc--cccccCCC
Confidence 32 23345676
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=297.32 Aligned_cols=159 Identities=29% Similarity=0.432 Sum_probs=141.9
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+.|+..++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4688889999999999999986 468999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcce
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 686 (695)
++|+|.+++... .+++.....|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+..+...
T Consensus 231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 999999998542 3899999999999999999999987 999999999999999999999999999988655432
Q ss_pred eccccccCC
Q 005471 687 AITKRVVGT 695 (695)
Q Consensus 687 ~~~~~~~GT 695 (695)
.+.++||
T Consensus 304 --~~~~~GT 310 (423)
T 4fie_A 304 --RKSLVGT 310 (423)
T ss_dssp --BCCCEEC
T ss_pred --ccccccC
Confidence 3446776
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=286.72 Aligned_cols=161 Identities=25% Similarity=0.380 Sum_probs=129.5
Q ss_pred CCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC----eeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----ENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E 604 (695)
+|.+.++||+|+||+||+|++ +|+.||||++.... .....++.|+..+.+++|||||+++|+|.+++ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 355678999999999999998 58999999997532 11223345666677899999999999998765 5799999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-----SRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
||++|+|.++|... .++|..+.+|+.|+++||+|||++ ..++||||||||+||||++++.+||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999643 489999999999999999999986 234699999999999999999999999999999
Q ss_pred ecCCccee--ccccccCC
Q 005471 680 FGGEEILA--ITKRVVGT 695 (695)
Q Consensus 680 ~~~~~~~~--~~~~~~GT 695 (695)
........ .+...+||
T Consensus 158 ~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EETTTTEESCC-----CC
T ss_pred ccCCCCceeeeccccccc
Confidence 86554332 23345666
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=293.10 Aligned_cols=174 Identities=28% Similarity=0.391 Sum_probs=145.3
Q ss_pred cHHHHHHhcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCC-CceeeeE
Q 005471 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQH-RNLVKLL 590 (695)
Q Consensus 519 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H-~nIv~l~ 590 (695)
+..+.+...++|++.++||+|+||+||+|++. .++.||||++..... ...++|.+|+++|.++.| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 44455566788999999999999999999853 246899999976543 345679999999999965 9999999
Q ss_pred eEEEeC-CeeEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 005471 591 GCCLEE-DENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL 656 (695)
Q Consensus 591 g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl 656 (695)
|+|.+. +..+||||||++|+|.++|..... ...++|..++.|+.|||+||.|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999775 568999999999999999975321 345899999999999999999999987 999999
Q ss_pred CCCCEEEcCCCceEEEeeccceeecCCcceeccccccCC
Q 005471 657 KASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 657 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 695 (695)
||+||||++++.+||+|||+|+.+..+.....+....||
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 999999999999999999999988766554444555565
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=283.19 Aligned_cols=153 Identities=27% Similarity=0.462 Sum_probs=126.8
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe--------
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE-------- 598 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-------- 598 (695)
+|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 578889999999999999986 4689999999875433 345678999999999999999999999986553
Q ss_pred ----eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEee
Q 005471 599 ----NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (695)
Q Consensus 599 ----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 674 (695)
.+|||||+++|+|.+++.........++.....|+.||++||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 6899999999999999976554445677888899999999999999987 999999999999999999999999
Q ss_pred ccceeecCCc
Q 005471 675 GTARVFGGEE 684 (695)
Q Consensus 675 Gla~~~~~~~ 684 (695)
|+|+.+..++
T Consensus 163 Gla~~~~~~~ 172 (299)
T 4g31_A 163 GLVTAMDQDE 172 (299)
T ss_dssp CCC-------
T ss_pred ccceecCCCc
Confidence 9999986544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=280.51 Aligned_cols=157 Identities=27% Similarity=0.401 Sum_probs=131.8
Q ss_pred CccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEe----CCeeEEEE
Q 005471 531 STSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENMLIY 603 (695)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 603 (695)
+..++||+|+||+||+|+.. +++.||||++... .....+.|.+|+++|++++|||||++++++.. ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34478999999999999864 6889999998653 23345679999999999999999999999876 24579999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~ 682 (695)
|||++|+|.+++... ..+++.....|+.||++||.|||+++ ++||||||||+||||+ +++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999653 35899999999999999999999875 4699999999999998 479999999999986543
Q ss_pred CcceeccccccCC
Q 005471 683 EEILAITKRVVGT 695 (695)
Q Consensus 683 ~~~~~~~~~~~GT 695 (695)
.. ++.++||
T Consensus 185 ~~----~~~~~GT 193 (290)
T 3fpq_A 185 SF----AKAVIGT 193 (290)
T ss_dssp TS----BEESCSS
T ss_pred Cc----cCCcccC
Confidence 32 3345676
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=284.93 Aligned_cols=157 Identities=25% Similarity=0.330 Sum_probs=131.5
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+.|...++||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577778999999999999986 4689999999975321 246999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-ceEEEeeccceeecCCcc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGEEI 685 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 685 (695)
++|+|.++|... ..+++.....|+.||+.||.|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+..
T Consensus 133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999653 34899999999999999999999987 99999999999999887 699999999999875543
Q ss_pred ee---ccccccCC
Q 005471 686 LA---ITKRVVGT 695 (695)
Q Consensus 686 ~~---~~~~~~GT 695 (695)
.. ....++||
T Consensus 207 ~~~~~~~~~~~GT 219 (336)
T 4g3f_A 207 GKSLLTGDYIPGT 219 (336)
T ss_dssp -------CCCCCC
T ss_pred ccceecCCccccC
Confidence 21 22345676
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=275.10 Aligned_cols=158 Identities=27% Similarity=0.486 Sum_probs=125.0
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|++.+.||+|+||+||+|+. .+++.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5789999999999999999986 468999999987542 233567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+ +|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 68998888653 34899999999999999999999987 999999999999999999999999999987644
Q ss_pred cceeccccccCC
Q 005471 684 EILAITKRVVGT 695 (695)
Q Consensus 684 ~~~~~~~~~~GT 695 (695)
.. .+..+||
T Consensus 166 ~~---~~~~~GT 174 (275)
T 3hyh_A 166 NF---LKTSCGS 174 (275)
T ss_dssp ------------
T ss_pred Cc---cCCeeEC
Confidence 32 2335666
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=285.20 Aligned_cols=160 Identities=29% Similarity=0.305 Sum_probs=130.2
Q ss_pred CCCCccceeeeeCceeEEEEEc----CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|++.++||+|+||+||+|+. ..++.||||++++.. ......+.+|+++|++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4688889999999999999975 246899999987542 2334568899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++|+|.++|... ..+++.....++.||+.||.|||+++ ||||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999653 34899999999999999999999987 9999999999999999999999999999765
Q ss_pred CCcceeccccccCC
Q 005471 682 GEEILAITKRVVGT 695 (695)
Q Consensus 682 ~~~~~~~~~~~~GT 695 (695)
..... ...+.||
T Consensus 178 ~~~~~--~~~~~GT 189 (304)
T 3ubd_A 178 DHEKK--AYSFCGT 189 (304)
T ss_dssp ---CC--CCSCCCC
T ss_pred CCCcc--ccccccC
Confidence 44332 3345676
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=272.60 Aligned_cols=161 Identities=24% Similarity=0.436 Sum_probs=134.0
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC------Ce
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------DE 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~ 598 (695)
++|.++++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5788999999999999999986 468999999997542 23356788999999999999999999997643 56
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.|||||||+ |+|.+++... ..+++.....|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 7798888543 35899999999999999999999987 9999999999999999999999999999
Q ss_pred eecCCcc--eeccccccCC
Q 005471 679 VFGGEEI--LAITKRVVGT 695 (695)
Q Consensus 679 ~~~~~~~--~~~~~~~~GT 695 (695)
.+..... ......++||
T Consensus 207 ~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp CC-------CCCCCSSCCC
T ss_pred ecccCccccccccccceeC
Confidence 8754322 2234446776
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=263.89 Aligned_cols=147 Identities=23% Similarity=0.381 Sum_probs=130.4
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC----CCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 600 (695)
..+.|++.++||+|+||+||+|+.+ .++.||||++.+.. ...++.+|+++|..+ +|||||++++++.+.++.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3467999999999999999999742 46789999986542 346788999999998 6999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CceEEEeecccee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARV 679 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~ 679 (695)
|||||+++|+|.+++. .+++.....++.||+.||.|||+++ ||||||||+||||+.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999883 2788999999999999999999987 9999999999999876 7999999999997
Q ss_pred ecCC
Q 005471 680 FGGE 683 (695)
Q Consensus 680 ~~~~ 683 (695)
....
T Consensus 168 ~~~~ 171 (361)
T 4f9c_A 168 THDT 171 (361)
T ss_dssp CTTC
T ss_pred cCCc
Confidence 7543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=279.11 Aligned_cols=158 Identities=28% Similarity=0.383 Sum_probs=134.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHH---HHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIE---ELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~---~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|.+.++||+|+||+||+|+.. +|+.||||++.+.. ..... +.+.++.+++.++|||||+|++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57889999999999999999864 68999999986431 12222 2334567778889999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|||||+++|+|..+|... ..+++.....++.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999653 34899999999999999999999987 999999999999999999999999999988
Q ss_pred cCCcceeccccccCC
Q 005471 681 GGEEILAITKRVVGT 695 (695)
Q Consensus 681 ~~~~~~~~~~~~~GT 695 (695)
.... +...+||
T Consensus 343 ~~~~----~~t~~GT 353 (689)
T 3v5w_A 343 SKKK----PHASVGT 353 (689)
T ss_dssp SSCC----CCSCCSC
T ss_pred CCCC----CCCccCC
Confidence 6544 3345777
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=278.34 Aligned_cols=153 Identities=25% Similarity=0.447 Sum_probs=137.3
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|.+.+.||+|+||.||+|+. .+|+.||||.+........+.+++|+.+|+.++|||||+|++++.+.+..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5788899999999999999986 468999999997765556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CceEEEeeccceeecCCc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK--MNPRISDFGTARVFGGEE 684 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 684 (695)
++|+|.++|.... ..+++.....++.||++||.|||+++ |+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999985432 34889999999999999999999987 9999999999999854 899999999999987654
Q ss_pred c
Q 005471 685 I 685 (695)
Q Consensus 685 ~ 685 (695)
.
T Consensus 312 ~ 312 (573)
T 3uto_A 312 S 312 (573)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=251.10 Aligned_cols=160 Identities=42% Similarity=0.739 Sum_probs=144.1
Q ss_pred HHHHHHhcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 520 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
+.++...+++|...+.||+|+||.||+|+..+++.||||++........+++.+|+.++++++||||+++++++.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33445577899999999999999999999988999999998876666778899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 600 MLIYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
++||||+++|+|.+++..... ...++|..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999998865432 235899999999999999999999987 9999999999999999999999999999
Q ss_pred eecC
Q 005471 679 VFGG 682 (695)
Q Consensus 679 ~~~~ 682 (695)
....
T Consensus 188 ~~~~ 191 (321)
T 2qkw_B 188 KGTE 191 (321)
T ss_dssp ECSS
T ss_pred cccc
Confidence 7654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=259.11 Aligned_cols=170 Identities=19% Similarity=0.262 Sum_probs=143.3
Q ss_pred HHHHHHhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEe
Q 005471 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE 595 (695)
Q Consensus 520 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 595 (695)
+.++....++|.+.++||+|+||+||+|+.. +++.||||++.+.. ....+.+++|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4445556788999999999999999999976 47899999986531 1223458899999999999999999999999
Q ss_pred CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeec
Q 005471 596 EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (695)
Q Consensus 596 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 675 (695)
.+..+|||||+++|+|.+++... ...+++.....++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999653 234899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCCcceeccccccCC
Q 005471 676 TARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 676 la~~~~~~~~~~~~~~~~GT 695 (695)
+|+.+..+.... ....+||
T Consensus 221 la~~~~~~~~~~-~~~~~GT 239 (437)
T 4aw2_A 221 SCLKLMEDGTVQ-SSVAVGT 239 (437)
T ss_dssp TCEECCTTSCEE-CCSCCSC
T ss_pred hhhhcccCCCcc-cccccCC
Confidence 999876554332 2234555
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=240.29 Aligned_cols=178 Identities=40% Similarity=0.631 Sum_probs=152.7
Q ss_pred ccceecHHHHHHhcCCCCcc------ceeeeeCceeEEEEEcCCCcEEEEEEcccCC----cccHHHHHHHHHHHHcCCC
Q 005471 514 DVTFFELSTLLAATDNFSTS------NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQH 583 (695)
Q Consensus 514 ~~~~~~~~~l~~~~~~f~~~------~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H 583 (695)
+...|.+.++..++++|... +.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678889999999999887 8999999999999997 57899999986532 2345678999999999999
Q ss_pred CceeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005471 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (695)
Q Consensus 584 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 663 (695)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||.|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976544556899999999999999999999987 9999999999999
Q ss_pred cCCCceEEEeeccceeecCCcceeccccccCC
Q 005471 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 664 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 695 (695)
++++.+||+|||+++...............||
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~ 198 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSC
T ss_pred cCCCcEEEeecccccccccccccccccccCCC
Confidence 99999999999999987654333333333443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-27 Score=246.95 Aligned_cols=171 Identities=43% Similarity=0.749 Sum_probs=149.9
Q ss_pred ccceecHHHHHHhcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeE
Q 005471 514 DVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGC 592 (695)
Q Consensus 514 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 592 (695)
....+.+.++....++|...+.||+|+||.||+|+..+++.||||++..... .....+.+|++++.+++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3456888999999999999999999999999999988899999999876432 233468999999999999999999999
Q ss_pred EEeCCeeEEEEEcCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEE
Q 005471 593 CLEEDENMLIYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (695)
Q Consensus 593 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 671 (695)
+...+..++||||+++|+|.+++..... ...+++..+..|+.|++.||.|||+.+..+|+||||||+|||+++++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999976542 345899999999999999999999984344999999999999999999999
Q ss_pred EeeccceeecCCc
Q 005471 672 SDFGTARVFGGEE 684 (695)
Q Consensus 672 ~DFGla~~~~~~~ 684 (695)
+|||+|+.+....
T Consensus 176 ~Dfg~~~~~~~~~ 188 (326)
T 3uim_A 176 GDFGLAKLMDYKD 188 (326)
T ss_dssp CCCSSCEECCSSS
T ss_pred ccCccccccCccc
Confidence 9999999886443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=240.78 Aligned_cols=152 Identities=29% Similarity=0.475 Sum_probs=136.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|...++||+|+||+||+++.. +++.||+|++........+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 45777899999999999999874 58899999987766667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 90 KGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp TTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999996532 34899999999999999999999987 9999999999999999999999999999875443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-26 Score=238.20 Aligned_cols=151 Identities=26% Similarity=0.448 Sum_probs=137.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|...+.||+|+||+||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 5788899999999999999985 568999999987655556778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
++|+|.+++... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999998543 4789999999999999999999987 99999999999999999999999999998865543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-26 Score=240.74 Aligned_cols=161 Identities=26% Similarity=0.383 Sum_probs=141.1
Q ss_pred eecHHHHHHhcCC----------CCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCc
Q 005471 517 FFELSTLLAATDN----------FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585 (695)
Q Consensus 517 ~~~~~~l~~~~~~----------f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n 585 (695)
.+.++++..+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3455555555443 566679999999999999875 78999999998766666788999999999999999
Q ss_pred eeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 005471 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 665 (695)
Q Consensus 586 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~ 665 (695)
|+++++++...+..++||||+++++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999998853 24899999999999999999999987 999999999999999
Q ss_pred CCceEEEeeccceeecCCc
Q 005471 666 KMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 666 ~~~~kl~DFGla~~~~~~~ 684 (695)
++.+||+|||+++.+..+.
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp TCCEEECCCTTCEECCSSS
T ss_pred CCcEEEeeeeeeeecccCc
Confidence 9999999999999886543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=242.27 Aligned_cols=153 Identities=25% Similarity=0.437 Sum_probs=134.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe-------
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE------- 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------- 598 (695)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45788899999999999999875 78999999987543 3346789999999999999999999999876543
Q ss_pred --------------------------------------------------eEEEEEcCCCCCHHHHHhccCCCCCCCHHH
Q 005471 599 --------------------------------------------------NMLIYEFMPNKSLDYFIFDESRKQLLDWKK 628 (695)
Q Consensus 599 --------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 628 (695)
.++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 789999999999999998766555678888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 629 ~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 8999999999999999987 999999999999999999999999999988654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=252.84 Aligned_cols=161 Identities=21% Similarity=0.273 Sum_probs=140.2
Q ss_pred cHHHHHHhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEE
Q 005471 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594 (695)
Q Consensus 519 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~ 594 (695)
.+.+.....++|.+.++||+|+||+||+++.. +++.||||++.+.. ....+.+++|+.++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34444556678999999999999999999874 68999999986532 223446889999999999999999999999
Q ss_pred eCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEee
Q 005471 595 EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (695)
Q Consensus 595 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 674 (695)
+.+..+|||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999996532 24889999999999999999999987 999999999999999999999999
Q ss_pred ccceeecCCc
Q 005471 675 GTARVFGGEE 684 (695)
Q Consensus 675 Gla~~~~~~~ 684 (695)
|+|+.+..+.
T Consensus 207 Gla~~~~~~~ 216 (412)
T 2vd5_A 207 GSCLKLRADG 216 (412)
T ss_dssp TTCEECCTTS
T ss_pred hhheeccCCC
Confidence 9999886544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=243.01 Aligned_cols=151 Identities=31% Similarity=0.469 Sum_probs=135.2
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
.++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788889999999999999986 57899999998654 2334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.+++.... .+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999986542 3889999999999999999999987 999999999999999999999999999877544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=246.90 Aligned_cols=154 Identities=28% Similarity=0.518 Sum_probs=134.7
Q ss_pred CCCCccceeeeeCceeEEEEEc--------CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~--------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 597 (695)
++|.+.+.||+|+||.||+|+. .++..||||++.... ....+++.+|+.+++++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 5678889999999999999975 235679999997643 33456789999999999 8999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 664 (695)
..++||||+++|+|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||||+
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEEC
Confidence 99999999999999999975431 234789999999999999999999987 99999999999999
Q ss_pred CCCceEEEeeccceeecCCc
Q 005471 665 EKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 665 ~~~~~kl~DFGla~~~~~~~ 684 (695)
+++.+||+|||+|+.+....
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~ 257 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNID 257 (370)
T ss_dssp TTCCEEECCCSSCEETTCCC
T ss_pred CCCCEEEccccCCcccCccc
Confidence 99999999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=251.49 Aligned_cols=167 Identities=22% Similarity=0.275 Sum_probs=141.2
Q ss_pred HHHHHhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC
Q 005471 521 STLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596 (695)
Q Consensus 521 ~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 596 (695)
.++....++|.+.++||+|+||+||+++.. +++.||||++.+.. ....+.+.+|+.+++.++|||||++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455678999999999999999999875 58899999986521 22344688999999999999999999999999
Q ss_pred CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
+..+|||||+++|+|.+++... .+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999988542 3788999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCcceeccccccCC
Q 005471 677 ARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 677 a~~~~~~~~~~~~~~~~GT 695 (695)
|+.+...... ......||
T Consensus 215 a~~~~~~~~~-~~~~~~gt 232 (410)
T 3v8s_A 215 CMKMNKEGMV-RCDTAVGT 232 (410)
T ss_dssp CEECCTTSEE-ECCSCCSC
T ss_pred eEeeccCCcc-cccCCcCC
Confidence 9988655432 22334555
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=241.23 Aligned_cols=162 Identities=30% Similarity=0.407 Sum_probs=136.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999865 78999999986543 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
+++|+|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999988843 234899999999999999999999987 99999999999999999999999999998754443
Q ss_pred eeccccccCC
Q 005471 686 LAITKRVVGT 695 (695)
Q Consensus 686 ~~~~~~~~GT 695 (695)
........||
T Consensus 161 ~~~~~~~~gt 170 (323)
T 3tki_A 161 ERLLNKMCGT 170 (323)
T ss_dssp ECCBCSCCSC
T ss_pred ccccCCCccC
Confidence 3333334444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-26 Score=241.65 Aligned_cols=148 Identities=22% Similarity=0.314 Sum_probs=132.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|+..+.||+|+||+||+++.. +++.||||++.+. .....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 46788899999999999999864 6899999998653 2334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||+++|+|..++... ..+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999988643 34789999999999999999999987 9999999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=241.28 Aligned_cols=162 Identities=29% Similarity=0.446 Sum_probs=134.8
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe----eEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE----NMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~~lV~ 603 (695)
++|++.++||+|+||.||+|+.. ++.||||++... ......+..|+.++.+++|||||++++++..... .++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 56788899999999999999875 789999998653 2334456679999999999999999999998553 69999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-------SRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
||+++|+|.+++... .+++..+..|+.||++||.|||+. +..+|+||||||+|||+++++.+||+|||+
T Consensus 102 e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999999999542 389999999999999999999987 011399999999999999999999999999
Q ss_pred ceeecCCcceeccccccCC
Q 005471 677 ARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 677 a~~~~~~~~~~~~~~~~GT 695 (695)
|+.+.............||
T Consensus 178 a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp CEEECTTSCCCCCTTCCCC
T ss_pred ccccccccCccccccCccC
Confidence 9988765443333333444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.4e-26 Score=242.34 Aligned_cols=149 Identities=28% Similarity=0.423 Sum_probs=132.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 601 (695)
.++|.+.++||+|+||+||+++.. +++.||||++.+. .....+.+.+|+.++..+ +||||+++++++.+.+..+|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467888999999999999999864 5889999998753 223456788899999988 79999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++|+|..++... ..+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999998653 34889999999999999999999987 9999999999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-26 Score=239.07 Aligned_cols=151 Identities=26% Similarity=0.492 Sum_probs=133.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC----CCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|.+.+.||+|+||.||+|+.. .+..||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999874 3456999999764 334456799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++++|.+++.... ..+++..+..|+.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 129 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999996432 34899999999999999999999987 99999999999999999999999999998865
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 204 ~ 204 (325)
T 3kul_A 204 D 204 (325)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=245.57 Aligned_cols=152 Identities=30% Similarity=0.534 Sum_probs=127.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC----CCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|.+.+.||+|+||.||+|+.. ++..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999875 5678999999764 234456799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++|+|.+++.... ..+++..++.|+.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 125 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999996532 34899999999999999999999987 99999999999999999999999999998765
Q ss_pred Cc
Q 005471 683 EE 684 (695)
Q Consensus 683 ~~ 684 (695)
+.
T Consensus 200 ~~ 201 (373)
T 2qol_A 200 DP 201 (373)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-26 Score=238.79 Aligned_cols=155 Identities=28% Similarity=0.556 Sum_probs=130.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45688889999999999999987 57899999987543 2335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+++|+|.+++........+++..+..++.||++||.|||+.+ .+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999999976544445899999999999999999999874 34999999999999999999999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-26 Score=246.06 Aligned_cols=152 Identities=28% Similarity=0.476 Sum_probs=134.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++|.+.+.||+|+||.||+|+.. +++.||||.+..... ...++|.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356778899999999999999985 689999999875432 334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+++|+|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999996532 24889999999999999999999987 999999999999999999999999999976543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=245.14 Aligned_cols=163 Identities=30% Similarity=0.457 Sum_probs=138.4
Q ss_pred cHHHHHHhcCCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcC-CCCceeeeE
Q 005471 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLL 590 (695)
Q Consensus 519 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~ 590 (695)
...+.....++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444555677899999999999999999973 3467999999976432 3456789999999999 899999999
Q ss_pred eEEEeCCe-eEEEEEcCCCCCHHHHHhccCC-------------------------------------------------
Q 005471 591 GCCLEEDE-NMLIYEFMPNKSLDYFIFDESR------------------------------------------------- 620 (695)
Q Consensus 591 g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------- 620 (695)
+++.+.+. .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99988655 8999999999999999975432
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 621 --------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 621 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122889999999999999999999987 9999999999999999999999999999775443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-26 Score=244.27 Aligned_cols=150 Identities=19% Similarity=0.246 Sum_probs=131.6
Q ss_pred hcCCCCccceeeeeCceeEEEEE------cCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC---CCceeeeEeEEEeC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGK------LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEE 596 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~------~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~ 596 (695)
..++|.+.++||+|+||.||+|. ..+++.||||++... ...++..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35678888999999999999994 456889999998753 3557788888888887 99999999999999
Q ss_pred CeeEEEEEcCCCCCHHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---------
Q 005471 597 DENMLIYEFMPNKSLDYFIFDES--RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--------- 665 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--------- 665 (695)
+..+|||||+++|+|.+++.... ....+++..+..|+.||++||.|||+++ ||||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996432 2345899999999999999999999987 999999999999998
Q ss_pred --CCceEEEeeccceeec
Q 005471 666 --KMNPRISDFGTARVFG 681 (695)
Q Consensus 666 --~~~~kl~DFGla~~~~ 681 (695)
++.+||+|||+|+.+.
T Consensus 217 ~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp --CTTEEECCCTTCEEGG
T ss_pred cccCCEEEeeCchhhhhh
Confidence 8999999999998775
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-25 Score=237.77 Aligned_cols=150 Identities=29% Similarity=0.413 Sum_probs=133.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc------ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
+.|.+.+.||+|+||.||+++.. +|+.||||.+.+... ...+.+.+|+.++.+++||||+++++++.+....+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 56888899999999999999865 689999999875432 23578999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----ceEEEeecc
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFGT 676 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 676 (695)
+||||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++ .+||+|||+
T Consensus 92 lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999998543 35899999999999999999999987 99999999999998776 799999999
Q ss_pred ceeecCC
Q 005471 677 ARVFGGE 683 (695)
Q Consensus 677 a~~~~~~ 683 (695)
|+.+...
T Consensus 166 a~~~~~~ 172 (361)
T 2yab_A 166 AHEIEDG 172 (361)
T ss_dssp CEECCTT
T ss_pred ceEcCCC
Confidence 9987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=236.10 Aligned_cols=149 Identities=26% Similarity=0.390 Sum_probs=133.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46788899999999999999874 68999999986532 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++|+|.+++... ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999998653 24789999999999999999999987 99999999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-25 Score=234.55 Aligned_cols=154 Identities=29% Similarity=0.431 Sum_probs=135.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC--eeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--ENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~ 603 (695)
++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 45778899999999999999875 48999999987543 334677889999999999999999999998766 679999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCceEEEeecccee
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTARV 679 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~~ 679 (695)
||+++++|.+++........+++..+..|+.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976655555899999999999999999999987 9999999999999 7888899999999998
Q ss_pred ecCCc
Q 005471 680 FGGEE 684 (695)
Q Consensus 680 ~~~~~ 684 (695)
+....
T Consensus 166 ~~~~~ 170 (319)
T 4euu_A 166 LEDDE 170 (319)
T ss_dssp CCTTC
T ss_pred cCCCC
Confidence 76543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=244.35 Aligned_cols=148 Identities=22% Similarity=0.348 Sum_probs=130.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|.+.++||+|+||+||+++.. +++.||||++++.. ....+.+.+|..++.++ +|||||++++++.+.+..+||
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 56888899999999999999875 57899999987542 22344678899999887 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 132 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999988653 34899999999999999999999987 9999999999999999999999999998643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-25 Score=227.95 Aligned_cols=153 Identities=27% Similarity=0.474 Sum_probs=137.2
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.++|.+.+.||+|+||.||+|+..++..||||++... ....+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 3567788999999999999999988889999999764 334577999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
++++|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999986542 34899999999999999999999987 99999999999999999999999999998765543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=232.95 Aligned_cols=150 Identities=26% Similarity=0.441 Sum_probs=132.6
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+++. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 5788889999999999999985 468899999985432 233567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 91 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999998643 24899999999999999999999987 999999999999999999999999999877543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-25 Score=233.51 Aligned_cols=152 Identities=21% Similarity=0.346 Sum_probs=135.1
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|.+.+.||+|+||.||+++.. +++.+|+|.+... ....+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367888999999999999999865 5789999998753 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--KMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 683 (695)
+++|+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999998543 234899999999999999999999987 999999999999997 789999999999988654
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 158 ~ 158 (321)
T 1tki_A 158 D 158 (321)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.3e-26 Score=235.34 Aligned_cols=151 Identities=30% Similarity=0.554 Sum_probs=131.1
Q ss_pred CCCCccceeeeeCceeEEEEEc-----CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 600 (695)
++|++.++||+|+||.||++++ .+++.||||++........+.+.+|++++.+++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4677889999999999999984 36889999999876666677899999999999999999999998654 4589
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 90 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 9999999999999996543 24899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 005471 681 GGE 683 (695)
Q Consensus 681 ~~~ 683 (695)
..+
T Consensus 165 ~~~ 167 (295)
T 3ugc_A 165 PQD 167 (295)
T ss_dssp ---
T ss_pred cCC
Confidence 544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=230.68 Aligned_cols=150 Identities=30% Similarity=0.532 Sum_probs=135.5
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|...+.||+|+||.||+|+..+++.||||++... ....+++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 467778999999999999999988899999999764 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 89 ~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 89 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999996533 35899999999999999999999987 999999999999999999999999999877543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=236.77 Aligned_cols=149 Identities=25% Similarity=0.357 Sum_probs=123.9
Q ss_pred CCCCccceeeeeCceeEEEEEc----CCCcEEEEEEcccCC----cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
++|.+.+.||+|+||.||+++. .+++.||||++.+.. ......+.+|+.++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4677889999999999999986 478999999987642 23345678899999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||+++++|.+++... ..+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999998643 24788999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005471 680 FGG 682 (695)
Q Consensus 680 ~~~ 682 (695)
...
T Consensus 171 ~~~ 173 (327)
T 3a62_A 171 SIH 173 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=241.96 Aligned_cols=150 Identities=25% Similarity=0.406 Sum_probs=134.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+++.. +++.||||.+.+.. ....+.+.+|+.++.+++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46778899999999999999864 58899999986532 334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+..+
T Consensus 95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999998643 34899999999999999999999987 999999999999999999999999999987544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=238.48 Aligned_cols=150 Identities=25% Similarity=0.395 Sum_probs=132.8
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 600 (695)
..++|.+.+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4567888999999999999999875 68899999987532 23456778899999876 9999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 95 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999998653 24889999999999999999999987 999999999999999999999999999875
Q ss_pred c
Q 005471 681 G 681 (695)
Q Consensus 681 ~ 681 (695)
.
T Consensus 169 ~ 169 (345)
T 1xjd_A 169 M 169 (345)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=237.98 Aligned_cols=148 Identities=23% Similarity=0.349 Sum_probs=131.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|...+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 45778899999999999999875 58899999987542 23355688999999988 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999998643 24889999999999999999999987 9999999999999999999999999998643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=9.2e-26 Score=240.41 Aligned_cols=156 Identities=29% Similarity=0.485 Sum_probs=136.8
Q ss_pred HhcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC
Q 005471 525 AATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (695)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 597 (695)
...++|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578899999999999999999874 34789999997643 234567899999999999999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESR---------------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL 656 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl 656 (695)
..++||||+++|+|.+++..... ...+++..++.|+.||++||.|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999975321 145899999999999999999999987 999999
Q ss_pred CCCCEEEcCCCceEEEeeccceeecCC
Q 005471 657 KASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 657 kp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+|||+++++.+||+|||+++.+...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~ 227 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSA 227 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred CcceEEECCCCeEEEeecCCCcccccC
Confidence 999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=233.51 Aligned_cols=149 Identities=32% Similarity=0.497 Sum_probs=130.7
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|.+.++||+|+||+||+|+..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 5788889999999999999999889999999987542 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++ ++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 101 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 101 ME-KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CS-EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CC-CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 98 47877775432 34889999999999999999999987 99999999999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=235.71 Aligned_cols=156 Identities=29% Similarity=0.486 Sum_probs=136.1
Q ss_pred cCCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
.++|.+.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45688889999999999999975 345789999997543 34456789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005471 600 MLIYEFMPNKSLDYFIFDESR---------------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp 658 (695)
++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999975432 234789999999999999999999987 99999999
Q ss_pred CCEEEcCCCceEEEeeccceeecCCcc
Q 005471 659 SNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 659 ~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
+|||+++++.+||+|||+++.+.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~ 205 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDS 205 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSC
T ss_pred heEEEcCCCCEEEcccccccccccccc
Confidence 999999999999999999998865443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=237.39 Aligned_cols=150 Identities=26% Similarity=0.322 Sum_probs=134.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|...+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46778899999999999999874 68999999986532 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.+++.... .+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999986532 4889999999999999999999987 999999999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=237.34 Aligned_cols=149 Identities=26% Similarity=0.340 Sum_probs=132.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 601 (695)
.++|.+.+.||+|+||.||+++.. +++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467888999999999999999875 4789999998753 223456788999999988 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++|+|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999986532 4889999999999999999999987 9999999999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=236.64 Aligned_cols=156 Identities=30% Similarity=0.504 Sum_probs=122.2
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCCCc----EEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQ----EIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~----~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
..++|.+.+.||+|+||.||+|+..... .||||++... .....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 4567889999999999999999875432 7999998754 334567899999999999999999999999887765
Q ss_pred ------EEEEEcCCCCCHHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceE
Q 005471 600 ------MLIYEFMPNKSLDYFIFDESR---KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670 (695)
Q Consensus 600 ------~lV~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 670 (695)
++||||+++|+|.+++..... ...+++..+..|+.||++||.|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999865322 225899999999999999999999987 99999999999999999999
Q ss_pred EEeeccceeecCCc
Q 005471 671 ISDFGTARVFGGEE 684 (695)
Q Consensus 671 l~DFGla~~~~~~~ 684 (695)
|+|||+|+.+....
T Consensus 178 l~Dfg~a~~~~~~~ 191 (323)
T 3qup_A 178 VADFGLSRKIYSGD 191 (323)
T ss_dssp ECCCCC--------
T ss_pred Eeeccccccccccc
Confidence 99999999875443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=231.19 Aligned_cols=149 Identities=28% Similarity=0.456 Sum_probs=126.8
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc--------------------------ccHHHHHHHHHHHHc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG--------------------------QGIEELKNEVLLIAK 580 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~--------------------------~~~~~~~~Ei~~l~~ 580 (695)
++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5788889999999999999986 4688999999865321 113568899999999
Q ss_pred CCCCceeeeEeEEEe--CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005471 581 LQHRNLVKLLGCCLE--EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658 (695)
Q Consensus 581 l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp 658 (695)
++||||+++++++.+ .+..++||||+++++|.+++ ....+++.....++.||++||.|||+.+ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999987 56789999999999997754 2335899999999999999999999987 99999999
Q ss_pred CCEEEcCCCceEEEeeccceeecCC
Q 005471 659 SNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 659 ~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+|||++.++.+||+|||+|+.+...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHEEECCCCCEEEecCCCccccccc
Confidence 9999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=240.76 Aligned_cols=154 Identities=29% Similarity=0.485 Sum_probs=134.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcC--------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE 596 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 596 (695)
.++|.+.++||+|+||.||+|+.. .+..||||++.... ....+++.+|++++.++ +|||||++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 356788899999999999999852 34579999987643 33456789999999999 999999999999999
Q ss_pred CeeEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005471 597 DENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 663 (695)
+..++||||+++|+|.+++..... ...+++..+..|+.||++||.|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976432 235899999999999999999999987 9999999999999
Q ss_pred cCCCceEEEeeccceeecCC
Q 005471 664 DEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 664 ~~~~~~kl~DFGla~~~~~~ 683 (695)
++++.+||+|||+|+.+...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCC
T ss_pred cCCCcEEEcccCcccccccc
Confidence 99999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=8.3e-25 Score=237.45 Aligned_cols=152 Identities=26% Similarity=0.387 Sum_probs=135.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 56888999999999999999864 68899999997665555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCceEEEeeccceeecCCc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--KMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 684 (695)
++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.+..+.
T Consensus 131 ~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 131 SGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999999988543 234899999999999999999999987 999999999999974 5789999999999886554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=229.91 Aligned_cols=151 Identities=25% Similarity=0.464 Sum_probs=133.1
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.++|...+.||+|+||.||+++..++..||||++... ....+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 3567788999999999999999988889999999764 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++++|.+++.... ..+++..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 102 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp TTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred CCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999996532 34899999999999999999999987 999999999999999999999999999877543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=249.70 Aligned_cols=153 Identities=30% Similarity=0.513 Sum_probs=136.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|.+.++||+|+||.||+|+... ++.||||.+... ....++|.+|+.+|++++|||||+++++|.+.+..+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3457778999999999999999764 789999999764 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
+++|+|.+++.... ...+++..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+..+.
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999997543 235899999999999999999999987 9999999999999999999999999999886543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.6e-25 Score=231.89 Aligned_cols=150 Identities=29% Similarity=0.425 Sum_probs=133.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc------ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|.+.+.||+|+||.||+++.. +++.||||.+..... ...+.+.+|+.++.+++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35778899999999999999874 689999999865422 24678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----ceEEEeecc
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFGT 676 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 676 (695)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 999999999999998542 35899999999999999999999987 99999999999999887 899999999
Q ss_pred ceeecCC
Q 005471 677 ARVFGGE 683 (695)
Q Consensus 677 a~~~~~~ 683 (695)
|+.+...
T Consensus 165 a~~~~~~ 171 (326)
T 2y0a_A 165 AHKIDFG 171 (326)
T ss_dssp CEECCTT
T ss_pred CeECCCC
Confidence 9988543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=247.97 Aligned_cols=152 Identities=32% Similarity=0.494 Sum_probs=135.1
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
..++|.+.++||+|+||.||+|+..++..||||+++.. ....++|.+|+.+|++++|||||++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 34567888999999999999999988899999999764 345788999999999999999999999986 6678999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++|+|.+++.... ...+++..+..++.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999996532 224788999999999999999999987 999999999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=235.95 Aligned_cols=156 Identities=29% Similarity=0.479 Sum_probs=133.8
Q ss_pred hcCCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 597 (695)
..++|.+.+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456788899999999999999985 245689999987542 34457899999999999 8999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRK--------------------QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 657 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 657 (695)
..++||||+++|+|.+++...... ..+++..+..++.||++||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999754321 24789999999999999999999987 9999999
Q ss_pred CCCEEEcCCCceEEEeeccceeecCCc
Q 005471 658 ASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 658 p~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
|+|||++.++.+||+|||+++.+....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~ 226 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDS 226 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCc
Confidence 999999999999999999999876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=242.14 Aligned_cols=151 Identities=32% Similarity=0.514 Sum_probs=131.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|.+.++||+|+||.||+|+.. +++.||||++... ......++.+|+.++.+++|||||++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 46778899999999999999843 4678999999754 3344567889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---ceEEEe
Q 005471 601 LIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM---NPRISD 673 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~D 673 (695)
+||||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+||||+.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997543 2235899999999999999999999987 99999999999999544 599999
Q ss_pred eccceeec
Q 005471 674 FGTARVFG 681 (695)
Q Consensus 674 FGla~~~~ 681 (695)
||+|+.+.
T Consensus 228 FG~a~~~~ 235 (367)
T 3l9p_A 228 FGMARDIY 235 (367)
T ss_dssp CHHHHHHH
T ss_pred Cccccccc
Confidence 99998664
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-25 Score=247.99 Aligned_cols=154 Identities=29% Similarity=0.398 Sum_probs=136.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
.++|...+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.+|.+++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999874 6899999998653 223456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999986543 234899999999999999999999987 99999999999999999999999999998865
Q ss_pred Cc
Q 005471 683 EE 684 (695)
Q Consensus 683 ~~ 684 (695)
..
T Consensus 339 ~~ 340 (576)
T 2acx_A 339 GQ 340 (576)
T ss_dssp TC
T ss_pred Cc
Confidence 43
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=233.57 Aligned_cols=154 Identities=27% Similarity=0.423 Sum_probs=133.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC-----CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-----SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
+.|.+.+.||+|+||.||+++. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4578889999999999999986 46899999998532 12346789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---eEEEeeccc
Q 005471 602 IYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDFGTA 677 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla 677 (695)
||||+++++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988775432 2335889999999999999999999987 999999999999986554 999999999
Q ss_pred eeecCCc
Q 005471 678 RVFGGEE 684 (695)
Q Consensus 678 ~~~~~~~ 684 (695)
+.+....
T Consensus 181 ~~~~~~~ 187 (351)
T 3c0i_A 181 IQLGESG 187 (351)
T ss_dssp EECCTTS
T ss_pred eEecCCC
Confidence 9886543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=229.45 Aligned_cols=149 Identities=27% Similarity=0.484 Sum_probs=132.2
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|...+.||+|+||.||+|+..+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688889999999999999998889999999986543 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++ +|.+++.... ..+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 985 8888885432 34889999999999999999999987 99999999999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=227.06 Aligned_cols=149 Identities=26% Similarity=0.476 Sum_probs=129.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|+..++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999874 68899999987543 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+++ ++...+... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9986 555554332 234899999999999999999999987 99999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=237.33 Aligned_cols=147 Identities=33% Similarity=0.450 Sum_probs=126.8
Q ss_pred cceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 533 SNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
.+.||+|+||.||+|+. .+++.||||++........+++.+|++++.+++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 47899999999999986 46899999999876556677899999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE--cCCCceEEEeeccceeecCCc
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL--DEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~ 684 (695)
.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 98886532 34889999999999999999999987 9999999999999 577899999999999886544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=231.98 Aligned_cols=155 Identities=28% Similarity=0.519 Sum_probs=134.0
Q ss_pred cCCCCccceeeeeCceeEEEEEc--------CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE 596 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~--------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 596 (695)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 35788889999999999999986 346789999997643 33456789999999999 899999999999999
Q ss_pred CeeEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005471 597 DENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 663 (695)
+..++||||+++|+|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999975432 124889999999999999999999987 9999999999999
Q ss_pred cCCCceEEEeeccceeecCCc
Q 005471 664 DEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 664 ~~~~~~kl~DFGla~~~~~~~ 684 (695)
+.++.+||+|||+++.+....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~ 211 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNID 211 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTS
T ss_pred cCCCCEEEccccccccccccc
Confidence 999999999999999876544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=234.30 Aligned_cols=150 Identities=24% Similarity=0.430 Sum_probs=132.3
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788889999999999999986 578999999986431 223457899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+ +|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 68888888553 24889999999999999999999987 999999999999999999999999999977554
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 162 ~ 162 (336)
T 3h4j_B 162 N 162 (336)
T ss_dssp B
T ss_pred c
Confidence 3
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=234.20 Aligned_cols=150 Identities=24% Similarity=0.396 Sum_probs=128.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee----
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN---- 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~---- 599 (695)
++|.+.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++.+++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788889999999999999985 5789999999976432 3345788999999999999999999998876544
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||+++++|.+++... ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 9999999999999998643 24899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 005471 680 FGGE 683 (695)
Q Consensus 680 ~~~~ 683 (695)
+...
T Consensus 166 ~~~~ 169 (311)
T 3ork_A 166 IADS 169 (311)
T ss_dssp ----
T ss_pred cccc
Confidence 7543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-25 Score=242.04 Aligned_cols=149 Identities=28% Similarity=0.497 Sum_probs=132.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-eeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-ENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey 605 (695)
.++|.+.+.||+|+||.||+|+.. ++.||||.++... ..++|.+|+.+|++++|||||++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456778899999999999999985 7899999997643 5578999999999999999999999988776 78999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999997543 334789999999999999999999987 99999999999999999999999999996543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=230.63 Aligned_cols=150 Identities=25% Similarity=0.290 Sum_probs=127.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|+..++||+|+||+||+|+.. +++.||||++..... ....++..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46888899999999999999875 789999999865322 2333455566666555 8999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+ +++|.+++.... ..++|..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 678988886543 35899999999999999999999987 999999999999999999999999999987544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=226.78 Aligned_cols=151 Identities=32% Similarity=0.588 Sum_probs=130.9
Q ss_pred CCCccceeeeeCceeEEEEEc-----CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENM 600 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 600 (695)
.|+..++||+|+||.||++++ .+++.||||++.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 477789999999999999983 468899999987543 34457899999999999999999999999887 5679
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 102 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence 9999999999999985533 34899999999999999999999987 999999999999999999999999999988
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
....
T Consensus 177 ~~~~ 180 (302)
T 4e5w_A 177 ETDK 180 (302)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 6544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=223.60 Aligned_cols=151 Identities=21% Similarity=0.364 Sum_probs=135.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|.+.++||+|+||.||+|+.. ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 45788899999999999999875 46799999997765666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~ 683 (695)
++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 89 TGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999988653 34889999999999999999999987 9999999999999 78899999999999987654
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 163 ~ 163 (277)
T 3f3z_A 163 K 163 (277)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=234.06 Aligned_cols=152 Identities=32% Similarity=0.576 Sum_probs=127.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCc----EEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|+..++||+|+||.||+|+.. +++ +||+|.+... .....+++.+|+.++++++||||++++++|.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 45778899999999999999853 344 4688887643 2345678999999999999999999999998754 789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|+||+++|+|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999986543 34899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCcc
Q 005471 682 GEEI 685 (695)
Q Consensus 682 ~~~~ 685 (695)
....
T Consensus 169 ~~~~ 172 (327)
T 3poz_A 169 AEEK 172 (327)
T ss_dssp TTCC
T ss_pred CCcc
Confidence 5443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=230.93 Aligned_cols=156 Identities=30% Similarity=0.464 Sum_probs=136.1
Q ss_pred cCCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCe
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 598 (695)
.++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35677889999999999999974 3567899999976433 3456789999999999 99999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 005471 599 NMLIYEFMPNKSLDYFIFDESR---------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 663 (695)
.++||||+++|+|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999975432 124899999999999999999999987 9999999999999
Q ss_pred cCCCceEEEeeccceeecCCcc
Q 005471 664 DEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 664 ~~~~~~kl~DFGla~~~~~~~~ 685 (695)
++++.+||+|||+++.+.....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~ 200 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSN 200 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTT
T ss_pred cCCCCEEEcccccccccccccc
Confidence 9999999999999998765543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=234.39 Aligned_cols=150 Identities=29% Similarity=0.453 Sum_probs=132.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 56888899999999999999864 68999999986542 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK---MNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~~ 681 (695)
|+++|+|.+++... ..+++.....++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 109 ~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 109 LVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred cCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999888543 34889999999999999999999987 9999999999999865 459999999999876
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 183 ~~ 184 (362)
T 2bdw_A 183 DS 184 (362)
T ss_dssp TC
T ss_pred CC
Confidence 44
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=245.09 Aligned_cols=154 Identities=30% Similarity=0.430 Sum_probs=136.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|...+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999875 68999999986532 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++|+|..++..... ...+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999865432 345899999999999999999999987 99999999999999999999999999998765
Q ss_pred Cc
Q 005471 683 EE 684 (695)
Q Consensus 683 ~~ 684 (695)
..
T Consensus 342 ~~ 343 (543)
T 3c4z_A 342 GQ 343 (543)
T ss_dssp TC
T ss_pred CC
Confidence 44
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=237.71 Aligned_cols=154 Identities=29% Similarity=0.431 Sum_probs=135.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC--eeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--ENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~ 603 (695)
++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 45778899999999999999875 48999999987543 234577889999999999999999999998766 679999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCceEEEeecccee
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTARV 679 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~~ 679 (695)
||+++|+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976554445899999999999999999999987 9999999999999 7888899999999998
Q ss_pred ecCCc
Q 005471 680 FGGEE 684 (695)
Q Consensus 680 ~~~~~ 684 (695)
+....
T Consensus 166 ~~~~~ 170 (396)
T 4eut_A 166 LEDDE 170 (396)
T ss_dssp CCCGG
T ss_pred ccCCC
Confidence 76544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=235.21 Aligned_cols=157 Identities=27% Similarity=0.457 Sum_probs=135.9
Q ss_pred HhcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC
Q 005471 525 AATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (695)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 597 (695)
...++|.+.+.||+|+||.||+|+.. +++.||||.+..... ....++.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34567888899999999999999764 367899999975432 34557889999999999999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceE
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESR-------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 670 (695)
..++||||+++|+|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+|||+++++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 99999999999999999865321 234689999999999999999999987 99999999999999999999
Q ss_pred EEeeccceeecCCc
Q 005471 671 ISDFGTARVFGGEE 684 (695)
Q Consensus 671 l~DFGla~~~~~~~ 684 (695)
|+|||+++.+....
T Consensus 179 l~Dfg~~~~~~~~~ 192 (322)
T 1p4o_A 179 IGDFGMTRDIYETD 192 (322)
T ss_dssp ECCTTCCCGGGGGG
T ss_pred ECcCcccccccccc
Confidence 99999998775443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=245.80 Aligned_cols=149 Identities=23% Similarity=0.306 Sum_probs=123.5
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.++||+|+||.||+++. .+++.||||++... .......+.+|+.++++++||||+++++++.+.+..+|||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 5688889999999999999986 46889999998753 2334556788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++|+|..++... ..+++..+..++.||++||.|||+ .+ |+||||||+||||+.++.+||+|||+|+....
T Consensus 228 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 228 EYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred eeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999988643 348999999999999999999998 66 99999999999999999999999999986543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-26 Score=243.08 Aligned_cols=148 Identities=19% Similarity=0.288 Sum_probs=124.3
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC--------cccHHHHHHHHHHHHcCC---------CCceeeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--------GQGIEELKNEVLLIAKLQ---------HRNLVKLL 590 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------H~nIv~l~ 590 (695)
++|.+.++||+|+||+||+|+. +++.||||++.... ....+.+.+|+.++++++ |||||++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4577889999999999999998 68999999987542 223478889999998885 88888887
Q ss_pred eEEE------------------------------eCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 005471 591 GCCL------------------------------EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640 (695)
Q Consensus 591 g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 640 (695)
+.+. ..+..+|||||+++|++.+.+.. ..+++.....|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 7754 26788999999999976555532 3478999999999999999
Q ss_pred HHHH-hCCCCCeEecCCCCCCEEEcCCC--------------------ceEEEeeccceeecCC
Q 005471 641 LYLH-QDSRLRIIHRDLKASNILLDEKM--------------------NPRISDFGTARVFGGE 683 (695)
Q Consensus 641 ~yLH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~ 683 (695)
.||| +.+ |+||||||+||||+.++ .+||+|||+|+.+...
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~ 235 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC
Confidence 9999 777 99999999999999887 8999999999987643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=242.70 Aligned_cols=151 Identities=29% Similarity=0.504 Sum_probs=134.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46788899999999999999875 78999999986532 223567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999998542 34899999999999999999999987 999999999999999999999999999987654
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 170 ~ 170 (476)
T 2y94_A 170 E 170 (476)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=225.33 Aligned_cols=148 Identities=28% Similarity=0.416 Sum_probs=126.3
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHc--CCCCceeeeEeEEEeC----CeeE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK--LQHRNLVKLLGCCLEE----DENM 600 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~----~~~~ 600 (695)
.++|.+.+.||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 35688889999999999999988 6899999998653 34555667776666 7999999999997653 3578
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH--------QDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
+||||+++|+|.+++.. ..+++..+..|+.||++||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999943 34899999999999999999999 554 9999999999999999999999
Q ss_pred eeccceeecCCcc
Q 005471 673 DFGTARVFGGEEI 685 (695)
Q Consensus 673 DFGla~~~~~~~~ 685 (695)
|||+|+.......
T Consensus 156 Dfg~a~~~~~~~~ 168 (301)
T 3q4u_A 156 DLGLAVMHSQSTN 168 (301)
T ss_dssp CCTTCEEEETTTT
T ss_pred eCCCeeecccccc
Confidence 9999998765443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=228.63 Aligned_cols=152 Identities=29% Similarity=0.511 Sum_probs=120.2
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999874 58899999986543 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDES---RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|++ |+|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69988886432 1234889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 005471 682 G 682 (695)
Q Consensus 682 ~ 682 (695)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=229.18 Aligned_cols=152 Identities=26% Similarity=0.454 Sum_probs=134.8
Q ss_pred CCCCccceeeeeCceeEEEEEc-----CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe--CCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~ 600 (695)
++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4677889999999999999983 4688999999987666666789999999999999999999999874 45688
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++++|.+++.... ..+++..+..|+.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999986532 24899999999999999999999987 999999999999999999999999999988
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
....
T Consensus 178 ~~~~ 181 (327)
T 3lxl_A 178 PLDK 181 (327)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 6543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.7e-25 Score=234.91 Aligned_cols=148 Identities=25% Similarity=0.326 Sum_probs=129.6
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|.+.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467888999999999999999875 68899999997543 3346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--eEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN--PRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~~~ 681 (695)
+++|+|.+++.... .+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +||+|||+|+...
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999986532 4889999999999999999999987 999999999999987765 9999999998543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-25 Score=244.71 Aligned_cols=151 Identities=31% Similarity=0.523 Sum_probs=131.0
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.++|.+.++||+|+||.||+|+..++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35677889999999999999999888899999997643 346789999999999999999999999866 6789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++|+|.+++.... ...+++..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus 261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999996432 234889999999999999999999987 999999999999999999999999999987643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.3e-25 Score=227.18 Aligned_cols=150 Identities=27% Similarity=0.447 Sum_probs=133.2
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-C-------cEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-G-------QEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g-------~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
++|.+.+.||+|+||.||+|+... + ..||+|.+........+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 467778999999999999998643 2 47999999776666678899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------eEE
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN--------PRI 671 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~kl 671 (695)
++||||+++++|.+++.... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999996543 23889999999999999999999987 999999999999998887 999
Q ss_pred EeeccceeecC
Q 005471 672 SDFGTARVFGG 682 (695)
Q Consensus 672 ~DFGla~~~~~ 682 (695)
+|||+++....
T Consensus 163 ~Dfg~~~~~~~ 173 (289)
T 4fvq_A 163 SDPGISITVLP 173 (289)
T ss_dssp CCCCSCTTTSC
T ss_pred ccCcccccccC
Confidence 99999976543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=234.65 Aligned_cols=150 Identities=19% Similarity=0.284 Sum_probs=133.9
Q ss_pred CCCCccceeeee--CceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQG--GFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G--~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|.+.++||+| +||.||+++.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 467888999999 99999999875 68999999987542 33456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|||+++|+|.+++.... ...+++..+..|+.||++||.|||+.+ |+||||||+||||+.++.+||+|||++..+.
T Consensus 105 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999986542 234899999999999999999999987 9999999999999999999999999998664
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=240.42 Aligned_cols=152 Identities=28% Similarity=0.403 Sum_probs=132.1
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
.++|.+.++||+|+||.||++.. .+++.+|+|++.... ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 35688889999999999999975 568999999987543 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCceEEEeeccceee
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVF 680 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~ 680 (695)
||+++|+|.+.+... ..+++.....++.||++||.|||+.+ |+||||||+|||++ +++.+||+|||+|+.+
T Consensus 90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999988653 34889999999999999999999987 99999999999998 5678999999999987
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
..+.
T Consensus 164 ~~~~ 167 (444)
T 3soa_A 164 EGEQ 167 (444)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 6543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-25 Score=233.33 Aligned_cols=152 Identities=28% Similarity=0.497 Sum_probs=129.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCc----EEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|...++||+|+||.||+|+.. +++ +||+|.+.... ....+++.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46778899999999999999864 344 38888875432 334456788999999999999999999885 567899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++|+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998654 235788999999999999999999987 9999999999999999999999999999876
Q ss_pred CCcc
Q 005471 682 GEEI 685 (695)
Q Consensus 682 ~~~~ 685 (695)
....
T Consensus 167 ~~~~ 170 (325)
T 3kex_A 167 PDDK 170 (325)
T ss_dssp CCTT
T ss_pred cccc
Confidence 5443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=229.88 Aligned_cols=149 Identities=23% Similarity=0.309 Sum_probs=131.8
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|.+.+.||+|+||.||+|+. .+++.||||.+.... ..+.+.+|+.++.++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5788889999999999999985 578999999986543 234688999999999 999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----eEEEeeccceee
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN-----PRISDFGTARVF 680 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DFGla~~~ 680 (695)
+ +++|.+++... ...+++..+..|+.||++||.|||+.+ |+||||||+|||++.++. +||+|||+|+.+
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 87 L-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred C-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9 99999998654 235899999999999999999999987 999999999999998887 999999999987
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
....
T Consensus 161 ~~~~ 164 (330)
T 2izr_A 161 IDPE 164 (330)
T ss_dssp BCTT
T ss_pred ecCC
Confidence 6543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-25 Score=236.01 Aligned_cols=151 Identities=26% Similarity=0.345 Sum_probs=133.4
Q ss_pred CCCCccceeeeeCceeEEEEEc----CCCcEEEEEEcccCC----cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCe
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 598 (695)
++|.+.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688889999999999999986 468999999987532 23345677899999999 69999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.+|||||+++++|.+++... ..+++.....++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999998653 24889999999999999999999987 9999999999999999999999999999
Q ss_pred eecCCc
Q 005471 679 VFGGEE 684 (695)
Q Consensus 679 ~~~~~~ 684 (695)
.+....
T Consensus 208 ~~~~~~ 213 (355)
T 1vzo_A 208 EFVADE 213 (355)
T ss_dssp ECCGGG
T ss_pred ecccCC
Confidence 875443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.5e-25 Score=237.09 Aligned_cols=148 Identities=25% Similarity=0.311 Sum_probs=122.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHH-HHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLL-IAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|.+.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46888899999999999999875 57899999987643 2234456677776 5678999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|||+++|+|.+++... ..+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 118 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998653 24788888999999999999999987 9999999999999999999999999998643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=221.90 Aligned_cols=151 Identities=30% Similarity=0.437 Sum_probs=133.0
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
.|.....||+|+||.||+|+. .+++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455567999999999999985 5688999999977655667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCceEEEeeccceeecC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFGG 682 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 682 (695)
+++|.+++........+++..+..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999976544445778889999999999999999987 999999999999997 89999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=232.44 Aligned_cols=161 Identities=23% Similarity=0.350 Sum_probs=131.2
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCC--CceeeeEeEEEeCCeeEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH--RNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV 602 (695)
.++|.+.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568888999999999999999988999999998653 23445788999999999976 9999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|| +.+++|.+++... ..+++..+..|+.||++||.|||+.+ |+||||||+|||++ ++.+||+|||+|+.+..
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999998653 34889999999999999999999987 99999999999997 57899999999998865
Q ss_pred CcceeccccccCC
Q 005471 683 EEILAITKRVVGT 695 (695)
Q Consensus 683 ~~~~~~~~~~~GT 695 (695)
+..........||
T Consensus 160 ~~~~~~~~~~~gt 172 (343)
T 3dbq_A 160 DTTSVVKDSQVGT 172 (343)
T ss_dssp ----------CCC
T ss_pred ccccccCCCCcCC
Confidence 5443333334444
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=238.16 Aligned_cols=150 Identities=24% Similarity=0.456 Sum_probs=130.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC-----Ce
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-----DE 598 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 598 (695)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 367889999999999999999864 5789999999753 233456788999999999999999999999876 56
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.++||||++ ++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 6999988542 34899999999999999999999987 9999999999999999999999999999
Q ss_pred eecCC
Q 005471 679 VFGGE 683 (695)
Q Consensus 679 ~~~~~ 683 (695)
.+...
T Consensus 178 ~~~~~ 182 (432)
T 3n9x_A 178 TINSE 182 (432)
T ss_dssp EC---
T ss_pred ccccc
Confidence 88654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.2e-25 Score=242.70 Aligned_cols=149 Identities=23% Similarity=0.422 Sum_probs=121.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC-----Ce
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-----DE 598 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 598 (695)
.++|.+.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|.+++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367889999999999999999864 6889999998653 233456788999999999999999999999544 46
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.++||||+. ++|..++... ..+++..+..|+.||++||.|||+.+ ||||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 7898888543 34899999999999999999999987 9999999999999999999999999999
Q ss_pred eecC
Q 005471 679 VFGG 682 (695)
Q Consensus 679 ~~~~ 682 (695)
.+..
T Consensus 205 ~~~~ 208 (458)
T 3rp9_A 205 TVDY 208 (458)
T ss_dssp CTTS
T ss_pred hccC
Confidence 8754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=222.18 Aligned_cols=149 Identities=30% Similarity=0.515 Sum_probs=134.9
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|...+.||+|+||.||+++..+++.||||.+.... ...+++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4677789999999999999998888999999997643 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
+++|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 87 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 87 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999986542 34789999999999999999999987 99999999999999999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=222.61 Aligned_cols=150 Identities=31% Similarity=0.415 Sum_probs=133.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46788899999999999999875 68999999986532 33457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+++++|.+++.. ...+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999988743 234889999999999999999999987 999999999999999999999999999977543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=222.48 Aligned_cols=154 Identities=28% Similarity=0.436 Sum_probs=133.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46788899999999999999875 7899999998753 234456788999999999 9999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----------------
Q 005471 604 EFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE----------------- 665 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~----------------- 665 (695)
||+++++|.+++..... ...+++..+..|+.||++||.|||+++ |+||||||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999965422 245899999999999999999999987 999999999999984
Q ss_pred --CCceEEEeeccceeecCCc
Q 005471 666 --KMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 666 --~~~~kl~DFGla~~~~~~~ 684 (695)
...+||+|||+++.+....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC
T ss_pred CCceEEEEcccccccccCCcc
Confidence 4479999999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=224.95 Aligned_cols=149 Identities=26% Similarity=0.412 Sum_probs=132.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|...++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999875 589999998865432 234668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+++++|..++... ..+++.....++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999998887543 34889999999999999999999987 99999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=222.68 Aligned_cols=151 Identities=32% Similarity=0.535 Sum_probs=133.4
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|.+.+.||+|+||.||+|+..+++.||||.+... ....+.+.+|++++.+++||||+++++++. .+..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 467788999999999999999888889999998754 345678999999999999999999999976 556899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
+++|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 91 ~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999985432 124889999999999999999999987 9999999999999999999999999999886543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=231.85 Aligned_cols=149 Identities=28% Similarity=0.427 Sum_probs=120.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 457888899999999999999875 57899999987542 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 682 (695)
+++++|.+++... ..+++.....++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 130 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999998543 34889999999999999999999987 999999999999975 89999999999998754
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 204 ~ 204 (349)
T 2w4o_A 204 Q 204 (349)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=221.92 Aligned_cols=150 Identities=29% Similarity=0.520 Sum_probs=133.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4577889999999999999986 578999999986432 223467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999998653 235899999999999999999999987 99999999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=232.26 Aligned_cols=156 Identities=25% Similarity=0.331 Sum_probs=131.7
Q ss_pred HHhcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC-----CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC
Q 005471 524 LAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-----SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (695)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 597 (695)
....++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34456788999999999999999986 46789999988643 2345678999999999999999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccC-------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 005471 598 ENMLIYEFMPNKSLDYFIFDES-------------------------------------RKQLLDWKKRFDIILGIARGV 640 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~gL 640 (695)
..++||||+++|+|.+++.... ....+++.....|+.||++||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999999999999884210 011235677788999999999
Q ss_pred HHHHhCCCCCeEecCCCCCCEEEcCCC--ceEEEeeccceeecC
Q 005471 641 LYLHQDSRLRIIHRDLKASNILLDEKM--NPRISDFGTARVFGG 682 (695)
Q Consensus 641 ~yLH~~~~~~iiHrDlkp~NILl~~~~--~~kl~DFGla~~~~~ 682 (695)
.|||+.+ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 9999987 99999999999998766 899999999997643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-25 Score=248.70 Aligned_cols=151 Identities=31% Similarity=0.523 Sum_probs=133.9
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.++|.+.++||+|+||.||+|++.++..||||+++... ...++|.+|+++|++++|||||++++++.+ +..+|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 35677789999999999999999888899999997643 346789999999999999999999999866 6789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++|+|.++|.... ...+++..++.|+.||++||.|||+++ ||||||||+||||++++.+||+|||+++.+..+
T Consensus 344 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 344 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp TTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred cCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999996432 234889999999999999999999987 999999999999999999999999999987543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=231.13 Aligned_cols=156 Identities=30% Similarity=0.467 Sum_probs=135.1
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCC------CcEEEEEEcccCCc-ccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 597 (695)
..++|...+.||+|+||.||+|+... .+.||||.+..... ...+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45678889999999999999998632 24799999876432 3456789999999999 8999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESR-----------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~ 666 (695)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++++
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999865321 235789999999999999999999987 9999999999999999
Q ss_pred CceEEEeeccceeecCCc
Q 005471 667 MNPRISDFGTARVFGGEE 684 (695)
Q Consensus 667 ~~~kl~DFGla~~~~~~~ 684 (695)
+.+||+|||+++.+..+.
T Consensus 201 ~~~kl~Dfg~~~~~~~~~ 218 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDS 218 (333)
T ss_dssp GEEEBCCCGGGCCGGGCT
T ss_pred CeEEECcccccccccccc
Confidence 999999999999775443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=220.80 Aligned_cols=151 Identities=36% Similarity=0.566 Sum_probs=124.1
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC----cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|+..+.||+|+||.||+|+.. ++.||||++.... ....+.+++|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56788899999999999999975 8899999986542 233567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------CCceEEEeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--------KMNPRISDFG 675 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--------~~~~kl~DFG 675 (695)
||+++++|.+++.. ..+++.....++.|+++||.|||+++..+|+||||||+|||+++ ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999842 34889999999999999999999987556999999999999986 7789999999
Q ss_pred cceeecCC
Q 005471 676 TARVFGGE 683 (695)
Q Consensus 676 la~~~~~~ 683 (695)
+++.+...
T Consensus 162 ~~~~~~~~ 169 (271)
T 3dtc_A 162 LAREWHRT 169 (271)
T ss_dssp C-------
T ss_pred cccccccc
Confidence 99877543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=229.35 Aligned_cols=161 Identities=30% Similarity=0.460 Sum_probs=136.5
Q ss_pred HHHHHhcCCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcC-CCCceeeeEeE
Q 005471 521 STLLAATDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGC 592 (695)
Q Consensus 521 ~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~ 592 (695)
.......++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34444567889999999999999999974 3568999999976433 3456789999999999 79999999999
Q ss_pred EEeCC-eeEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005471 593 CLEED-ENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658 (695)
Q Consensus 593 ~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp 658 (695)
+...+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 98765 48999999999999999975432 123789999999999999999999987 99999999
Q ss_pred CCEEEcCCCceEEEeeccceeecCCc
Q 005471 659 SNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 659 ~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
+|||++.++.+||+|||+++.+....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~ 202 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDP 202 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred ceEEECCCCCEEECCCccccccccCc
Confidence 99999999999999999999875543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=226.30 Aligned_cols=152 Identities=30% Similarity=0.554 Sum_probs=134.0
Q ss_pred CCCCccceeeeeCceeEEEEEc-----CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC--eeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--ENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~ 600 (695)
++|.+.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577889999999999999983 468899999998766666778999999999999999999999987654 679
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 121 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999996542 34899999999999999999999987 999999999999999999999999999988
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
....
T Consensus 196 ~~~~ 199 (326)
T 2w1i_A 196 PQDK 199 (326)
T ss_dssp CSSC
T ss_pred cccc
Confidence 6543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=223.70 Aligned_cols=154 Identities=26% Similarity=0.416 Sum_probs=131.5
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|.+.++||+|+||.||+++. .+++.+|||++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 3577789999999999999986 468899999987543 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 681 (695)
+++|+|.+++.... ....+++..+..|+.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999886432 2345899999999999999999999987 9999999999999 456889999999998875
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 179 ~~~ 181 (285)
T 3is5_A 179 SDE 181 (285)
T ss_dssp ---
T ss_pred Ccc
Confidence 543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=225.34 Aligned_cols=150 Identities=29% Similarity=0.419 Sum_probs=133.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc------ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|.+.+.||+|+||.||+++.. +++.||||.+..... ...+++.+|+.++.+++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45778899999999999999865 689999999865422 23678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----ceEEEeecc
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFGT 676 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 676 (695)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999998643 34789999999999999999999987 99999999999999887 799999999
Q ss_pred ceeecCC
Q 005471 677 ARVFGGE 683 (695)
Q Consensus 677 a~~~~~~ 683 (695)
++.+...
T Consensus 166 ~~~~~~~ 172 (321)
T 2a2a_A 166 AHEIEDG 172 (321)
T ss_dssp CEECCTT
T ss_pred ceecCcc
Confidence 9987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=223.86 Aligned_cols=148 Identities=35% Similarity=0.557 Sum_probs=122.9
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++|.+.++||+|+||.||+|+.. ..||||++.... ....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 457888899999999999999875 369999987543 34456789999999999999999999964 5667899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999998543 234899999999999999999999987 99999999999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=223.45 Aligned_cols=150 Identities=23% Similarity=0.398 Sum_probs=122.6
Q ss_pred CCCCccceeeeeCceeEEEEEcCC----CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|.+.+.||+|+||.||+|+... +..||||++.... ....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEE
Confidence 467788999999999999998643 4579999987643 33456789999999999999999999997 45678999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999996532 34899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 169 ~ 169 (281)
T 1mp8_A 169 S 169 (281)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=233.70 Aligned_cols=160 Identities=23% Similarity=0.345 Sum_probs=131.4
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCC--CCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 358888999999999999999888999999998653 2344578899999999996 599999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
| +.+++|.+++.... .+++..+..|+.||++||.|||+.+ |+||||||+||||+ ++.+||+|||+|+.+..+
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 57899999986542 4788899999999999999999987 99999999999996 578999999999988655
Q ss_pred cceeccccccCC
Q 005471 684 EILAITKRVVGT 695 (695)
Q Consensus 684 ~~~~~~~~~~GT 695 (695)
.........+||
T Consensus 208 ~~~~~~~~~~gt 219 (390)
T 2zmd_A 208 TTSVVKDSQVGA 219 (390)
T ss_dssp ------CCSCCC
T ss_pred CccccCCCCCcC
Confidence 433333334454
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-24 Score=223.36 Aligned_cols=148 Identities=27% Similarity=0.359 Sum_probs=129.6
Q ss_pred CCCCcc-ceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTS-NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~-~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+.|.+. +.||+|+||.||+|+. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 7899999999999986 46899999999776556677899999999985 79999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---eEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~~ 681 (695)
|+++++|.+++... ..+++.....++.||++||.|||+.+ |+||||||+|||++.++. +||+|||+++.+.
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999998653 34789999999999999999999987 999999999999998766 9999999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.3e-24 Score=220.83 Aligned_cols=149 Identities=25% Similarity=0.363 Sum_probs=132.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|...+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 45777899999999999999875 57899999886532 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 95 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988543 34889999999999999999999987 99999999999999999999999999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-24 Score=226.09 Aligned_cols=149 Identities=25% Similarity=0.363 Sum_probs=133.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46778899999999999999875 57899999986532 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999988543 34889999999999999999999987 99999999999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=230.78 Aligned_cols=152 Identities=26% Similarity=0.386 Sum_probs=133.3
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc--------ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG--------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 597 (695)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 35788899999999999999985 5688999999876421 13346778999999999999999999999999
Q ss_pred eeEEEEEcCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 598 ENMLIYEFMPNK-SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 598 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
..++||||+..| +|..++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999777 999988543 24899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCc
Q 005471 677 ARVFGGEE 684 (695)
Q Consensus 677 a~~~~~~~ 684 (695)
++.+....
T Consensus 177 a~~~~~~~ 184 (335)
T 3dls_A 177 AAYLERGK 184 (335)
T ss_dssp CEECCTTC
T ss_pred ceECCCCC
Confidence 99876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=229.19 Aligned_cols=149 Identities=32% Similarity=0.528 Sum_probs=130.6
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
+.|...+.||+|+||.||+|+. .+++.||||++..... ...+++.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477889999999999999985 5789999999875432 23457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||++ |+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 6787777543 235899999999999999999999987 99999999999999999999999999987754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=227.98 Aligned_cols=157 Identities=27% Similarity=0.514 Sum_probs=125.7
Q ss_pred HHhcCCCCccceeeeeCceeEEEEEcC----CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC
Q 005471 524 LAATDNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (695)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 597 (695)
....++|.+.+.||+|+||.||+|+.. .++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334567888899999999999999764 34589999987542 334567899999999999999999999998765
Q ss_pred e-----eEEEEEcCCCCCHHHHHhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 598 E-----NMLIYEFMPNKSLDYFIFDE---SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 598 ~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
. .++||||+++++|.+++... .....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 4 49999999999999998543 23345899999999999999999999987 9999999999999999999
Q ss_pred EEEeeccceeecCC
Q 005471 670 RISDFGTARVFGGE 683 (695)
Q Consensus 670 kl~DFGla~~~~~~ 683 (695)
||+|||+++.+...
T Consensus 187 kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 187 CVADFGLSKKIYSG 200 (313)
T ss_dssp EECSCSCC------
T ss_pred EEeecCcceecccc
Confidence 99999999977543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=248.68 Aligned_cols=162 Identities=27% Similarity=0.341 Sum_probs=137.8
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 600 (695)
..++|.+.++||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3567999999999999999999865 5789999998753 233456788899999988 7999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
|||||+++|+|..++.... .+++..+..|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999986542 4899999999999999999999987 999999999999999999999999999975
Q ss_pred cCCcceeccccccCC
Q 005471 681 GGEEILAITKRVVGT 695 (695)
Q Consensus 681 ~~~~~~~~~~~~~GT 695 (695)
..+... +..+.||
T Consensus 493 ~~~~~~--~~~~~GT 505 (674)
T 3pfq_A 493 IWDGVT--TKTFCGT 505 (674)
T ss_dssp CCTTCC--BCCCCSC
T ss_pred ccCCcc--cccccCC
Confidence 433322 3334555
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=217.86 Aligned_cols=152 Identities=30% Similarity=0.465 Sum_probs=133.3
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
.++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888999999999999999864 5889999998653 2334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---eEEEeeccceee
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDFGTARVF 680 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~ 680 (695)
||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998888643 34889999999999999999999987 999999999999986655 999999999887
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
....
T Consensus 159 ~~~~ 162 (284)
T 3kk8_A 159 NDSE 162 (284)
T ss_dssp CSSC
T ss_pred ccCc
Confidence 6543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.9e-24 Score=223.65 Aligned_cols=142 Identities=25% Similarity=0.332 Sum_probs=125.1
Q ss_pred cceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEcCCCCC
Q 005471 533 SNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 610 (695)
.++||+|+||.||+++.. +++.||||++... ....+.+|+.++.++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999874 6899999998642 4567788999999997 9999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---ceEEEeeccceeecCC
Q 005471 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM---NPRISDFGTARVFGGE 683 (695)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~ 683 (695)
|.+++... ..+++..+..|+.||++||.|||+.+ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99998653 34899999999999999999999987 99999999999997665 8999999999977543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=226.28 Aligned_cols=153 Identities=31% Similarity=0.514 Sum_probs=136.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|...+.||+|+||.||+|+.. +++.||||.+... ....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 456778899999999999999875 4789999998753 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+.
T Consensus 91 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999996543 345899999999999999999999987 9999999999999999999999999999876544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=229.10 Aligned_cols=159 Identities=25% Similarity=0.390 Sum_probs=132.1
Q ss_pred cHHHHHHhcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc-----------cHHHHHHHHHHHHcCCCCcee
Q 005471 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ-----------GIEELKNEVLLIAKLQHRNLV 587 (695)
Q Consensus 519 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~nIv 587 (695)
...++....++|.+.+.||+|+||.||+|...+++.||||++...... ..+.+.+|+.++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 345677788999999999999999999999888999999988643211 136789999999999999999
Q ss_pred eeEeEEEeCC-----eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005471 588 KLLGCCLEED-----ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 662 (695)
Q Consensus 588 ~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 662 (695)
++++++...+ ..++||||++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999996533 5799999998 6888877643 335899999999999999999999987 999999999999
Q ss_pred EcCCCceEEEeeccceeecCC
Q 005471 663 LDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 663 l~~~~~~kl~DFGla~~~~~~ 683 (695)
++.++.+||+|||+|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~ 187 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD 187 (362)
T ss_dssp ECTTCCEEECCTTC-------
T ss_pred EcCCCCEEEEecCcccccccc
Confidence 999999999999999865443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-23 Score=221.59 Aligned_cols=148 Identities=30% Similarity=0.490 Sum_probs=130.5
Q ss_pred CCccceeeeeCceeEEEEEcC-----CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS-----NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENML 601 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 601 (695)
|+..++||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377899999999999998642 67899999997643 24456789999999999999999999999984 56799
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999998543 3889999999999999999999987 9999999999999999999999999999886
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 186 ~~~ 188 (318)
T 3lxp_A 186 EGH 188 (318)
T ss_dssp TTC
T ss_pred ccc
Confidence 543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-24 Score=231.97 Aligned_cols=148 Identities=27% Similarity=0.548 Sum_probs=122.0
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCC--eeE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEED--ENM 600 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~~~ 600 (695)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46788999999999999999986 46899999998653 2344567789999999997 999999999998655 679
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||++ ++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999998 689888854 24788999999999999999999987 999999999999999999999999999987
Q ss_pred cC
Q 005471 681 GG 682 (695)
Q Consensus 681 ~~ 682 (695)
..
T Consensus 160 ~~ 161 (388)
T 3oz6_A 160 VN 161 (388)
T ss_dssp SS
T ss_pred cc
Confidence 43
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=225.86 Aligned_cols=150 Identities=29% Similarity=0.461 Sum_probs=125.6
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|.+.+.||+|+||.||+++.. ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 45777899999999999999985 789999998643 34578899999999999999999999876 45899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-eEEEeeccceeecC
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN-PRISDFGTARVFGG 682 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-~kl~DFGla~~~~~ 682 (695)
+++|.+++........+++...+.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||+++.+..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999976554445789999999999999999999954345999999999999998876 79999999987643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-24 Score=224.23 Aligned_cols=152 Identities=29% Similarity=0.425 Sum_probs=132.2
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe----CCeeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~l 601 (695)
.++|.+.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35688889999999999999986 5789999999876656667789999999999999999999999973 346789
Q ss_pred EEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 602 IYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
||||+++|+|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999986532 2345899999999999999999999987 999999999999999999999999998875
Q ss_pred c
Q 005471 681 G 681 (695)
Q Consensus 681 ~ 681 (695)
.
T Consensus 185 ~ 185 (317)
T 2buj_A 185 C 185 (317)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.3e-24 Score=228.05 Aligned_cols=159 Identities=28% Similarity=0.339 Sum_probs=136.4
Q ss_pred ecHHHHHHhcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-----CCceeeeEe
Q 005471 518 FELSTLLAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-----HRNLVKLLG 591 (695)
Q Consensus 518 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv~l~g 591 (695)
+.+.+.....++|.+.++||+|+||.||+|+. .+++.||||++... ....+.+..|+.++.+++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 33344444567899999999999999999987 46889999998753 344567788999999986 999999999
Q ss_pred EEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC------
Q 005471 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE------ 665 (695)
Q Consensus 592 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~------ 665 (695)
++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+||||++
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 8999999865432 34889999999999999999999987 999999999999975
Q ss_pred -------------------CCceEEEeeccceeecC
Q 005471 666 -------------------KMNPRISDFGTARVFGG 682 (695)
Q Consensus 666 -------------------~~~~kl~DFGla~~~~~ 682 (695)
++.+||+|||+|+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78999999999997654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=245.95 Aligned_cols=143 Identities=27% Similarity=0.551 Sum_probs=126.3
Q ss_pred eeeeeCceeEEEEEcC---CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCCCC
Q 005471 535 KLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (695)
Q Consensus 535 ~LG~G~fG~Vy~g~~~---~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 610 (695)
+||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 45689999997643 3456789999999999999999999999976 56899999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|.+++... ...+++..+..|+.||++||.|||+++ ||||||||+||||++++.+||+|||+|+.+..+
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999643 335899999999999999999999987 999999999999999999999999999987544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=218.01 Aligned_cols=150 Identities=29% Similarity=0.458 Sum_probs=132.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC------cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS------GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|.+.+.||+|+||.||+++.. +++.||||.+.... ....+++.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 35778899999999999999875 68999999886532 123678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----ceEEEeecc
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFGT 676 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 676 (695)
+||||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||++++++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999998643 34899999999999999999999987 99999999999999877 899999999
Q ss_pred ceeecCC
Q 005471 677 ARVFGGE 683 (695)
Q Consensus 677 a~~~~~~ 683 (695)
++.+...
T Consensus 159 ~~~~~~~ 165 (283)
T 3bhy_A 159 AHKIEAG 165 (283)
T ss_dssp CEECC--
T ss_pred ceeccCC
Confidence 9987543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.6e-24 Score=225.71 Aligned_cols=151 Identities=32% Similarity=0.584 Sum_probs=125.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCc----EEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|++.++||+|+||.||+|+.. +++ +||+|.+... .....+++.+|+.++.+++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56888899999999999999863 344 4688877543 3445678999999999999999999999998754 789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|+||+++|+|.+++.... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999986543 34889999999999999999999987 9999999999999999999999999999875
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 169 ~~~ 171 (327)
T 3lzb_A 169 AEE 171 (327)
T ss_dssp ---
T ss_pred Ccc
Confidence 543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-24 Score=235.22 Aligned_cols=151 Identities=25% Similarity=0.396 Sum_probs=126.6
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--------cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--------GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 596 (695)
..++|.+.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 357899999999999999999986 457899999986531 112235889999999999999999999975 5
Q ss_pred CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CceEEEe
Q 005471 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK---MNPRISD 673 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~D 673 (695)
+..++||||+++|+|.+++... ..+++.....++.||++||.|||+++ |+||||||+|||++.+ ..+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 5689999999999998887532 35899999999999999999999987 9999999999999754 4599999
Q ss_pred eccceeecCC
Q 005471 674 FGTARVFGGE 683 (695)
Q Consensus 674 FGla~~~~~~ 683 (695)
||+|+.+...
T Consensus 286 FG~a~~~~~~ 295 (419)
T 3i6u_A 286 FGHSKILGET 295 (419)
T ss_dssp SSTTTSCC--
T ss_pred cccceecCCC
Confidence 9999987643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=9.6e-24 Score=219.26 Aligned_cols=150 Identities=27% Similarity=0.558 Sum_probs=130.4
Q ss_pred CCCccc-eeeeeCceeEEEEEcC---CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 529 NFSTSN-KLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 529 ~f~~~~-~LG~G~fG~Vy~g~~~---~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
+|.+.+ .||+|+||.||+|+.. +++.||||++.... ....+++.+|++++.+++||||+++++++ +.+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 444445 8999999999999853 57789999997643 34567889999999999999999999999 566789999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 89 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp ECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 999999999998643 334899999999999999999999987 999999999999999999999999999988654
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 164 ~ 164 (287)
T 1u59_A 164 D 164 (287)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-24 Score=226.44 Aligned_cols=151 Identities=30% Similarity=0.516 Sum_probs=127.5
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-----CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|...+.||+|+||.||+|+... +..||||.+.... .....++.+|+.++.+++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467777999999999999998643 2469999987543 2345578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 124 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999986532 34899999999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 199 ~~ 200 (333)
T 1mqb_A 199 DD 200 (333)
T ss_dssp --
T ss_pred cc
Confidence 44
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=237.86 Aligned_cols=148 Identities=28% Similarity=0.416 Sum_probs=123.8
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 597 (695)
.++|.+.++||+|+||+||+|.. .+++.||||++... .....+++.+|+.+++.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46788999999999999999975 46889999999754 2334567889999999999999999999997653
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..+|||||++++ |...+.. .+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999865 5555522 2789999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 005471 678 RVFGGE 683 (695)
Q Consensus 678 ~~~~~~ 683 (695)
+.....
T Consensus 212 ~~~~~~ 217 (464)
T 3ttj_A 212 RTAGTS 217 (464)
T ss_dssp -----C
T ss_pred eecCCC
Confidence 987643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=218.48 Aligned_cols=150 Identities=28% Similarity=0.482 Sum_probs=134.6
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+.|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4577889999999999999985 468899999986543 34467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 102 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999843 34889999999999999999999987 9999999999999999999999999999876543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=226.69 Aligned_cols=154 Identities=26% Similarity=0.421 Sum_probs=135.3
Q ss_pred HhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--------ccHHHHHHHHHHHHcC-CCCceeeeEeEEE
Q 005471 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--------QGIEELKNEVLLIAKL-QHRNLVKLLGCCL 594 (695)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--------~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 594 (695)
...++|.+.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34467888999999999999999975 689999999865431 1134678899999999 7999999999999
Q ss_pred eCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEee
Q 005471 595 EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (695)
Q Consensus 595 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 674 (695)
.....++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence 999999999999999999998643 34899999999999999999999987 999999999999999999999999
Q ss_pred ccceeecCCc
Q 005471 675 GTARVFGGEE 684 (695)
Q Consensus 675 Gla~~~~~~~ 684 (695)
|+++.+....
T Consensus 245 G~~~~~~~~~ 254 (365)
T 2y7j_A 245 GFSCHLEPGE 254 (365)
T ss_dssp TTCEECCTTC
T ss_pred CcccccCCCc
Confidence 9999886543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=219.66 Aligned_cols=151 Identities=23% Similarity=0.384 Sum_probs=128.6
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC----cccHHHHHHHHHHHHcCCCCceeeeEeEEE--eCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQHRNLVKLLGCCL--EEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~ 599 (695)
.++|.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++.+++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999874 68899999986532 234578899999999999999999999985 34578
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||++++ |.+++.... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999977 666665432 345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecC
Q 005471 680 FGG 682 (695)
Q Consensus 680 ~~~ 682 (695)
+..
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.7e-24 Score=221.90 Aligned_cols=151 Identities=21% Similarity=0.260 Sum_probs=129.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
.++|.+.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367888999999999999999864 688999999875422 2246788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998653 24889999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 187 ~ 187 (309)
T 2h34_A 187 E 187 (309)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-24 Score=229.93 Aligned_cols=151 Identities=23% Similarity=0.349 Sum_probs=125.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC------CcEEEEEEcccCCccc-----------HHHHHHHHHHHHcCCCCceeee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTTSGQG-----------IEELKNEVLLIAKLQHRNLVKL 589 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~nIv~l 589 (695)
.++|.+.++||+|+||.||+|.... ++.||||++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578888999999999999998754 4789999987543211 1123346667788899999999
Q ss_pred EeEEEeC----CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-
Q 005471 590 LGCCLEE----DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD- 664 (695)
Q Consensus 590 ~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~- 664 (695)
++++... ...+|||||+ +++|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9999875 4579999999 99999998653 235899999999999999999999987 99999999999999
Q ss_pred -CCCceEEEeeccceeecCC
Q 005471 665 -EKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 665 -~~~~~kl~DFGla~~~~~~ 683 (695)
.++.+||+|||+|+.+...
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SCTTCEEECCCTTCEESSGG
T ss_pred CCCCeEEEEECCcceecccC
Confidence 8899999999999987644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=220.52 Aligned_cols=152 Identities=28% Similarity=0.516 Sum_probs=127.3
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-----cccHHHHHHHHHHHHcC---CCCceeeeEeEEEeCC
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKL---QHRNLVKLLGCCLEED 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~ 597 (695)
.++|++.++||+|+||+||+|+. .+++.||||++.... ......+.+|+.++.++ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56899999999999999999996 568899999986422 12234667788777766 4999999999998865
Q ss_pred -----eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 598 -----ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 598 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
..++||||++ ++|.+++..... ..+++..+..|+.||++||.|||+++ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 4789999997 699999865432 34899999999999999999999987 9999999999999999999999
Q ss_pred eeccceeecCC
Q 005471 673 DFGTARVFGGE 683 (695)
Q Consensus 673 DFGla~~~~~~ 683 (695)
|||+|+.+...
T Consensus 163 Dfg~a~~~~~~ 173 (308)
T 3g33_A 163 DFGLARIYSYQ 173 (308)
T ss_dssp SCSCTTTSTTC
T ss_pred eCccccccCCC
Confidence 99999877543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=6.9e-24 Score=221.37 Aligned_cols=151 Identities=32% Similarity=0.536 Sum_probs=129.2
Q ss_pred CCCccceeeeeCceeEEEEEcCC----CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEe-CCeeEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDENMLI 602 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV 602 (695)
+|...++||+|+||.||+|+..+ ...+|||.+.... ....+.+.+|+.++++++||||+++++++.+ .+..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 46677999999999999998642 2368999987643 3445678999999999999999999999755 4578999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++|+|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 106 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999996532 34789999999999999999999987 99999999999999999999999999997754
Q ss_pred Cc
Q 005471 683 EE 684 (695)
Q Consensus 683 ~~ 684 (695)
..
T Consensus 181 ~~ 182 (298)
T 3f66_A 181 KE 182 (298)
T ss_dssp GG
T ss_pred cc
Confidence 43
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=223.62 Aligned_cols=150 Identities=27% Similarity=0.418 Sum_probs=125.9
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcC--CCCceeeeEeEEEeC----CeeE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL--QHRNLVKLLGCCLEE----DENM 600 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l--~H~nIv~l~g~~~~~----~~~~ 600 (695)
.++|.+.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++... ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 357889999999999999999985 899999998643 234445566666554 899999999999988 6789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEEcCCCceEEEeec
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS-----RLRIIHRDLKASNILLDEKMNPRISDFG 675 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~kl~DFG 675 (695)
+||||+++|+|.+++... .+++..+..++.|++.||.|||++. +.+|+||||||+|||++.++.+||+|||
T Consensus 112 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 999999999999999543 4889999999999999999999871 1249999999999999999999999999
Q ss_pred cceeecCCc
Q 005471 676 TARVFGGEE 684 (695)
Q Consensus 676 la~~~~~~~ 684 (695)
+|+.+....
T Consensus 188 ~a~~~~~~~ 196 (337)
T 3mdy_A 188 LAVKFISDT 196 (337)
T ss_dssp TCEECC---
T ss_pred Cceeecccc
Confidence 998875443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=5.8e-24 Score=219.88 Aligned_cols=150 Identities=27% Similarity=0.408 Sum_probs=131.0
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 356888899999999999999864 57799999986432 22356788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999998653 24789999999999999999999887 99999999999999999999999999976543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=218.46 Aligned_cols=149 Identities=20% Similarity=0.311 Sum_probs=131.6
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|.+.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 5688889999999999999985 578999999986532 335688899999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----eEEEeeccceee
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN-----PRISDFGTARVF 680 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DFGla~~~ 680 (695)
+ +++|.+++.... ..+++..+..|+.||++||.|||+.+ |+||||||+|||++.++. +||+|||+|+.+
T Consensus 88 ~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 88 L-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 9 999999996542 34899999999999999999999987 999999999999987776 999999999988
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
....
T Consensus 162 ~~~~ 165 (298)
T 1csn_A 162 RDPV 165 (298)
T ss_dssp BCTT
T ss_pred cccc
Confidence 6543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.7e-24 Score=222.32 Aligned_cols=149 Identities=30% Similarity=0.477 Sum_probs=131.1
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 356888899999999999999875 5889999999876666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 99999999886532 34899999999999999999999987 999999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=235.34 Aligned_cols=151 Identities=19% Similarity=0.256 Sum_probs=124.8
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC---CcccHHHHHHHH---HHHHcCCCCceeeeE-------eE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEV---LLIAKLQHRNLVKLL-------GC 592 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~nIv~l~-------g~ 592 (695)
.++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35677889999999999999996 56899999998743 334467889999 555666899999998 66
Q ss_pred EEeCCe-----------------eEEEEEcCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005471 593 CLEEDE-----------------NMLIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651 (695)
Q Consensus 593 ~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 651 (695)
+...+. .+|||||+ +|+|.+++..... ...+++..+..|+.||++||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 6899999865321 123456888899999999999999987 9
Q ss_pred EecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 652 IHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 652 iHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+||||||+||||+.++.+||+|||+|+..+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999999999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=235.55 Aligned_cols=151 Identities=30% Similarity=0.424 Sum_probs=128.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++|||||++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 35888899999999999999875 68899999987542 3346788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 681 (695)
|+++|+|.+++... ..+++..+..|+.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999998888543 24889999999999999999999987 999999999999976 4559999999999886
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 191 ~~~ 193 (494)
T 3lij_A 191 NQK 193 (494)
T ss_dssp TTB
T ss_pred CCc
Confidence 543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=235.53 Aligned_cols=152 Identities=32% Similarity=0.471 Sum_probs=131.2
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-------------ccHHHHHHHHHHHHcCCCCceeeeEeE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-------------QGIEELKNEVLLIAKLQHRNLVKLLGC 592 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 592 (695)
.++|.+.++||+|+||+||+|+.. +++.||||++..... ...+++.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 457888999999999999999875 578999999865321 235678999999999999999999999
Q ss_pred EEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---ce
Q 005471 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM---NP 669 (695)
Q Consensus 593 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ 669 (695)
+.+....++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999888653 34899999999999999999999987 99999999999999765 69
Q ss_pred EEEeeccceeecCCc
Q 005471 670 RISDFGTARVFGGEE 684 (695)
Q Consensus 670 kl~DFGla~~~~~~~ 684 (695)
||+|||+|+.+....
T Consensus 189 kl~Dfg~a~~~~~~~ 203 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY 203 (504)
T ss_dssp EECCCTTCEECCTTS
T ss_pred EEEECCCCEEcCCCC
Confidence 999999999886543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=217.59 Aligned_cols=151 Identities=28% Similarity=0.391 Sum_probs=133.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---------ccHHHHHHHHHHHHcCC-CCceeeeEeEEEe
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---------QGIEELKNEVLLIAKLQ-HRNLVKLLGCCLE 595 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---------~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~ 595 (695)
.++|...+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 367888899999999999999874 688999999865421 12456789999999995 9999999999999
Q ss_pred CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeec
Q 005471 596 EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (695)
Q Consensus 596 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 675 (695)
.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999998653 34889999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCC
Q 005471 676 TARVFGGE 683 (695)
Q Consensus 676 la~~~~~~ 683 (695)
+++.+...
T Consensus 170 ~~~~~~~~ 177 (298)
T 1phk_A 170 FSCQLDPG 177 (298)
T ss_dssp TCEECCTT
T ss_pred chhhcCCC
Confidence 99987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.2e-24 Score=218.80 Aligned_cols=148 Identities=32% Similarity=0.535 Sum_probs=130.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe-----------
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----------- 595 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----------- 595 (695)
++|+..+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++.+++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 45778899999999999999875 78999999987543 357789999999999999999999865
Q ss_pred -----CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceE
Q 005471 596 -----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670 (695)
Q Consensus 596 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 670 (695)
....++||||+++++|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence 345789999999999999996542 235899999999999999999999987 99999999999999999999
Q ss_pred EEeeccceeecCC
Q 005471 671 ISDFGTARVFGGE 683 (695)
Q Consensus 671 l~DFGla~~~~~~ 683 (695)
|+|||+++.+...
T Consensus 163 l~Dfg~~~~~~~~ 175 (284)
T 2a19_B 163 IGDFGLVTSLKND 175 (284)
T ss_dssp ECCCTTCEESSCC
T ss_pred ECcchhheecccc
Confidence 9999999987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.2e-24 Score=217.74 Aligned_cols=150 Identities=26% Similarity=0.463 Sum_probs=133.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 56888899999999999999875 68999999986432 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++++|.+++.... .+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999986532 4789999999999999999999987 999999999999999999999999999887543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-24 Score=221.20 Aligned_cols=149 Identities=32% Similarity=0.488 Sum_probs=128.4
Q ss_pred CCccceeeeeCceeEEEEEcCC----CcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee-EEEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN-MLIY 603 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~lV~ 603 (695)
|...++||+|+||.||+|+..+ +..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4455899999999999998532 23799999875433 4457889999999999999999999999877665 9999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+.+++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 103 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999653 334789999999999999999999987 999999999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=226.50 Aligned_cols=149 Identities=28% Similarity=0.509 Sum_probs=127.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcc-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|...++||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 56888899999999999999875 6889999998654322 122455799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 98 58888886542 35889999999999999999999987 99999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-24 Score=226.94 Aligned_cols=150 Identities=32% Similarity=0.510 Sum_probs=125.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcc-----cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-----GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
.++|...+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 467899999999999999999975 5899999998753221 1246789999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++ +|..++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 89 lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 99999985 8888875432 34788888999999999999999987 999999999999999999999999999977
Q ss_pred cC
Q 005471 681 GG 682 (695)
Q Consensus 681 ~~ 682 (695)
..
T Consensus 163 ~~ 164 (346)
T 1ua2_A 163 GS 164 (346)
T ss_dssp TS
T ss_pred cC
Confidence 54
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=231.37 Aligned_cols=149 Identities=32% Similarity=0.552 Sum_probs=121.4
Q ss_pred CCccceeeeeCceeEEEEEcC--CC--cEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEe-CCeeEEEE
Q 005471 530 FSTSNKLGQGGFGPVYKGKLS--NG--QEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDENMLIY 603 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~g--~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~ 603 (695)
|...++||+|+||.||+|+.. ++ ..||||.+.... ....+++.+|+.++++++||||+++++++.+ .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 556689999999999999863 22 368999987543 3456789999999999999999999999765 45789999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 171 e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999996533 34788999999999999999999987 999999999999999999999999999977543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=225.67 Aligned_cols=153 Identities=31% Similarity=0.499 Sum_probs=129.3
Q ss_pred CCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|.+.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++.+++||||+++++++.+.+..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 5688889999999999999984 34678999999754 3344567889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCceEEEe
Q 005471 601 LIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISD 673 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~D 673 (695)
+||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999976432 234889999999999999999999987 999999999999994 45699999
Q ss_pred eccceeecCC
Q 005471 674 FGTARVFGGE 683 (695)
Q Consensus 674 FGla~~~~~~ 683 (695)
||+++.+...
T Consensus 187 fg~~~~~~~~ 196 (327)
T 2yfx_A 187 FGMARDIYRA 196 (327)
T ss_dssp CHHHHHHHC-
T ss_pred cccccccccc
Confidence 9999866443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=217.89 Aligned_cols=150 Identities=30% Similarity=0.606 Sum_probs=128.1
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCccc-------HHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQG-------IEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
++|...+.||+|+||.||+|+. .+++.||||++....... .+.+.+|++++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5688889999999999999987 478999999986543221 267899999999999999999999986544
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----eEEEee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN-----PRISDF 674 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DF 674 (695)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 79999999999988886543 35899999999999999999999874 34999999999999987776 999999
Q ss_pred ccceeecC
Q 005471 675 GTARVFGG 682 (695)
Q Consensus 675 Gla~~~~~ 682 (695)
|+|+....
T Consensus 174 g~~~~~~~ 181 (287)
T 4f0f_A 174 GLSQQSVH 181 (287)
T ss_dssp TTCBCCSS
T ss_pred Cccccccc
Confidence 99986544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=224.85 Aligned_cols=147 Identities=25% Similarity=0.426 Sum_probs=127.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|.+.+.||+|+||.||+++.. +++.||||.+.+... ...+|++++.++ +||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 46888899999999999999875 688999999976432 235688888887 799999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK----MNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~~~ 681 (695)
+++|+|.+++... ..+++.....++.||+.||.|||+++ |+||||||+|||+.++ +.+||+|||+++.+.
T Consensus 98 ~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 98 MKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999988643 34899999999999999999999987 9999999999998533 359999999999876
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 172 ~~~ 174 (342)
T 2qr7_A 172 AEN 174 (342)
T ss_dssp CTT
T ss_pred CCC
Confidence 543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.1e-24 Score=224.22 Aligned_cols=157 Identities=32% Similarity=0.510 Sum_probs=134.3
Q ss_pred HHHHHhcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEe---
Q 005471 521 STLLAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE--- 595 (695)
Q Consensus 521 ~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~--- 595 (695)
.++....++|.+.+.||+|+||.||+|+. .+++.||||++... ....+++.+|+.++.++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33444567899999999999999999987 46899999998653 33457889999999999 89999999999987
Q ss_pred ---CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 596 ---EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 596 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
.+..++||||+++++|.+++.... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 457899999999999999986542 335889999999999999999999987 9999999999999999999999
Q ss_pred eeccceeecC
Q 005471 673 DFGTARVFGG 682 (695)
Q Consensus 673 DFGla~~~~~ 682 (695)
|||+++.+..
T Consensus 172 Dfg~~~~~~~ 181 (326)
T 2x7f_A 172 DFGVSAQLDR 181 (326)
T ss_dssp CCTTTC----
T ss_pred eCcCceecCc
Confidence 9999987754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=222.41 Aligned_cols=149 Identities=30% Similarity=0.519 Sum_probs=121.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHH--HHcCCCCceeeeEeEEEeC-----Cee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLL--IAKLQHRNLVKLLGCCLEE-----DEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~--l~~l~H~nIv~l~g~~~~~-----~~~ 599 (695)
.++|.+.++||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++.+... ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35788889999999999999987 5799999998643 23344444444 4568999999999876542 246
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCEEEcCCCceEEEe
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS------RLRIIHRDLKASNILLDEKMNPRISD 673 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiHrDlkp~NILl~~~~~~kl~D 673 (695)
++||||+++|+|.+++... ..++..+..|+.||++||.|||+.. +.+|+||||||+||||+.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 8999999999999999543 2488999999999999999999881 11399999999999999999999999
Q ss_pred eccceeecCC
Q 005471 674 FGTARVFGGE 683 (695)
Q Consensus 674 FGla~~~~~~ 683 (695)
||+|+.+...
T Consensus 164 FG~a~~~~~~ 173 (336)
T 3g2f_A 164 FGLSMRLTGN 173 (336)
T ss_dssp CTTCEECSSS
T ss_pred ccceeecccc
Confidence 9999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=223.80 Aligned_cols=148 Identities=26% Similarity=0.508 Sum_probs=128.3
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--------
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-------- 596 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-------- 596 (695)
++|.+.++||+|+||.||+|+. .+++.||||++.... ......+.+|+.++.+++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4678889999999999999987 578999999986543 23355788999999999999999999999874
Q ss_pred CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
+..++||||+++ +|...+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999985 7777665432 34899999999999999999999987 99999999999999999999999999
Q ss_pred ceeec
Q 005471 677 ARVFG 681 (695)
Q Consensus 677 a~~~~ 681 (695)
|+.+.
T Consensus 171 a~~~~ 175 (351)
T 3mi9_A 171 ARAFS 175 (351)
T ss_dssp CEECC
T ss_pred ccccc
Confidence 99875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=220.81 Aligned_cols=153 Identities=22% Similarity=0.454 Sum_probs=126.4
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688889999999999999986 578999999987532 334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999986422 2345889999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 189 ~ 189 (310)
T 2wqm_A 189 K 189 (310)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=227.48 Aligned_cols=148 Identities=26% Similarity=0.443 Sum_probs=123.9
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 597 (695)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35788899999999999999986 46899999998653 2233567889999999999999999999998763
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++||||+ +++|.+++.. ..+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 7899998854 24789999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+....
T Consensus 176 ~~~~~ 180 (367)
T 1cm8_A 176 RQADS 180 (367)
T ss_dssp EECCS
T ss_pred ccccc
Confidence 98754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9e-24 Score=219.92 Aligned_cols=150 Identities=28% Similarity=0.500 Sum_probs=128.9
Q ss_pred CCCCccc-eeeeeCceeEEEEEc---CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSN-KLGQGGFGPVYKGKL---SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~-~LG~G~fG~Vy~g~~---~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|.+.+ .||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++++++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 999999999999954 346789999987543 23356899999999999999999999999 6677899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 95 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999653 24889999999999999999999987 9999999999999999999999999999886
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 169 ~~~ 171 (291)
T 1xbb_A 169 ADE 171 (291)
T ss_dssp TTC
T ss_pred cCC
Confidence 543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-23 Score=218.75 Aligned_cols=151 Identities=27% Similarity=0.474 Sum_probs=129.8
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
..++|.+.+.||+|+||.||+|... +++.||||.+... ...+++.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3467888999999999999999875 5899999998753 245778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.+...
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999998633 234899999999999999999999987 999999999999999999999999999987644
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=228.91 Aligned_cols=145 Identities=23% Similarity=0.322 Sum_probs=122.9
Q ss_pred CCCcc-ceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHc-CCCCceeeeEeEEEe----CCeeEE
Q 005471 529 NFSTS-NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAK-LQHRNLVKLLGCCLE----EDENML 601 (695)
Q Consensus 529 ~f~~~-~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~----~~~~~l 601 (695)
+|... +.||+|+||+||++... +++.||||++... ..+.+|++++.+ .+||||+++++++.. ....+|
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 45554 68999999999999864 6889999998642 456788888754 589999999999876 556899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCceEEEeeccce
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTAR 678 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~ 678 (695)
||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+|+
T Consensus 137 v~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999996542 235899999999999999999999987 999999999999997 7899999999999
Q ss_pred eecC
Q 005471 679 VFGG 682 (695)
Q Consensus 679 ~~~~ 682 (695)
....
T Consensus 213 ~~~~ 216 (400)
T 1nxk_A 213 ETTS 216 (400)
T ss_dssp ECC-
T ss_pred ccCC
Confidence 7754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=220.69 Aligned_cols=149 Identities=27% Similarity=0.413 Sum_probs=130.1
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|.+.+.||+|+||.||+++.. +++.||||.+........+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 45778899999999999999864 68999999998655445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 682 (695)
++++|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 89 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 89 SGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999988543 24789999999999999999999987 9999999999999 7889999999999987643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-24 Score=226.67 Aligned_cols=152 Identities=25% Similarity=0.403 Sum_probs=133.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcc---c--------------HHHHHHHHHHHHcCCCCceeee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ---G--------------IEELKNEVLLIAKLQHRNLVKL 589 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~---~--------------~~~~~~Ei~~l~~l~H~nIv~l 589 (695)
.++|.+.+.||+|+||.||+|+. +++.||||++...... . .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788899999999999999998 8999999998643211 1 1789999999999999999999
Q ss_pred EeEEEeCCeeEEEEEcCCCCCHHHH------HhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEE
Q 005471 590 LGCCLEEDENMLIYEFMPNKSLDYF------IFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNIL 662 (695)
Q Consensus 590 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NIL 662 (695)
++++.+.+..++||||+++++|.++ +... ....+++..+..++.||+.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999888 4321 23468999999999999999999998 76 999999999999
Q ss_pred EcCCCceEEEeeccceeecCC
Q 005471 663 LDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 663 l~~~~~~kl~DFGla~~~~~~ 683 (695)
++.++.+||+|||+++.+...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~ 205 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK 205 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT
T ss_pred EcCCCcEEEeccccccccccc
Confidence 999999999999999987544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9.7e-24 Score=220.07 Aligned_cols=148 Identities=30% Similarity=0.509 Sum_probs=130.4
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe-----------
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----------- 595 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----------- 595 (695)
++|++.+.||+|+||.||+|+. .+++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4678889999999999999986 4789999999864 23445778999999999999999999999876
Q ss_pred --CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEe
Q 005471 596 --EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (695)
Q Consensus 596 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 673 (695)
.+..++||||+++++|.+++.... ..+++.....++.||++||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 346789999999999999996532 34788889999999999999999987 99999999999999999999999
Q ss_pred eccceeec
Q 005471 674 FGTARVFG 681 (695)
Q Consensus 674 FGla~~~~ 681 (695)
||+++.+.
T Consensus 160 fg~~~~~~ 167 (303)
T 1zy4_A 160 FGLAKNVH 167 (303)
T ss_dssp CCCCSCTT
T ss_pred Ccchhhcc
Confidence 99998765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=223.60 Aligned_cols=149 Identities=28% Similarity=0.502 Sum_probs=128.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|...+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46888899999999999999875 588999998865432 234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 105 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999998876433 24899999999999999999999987 99999999999999999999999999987654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-24 Score=222.87 Aligned_cols=154 Identities=26% Similarity=0.426 Sum_probs=120.2
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3568889999999999999999864 68899999886532 334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 604 EFMPNKSLDYFIFDE-----SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
||+++++|.+++... .....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998642 12345899999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 005471 679 VFGG 682 (695)
Q Consensus 679 ~~~~ 682 (695)
.+..
T Consensus 170 ~~~~ 173 (303)
T 2vwi_A 170 FLAT 173 (303)
T ss_dssp HCC-
T ss_pred eecc
Confidence 7653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-24 Score=225.28 Aligned_cols=150 Identities=30% Similarity=0.481 Sum_probs=126.2
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc--ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
..++|.+.++||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 345788899999999999999985 4688999999975432 2245678999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-----cCCCceEEEeeccc
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL-----DEKMNPRISDFGTA 677 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-----~~~~~~kl~DFGla 677 (695)
|||++ |+|.+++.... .+++..+..|+.||++||.|||+.+ |+||||||+|||+ ++++.+||+|||+|
T Consensus 112 ~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99998 59998886432 4889999999999999999999987 9999999999999 45566999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+.+..
T Consensus 185 ~~~~~ 189 (329)
T 3gbz_A 185 RAFGI 189 (329)
T ss_dssp HHHC-
T ss_pred cccCC
Confidence 87753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=216.34 Aligned_cols=149 Identities=26% Similarity=0.421 Sum_probs=132.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46778899999999999999875 57889999986431 223567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
||+++++|.+++.... .+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999986532 4789999999999999999999987 99999999999999999999999999987654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-24 Score=243.97 Aligned_cols=144 Identities=28% Similarity=0.503 Sum_probs=125.5
Q ss_pred ceeeeeCceeEEEEEcC---CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~---~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+++|.+++|||||++++++. .+..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 57999999999999653 46789999997642 234678999999999999999999999986 4568899999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
|+|.+++... ..+++..+..|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.+..+.
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999543 34899999999999999999999987 9999999999999999999999999999876543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-23 Score=220.54 Aligned_cols=148 Identities=26% Similarity=0.407 Sum_probs=130.6
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHc--CCCCceeeeEeEEEeCC----ee
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK--LQHRNLVKLLGCCLEED----EN 599 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~ 599 (695)
..++|.+.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++.... ..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 345788999999999999999998 4899999998643 34667788888887 78999999999999876 78
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCCceEE
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH--------QDSRLRIIHRDLKASNILLDEKMNPRI 671 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~kl 671 (695)
++||||+++|+|.+++... .+++..+..++.||+.||.||| +.+ |+||||||+||||++++.+||
T Consensus 116 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEE
T ss_pred EEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999542 4889999999999999999999 554 999999999999999999999
Q ss_pred EeeccceeecCCc
Q 005471 672 SDFGTARVFGGEE 684 (695)
Q Consensus 672 ~DFGla~~~~~~~ 684 (695)
+|||+++.+....
T Consensus 189 ~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 189 ADLGLAVRHDSAT 201 (342)
T ss_dssp CCCTTCEEEETTT
T ss_pred EECCCceeccccc
Confidence 9999999886544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.3e-24 Score=236.43 Aligned_cols=150 Identities=30% Similarity=0.460 Sum_probs=132.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|.+.++||+|+||+||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46788899999999999999874 6899999998643 23346788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~~ 681 (695)
|+++|+|.+.+... ..+++.....|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 102 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 102 LYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999998888653 24889999999999999999999987 99999999999995 56679999999998775
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 176 ~~ 177 (486)
T 3mwu_A 176 QN 177 (486)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-23 Score=219.20 Aligned_cols=145 Identities=23% Similarity=0.416 Sum_probs=128.7
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEe--CCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLE--EDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~ 603 (695)
++|++.++||+|+||.||+|+. .+++.||||++... ..+.+.+|+.++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688889999999999999975 57899999998643 3567899999999997 9999999999998 56789999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-ceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 682 (695)
||+++++|.+++. .+++..+..++.||++||.|||+.+ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999998873 2788899999999999999999987 99999999999999766 899999999998764
Q ss_pred Cc
Q 005471 683 EE 684 (695)
Q Consensus 683 ~~ 684 (695)
..
T Consensus 184 ~~ 185 (330)
T 3nsz_A 184 GQ 185 (330)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=228.41 Aligned_cols=150 Identities=25% Similarity=0.400 Sum_probs=124.7
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe------eEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE------NML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~l 601 (695)
.+|...++||+|+||.||+|+...+..+|+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 35778899999999999999987777899998865322 22369999999999999999999976543 789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEEeeccceee
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVF 680 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~ 680 (695)
||||++++.+............+++.....++.||++||.|||+.+ |+||||||+||||+ .++.+||+|||+|+.+
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987655444332233446899999999999999999999987 99999999999999 8999999999999987
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
....
T Consensus 193 ~~~~ 196 (394)
T 4e7w_A 193 IAGE 196 (394)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 5443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=226.39 Aligned_cols=148 Identities=24% Similarity=0.366 Sum_probs=132.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|...+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46788899999999999999875 68899999987642 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+++++|.+++.... .+++.....++.+++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 ~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999986532 478999999999999999999985 5 9999999999999999999999999997653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=220.15 Aligned_cols=147 Identities=27% Similarity=0.463 Sum_probs=123.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEE------------
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL------------ 594 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~------------ 594 (695)
++|.+.+.||+|+||.||+|+.. +++.||||++........+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57888899999999999999875 48999999987766666778999999999999999999999874
Q ss_pred --eCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEE
Q 005471 595 --EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRI 671 (695)
Q Consensus 595 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl 671 (695)
+....++||||++ |+|.+++.. ..+++.....++.||++||.|||+.+ |+||||||+|||++ +++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999998 699998843 34789999999999999999999987 99999999999997 6779999
Q ss_pred EeeccceeecC
Q 005471 672 SDFGTARVFGG 682 (695)
Q Consensus 672 ~DFGla~~~~~ 682 (695)
+|||+++.+..
T Consensus 163 ~Dfg~~~~~~~ 173 (320)
T 2i6l_A 163 GDFGLARIMDP 173 (320)
T ss_dssp CCCTTCBCC--
T ss_pred ccCccccccCC
Confidence 99999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=222.00 Aligned_cols=150 Identities=31% Similarity=0.548 Sum_probs=129.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcE--EEEEEcccC-CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQE--IAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~--vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|.+.+.||+|+||.||+|+.. ++.. +|||++... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46788899999999999999864 4554 499988653 233456789999999999 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 603 YEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
|||+++++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996542 2235899999999999999999999987 9999999999999999999
Q ss_pred EEEeeccceee
Q 005471 670 RISDFGTARVF 680 (695)
Q Consensus 670 kl~DFGla~~~ 680 (695)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=226.41 Aligned_cols=152 Identities=24% Similarity=0.372 Sum_probs=125.7
Q ss_pred HhcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC-------
Q 005471 525 AATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------- 596 (695)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------- 596 (695)
...++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+|+++++.++|||||++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999986 5789999999865322 234799999999999999999998543
Q ss_pred -------------------------------CeeEEEEEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005471 597 -------------------------------DENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLH 644 (695)
Q Consensus 597 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH 644 (695)
...++||||++ ++|.+.+... .....+++.....++.||++||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 33789999998 5887777542 22345899999999999999999999
Q ss_pred hCCCCCeEecCCCCCCEEEc-CCCceEEEeeccceeecCCc
Q 005471 645 QDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 645 ~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~ 684 (695)
+.+ |+||||||+|||++ +++.+||+|||+|+.+....
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 987 99999999999998 68999999999999875543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=234.95 Aligned_cols=150 Identities=33% Similarity=0.462 Sum_probs=133.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|...++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46788899999999999999875 78999999986532 345678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCceEEEeeccceee
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVF 680 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~ 680 (695)
||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 106 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 106 EVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp CCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999888643 34889999999999999999999987 9999999999999 56789999999999887
Q ss_pred cCC
Q 005471 681 GGE 683 (695)
Q Consensus 681 ~~~ 683 (695)
...
T Consensus 180 ~~~ 182 (484)
T 3nyv_A 180 EAS 182 (484)
T ss_dssp CCC
T ss_pred ccc
Confidence 544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=217.45 Aligned_cols=151 Identities=27% Similarity=0.441 Sum_probs=128.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC----CcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
.++|.+.+.||+|+||.||+|+..+ +..||||.+.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3567788999999999999998542 3469999987643 3446788999999999999999999999764 56799
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999996532 34789999999999999999999987 9999999999999999999999999999775
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 165 ~~ 166 (281)
T 3cc6_A 165 DE 166 (281)
T ss_dssp --
T ss_pred cc
Confidence 44
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=223.43 Aligned_cols=154 Identities=28% Similarity=0.418 Sum_probs=132.7
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEe--------CC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLE--------ED 597 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~--------~~ 597 (695)
.+|.+.++||+|+||.||+++. .+++.||||++........+.+.+|+.++.++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 4677889999999999999986 468999999987665566678899999999996 9999999999953 33
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++||||++ |+|.+++........+++..+..|+.||+.||.|||+.+ .+|+||||||+|||+++++.+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccc
Confidence 4789999996 799888865444456899999999999999999999874 34999999999999999999999999999
Q ss_pred eeecCC
Q 005471 678 RVFGGE 683 (695)
Q Consensus 678 ~~~~~~ 683 (695)
+.+...
T Consensus 186 ~~~~~~ 191 (337)
T 3ll6_A 186 TTISHY 191 (337)
T ss_dssp BCCSSC
T ss_pred eecccc
Confidence 987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=215.04 Aligned_cols=151 Identities=25% Similarity=0.422 Sum_probs=131.7
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--CeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 603 (695)
++|...+.||+|+||.||+|+.. ++.||||++.... ....+++.+|+.++.+++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46778899999999999999985 8899999987543 34456799999999999999999999999887 6789999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||+++|+|.+++.... ...+++..+..++.||++||.|||+.+ .+|+||||||+|||+++++.+||+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999996543 235899999999999999999999864 359999999999999999999999999876543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=216.64 Aligned_cols=150 Identities=29% Similarity=0.534 Sum_probs=130.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57888899999999999999875 68999999986542 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|++ ++|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 998 69999886543 234789999999999999999999987 99999999999999999999999999987653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=222.80 Aligned_cols=150 Identities=23% Similarity=0.422 Sum_probs=130.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC-----ee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----EN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~ 599 (695)
.++|.+.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|++++.+++||||+++++++.... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357888999999999999999864 688999999975432 33467889999999999999999999997653 57
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||++ ++|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 5898888542 4889999999999999999999987 99999999999999999999999999998
Q ss_pred ecCCc
Q 005471 680 FGGEE 684 (695)
Q Consensus 680 ~~~~~ 684 (695)
.....
T Consensus 178 ~~~~~ 182 (364)
T 3qyz_A 178 ADPDH 182 (364)
T ss_dssp CCGGG
T ss_pred cCCCC
Confidence 76543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=219.38 Aligned_cols=149 Identities=27% Similarity=0.417 Sum_probs=126.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--------cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--------GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 598 (695)
++|.+.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 46888899999999999999864 57899999986532 122346889999999999999999999987654
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---eEEEeec
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDFG 675 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFG 675 (695)
.++||||+++++|.+++... ..+++.....++.||++||.|||+++ |+||||||+|||++.++. +||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 89999999999999988542 35889999999999999999999987 999999999999987654 9999999
Q ss_pred cceeecCC
Q 005471 676 TARVFGGE 683 (695)
Q Consensus 676 la~~~~~~ 683 (695)
+++.+...
T Consensus 163 ~~~~~~~~ 170 (322)
T 2ycf_A 163 HSKILGET 170 (322)
T ss_dssp TCEECCCC
T ss_pred cceecccc
Confidence 99987654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.1e-23 Score=214.85 Aligned_cols=143 Identities=8% Similarity=0.039 Sum_probs=125.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|.+.+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999875 489999999976432 23467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
||+++++|.+++... ........|+.||++||.|||+++ |+||||||+||||++++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 999999999998432 244567889999999999999987 9999999999999999999999877653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=223.95 Aligned_cols=150 Identities=18% Similarity=0.298 Sum_probs=123.1
Q ss_pred cCCCCccceeeeeCceeEEEEEcC----CCcEEEEEEcccCCcc-----------cHHHHHHHHHHHHcCCCCceeeeEe
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTSGQ-----------GIEELKNEVLLIAKLQHRNLVKLLG 591 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~nIv~l~g 591 (695)
.++|.+.+.||+|+||.||+|+.. ++..+|||++...... ..+.+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356888899999999999999875 5678999998754321 1234667889999999999999999
Q ss_pred EEEe----CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 005471 592 CCLE----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667 (695)
Q Consensus 592 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~ 667 (695)
++.. ....++||||+ +++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9998 67889999999 999999985433 5899999999999999999999987 99999999999999877
Q ss_pred --ceEEEeeccceeecCC
Q 005471 668 --NPRISDFGTARVFGGE 683 (695)
Q Consensus 668 --~~kl~DFGla~~~~~~ 683 (695)
.+||+|||+|+.+..+
T Consensus 189 ~~~~kL~Dfg~a~~~~~~ 206 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPN 206 (345)
T ss_dssp TTSEEECCCTTCEESSGG
T ss_pred CCcEEEEeCCCceecccc
Confidence 9999999999987543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=216.35 Aligned_cols=156 Identities=25% Similarity=0.429 Sum_probs=130.5
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEe--CCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV 602 (695)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 46788899999999999999874 68999999987542 3345678999999999999999999998865 5678999
Q ss_pred EEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 603 YEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDS--RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
|||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ..+|+||||||+|||+++++.+||+|||+++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999999986532 2335899999999999999999999875 13499999999999999999999999999987
Q ss_pred ecCC
Q 005471 680 FGGE 683 (695)
Q Consensus 680 ~~~~ 683 (695)
+...
T Consensus 166 ~~~~ 169 (279)
T 2w5a_A 166 LNHD 169 (279)
T ss_dssp C---
T ss_pred eccc
Confidence 7543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=228.48 Aligned_cols=148 Identities=27% Similarity=0.434 Sum_probs=121.1
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------eeEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ENML 601 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~l 601 (695)
+|...+.||+|+||.||+|+.. +++.||||++.... ..+.+|+++|++++|||||++++++.... ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4777899999999999999875 58999999986532 22347999999999999999999986532 2579
Q ss_pred EEEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CceEEEeecccee
Q 005471 602 IYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARV 679 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~ 679 (695)
||||+++ +|...+... .....+++.....++.||++||.|||+.+ |+||||||+||||+.+ +.+||+|||+|+.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999985 555555321 22345899999999999999999999987 9999999999999954 6789999999998
Q ss_pred ecCCc
Q 005471 680 FGGEE 684 (695)
Q Consensus 680 ~~~~~ 684 (695)
+....
T Consensus 207 ~~~~~ 211 (420)
T 1j1b_A 207 LVRGE 211 (420)
T ss_dssp CCTTC
T ss_pred cccCC
Confidence 75443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.6e-23 Score=213.72 Aligned_cols=151 Identities=26% Similarity=0.379 Sum_probs=129.0
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEe----CCeeEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENML 601 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~l 601 (695)
.|.+.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 356668999999999999986 45789999988653 23445678999999999999999999999876 345799
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEEeeccceee
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVF 680 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~ 680 (695)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||+++..
T Consensus 107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999999999643 34789999999999999999999874 3599999999999998 8899999999999866
Q ss_pred cCC
Q 005471 681 GGE 683 (695)
Q Consensus 681 ~~~ 683 (695)
...
T Consensus 183 ~~~ 185 (290)
T 1t4h_A 183 RAS 185 (290)
T ss_dssp CTT
T ss_pred ccc
Confidence 544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=216.99 Aligned_cols=148 Identities=28% Similarity=0.498 Sum_probs=124.7
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC-CeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-DENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~ 606 (695)
++|++.+.||+|+||.||+++.. ++.||||.+... ...+.+.+|+.++.+++||||+++++++.+. +..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 46778899999999999999874 789999998753 3457889999999999999999999997665 4689999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
++++|.+++.... ...+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 98 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 98 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999986532 223788999999999999999999987 99999999999999999999999999987654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.9e-23 Score=213.82 Aligned_cols=147 Identities=24% Similarity=0.340 Sum_probs=126.9
Q ss_pred CCCcc-ceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHH-HcCCCCceeeeEeEEEe----CCeeEE
Q 005471 529 NFSTS-NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLI-AKLQHRNLVKLLGCCLE----EDENML 601 (695)
Q Consensus 529 ~f~~~-~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~~l 601 (695)
+|.+. +.||+|+||.||++.. .+++.||||++.. ...+.+|+.++ ..++||||+++++++.. ....++
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 45555 7799999999999986 5688999999864 24567888888 55699999999999987 667899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCceEEEeeccce
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTAR 678 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~ 678 (695)
||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999999997643 235899999999999999999999987 999999999999998 7899999999999
Q ss_pred eecCCc
Q 005471 679 VFGGEE 684 (695)
Q Consensus 679 ~~~~~~ 684 (695)
.+.+..
T Consensus 169 ~~~~~~ 174 (299)
T 3m2w_A 169 ETTGEK 174 (299)
T ss_dssp ECTTCG
T ss_pred cccccc
Confidence 876543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-23 Score=219.01 Aligned_cols=152 Identities=28% Similarity=0.405 Sum_probs=130.4
Q ss_pred CCCCcc-ceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTS-NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~-~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 602 (695)
+.|.+. ++||+|+||.||+|+.. +++.||||++.... .....++.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 455555 78999999999999865 68999999987532 33467889999999999 569999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCceEEEeecccee
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTARV 679 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~ 679 (695)
|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 108 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 9999999999888543 2345899999999999999999999987 999999999999997 78999999999998
Q ss_pred ecCC
Q 005471 680 FGGE 683 (695)
Q Consensus 680 ~~~~ 683 (695)
+...
T Consensus 184 ~~~~ 187 (327)
T 3lm5_A 184 IGHA 187 (327)
T ss_dssp C---
T ss_pred cCCc
Confidence 7644
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=242.18 Aligned_cols=147 Identities=21% Similarity=0.359 Sum_probs=127.4
Q ss_pred CCCCccceeeeeCceeEEEEEcC--CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe-----e
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS--NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE-----N 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~ 599 (695)
++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++|||||++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57888899999999999999875 58999999986542 3345678899999999999999999999998766 6
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
+|||||+++++|.+++.. .+++..+..|+.||++||.|||+++ ||||||||+||||+++ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999887633 4899999999999999999999987 9999999999999986 899999999998
Q ss_pred ecCC
Q 005471 680 FGGE 683 (695)
Q Consensus 680 ~~~~ 683 (695)
+...
T Consensus 231 ~~~~ 234 (681)
T 2pzi_A 231 INSF 234 (681)
T ss_dssp TTCC
T ss_pred cccC
Confidence 7543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.1e-23 Score=219.57 Aligned_cols=148 Identities=26% Similarity=0.450 Sum_probs=129.5
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC-----Cee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-----DEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 599 (695)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888899999999999999865 68899999997543 23356788999999999999999999998764 568
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
++||||++ ++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689888854 24889999999999999999999987 99999999999999999999999999998
Q ss_pred ecC
Q 005471 680 FGG 682 (695)
Q Consensus 680 ~~~ 682 (695)
+..
T Consensus 162 ~~~ 164 (353)
T 2b9h_A 162 IDE 164 (353)
T ss_dssp CC-
T ss_pred ccc
Confidence 754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=215.43 Aligned_cols=151 Identities=30% Similarity=0.462 Sum_probs=123.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC--CCc--EEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS--NGQ--EIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~g~--~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|++.+.||+|+||.||+|+.. +++ .||||++... .....+.+.+|++++.+++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 46778899999999999999853 333 6899988654 2344578899999999999999999999987654 89
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++++|.+++.... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999986542 34889999999999999999999987 999999999999999999999999999988
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
....
T Consensus 172 ~~~~ 175 (291)
T 1u46_A 172 PQND 175 (291)
T ss_dssp CC-C
T ss_pred cccc
Confidence 6543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=222.29 Aligned_cols=148 Identities=27% Similarity=0.406 Sum_probs=123.7
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 597 (695)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36788899999999999999985 46889999998653 2234567889999999999999999999998765
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++||||++ ++|.+++.. .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999997 477777742 3789999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 005471 678 RVFGGE 683 (695)
Q Consensus 678 ~~~~~~ 683 (695)
+.....
T Consensus 175 ~~~~~~ 180 (371)
T 2xrw_A 175 RTAGTS 180 (371)
T ss_dssp ------
T ss_pred cccccc
Confidence 977543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=224.67 Aligned_cols=148 Identities=30% Similarity=0.448 Sum_probs=114.9
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC------C
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------D 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 597 (695)
.++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788999999999999999985 56899999998653 223456788999999999999999999998764 5
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
..++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 6899888743 34899999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 97654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=216.08 Aligned_cols=153 Identities=27% Similarity=0.389 Sum_probs=120.3
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc-c-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG-Q-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~-~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
.++|+..+.||+|+||.||+++. .+++.||||++..... . ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 35688889999999999999986 5789999999875422 2 2233455555688889999999999999999999999
Q ss_pred EcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 604 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||++ |+|.+++... .....+++..+..|+.||+.||.|||++ + |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9998 5887777542 2234589999999999999999999997 6 9999999999999999999999999998875
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 162 ~~ 163 (290)
T 3fme_A 162 DD 163 (290)
T ss_dssp --
T ss_pred cc
Confidence 44
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-23 Score=221.24 Aligned_cols=157 Identities=25% Similarity=0.344 Sum_probs=118.5
Q ss_pred HHHhcCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe---
Q 005471 523 LLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE--- 598 (695)
Q Consensus 523 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~--- 598 (695)
.....++|.+.+.||+|+||.||+|+.. +++.||||++.... .....+.+|++.+..++||||+++++++...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3455678999999999999999999874 68999999886532 233456678888999999999999999987544
Q ss_pred ----eEEEEEcCCCCCHHHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCEEEcC-CCceE
Q 005471 599 ----NMLIYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLH--QDSRLRIIHRDLKASNILLDE-KMNPR 670 (695)
Q Consensus 599 ----~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~iiHrDlkp~NILl~~-~~~~k 670 (695)
.++||||++++ |...+.. ......+++.....++.|++.||.||| +.+ |+||||||+||||+. ++.+|
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred cceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 78999999864 4443332 233445889999999999999999999 665 999999999999996 89999
Q ss_pred EEeeccceeecCCc
Q 005471 671 ISDFGTARVFGGEE 684 (695)
Q Consensus 671 l~DFGla~~~~~~~ 684 (695)
|+|||+|+.+....
T Consensus 173 l~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE 186 (360)
T ss_dssp ECCCTTCBCCCTTS
T ss_pred EeeCCCceecCCCC
Confidence 99999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=223.66 Aligned_cols=146 Identities=16% Similarity=0.255 Sum_probs=127.2
Q ss_pred CCCCccceeeeeCceeEEEEEcCC---------CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceee----------
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN---------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK---------- 588 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~---------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~---------- 588 (695)
++|.+.+.||+|+||.||+|+... ++.||||.+... +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578888999999999999998753 789999998653 46789999999999999988
Q ss_pred -----eEeEEEe-CCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005471 589 -----LLGCCLE-EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 662 (695)
Q Consensus 589 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 662 (695)
+++++.. ....++||||+ +++|.+++.... ...+++..+..|+.||++||.|||+++ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6788877 67889999999 999999997542 245899999999999999999999987 999999999999
Q ss_pred EcCCC--ceEEEeeccceeecCC
Q 005471 663 LDEKM--NPRISDFGTARVFGGE 683 (695)
Q Consensus 663 l~~~~--~~kl~DFGla~~~~~~ 683 (695)
++.++ .+||+|||+|+.+...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGG
T ss_pred EcCCCCceEEEecCcceeeccCC
Confidence 99998 9999999999987643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.5e-23 Score=211.73 Aligned_cols=150 Identities=31% Similarity=0.465 Sum_probs=132.3
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 46888899999999999999875 68899999986532 3456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK---MNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~~ 681 (695)
|+++++|.+++.... .+++..+..++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 102 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 102 LYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999988886432 4889999999999999999999987 9999999999999754 479999999998775
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 176 ~~ 177 (287)
T 2wei_A 176 QN 177 (287)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-23 Score=237.16 Aligned_cols=142 Identities=18% Similarity=0.241 Sum_probs=110.5
Q ss_pred ceeeeeCceeEEEEE-cCCCcEEEEEEcccCC----------cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEE
Q 005471 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS----------GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~-~~~g~~vAvK~l~~~~----------~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 601 (695)
..++.|++|.+..++ .--|+.+|||.+.+.. ....++|.+|+++|.++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 345666666655543 2247889999986531 23346799999999999 79999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||++|++|.++|.... .++.. +|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.+.
T Consensus 320 VMEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999996542 35544 48999999999999998 9999999999999999999999999999876
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
.+.
T Consensus 391 ~~~ 393 (569)
T 4azs_A 391 QDC 393 (569)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=6.3e-23 Score=224.18 Aligned_cols=144 Identities=29% Similarity=0.479 Sum_probs=113.8
Q ss_pred cceeeeeCceeEEEEEcC---CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe--CCeeEEEEEcCC
Q 005471 533 SNKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENMLIYEFMP 607 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~ 607 (695)
.++||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+|.+++|||||++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 368999999999999865 57899999997542 23568899999999999999999999965 567899999997
Q ss_pred CCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCceEEEeeccc
Q 005471 608 NKSLDYFIFDES------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTA 677 (695)
Q Consensus 608 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla 677 (695)
++|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+|
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 57777764321 1224899999999999999999999987 9999999999999 77899999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+.+..
T Consensus 180 ~~~~~ 184 (405)
T 3rgf_A 180 RLFNS 184 (405)
T ss_dssp C----
T ss_pred eecCC
Confidence 98754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=211.23 Aligned_cols=151 Identities=25% Similarity=0.395 Sum_probs=125.5
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEE-EeCCeeEEEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC-LEEDENMLIY 603 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~ 603 (695)
..++|.+.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|++++.+++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346899999999999999999985 578899999865432 224678899999999988877766665 5667789999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCceEEEeeccceee
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVF 680 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~ 680 (695)
||+ +++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999986432 24899999999999999999999987 9999999999999 78899999999999988
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
....
T Consensus 159 ~~~~ 162 (296)
T 4hgt_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cCcc
Confidence 6543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.7e-23 Score=222.44 Aligned_cols=149 Identities=11% Similarity=0.154 Sum_probs=111.8
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHcC--CCCceeeeE-------eEEEe
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKL--QHRNLVKLL-------GCCLE 595 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l--~H~nIv~l~-------g~~~~ 595 (695)
+|...+.||+|+||.||+|+.. +++.||||++..... ...+.+++|+.++..+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4777899999999999999864 789999999976532 3355677885444444 699987755 55544
Q ss_pred CC-----------------eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 005471 596 ED-----------------ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKR------FDIILGIARGVLYLHQDSRLRII 652 (695)
Q Consensus 596 ~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ii 652 (695)
.+ ..+|||||++ |+|.+++..... .+.+..+ +.++.||++||.|||+++ |+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 32 3799999999 999999975422 2455555 778899999999999987 99
Q ss_pred ecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 653 HRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 653 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||||||+||||+.++.+||+|||+|+..+..
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence 9999999999999999999999999987543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.4e-23 Score=215.82 Aligned_cols=151 Identities=23% Similarity=0.348 Sum_probs=129.4
Q ss_pred hcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCC--CCceeeeEeEEEeCCeeEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~l 601 (695)
..++|.+.+.||+|+||.||+++..+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34568888999999999999999988999999998653 2344578899999999997 5999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||| +.+++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||+++.+.
T Consensus 106 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 5689999998653 34789999999999999999999987 999999999999975 799999999999876
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 178 ~~~ 180 (313)
T 3cek_A 178 PDT 180 (313)
T ss_dssp ---
T ss_pred Ccc
Confidence 543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.88 E-value=8.8e-23 Score=215.69 Aligned_cols=153 Identities=26% Similarity=0.507 Sum_probs=127.7
Q ss_pred hcCCCCccceeeeeCceeEEEEEc--CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcC---CCCceeeeEeEEE----
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL--SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKL---QHRNLVKLLGCCL---- 594 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~---- 594 (695)
+.++|.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++..+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346788899999999999999987 467899999886432 12233566777777665 8999999999998
Q ss_pred -eCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEe
Q 005471 595 -EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (695)
Q Consensus 595 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 673 (695)
.....++||||++ |+|.+++..... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 699998865432 34889999999999999999999987 99999999999999999999999
Q ss_pred eccceeecCC
Q 005471 674 FGTARVFGGE 683 (695)
Q Consensus 674 FGla~~~~~~ 683 (695)
||+++.+...
T Consensus 164 fg~~~~~~~~ 173 (326)
T 1blx_A 164 FGLARIYSFQ 173 (326)
T ss_dssp CCSCCCCCGG
T ss_pred CcccccccCC
Confidence 9999987543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.9e-23 Score=236.12 Aligned_cols=152 Identities=24% Similarity=0.392 Sum_probs=131.3
Q ss_pred hcCCCCccceeeeeCceeEEEEEcC----CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
..++|.+.+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3466888899999999999999864 24679999987543 233567899999999999999999999984 56789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++|+|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999999653 234899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 005471 681 GGE 683 (695)
Q Consensus 681 ~~~ 683 (695)
...
T Consensus 542 ~~~ 544 (656)
T 2j0j_A 542 EDS 544 (656)
T ss_dssp CC-
T ss_pred CCC
Confidence 544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-22 Score=208.02 Aligned_cols=150 Identities=25% Similarity=0.398 Sum_probs=128.2
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEE-EeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC-LEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E 604 (695)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++.+++|++++..+..+ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788899999999999999985 678999999986543 234688999999999988876666655 56677899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 681 (695)
|+ +++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ ++++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 899999986432 34899999999999999999999987 9999999999999 488999999999999886
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=223.49 Aligned_cols=150 Identities=25% Similarity=0.382 Sum_probs=129.0
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCC-CceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++|.+.++||+|+||.||+|+. .+++.||||++..... .+++..|++++..++| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36788999999999999999985 5689999998765432 3457889999999976 666677777788888999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCceEEEeeccceeec
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFG 681 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 681 (695)
|+ +++|.+++.... ..+++..++.|+.||+.||.|||+++ ||||||||+|||| ++++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999986433 34899999999999999999999987 9999999999999 688999999999999886
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-22 Score=221.67 Aligned_cols=150 Identities=22% Similarity=0.285 Sum_probs=128.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcC------CCCceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL------QHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l------~H~nIv~l~g~~~~~~~~ 599 (695)
..+|.+.++||+|+||.||+|... +++.||||++... ....+++.+|+.++..+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 356888999999999999999764 5889999999753 33445677888888776 577999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--eEEEeeccc
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN--PRISDFGTA 677 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla 677 (695)
++||||++ ++|.+++..... ..+++..+..|+.||++||.|||+.+ |+||||||+||||+.++. +||+|||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 689888865432 34899999999999999999999987 999999999999999887 999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+....
T Consensus 250 ~~~~~ 254 (429)
T 3kvw_A 250 CYEHQ 254 (429)
T ss_dssp EETTC
T ss_pred eecCC
Confidence 87543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-23 Score=214.84 Aligned_cols=153 Identities=24% Similarity=0.395 Sum_probs=125.4
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcc------cHHHHHHHHHHHHcC----CCCceeeeEeEEE
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQ------GIEELKNEVLLIAKL----QHRNLVKLLGCCL 594 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~------~~~~~~~Ei~~l~~l----~H~nIv~l~g~~~ 594 (695)
..++|.+.+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 356799999999999999999986 46889999998654321 223456789999888 8999999999999
Q ss_pred eCCeeEEEEEc-CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEE
Q 005471 595 EEDENMLIYEF-MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRIS 672 (695)
Q Consensus 595 ~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~ 672 (695)
..+..++|+|| +++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++ +++.+||+
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999 7999999998653 24899999999999999999999987 99999999999999 88999999
Q ss_pred eeccceeecCCc
Q 005471 673 DFGTARVFGGEE 684 (695)
Q Consensus 673 DFGla~~~~~~~ 684 (695)
|||+++.+....
T Consensus 183 dfg~~~~~~~~~ 194 (312)
T 2iwi_A 183 DFGSGALLHDEP 194 (312)
T ss_dssp CCSSCEECCSSC
T ss_pred EcchhhhcccCc
Confidence 999999886543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=219.26 Aligned_cols=148 Identities=26% Similarity=0.455 Sum_probs=125.5
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee----
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN---- 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~---- 599 (695)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 36788889999999999999986 468999999987542 23356788999999999999999999999887765
Q ss_pred --EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 600 --MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 600 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 68877762 23889999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 005471 678 RVFGGE 683 (695)
Q Consensus 678 ~~~~~~ 683 (695)
+.....
T Consensus 192 ~~~~~~ 197 (371)
T 4exu_A 192 RHADAE 197 (371)
T ss_dssp ------
T ss_pred cccccC
Confidence 876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=219.25 Aligned_cols=135 Identities=25% Similarity=0.345 Sum_probs=112.9
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC--------CCceeeeEeEEE---
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ--------HRNLVKLLGCCL--- 594 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~nIv~l~g~~~--- 594 (695)
.++|.+.++||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++..++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36789999999999999999985 46889999999753 344567889999999985 788999999998
Q ss_pred -eCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCC
Q 005471 595 -EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKM 667 (695)
Q Consensus 595 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~ 667 (695)
.....++||||+ +++|.+.+.... ...+++..+..|+.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 455789999999 556655554432 23489999999999999999999997 6 99999999999999775
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.4e-22 Score=211.83 Aligned_cols=149 Identities=23% Similarity=0.377 Sum_probs=129.3
Q ss_pred CCCCccceeeeeCceeEEEEEc--CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCC------ceeeeEeEEEeCCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL--SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR------NLVKLLGCCLEEDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~--~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~------nIv~l~g~~~~~~~~ 599 (695)
++|.+.+.||+|+||.||++.. .+++.||||++... ....+.+.+|++++..++|+ +++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788889999999999999985 36889999998753 34456788999999988765 499999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------------
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-------------- 665 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-------------- 665 (695)
++||||+ +++|.+++.... ...+++..+..++.||++||.|||+++ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999 899999886543 235789999999999999999999987 999999999999987
Q ss_pred -----CCceEEEeeccceeecC
Q 005471 666 -----KMNPRISDFGTARVFGG 682 (695)
Q Consensus 666 -----~~~~kl~DFGla~~~~~ 682 (695)
++.+||+|||+|+....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS
T ss_pred cccccCCCceEeeCcccccCcc
Confidence 67899999999997654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=213.18 Aligned_cols=153 Identities=26% Similarity=0.395 Sum_probs=125.7
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHH-HHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVL-LIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
.++|...+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 357888899999999999999874 68999999987643 233445556666 677789999999999999999999999
Q ss_pred EcCCCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 604 EFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
||+++ +|.+++... .....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 787776531 1234589999999999999999999997 6 999999999999999999999999999877
Q ss_pred cCC
Q 005471 681 GGE 683 (695)
Q Consensus 681 ~~~ 683 (695)
...
T Consensus 177 ~~~ 179 (327)
T 3aln_A 177 VDS 179 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=216.22 Aligned_cols=146 Identities=26% Similarity=0.453 Sum_probs=125.4
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe------
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE------ 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------ 598 (695)
++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5688889999999999999986 468999999986532 2335678899999999999999999999987654
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.++||||++ ++|.+++. ..+++..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 68877652 23889999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 005471 679 VFGG 682 (695)
Q Consensus 679 ~~~~ 682 (695)
....
T Consensus 175 ~~~~ 178 (353)
T 3coi_A 175 HADA 178 (353)
T ss_dssp C---
T ss_pred CCCC
Confidence 7653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=4e-23 Score=217.66 Aligned_cols=149 Identities=28% Similarity=0.533 Sum_probs=127.0
Q ss_pred HhcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 525 AATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
...++|.+.+.||+|+||.||+|+... .+|||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345778889999999999999998753 59999986532 23345678899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
|||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999998543 235889999999999999999999987 99999999999998 6799999999988764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=212.55 Aligned_cols=152 Identities=26% Similarity=0.401 Sum_probs=131.8
Q ss_pred hcCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcc------cHHHHHHHHHHHHcCC--CCceeeeEeEEEeC
Q 005471 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQ------GIEELKNEVLLIAKLQ--HRNLVKLLGCCLEE 596 (695)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~------~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~ 596 (695)
..++|.+.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++.+++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 346788899999999999999985 56889999998654221 2345678999999996 59999999999999
Q ss_pred CeeEEEEEcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEEee
Q 005471 597 DENMLIYEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDF 674 (695)
Q Consensus 597 ~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DF 674 (695)
+..++|+||+.+ ++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999976 8999998653 34789999999999999999999987 99999999999999 7899999999
Q ss_pred ccceeecCC
Q 005471 675 GTARVFGGE 683 (695)
Q Consensus 675 Gla~~~~~~ 683 (695)
|+++.+...
T Consensus 195 g~~~~~~~~ 203 (320)
T 3a99_A 195 GSGALLKDT 203 (320)
T ss_dssp TTCEECCSS
T ss_pred ccccccccc
Confidence 999987654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=222.07 Aligned_cols=148 Identities=26% Similarity=0.323 Sum_probs=119.2
Q ss_pred CCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +|||||++++++.+.+..++||||++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 3445889999999998776667999999998642 345678899999886 89999999999999999999999996
Q ss_pred CCHHHHHhccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-------------CceEE
Q 005471 609 KSLDYFIFDESRKQ----LLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-------------MNPRI 671 (695)
Q Consensus 609 gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-------------~~~kl 671 (695)
|+|.+++....... ...+..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 69999996543211 1133345679999999999999987 9999999999999754 58999
Q ss_pred EeeccceeecCCc
Q 005471 672 SDFGTARVFGGEE 684 (695)
Q Consensus 672 ~DFGla~~~~~~~ 684 (695)
+|||+|+.+..+.
T Consensus 170 ~DFG~a~~~~~~~ 182 (434)
T 2rio_A 170 SDFGLCKKLDSGQ 182 (434)
T ss_dssp CCCTTCEECCC--
T ss_pred cccccceecCCCC
Confidence 9999999886544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=221.12 Aligned_cols=147 Identities=23% Similarity=0.346 Sum_probs=119.4
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
.+|...++||+|+||+|+.....+++.||||++..... +.+.+|++++.++ +|||||++++++.+....+|||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 35777799999999996655556789999999865332 2356799999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-----CCCceEEEeeccceeec
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-----EKMNPRISDFGTARVFG 681 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-----~~~~~kl~DFGla~~~~ 681 (695)
+ |+|.+++..... .+.+.....++.||++||.|||+.+ |+||||||+||||+ ....+||+|||+|+.+.
T Consensus 101 ~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 7 699999865432 2334455689999999999999987 99999999999995 33468899999999876
Q ss_pred CC
Q 005471 682 GE 683 (695)
Q Consensus 682 ~~ 683 (695)
..
T Consensus 175 ~~ 176 (432)
T 3p23_A 175 VG 176 (432)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=208.92 Aligned_cols=148 Identities=24% Similarity=0.291 Sum_probs=119.8
Q ss_pred CCCCccc-eeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEe----CCeeEE
Q 005471 528 DNFSTSN-KLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENML 601 (695)
Q Consensus 528 ~~f~~~~-~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~l 601 (695)
++|.+.+ .||+|+||.||+|+.. +++.||||++... ..........+..++||||+++++++.. ....++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 4677744 6999999999999875 6899999998653 1222233334567799999999999987 345799
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCceEEEeeccce
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTAR 678 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~ 678 (695)
||||+++|+|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 104 v~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999997543 235899999999999999999999987 999999999999986 4569999999999
Q ss_pred eecCC
Q 005471 679 VFGGE 683 (695)
Q Consensus 679 ~~~~~ 683 (695)
.....
T Consensus 180 ~~~~~ 184 (336)
T 3fhr_A 180 ETTQN 184 (336)
T ss_dssp EC---
T ss_pred ecccc
Confidence 77543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-22 Score=231.66 Aligned_cols=154 Identities=27% Similarity=0.381 Sum_probs=131.7
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEe------CCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE------EDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~ 599 (695)
++|.+.++||+|+||.||+|.. .+++.||||++... .....+.+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5789999999999999999987 46889999998754 33445678999999999999999999999765 6677
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---eEEEeecc
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDFGT 676 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGl 676 (695)
++||||+++|+|.+++........+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976554446888999999999999999999987 999999999999996654 99999999
Q ss_pred ceeecCCc
Q 005471 677 ARVFGGEE 684 (695)
Q Consensus 677 a~~~~~~~ 684 (695)
++.+....
T Consensus 171 a~~~~~~~ 178 (676)
T 3qa8_A 171 AKELDQGE 178 (676)
T ss_dssp CCBTTSCC
T ss_pred cccccccc
Confidence 99875543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-21 Score=211.18 Aligned_cols=152 Identities=24% Similarity=0.365 Sum_probs=128.2
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CC-----ceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HR-----NLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----nIv~l~g~~~~~~~~ 599 (695)
.++|.+.++||+|+||+||+|+.. +++.||||++... ....+++..|+.++..++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 468889999999999999999864 6789999999753 334567788999888874 55 499999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCceEEEeeccc
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--EKMNPRISDFGTA 677 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla 677 (695)
+|||||++ ++|.+++..... ..+++..+..++.||+.||.|||.+ ..+|+||||||+||||+ .++.+||+|||+|
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999996 599998865432 3489999999999999999999953 23499999999999994 5788999999999
Q ss_pred eeecC
Q 005471 678 RVFGG 682 (695)
Q Consensus 678 ~~~~~ 682 (695)
+.+..
T Consensus 209 ~~~~~ 213 (382)
T 2vx3_A 209 CQLGQ 213 (382)
T ss_dssp EETTC
T ss_pred eeccc
Confidence 98754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-21 Score=208.10 Aligned_cols=149 Identities=21% Similarity=0.361 Sum_probs=126.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CC-cEEEEEEcccCCcccHHHHHHHHHHHHcCCCCc------eeeeEeEEEeCCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NG-QEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN------LVKLLGCCLEEDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g-~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~~ 599 (695)
++|.+.+.||+|+||.||+|+.. ++ +.||||++... ....+.+.+|+.++.+++|++ ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 57888999999999999999864 34 68999999753 344567888999999987766 99999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----------------
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---------------- 663 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---------------- 663 (695)
++||||+ +++|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 9999999 566666665432 235899999999999999999999987 9999999999999
Q ss_pred ---cCCCceEEEeeccceeecC
Q 005471 664 ---DEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 664 ---~~~~~~kl~DFGla~~~~~ 682 (695)
+.++.+||+|||+++....
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS
T ss_pred ccccCCCcEEEeecCccccccc
Confidence 6688999999999987544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.5e-22 Score=208.14 Aligned_cols=150 Identities=22% Similarity=0.402 Sum_probs=114.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-c-cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-Q-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|...+.||+|+||.||+|+.. +++.||||++..... . ..+.+..+..+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 46778899999999999999875 689999999875432 2 22344555567888899999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+ ++.+..+.... ...+++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+|||+++.+...
T Consensus 105 ~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 45555554322 23488999999999999999999985 6 999999999999999999999999999876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.5e-22 Score=225.81 Aligned_cols=137 Identities=20% Similarity=0.264 Sum_probs=110.2
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEEcccCCc--------ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG--------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
..++||+|+||.||+|+. .++.+++|+...... ...+.+.+|++++++++||||+++..++...++.+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999965 468889987644221 11345889999999999999997777777888899999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++++|.+++.. +..|+.||++||.|||+++ |+||||||+|||+++ .+||+|||+|+.+...
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999854 4579999999999999987 999999999999999 9999999999998765
Q ss_pred cc
Q 005471 684 EI 685 (695)
Q Consensus 684 ~~ 685 (695)
+.
T Consensus 483 ~~ 484 (540)
T 3en9_A 483 ED 484 (540)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.86 E-value=9.1e-22 Score=211.96 Aligned_cols=149 Identities=23% Similarity=0.370 Sum_probs=127.7
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-----------CCceeeeEeEEEe
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-----------HRNLVKLLGCCLE 595 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~~ 595 (695)
++|.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++.+++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788889999999999999986 56889999998753 334567889999999886 8999999999987
Q ss_pred CC----eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEc------
Q 005471 596 ED----ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLD------ 664 (695)
Q Consensus 596 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~------ 664 (695)
.+ ..++||||+ +++|.+++.... ...+++..+..|+.||+.||.|||++ + |+||||||+||||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 54 689999999 899999986543 23488999999999999999999997 6 99999999999994
Q ss_pred CCCceEEEeeccceeecC
Q 005471 665 EKMNPRISDFGTARVFGG 682 (695)
Q Consensus 665 ~~~~~kl~DFGla~~~~~ 682 (695)
..+.+||+|||+|+.+..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TEEEEEECCCTTCEETTB
T ss_pred CcceEEEcccccccccCC
Confidence 445899999999998754
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=203.09 Aligned_cols=147 Identities=21% Similarity=0.218 Sum_probs=118.1
Q ss_pred cHHHHHHhcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCc------------------ccHHHHHHHHHHHHc
Q 005471 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG------------------QGIEELKNEVLLIAK 580 (695)
Q Consensus 519 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~------------------~~~~~~~~Ei~~l~~ 580 (695)
.+..+......|.+.+.||+|+||.||+|+..+|+.||||.++.... .....+.+|+.++.+
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34455556667778899999999999999997799999999864321 134568899999999
Q ss_pred CCCCceeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 005471 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660 (695)
Q Consensus 581 l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N 660 (695)
++ | +++.+++.. +..++||||+++++|.+ +.. .....++.||++||.|||+.+ |+||||||+|
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 99 4 666665543 56799999999999987 411 123469999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeeccceeecCC
Q 005471 661 ILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 661 ILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||++ ++.+||+|||+|+.....
T Consensus 224 ILl~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp EEEE-TTEEEECCCTTCEETTST
T ss_pred EEEE-CCcEEEEECCCCeECCCC
Confidence 9999 999999999999977543
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=6.7e-21 Score=170.06 Aligned_cols=108 Identities=19% Similarity=0.327 Sum_probs=93.9
Q ss_pred ccccccCCCCccCCCCEEE--eCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCee
Q 005471 21 TSIDTISLSQPIKDGDVIV--SSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLV 98 (695)
Q Consensus 21 ~~~~~l~~~~~l~~~~~l~--S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~ 98 (695)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+|+ -+||++ +++||+|||+.| +.++.|+|+.|||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 4568999999999999999 999999999999886 368985 799999999977 345799999999999
Q ss_pred eeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEee
Q 005471 99 LHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (695)
Q Consensus 99 l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqS 146 (695)
|+|.++. ++|+|++. ...+...++|+|+|||||++. ++|||
T Consensus 75 l~d~~~~--~lW~S~~~-~~~g~~~l~l~~~Gnlvl~~~----~~W~S 115 (119)
T 1b2p_A 75 VITNENV--TVWQSPVA-GKAGHYVLVLQPDRNVVIYGD----ALWAT 115 (119)
T ss_dssp EECTTCC--EEEECSCC-CCSSCEEEEECTTSCEEEEES----EEEEC
T ss_pred EEeCCCc--EEEcCCCC-CCCCCEEEEEECCCcEEEECc----cEeCC
Confidence 9998888 99999975 334456899999999999972 79998
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.8e-21 Score=165.68 Aligned_cols=104 Identities=16% Similarity=0.358 Sum_probs=89.8
Q ss_pred cccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeeccC
Q 005471 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERN 103 (695)
Q Consensus 24 ~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~~ 103 (695)
++|.+||.|.+|++|+| |.|.|.|..+++ |.++. ..++||+|||+.|.. ..+.|+|+.||+|||+|++
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~-~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGK-SGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTC-CSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCC-ccEEEEEeCCccEEEECCC
Confidence 67999999999999998 889999999887 56654 358999999999975 3578999999999999999
Q ss_pred CCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEee
Q 005471 104 QSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (695)
Q Consensus 104 ~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqS 146 (695)
+. +||+|++. ...+..+|+|+|+|||||++. .||||
T Consensus 70 ~~--~vWss~t~-~~~~~~~l~L~ddGNlVly~~----~~W~S 105 (105)
T 4h3o_A 70 GR--SLWASHST-RGSGNYILILQDDGNVIIYGS----DIWST 105 (105)
T ss_dssp CC--EEEECCCC-CCSSCEEEEECTTSCEEEEES----EEEEC
T ss_pred cE--EEEEecCC-CCCCCEEEEEeCCCeEEEECC----cEecC
Confidence 98 99999976 334557899999999999964 69998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=166.36 Aligned_cols=110 Identities=19% Similarity=0.351 Sum_probs=94.4
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeecc
Q 005471 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (695)
Q Consensus 23 ~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~ 102 (695)
+|+|.+|+.|.+|++|+ ++|.|+|+|+.+|+ -|+|+ ..++||.||++.|. ..+.++|..||||||+|.
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn------lvl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN------FVLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC------EEEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc------EEEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECC
Confidence 47899999999999999 99999999999887 37787 36999999999773 457899999999999998
Q ss_pred CCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCC
Q 005471 103 NQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPT 151 (695)
Q Consensus 103 ~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~Pt 151 (695)
++. ++|+|++. ...+..+++|+|+|||||++. .+||||+||.
T Consensus 69 ~~~--~~W~S~t~-~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNR--VIWQTKTN-GKEDHYVLVLQQDRNVVIYGP----VVWATGSGPA 110 (110)
T ss_dssp TCC--EEEECCCC-CSSSCCEEEECTTSCEEEECS----EEEECSCCC-
T ss_pred CCc--EEEecCCC-CCCCCEEEEEeCCccEEEECC----CEecCCCcCC
Confidence 887 99999976 333456899999999999863 7999999984
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.3e-20 Score=164.19 Aligned_cols=110 Identities=19% Similarity=0.320 Sum_probs=93.0
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeecc
Q 005471 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (695)
Q Consensus 23 ~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~ 102 (695)
.|+|.+||+|.+|++|+ +|.|+|+|+.+|+ | ++|+ ..++||+||++.|. .++.|+|+.+|+|||+|.
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence 47899999999999998 7999999998876 2 3465 37899999999883 457899999999999998
Q ss_pred CCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCC
Q 005471 103 NQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTD 152 (695)
Q Consensus 103 ~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtD 152 (695)
++. ++|+|++. .+.+..+|+|+|+|||||++. ++||||.+++.
T Consensus 69 ~~~--~vW~S~~~-~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNN--DVWGSACW-GDNGKYALVLQKDGRFVIYGP----VLWSLGPNGCR 111 (115)
T ss_dssp TCC--EEEECCCC-CSSSCCEEEECTTSCEEEECS----EEECSSTTCBC
T ss_pred Cce--EEEEcCCC-CCCCCEEEEEeCCCeEEEECC----CEEECCCCCCc
Confidence 787 89999875 233456899999999999952 79999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=160.88 Aligned_cols=110 Identities=20% Similarity=0.402 Sum_probs=92.5
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeecc
Q 005471 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (695)
Q Consensus 23 ~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~ 102 (695)
+|+|.+||.|.+|++| ++|.|+|+|+.+|+ -+||++ .++||+||++.+ +.++.|+|..+|||||+|
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn------lvl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN------LVLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc------EEEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 4889999999999999 57999999999987 356775 689999999864 345789999999999999
Q ss_pred CCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCC
Q 005471 103 NQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHP 150 (695)
Q Consensus 103 ~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~P 150 (695)
++. ++|+|++. ...+...++|+++|||||++. .+.++||||++.
T Consensus 67 ~~~--~~W~S~~~-~~~g~~~l~l~~dGnlvl~~~-~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSR--AIWASNTN-RQNGNYYLILQRDRNVVIYDN-SNNAIWATHTNV 110 (112)
T ss_dssp TTE--EEEECCCC-CSCCCCEEEECTTSCEEEECT-TSCEEEECCCCC
T ss_pred CCE--EEEECCcc-CCCCCEEEEEeCCCcEEEECC-CCceEEECCCcc
Confidence 666 89999875 233456899999999999974 467999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.1e-20 Score=200.53 Aligned_cols=150 Identities=22% Similarity=0.278 Sum_probs=113.3
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCC-Ccee---------------e
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQH-RNLV---------------K 588 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H-~nIv---------------~ 588 (695)
.|...+.||+|+||.||+|+. .+++.||||++..... ...+.+++|+.++..++| +|.. .
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 456668999999999999994 5789999999874322 336789999999999987 2211 1
Q ss_pred ------eEeEEEe-----CCeeEEEEEcCCCCCHHHHHhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 005471 589 ------LLGCCLE-----EDENMLIYEFMPNKSLDYFIFD----ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653 (695)
Q Consensus 589 ------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 653 (695)
+..++.. ....+++|+++ .++|.+++.. ......+++..++.|+.||++||.|||+++ |||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 1111111 12345666654 6899988842 122345788899999999999999999987 999
Q ss_pred cCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 654 RDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 654 rDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||||+||||+.++.+||+|||+|+..+.
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred CCcccceEEEecCCeEEEEeccceeecCC
Confidence 99999999999999999999999987653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=183.66 Aligned_cols=139 Identities=17% Similarity=0.184 Sum_probs=107.1
Q ss_pred CCccceeeeeCceeEEEEEc-CCCcE--EEEEEcccCCcc------------------------cHHHHHHHHHHHHcCC
Q 005471 530 FSTSNKLGQGGFGPVYKGKL-SNGQE--IAVKRLSTTSGQ------------------------GIEELKNEVLLIAKLQ 582 (695)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~-~~g~~--vAvK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~ 582 (695)
|.+.+.||+|+||.||+|.. .+|+. ||||.++..... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678999999999999998 67888 999986543111 1135788999999998
Q ss_pred CCce--eeeEeEEEeCCeeEEEEEcCCC-C----CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEec
Q 005471 583 HRNL--VKLLGCCLEEDENMLIYEFMPN-K----SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH-QDSRLRIIHR 654 (695)
Q Consensus 583 H~nI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHr 654 (695)
|+++ ..++.. +..+|||||+.+ | +|.++... .++.....++.||+.||.||| +.+ ||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8764 344432 367899999942 4 66665432 123345679999999999999 776 9999
Q ss_pred CCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 655 DLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 655 Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||||+|||+++ .+||+|||+|......
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 99999999998 9999999999987544
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.1e-18 Score=150.56 Aligned_cols=103 Identities=22% Similarity=0.444 Sum_probs=86.6
Q ss_pred cccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeeccC
Q 005471 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERN 103 (695)
Q Consensus 24 ~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~~ 103 (695)
++|.+||.|.+|+.|+ +|.|+|+|+.+|+ | +.|.. .++||.+|++.+ +..+.|+|..||+|||+|.+
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----L-vly~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN-----L-VLYDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----E-EEEeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 5799999999999997 6999999999886 2 33664 589999999976 34578999999999999988
Q ss_pred CCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEee
Q 005471 104 QSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (695)
Q Consensus 104 ~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqS 146 (695)
+. ++|+|++. ......+|+|+|+|||||++. .+|||
T Consensus 69 ~~--~~W~S~t~-~~~~~~~~~L~ddGNlvly~~----~~W~s 104 (109)
T 3dzw_A 69 NN--PIWASNTG-GENGNYVCVLQKDRNVVIYGT----ARWAT 104 (109)
T ss_dssp SC--EEEECCCC-CSSSCEEEEECTTSCEEEEES----CCCCC
T ss_pred CC--EEEECCCC-CCCCCEEEEEeCCCEEEEECC----CEEeC
Confidence 87 89999975 222346899999999999974 79998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.7e-17 Score=143.03 Aligned_cols=105 Identities=18% Similarity=0.300 Sum_probs=85.8
Q ss_pred ccccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeee
Q 005471 21 TSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLH 100 (695)
Q Consensus 21 ~~~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~ 100 (695)
.+.|+|.+||.|.+|+.|+| |.|+|-|...|+ |.+ |.. ++||.+|++.. +..+.|+|+.||+|||+
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 46799999999999999998 559998877765 444 654 48999999863 34578999999999999
Q ss_pred ccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEee
Q 005471 101 ERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (695)
Q Consensus 101 ~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqS 146 (695)
|.++. ++|++++. ...+..+|+|+|+|||||++ ..+|+|
T Consensus 70 d~~~~--~iW~S~t~-~~~~~~~~~L~~dGNlvly~----~~~W~t 108 (110)
T 3r0e_B 70 DDDFK--TIWSSRSS-SKQGEYVLILQDDGFGVIYG----PAIFET 108 (110)
T ss_dssp CTTCC--EEEECCCC-CSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred eCCCC--EEEEcCCc-CCCCCEEEEEcCCccEEEec----CCEecC
Confidence 98888 89999975 22344789999999999996 379997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.67 E-value=3.2e-16 Score=138.46 Aligned_cols=107 Identities=16% Similarity=0.278 Sum_probs=88.1
Q ss_pred cccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeec
Q 005471 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHE 101 (695)
Q Consensus 22 ~~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~ 101 (695)
+.++|.+||.|.+|+.|.+ |.|.|-|...|+ |.++... ..++||.+|+..+ +..+.|.|+.+|+|||+|
T Consensus 5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~~--~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKGS--KTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEETT--TTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEECC--CCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 4589999999999999985 889999988876 5554321 3689999999876 345789999999999999
Q ss_pred cCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEee
Q 005471 102 RNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (695)
Q Consensus 102 ~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqS 146 (695)
.++. ++|+|++. ...+..+|+|+|+|||||++ ..+|+|
T Consensus 74 ~~~~--~iW~S~t~-~~~~~~~~~L~~dGnlvly~----~~~W~s 111 (113)
T 3mez_B 74 DRLN--TVFVSNTV-GQEGDYVLILQINGQAVVYG----PAVWST 111 (113)
T ss_dssp TTSC--EEEECSCC-CSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred CCCC--EEEECCCc-CCCCCEEEEEcCCceEEEec----CCEecC
Confidence 8887 89999975 22334789999999999996 479997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.65 E-value=4.4e-16 Score=137.62 Aligned_cols=96 Identities=21% Similarity=0.445 Sum_probs=78.0
Q ss_pred CCCCCCceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCcee
Q 005471 81 PINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRF 160 (695)
Q Consensus 81 p~~~~~~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l 160 (695)
|+.+....|.|+.||+|+|++. ++ ++|++++.. .....+|+|+|+|||||++ .+.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~--~vW~sn~~~-~~~~~~l~l~~~GNLvl~d--~~~~~W~S~~------------ 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NR--AVWASGTNG-KASGCVLKMQNDGNLVIYS--GSRAIWASNT------------ 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TE--EEEECCCTT-SCSSEEEEECTTSCEEEEE--TTEEEEECCC------------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CE--EEEeCCCcC-CCCCEEEEEeCCCCEEEEc--CCEEEEECCc------------
Confidence 3434567899999999999987 56 899999752 2235789999999999998 4679999993
Q ss_pred ccccCCCceeeEEEccCCCCCCCcceeeeecCCCCCceEEEc-CCeeEEEeCCCCC
Q 005471 161 GWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYK-DDVKLWRAGPWTG 215 (695)
Q Consensus 161 ~~~~~tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~-~~~~y~~~g~~~g 215 (695)
||++|.|++.++++|. +++++ +..+||++++|+|
T Consensus 77 -------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp -------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred -------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999998 66675 4679999999987
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.9e-17 Score=171.25 Aligned_cols=146 Identities=15% Similarity=0.175 Sum_probs=101.6
Q ss_pred HHHHhcCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCc--------------ccHHHH--------HHHHHHHH
Q 005471 522 TLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG--------------QGIEEL--------KNEVLLIA 579 (695)
Q Consensus 522 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~--------------~~~~~~--------~~Ei~~l~ 579 (695)
.+.....-|.+.+.||+|+||.||+|...+|+.||||+++.... ...... ..|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33333344888999999999999999999999999998753210 001111 23555555
Q ss_pred cCCCCceeeeEeEEEeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 005471 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKAS 659 (695)
Q Consensus 580 ~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~ 659 (695)
++.+.++....-+.. ...+|||||+++++|..+.. . .....++.||+.+|.|||+.+ ||||||||.
T Consensus 169 rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 554443322111111 23479999999988854421 1 123457899999999999987 999999999
Q ss_pred CEEEcCCC----------ceEEEeeccceeec
Q 005471 660 NILLDEKM----------NPRISDFGTARVFG 681 (695)
Q Consensus 660 NILl~~~~----------~~kl~DFGla~~~~ 681 (695)
||||++++ .+.|+||+-+.-..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99998776 38999999887543
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.63 E-value=8.5e-16 Score=134.77 Aligned_cols=108 Identities=20% Similarity=0.330 Sum_probs=88.2
Q ss_pred cccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeec
Q 005471 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHE 101 (695)
Q Consensus 22 ~~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~ 101 (695)
+.|+|.+||.|.+|+.| .+|.|.|.|..+|+ -+.|.. +|.+|+..+ ...+.|+|+.||+|||+|
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN------Lvl~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN------LVLYNG------NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC------EEEETT------TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe------EEEEeC------eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 56899999999999999 46999999988887 344542 699998865 345789999999999999
Q ss_pred cCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCC
Q 005471 102 RNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPN 157 (695)
Q Consensus 102 ~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg 157 (695)
.++. ++|++++. ......+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 66 ~~~~--~vWss~t~-~~~~~~~~~L~~dGNlvly~----~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGS--TVWKSGAQ-SVKGNYAAVVHPDGRLVVFG----PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSC--EEEECCCC-CSSSCCEEEEETTTEEEEEC----SEEEEE-----CTTSCC
T ss_pred CCCC--EEEcCCCc-CCCcCEEEEEcCCCeEEEEe----cCEECC-----CCccCC
Confidence 8887 89999875 22345689999999999996 479997 666554
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.9e-15 Score=131.72 Aligned_cols=89 Identities=22% Similarity=0.418 Sum_probs=73.4
Q ss_pred CCceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceecccc
Q 005471 85 TSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDK 164 (695)
Q Consensus 85 ~~~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~ 164 (695)
....|.|+.||+|+|++ .++ +||++++... ....+|+|+|+|||||++. .+.++||||
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~--~vW~sn~~~~-~~~~~l~l~~dGNLVl~~~-~~~~~W~S~----------------- 77 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGK--PVWASNTGGL-GSGCRLTLHNNGNLVIYDQ-SNRVIWQTK----------------- 77 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTE--EEEECCCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECC-----------------
T ss_pred CCEEEEEcCCCcEEEEE-CCE--EEEECCCCCC-CCcEEEEEeCCCCEEEECC-CCcEEEecC-----------------
Confidence 45789999999999998 456 8999997622 2356899999999999986 567999999
Q ss_pred CCCceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCCC
Q 005471 165 RTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPW 213 (695)
Q Consensus 165 ~tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~~ 213 (695)
+++++|.|++.++++|. ++++++ .||+++++
T Consensus 78 --------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 --------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp --------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred --------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35667999999999997 667765 89999875
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.57 E-value=1e-14 Score=129.93 Aligned_cols=86 Identities=26% Similarity=0.427 Sum_probs=71.4
Q ss_pred ceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccCC
Q 005471 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (695)
Q Consensus 87 ~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (695)
..|.|+.||+|+|++. ++ +||++++... ....+|+|+|+|||||++. .+.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~--~vW~sn~~~~-~~~~~l~l~~dGNLVl~d~-~~~~lW~S~------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NN--PIWATNTGGL-GNGCRAVLQPDGVLVVITN-ENVTVWQSP------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TE--EEEECCCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECS-------------------
T ss_pred EEEEEecCCCEEEEEC-CE--EEEeCCCccC-CCceEEEEccCCEEEEEeC-CCcEEEcCC-------------------
Confidence 5788999999999986 66 8999997522 2347899999999999986 567999999
Q ss_pred CceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCC
Q 005471 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (695)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~ 212 (695)
+||++|.|++.++++|. +++++ .+||++|+
T Consensus 88 ------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 ------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp ------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred ------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999998 66666 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.5e-14 Score=128.37 Aligned_cols=91 Identities=25% Similarity=0.465 Sum_probs=74.6
Q ss_pred CceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccC
Q 005471 86 SGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKR 165 (695)
Q Consensus 86 ~~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~ 165 (695)
...|.|+.||+|+|++ .++ ++|++++... .....++|+|+|||||++. .+.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~--~vW~sn~~~~-~~~~~l~l~~~GnLvl~d~-~~~~vW~S~~~---------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGR--QIWASNTDRR-GSGCRLTLLSDGNLVIYDH-NNNDVWGSACW---------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTE--EEEECSCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECCCC----------------
T ss_pred CEEEEEcCCCcEEEEe-CCE--EEEeCCCCCC-CCceEEEECCCCcEEEECC-CceEEEEcCCC----------------
Confidence 4679999999999998 455 8999997522 2356899999999999986 56799999997
Q ss_pred CCceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCCCCCc
Q 005471 166 TGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQ 216 (695)
Q Consensus 166 tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~~~g~ 216 (695)
+++|.|++.++++|. +++++. .||++++|...
T Consensus 80 ---------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ---------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ---------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ---------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356789999999997 667765 89999999754
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.51 E-value=4.4e-14 Score=124.21 Aligned_cols=105 Identities=21% Similarity=0.324 Sum_probs=83.7
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeecc
Q 005471 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (695)
Q Consensus 23 ~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~ 102 (695)
.++|.+||.|.+|+.|. +|.|.|.|..+|+ | +.|.. .. ||.+|+..+ ...+.|+|..+|+|||+|.
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----L-vl~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----L-VLYNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----E-EEECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----E-EEECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence 47899999999999994 6999999988876 3 33653 23 999999876 3357899999999999998
Q ss_pred CCCceeEEeecccc-CCCCccEEEEccCCCEEEEeCCCCceEEee
Q 005471 103 NQSTVPVWQANISE-ASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (695)
Q Consensus 103 ~~~~~~~Wss~~~~-~~~~~~~a~L~d~GNlVl~~~~~~~~lWqS 146 (695)
++.. ++|+|++.. ...+..+|+|+|+|||||++ ..+|+|
T Consensus 68 ~~~~-~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----~~~W~s 107 (111)
T 3mez_A 68 NSNT-PVWVYPRSVNTVRGNYAATLGPDQHVTIYG----PAIWST 107 (111)
T ss_dssp SCSS-CSEEESSSCCCCSSCCEEEECTTSCEEEEC----SEEEEC
T ss_pred CCCE-EEEEeccccCCCCcCEEEEECCCCeEEEec----cCEEcc
Confidence 7651 499998631 22345689999999999996 479997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=8e-12 Score=127.38 Aligned_cols=145 Identities=16% Similarity=0.074 Sum_probs=113.9
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.+.|.....++.|+.+.||+.... ++.+++|+...........+.+|+.++..+. |..+.++++++...+..++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 356777778888889999999865 6899999986532233446889999999884 77888999999998899999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD--------------------------------------- 646 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 646 (695)
++|.+|.+.+.. ......++.+++++|..||+.
T Consensus 92 i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999998765311 112236888999999999981
Q ss_pred -----------------CCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 647 -----------------SRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 647 -----------------~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
.+..++|+|++|.|||++++..+.|+||+.+..-
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 1134899999999999988766789999998753
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.25 E-value=2.1e-11 Score=107.40 Aligned_cols=96 Identities=20% Similarity=0.351 Sum_probs=71.3
Q ss_pred CCCCCCCCCceEEEEecCCeeeeccC-CCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCC
Q 005471 78 RNNPINDTSGVLSVNIQGNLVLHERN-QSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLP 156 (695)
Q Consensus 78 r~~p~~~~~~~l~~~~~G~l~l~~~~-~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLp 156 (695)
.+.|+.+....|.++.||+|||++.+ +. ++|++++... .....|+|+|+|||||++. .+.++|||=.+
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~--~vWssnt~~~-~~~~~l~l~~dGNLVl~d~-~~~~iW~S~t~------- 85 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTN--IVWESGTSGR-GQHCFMRLGHSGELDITDD-RLNTVFVSNTV------- 85 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTE--EEEECCCTTS-CSSCEEEECTTSCEEEECT-TSCEEEECSCC-------
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCE--EEEECCcccC-CcCEEEEEeCCCcEEEECC-CCCEEEECCCc-------
Confidence 34555555678999999999999873 66 8999997622 2346899999999999986 45789997110
Q ss_pred CceeccccCCCceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCC
Q 005471 157 NMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (695)
Q Consensus 157 g~~l~~~~~tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~ 212 (695)
-..|.|.+.++.+|. +++++ .+.|.+|+
T Consensus 86 ------------------------~~~~~~~~~L~~dGn--lvly~--~~~W~s~~ 113 (113)
T 3mez_B 86 ------------------------GQEGDYVLILQINGQ--AVVYG--PAVWSTAA 113 (113)
T ss_dssp ------------------------CSSSCCEEEECTTSC--EEEEC--SEEEESCC
T ss_pred ------------------------CCCCCEEEEEcCCce--EEEec--CCEecCCC
Confidence 013568899999998 44554 57898874
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.8e-11 Score=125.35 Aligned_cols=113 Identities=16% Similarity=0.290 Sum_probs=86.6
Q ss_pred ccccccCCCCc----cCCCCEEEeCCCeEEEeeeCCC--CCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEec
Q 005471 21 TSIDTISLSQP----IKDGDVIVSSRKIYALGFFSPG--NSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQ 94 (695)
Q Consensus 21 ~~~~~l~~~~~----l~~~~~l~S~~g~F~lgFf~~~--~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~ 94 (695)
..+|++.||++ |..|+.|.| ...++.|+|... ...+.+ + |.+ ..+++|.+++..+ +. ..|.++.+
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S-~~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~--~~-~~l~l~~d 204 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQ-GVVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGK--GA-VRAVFQGD 204 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECT-TCEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTT--TC-CEEEECTT
T ss_pred ccccccccccccccccccCccccc-CCCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCC--cc-EEEEEcCC
Confidence 45699999999 888999865 456777766532 112333 3 433 2588999999887 23 78999999
Q ss_pred CCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCC
Q 005471 95 GNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDH 149 (695)
Q Consensus 95 G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~ 149 (695)
|+|+++|.++. .+|++++. .....+|+|+|+|||||++. .++||||||
T Consensus 205 GnLvl~d~~~~--~vWsS~t~--~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~ 252 (276)
T 3m7h_A 205 GNLVVYGAGNA--VLWHSHTG--GHASAVLRLQANGSIAILDE---KPVWARFGF 252 (276)
T ss_dssp SCEEEECTTSC--EEEECSCT--TCTTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred CeEEEEeCCCc--EEEEecCC--CCCCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence 99999998877 89999875 23457899999999999974 589999997
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.18 E-value=6.6e-11 Score=103.85 Aligned_cols=94 Identities=18% Similarity=0.276 Sum_probs=68.6
Q ss_pred CCCCCCceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCcee
Q 005471 81 PINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRF 160 (695)
Q Consensus 81 p~~~~~~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l 160 (695)
++......|.++.||+|||++.++ +|++++... .....|+|+|+|||||++.+.+.++|||..+
T Consensus 16 ~L~~g~~~L~~q~dGnLvl~~~~~----vW~snt~~~-~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~----------- 79 (111)
T 3mez_A 16 QLSYESAAFVMQGDCNLVLYNEAG----GFQSNTHGR-GVDCTLRLNNRGQLEIHSANSNTPVWVYPRS----------- 79 (111)
T ss_dssp EEEETTEEEEECTTSCEEEECSSC----CEECCCTTS-CSSCEEEECTTSCEEEECSSCSSCSEEESSS-----------
T ss_pred EEecCCEEEEEccCCeEEEECCCC----EEECCcccC-CcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-----------
Confidence 333445789999999999998653 899997522 2347899999999999986333469998621
Q ss_pred ccccCCCceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCC
Q 005471 161 GWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (695)
Q Consensus 161 ~~~~~tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~ 212 (695)
.....|.|.+.++++|. ++++. .++|.+++
T Consensus 80 ------------------~~~~~~~~~l~Lq~dGN--lvly~--~~~W~s~t 109 (111)
T 3mez_A 80 ------------------VNTVRGNYAATLGPDQH--VTIYG--PAIWSTPA 109 (111)
T ss_dssp ------------------CCCCSSCCEEEECTTSC--EEEEC--SEEEECCC
T ss_pred ------------------cCCCCcCEEEEECCCCe--EEEec--cCEEccCC
Confidence 11134789999999998 44554 68898875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=3.6e-11 Score=121.90 Aligned_cols=133 Identities=18% Similarity=0.173 Sum_probs=100.2
Q ss_pred eee-eeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCc--eeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 535 KLG-QGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 535 ~LG-~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
.++ .|..+.||+....+|+.+++|..... ....+.+|+.++..+.+.+ +.+++++....+..++||||+++.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 444 55569999998877888999987543 2346788999998885444 55689988888888999999999887
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 005471 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS-------------------------------------------- 647 (695)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 647 (695)
. ... .+ ...++.++++.|..||...
T Consensus 103 ~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 211 11 1246777788888888643
Q ss_pred -----------CCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 648 -----------RLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 648 -----------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
+..++|+|++|.|||++++..++|+||+.|..-.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 1239999999999999887777899999987643
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.04 E-value=7.2e-10 Score=97.03 Aligned_cols=86 Identities=22% Similarity=0.393 Sum_probs=64.1
Q ss_pred CceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccC
Q 005471 86 SGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKR 165 (695)
Q Consensus 86 ~~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~ 165 (695)
...|.++.||+|+|++. . ++|++++.. ......++|+|+|||||++. .+.++|||-.+
T Consensus 25 ~~~L~~q~dGnLvl~~~--~--~vW~snt~~-~~~~~~l~l~~dGNLvl~d~-~~~~iW~S~t~---------------- 82 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--K--YGWQSNTHG-NGEHCFLRLNHKGELIIKDD-DFKTIWSSRSS---------------- 82 (110)
T ss_dssp SCEEEECTTSCEEEECS--S--SCEECCCTT-SSSSCEEEECTTSCEEEECT-TCCEEEECCCC----------------
T ss_pred CEEEEEcCCCeEEEECC--e--EEEECCCcC-CCcCEEEEEeCCCcEEEEeC-CCCEEEEcCCc----------------
Confidence 46899999999999876 4 789999762 22346899999999999986 46789998321
Q ss_pred CCceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCC
Q 005471 166 TGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (695)
Q Consensus 166 tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~ 212 (695)
-..|.|.+.++++|. +++++ ...|.+|+
T Consensus 83 ---------------~~~~~~~~~L~~dGN--lvly~--~~~W~t~~ 110 (110)
T 3r0e_B 83 ---------------SKQGEYVLILQDDGF--GVIYG--PAIFETSS 110 (110)
T ss_dssp ---------------CSSSCCEEEECTTSC--EEEEC--SEEEESCC
T ss_pred ---------------CCCCCEEEEEcCCcc--EEEec--CCEecCCC
Confidence 013458889999998 44555 37888763
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=9.6e-10 Score=96.16 Aligned_cols=87 Identities=23% Similarity=0.416 Sum_probs=64.4
Q ss_pred CceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccC
Q 005471 86 SGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKR 165 (695)
Q Consensus 86 ~~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~ 165 (695)
...|.|+.||+|+|++. +. ++|++++... .....++|+|+|||||++. .+.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~--~vW~snt~~~-~~~~~l~l~~dGNLvl~~~-~~~~~W~S~t~~--------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DK--PIWATNTGGL-DRRCHLSMQSDGNLVVYSP-RNNPIWASNTGG--------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TE--EEEECCCTTS-SSSCEEEECTTSCEEEECT-TSCEEEECCCCC---------------
T ss_pred CEEEEEcCCCcEEEEeC-CE--EEEECCcccC-CCCEEEEEeCCCCEEEECC-CCCEEEECCCCC---------------
Confidence 46899999999999987 55 8999997622 2346899999999999986 457899984211
Q ss_pred CCceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCC
Q 005471 166 TGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (695)
Q Consensus 166 tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~ 212 (695)
..+.|.+.++++|.. ++++. +.|.+++
T Consensus 80 ----------------~~~~~~~~L~ddGNl--vly~~--~~W~s~t 106 (109)
T 3dzw_A 80 ----------------ENGNYVCVLQKDRNV--VIYGT--ARWATGT 106 (109)
T ss_dssp ----------------SSSCEEEEECTTSCE--EEEES--CCCCCCC
T ss_pred ----------------CCCCEEEEEeCCCEE--EEECC--CEEeCCC
Confidence 124678889999984 44543 5676654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.5e-09 Score=116.02 Aligned_cols=142 Identities=15% Similarity=0.224 Sum_probs=106.8
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEEcc--cCC-cccHHHHHHHHHHHHcCC--CCceeeeEeEEEeC---CeeEEEE
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLS--TTS-GQGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEE---DENMLIY 603 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~--~~~-~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~lV~ 603 (695)
..+.|+.|.++.||+.+..+ ..+++|+.. ... ......+.+|+.++..+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 34789999999999998865 678888765 321 123457888999999886 55688999988776 3489999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS------------------------------------ 647 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 647 (695)
||+++..+.+. ....++...+..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~-----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQ-----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCT-----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCC-----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99998877331 1123667788889999999999999731
Q ss_pred -------------------CCCeEecCCCCCCEEEcCCCc--eEEEeecccee
Q 005471 648 -------------------RLRIIHRDLKASNILLDEKMN--PRISDFGTARV 679 (695)
Q Consensus 648 -------------------~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~ 679 (695)
+..++|+|++|.|||++.++. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997653 69999999985
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.4e-09 Score=94.96 Aligned_cols=93 Identities=24% Similarity=0.447 Sum_probs=68.0
Q ss_pred CCCCCCCCceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCc
Q 005471 79 NNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNM 158 (695)
Q Consensus 79 ~~p~~~~~~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~ 158 (695)
+.|+.+....|.++.||||||+++ +|++++... .....++|+++|||||++. .+.++|+|- |
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~------~Wssnt~~~-~~~~~l~l~~dGnLvl~d~-~~~~vWss~-----t----- 76 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG------NWQSNTANN-GRDCKLTLTDYGELVIKNG-DGSTVWKSG-----A----- 76 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT------TEECCCTTS-CSSCEEEECTTSCEEEECT-TSCEEEECC-----C-----
T ss_pred CCEeECCCEEEEEecCCeEEEEeC------eEEcCCCCC-CCcEEEEEcCCCeEEEEeC-CCCEEEcCC-----C-----
Confidence 344444567899999999999873 599997622 2356899999999999986 457899761 1
Q ss_pred eeccccCCCceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCCCC
Q 005471 159 RFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWT 214 (695)
Q Consensus 159 ~l~~~~~tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~~~ 214 (695)
....+.|.+.++++|. +++++ .+.|.+++|-
T Consensus 77 ---------------------~~~~~~~~~~L~~dGN--lvly~--~~~W~s~t~~ 107 (109)
T 3r0e_A 77 ---------------------QSVKGNYAAVVHPDGR--LVVFG--PSVFKIDPWV 107 (109)
T ss_dssp ---------------------CCSSSCCEEEEETTTE--EEEEC--SEEEEECTTS
T ss_pred ---------------------cCCCcCEEEEEcCCCe--EEEEe--cCEECCCCcc
Confidence 0123568899999997 44554 5889999873
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.86 E-value=1.5e-08 Score=87.76 Aligned_cols=84 Identities=27% Similarity=0.527 Sum_probs=62.3
Q ss_pred ceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccCC
Q 005471 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (695)
Q Consensus 87 ~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (695)
-.|.++.||||||++. +. +||++++.........++|+++|||||+|. .+.++|+|=
T Consensus 21 y~l~~q~DgNLvly~~-~~--~vW~ant~~~~~~~~~L~l~~dGnLvL~d~-~~~~vWss~------------------- 77 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-ST--STWASNTEIGGKSGCSAVLQSDGNFVVYDS-SGRSLWASH------------------- 77 (105)
T ss_dssp EEEEECTTSCEEEEET-TE--EEEECCCCCTTCCSCEEEECTTSCEEEECT-TCCEEEECC-------------------
T ss_pred EEEEECCCCeEEEEEC-CE--EEEEecCCCCCCccEEEEEeCCccEEEECC-CcEEEEEec-------------------
Confidence 5799999999999985 45 899999863444457899999999999986 567899861
Q ss_pred CceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEE
Q 005471 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWR 209 (695)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~ 209 (695)
+....+.|.+.++++|.. ++++. ..|.
T Consensus 78 ------------t~~~~~~~~l~L~ddGNl--Vly~~--~~W~ 104 (105)
T 4h3o_A 78 ------------STRGSGNYILILQDDGNV--IIYGS--DIWS 104 (105)
T ss_dssp ------------CCCCSSCEEEEECTTSCE--EEEES--EEEE
T ss_pred ------------CCCCCCCEEEEEeCCCeE--EEECC--cEec
Confidence 112346788999999984 44532 3554
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.76 E-value=1.3e-08 Score=101.91 Aligned_cols=87 Identities=25% Similarity=0.392 Sum_probs=64.6
Q ss_pred ceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccCC
Q 005471 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (695)
Q Consensus 87 ~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (695)
-.|.|..+|+|+|++. ++ +||++|+.. .....++|+++|||||++. .+.++|+|+++.
T Consensus 28 f~l~f~~~gnl~ly~~-~~--~vW~an~~~--~~~~~l~l~~dGnLvl~d~-~~~~vW~s~~~~---------------- 85 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DV--RVWASNTAG--ATGCRAVLQSDGLLVILTA-QNTIRWSSGTKG---------------- 85 (236)
T ss_dssp EEEEECTTSCEEEEES-SS--EEECCCCCS--CSCCBCCBCSSSCBCCBCT-TTCCSCCCCCCC----------------
T ss_pred EEEEECCCCcEEEEEC-CE--EEEECCCCC--CCCeEEEEcCCCcEEEEcC-CCcEEEeCCccc----------------
Confidence 5677788899999886 55 899999752 2556899999999999986 567899998651
Q ss_pred CceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCCCC
Q 005471 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWT 214 (695)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~~~ 214 (695)
++|.|.+.++++|.. ++++. .+|.+..+.
T Consensus 86 ---------------~~~~~~~~l~d~Gnl--vl~~~--~~W~S~~~p 114 (236)
T 1dlp_A 86 ---------------SIGNYVLVLQPDRTV--TIYGP--GLWDSGTSN 114 (236)
T ss_dssp ---------------CSSCCEEEECSSSCE--EEECS--EEEECSCCC
T ss_pred ---------------cCCcEEEEEeCCCCE--EEecC--CEEECCCCC
Confidence 235567788888774 33432 788876654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=2.7e-07 Score=95.92 Aligned_cols=138 Identities=19% Similarity=0.219 Sum_probs=98.6
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCc--eeeeEeEEEeCC---eeEEEEEcC
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRN--LVKLLGCCLEED---ENMLIYEFM 606 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~n--Iv~l~g~~~~~~---~~~lV~Ey~ 606 (695)
.+.++.|....||+.. ..+++|.... ......+.+|..+|..+ .+.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3679999999999863 5688887543 23456788999999887 3333 345555443333 348999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD---------------------------------------- 646 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 646 (695)
+|.+|..... ..++..++..++.++++.|..||..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865332 1255666677888888888888851
Q ss_pred ---------------CCCCeEecCCCCCCEEEcC--CCceEEEeeccceeec
Q 005471 647 ---------------SRLRIIHRDLKASNILLDE--KMNPRISDFGTARVFG 681 (695)
Q Consensus 647 ---------------~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~ 681 (695)
.+..++|+|++|.|||+++ ...+.|+||+.+..-.
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 1235899999999999998 5668999999998643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.2e-06 Score=89.16 Aligned_cols=136 Identities=21% Similarity=0.193 Sum_probs=91.3
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCC---ceeeeEeEEE-eCCeeEEEEEcCCCC
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR---NLVKLLGCCL-EEDENMLIYEFMPNK 609 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~Ey~~~g 609 (695)
+.++.|....||+. ++.+++|.-. .......+.+|..+|..+.+. .+.+.+.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56888888999988 5678888742 223456788999999998652 3566777765 345578999999998
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 005471 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD------------------------------------------- 646 (695)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 646 (695)
.+...... .++...+..++.++++.|..||..
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 87653211 022233333333344433333321
Q ss_pred --------------CCCCeEecCCCCCCEEEcC---CCc-eEEEeeccceee
Q 005471 647 --------------SRLRIIHRDLKASNILLDE---KMN-PRISDFGTARVF 680 (695)
Q Consensus 647 --------------~~~~iiHrDlkp~NILl~~---~~~-~kl~DFGla~~~ 680 (695)
.+..++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3345799999999999997 345 589999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=4.9e-06 Score=84.55 Aligned_cols=138 Identities=17% Similarity=0.175 Sum_probs=96.6
Q ss_pred ceeeeeCce-eEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEcCCCCC
Q 005471 534 NKLGQGGFG-PVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (695)
Q Consensus 534 ~~LG~G~fG-~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 610 (695)
+.+..|..| .||+.... ++..+.+|+-.. ....++.+|..+|..+. +--+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556555 68988765 456788887543 23456888999988774 4446788999999999999999999988
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 005471 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-------------------------------------------- 646 (695)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------- 646 (695)
+.+...... .....+..++++.|.-||..
T Consensus 107 ~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 766542211 11223455555555555542
Q ss_pred -----------CCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 647 -----------SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 647 -----------~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
.+..++|+|+.+.|||++++..+-|+||+.+..-.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 11237999999999999988778899999997643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=2.5e-06 Score=90.61 Aligned_cols=79 Identities=5% Similarity=-0.029 Sum_probs=54.9
Q ss_pred cee-eeeCceeEEEEEcC-------CCcEEEEEEcccCC---cccHHHHHHHHHHHHcCC-C--CceeeeEeEEEeC---
Q 005471 534 NKL-GQGGFGPVYKGKLS-------NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQ-H--RNLVKLLGCCLEE--- 596 (695)
Q Consensus 534 ~~L-G~G~fG~Vy~g~~~-------~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~-H--~nIv~l~g~~~~~--- 596 (695)
+.| +.|....+|+.... +++.+++|.-.... ......+.+|+.++..+. | ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999998764 26678888764322 111245778888888774 3 3567788877655
Q ss_pred CeeEEEEEcCCCCCHH
Q 005471 597 DENMLIYEFMPNKSLD 612 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~ 612 (695)
+..++||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999986653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.9e-05 Score=83.61 Aligned_cols=75 Identities=9% Similarity=0.185 Sum_probs=50.2
Q ss_pred cceeeeeCceeEEEEEcC-CCcEEEEEEcccCCc-------ccHHHHHHHHHHHHcCCC--Cc-eeeeEeEEEeCCeeEE
Q 005471 533 SNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-------QGIEELKNEVLLIAKLQH--RN-LVKLLGCCLEEDENML 601 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~n-Iv~l~g~~~~~~~~~l 601 (695)
.+.||.|..+.||+++.. +++.++||....... ...+.+..|.+++..+.+ +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 368999999999999764 467899997643211 123456778888887732 33 4456543 4556789
Q ss_pred EEEcCCCC
Q 005471 602 IYEFMPNK 609 (695)
Q Consensus 602 V~Ey~~~g 609 (695)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=3e-05 Score=81.33 Aligned_cols=141 Identities=16% Similarity=0.227 Sum_probs=81.2
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-----CCCceeeeE-e--EEEeCCeeEEEEEc
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-----QHRNLVKLL-G--CCLEEDENMLIYEF 605 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~l~-g--~~~~~~~~~lV~Ey 605 (695)
+.|+.|..+.||+....++ .+++|+.... ..++..|+.++..| ..|.++.-. | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987654 5889988652 23344455555444 234444310 1 12346678999999
Q ss_pred CCCCCHH-----H---------HHhccCC-----------CCCCCHHHHHH-----------------------------
Q 005471 606 MPNKSLD-----Y---------FIFDESR-----------KQLLDWKKRFD----------------------------- 631 (695)
Q Consensus 606 ~~~gsL~-----~---------~l~~~~~-----------~~~l~~~~~~~----------------------------- 631 (695)
+++..+. . .++.... .....|...+.
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 1111100 01123432110
Q ss_pred --HHHHHHHHHHHHHh----------CCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 632 --IILGIARGVLYLHQ----------DSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 632 --i~~~ia~gL~yLH~----------~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
+...+.+++.+|+. ..+..++|+|+++.|||++.+..+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11123446667763 1245699999999999998888999999999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00017 Score=73.95 Aligned_cols=76 Identities=18% Similarity=0.242 Sum_probs=56.2
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-C--CceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-H--RNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
..+.+|.|..+.||+.++.+|+.+.+|+-..........|..|...|+.|. . --+.+++++ +..++||||++.
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~ 94 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCC
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecc
Confidence 347899999999999999999999999876544444456788998888773 2 234455554 235899999987
Q ss_pred CCH
Q 005471 609 KSL 611 (695)
Q Consensus 609 gsL 611 (695)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00023 Score=77.19 Aligned_cols=73 Identities=10% Similarity=0.142 Sum_probs=46.0
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccC----C---c--ccHHHHHHHHHHHH-cCCCCceeeeEeEEEeCCeeEEE
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT----S---G--QGIEELKNEVLLIA-KLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~----~---~--~~~~~~~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
.+.||.|....||+... +++.++||..... . . .....++.|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999975 4678999943221 0 1 12233444443332 22234566777664 5678999
Q ss_pred EEcC-CC
Q 005471 603 YEFM-PN 608 (695)
Q Consensus 603 ~Ey~-~~ 608 (695)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00024 Score=73.82 Aligned_cols=138 Identities=17% Similarity=0.134 Sum_probs=92.9
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC---CCceeeeEeEEEeCCeeEEEEEcCCCC
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEEDENMLIYEFMPNK 609 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~~g 609 (695)
.+.|+.|....+|+... +++.+++|+-... ....+..|...|..|. ...+.+++.++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999987 4678888876532 3567888988888773 367888999988888899999999987
Q ss_pred CHHH-----------HHhccCC-C------------------CCCCHHHHH---HHHH----------------HHHHHH
Q 005471 610 SLDY-----------FIFDESR-K------------------QLLDWKKRF---DIIL----------------GIARGV 640 (695)
Q Consensus 610 sL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~gL 640 (695)
.+.. .|+.... . -.-+|...+ ++.. .+...+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1222111 0 012565432 1111 111111
Q ss_pred -HHHHh-CCCCCeEecCCCCCCEEEcCCCceEEEeec
Q 005471 641 -LYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (695)
Q Consensus 641 -~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 675 (695)
..|.. ..++.+||+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 2356799999999999999887 8999984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.002 Score=66.79 Aligned_cols=143 Identities=16% Similarity=0.103 Sum_probs=80.8
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCc--eeeeEeE------EEeCCeeEEEEEc
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGC------CLEEDENMLIYEF 605 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~------~~~~~~~~lV~Ey 605 (695)
+.|+.|....+|+....++ .+++|..... ...+++..|+.++..+...+ +.+++.. ....+..++++||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4566788889999987655 6788887652 12234566777776653211 2333321 1234567899999
Q ss_pred CCCCCHHH--------------HHhccC----CC-----CCCCHHHHHHH------------HHHHHHHHHHHHhC----
Q 005471 606 MPNKSLDY--------------FIFDES----RK-----QLLDWKKRFDI------------ILGIARGVLYLHQD---- 646 (695)
Q Consensus 606 ~~~gsL~~--------------~l~~~~----~~-----~~l~~~~~~~i------------~~~ia~gL~yLH~~---- 646 (695)
+++..+.. .++... .. ....|...+.- ...+.+.+.+++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865311 011110 00 01124332111 11244556666532
Q ss_pred CCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 647 ~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
.+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234699999999999999876668999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0029 Score=66.06 Aligned_cols=142 Identities=15% Similarity=0.138 Sum_probs=73.4
Q ss_pred ceeeeeCcee-EEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC--CCceeeeEeEEEeCCeeEEEEEcCCCCC
Q 005471 534 NKLGQGGFGP-VYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (695)
Q Consensus 534 ~~LG~G~fG~-Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 610 (695)
+.|+.|.... +|+....+++.+++|....... +++..|+.++..+. .-.+.+++.+.. +..+++||++++..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 4565554443 6777765467777776443211 23445666666553 223556666533 33378999998766
Q ss_pred HHHHHhccC---------------------C--CCCCCHHHHH--------------------HHHHHHHHHHHHHH---
Q 005471 611 LDYFIFDES---------------------R--KQLLDWKKRF--------------------DIILGIARGVLYLH--- 644 (695)
Q Consensus 611 L~~~l~~~~---------------------~--~~~l~~~~~~--------------------~i~~~ia~gL~yLH--- 644 (695)
+...+.... . ....+..... .....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 644332110 0 0011111000 00011122222331
Q ss_pred hCCCCCeEecCCCCCCEEEcCC----CceEEEeeccceee
Q 005471 645 QDSRLRIIHRDLKASNILLDEK----MNPRISDFGTARVF 680 (695)
Q Consensus 645 ~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~~ 680 (695)
...+..++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1234569999999999999874 68999999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0011 Score=68.34 Aligned_cols=139 Identities=12% Similarity=0.119 Sum_probs=75.0
Q ss_pred cceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCce-eeeEeEEEeCCeeEEEEEcC-CCCC
Q 005471 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYEFM-PNKS 610 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~-~~gs 610 (695)
.+.|+.|....+|+. +.+.+|+-...... .....+|+.++..+...++ .++++. ..+..++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 45788876542111 1123457777766632222 355543 444567999999 6544
Q ss_pred HHHH------------------HhccCCC--CCCC-HHHHHHHHH--------------HHHHHHH----HHHh-CCCCC
Q 005471 611 LDYF------------------IFDESRK--QLLD-WKKRFDIIL--------------GIARGVL----YLHQ-DSRLR 650 (695)
Q Consensus 611 L~~~------------------l~~~~~~--~~l~-~~~~~~i~~--------------~ia~gL~----yLH~-~~~~~ 650 (695)
+... ++..... ...+ +.....+.. .+.+.+. .|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4210 1111100 0011 111111100 0111111 1111 23345
Q ss_pred eEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 651 IIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 651 iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
++|+|+.+.||| .+++.+.|+||..|..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 55667899999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0045 Score=64.29 Aligned_cols=143 Identities=13% Similarity=0.149 Sum_probs=83.4
Q ss_pred ceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCC--CceeeeEeE-----EEeCCeeEEEEEcC
Q 005471 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH--RNLVKLLGC-----CLEEDENMLIYEFM 606 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~-----~~~~~~~~lV~Ey~ 606 (695)
..|+ |....||+....+|+.+++|..... ....+.+..|..++..+.. -.+.+++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 7788999988777778999987642 1234567778887777632 224444442 22345668899999
Q ss_pred CCCCHH-----HH---------Hhcc----C--CCCCCCHHHHH----HH---------------HHHHHHHHHHHHh--
Q 005471 607 PNKSLD-----YF---------IFDE----S--RKQLLDWKKRF----DI---------------ILGIARGVLYLHQ-- 645 (695)
Q Consensus 607 ~~gsL~-----~~---------l~~~----~--~~~~l~~~~~~----~i---------------~~~ia~gL~yLH~-- 645 (695)
++..+. .. ++.. . .....++.... .+ ...+.+.+..+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 11 1110 0 01122322110 01 0111122333322
Q ss_pred --CCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 646 --DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 646 --~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
..+..++|+|+++.|||++ + .+.|+||+.+..-
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1234589999999999999 4 8999999887643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00066 Score=73.85 Aligned_cols=72 Identities=19% Similarity=0.319 Sum_probs=48.9
Q ss_pred ceeeeeCceeEEEEEcCC--------CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCce-eeeEeEEEeCCeeEEEEE
Q 005471 534 NKLGQGGFGPVYKGKLSN--------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E 604 (695)
+.|+.|-...||+....+ ++.+.+|+-... ...+.+.+|..++..+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 578888889999998753 478888877431 112456678888888743333 56776543 2 38999
Q ss_pred cCCCCCH
Q 005471 605 FMPNKSL 611 (695)
Q Consensus 605 y~~~gsL 611 (695)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0017 Score=69.13 Aligned_cols=141 Identities=18% Similarity=0.209 Sum_probs=81.5
Q ss_pred ceeeeeCceeEEEEEcCC--------CcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEE
Q 005471 534 NKLGQGGFGPVYKGKLSN--------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+.|..|-...+|+....+ ++.+.+|+-... ......+.+|.++++.+. +.-..++++.+.+ -+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567778888899998752 478888875332 234556678988887774 2223566666543 29999
Q ss_pred cCCCCCHHHH-----------------HhccCC--CCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 005471 605 FMPNKSLDYF-----------------IFDESR--KQLLD--WKKRFDIILGIA-------------------RGVLYLH 644 (695)
Q Consensus 605 y~~~gsL~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~ia-------------------~gL~yLH 644 (695)
|+++..|..- |+.... ..... |.+..++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665310 111110 11112 333333333221 2233332
Q ss_pred ----h-CCCCCeEecCCCCCCEEEcCC----CceEEEeecccee
Q 005471 645 ----Q-DSRLRIIHRDLKASNILLDEK----MNPRISDFGTARV 679 (695)
Q Consensus 645 ----~-~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~ 679 (695)
. ..+..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 233468999999999999876 7899999999874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0061 Score=66.64 Aligned_cols=73 Identities=18% Similarity=0.143 Sum_probs=47.1
Q ss_pred ceeeeeCceeEEEEEcCC-CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCce-eeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 534 NKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
+.|+.|-...+|+....+ +..+.+|+....... .-.-.+|..++..|...++ .++++.+. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 578888889999998765 477888876432211 1112578888888864444 46777662 2 359999997554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0023 Score=67.89 Aligned_cols=73 Identities=11% Similarity=0.131 Sum_probs=43.1
Q ss_pred ceeeeeCceeEEEEEcCC---------CcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCc-eeeeEeEEEeCCeeEEEE
Q 005471 534 NKLGQGGFGPVYKGKLSN---------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN-LVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~---------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~ 603 (695)
+.|+.|-.-.+|+....+ ++.+.+|+-.... ........|..++..+...+ ..++++.. . ..+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567778888999988654 2678888764422 11123456777777774333 34666543 2 37899
Q ss_pred EcCCCCCH
Q 005471 604 EFMPNKSL 611 (695)
Q Consensus 604 Ey~~~gsL 611 (695)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99997543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.06 E-value=0.013 Score=61.30 Aligned_cols=33 Identities=21% Similarity=0.376 Sum_probs=28.9
Q ss_pred CCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 648 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+..++|+|+.+.|||+++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998888999999888754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.28 E-value=0.26 Score=53.06 Aligned_cols=73 Identities=15% Similarity=0.138 Sum_probs=46.2
Q ss_pred ceeeeeCceeEEEEEcCC--------CcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEE
Q 005471 534 NKLGQGGFGPVYKGKLSN--------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 604 (695)
+.|..|-...+|+....+ ++.+.+|+-..... ..-...+|..+++.+. +.-..++++.+ . ..+|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 567778888999988753 57888887543221 1112356777777764 22234556533 2 378999
Q ss_pred cCCCCCH
Q 005471 605 FMPNKSL 611 (695)
Q Consensus 605 y~~~gsL 611 (695)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.42 E-value=1 Score=48.00 Aligned_cols=30 Identities=33% Similarity=0.423 Sum_probs=25.6
Q ss_pred CeEecCCCCCCEEE------cCCCceEEEeecccee
Q 005471 650 RIIHRDLKASNILL------DEKMNPRISDFGTARV 679 (695)
Q Consensus 650 ~iiHrDlkp~NILl------~~~~~~kl~DFGla~~ 679 (695)
.++|+|+.+.|||+ +++..++++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567899999998875
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=83.50 E-value=0.79 Score=36.74 Aligned_cols=34 Identities=21% Similarity=0.454 Sum_probs=28.4
Q ss_pred CCChHHHHHHhhccCCccceeccccCCCCCcceeeecc
Q 005471 367 NLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHG 404 (695)
Q Consensus 367 ~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~~C~~w~~ 404 (695)
..++++|+..|+.+=.|.||.|... ...|+++.+
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~----s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVK----SGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETT----TTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEeccC----CCceEcccC
Confidence 4689999999999999999999742 336999765
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.34 E-value=0.15 Score=55.65 Aligned_cols=60 Identities=10% Similarity=0.093 Sum_probs=18.3
Q ss_pred cceeeeeCceeEEEEEcCC-CcEEEE------EEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEe
Q 005471 533 SNKLGQGGFGPVYKGKLSN-GQEIAV------KRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE 595 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~-g~~vAv------K~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 595 (695)
.++|| ||.||+|.+.. ..+||| |..... ..+....+.+|..++..++|||+++.+++-..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 36676 99999999864 357888 665432 22334567889999999999999999988664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 695 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-17 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 6e-17 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 7e-16 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 8e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 6e-14 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-13 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-12 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 4e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-47
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 6/168 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ ++G G FG VYKGK + + ++ + Q ++ KNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+G + ++ ++ SL + + K + K DI A+G+ YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
IIHRDLK++NI L E + +I DFG A V +++ G+
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 40/172 (23%), Positives = 74/172 (43%), Gaps = 11/172 (6%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGI-EELKNEVLLIAKLQH 583
D+F ++LG G G V+K +G +A K + I ++ E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
+V G + E + E M SLD + R + + + + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ +I+HRD+K SNIL++ + ++ DFG + VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGT 166
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (399), Expect = 8e-44
Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 16/173 (9%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG---IEELKNEVLLIAKLQ 582
FS ++G G FG VY + + N + +A+K++S + Q +++ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H N ++ GC L E L+ E+ + D K+ L + + G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
LH +IHRD+KA NILL E ++ DFG+A I+A VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGT 174
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 7/168 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ +LG G FG V+ G + ++AVK L S + E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L ++ +I E+M N SL F+ S + L K D+ IA G+ ++ + +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
IHRDL+A+NIL+ + ++ +I+DFG AR+ E A
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-43
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 6/159 (3%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
D + +LG G FG VYK + A K + T S + +E+ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+VKLL E+ ++ EF ++D + + ++ L + + + YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+IIHRDLKA NIL + +++DFG +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (387), Expect = 2e-42
Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 6/166 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+ + +KLG G +G VY+G +AVK L + + +EE E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
V+LLG C E +I EFM +L ++ E +Q + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692
+ IHRDL A N L+ E +++DFG +R+ G+ A
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 6e-42
Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 7/168 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ ++G G FG V+ G N ++A+K + E+ E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L G CLE+ L++EFM + L ++ +++ L + + L + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+IHRDL A N L+ E ++SDFG R ++ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 9e-42
Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 8/170 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHR 584
+++ +G G +G K + S+G+ + K L + + + L +EV L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 585 NLVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVL 641
N+V+ ++ L + E+ L I ++ +Q LD + ++ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 642 YLHQ--DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
H+ D ++HRDLK +N+ LD K N ++ DFG AR+ + A
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-41
Identities = 40/168 (23%), Positives = 76/168 (45%), Gaps = 7/168 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ + +LG G FG V GK ++A+K + S +E E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L G C ++ +I E+M N L ++ + + ++ ++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ +HRDL A N L++++ ++SDFG +R +E +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFP 164
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 3e-41
Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 19/197 (9%)
Query: 512 KVDVTFFELSTLLAATDNFSTS---------NKLGQGGFGPVYKGKL----SNGQEIAVK 558
K+ + F A F+ +G G FG V G L +A+K
Sbjct: 1 KIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK 60
Query: 559 RL-STTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617
L S + + + +E ++ + H N++ L G + M+I EFM N SLD F+
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
+ + ++ GIA G+ YL + +HRDL A NIL++ + ++SDFG +
Sbjct: 121 NDGQF--TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLS 175
Query: 678 RVFGGEEILAITKRVVG 694
R + +G
Sbjct: 176 RFLEDDTSDPTYTSALG 192
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-41
Identities = 43/179 (24%), Positives = 83/179 (46%), Gaps = 12/179 (6%)
Query: 523 LLAATDNFSTSN-KLGQGGFGPVYKGKL---SNGQEIAVKRLSTTSGQG-IEELKNEVLL 577
L DN ++ +LG G FG V +G ++A+K L + + EE+ E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 578 IAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIA 637
+ +L + +V+L+G C + + ML+ E L F+ +++ + +++ ++
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI-LAITKRVVGT 695
G+ YL + +HRDL A N+LL + +ISDFG ++ G ++
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-41
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 8/170 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGI-EELKNEVLLIAKLQHRN 585
+++ LG+G +G V + +AVK + E +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+VK G E + L E+ L I + + GV+YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ I HRD+K N+LLDE+ N +ISDFG A VF + ++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 17/172 (9%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
+G+G FG V++GK G+E+AVK S+ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 595 EEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD---- 646
+++ L+ ++ + SL ++ + + + + L A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 647 -SRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGT 695
+ I HRDLK+ NIL+ + I+D G A + I VGT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 8/154 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+G+G FG V G G ++AVK + + + E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 588 KLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+LLG +EE + ++ E+M SL ++ R +L L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
+HRDL A N+L+ E ++SDFG +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 6/166 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
++ KLGQG FG V+ G + +A+K L + E E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L E+ ++ E+M SL F+ E+ K L + D+ IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
+ +HRDL+A+NIL+ E + +++DFG AR+ E A
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 5e-40
Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 31/205 (15%)
Query: 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLS-TTSGQGIEEL 571
+L +L +N +G+G FG V++ + +AVK L S +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 572 KNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL-------- 623
+ E L+A+ + N+VKLLG C L++E+M L+ F+ S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 624 -------------LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670
L ++ I +A G+ YL + + +HRDL N L+ E M +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 671 ISDFGTARVFGGEEILAITKRVVGT 695
I+DFG +R +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIP 205
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 8e-40
Identities = 48/191 (25%), Positives = 72/191 (37%), Gaps = 26/191 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSGQG-IEELKNEVLLIAK 580
+ S LG G FG V + +AVK L ++ E L +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD---------------ESRKQLL 624
L H N+V LLG C ++I E+ L F+ E + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
D + +A+G+ +L IHRDL A NILL +I DFG AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 685 ILAITKRVVGT 695
+
Sbjct: 200 NYVVKGNARLP 210
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 45/196 (22%), Positives = 73/196 (37%), Gaps = 31/196 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKG------KLSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAK 580
+N LG G FG V K ++AVK L + E L +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRK------------------ 621
L H N+V LLG C LI+E+ L ++ + K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 622 --QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+L ++ +A+G+ +L +HRDL A N+L+ +I DFG AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 680 FGGEEILAITKRVVGT 695
+ +
Sbjct: 214 IMSDSNYVVRGNARLP 229
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-39
Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
++F LG+G FG VY + + +A+K L +L+ EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
N+++L G + LI E+ P ++ + S+ D ++ I +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
H R+IHRD+K N+LL +I+DFG + + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 43/170 (25%), Positives = 84/170 (49%), Gaps = 10/170 (5%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
++ K+GQG G VY ++ GQE+A+++++ E + NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+V L L DE ++ E++ SL + + D + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
++IHRD+K+ NILL + +++DFG E+ + +VGT
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGT 179
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-38
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 16/170 (9%)
Query: 534 NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLL 590
++G+G F VYKG E+A L + + K E ++ LQH N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 591 GCCLEEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ +L+ E M + +L ++ R +++ K I +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 647 SRLRIIHRDLKASNILL-DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ IIHRDLK NI + + +I D G A + K V+GT
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 52/179 (29%), Positives = 90/179 (50%), Gaps = 13/179 (7%)
Query: 523 LLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQE----IAVKRLS-TTSGQGIEELKNEVL 576
+L T+ F LG G FG VYKG + G++ +A+K L TS + +E+ +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
++A + + ++ +LLG C LI + MP L ++ + K + + + + I
Sbjct: 64 VMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQI 120
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
A+G+ YL R++HRDL A N+L+ + +I+DFG A++ G EE +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 140 bits (354), Expect = 3e-37
Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 8/170 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
D++ +LG G FG V++ + G A K + T E ++ E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
V L +++E ++IYEFM L + DE K + + + + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 647 SRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVFGGEEILAITKRVVG 694
+H DLK NI+ K + + DFG ++ + +T
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-37
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 13/168 (7%)
Query: 534 NKLGQGGFGPVYKGKLSN---GQEIAVKRLSTTSGQG--IEELKNEVLLIAKLQHRNLVK 588
+LG G FG V KG + +AVK L + +EL E ++ +L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
++G C E + ML+ E L+ ++ + K +++ ++ G+ YL +
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-- 126
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK-RVVGT 695
+HRDL A N+LL + +ISDFG ++ +E +
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 8e-37
Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 10/171 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
++F LG+G F V + L+ +E A+K L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
VKL ++++ + N L +I D I + YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
H IIHRDLK NILL+E M+ +I+DFGTA+V E A VG
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 9e-37
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 21/171 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNG---QEIAVKRLS-TTSGQGIEELKNEVLLIAKL-Q 582
++ + +G+G FG V K ++ + A+KR+ S + E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-------------FDESRKQLLDWKKR 629
H N++ LLG C L E+ P+ +L F+ S L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
+ARG+ YL Q + IHRDL A NIL+ E +I+DFG +R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ 177
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 49/182 (26%), Positives = 74/182 (40%), Gaps = 14/182 (7%)
Query: 522 TLLAATDNFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLS---TTSGQGIEELKNE 574
T L + KLG G FG V +G+ +AVK L + + +++ E
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 575 VLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 634
V + L HRNL++L G ++ E P SL + LL R +
Sbjct: 62 VNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAV 118
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG-GEEILAITKRVV 693
+A G+ YL R IHRDL A N+LL + +I DFG R ++ + +
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 694 GT 695
Sbjct: 176 VP 177
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (346), Expect = 3e-36
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 8/162 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
D + +LG G FG V++ + G+ K ++T +KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ L ++ E +LI EF+ L I + + + + + G+ ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 647 SRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVFGGEEIL 686
I+H D+K NI+ + K + DFG A +EI+
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (347), Expect = 3e-36
Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQ- 582
++FS +G+GGFG VY + G+ A+K L QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 583 --HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640
+V + D+ I + M L Y + S+ + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
++H +++RDLK +NILLDE + RISD G A F ++
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-36
Identities = 35/160 (21%), Positives = 71/160 (44%), Gaps = 5/160 (3%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHR 584
++ + +G+G +G V N +A+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N++ + + ++ + ++ + Q L + I RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
++HRDLK SN+LL+ + +I DFG ARV +
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 44/175 (25%), Positives = 82/175 (46%), Gaps = 15/175 (8%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQH 583
+F+ +G+G FG VY G L + AVK L+ + G + + E +++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 584 RNLVKLLGCCLEEDEN-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
N++ LLG CL + + +++ +M + L FI +E+ + F + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
+ + + +HRDL A N +LDEK +++DFG AR +E ++ +
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-35
Identities = 49/190 (25%), Positives = 73/190 (38%), Gaps = 25/190 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKG------KLSNGQEIAVKRLSTTSGQG--IEELKNEVLLIA 579
D LG+G FG V + K + + +AVK L + + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 580 KLQHRNLVKLLGCCLEEDEN-MLIYEFMPNKSLDYFIF-------------DESRKQLLD 625
H N+V LLG C + M+I EF +L ++ ++ K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 626 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
+ +A+G+ +L + IHRDL A NILL EK +I DFG AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 686 LAITKRVVGT 695
Sbjct: 190 YVRKGDARLP 199
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-35
Identities = 42/182 (23%), Positives = 75/182 (41%), Gaps = 17/182 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLS-TTSGQGIEELKNEVLLIAK 580
+ + S +LGQG FG VY+G +A+K ++ S + E NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIF-------DESRKQLLDWKKRFDII 633
++V+LLG + ++I E M L ++ + K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
IA G+ YL+ + + +HRDL A N ++ E +I DFG R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 694 GT 695
Sbjct: 197 LP 198
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (327), Expect = 6e-34
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 10/158 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
+F LG G FG V+ + NG+ A+K L + +E +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
++++ G + + +I +++ L + R K + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
II+RDLK NILLD+ + +I+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-34
Identities = 36/173 (20%), Positives = 66/173 (38%), Gaps = 12/173 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSGQGI-EELKNEVLLIAKLQ 582
+ +G+G FG V++G + +A+K + + E+ E L + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H ++VKL+G E+ +I E L F+ LD ++ + Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
L R +HRD+ A N+L+ ++ DFG +R +
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLP 172
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-33
Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 11/163 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-----IAVKRLSTTSGQG-IEELKNEVLLIAKL 581
+ +G G FG VYKG L +A+K L + + E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL 641
H N+++L G + M+I E+M N +LD F+ + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
YL + +HRDL A NIL++ + ++SDFG +RV +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 15/165 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+++ + +G G FG VY+ KL +G+ +A+K++ Q E+ ++ KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 587 VKLLGCCLEEDENM------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640
V+L E L+ +++P KQ L + + R +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVFGGEE 684
Y+H I HRD+K N+LLD ++ DFG+A+ E
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 124 bits (311), Expect = 3e-32
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 20/179 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGI---------EELKNEVLL 577
+N+ LG+G V + +E AVK + T G E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 578 IAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
+ K+ H N+++L L+++ M L ++ + K L K+ I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ LH +L I+HRDLK NILLD+ MN +++DFG + E + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 172
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-32
Identities = 33/157 (21%), Positives = 69/157 (43%), Gaps = 9/157 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+ + + LG+G FG V++ S+ + K + G +K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNI 63
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ L +E ++I+EF+ + I + L+ ++ + + + +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 647 SRLRIIHRDLKASNILLDEKMNPR--ISDFGTARVFG 681
I H D++ NI+ + + I +FG AR
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 123 bits (309), Expect = 5e-32
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 8/156 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRN 585
+ + K+G+G +G VYK + + G+ A+K RL E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+VKL + +L++E + E L+ +L + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
R++HRDLK N+L++ + +I+DFG AR FG
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFG 151
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-31
Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 26/191 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRL-STTSGQGIEELKNEVLLI 578
D LG+G FG V + + ++AVK L S + + + +L +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 579 AKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL-------------L 624
+ +H+N++ LLG C ++ +I E+ +L ++ L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
K +ARG+ YL + IHRDL A N+L+ E +I+DFG AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 685 ILAITKRVVGT 695
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (304), Expect = 5e-31
Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 14/174 (8%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHR 584
D + + LG G F V + + +A+K ++ + +G E ++NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+V L LI + + L I K + +I + V YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 645 QDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
I+HRDLK N+L DE ISDFG +++ +L GT
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGT 172
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 7e-31
Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 8/160 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHR 584
+NF K+G+G +G VYK + G+ +A+K RL T + E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+VKLL E++ L++EF+ + D S + + + +G+ + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
R++HRDLK N+L++ + +++DFG AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (298), Expect = 2e-30
Identities = 40/178 (22%), Positives = 73/178 (41%), Gaps = 15/178 (8%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG---IEELKNEVLLIAKLQ 582
+D + LG GG V+ + L +++AVK L + + E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 583 HRNLVKLLGCCLEEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
H +V + E ++ E++ +L + E + K+ ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG-GEEILAITKRVVGT 695
+ + H + IIHRD+K +NI++ ++ DFG AR + T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-30
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-----LKNEVLLIAKLQHRNLV 587
+ LG+G F VYK + + Q +A+K++ ++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
LL + L+++FM +L +L +G+ YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683
I+HRDLK +N+LLDE +++DFG A+ FG
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 1e-29
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 13/173 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEV-LLIAKLQ 582
++F LG+G FG V+ + Q A+K L +E E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H L + ++ + E++ L Y I D + I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
LH I++RDLK NILLD+ + +I+DFG + + A T GT
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGT 166
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 4e-28
Identities = 36/172 (20%), Positives = 69/172 (40%), Gaps = 12/172 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
++F LG+G FG V + + G+ A+K L + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
L L D + E+ L + + SR+++ ++ I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+++RD+K N++LD+ + +I+DFG + + A K GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 168
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 19/181 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG--IEELKNEVLLIAKLQHR 584
+ K+GQG FG V+K + GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 585 NLVKLLGCCLEEDENM--------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
N+V L+ C + L+++F + + L + K+ ++L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL-- 127
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVG 694
L+ R +I+HRD+KA+N+L+ +++DFG AR F + + V
Sbjct: 128 ----NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 695 T 695
T
Sbjct: 184 T 184
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 43/180 (23%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKGK--LSNGQEIAVKRLSTTSGQG--IEELKNEVLLIAKL 581
A + ++G+G +G V+K + + G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 582 ---QHRNLVKLLGCCLEEDENMLIYEFMPNKSLD---YFIFDESRKQLLDWKKRFDIILG 635
+H N+V+L C + + + +D D+ + + + D++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ RG+ +LH R++HRDLK NIL+ +++DFG AR++ + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 1e-27
Identities = 48/196 (24%), Positives = 77/196 (39%), Gaps = 11/196 (5%)
Query: 491 SSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-L 549
++ + SE+E S+ K + S A D F LG G FG V K
Sbjct: 5 AAKKGSEQE-SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 550 SNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606
+G A+K L + IE NE ++ + LVKL + ++ E++
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666
+ + R I YLH L +I+RDLK N+L+D++
Sbjct: 124 AGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177
Query: 667 MNPRISDFGTARVFGG 682
+++DFG A+ G
Sbjct: 178 GYIQVTDFGFAKRVKG 193
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 9/157 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHR 584
+ K+G+G +G V+K K + +A+K RL E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+V+L + + L++EF YF + + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
++HRDLK N+L++ ++++FG AR FG
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (273), Expect = 6e-27
Identities = 39/177 (22%), Positives = 68/177 (38%), Gaps = 16/177 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+ + K+G G FG +Y G ++ G+E+A+K + +L E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ + C E + ++ + SL+ SRK K + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 647 SRLRIIHRDLKASNIL---LDEKMNPRISDFGTARVFGGEEILAI-----TKRVVGT 695
IHRD+K N L + I DFG A+ + K + GT
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 7e-27
Identities = 41/171 (23%), Positives = 69/171 (40%), Gaps = 19/171 (11%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN------EVLLIAKLQ--HRN 585
LG GGFG VY G +S+ +A+K + EL N EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+++LL D +LI E + + + L + + V + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 646 DSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEILAITKRVVGT 695
++HRD+K NIL+D + ++ DFG+ + + GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 172
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-26
Identities = 36/167 (21%), Positives = 70/167 (41%), Gaps = 19/167 (11%)
Query: 528 DNFSTSNK-LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHR 584
D++ +++ LG G G V + ++ A+K L Q + + EV L + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 65
Query: 585 NLVKLLGCC----LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640
++V+++ +++ E + L I + Q ++ +I+ I +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAI 124
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVFGGEE 684
YLH + I HRD+K N+L K +++DFG A+
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (269), Expect = 2e-26
Identities = 31/179 (17%), Positives = 69/179 (38%), Gaps = 18/179 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
++ ++G+G FG +++G L N Q++A+K S +L++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ + +E + ++ + SL+ + + + K + V +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 647 SRLRIIHRDLKASNILLDEKMNP-----RISDFGTARVFGGEE-----ILAITKRVVGT 695
+++RD+K N L+ + + DFG + + K + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-26
Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL------STTSGQGIEELKNEVLLIAK 580
D + T +LG G F V K + S G + A K + S+ G E+++ EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640
+QH N++ L + + +LI E + L F+ K+ L ++ + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPR----ISDFGTARVF 680
++ L+I H DLK NI+L ++ P+ I DFG A
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 2e-25
Identities = 36/160 (22%), Positives = 69/160 (43%), Gaps = 7/160 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHR 584
+ +G G +G V G ++A+K+L S + E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 585 NLVKLLGCCLEEDENMLIYEF-MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
N++ LL ++ +F + + + + + L + ++ + +G+ Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683
H IIHRDLK N+ ++E +I DFG AR E
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 9e-25
Identities = 40/166 (24%), Positives = 68/166 (40%), Gaps = 15/166 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLS----TTSGQGIEELKNEVLLIA 579
+NF LG G +G V+ + G+ A+K L + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 580 KLQHR-NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
++ LV L E + LI +++ L + R + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
VL L +L II+RD+K NILLD + ++DFG ++ F +E
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (254), Expect = 3e-24
Identities = 34/162 (20%), Positives = 72/162 (44%), Gaps = 17/162 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRN 585
D++ KLG+G + V++ ++N +++ VK L +++K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 586 LVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
++ L + L++E + N Q L + I + + Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 644 HQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVFGGEE 684
H + I+HRD+K N+++D + R+ D+G A + +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.8 bits (240), Expect = 1e-23
Identities = 36/174 (20%), Positives = 59/174 (33%), Gaps = 28/174 (16%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVK--RLSTTSGQ--------GIEELKNEVLLIAKLQH 583
+G+G V+ E VK ++ TS + G + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 584 RNLVKLLGCC----LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
R L KL G + N ++ E + K L + + ++ I
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE----------VLDMILEE 115
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
V + I+H DL N+L+ E I DF + G E I +R V
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDV 165
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (242), Expect = 1e-22
Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 13/175 (7%)
Query: 511 RKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQG 567
++++ T +E+ + + + +G G +G V G +AVK+LS S
Sbjct: 7 QELNKTIWEV------PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 568 IEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI-YEFMPNKSLDYFIFDESRKQLLDW 626
+ E+ L+ ++H N++ LL ++ + + + + Q L
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 627 KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+I I RG+ Y+H IIHRDLK SN+ ++E +I DFG AR
Sbjct: 121 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.4 bits (236), Expect = 9e-22
Identities = 42/177 (23%), Positives = 71/177 (40%), Gaps = 21/177 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS--TTSGQGIEELKNEVLLIAKLQHR 584
+ +G G G V + +A+K+LS + + E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 585 NLVKLLGCCL------EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
N++ LL E + L+ E M + LD ++ ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
G+ +LH IIHRDLK SNI++ +I DFG AR G + V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVT 181
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 81.6 bits (200), Expect = 3e-17
Identities = 28/151 (18%), Positives = 56/151 (37%), Gaps = 17/151 (11%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
KLG G F V+ K + N +A+K + E ++E+ L+ ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 594 LE-------------EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640
+ ++ F + + + + I + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671
Y+H+ R IIH D+K N+L++ +P
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 75.0 bits (184), Expect = 6e-17
Identities = 20/126 (15%), Positives = 44/126 (34%), Gaps = 19/126 (15%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ ++ + + G + Y N V ++ + T +W +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNLV-----LYDHS----TSVWASNTGILGK 50
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
+ GN V++ + +W ++ GN V L + GN+V+ G +
Sbjct: 51 KGCK-AVLQSDGNFVVY--DAEGRSLWASHSV-RGNGNYVLVLQEDGNVVIY----GSDI 102
Query: 144 WQSFDH 149
W + +
Sbjct: 103 WSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 72.3 bits (177), Expect = 7e-16
Identities = 18/96 (18%), Positives = 31/96 (32%), Gaps = 7/96 (7%)
Query: 62 IWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGN 121
I Y+ + + + LS+ NLVL +R+ VW N +
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDD---RVWSTNTA-GKGTG 67
Query: 122 TVAQLLDTGNLVLVRNDTGETLWQSFD--HPTDTVL 155
A L G + + + +W S + V
Sbjct: 68 CRAVLQPNGRMDV-LTNQNIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 37.6 bits (87), Expect = 8e-04
Identities = 19/110 (17%), Positives = 36/110 (32%), Gaps = 10/110 (9%)
Query: 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEA-SAGNTVAQLLDTGNLVLVRNDTGETLWQ 145
G + V GN +L+ + + +++ + NLVL D + +W
Sbjct: 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVL--FDRDDRVWS 58
Query: 146 SFDHPTDTVLPNMRFGWDKRTGL----NRYVTAWKSPDDPGSGNFSFTLD 191
T R + N+ + W S + +G + F L
Sbjct: 59 ---TNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQ 105
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 66.4 bits (161), Expect = 6e-14
Identities = 21/129 (16%), Positives = 45/129 (34%), Gaps = 18/129 (13%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
D ++ + G + Y + N V W + N +
Sbjct: 2 DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNLVLYDNNRAV---------WASGTNGKAS 50
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
VL + GNLV++ ++ +W +N + GN L N+V+ +++ +
Sbjct: 51 GC--VLKMQNDGNLVIYSGSR---AIWASNTNR-QNGNYYLILQRDRNVVI-YDNSNNAI 103
Query: 144 WQSFDHPTD 152
W + + +
Sbjct: 104 WATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 63.5 bits (154), Expect = 5e-13
Identities = 27/126 (21%), Positives = 42/126 (33%), Gaps = 20/126 (15%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ + + + G+ + + N V V W N
Sbjct: 2 NILYSGETLSTGEFLNYGS--FVFIMQEDCNLVLYDVDKPI---------WATNTGGL-- 48
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
S LS+ GNLV++ N S P+W +N GN V L N+V+ G
Sbjct: 49 SRSCFLSMQTDGNLVVY--NPSNKPIWASNTG-GQNGNYVCILQKDRNVVIY----GTDR 101
Query: 144 WQSFDH 149
W + H
Sbjct: 102 WATGTH 107
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 62.3 bits (151), Expect = 2e-12
Identities = 17/88 (19%), Positives = 30/88 (34%), Gaps = 6/88 (6%)
Query: 62 IWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGN 121
I + + + + + +S ++ NLVL + + VW +N + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDV---RVWASNTA--GATG 57
Query: 122 TVAQLLDTGNLVLVRNDTGETLWQSFDH 149
A L G LV+ W S
Sbjct: 58 CRAVLQSDGLLVI-LTAQNTIRWSSGTK 84
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.7 bits (126), Expect = 4e-09
Identities = 24/135 (17%), Positives = 42/135 (31%), Gaps = 22/135 (16%)
Query: 12 LFFQFSQISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLT 71
+ F + ++ ++ I+ +Y + N V
Sbjct: 3 IIFSKQPDDNHPQILHATESLE----ILFGTHVYRFIMQTDCNLVLYDNN---------N 49
Query: 72 LLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGN 131
+W N N + G LV+ V VWQ+ AG+ V L N
Sbjct: 50 PIWATNTGGLGNGCR--AVLQPDGVLVVI--TNENVTVWQSP-VAGKAGHYVLVLQPDRN 104
Query: 132 LVLVRNDTGETLWQS 146
+V+ G+ LW +
Sbjct: 105 VVI----YGDALWAT 115
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 695 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.98 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.95 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.95 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.95 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.95 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.95 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.95 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.94 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.94 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.94 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.93 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.93 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.93 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.93 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.93 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.92 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.92 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.84 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.83 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.82 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.82 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.66 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.56 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.55 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.41 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.06 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.88 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.84 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.8 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.23 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.85 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.28 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.83 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.81 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 86.72 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 83.76 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 83.42 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.04 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 81.2 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.34 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1e-32 Score=282.24 Aligned_cols=162 Identities=30% Similarity=0.405 Sum_probs=139.8
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|++.++||+|+||+||+|+. .+++.||||++.... ....+++.+|++++++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5688889999999999999986 468999999986543 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
+++|+|.+++.. ...+++.....|+.||++||.|||+++ ||||||||+||||++++.+||+|||+|+.+..+..
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999998843 335899999999999999999999987 99999999999999999999999999999876554
Q ss_pred eeccccccCC
Q 005471 686 LAITKRVVGT 695 (695)
Q Consensus 686 ~~~~~~~~GT 695 (695)
....+..+||
T Consensus 159 ~~~~~~~~GT 168 (271)
T d1nvra_ 159 ERLLNKMCGT 168 (271)
T ss_dssp ECCBCCCCSC
T ss_pred cccccceeeC
Confidence 4445556776
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-32 Score=280.78 Aligned_cols=153 Identities=32% Similarity=0.524 Sum_probs=135.2
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|++.++||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++|||||+++|++. .+..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 467778999999999999999988899999999764 345678999999999999999999999875 456799999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcce
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 686 (695)
+|+|.+++.... ...++|..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999998875433 234899999999999999999999987 999999999999999999999999999998765443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-32 Score=278.99 Aligned_cols=151 Identities=30% Similarity=0.538 Sum_probs=130.8
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|+..++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467788999999999999999988899999999764 4456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
+|+|.+++... ...++|..++.|+.|||+||.|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999998653 345899999999999999999999987 9999999999999999999999999999886544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=7.1e-33 Score=286.10 Aligned_cols=155 Identities=30% Similarity=0.503 Sum_probs=138.4
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|.+.++||+|+||+||+|+.. +++.||||+++.. ....++|.+|+.+|++++|||||+++++|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 456777899999999999999875 5889999999764 44567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
+++|+|.+++.... ...+++..+..|+.||++||.|||+++ ||||||||+||||++++.+||+|||+|+.+..+..
T Consensus 95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999986543 345899999999999999999999987 99999999999999999999999999998866544
Q ss_pred e
Q 005471 686 L 686 (695)
Q Consensus 686 ~ 686 (695)
.
T Consensus 171 ~ 171 (287)
T d1opja_ 171 T 171 (287)
T ss_dssp E
T ss_pred e
Confidence 3
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.9e-32 Score=278.75 Aligned_cols=161 Identities=32% Similarity=0.491 Sum_probs=131.9
Q ss_pred cCCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++|.+.++||+|+||+||+|+.. ..||||+++.. .....++|++|+.+|++++|||||++++++. .+..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467888999999999999999875 46999998654 3455678999999999999999999999875 456899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
|+++|+|.+++.... ..+++..++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999996543 34899999999999999999999987 9999999999999999999999999999886554
Q ss_pred ceeccccccCC
Q 005471 685 ILAITKRVVGT 695 (695)
Q Consensus 685 ~~~~~~~~~GT 695 (695)
.....+++.||
T Consensus 159 ~~~~~~~~~gt 169 (276)
T d1uwha_ 159 GSHQFEQLSGS 169 (276)
T ss_dssp -------CCCC
T ss_pred CcccccccccC
Confidence 44444555665
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=276.75 Aligned_cols=159 Identities=27% Similarity=0.450 Sum_probs=140.5
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|...++||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4789999999999999999986 568999999987655556778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcce
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 686 (695)
++|+|.+++.. ..+++.....|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+..+...
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999988753 24889999999999999999999987 999999999999999999999999999988654432
Q ss_pred eccccccCC
Q 005471 687 AITKRVVGT 695 (695)
Q Consensus 687 ~~~~~~~GT 695 (695)
....+||
T Consensus 173 --~~~~~gt 179 (293)
T d1yhwa1 173 --RSTMVGT 179 (293)
T ss_dssp --BCCCCSC
T ss_pred --ccccccC
Confidence 2234565
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.6e-32 Score=278.23 Aligned_cols=151 Identities=29% Similarity=0.427 Sum_probs=137.1
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+.|++.++||+|+||+||+|+. .+++.||||++........+.+.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4577889999999999999986 468899999998766667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
++|+|.+++.+.. ..+++..+..|+.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999999876532 34899999999999999999999987 999999999999999999999999999877543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.7e-31 Score=268.69 Aligned_cols=152 Identities=26% Similarity=0.467 Sum_probs=138.0
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|+..++||+|+||+||+|+.+++++||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 578899999999999999999988889999999764 4456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
+|+|..++.... ..+++..+.+|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+.....
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999876543 34789999999999999999999987 99999999999999999999999999998765443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=1.2e-31 Score=278.50 Aligned_cols=153 Identities=29% Similarity=0.499 Sum_probs=125.3
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-C---cEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-G---QEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g---~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|++.++||+|+||+||+|+... + ..||||++... .....++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 356677899999999999998742 2 36899998654 334456899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++|+|.+++.... ..++|..++.|+.|||+||.|||+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999886533 34899999999999999999999987 99999999999999999999999999998865
Q ss_pred Ccc
Q 005471 683 EEI 685 (695)
Q Consensus 683 ~~~ 685 (695)
+..
T Consensus 181 ~~~ 183 (299)
T d1jpaa_ 181 DTS 183 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=274.98 Aligned_cols=162 Identities=30% Similarity=0.406 Sum_probs=136.5
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|++.+.||+|+||+||+|+. .+++.||||++.+. .....+.+.+|++++++++|||||++++++.+++..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4588889999999999999986 46899999998643 2334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.+++... ..+++.....++.|++.||.|||+.+ ||||||||+||||++++.+||+|||+|+.+..+
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988643 34899999999999999999999987 999999999999999999999999999998765
Q ss_pred cceeccccccCC
Q 005471 684 EILAITKRVVGT 695 (695)
Q Consensus 684 ~~~~~~~~~~GT 695 (695)
.........+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 544444556676
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.7e-31 Score=267.99 Aligned_cols=151 Identities=26% Similarity=0.409 Sum_probs=134.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46788899999999999999874 6889999998643 2334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.+++... ..+++.....|+.||++||.|||+++ ||||||||+||||++++.+||+|||+|+....+
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999998643 34899999999999999999999987 999999999999999999999999999877654
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 160 ~ 160 (263)
T d2j4za1 160 R 160 (263)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.7e-32 Score=282.32 Aligned_cols=159 Identities=24% Similarity=0.366 Sum_probs=137.2
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++|||||+++++|.+.++.+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46788899999999999999986 468999999987542 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+++|+|.+++.+.. .+++..+..++.||++||.|||+. + |+||||||+||||++++.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999996542 489999999999999999999974 5 999999999999999999999999999977543
Q ss_pred cceeccccccCC
Q 005471 684 EILAITKRVVGT 695 (695)
Q Consensus 684 ~~~~~~~~~~GT 695 (695)
. .+..+||
T Consensus 159 ~----~~~~~GT 166 (322)
T d1s9ja_ 159 M----ANSFVGT 166 (322)
T ss_dssp T----C---CCS
T ss_pred c----cccccCC
Confidence 2 2335665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-30 Score=268.45 Aligned_cols=151 Identities=27% Similarity=0.543 Sum_probs=130.0
Q ss_pred CCCccc-eeeeeCceeEEEEEcC---CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 529 NFSTSN-KLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 529 ~f~~~~-~LG~G~fG~Vy~g~~~---~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
+|...+ +||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|++.. +..+|||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 444555 4999999999999764 35589999997643 3446789999999999999999999999864 5689999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.+++... ...+++..+..|+.||++||.|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 88 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 999999999988543 235899999999999999999999987 999999999999999999999999999998765
Q ss_pred cc
Q 005471 684 EI 685 (695)
Q Consensus 684 ~~ 685 (695)
..
T Consensus 163 ~~ 164 (285)
T d1u59a_ 163 DS 164 (285)
T ss_dssp SC
T ss_pred cc
Confidence 43
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5e-31 Score=271.52 Aligned_cols=152 Identities=32% Similarity=0.521 Sum_probs=131.2
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 607 (695)
++|++.+.||+|+||+||+|+++++++||||+++.. ....++|.+|+.++++++|||||+++|+|. .++.++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 467888999999999999999988889999999754 445678999999999999999999999985 567899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
+|+|..++.... ...++|..++.|+.||+.||.|||+.+ |+||||||+||||++++.+||+|||+|+.+.....
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999998886543 235899999999999999999999987 99999999999999999999999999998865443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=2.3e-30 Score=274.34 Aligned_cols=153 Identities=25% Similarity=0.441 Sum_probs=137.4
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|.+.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4788899999999999999986 468999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCceEEEeeccceeecCCc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--EKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~ 684 (695)
++|+|.+++.... ..+++.....|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999985432 34899999999999999999999987 99999999999996 46889999999999987654
Q ss_pred c
Q 005471 685 I 685 (695)
Q Consensus 685 ~ 685 (695)
.
T Consensus 181 ~ 181 (350)
T d1koaa2 181 S 181 (350)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.8e-31 Score=270.36 Aligned_cols=166 Identities=27% Similarity=0.440 Sum_probs=127.0
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEe--CCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV 602 (695)
++|++.+.||+|+||+||+|+. .+|+.||||.+.... ....+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 4688889999999999999986 568999999987643 3345678999999999999999999999975 3457999
Q ss_pred EEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 603 YEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDS--RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
|||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ ..+||||||||+||||++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 2346899999999999999999999864 23599999999999999999999999999998
Q ss_pred ecCCcceeccccccCC
Q 005471 680 FGGEEILAITKRVVGT 695 (695)
Q Consensus 680 ~~~~~~~~~~~~~~GT 695 (695)
+..+... .+...||
T Consensus 164 ~~~~~~~--~~~~~gt 177 (269)
T d2java1 164 LNHDTSF--AKAFVGT 177 (269)
T ss_dssp C-------------CC
T ss_pred cccCCCc--cccCCCC
Confidence 8654432 2334554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-30 Score=274.54 Aligned_cols=166 Identities=27% Similarity=0.425 Sum_probs=136.2
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC------CcEEEEEEcccC-CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCe
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDE 598 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 598 (695)
.++|++.++||+|+||+||+|+... ...||||++... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4578888999999999999998642 236999998654 334456789999999998 89999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005471 599 NMLIYEFMPNKSLDYFIFDESR--------------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp 658 (695)
.+|||||+++|+|.++|..... ...+++..++.|+.||++||.|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965421 235899999999999999999999987 99999999
Q ss_pred CCEEEcCCCceEEEeeccceeecCCcceeccccccCC
Q 005471 659 SNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 659 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 695 (695)
+|||++.++.+||+|||+|+...............||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 9999999999999999999987665544333333443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.7e-31 Score=269.60 Aligned_cols=152 Identities=30% Similarity=0.514 Sum_probs=127.4
Q ss_pred CCCCccceeeeeCceeEEEEEcCCC-----cEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNG-----QEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g-----~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
+.|+..++||+|+||+||+|.++.. ..||||++.... ....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4567779999999999999987542 379999987543 3345578999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+.++++.+++.... ..++|..+..|+.||+.||.|||+.+ ||||||||+||||++++.+||+|||+|+.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999998876543 35899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 162 ~~~ 164 (283)
T d1mqba_ 162 DDP 164 (283)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=3.1e-30 Score=273.50 Aligned_cols=153 Identities=27% Similarity=0.398 Sum_probs=137.0
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
++|++.++||+|+||+||+|+. .+|+.||||++........+.+++|+++|++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688889999999999999986 579999999998765556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCceEEEeeccceeecCCc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--EKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~ 684 (695)
++|+|.+++... ...+++.....|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|+.+..+.
T Consensus 109 ~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999998877543 234899999999999999999999987 99999999999998 67899999999999987654
Q ss_pred c
Q 005471 685 I 685 (695)
Q Consensus 685 ~ 685 (695)
.
T Consensus 184 ~ 184 (352)
T d1koba_ 184 I 184 (352)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4e-30 Score=263.88 Aligned_cols=146 Identities=28% Similarity=0.490 Sum_probs=125.8
Q ss_pred ceeeeeCceeEEEEEcCC---CcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcCCC
Q 005471 534 NKLGQGGFGPVYKGKLSN---GQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~---g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 608 (695)
++||+|+||+||+|.+.+ ++.||||+++... ....++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 4689999986532 2335689999999999999999999999864 567899999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcce
Q 005471 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 686 (695)
|+|.+++... ..+++..++.|+.||++||.|||+++ ||||||||+||||+.++.+||+|||+|+.+......
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999998643 34899999999999999999999987 999999999999999999999999999988655433
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1.1e-30 Score=271.76 Aligned_cols=160 Identities=28% Similarity=0.471 Sum_probs=138.3
Q ss_pred HHhcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeC
Q 005471 524 LAATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596 (695)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 596 (695)
+...++|++.+.||+|+||+||+|+.. +++.||||++..... ...++|.+|+++|++++||||++++++|...
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 345678999999999999999999853 457899999976433 3356799999999999999999999999999
Q ss_pred CeeEEEEEcCCCCCHHHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 005471 597 DENMLIYEFMPNKSLDYFIFDES---------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRD 655 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 655 (695)
+..++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+++ |||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence 99999999999999999986422 1234899999999999999999999987 99999
Q ss_pred CCCCCEEEcCCCceEEEeeccceeecCCcce
Q 005471 656 LKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (695)
Q Consensus 656 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 686 (695)
|||+||||+.++.+||+|||+|+.+......
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~ 196 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYY 196 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB
T ss_pred EcccceEECCCCcEEEccchhheeccCCccc
Confidence 9999999999999999999999987654433
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.6e-30 Score=262.29 Aligned_cols=149 Identities=26% Similarity=0.389 Sum_probs=127.3
Q ss_pred CccceeeeeCceeEEEEEcC-CCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEe----CCeeEEEE
Q 005471 531 STSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENMLIY 603 (695)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 603 (695)
+..++||+|+||+||+|+.. +++.||||++... .....+.|.+|+++|++++|||||++++++.. ....+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34468999999999999864 6889999998653 23345678999999999999999999999876 34578999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~ 682 (695)
||+++|+|.+++... ..+++..+..++.||++||.|||+++ .+||||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999998643 34899999999999999999999874 4599999999999996 578999999999987654
Q ss_pred C
Q 005471 683 E 683 (695)
Q Consensus 683 ~ 683 (695)
.
T Consensus 168 ~ 168 (270)
T d1t4ha_ 168 S 168 (270)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=3.6e-30 Score=268.16 Aligned_cols=148 Identities=31% Similarity=0.544 Sum_probs=131.7
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
.|+.+++||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++|++++|||||++++++.+++..+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 477889999999999999985 5688999999875432 334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|+++|+|..++... ..+++..+..|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999997766433 35899999999999999999999987 99999999999999999999999999997654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.2e-30 Score=270.67 Aligned_cols=160 Identities=23% Similarity=0.317 Sum_probs=138.8
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|++++.||+|+||.||+|+. .+++.||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688899999999999999986 57899999998753 2334677889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|.+++... ..+++.....++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998653 34788888999999999999999987 999999999999999999999999999977543
Q ss_pred cceeccccccCC
Q 005471 684 EILAITKRVVGT 695 (695)
Q Consensus 684 ~~~~~~~~~~GT 695 (695)
... ....+||
T Consensus 159 ~~~--~~~~~GT 168 (337)
T d1o6la_ 159 GAT--MKTFCGT 168 (337)
T ss_dssp TCC--BCCCEEC
T ss_pred Ccc--cccceeC
Confidence 332 2335565
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=9.4e-30 Score=260.95 Aligned_cols=151 Identities=28% Similarity=0.397 Sum_probs=134.6
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcc---------cHHHHHHHHHHHHcCC-CCceeeeEeEEEeC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQ---------GIEELKNEVLLIAKLQ-HRNLVKLLGCCLEE 596 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~---------~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~ 596 (695)
++|++.+.||+|+||+||+|+. .+++.||||++.+.... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999986 57899999998654211 1235788999999997 99999999999999
Q ss_pred CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
+..+|||||+++|+|.++|... ..+++.....++.||++||+|||+++ |+||||||+||||++++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999653 24899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCc
Q 005471 677 ARVFGGEE 684 (695)
Q Consensus 677 a~~~~~~~ 684 (695)
|+.+....
T Consensus 157 a~~~~~~~ 164 (277)
T d1phka_ 157 SCQLDPGE 164 (277)
T ss_dssp CEECCTTC
T ss_pred eeEccCCC
Confidence 99886543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=8.8e-30 Score=266.20 Aligned_cols=150 Identities=25% Similarity=0.381 Sum_probs=133.7
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|++.++||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688889999999999999986 56899999998643 2344678899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+++|+|..++.... .+++.....++.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999998886433 3678888889999999999999987 999999999999999999999999999987543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-29 Score=260.87 Aligned_cols=151 Identities=30% Similarity=0.446 Sum_probs=134.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC------cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS------GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|++.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688889999999999999986 568999999986432 223678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----ceEEEeecc
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFGT 676 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 676 (695)
|||||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999998653 24899999999999999999999987 99999999999998776 499999999
Q ss_pred ceeecCCc
Q 005471 677 ARVFGGEE 684 (695)
Q Consensus 677 a~~~~~~~ 684 (695)
|+.+....
T Consensus 164 a~~~~~~~ 171 (293)
T d1jksa_ 164 AHKIDFGN 171 (293)
T ss_dssp CEECTTSC
T ss_pred hhhcCCCc
Confidence 99886543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=5e-30 Score=266.96 Aligned_cols=151 Identities=25% Similarity=0.363 Sum_probs=121.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
+.|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 46888899999999999999864 68999999987543 23345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~~~ 682 (695)
+++|+|.+++... ..+++.....++.||+.||.|||+++ ||||||||+|||+. +++.+||+|||+|+....
T Consensus 89 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999643 35899999999999999999999987 99999999999995 578999999999998765
Q ss_pred Cc
Q 005471 683 EE 684 (695)
Q Consensus 683 ~~ 684 (695)
..
T Consensus 163 ~~ 164 (307)
T d1a06a_ 163 GS 164 (307)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-29 Score=265.27 Aligned_cols=162 Identities=30% Similarity=0.516 Sum_probs=131.0
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCc----EEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
++|++.++||+|+||+||+|+.. +|+ +||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888899999999999999864 343 6899988653 345577899999999999999999999999864 5678
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
++||+.+|+|.+++... ...+++..++.|+.|||+||.|||+++ ||||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999887654 335899999999999999999999987 9999999999999999999999999999987
Q ss_pred CCcceeccccccCC
Q 005471 682 GEEILAITKRVVGT 695 (695)
Q Consensus 682 ~~~~~~~~~~~~GT 695 (695)
.++....+....||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 66555444444554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.7e-30 Score=267.02 Aligned_cols=166 Identities=25% Similarity=0.400 Sum_probs=139.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
.++|.+.++||+|+||+||+|++. +++.||||+++... ......|.+|+.++++++|||||+++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 356778899999999999999863 35789999997543 33445789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEE
Q 005471 600 MLIYEFMPNKSLDYFIFDES-------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 672 (695)
++||||+++|+|.+++.... ....+++..+..|+.|+|+||.|||++. |+||||||+||||++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999886431 2234789999999999999999999986 9999999999999999999999
Q ss_pred eeccceeecCCcceeccccccCC
Q 005471 673 DFGTARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 673 DFGla~~~~~~~~~~~~~~~~GT 695 (695)
|||+|+.+..........+..||
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t 198 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLP 198 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEEC
T ss_pred ecccceeccCCcceeeccceecc
Confidence 99999988665544434433443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.1e-29 Score=261.03 Aligned_cols=152 Identities=21% Similarity=0.349 Sum_probs=134.3
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
.++|.+.+.||+|+||+||+|+.. +++.||||.++.. ......+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367889999999999999999864 6889999999764 33445688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--KMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 683 (695)
+++|+|.+++.... ..+++.....|+.||++||.|||+++ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999985432 24899999999999999999999987 999999999999984 458999999999988654
Q ss_pred c
Q 005471 684 E 684 (695)
Q Consensus 684 ~ 684 (695)
.
T Consensus 158 ~ 158 (321)
T d1tkia_ 158 D 158 (321)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.5e-30 Score=264.67 Aligned_cols=168 Identities=29% Similarity=0.408 Sum_probs=130.3
Q ss_pred HhcCCCCccceeeeeCceeEEEEEcC------CCcEEEEEEcccCC-cccHHHHHHHHHHHHcC-CCCceeeeEeEEEeC
Q 005471 525 AATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE 596 (695)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 596 (695)
...++|++.++||+|+||.||+|+.. +++.||||+++... ....+++.+|+.++.++ +|+|||++++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 34467888999999999999999853 35689999997543 33456778888888877 799999999998775
Q ss_pred C-eeEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 005471 597 D-ENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 662 (695)
Q Consensus 597 ~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 662 (695)
+ ..++||||+++|+|.+++..... ...+++..+..++.||++||.|||+++ ||||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 5 57999999999999999965321 235899999999999999999999987 999999999999
Q ss_pred EcCCCceEEEeeccceeecCCcceeccccccCC
Q 005471 663 LDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 663 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 695 (695)
|++++.+||+|||+|+.+...........+.||
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeC
Confidence 999999999999999988665554444455665
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=6e-29 Score=263.47 Aligned_cols=150 Identities=26% Similarity=0.323 Sum_probs=134.6
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 603 (695)
++|+++++||+|+||.||+|+. .+|+.||||++.+. .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4688889999999999999986 46899999998643 2234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
||+.+|+|..++.... .+++.....|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999986542 4899999999999999999999987 999999999999999999999999999988643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=6.4e-29 Score=264.64 Aligned_cols=152 Identities=28% Similarity=0.356 Sum_probs=130.8
Q ss_pred cCCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC---cccHHHHH---HHHHHHHcCCCCceeeeEeEEEeCCee
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELK---NEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~---~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 599 (695)
.++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+. .|+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367889999999999999999864 68999999986421 12223333 457778888999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
+|||||+++|+|.++|... ..+++.....++.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998653 34788999999999999999999987 99999999999999999999999999998
Q ss_pred ecCCc
Q 005471 680 FGGEE 684 (695)
Q Consensus 680 ~~~~~ 684 (695)
+....
T Consensus 157 ~~~~~ 161 (364)
T d1omwa3 157 FSKKK 161 (364)
T ss_dssp CSSSC
T ss_pred cCCCc
Confidence 86554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.3e-29 Score=256.48 Aligned_cols=153 Identities=29% Similarity=0.437 Sum_probs=124.2
Q ss_pred CCCCccceeeeeCceeEEEEEcC--CC--cEEEEEEcccC---CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS--NG--QEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~g--~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 600 (695)
++|++.+.||+|+||+||+|++. ++ .+||||++.+. .....++|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45778899999999999999863 22 37899988653 23345689999999999999999999999965 5678
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+||||+++|++.+++.... ..+++..++.++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999998876543 34899999999999999999999987 999999999999999999999999999998
Q ss_pred cCCcce
Q 005471 681 GGEEIL 686 (695)
Q Consensus 681 ~~~~~~ 686 (695)
......
T Consensus 162 ~~~~~~ 167 (273)
T d1u46a_ 162 PQNDDH 167 (273)
T ss_dssp CC-CCE
T ss_pred ccCCCc
Confidence 665443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.2e-29 Score=255.91 Aligned_cols=152 Identities=24% Similarity=0.397 Sum_probs=123.2
Q ss_pred cCCCCccceeeeeCceeEEEEEcCC----CcEEEEEEcccCCc-ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 601 (695)
.++|++.+.||+|+||.||+|+... +..||||.++.... ...+.|.+|++++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3568888999999999999998642 35799999875433 34567999999999999999999999985 567899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeec
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 681 (695)
||||+++|+|.+++... ...+++..++.++.||++||.|||+++ ||||||||+|||+++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999987543 335899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCc
Q 005471 682 GEE 684 (695)
Q Consensus 682 ~~~ 684 (695)
...
T Consensus 160 ~~~ 162 (273)
T d1mp8a_ 160 DST 162 (273)
T ss_dssp ---
T ss_pred CCc
Confidence 543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.2e-29 Score=258.52 Aligned_cols=151 Identities=28% Similarity=0.506 Sum_probs=129.3
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999986 578999999986532 2345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
|+.++.+. ++... ....+++.....++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+....+
T Consensus 82 ~~~~~~~~-~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKK-FMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHH-HHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhh-hhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 99765444 44322 2335899999999999999999999987 999999999999999999999999999987543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.6e-28 Score=256.10 Aligned_cols=147 Identities=31% Similarity=0.549 Sum_probs=127.9
Q ss_pred ceeeeeCceeEEEEEcCCC----cEEEEEEcccC-CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC-CeeEEEEEcCC
Q 005471 534 NKLGQGGFGPVYKGKLSNG----QEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-DENMLIYEFMP 607 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g----~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~~ 607 (695)
++||+|+||+||+|++.+. ..||||+++.. .....++|.+|+++|++++|||||+++|++.+. +..++||||++
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 7899999999999987532 36899999753 344567899999999999999999999998864 57899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCcc
Q 005471 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (695)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 685 (695)
+|+|.+++.... ..+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.+.....
T Consensus 113 ~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 113 HGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred cCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999886543 34788899999999999999999987 99999999999999999999999999998765443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.5e-29 Score=259.88 Aligned_cols=165 Identities=28% Similarity=0.432 Sum_probs=139.9
Q ss_pred CCCCccceeeeeCceeEEEEEc------CCCcEEEEEEcccCCc-ccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCee
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 599 (695)
++|++.++||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5677789999999999999975 3467899999976433 3456789999999999 699999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005471 600 MLIYEFMPNKSLDYFIFDES---------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (695)
Q Consensus 600 ~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 664 (695)
+|||||+++|+|.+++.... ....+++..+..++.||++||.|||+++ ||||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999986532 1235899999999999999999999987 99999999999999
Q ss_pred CCCceEEEeeccceeecCCcceeccccccCC
Q 005471 665 EKMNPRISDFGTARVFGGEEILAITKRVVGT 695 (695)
Q Consensus 665 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 695 (695)
.++.+||+|||+++.+.............||
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred ccCcccccccchheeccCCCcceEeeecccC
Confidence 9999999999999988765544444444444
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=9.5e-29 Score=257.01 Aligned_cols=151 Identities=25% Similarity=0.384 Sum_probs=125.4
Q ss_pred CCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC----eeEEEEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----ENMLIYE 604 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E 604 (695)
+|.+.+.||+|+||.||+|++ +|+.||||+++... ......+.|+..+.+++|||||+++++|.+.+ ..++|||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 355668999999999999997 57899999986532 11222334555666789999999999998765 5789999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-----SRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
||++|+|.++|... .++|..++.++.|+|.||.|||+. ...+||||||||+||||++++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999643 489999999999999999999974 234699999999999999999999999999999
Q ss_pred ecCCcc
Q 005471 680 FGGEEI 685 (695)
Q Consensus 680 ~~~~~~ 685 (695)
+.....
T Consensus 158 ~~~~~~ 163 (303)
T d1vjya_ 158 HDSATD 163 (303)
T ss_dssp EETTTT
T ss_pred ccCCCc
Confidence 865443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8.2e-29 Score=258.32 Aligned_cols=152 Identities=32% Similarity=0.539 Sum_probs=130.6
Q ss_pred CCCCccceeeeeCceeEEEEEcCC-Cc--EEEEEEcccC-CcccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQ--EIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~--~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|++.++||+|+||+||+|++.+ +. .||||++... .....++|.+|+++|.++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 467778999999999999998754 33 5788988643 334556899999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCce
Q 005471 603 YEFMPNKSLDYFIFDE-------------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 669 (695)
|||+++|+|.++|+.. .....+++..+++++.|||+||.|||+.+ ||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999653 22356899999999999999999999987 9999999999999999999
Q ss_pred EEEeeccceeecC
Q 005471 670 RISDFGTARVFGG 682 (695)
Q Consensus 670 kl~DFGla~~~~~ 682 (695)
||+|||+|+....
T Consensus 167 kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 167 KIADFGLSRGQEV 179 (309)
T ss_dssp EECCTTCEESSCE
T ss_pred EEccccccccccc
Confidence 9999999987643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4e-29 Score=254.12 Aligned_cols=150 Identities=27% Similarity=0.495 Sum_probs=125.5
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC-CeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-DENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~ 606 (695)
++|++.++||+|+||.||+|+++ |++||||++++. ...++|.+|++++++++|||||+++|+|.+. +..+|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45677799999999999999985 789999999753 3457899999999999999999999999664 5689999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
++|+|.++|.... ...++|..++.|+.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999996532 235899999999999999999999986 9999999999999999999999999999875443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=1e-28 Score=254.84 Aligned_cols=150 Identities=26% Similarity=0.470 Sum_probs=133.8
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|.+.++||+|+||+||+|+.++++.||||++.... ....+.+.+|+.+|++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999999999999999986543 23357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 683 (695)
+.++.+..+... ...+++.....|+.||++||+|||+.+ ||||||||+||||+.++.+||+|||+|..+...
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 988777666533 345899999999999999999999987 999999999999999999999999999987644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2e-28 Score=256.25 Aligned_cols=160 Identities=26% Similarity=0.387 Sum_probs=135.6
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccC---CcccHHHHHHHHHHHH-cCCCCceeeeEeEEEeCCeeEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIA-KLQHRNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV 602 (695)
++|.+.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|+.++. .++|||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999874 6899999998653 1234556677777765 68999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecC
Q 005471 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (695)
Q Consensus 603 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 682 (695)
|||+++|+|.+++.... .+++.....++.||+.||.|||+++ ||||||||+|||+++++.+||+|||+|+.+..
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999986533 3788899999999999999999987 99999999999999999999999999997765
Q ss_pred CcceeccccccCC
Q 005471 683 EEILAITKRVVGT 695 (695)
Q Consensus 683 ~~~~~~~~~~~GT 695 (695)
.... .+...||
T Consensus 156 ~~~~--~~~~~gt 166 (320)
T d1xjda_ 156 GDAK--TNTFCGT 166 (320)
T ss_dssp TTCC--BCCCCSC
T ss_pred cccc--ccccCCC
Confidence 4332 2334565
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.3e-28 Score=255.55 Aligned_cols=146 Identities=30% Similarity=0.444 Sum_probs=124.2
Q ss_pred cceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcc-----cHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEEcC
Q 005471 533 SNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-----GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999974 6899999998654221 1346889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
+++++..++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9887766553 2334788888999999999999999987 9999999999999999999999999999876544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.95 E-value=3.4e-28 Score=249.63 Aligned_cols=151 Identities=24% Similarity=0.384 Sum_probs=131.8
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc---ccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCe----
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE---- 598 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~---- 598 (695)
.++|.+.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|++++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35788899999999999999985 5789999999975432 334578999999999999999999999987653
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.+|||||+++++|.+++... ..+++.....|+.||++||.|||+++ ||||||||+||||+.++..||+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999888543 24899999999999999999999987 9999999999999999999999999998
Q ss_pred eecCC
Q 005471 679 VFGGE 683 (695)
Q Consensus 679 ~~~~~ 683 (695)
.....
T Consensus 160 ~~~~~ 164 (277)
T d1o6ya_ 160 AIADS 164 (277)
T ss_dssp ECC--
T ss_pred hhccc
Confidence 77543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.5e-28 Score=255.11 Aligned_cols=164 Identities=27% Similarity=0.440 Sum_probs=133.7
Q ss_pred CCCCccceeeeeCceeEEEEEcC--------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHcC-CCCceeeeEeEEEeCC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 597 (695)
++|.+.++||+|+||.||+|+.. ++..||||+++.... ....++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 46777899999999999999753 234799999976533 4457888999999888 8999999999999999
Q ss_pred eeEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 664 (695)
..++||||+++|+|.++|..... ...+++..++.++.||+.||.|||+++ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999965431 235899999999999999999999987 99999999999999
Q ss_pred CCCceEEEeeccceeecCCcceeccccccC
Q 005471 665 EKMNPRISDFGTARVFGGEEILAITKRVVG 694 (695)
Q Consensus 665 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 694 (695)
.++.+||+|||+++.+.............|
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred CCCCeEeccchhhccccccccccccccCCC
Confidence 999999999999998876554443333444
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8.6e-28 Score=253.03 Aligned_cols=148 Identities=24% Similarity=0.329 Sum_probs=126.3
Q ss_pred CCCCccc-eeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcC-CCCceeeeEeEEEe----CCeeE
Q 005471 528 DNFSTSN-KLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE----EDENM 600 (695)
Q Consensus 528 ~~f~~~~-~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~ 600 (695)
++|.+.. .||+|+||+||+|+. .+++.||||+++. .+.+++|++++.++ +|||||++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4677664 599999999999986 5789999999864 24677899987655 89999999999876 35689
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCceEEEeeccc
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTA 677 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla 677 (695)
||||||++|+|.++|.... ...+++.....|+.||+.||.|||+.+ |+||||||+|||+++ ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 9999999999999996532 235899999999999999999999987 999999999999985 567999999999
Q ss_pred eeecCCc
Q 005471 678 RVFGGEE 684 (695)
Q Consensus 678 ~~~~~~~ 684 (695)
+.+....
T Consensus 162 ~~~~~~~ 168 (335)
T d2ozaa1 162 KETTSHN 168 (335)
T ss_dssp EECCCCC
T ss_pred eeccCCC
Confidence 9886544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.2e-27 Score=245.00 Aligned_cols=150 Identities=26% Similarity=0.400 Sum_probs=128.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCc------ccHHHHHHHHHHHHcCC--CCceeeeEeEEEeCCe
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEEDE 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~ 598 (695)
++|.+.++||+|+||+||+|+. .+++.||||++.+... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788899999999999999986 5789999999865321 12234678999999986 9999999999999999
Q ss_pred eEEEEEcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCceEEEeecc
Q 005471 599 NMLIYEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGT 676 (695)
Q Consensus 599 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGl 676 (695)
.++||||+.+ +++.+++... ..+++.....++.||++||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 6777777543 34899999999999999999999987 999999999999985 57999999999
Q ss_pred ceeecCC
Q 005471 677 ARVFGGE 683 (695)
Q Consensus 677 a~~~~~~ 683 (695)
|+.....
T Consensus 158 a~~~~~~ 164 (273)
T d1xwsa_ 158 GALLKDT 164 (273)
T ss_dssp CEECCSS
T ss_pred ceecccc
Confidence 9987544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.2e-27 Score=250.63 Aligned_cols=149 Identities=27% Similarity=0.423 Sum_probs=123.1
Q ss_pred CCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------eeEE
Q 005471 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ENML 601 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~l 601 (695)
+|+..++||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++|||||++++++.... +.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3666789999999999999974 689999999875432 2347999999999999999999996532 4689
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-ceEEEeeccceee
Q 005471 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVF 680 (695)
Q Consensus 602 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 680 (695)
||||++++.+..+.........+++..+..++.||++||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755544433333446899999999999999999999987 99999999999999764 8999999999988
Q ss_pred cCCc
Q 005471 681 GGEE 684 (695)
Q Consensus 681 ~~~~ 684 (695)
...+
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 6544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.7e-27 Score=241.08 Aligned_cols=151 Identities=26% Similarity=0.465 Sum_probs=134.2
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCCeeEEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 604 (695)
++|+++++||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.+++.++|||||++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788999999999999999986 578899999986542 2346788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceeecCCc
Q 005471 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (695)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 684 (695)
++.+++|..++... ..+++..+..++.|+++||+|||+++ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999988877432 34788999999999999999999987 9999999999999999999999999999876543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.1e-27 Score=249.25 Aligned_cols=152 Identities=22% Similarity=0.391 Sum_probs=127.8
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC-cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC----eeE
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----ENM 600 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 600 (695)
+++|.++++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35788999999999999999975 579999999997643 234567889999999999999999999997654 235
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 601 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+++||+.+|+|.+++... .+++.....++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666777899999998542 4899999999999999999999987 999999999999999999999999999987
Q ss_pred cCCcc
Q 005471 681 GGEEI 685 (695)
Q Consensus 681 ~~~~~ 685 (695)
.....
T Consensus 160 ~~~~~ 164 (345)
T d1pmea_ 160 DPDHD 164 (345)
T ss_dssp CGGGC
T ss_pred cCCCc
Confidence 65443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.94 E-value=1.2e-26 Score=243.97 Aligned_cols=145 Identities=23% Similarity=0.425 Sum_probs=126.5
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeC--CeeEEEE
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEE--DENMLIY 603 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~ 603 (695)
++|+++++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788999999999999999986 56899999998753 3567889999999995 99999999999854 4589999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CceEEEeeccceeecC
Q 005471 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVFGG 682 (695)
Q Consensus 604 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 682 (695)
||+++++|..+. ..+++.....++.||+.||.|||+++ ||||||||+||||+.+ ..+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999986653 24889999999999999999999987 9999999999999865 4699999999998865
Q ss_pred Cc
Q 005471 683 EE 684 (695)
Q Consensus 683 ~~ 684 (695)
.+
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 44
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.3e-26 Score=239.48 Aligned_cols=151 Identities=25% Similarity=0.467 Sum_probs=125.6
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccC--CcccHHHHHHHHHHHHcCCCCceeeeEeEEEeC--------
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-------- 596 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-------- 596 (695)
++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++.+...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788899999999999999986 57899999998643 233456788999999999999999999998663
Q ss_pred CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeecc
Q 005471 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (695)
Q Consensus 597 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 676 (695)
+..++||||++++.+..+.. ....++......|+.||++||.|||+++ |+||||||+||||++++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 45789999999887765442 2234788888899999999999999987 99999999999999999999999999
Q ss_pred ceeecCCc
Q 005471 677 ARVFGGEE 684 (695)
Q Consensus 677 a~~~~~~~ 684 (695)
|+.+....
T Consensus 164 ~~~~~~~~ 171 (318)
T d3blha1 164 ARAFSLAK 171 (318)
T ss_dssp CEECCC--
T ss_pred eeeccccc
Confidence 99876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-26 Score=243.36 Aligned_cols=153 Identities=25% Similarity=0.330 Sum_probs=132.6
Q ss_pred CCCCccceeeeeCceeEEEEEc----CCCcEEEEEEcccCC----cccHHHHHHHHHHHHcCCC-CceeeeEeEEEeCCe
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQH-RNLVKLLGCCLEEDE 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~ 598 (695)
++|++.+.||+|+||+||+|+. .+|+.||||.+++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4688889999999999999974 247899999986532 2335678899999999966 899999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.++||||+.+|+|..++.... .+.......++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986543 3567888889999999999999987 9999999999999999999999999999
Q ss_pred eecCCcce
Q 005471 679 VFGGEEIL 686 (695)
Q Consensus 679 ~~~~~~~~ 686 (695)
.+......
T Consensus 178 ~~~~~~~~ 185 (322)
T d1vzoa_ 178 EFVADETE 185 (322)
T ss_dssp ECCGGGGG
T ss_pred hhcccccc
Confidence 88655443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.5e-26 Score=243.35 Aligned_cols=149 Identities=26% Similarity=0.437 Sum_probs=123.4
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeCC------
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 597 (695)
.++|+++++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35788999999999999999986 568999999997532 233567889999999999999999999998765
Q ss_pred eeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccc
Q 005471 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (695)
Q Consensus 598 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 677 (695)
+.++||||+ +.+|..++.. ..+++.....++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 5677776643 24899999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 005471 678 RVFGGE 683 (695)
Q Consensus 678 ~~~~~~ 683 (695)
+.....
T Consensus 169 ~~~~~~ 174 (346)
T d1cm8a_ 169 RQADSE 174 (346)
T ss_dssp EECCSS
T ss_pred eccCCc
Confidence 987654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.2e-26 Score=238.08 Aligned_cols=153 Identities=25% Similarity=0.472 Sum_probs=124.0
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CC-CcEEEEEEcccCC--cccHHHHHHHHHHHHcC---CCCceeeeEeEEEeC---
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SN-GQEIAVKRLSTTS--GQGIEELKNEVLLIAKL---QHRNLVKLLGCCLEE--- 596 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~-g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~--- 596 (695)
.++|+++++||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+|+.| +|||||+++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36789999999999999999986 34 5679999986432 22233456677776655 899999999998642
Q ss_pred --CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEee
Q 005471 597 --DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (695)
Q Consensus 597 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 674 (695)
...+++|||++++.+...... ....+++.....++.||+.||+|||+++ ||||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 357899999998877655433 3345889999999999999999999987 999999999999999999999999
Q ss_pred ccceeecCCc
Q 005471 675 GTARVFGGEE 684 (695)
Q Consensus 675 Gla~~~~~~~ 684 (695)
|+++......
T Consensus 161 g~~~~~~~~~ 170 (305)
T d1blxa_ 161 GLARIYSFQM 170 (305)
T ss_dssp CSCCCCCGGG
T ss_pred hhhhhhcccc
Confidence 9999765443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.93 E-value=9.5e-26 Score=233.07 Aligned_cols=148 Identities=20% Similarity=0.312 Sum_probs=128.3
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCC-CceeeeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RNLVKLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey 605 (695)
++|++.++||+|+||+||+|+. .+++.||||.+.... ..+.+++|+++++.++| +|++.+++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 5788999999999999999986 468999999886532 23457889999999965 8999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCceEEEeeccceee
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-----KMNPRISDFGTARVF 680 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~~~ 680 (695)
+ +++|.+++.... ..+++.....++.|++.||+|||+.+ ||||||||+||||+. ++.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9 689988886543 34889999999999999999999987 999999999999974 578999999999998
Q ss_pred cCC
Q 005471 681 GGE 683 (695)
Q Consensus 681 ~~~ 683 (695)
...
T Consensus 157 ~~~ 159 (293)
T d1csna_ 157 RDP 159 (293)
T ss_dssp BCT
T ss_pred ccC
Confidence 643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=4.1e-25 Score=228.97 Aligned_cols=149 Identities=24% Similarity=0.384 Sum_probs=121.9
Q ss_pred CCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCcee-eeEeEEEeCCeeEEEEEc
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV-KLLGCCLEEDENMLIYEF 605 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey 605 (695)
++|++.++||+|+||.||+|+. .+++.||||.+.... ..+++..|++++++++|+|+| .+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5688999999999999999986 568999999886543 234688899999999877655 455556777888999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCceEEEeeccceeecC
Q 005471 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVFGG 682 (695)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~~~ 682 (695)
++ ++|...+... ...+++..+..++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 5665555433 234899999999999999999999987 99999999999986 456799999999999865
Q ss_pred Cc
Q 005471 683 EE 684 (695)
Q Consensus 683 ~~ 684 (695)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.1e-25 Score=238.62 Aligned_cols=149 Identities=28% Similarity=0.405 Sum_probs=125.7
Q ss_pred cCCCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC-----Ce
Q 005471 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-----DE 598 (695)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 598 (695)
.++|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999985 579999999997543 23455788999999999999999999998743 33
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.++++||+.+|+|.+++.. ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4677888899999999843 24899999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 005471 679 VFGG 682 (695)
Q Consensus 679 ~~~~ 682 (695)
....
T Consensus 170 ~~~~ 173 (348)
T d2gfsa1 170 HTDD 173 (348)
T ss_dssp CCTG
T ss_pred ccCc
Confidence 7643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=5.7e-25 Score=233.54 Aligned_cols=148 Identities=27% Similarity=0.407 Sum_probs=119.8
Q ss_pred CCCCccceeeeeCceeEEEEEcC-CCcEEEEEEcccCC--cccHHHHHHHHHHHHcCCCCceeeeEeEEEeC------Ce
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------DE 598 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~ 598 (695)
++|+++++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67899999999999999999864 68999999997542 33445788999999999999999999999743 57
Q ss_pred eEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEeeccce
Q 005471 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (695)
Q Consensus 599 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 678 (695)
.++||||+.++.+. .+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999766554 332 23789999999999999999999987 9999999999999999999999999999
Q ss_pred eecCCc
Q 005471 679 VFGGEE 684 (695)
Q Consensus 679 ~~~~~~ 684 (695)
......
T Consensus 168 ~~~~~~ 173 (355)
T d2b1pa1 168 TAGTSF 173 (355)
T ss_dssp ------
T ss_pred cccccc
Confidence 776543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=8.6e-22 Score=189.87 Aligned_cols=134 Identities=23% Similarity=0.249 Sum_probs=106.0
Q ss_pred ccceeeeeCceeEEEEEcCCCcEEEEEEcccCCc------------------ccHHHHHHHHHHHHcCCCCceeeeEeEE
Q 005471 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG------------------QGIEELKNEVLLIAKLQHRNLVKLLGCC 593 (695)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 593 (695)
+.++||+|+||+||+|+..+|++||||.++.... ........|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4689999999999999988999999998653210 0112345688899999999999988653
Q ss_pred EeCCeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCceEEEe
Q 005471 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (695)
Q Consensus 594 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 673 (695)
..+++|||+++..+.. ++......++.|++++|.|||+++ |+||||||+|||++++ .++|+|
T Consensus 84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 3479999998765532 223334568999999999999987 9999999999999965 589999
Q ss_pred eccceeecCC
Q 005471 674 FGTARVFGGE 683 (695)
Q Consensus 674 FGla~~~~~~ 683 (695)
||+|+....+
T Consensus 146 FG~a~~~~~~ 155 (191)
T d1zara2 146 FPQSVEVGEE 155 (191)
T ss_dssp CTTCEETTST
T ss_pred CCCcccCCCC
Confidence 9999887644
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.84 E-value=3.3e-21 Score=168.38 Aligned_cols=112 Identities=19% Similarity=0.373 Sum_probs=94.2
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeecc
Q 005471 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (695)
Q Consensus 23 ~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~ 102 (695)
+|+|.+||.|.+|++|+| |.|+|.|+.+|+ |.+++ ..++||.||++.|. ..+.|.|+.||+|+|+|.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKA--SGCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCC--CCcEEEEeccccEEEEec
Confidence 489999999999999986 999999999987 56654 35899999999884 456899999999999986
Q ss_pred CCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCC
Q 005471 103 NQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTD 152 (695)
Q Consensus 103 ~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtD 152 (695)
+. .+|++++. ...+..+|+|+|+|||||++. .+.++|||+.+|++
T Consensus 68 -~~--~~w~s~t~-~~~~~~~l~L~ddGNlvly~~-~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 -SR--AIWASNTN-RQNGNYYLILQRDRNVVIYDN-SNNAIWATHTNVGN 112 (112)
T ss_dssp -TE--EEEECCCC-CSCCCCEEEECTTSCEEEECT-TSCEEEECCCCCCC
T ss_pred -CC--eEEEEeec-cCCCceEEEEcCCCCEEEECC-CCcEEecCCCccCC
Confidence 44 67887765 234567899999999999986 56799999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.83 E-value=6.2e-21 Score=202.49 Aligned_cols=151 Identities=21% Similarity=0.291 Sum_probs=119.7
Q ss_pred CCCccceeeeeCceeEEEEEc-CCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-----------CCceeeeEeEEEeC
Q 005471 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-----------HRNLVKLLGCCLEE 596 (695)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~~~ 596 (695)
+|+++++||+|+||+||+|+. .+|+.||||++++. ....+.+.+|+.++++++ |+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488899999999999999986 57999999999764 233467788999888775 57899999998754
Q ss_pred --CeeEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC------c
Q 005471 597 --DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM------N 668 (695)
Q Consensus 597 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~------~ 668 (695)
...+++++++..+..............+++.....++.||++||.|||+.. +|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence 456777777766554333333344456788899999999999999999832 399999999999998654 4
Q ss_pred eEEEeeccceeecC
Q 005471 669 PRISDFGTARVFGG 682 (695)
Q Consensus 669 ~kl~DFGla~~~~~ 682 (695)
+||+|||.|+....
T Consensus 171 ~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 171 IKIADLGNACWYDE 184 (362)
T ss_dssp EEECCCTTCEETTB
T ss_pred eeEeeccccccccc
Confidence 99999999987654
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.82 E-value=1.5e-20 Score=162.60 Aligned_cols=107 Identities=21% Similarity=0.372 Sum_probs=91.1
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeecc
Q 005471 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (695)
Q Consensus 23 ~~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~ 102 (695)
.|+|.+||.|.+|++|. +|.|+|.|+.+|+ |.|+.. .++||.||++.| +..+.|.|+.+|+|+|+|+
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV----DKPIWATNTGGL--SRSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET----TEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC----CceeeEeCCCCC--CCccEEEEeccceEEEECC
Confidence 36899999999999996 5999999999987 677653 488999999988 3456899999999999999
Q ss_pred CCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCC
Q 005471 103 NQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDH 149 (695)
Q Consensus 103 ~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~ 149 (695)
++. ++|+|++. ......+|+|+|+|||||++. .+||||+|
T Consensus 68 ~g~--~vWsS~t~-~~~~~~~l~L~ddGNlVly~~----~~W~S~t~ 107 (108)
T d1jpca_ 68 SNK--PIWASNTG-GQNGNYVCILQKDRNVVIYGT----DRWATGTH 107 (108)
T ss_dssp TCC--EEEECCCC-CSCSCEEEEECTTSCEEEEEC----CCCCCCCC
T ss_pred Ccc--ceEEcccc-CCCCcEEEEEcCCCCEEEeCC----CcccCCCC
Confidence 998 99999875 333456789999999999964 49999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.82 E-value=3.7e-20 Score=160.22 Aligned_cols=107 Identities=17% Similarity=0.306 Sum_probs=90.8
Q ss_pred cccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeeccC
Q 005471 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERN 103 (695)
Q Consensus 24 ~~l~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~~ 103 (695)
|+|.+||.|.+|++|.+ |.|.|+|..+|+ |.++. ..++||+||++.|.. ..+.|.|+.||+|+|+|++
T Consensus 2 ~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~-~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGK-KGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTC-CCCEEEECTTSCEEEECSS
T ss_pred CCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCc-eeEEEEEcCCceEEEEeCC
Confidence 68999999999999975 889999999887 44543 358899999999975 3578999999999999999
Q ss_pred CCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCC
Q 005471 104 QSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDH 149 (695)
Q Consensus 104 ~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~ 149 (695)
|. ++|+|+++ .+.+..+|+|+|+|||||++. .+|||+-|
T Consensus 70 g~--~vW~s~t~-~~~~~~~l~L~ddGNlvly~~----~~W~S~t~ 108 (109)
T d1kj1a_ 70 GR--SLWASHSV-RGNGNYVLVLQEDGNVVIYGS----DIWSTGTY 108 (109)
T ss_dssp SC--EEEECCCC-CCSSCCEEEECTTSCEEEECC----EEEECCCC
T ss_pred Cc--EEEEEeeE-CCCCCEEEEEeCCCcEEEECC----CEecCCCc
Confidence 98 99999876 334567899999999999953 59999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.66 E-value=5.2e-17 Score=142.49 Aligned_cols=103 Identities=21% Similarity=0.335 Sum_probs=84.8
Q ss_pred EEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCC
Q 005471 61 GIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTG 140 (695)
Q Consensus 61 giw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~ 140 (695)
-|||..++.++.+|++|++.|+.....+|.++.||+|+|++. +. ++|++++. ......+|+|+|+|||||++. .+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~--~vW~s~t~-~~~~~~~~~l~~~GnLvl~d~-~~ 85 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DD--RVWSTNTA-GKGTGCRAVLQPNGRMDVLTN-QN 85 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TB--CCSCCCCC-SSCSSCEEEEETTTEEEEEET-TT
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-Cc--EEEEEccc-cCCCcEEEEEeCCeeEEEEcC-CC
Confidence 699999999999999999999987777999999999999986 55 78999876 223457899999999999987 57
Q ss_pred ceEEeecCCCCCCcCCCceeccccCCCceeeEEEccCCCCCCCcceeeeecCCCCCceEEE
Q 005471 141 ETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLY 201 (695)
Q Consensus 141 ~~lWqSFd~PtDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~ 201 (695)
.++||||. +.++|.|.|.++++|.. ++|
T Consensus 86 ~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnl--vlY 113 (120)
T d1dlpa2 86 IAVWTSGN-------------------------------SRSAGRYVFVLQPDRNL--AIY 113 (120)
T ss_dssp EEEEECCC-------------------------------CCSSSCCEEEECSSSCE--EEE
T ss_pred CEEEEeCC-------------------------------CCCCCcEEEEECCCCcE--EEe
Confidence 89999972 34568899999999984 445
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.56 E-value=1.5e-14 Score=126.24 Aligned_cols=101 Identities=21% Similarity=0.370 Sum_probs=80.0
Q ss_pred CccCCCCE--EEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeeccCCCce
Q 005471 30 QPIKDGDV--IVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTV 107 (695)
Q Consensus 30 ~~l~~~~~--l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~ 107 (695)
|.|.++|. +.+..|.|.|.|..+|| |.+ |. ..++||.||+..|. ..+.|.|+.||+|+|.|.++.
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~~g~-- 81 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLG--NGCRAVLQPDGVLVVITNENV-- 81 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCC--
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCC--cceEEEEEeCCCEEEECCCCc--
Confidence 34444444 46789999999999998 444 54 35889999998874 347899999999999999998
Q ss_pred eEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecC
Q 005471 108 PVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFD 148 (695)
Q Consensus 108 ~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd 148 (695)
+||++++. ...+..+|+|+|+|||||++. .+|||-.
T Consensus 82 ~vWsS~t~-~~~~~~~l~Lq~DGNlvlYg~----~~W~S~T 117 (119)
T d1b2pa_ 82 TVWQSPVA-GKAGHYVLVLQPDRNVVIYGD----ALWATQT 117 (119)
T ss_dssp EEEECSCC-CCSSCEEEEECTTSCEEEEES----EEEECCC
T ss_pred EEEECCCc-CCCCceEEEEcCCCCEEEECC----CEeccCC
Confidence 99999875 233456799999999999963 6999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.55 E-value=7.4e-16 Score=133.65 Aligned_cols=110 Identities=22% Similarity=0.321 Sum_probs=90.6
Q ss_pred EEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCc
Q 005471 62 IWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGE 141 (695)
Q Consensus 62 iw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~ 141 (695)
|||.-.+..+..|+.+.+.++.+...+|.|+.||||||+++ +. ++|++++. +..+..|.|+|+|||||++. .+.
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~--~vW~s~t~--~~~~~~l~l~~dGNLvl~d~-~~~ 76 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DV--RVWASNTA--GATGCRAVLQSDGLLVILTA-QNT 76 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SS--EEECCCCC--SCSCCBCCBCSSSCBCCBCT-TTC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-Ce--eEEEcccC--CCCceEEEEeccCCEEEEcc-CCC
Confidence 67776667778899999999987778999999999999985 55 79999976 34578899999999999986 567
Q ss_pred eEEeecCCCCCCcCCCceeccccCCCceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCC
Q 005471 142 TLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (695)
Q Consensus 142 ~lWqSFd~PtDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~ 212 (695)
+||||+. +.++|.|.|.|+++|.. +++. .++|.+|.
T Consensus 77 ~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNl--vlY~--~~~Wssgt 112 (115)
T d1dlpa1 77 IRWSSGT-------------------------------KGSIGNYVLVLQPDRTV--TIYG--PGLWDSGT 112 (115)
T ss_dssp CSCCCCC-------------------------------CCCSSCCEEEECSSSCE--EEEC--SEEEECSC
T ss_pred EEEEcCC-------------------------------CCCCCCEEEEECCCCcE--EEeC--CCeecCCC
Confidence 8999752 34679999999999984 5563 47999876
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.41 E-value=7.7e-14 Score=120.73 Aligned_cols=98 Identities=18% Similarity=0.284 Sum_probs=77.1
Q ss_pred CCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeeccCCCcee
Q 005471 29 SQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVP 108 (695)
Q Consensus 29 ~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~~ 108 (695)
.|.|.+++.| .+|.|.|.|..+|+ |.++. ...+||.+|...+ ..+.+.|..+|+|||+|.++. +
T Consensus 14 ~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~--~ 77 (115)
T d1dlpa1 14 PQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNT--I 77 (115)
T ss_dssp CSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTC--C
T ss_pred cceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCC--E
Confidence 4556666666 46889999999988 66654 3478999997653 357899999999999999888 8
Q ss_pred EEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeec
Q 005471 109 VWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSF 147 (695)
Q Consensus 109 ~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSF 147 (695)
||++++. ...+..+++|+++|||||++. .+|+|-
T Consensus 78 vWsS~t~-~~~g~y~l~Lq~DGNlvlY~~----~~Wssg 111 (115)
T d1dlpa1 78 RWSSGTK-GSIGNYVLVLQPDRTVTIYGP----GLWDSG 111 (115)
T ss_dssp SCCCCCC-CCSSCCEEEECSSSCEEEECS----EEEECS
T ss_pred EEEcCCC-CCCCCEEEEECCCCcEEEeCC----CeecCC
Confidence 9999876 334556799999999999953 699984
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.06 E-value=1.4e-10 Score=100.94 Aligned_cols=97 Identities=21% Similarity=0.313 Sum_probs=70.6
Q ss_pred CccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEecCCCCeEEEEecCCCCCCCCCceEEEEecCCeeeeccCCCceeE
Q 005471 30 QPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPV 109 (695)
Q Consensus 30 ~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~tvVW~Anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~~~ 109 (695)
+.|..++.|. .|.|.|.|-..|+ |.++. ...+||.++.... .....+.|..+|+|+|+|.++. ++
T Consensus 24 ~~l~~~q~l~--~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~~~--~~~~~~~l~~~GnLvl~d~~~~--~l 88 (120)
T d1dlpa2 24 QTLHATQSLQ--LSPYRLSMETDCN-----LVLFD----RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNI--AV 88 (120)
T ss_dssp CEECSSCCCB--CSSCEEEEETTTE-----EEEEB----TTBCCSCCCCCSS--CSSCEEEEETTTEEEEEETTTE--EE
T ss_pred cEEcCCCeeE--cCCEEEEEcCCCc-----EEEec----CCcEEEEEccccC--CCcEEEEEeCCeeEEEEcCCCC--EE
Confidence 3344444442 3668888888876 55543 3467899885433 4457899999999999999888 89
Q ss_pred EeeccccCCCCccEEEEccCCCEEEEeCCCCceEEee
Q 005471 110 WQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (695)
Q Consensus 110 Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqS 146 (695)
|+|++. ...+..+++|+++|||||++. .+|.|
T Consensus 89 W~S~t~-~~~~~~~l~Lq~DGnlvlY~~----~~W~t 120 (120)
T d1dlpa2 89 WTSGNS-RSAGRYVFVLQPDRNLAIYGG----ALWTT 120 (120)
T ss_dssp EECCCC-CSSSCCEEEECSSSCEEEECC----CCCBC
T ss_pred EEeCCC-CCCCcEEEEECCCCcEEEeCC----CcccC
Confidence 999976 233456799999999999953 58875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.88 E-value=2.8e-09 Score=92.14 Aligned_cols=85 Identities=26% Similarity=0.444 Sum_probs=64.6
Q ss_pred eEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccCCC
Q 005471 88 VLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTG 167 (695)
Q Consensus 88 ~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~tg 167 (695)
.|.+..||||||+++ +. ++|++++.. ......+.|.++|||||++. .+.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~--~vWssnt~~-~~~~~~l~l~~dGnLvL~d~-~g~~vWsS~-------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NN--PIWATNTGG-LGNGCRAVLQPDGVLVVITN-ENVTVWQSP-------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEET-TE--EEEECCCTT-SCSSCEEEECTTSCEEEECT-TCCEEEECS--------------------
T ss_pred EEEECCCCcEEEEEC-Ce--EEEEecCCC-CCcceEEEEEeCCCEEEECC-CCcEEEECC--------------------
Confidence 688999999999975 44 799999762 23357899999999999986 567899751
Q ss_pred ceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCC
Q 005471 168 LNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (695)
Q Consensus 168 ~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~ 212 (695)
+.-+.|.|.+.|+++|.. +++. .+.|.+++
T Consensus 88 -----------t~~~~~~~~l~Lq~DGNl--vlYg--~~~W~S~T 117 (119)
T d1b2pa_ 88 -----------VAGKAGHYVLVLQPDRNV--VIYG--DALWATQT 117 (119)
T ss_dssp -----------CCCCSSCEEEEECTTSCE--EEEE--SEEEECCC
T ss_pred -----------CcCCCCceEEEEcCCCCE--EEEC--CCEeccCC
Confidence 122457789999999984 4453 36898875
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.84 E-value=7e-09 Score=88.31 Aligned_cols=88 Identities=27% Similarity=0.519 Sum_probs=66.4
Q ss_pred ceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccCC
Q 005471 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (695)
Q Consensus 87 ~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (695)
-.|.|..||+|+|++. +. +||++++.........+.|.++|||||++. .+.++|+|
T Consensus 21 ~~l~~q~dgnLvl~~~-~~--~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~s-------------------- 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYDH-ST--SVWASNTGILGKKGCKAVLQSDGNFVVYDA-EGRSLWAS-------------------- 76 (109)
T ss_dssp EEEEECTTSCEEEEET-TE--EEEECCCCCTTCCCCEEEECTTSCEEEECS-SSCEEEEC--------------------
T ss_pred EEEEecCCCeEEEEeC-CE--EEEEeCCCCCCceeEEEEEcCCceEEEEeC-CCcEEEEE--------------------
Confidence 5788899999999874 45 899999763344467899999999999986 56789986
Q ss_pred CceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCCC
Q 005471 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPW 213 (695)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~~ 213 (695)
.+....|.|.+.++++|.. ++++ .+.|.++++
T Consensus 77 -----------~t~~~~~~~~l~L~ddGNl--vly~--~~~W~S~t~ 108 (109)
T d1kj1a_ 77 -----------HSVRGNGNYVLVLQEDGNV--VIYG--SDIWSTGTY 108 (109)
T ss_dssp -----------CCCCCSSCCEEEECTTSCE--EEEC--CEEEECCCC
T ss_pred -----------eeECCCCCEEEEEeCCCcE--EEEC--CCEecCCCc
Confidence 1112356788999999984 4554 368887764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.80 E-value=8.8e-09 Score=87.63 Aligned_cols=85 Identities=24% Similarity=0.460 Sum_probs=63.0
Q ss_pred ceEEEEecCCeeeeccCCCceeEEeeccccCCCCccEEEEccCCCEEEEeCCCCceEEeecCCCCCCcCCCceeccccCC
Q 005471 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (695)
Q Consensus 87 ~~l~~~~~G~l~l~~~~~~~~~~Wss~~~~~~~~~~~a~L~d~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (695)
-+|.++.||||||++. +. +||++++... .....+.|+++|||||++. .+.++|+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~--~vW~s~~~~~-~~~~~l~l~~~Gnlvl~~~-~g~~vWsS-------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DK--PIWATNTGGL-SRSCFLSMQTDGNLVVYNP-SNKPIWAS-------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TE--EEEECCCTTS-CSSCEEEECTTSCEEEECT-TCCEEEEC--------------------
T ss_pred EEEEECCCCeEEEEeC-Cc--eeeEeCCCCC-CCccEEEEeccceEEEECC-CccceEEc--------------------
Confidence 5789999999999975 45 8999997622 2346899999999999986 57789986
Q ss_pred CceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeC
Q 005471 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAG 211 (695)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g 211 (695)
.+..+.+.|.+.++++|.. +++.. +.|.++
T Consensus 76 -----------~t~~~~~~~~l~L~ddGNl--Vly~~--~~W~S~ 105 (108)
T d1jpca_ 76 -----------NTGGQNGNYVCILQKDRNV--VIYGT--DRWATG 105 (108)
T ss_dssp -----------CCCCSCSCEEEEECTTSCE--EEEEC--CCCCCC
T ss_pred -----------cccCCCCcEEEEEcCCCCE--EEeCC--CcccCC
Confidence 1222456788999999984 44533 356554
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.56 E-value=2.3e-07 Score=79.26 Aligned_cols=111 Identities=13% Similarity=0.176 Sum_probs=70.5
Q ss_pred CCCcCCCceeccccCCCceeeEEEccCCCCCCCcceeeeecCCCCCceEEEcCCeeEEEeCCCCCceeecccccceeeee
Q 005471 151 TDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIF 230 (695)
Q Consensus 151 tDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~y~~~g~~~g~~~~~~~~~~~~~~~ 230 (695)
||||+|||.|..+ ..|++ |+|+|.|+.+|. ++++....++|.++......- ..-.++...
T Consensus 1 tDtL~~gq~L~~g------~~l~~---------g~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~~-~~l~l~~dG-- 60 (112)
T d1xd5a_ 1 SDRLNSGHQLDTG------GSLAE---------GGYLFIIQNDCN--LVLYDNNRAVWASGTNGKASG-CVLKMQNDG-- 60 (112)
T ss_dssp CCEEETTEEECTT------CEEEE---------TTEEEEECTTSC--EEEEETTEEEEECCCTTSCSS-EEEEECTTS--
T ss_pred CCEecCCCEecCC------CEEEE---------CCEEEEEcCCCC--EEEEcCCcEEEEccCccCCCC-cEEEEeccc--
Confidence 7999999999988 56753 999999999998 566788889998875432110 011122211
Q ss_pred eEEEeecCCeeEEEEeecCCCeEEEEEECccCceEEEEEeCCCCcEEEEEEccCCCC
Q 005471 231 NITYIDNQDEVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERC 287 (695)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~w~~p~~~C 287 (695)
.+...+. ................+++|+.||+|++|. . .....|+...+.|
T Consensus 61 nLvl~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~--~---~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 61 NLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYD--N---SNNAIWATHTNVG 111 (112)
T ss_dssp CEEEEET-TEEEEECCCCCSCCCCEEEECTTSCEEEEC--T---TSCEEEECCCCCC
T ss_pred cEEEEec-CCeEEEEeeccCCCceEEEEcCCCCEEEEC--C---CCcEEecCCCccC
Confidence 1112233 333333233333345689999999999983 2 2246788776665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=5.3e-07 Score=88.80 Aligned_cols=144 Identities=17% Similarity=0.094 Sum_probs=97.4
Q ss_pred CCCCccceeeeeCceeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC-CCceeeeEeEEEeCCeeEEEEEcC
Q 005471 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFM 606 (695)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 606 (695)
+.|...+..+.++...||+... +++.+.+|+...........+.+|...+..+. |--+.+++.+...++..++|||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred hceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 4555444444444578999875 45667888876544444556778888877663 444677888888888999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 005471 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS--------------------------------------- 647 (695)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 647 (695)
++..+........ . ...++.++++.|..||+..
T Consensus 93 ~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 93 DGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp SSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred ccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 9988855432111 1 1224455555555555421
Q ss_pred -----------------CCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 648 -----------------RLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 648 -----------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+..++|+|+.|.|||++++..+-|+||+.+..-
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 123799999999999998877789999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=3.4e-05 Score=74.91 Aligned_cols=143 Identities=17% Similarity=0.140 Sum_probs=86.9
Q ss_pred eeeeeCc-eeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCC--CCceeeeEeEEEeCCeeEEEEEcCCCCCH
Q 005471 535 KLGQGGF-GPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (695)
Q Consensus 535 ~LG~G~f-G~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 611 (695)
.+..|.. ..||+....++..+.+|.-.... ...+..|...+..+. .--+.+++.+..+.+..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4444543 67999998888888888765432 234667777776663 33467788888888889999999988665
Q ss_pred HHH--------------H---hccC-CCCC--CCHHHHHHHHH--------------------HHHHHHHHHHhC----C
Q 005471 612 DYF--------------I---FDES-RKQL--LDWKKRFDIIL--------------------GIARGVLYLHQD----S 647 (695)
Q Consensus 612 ~~~--------------l---~~~~-~~~~--l~~~~~~~i~~--------------------~ia~gL~yLH~~----~ 647 (695)
.+. + +... .... -.+.....-.. .....+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 321 0 1000 0000 01111100000 012223333332 1
Q ss_pred CCCeEecCCCCCCEEEcCCCceEEEeeccceee
Q 005471 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (695)
Q Consensus 648 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 680 (695)
+..++|+|+.|.|||++++..+-|+||+.+..-
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 223899999999999998877889999998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.23 E-value=0.00061 Score=70.63 Aligned_cols=75 Identities=11% Similarity=0.204 Sum_probs=48.6
Q ss_pred ceeeeeCceeEEEEEcCC-CcEEEEEEcccC----C---cccHHHHHHHHHHHHcC-CC--CceeeeEeEEEeCCeeEEE
Q 005471 534 NKLGQGGFGPVYKGKLSN-GQEIAVKRLSTT----S---GQGIEELKNEVLLIAKL-QH--RNLVKLLGCCLEEDENMLI 602 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-g~~vAvK~l~~~----~---~~~~~~~~~Ei~~l~~l-~H--~nIv~l~g~~~~~~~~~lV 602 (695)
+.||.|....||+....+ ++.+.||.-... . ....+....|.+.|..+ .+ ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998764 678899964321 1 12234455677777665 22 345566654 56677899
Q ss_pred EEcCCCCC
Q 005471 603 YEFMPNKS 610 (695)
Q Consensus 603 ~Ey~~~gs 610 (695)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.81 E-value=0.0024 Score=64.08 Aligned_cols=135 Identities=13% Similarity=0.193 Sum_probs=78.5
Q ss_pred eeEEEEEcCCCcEEEEEEcccCCcccHHHHHHHHHHHHcCCCCce-----eee--EeEEEeCCeeEEEEEcCCCCCHH--
Q 005471 542 GPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-----VKL--LGCCLEEDENMLIYEFMPNKSLD-- 612 (695)
Q Consensus 542 G~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-----v~l--~g~~~~~~~~~lV~Ey~~~gsL~-- 612 (695)
-.||+.+..+|+.+++|.-+.. ....+++..|+..+..|....| +.. -......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999987653 3456778888888877642222 111 11223456678999999864431
Q ss_pred ---HH---------Hhc----c--CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CCCCCe
Q 005471 613 ---YF---------IFD----E--SRKQLLDWKK-------------------RFDIILGIARGVLYLHQ----DSRLRI 651 (695)
Q Consensus 613 ---~~---------l~~----~--~~~~~l~~~~-------------------~~~i~~~ia~gL~yLH~----~~~~~i 651 (695)
.+ ++. . .....+++.. +-.+...+.+.+..+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 110 0 0011122211 11111222233333322 233468
Q ss_pred EecCCCCCCEEEcCCCceEEEeecccee
Q 005471 652 IHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 652 iHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.85 E-value=0.0058 Score=62.94 Aligned_cols=72 Identities=19% Similarity=0.305 Sum_probs=47.6
Q ss_pred ceeeeeCceeEEEEEcCCC--------cEEEEEEcccCCcccHHHHHHHHHHHHcCCCCce-eeeEeEEEeCCeeEEEEE
Q 005471 534 NKLGQGGFGPVYKGKLSNG--------QEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYE 604 (695)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~g--------~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E 604 (695)
+.|+.|-.=.+|+...+++ +.|.++.... ........+|..+++.+.-.++ .++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 5788888889999986542 4566655432 2233455678888887743344 47777763 268999
Q ss_pred cCCCCCH
Q 005471 605 FMPNKSL 611 (695)
Q Consensus 605 y~~~gsL 611 (695)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.28 E-value=0.17 Score=49.31 Aligned_cols=31 Identities=26% Similarity=0.233 Sum_probs=27.6
Q ss_pred CCeEecCCCCCCEEEcCCCceEEEeecccee
Q 005471 649 LRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (695)
Q Consensus 649 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 679 (695)
.++||+|+.+.||+++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4599999999999999988788999999863
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.83 E-value=0.026 Score=35.13 Aligned_cols=34 Identities=41% Similarity=0.927 Sum_probs=26.7
Q ss_pred CCCCccccCCCCCcccccCCCCCcccccCCCCCCCC
Q 005471 284 AERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKY 319 (695)
Q Consensus 284 ~~~C~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~~~ 319 (695)
.|+|.+-..||. |.|+.- .++-.|.|-.||+|..
T Consensus 1 tdECsignpCGn-GTCtNv-iGgFec~C~~GFepgp 34 (39)
T d1emoa2 1 TDECSVGNPCGN-GTCKNV-IGGFECTCEEGFEPGP 34 (39)
T ss_dssp CCGGGTTCSSSS-SCEEEC-SSSEEECCSSSSCCCS
T ss_pred CCccccCCccCC-ceeeec-ccceEEeecCCcCCCc
Confidence 378999999996 889743 3347799999999854
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.81 E-value=0.069 Score=35.45 Aligned_cols=32 Identities=31% Similarity=0.841 Sum_probs=25.0
Q ss_pred CCCcc-ccCCCCCcccccCCCCCcccccCCCCCC
Q 005471 285 ERCDY-YGHCGPNSNCNLNLTDGFECTCLPGFEP 317 (695)
Q Consensus 285 ~~C~~-~~~CG~~g~C~~~~~~~~~C~C~~GF~~ 317 (695)
|+|.. ...|..+|.|.... ++.+|.|++||+-
T Consensus 4 deC~~~~~pC~n~g~C~n~~-g~y~C~C~~G~~G 36 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTL-GSFECQCLQGYTG 36 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECS-SSEEEECCTTEES
T ss_pred ccccCCCCCCCCCcEeECCC-CCEEeECCCCCcC
Confidence 67875 57899999997543 3488999999963
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.72 E-value=0.13 Score=33.35 Aligned_cols=31 Identities=35% Similarity=0.955 Sum_probs=23.6
Q ss_pred CCCccccCCCCCcccccCCCCCcccccCCCCCC
Q 005471 285 ERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEP 317 (695)
Q Consensus 285 ~~C~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~ 317 (695)
|+|. ...|...|.|.... ++..|.|++||+-
T Consensus 1 D~C~-~~PC~ngg~C~~~~-~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGL-GEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCS-SSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCC-CCEEEECCCCCCc
Confidence 4576 47899999997543 3488999999964
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.76 E-value=0.18 Score=32.72 Aligned_cols=32 Identities=28% Similarity=0.793 Sum_probs=24.8
Q ss_pred CCCCccccCCCCCcccccCCCCCcccccCCCCCC
Q 005471 284 AERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEP 317 (695)
Q Consensus 284 ~~~C~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~ 317 (695)
.|+|. ...|-..|.|..... +.+|.|++||+-
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~-~y~C~C~~g~~G 34 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDIN-SYECWCPFGFEG 34 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETT-EEEEECCTTCCS
T ss_pred cccCC-CCCCCCCcEEEcCCC-CEEEECCCCCCC
Confidence 46787 578999999975432 388999999974
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.42 E-value=0.19 Score=32.66 Aligned_cols=31 Identities=29% Similarity=0.894 Sum_probs=23.3
Q ss_pred CCCccccCCCCCcccccCCCCCcccccCCCCCC
Q 005471 285 ERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEP 317 (695)
Q Consensus 285 ~~C~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~ 317 (695)
|+|. ...|...|.|.... ++..|.|++||+-
T Consensus 2 d~C~-~~PC~n~g~C~~~~-~~y~C~C~~G~~G 32 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQI-GEFQCICMPGYEG 32 (39)
T ss_dssp CTTT-TCCCCSSCEEEECS-SCEEEECCTTEES
T ss_pred cCCc-CCCCCCCCEEECCC-CCEEEeCCCCCcc
Confidence 5564 46799999997543 2488999999964
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.04 E-value=0.18 Score=33.49 Aligned_cols=33 Identities=27% Similarity=0.611 Sum_probs=24.8
Q ss_pred CCCCccccCCCCCcccccCCCCCcccccCCCCCCC
Q 005471 284 AERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPK 318 (695)
Q Consensus 284 ~~~C~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~~ 318 (695)
-|+|.....| -.+.|.... ++..|.|++||+..
T Consensus 3 idEC~~~~~~-c~~~C~Nt~-G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 3 VNECLDPTTC-ISGNCVNTP-GSYICDCPPDFELN 35 (43)
T ss_dssp CCGGGSTTSS-BTSEEEEET-TEEEEECCTTCEEC
T ss_pred ccccCCCCcC-cCCEeECCC-CCEEEecCCCCEEC
Confidence 3789887666 468997543 34889999999875
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.20 E-value=0.35 Score=31.65 Aligned_cols=32 Identities=25% Similarity=0.647 Sum_probs=23.7
Q ss_pred CCCccccCCCCCcccccCCCCCcccccCCCCCCCC
Q 005471 285 ERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKY 319 (695)
Q Consensus 285 ~~C~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~~~ 319 (695)
|+|...+.|. .+|.... ++..|.|++||+...
T Consensus 2 dEC~~~~~C~--~~C~n~~-Gsy~C~C~~Gy~L~~ 33 (41)
T d1i0ua2 2 DECQDPDTCS--QLCVNLE-GGYKCQCEEGFQLDP 33 (41)
T ss_dssp CTTTTTTSCS--SCEECSS-SCCEECCCTTEEECT
T ss_pred ccCCCCCCCC--CEeECCC-CCEEeECCCCCeECC
Confidence 6788777774 5887543 348899999998753
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.34 E-value=0.28 Score=32.69 Aligned_cols=33 Identities=27% Similarity=0.780 Sum_probs=23.6
Q ss_pred CCCccc-cCCCCCcccccCCCCCcccccCCCCCCCC
Q 005471 285 ERCDYY-GHCGPNSNCNLNLTDGFECTCLPGFEPKY 319 (695)
Q Consensus 285 ~~C~~~-~~CG~~g~C~~~~~~~~~C~C~~GF~~~~ 319 (695)
|+|... ..| .++.|... .++..|.|++||+...
T Consensus 4 dEC~~~~~~C-~~~~C~Nt-~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNT-PGDFECKCDEGYESGF 37 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEE-TTEEEECCCSSEEECT
T ss_pred cccCCCCCCC-CCCEeEcC-CCCeEEeCCCCCccCC
Confidence 678764 456 47899754 3348899999998653
|